data_1y00_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1y00 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.753 0.311 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 mp -119.98 113.2 20.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 tt -105.04 107.86 23.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 110.737 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.428 ' HG ' ' CG ' ' B' ' 48' ' ' TYR . 1.4 mm? -124.09 126.03 45.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.095 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.76 145.2 46.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.409 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -155.89 146.28 21.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.164 0.507 . . . . 0.0 111.304 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.443 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 2.3 ttt180 175.92 74.31 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER 176.97 -60.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.663 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.74 82.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.73 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.17 -161.9 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.556 0.217 . . . . 0.0 110.569 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 172.35 89.43 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.633 0.254 . . . . 0.0 111.056 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.418 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -110.53 152.33 26.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.126 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.426 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -132.98 100.27 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.901 0.381 . . . . 0.0 111.546 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -111.35 127.07 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.258 179.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.52 -102.69 0.64 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.877 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.461 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.4 m-20 -165.77 17.39 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.4 OUTLIER 158.92 59.42 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.734 0.302 . . . . 0.0 110.884 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.426 ' CG2' ' HA ' ' A' ' 13' ' ' MET . 11.1 m -120.5 -157.37 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 120.638 0.256 . . . . 0.0 111.632 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.429 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 167.58 105.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.418 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 28.6 t -122.91 114.3 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.827 0.346 . . . . 0.0 111.737 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -104.4 118.4 36.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.513 ' O ' ' C ' ' A' ' 23' ' ' LEU . 17.1 m -91.85 63.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.427 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.513 ' C ' ' O ' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -13.16 -70.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.586 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . 90.74 -45.4 2.9 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.26 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -85.25 137.35 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 3.9 tptt 174.7 165.49 0.25 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.645 0.259 . . . . 0.0 110.383 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.37 -105.94 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.465 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.33 -41.5 11.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.069 0.461 . . . . 0.0 110.271 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -105.56 136.52 44.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.926 179.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.403 ' HA ' ' CB ' ' A' ' 26' ' ' LYS . 21.3 t -93.18 114.15 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 0.0 111.417 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.87 100.64 4.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.657 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.11 131.76 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.44 120.76 6.23 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.048 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -118.19 103.69 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.883 0.373 . . . . 0.0 111.199 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 19' ' ' THR . 3.0 t-20 -99.48 107.47 19.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.12 0.486 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.67 144.17 28.99 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.675 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.29 156.36 22.47 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.747 2.298 . . . . 0.0 112.129 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -93.25 34.6 1.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.103 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.42 -44.08 6.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.3 t -89.33 158.07 2.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.781 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.64 97.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.817 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.45 120.95 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.178 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -120.73 136.29 54.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -146.61 -176.32 5.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.69 0.281 . . . . 0.0 110.569 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.75 133.75 56.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 0.0 110.698 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -51.78 -60.27 3.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.31 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.419 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 1.3 tp -55.08 -42.86 67.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.482 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.435 ' CG ' ' HG ' ' B' ' 4' ' ' LEU . 2.7 m-85 -46.53 -68.08 0.22 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.443 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -70.52 -21.04 62.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.469 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 12.9 mtp85 -65.97 -23.02 66.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.677 0.275 . . . . 0.0 111.358 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.6 pt -109.91 -21.62 5.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -107.09 -58.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 111.441 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.44 -73.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.451 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.8 127.21 54.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.389 . . . . 0.0 111.12 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.529 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.027 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.787 0.327 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 mp -119.98 113.27 20.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 tt -105.05 107.84 23.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.09 0.472 . . . . 0.0 110.743 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.435 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 1.4 mm? -124.17 126.11 45.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.78 145.3 45.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.376 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -155.96 146.26 21.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.141 0.496 . . . . 0.0 111.27 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.439 ' HA ' ' HA3' ' B' ' 24' ' ' GLY . 2.3 ttt180 175.93 74.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.089 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER 176.87 -60.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.685 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.71 82.45 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.668 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.17 -161.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.547 0.213 . . . . 0.0 110.549 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 172.3 89.42 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.695 0.283 . . . . 0.0 111.095 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.417 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.2 OUTLIER -110.46 152.25 26.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.243 179.27 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.418 ' HA ' ' CG2' ' B' ' 18' ' ' VAL . 0.3 OUTLIER -132.96 100.36 4.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.4 . . . . 0.0 111.542 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.31 127.0 68.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.239 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.51 -102.64 0.64 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.888 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.4 m-20 -165.75 17.35 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.468 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.4 OUTLIER 158.9 59.55 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.747 0.308 . . . . 0.0 110.846 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.418 ' CG2' ' HA ' ' B' ' 13' ' ' MET . 11.2 m -120.6 -157.34 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.721 0.296 . . . . 0.0 111.55 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.424 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 167.61 105.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.417 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 28.9 t -122.94 114.34 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.32 . . . . 0.0 111.701 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 9.7 t -104.42 118.42 36.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.782 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.503 ' O ' ' C ' ' B' ' 23' ' ' LEU . 17.1 m -91.89 63.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.445 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.503 ' C ' ' O ' ' B' ' 22' ' ' VAL . 0.4 OUTLIER -13.19 -70.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.519 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . 90.75 -45.44 2.9 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.222 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -85.28 137.36 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.652 0.263 . . . . 0.0 110.831 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 3.9 tptt 174.69 165.52 0.25 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.64 0.257 . . . . 0.0 110.454 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.42 -105.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.445 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.32 -41.54 11.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.065 0.46 . . . . 0.0 110.265 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 0.2 OUTLIER -105.46 136.49 44.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.956 179.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.2 114.22 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 111.398 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.85 100.58 4.82 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.634 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 10.6 mm -87.11 131.76 34.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.42 120.72 6.22 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.091 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 16.2 t -118.17 103.72 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.899 0.38 . . . . 0.0 111.201 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' B' ' 19' ' ' THR . 3.0 t-20 -99.49 107.51 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.371 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.72 144.15 28.76 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.65 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.17 156.34 22.84 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.784 2.323 . . . . 0.0 112.152 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -93.29 34.67 1.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.44 -44.19 5.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 24.2 t -89.22 158.09 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.815 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.64 97.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.786 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.55 120.91 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.179 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -120.75 136.31 54.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.267 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -146.61 -176.3 5.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.522 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.73 133.75 56.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -51.8 -60.29 3.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.249 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.421 ' HA ' ' HB2' ' B' ' 50' ' ' ARG . 1.3 tp -55.05 -42.84 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.489 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.428 ' CG ' ' HG ' ' A' ' 4' ' ' LEU . 2.7 m-85 -46.57 -68.03 0.23 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.476 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -70.59 -21.03 62.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.498 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . 0.421 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 13.0 mtp85 -65.96 -22.91 66.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.662 0.268 . . . . 0.0 111.35 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 18.6 pt -109.99 -21.76 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -107.04 -58.05 1.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.736 0.303 . . . . 0.0 111.468 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.47 -73.48 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.478 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.28 128.92 55.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.925 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.787 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.835 0.35 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 4.8 mp -119.87 116.07 25.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.707 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 mm -93.0 105.66 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.984 0.421 . . . . 0.0 110.58 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.41 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 2.5 mm? -116.77 156.79 26.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.666 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.01 133.63 41.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.951 0.405 . . . . 0.0 110.649 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -151.42 148.1 27.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.84 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 2.8 ttt180 177.39 -6.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.176 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.7 -57.29 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.768 0.318 . . . . 0.0 111.044 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.48 88.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.645 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.84 -70.55 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.732 0.301 . . . . 0.0 110.787 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m 75.87 103.45 0.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.529 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -108.94 154.46 22.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.967 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' B' ' 42' ' ' VAL . 24.5 ttp -128.12 100.54 5.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.097 0.475 . . . . 0.0 111.24 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.408 ' CD1' ' HB ' ' B' ' 42' ' ' VAL . 2.1 tp -112.78 122.97 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.423 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.8 -104.87 0.54 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.996 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.5 t70 -159.41 11.65 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 157.4 61.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.964 0.412 . . . . 0.0 109.954 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.7 m -118.48 -155.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.723 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.428 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 168.59 103.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.72 111.22 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 111.769 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.29 113.07 25.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.48 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.6 m -84.76 62.94 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.779 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.32 121.83 3.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . -99.52 -15.71 31.36 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.001 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.2 t -85.48 125.8 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.743 0.271 . . . . 0.0 110.473 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 1.3 tpmp? 176.9 165.29 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.814 0.34 . . . . 0.0 110.66 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 29' ' ' GLN . . . -90.96 108.42 3.58 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.539 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 65.68 -69.52 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.876 0.37 . . . . 0.0 110.796 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 1.8 mt-30 -84.82 136.57 33.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.62 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 t -93.0 119.69 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.044 0.45 . . . . 0.0 111.493 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -82.88 98.21 9.07 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.3 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' B' ' 6' ' ' ARG . 4.7 mm -93.05 127.66 45.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.61 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.08 112.38 4.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.328 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.0 t -106.35 103.68 15.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.871 0.367 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -98.37 107.33 19.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.368 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.16 146.08 52.85 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.677 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -83.44 156.22 14.33 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.005 2.47 . . . . 0.0 112.358 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -3.25 41.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.332 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -42.63 70.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.643 0.259 . . . . 0.0 111.171 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 t -91.0 152.53 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.803 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.3 t -76.09 106.08 7.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.966 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' B' ' 13' ' ' MET . 14.6 p -121.07 120.23 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.46 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -128.68 134.32 48.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.666 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.65 -49.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.706 0.288 . . . . 0.0 111.257 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.442 ' CB ' ' CG ' ' A' ' 48' ' ' TYR . 3.4 mm-40 -161.27 124.49 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.929 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.45 -59.07 5.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.101 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.1 -42.49 83.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.176 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.442 ' CG ' ' CB ' ' A' ' 45' ' ' GLU . 3.1 m-85 -44.25 -58.06 3.11 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.401 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . 11.6 pt20 -76.65 -21.62 55.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.793 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -67.38 -15.01 63.44 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.261 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.44 HG22 HD12 ' A' ' 51' ' ' ILE . 23.7 mm -116.05 -26.43 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.337 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.57 -58.66 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.909 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.401 ' CB ' ' HB2' ' A' ' 49' ' ' GLN . . . -60.78 -64.09 1.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.588 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -109.58 116.28 31.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.387 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.465 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.792 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.82 0.343 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' B' ' 2' ' ' LEU . 4.8 mp -119.88 116.09 25.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 mm -93.05 105.73 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.994 0.426 . . . . 0.0 110.579 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' B' ' 4' ' ' LEU . 2.5 mm? -116.77 156.78 26.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.679 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.01 133.63 41.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.949 0.404 . . . . 0.0 110.653 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -151.44 148.11 27.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.796 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 2.8 ttt180 177.37 -6.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.13 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.67 -57.3 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.805 0.336 . . . . 0.0 111.044 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.47 88.34 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.601 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.88 -70.59 0.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.759 0.314 . . . . 0.0 110.735 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m 75.83 103.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.604 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -108.87 154.44 22.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.951 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 42' ' ' VAL . 24.4 ttp -128.09 100.47 5.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 111.227 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . 0.404 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 2.1 tp -112.74 122.93 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.87 -104.81 0.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.993 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.47 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.5 t70 -159.49 11.71 0.13 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.3 OUTLIER 157.35 61.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.699 0.399 . . . . 0.0 109.943 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.48 -155.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.705 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.429 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 168.66 103.13 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 25.3 t -119.71 111.21 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.866 0.365 . . . . 0.0 111.785 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.29 113.04 25.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.486 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.68 62.91 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.841 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.33 121.84 3.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . -99.57 -15.61 31.5 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.053 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' B' ' 26' ' ' LYS . 2.2 t -85.51 125.78 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.69 0.245 . . . . 0.0 110.465 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 1.3 tpmp? 176.91 165.3 0.5 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.626 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' B' ' 29' ' ' GLN . . . -91.0 108.34 3.57 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.55 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 65.77 -69.5 0.11 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.879 0.371 . . . . 0.0 110.739 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 1.8 mt-30 -84.8 136.57 33.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 5.3 t -92.99 119.78 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 0.0 111.497 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -82.95 98.26 9.13 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.281 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 6' ' ' ARG . 4.7 mm -93.08 127.7 45.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.636 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.08 112.33 4.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.384 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 27.0 t -106.3 103.67 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.846 0.355 . . . . 0.0 111.242 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' B' ' 19' ' ' THR . 0.1 OUTLIER -98.36 107.35 19.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.369 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.19 146.1 52.86 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.633 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -83.46 156.26 14.28 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.966 2.444 . . . . 0.0 112.356 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -3.36 41.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.35 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.49 -42.71 71.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.689 0.28 . . . . 0.0 111.184 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 t -90.98 152.58 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.802 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 39.4 t -76.08 105.98 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.982 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 13' ' ' MET . 14.6 p -121.0 120.17 61.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.494 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -128.63 134.3 48.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.665 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.66 -49.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 111.309 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.442 ' CB ' ' CG ' ' B' ' 48' ' ' TYR . 3.4 mm-40 -161.23 124.53 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.5 -59.04 5.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.1 -42.52 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.198 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.442 ' CG ' ' CB ' ' B' ' 45' ' ' GLU . 3.1 m-85 -44.22 -58.05 3.1 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.755 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.77 -21.52 55.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.782 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . 0.411 ' HA ' ' HG2' ' B' ' 54' ' ' GLU . 0.8 OUTLIER -67.47 -14.75 63.21 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.34 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.402 HG22 HD12 ' B' ' 51' ' ' ILE . 23.6 mm -116.23 -26.76 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.311 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.24 -58.7 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.95 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.8 -63.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.629 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.411 ' HG2' ' HA ' ' B' ' 50' ' ' ARG . 0.0 OUTLIER -111.21 120.06 41.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.649 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.447 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.823 0.344 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.0 mp -122.03 107.39 12.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.1 tt -115.06 114.73 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.181 0.515 . . . . 0.0 110.967 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.45 ' HB3' ' CZ ' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -125.44 135.67 52.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.824 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -62.37 150.86 38.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -170.67 148.03 2.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.25 0.548 . . . . 0.0 111.474 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.402 ' CG ' ' HA3' ' A' ' 24' ' ' GLY . 2.2 ttp180 -176.69 7.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.782 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.62 -61.59 2.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.331 . . . . 0.0 111.011 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.6 86.05 0.16 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.494 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -82.02 171.68 14.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t 178.8 122.71 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.402 ' CD2' ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -144.39 141.36 29.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.402 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.0 ttt -133.0 99.73 4.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.419 . . . . 0.0 111.09 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.4 ' CG2' ' CG2' ' B' ' 14' ' ' ILE . 0.0 OUTLIER -116.3 129.27 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.484 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.8 -105.09 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.907 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.3 p30 -162.76 16.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 6.9 mt-10 158.2 60.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.849 0.357 . . . . 0.0 110.501 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.36 -159.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 120.766 0.317 . . . . 0.0 111.646 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 168.57 103.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.402 ' CG2' ' CD2' ' A' ' 12' ' ' LEU . 35.1 m -122.57 114.37 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.9 p -108.2 117.03 33.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.299 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.4 m -108.88 54.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.349 . . . . 0.0 111.693 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pp -47.94 151.17 0.97 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.863 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' HA3' ' CG ' ' A' ' 7' ' ' ARG . . . -107.7 2.56 34.11 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.601 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -85.21 120.66 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.928 0.364 . . . . 0.0 110.618 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER 174.73 165.34 0.25 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.76 0.315 . . . . 0.0 110.675 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.81 108.28 3.14 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.852 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.02 -74.41 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.859 0.362 . . . . 0.0 111.043 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 16.8 mt-30 -84.72 136.26 33.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.013 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.33 117.2 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 111.535 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.64 99.85 4.45 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.515 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.1 mm -87.08 124.5 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.165 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 118.43 6.09 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.569 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.7 t -117.79 103.53 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 0.0 111.396 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.4 OUTLIER -99.38 107.53 19.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.501 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.97 143.36 24.8 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.654 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.12 156.49 33.77 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.759 2.306 . . . . 0.0 112.078 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -89.17 30.08 1.0 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.278 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.58 -38.64 7.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 t -93.25 159.35 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.848 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.8 t -65.28 97.94 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.009 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.31 120.76 62.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.857 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.12 136.39 51.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.722 0.296 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -133.38 -176.12 4.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -64.17 147.79 51.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -50.96 -60.68 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.199 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 tp -55.07 -35.6 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.203 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' B' ' 4' ' ' LEU . 0.4 OUTLIER -53.04 -73.14 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.033 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . 5.3 pt20 -64.2 -17.28 63.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.542 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.48 -31.26 69.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.728 0.299 . . . . 0.0 111.328 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.0 mm -104.53 -12.84 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.917 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -114.88 -57.74 2.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.666 0.269 . . . . 0.0 111.716 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 49' ' ' GLN . . . -67.53 -71.69 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.383 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -118.18 117.82 30.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.003 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.407 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.993 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptt? . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.781 0.324 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 5.0 mp -122.06 107.39 12.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.971 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 3.0 tt -115.09 114.81 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.216 0.531 . . . . 0.0 110.942 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -125.49 135.73 52.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.763 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.39 150.9 38.44 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -170.69 148.04 2.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.268 0.556 . . . . 0.0 111.464 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -176.74 7.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.789 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.67 -61.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.848 0.356 . . . . 0.0 111.032 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.54 86.1 0.16 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -82.11 171.72 14.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.739 0.304 . . . . 0.0 110.944 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t 178.77 122.71 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.125 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.37 141.35 29.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.41 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 4.0 ttt -133.03 99.7 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . 0.4 ' CG2' ' CG2' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -116.29 129.33 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.478 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.76 -105.09 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.936 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.3 p30 -162.82 16.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 7.0 mt-10 158.19 60.84 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.857 0.361 . . . . 0.0 110.552 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 17.6 m -120.33 -159.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 120.807 0.337 . . . . 0.0 111.651 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 168.59 103.6 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.53 114.42 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.9 p -108.26 117.03 33.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.221 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 30.4 m -108.84 54.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.724 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pp -47.91 151.1 0.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.69 2.63 34.14 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.568 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -85.24 120.65 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.973 0.387 . . . . 0.0 110.588 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER 174.74 165.34 0.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.807 0.336 . . . . 0.0 110.634 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.8 108.22 3.13 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.813 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.03 -74.49 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 111.003 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 16.8 mt-30 -84.7 136.2 33.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.994 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.25 117.21 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.976 0.417 . . . . 0.0 111.532 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.61 99.8 4.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.543 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.05 124.51 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.114 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 118.39 6.08 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.558 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -117.75 103.57 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.41 . . . . 0.0 111.383 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' B' ' 19' ' ' THR . 0.4 OUTLIER -99.49 107.54 19.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.48 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.96 143.37 24.88 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.585 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.12 156.49 33.77 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.752 2.301 . . . . 0.0 112.066 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -89.14 29.95 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.281 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.47 -38.73 7.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.791 0.329 . . . . 0.0 110.816 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.19 159.31 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 5.8 t -65.21 97.89 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.029 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.29 120.79 62.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.866 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 136.38 51.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.752 0.311 . . . . 0.0 110.767 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -133.34 -176.07 4.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.693 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -64.27 147.81 51.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.03 -60.62 2.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 tp -55.0 -35.6 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.285 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -53.1 -73.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.039 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.404 ' HB2' ' CB ' ' B' ' 53' ' ' ALA . 5.3 pt20 -64.26 -17.32 63.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.531 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -31.17 69.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.734 0.302 . . . . 0.0 111.367 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 29.2 mm -104.64 -12.58 9.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.854 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -115.12 -57.85 2.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.709 0.29 . . . . 0.0 111.746 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.404 ' CB ' ' HB2' ' B' ' 49' ' ' GLN . . . -67.48 -71.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.33 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -117.81 116.94 27.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.706 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.896 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.32 117.02 25.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.413 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 4.1 tt -97.97 104.76 16.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.221 0.534 . . . . 0.0 110.5 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.44 121.52 34.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.223 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -54.35 138.59 39.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.104 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 72.1 mtt180 -148.66 144.77 27.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.296 0.57 . . . . 0.0 111.787 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 174.98 -77.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.551 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.73 3.75 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.139 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.52 -139.49 4.4 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.907 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -108.61 -175.49 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.869 0.366 . . . . 0.0 111.218 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.5 p -102.17 165.53 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.028 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.447 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -110.53 154.63 23.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.525 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttt -130.67 100.06 5.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.072 0.463 . . . . 0.0 111.389 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.8 tp -115.9 125.52 73.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.505 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.49 -106.32 0.62 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.078 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.412 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.6 t0 -155.57 4.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 3.1 mt-10 163.37 61.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.017 0.436 . . . . 0.0 109.993 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.51 -159.91 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.824 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 171.49 99.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.447 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 42.9 t -106.42 107.52 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.827 0.346 . . . . 0.0 111.669 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 m -91.2 112.77 24.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.021 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.76 70.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.497 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.03 -152.76 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 31' ' ' ARG . . . 60.36 66.44 2.71 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.996 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -85.88 107.77 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 120.979 0.419 . . . . 0.0 111.049 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.1 165.41 36.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.136 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.98 156.45 47.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.512 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 70.03 -89.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.404 0.145 . . . . 0.0 110.985 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -110.48 124.56 52.02 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.906 0.384 . . . . 0.0 111.082 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.0 m -93.32 137.37 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.318 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 4.7 mtp180 -78.09 102.91 7.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.418 HG13 ' HB2' ' B' ' 6' ' ' ARG . 14.7 mm -87.32 134.52 27.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.137 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.53 115.79 4.99 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.512 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.12 103.34 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.944 0.402 . . . . 0.0 111.336 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -96.43 107.23 19.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.075 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.06 147.96 33.68 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.9 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.37 156.29 25.39 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.919 2.413 . . . . 0.0 111.984 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -91.38 41.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.114 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.15 -41.92 3.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.994 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 t -81.48 158.9 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.35 99.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.784 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 p -122.18 124.23 70.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.986 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -128.53 136.18 50.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.311 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -166.98 -170.67 1.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.719 0.295 . . . . 0.0 110.709 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 30.7 mm-40 -54.04 123.97 14.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.008 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.48 -54.91 41.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.115 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.0 tp -60.21 -41.18 85.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.026 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.418 ' CG ' ' HB2' ' A' ' 45' ' ' GLU . 4.4 m-85 -47.42 -55.51 8.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.237 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -80.0 -21.9 43.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.139 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -71.23 -13.33 61.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.285 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.4 tt -115.7 -36.39 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.877 0.37 . . . . 0.0 110.65 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -87.45 -58.3 2.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.098 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.51 -51.65 67.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.258 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -112.57 116.73 30.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.596 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.644 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttp . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.789 0.328 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 5.0 mp -122.35 117.02 25.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -98.03 104.81 16.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.219 0.533 . . . . 0.0 110.494 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.47 121.52 34.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.253 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -54.39 138.6 39.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.082 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 72.0 mtt180 -148.66 144.72 27.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.258 0.551 . . . . 0.0 111.802 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER 175.01 -77.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.491 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.72 3.73 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.211 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.5 -139.5 4.39 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.922 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -108.59 -175.52 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.923 0.392 . . . . 0.0 111.174 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 22.5 p -102.18 165.54 11.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.084 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.447 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -110.51 154.62 23.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.526 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttt -130.64 100.03 5.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.009 0.433 . . . . 0.0 111.395 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 5.8 tp -115.89 125.5 73.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.505 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.53 -106.32 0.62 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.065 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 2.6 t0 -155.61 4.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 3.1 mt-10 163.34 61.12 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.996 0.427 . . . . 0.0 110.0 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.48 -159.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.831 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 171.51 99.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.342 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.447 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 43.0 t -106.49 107.58 23.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.822 0.344 . . . . 0.0 111.602 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.2 m -91.22 112.89 24.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.979 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 26.3 m -76.9 70.55 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.457 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.07 -152.79 0.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.681 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' B' ' 31' ' ' ARG . . . 60.42 66.38 2.75 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.992 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 t -85.79 107.74 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.05 165.47 36.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.192 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.04 156.43 47.33 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.481 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 70.08 -89.51 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.041 0.136 . . . . 0.0 110.97 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -110.45 124.53 51.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.895 0.379 . . . . 0.0 111.158 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 m -93.26 137.41 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.381 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.8 mtp180 -78.19 102.94 7.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.424 HG13 ' HB2' ' A' ' 6' ' ' ARG . 14.9 mm -87.34 134.58 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.57 115.76 4.97 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.503 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.17 103.3 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 111.264 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -96.41 107.22 19.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.085 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.08 147.92 33.51 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.922 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.29 156.28 25.63 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.951 2.434 . . . . 0.0 112.007 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -91.34 41.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.166 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.14 -41.93 3.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 t -81.48 158.89 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.809 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.31 99.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.829 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 p -122.2 124.18 70.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.959 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -128.51 136.25 50.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.311 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -167.03 -170.71 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.722 0.296 . . . . 0.0 110.711 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.431 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 30.5 mm-40 -54.03 123.98 14.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 111.049 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.48 -54.93 41.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 8.0 tp -60.2 -41.17 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.059 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.431 ' CG ' ' HB2' ' B' ' 45' ' ' GLU . 4.4 m-85 -47.41 -55.49 8.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.256 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -79.91 -21.98 43.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.173 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -71.25 -13.3 61.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.252 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 1.4 tt -115.71 -36.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.657 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -87.45 -58.3 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.085 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.47 -51.67 67.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.309 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -112.61 116.75 30.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.522 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.951 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.871 0.367 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -119.73 112.84 19.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.403 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 4.1 tt -99.97 105.03 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.179 0.514 . . . . 0.0 110.827 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.421 ' HG ' ' CD2' ' B' ' 48' ' ' TYR . 0.2 OUTLIER -124.76 121.49 34.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.036 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -56.16 140.59 43.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 0.0 110.618 179.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 66.8 mtt85 -155.84 145.33 20.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.422 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 0.0 OUTLIER 179.11 1.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.975 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 177.2 30.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 120.532 0.206 . . . . 0.0 111.356 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.93 -118.13 3.51 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.762 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -110.13 -178.31 3.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.912 0.387 . . . . 0.0 111.203 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.6 168.04 10.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.737 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.431 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -111.52 154.51 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -127.39 100.56 6.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.43 . . . . 0.0 110.873 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.1 tp -112.7 125.48 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.606 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.43 -105.44 0.65 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.195 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 12.0 m-20 -156.8 6.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 0.8 OUTLIER 161.15 61.89 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.23 -157.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.526 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 172.53 101.61 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.431 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 59.0 t -111.04 108.19 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.88 0.372 . . . . 0.0 111.697 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.1 p -105.08 110.43 22.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.011 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.2 m -77.4 72.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.61 -143.56 0.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.628 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.5 74.31 0.27 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.819 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.6 t -93.03 108.3 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.92 157.57 45.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.018 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.8 148.02 50.71 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.72 -79.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.634 0.254 . . . . 0.0 110.767 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -116.78 126.28 52.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.986 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.5 m -93.39 136.93 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.269 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 3.9 mtt85 -77.93 104.91 8.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.257 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.46 HG22 HD12 ' A' ' 32' ' ' ILE . 12.0 mm -87.37 137.75 20.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.848 0.356 . . . . 0.0 111.328 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.86 117.41 5.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.472 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 t -118.08 103.18 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.411 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.6 OUTLIER -95.74 107.17 19.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.378 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.11 145.49 55.85 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.588 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.28 156.32 29.33 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.834 2.356 . . . . 0.0 112.121 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.26 26.75 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.185 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -40.23 5.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.849 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -82.45 152.85 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.5 98.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.077 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.17 120.59 61.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.1 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -128.55 136.17 50.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.405 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -165.53 -40.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.685 0.279 . . . . 0.0 111.135 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' N ' ' HG3' ' A' ' 44' ' ' ARG . 1.2 mm-40 177.86 114.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.962 0.41 . . . . 0.0 110.882 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -58.48 -38.78 78.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.684 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.1 mm -69.33 -43.23 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.837 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.424 ' CD2' ' HG ' ' B' ' 4' ' ' LEU . 2.8 m-85 -51.36 -42.68 61.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.416 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -87.72 -58.9 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 111.534 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -52.2 -21.38 3.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.3 mm -106.07 -50.58 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.79 -58.79 3.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.668 0.271 . . . . 0.0 111.299 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.09 -29.71 69.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.343 . . . . 0.0 111.23 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.2 tt0 -137.97 157.53 46.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 54' ' ' GLU . 1.8 tttp . . . . . 0 N--CA 1.464 0.23 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.879 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.833 0.349 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -119.75 112.85 19.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' B' ' 3' ' ' ILE . 4.1 tt -100.0 105.09 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.252 0.548 . . . . 0.0 110.79 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.424 ' HG ' ' CD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -124.81 121.55 34.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.019 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -56.24 140.66 43.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.369 . . . . 0.0 110.589 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 66.7 mtt85 -155.9 145.34 20.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.42 ' O ' ' CG1' ' B' ' 8' ' ' VAL . 0.0 OUTLIER 179.06 1.55 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.959 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER 177.13 30.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.573 0.225 . . . . 0.0 111.371 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.0 -118.18 3.5 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.685 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -110.15 -178.31 3.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.955 0.407 . . . . 0.0 111.178 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.57 168.04 10.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.805 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.415 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.8 OUTLIER -111.49 154.5 24.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.516 179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -127.42 100.46 6.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.022 0.439 . . . . 0.0 110.918 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 3.1 tp -112.69 125.5 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.563 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.46 -105.47 0.65 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.2 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 12.0 m-20 -156.89 6.97 0.17 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 0.8 OUTLIER 161.09 61.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.631 0.372 . . . . 0.0 110.023 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.23 -157.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.568 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 172.55 101.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.415 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 58.4 t -111.0 108.1 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.816 0.341 . . . . 0.0 111.747 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 5.0 p -104.98 110.45 22.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.03 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 30.7 m -77.5 72.56 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.56 -143.65 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.638 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.53 74.32 0.27 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.818 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 10.6 t -93.08 108.33 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 111.279 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.89 157.57 45.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.999 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.83 148.04 50.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.74 -80.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.642 0.258 . . . . 0.0 110.741 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -116.72 126.26 52.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.88 0.371 . . . . 0.0 110.96 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.5 m -93.4 136.98 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 3.9 mtt85 -77.95 104.93 8.81 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.254 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.454 HD12 HG22 ' B' ' 32' ' ' ILE . 12.2 mm -87.38 137.83 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.858 0.361 . . . . 0.0 111.305 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.94 117.44 5.14 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.458 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 t -118.03 103.14 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 111.489 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' B' ' 19' ' ' THR . 0.6 OUTLIER -95.8 107.22 19.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.17 145.5 55.79 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.597 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.28 156.34 29.32 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.814 2.343 . . . . 0.0 112.07 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.23 26.77 2.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.221 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.3 -40.28 5.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.753 0.311 . . . . 0.0 110.831 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -82.38 152.81 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.42 98.63 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.121 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.19 120.61 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.104 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -128.51 136.18 50.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.553 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' B' ' 45' ' ' GLU . 0.0 OUTLIER -165.57 -40.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 0.0 111.133 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.406 ' N ' ' HG3' ' B' ' 44' ' ' ARG . 1.2 mm-40 177.83 114.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.965 0.412 . . . . 0.0 110.918 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -58.52 -38.64 78.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.714 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 35.9 mm -69.38 -43.21 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.804 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.421 ' CD2' ' HG ' ' A' ' 4' ' ' LEU . 2.8 m-85 -51.38 -42.74 61.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.347 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -87.77 -58.82 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.771 0.319 . . . . 0.0 111.522 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -52.14 -21.54 3.39 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 40.2 mm -105.93 -50.51 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -58.8 3.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.713 0.292 . . . . 0.0 111.314 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.07 -29.71 69.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.342 . . . . 0.0 111.199 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -138.05 156.78 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.774 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.804 0.335 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.6 tt -116.55 103.15 10.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 4.1 tt -98.08 105.48 17.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.195 0.521 . . . . 0.0 110.785 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 tp -125.28 121.33 33.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.924 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -56.88 149.3 18.84 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.389 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.446 ' HG2' ' HB2' ' A' ' 10' ' ' GLU . 1.1 tpt180 -179.53 143.15 0.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.224 0.535 . . . . 0.0 111.399 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.41 ' NE ' ' CG1' ' A' ' 25' ' ' VAL . 36.4 ttt180 -170.1 23.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.063 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.08 -53.43 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.165 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.08 105.49 0.19 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.683 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . 0.7 OUTLIER -113.13 -58.25 2.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 0.0 110.869 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p 65.52 96.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.124 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.42 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 1.6 pt? -114.57 154.72 27.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.069 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 34.8 ttm -128.98 99.93 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.059 0.457 . . . . 0.0 111.015 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.412 ' HA ' HD11 ' A' ' 14' ' ' ILE . 6.1 tp -118.02 102.86 13.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.814 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.28 -107.33 0.32 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.972 -0.633 . . . . 0.0 111.887 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.36 -4.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 165.05 57.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.8 m -112.45 -161.58 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.816 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.5 OUTLIER 170.13 102.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 21.4 t -111.2 110.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.906 0.384 . . . . 0.0 111.894 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.4 m -98.35 111.65 23.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.767 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.5 m -77.01 68.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.347 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.45 -142.39 0.26 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.751 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 31' ' ' ARG . . . 53.82 70.77 0.84 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.566 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.41 ' CG1' ' NE ' ' A' ' 7' ' ' ARG . 40.5 t -85.94 107.66 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.909 0.385 . . . . 0.0 111.455 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -143.97 151.57 39.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.046 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.43 150.54 47.16 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.419 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 72.58 -75.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.606 0.241 . . . . 0.0 111.004 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -120.95 128.84 53.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.985 0.422 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 m -93.29 137.18 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.248 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 0.1 OUTLIER -75.77 104.63 6.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.28 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.3 mm -87.47 130.14 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.215 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.73 108.44 3.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.156 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.28 103.17 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 111.615 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 19' ' ' THR . 3.6 t-20 -96.19 107.22 19.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.384 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.9 146.84 58.53 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.715 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.58 156.36 21.55 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.961 2.441 . . . . 0.0 112.104 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -92.47 32.87 1.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.188 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.32 -41.26 3.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.739 0.304 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 t -77.9 160.68 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.79 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 t -66.75 106.68 1.92 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.838 0.352 . . . . 0.0 110.859 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.94 126.11 74.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -128.88 124.1 34.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.207 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -156.76 -65.82 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 110.461 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 5.3 tp10 -171.69 130.46 0.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.56 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -58.79 -38.75 79.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.047 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.1 mt -73.05 -43.56 58.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.302 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 3.2 m-85 -50.46 -46.63 56.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.651 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -58.09 3.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.401 ' HA ' ' CB ' ' A' ' 54' ' ' GLU . 3.6 mtp85 -55.05 -9.78 0.43 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.86 -55.45 4.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 O-C-N 122.258 -0.276 . . . . 0.0 111.728 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 7.2 mp0 -75.89 -54.3 7.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 110.999 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.04 -36.83 61.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.892 0.377 . . . . 0.0 110.962 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 50' ' ' ARG . 3.7 tp10 -103.56 122.42 44.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.753 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.877 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.832 0.349 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 6.6 tt -116.58 103.12 10.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -98.04 105.56 17.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.26 0.552 . . . . 0.0 110.763 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 tp -125.32 121.37 33.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.831 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -56.97 149.27 19.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.397 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.457 ' HG2' ' HB2' ' B' ' 10' ' ' GLU . 1.1 tpt180 -179.53 143.17 0.19 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.253 0.549 . . . . 0.0 111.418 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.402 ' NE ' ' CG1' ' B' ' 25' ' ' VAL . 36.2 ttt180 -170.18 23.53 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.102 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.07 -53.51 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.161 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.13 105.52 0.19 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.703 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.457 ' HB2' ' HG2' ' B' ' 6' ' ' ARG . 0.7 OUTLIER -113.1 -58.33 2.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 110.854 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.9 p 65.53 96.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.165 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.425 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 1.6 pt? -114.48 154.76 27.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.121 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 34.8 ttm -129.04 99.96 5.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.01 0.433 . . . . 0.0 111.032 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 6.1 tp -117.97 102.85 13.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.854 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.3 -107.34 0.32 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.883 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.39 -4.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 165.07 57.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 m -112.42 -161.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.796 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.5 OUTLIER 170.09 102.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.443 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.425 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 21.4 t -111.22 110.16 31.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 111.948 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 6.4 m -98.35 111.65 23.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.794 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 17.5 m -76.98 68.42 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.312 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.52 -142.38 0.26 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.401 ' HA3' ' CB ' ' B' ' 31' ' ' ARG . . . 53.86 70.77 0.84 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.556 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.402 ' CG1' ' NE ' ' B' ' 7' ' ' ARG . 40.4 t -85.96 107.62 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.0 111.428 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -143.97 151.57 39.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.031 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.46 150.49 47.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.476 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 72.62 -75.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.585 0.231 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -121.05 128.78 52.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 111.089 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 m -93.23 137.16 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.266 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -75.77 104.6 6.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.289 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 9.3 mm -87.44 130.17 37.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.201 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.78 108.44 3.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.161 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.24 103.17 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.91 0.385 . . . . 0.0 111.577 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' B' ' 19' ' ' THR . 3.6 t-20 -96.13 107.15 19.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.402 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.85 146.78 58.38 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.751 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.57 156.34 21.56 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.963 2.442 . . . . 0.0 112.101 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -92.46 32.93 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.224 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.34 -41.21 3.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.78 0.324 . . . . 0.0 110.973 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 t -77.94 160.76 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.792 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 3.8 t -66.81 106.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 0.0 110.839 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.95 126.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.142 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -128.91 124.15 34.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.168 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -156.77 -65.84 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.441 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 5.3 tp10 -171.72 130.49 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.586 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -58.81 -38.73 79.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 mt -73.03 -43.49 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.307 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.402 ' HB2' ' HB3' ' B' ' 45' ' ' GLU . 3.2 m-85 -50.61 -46.47 58.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.635 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -58.11 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -55.13 -9.71 0.44 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.86 -55.53 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 7.2 mp0 -75.88 -54.32 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.684 0.278 . . . . 0.0 110.93 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.06 -36.72 61.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.945 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -103.79 124.01 48.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.1 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.059 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mmm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.882 0.372 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 5.2 mp -116.7 104.74 11.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.682 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 mm -96.83 105.13 16.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 110.74 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.461 ' HG ' ' CG ' ' B' ' 48' ' ' TYR . 0.6 OUTLIER -124.63 116.7 22.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.976 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -54.7 140.22 36.45 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.394 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 24.3 mtt180 -154.76 141.13 18.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.184 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 179.11 4.3 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.299 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.24 -76.41 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 O-C-N 122.213 -0.304 . . . . 0.0 111.517 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.33 97.94 0.51 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.662 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 6' ' ' ARG . 6.6 mp0 -113.21 174.7 5.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.723 0.297 . . . . 0.0 111.034 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.402 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER 164.86 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.141 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.435 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -112.35 154.1 26.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.4 ttp -133.29 100.69 4.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.053 0.454 . . . . 0.0 111.755 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.405 ' HA ' HD11 ' A' ' 14' ' ' ILE . 5.1 tp -114.36 120.61 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.186 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.85 -106.92 0.59 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.058 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.466 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -152.55 6.43 0.41 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 4.6 mt-10 159.31 64.19 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.907 0.384 . . . . 0.0 110.29 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 m -118.85 -158.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 35' ' ' ASN . 0.1 OUTLIER 170.18 104.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 22.0 t -117.95 116.14 50.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.0 111.751 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.0 t -114.79 115.63 27.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.006 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.404 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 26.7 m -80.95 73.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.389 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.91 -136.04 0.1 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.472 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.05 74.7 0.21 Allowed Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.933 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.04 108.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.465 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -140.24 153.38 46.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.048 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.15 149.45 47.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.453 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 69.14 -83.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.638 0.256 . . . . 0.0 110.721 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -107.32 125.24 50.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.356 . . . . 0.0 110.947 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 m -93.13 136.89 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.283 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 28.8 mtt85 -75.96 104.39 6.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.491 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' B' ' 6' ' ' ARG . 28.4 mm -87.17 131.36 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.281 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.5 125.12 8.14 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.745 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.2 t -118.05 129.72 73.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.835 0.35 . . . . 0.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 19' ' ' THR . 2.4 t-20 -123.16 107.21 11.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.13 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.86 144.25 26.12 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.745 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.93 156.45 30.7 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.736 2.29 . . . . 0.0 112.081 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.08 38.01 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.398 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.73 -38.7 4.2 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.759 0.314 . . . . 0.0 110.803 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.3 t -89.58 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -57.49 97.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.943 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.35 120.71 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 136.11 50.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.674 0.274 . . . . 0.0 110.81 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -147.4 -172.6 4.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.54 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.42 ' HB3' ' CG ' ' A' ' 48' ' ' TYR . 1.5 tp10 -63.16 139.2 58.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.766 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -62.36 1.67 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.383 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.41 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 39.1 mm -56.82 -45.57 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.792 0.329 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.458 ' CG ' ' HG ' ' B' ' 4' ' ' LEU . 4.1 m-30 -41.5 -73.33 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.545 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.403 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . 13.8 pt20 -66.48 -19.26 65.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.54 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.41 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 6.0 mtm180 -69.0 -20.0 64.15 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.39 -23.87 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 4.3 pt20 -107.68 -52.38 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.623 0.249 . . . . 0.0 111.547 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.403 ' CB ' ' HB2' ' A' ' 49' ' ' GLN . . . -70.36 -72.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 111.224 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.5 118.81 37.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.727 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.5 mttt . . . . . 0 N--CA 1.451 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.138 -179.904 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.7 mmm . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.87 0.367 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.436 ' N ' ' CD1' ' B' ' 2' ' ' LEU . 5.2 mp -116.76 104.74 11.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 mm -96.81 105.17 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.98 0.419 . . . . 0.0 110.725 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.458 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -124.66 116.67 22.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.961 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -54.72 140.24 36.54 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.413 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.494 ' HB3' ' HG2' ' B' ' 10' ' ' GLU . 24.4 mtt180 -154.74 141.13 18.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.205 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER 179.1 4.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.269 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.24 -76.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 O-C-N 122.167 -0.333 . . . . 0.0 111.544 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.33 97.89 0.51 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.666 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.494 ' HG2' ' HB3' ' B' ' 6' ' ' ARG . 6.6 mp0 -113.16 174.7 5.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.748 0.309 . . . . 0.0 111.051 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' THR . . . . . 0.403 ' CB ' ' O ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 164.81 91.71 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.14 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.443 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -112.31 154.05 26.27 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.4 ttp -133.26 100.58 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.999 0.428 . . . . 0.0 111.785 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . 0.439 ' HA ' HD11 ' B' ' 14' ' ' ILE . 5.1 tp -114.33 120.61 64.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.189 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.86 -106.92 0.59 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.086 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 0.4 OUTLIER -152.53 6.46 0.41 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.469 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 4.6 mt-10 159.32 64.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.957 0.408 . . . . 0.0 110.289 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 m -118.78 -158.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.417 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.459 ' O ' ' HB3' ' B' ' 35' ' ' ASN . 0.1 OUTLIER 170.18 104.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.443 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 21.9 t -117.9 116.1 50.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 0.0 111.741 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 3.0 t -114.75 115.62 27.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.005 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.402 ' CG1' HG21 ' B' ' 32' ' ' ILE . 26.8 m -80.97 73.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.0 0.429 . . . . 0.0 111.343 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.94 -136.08 0.1 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.483 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.08 74.67 0.22 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.975 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.99 108.15 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 0.0 111.47 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -140.27 153.34 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.058 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.11 149.45 47.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.465 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 69.06 -83.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.541 0.21 . . . . 0.0 110.701 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -107.35 125.24 50.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 110.941 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 m -93.14 136.91 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.32 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 28.6 mtt85 -76.0 104.35 6.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.454 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.412 HG13 ' HB2' ' A' ' 6' ' ' ARG . 28.4 mm -87.15 131.32 35.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.299 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.47 125.2 8.17 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.792 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 12.4 t -118.1 129.75 73.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.827 0.346 . . . . 0.0 111.063 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' B' ' 19' ' ' THR . 2.4 t-20 -123.23 107.26 11.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.074 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.89 144.22 25.91 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.75 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.83 156.45 31.08 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.797 2.331 . . . . 0.0 112.103 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.09 38.02 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.38 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.77 -38.69 4.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.79 0.329 . . . . 0.0 110.804 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 13.3 t -89.63 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.846 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -57.42 97.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.013 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.38 120.75 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 136.13 50.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.657 0.265 . . . . 0.0 110.816 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -147.41 -172.66 4.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.421 ' HB3' ' CD1' ' B' ' 48' ' ' TYR . 1.5 tp10 -63.01 139.19 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.824 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -62.33 1.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.421 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.415 ' HA ' ' HB2' ' B' ' 50' ' ' ARG . 39.2 mm -56.86 -45.53 83.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.78 0.324 . . . . 0.0 111.164 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.461 ' CG ' ' HG ' ' A' ' 4' ' ' LEU . 4.1 m-30 -41.52 -73.34 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.568 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.403 ' HB2' ' CB ' ' B' ' 53' ' ' ALA . 13.8 pt20 -66.48 -19.24 65.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.538 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . 0.415 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 6.0 mtm180 -69.0 -19.92 64.14 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.57 -23.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' B' ' 48' ' ' TYR . 4.3 pt20 -107.82 -52.29 2.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.563 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.403 ' CB ' ' HB2' ' B' ' 49' ' ' GLN . . . -70.47 -72.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.807 0.337 . . . . 0.0 111.185 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.58 119.43 39.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.617 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.733 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.799 0.333 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.419 ' HB3' ' CE2' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -118.11 108.48 15.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.2 tt -84.36 115.0 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.009 0.433 . . . . 0.0 111.535 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.405 HD12 ' CZ ' ' B' ' 48' ' ' TYR . 0.3 OUTLIER -115.1 156.24 25.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.653 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' B' ' 30' ' ' VAL . 0.3 OUTLIER -95.8 121.22 37.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 0.0 111.476 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.538 ' HB2' HG13 ' B' ' 32' ' ' ILE . 0.0 OUTLIER -92.21 149.16 21.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.475 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 6.6 mtp180 78.01 87.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.706 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 7' ' ' ARG . 56.2 t 80.74 55.49 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.193 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.89 -148.54 4.96 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.536 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.28 121.46 44.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 111.616 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -58.55 147.53 31.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.402 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.82 154.73 31.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.766 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.6 ttt -127.91 100.7 6.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 0.0 110.766 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 tp -115.42 137.7 48.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.952 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.71 -107.19 0.89 Allowed Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.339 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -153.39 -4.42 0.19 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 1.0 OUTLIER 171.38 57.43 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 m -111.31 -159.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.615 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 173.72 102.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.6 t -102.93 101.99 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.856 0.36 . . . . 0.0 111.172 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -93.17 157.3 16.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.22 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -106.86 -173.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.577 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.38 -53.52 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 0.0 110.291 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.464 ' CA ' ' HG2' ' A' ' 7' ' ' ARG . . . 93.64 -39.99 2.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.162 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 11.4 t -85.66 149.83 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.596 0.236 . . . . 0.0 111.495 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 25' ' ' VAL . 10.8 tttp 101.25 116.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.245 0.618 . . . . 0.0 110.85 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.81 174.74 46.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.683 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.83 -84.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.677 0.275 . . . . 0.0 110.301 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.9 136.95 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.423 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' B' ' 5' ' ' THR . 21.7 t -92.89 115.71 32.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.807 0.337 . . . . 0.0 110.888 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -86.44 99.46 11.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.99 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.536 HG13 ' HB2' ' B' ' 6' ' ' ARG . 33.0 mm -112.76 135.57 51.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.935 0.397 . . . . 0.0 111.425 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.37 112.72 4.19 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.302 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.07 103.17 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 111.103 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.7 107.29 19.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.638 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.02 145.52 56.06 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.431 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.24 156.55 19.65 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.93 2.42 . . . . 0.0 112.231 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -89.45 27.29 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.278 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -112.67 -37.17 4.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.757 0.313 . . . . 0.0 111.034 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.1 t -81.82 144.64 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.806 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -54.89 100.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.0 p -122.09 124.11 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.077 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.57 136.17 50.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.373 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -151.86 -60.69 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.931 0.396 . . . . 0.0 110.612 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 178.78 143.7 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.655 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -43.83 92.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.617 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.4 mm -64.56 -49.08 82.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.061 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' B' ' 2' ' ' LEU . 88.9 t80 -50.63 -45.84 57.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.55 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -75.55 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 111.729 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -51.44 -17.35 0.76 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.5 mt -108.89 -54.78 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.75 0.309 . . . . 0.0 111.205 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HG3' ' CD1' ' A' ' 48' ' ' TYR . 60.5 mm-40 -69.14 -62.05 1.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.922 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.3 -33.54 75.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.008 0.433 . . . . 0.0 110.731 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -118.19 124.06 47.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.606 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.5 tptp . . . . . 0 N--CA 1.451 -0.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.267 -179.631 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.825 0.345 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.422 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -118.07 108.44 15.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 5.3 tt -84.38 115.05 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 111.531 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.41 HD12 ' CZ ' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -115.12 156.15 25.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.686 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -95.7 121.19 37.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.018 0.437 . . . . 0.0 111.446 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.536 ' HB2' HG13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -92.21 149.12 21.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.53 179.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.476 ' O ' ' HB ' ' B' ' 8' ' ' VAL . 6.6 mtp180 78.02 87.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.691 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' B' ' 7' ' ' ARG . 55.3 t 80.67 55.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.188 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.88 -148.54 4.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.593 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.24 121.4 44.33 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.879 0.371 . . . . 0.0 111.614 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -58.48 147.57 31.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.413 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.83 154.76 31.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.728 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.6 ttt -127.97 100.59 5.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.856 0.36 . . . . 0.0 110.775 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . 0.4 ' HA ' HD11 ' B' ' 14' ' ' ILE . 4.6 tp -115.37 137.75 47.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.71 -107.22 0.89 Allowed Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.329 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.3 OUTLIER -153.41 -4.37 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 1.0 OUTLIER 171.27 57.42 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 m -111.33 -159.48 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.564 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 173.84 102.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.501 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 41.4 t -102.84 101.89 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.821 0.343 . . . . 0.0 111.227 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -93.1 157.25 16.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.237 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 34.9 m -106.81 -173.11 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.545 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.48 -53.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 110.3 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.47 ' CA ' ' HG2' ' B' ' 7' ' ' ARG . . . 93.61 -39.89 2.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.157 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.573 ' O ' ' CB ' ' B' ' 26' ' ' LYS . 11.4 t -85.66 149.82 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.543 0.211 . . . . 0.0 111.502 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' B' ' 25' ' ' VAL . 10.8 tttp 101.22 116.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.249 0.62 . . . . 0.0 110.804 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.84 174.78 46.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.644 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.75 -84.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.657 0.265 . . . . 0.0 110.319 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.89 136.96 33.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.437 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 5' ' ' THR . 21.6 t -92.89 115.7 32.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.361 . . . . 0.0 110.905 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -86.45 99.48 11.68 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.994 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.538 HG13 ' HB2' ' A' ' 6' ' ' ARG . 33.2 mm -112.77 135.63 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 111.395 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.44 112.72 4.18 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.294 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 25.4 t -98.11 103.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.093 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.66 107.25 19.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.659 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.98 145.51 56.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.476 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.29 156.46 19.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.891 2.394 . . . . 0.0 112.193 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -89.32 27.25 1.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.314 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -112.68 -37.22 4.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 110.995 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.1 t -81.69 144.63 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.825 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -54.96 100.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.128 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 13.1 p -122.13 124.07 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.062 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.48 136.2 50.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.407 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -151.88 -60.73 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.625 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 178.79 143.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.614 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.72 -43.86 92.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.932 0.396 . . . . 0.0 110.615 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 42.4 mm -64.59 -49.05 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.061 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 2' ' ' LEU . 88.8 t80 -50.68 -45.78 58.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.541 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -75.6 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.713 0.292 . . . . 0.0 111.715 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -51.47 -17.28 0.75 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 mt -109.0 -54.67 5.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.761 0.315 . . . . 0.0 111.221 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.417 ' HG3' ' CD1' ' B' ' 48' ' ' TYR . 60.6 mm-40 -69.16 -62.14 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.854 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.33 -33.36 75.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.97 0.414 . . . . 0.0 110.769 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -119.08 127.19 53.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.839 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.536 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.805 0.336 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.51 102.83 10.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.034 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.42 ' CG2' ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -92.92 105.75 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.331 0.586 . . . . 0.0 110.949 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.454 ' CD1' ' CD2' ' B' ' 48' ' ' TYR . 0.1 OUTLIER -124.28 156.59 36.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.074 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.72 138.43 31.64 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.533 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.413 ' HB3' ' CG2' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -150.94 145.95 25.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.072 0.463 . . . . 0.0 111.324 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 7' ' ' ARG . 0.6 OUTLIER -179.37 10.98 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.89 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.54 -41.22 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 122.165 -0.334 . . . . 0.0 111.507 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.7 94.46 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.802 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -97.11 -61.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.458 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 m 64.94 98.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.385 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.442 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -120.44 154.37 35.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.086 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.98 100.05 5.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.939 0.4 . . . . 0.0 110.991 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.2 tp -119.15 102.85 13.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.037 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.54 -108.15 0.35 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.325 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.06 -15.51 4.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 164.29 61.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.993 0.425 . . . . 0.0 110.055 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.5 m -107.76 -168.62 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.64 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 t -175.33 103.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.751 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.442 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 21.5 t -102.76 106.9 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 t -91.57 111.85 23.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.569 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.413 ' CG2' ' HB3' ' A' ' 6' ' ' ARG . 30.1 m -84.01 62.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.569 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.43 -142.42 0.24 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.829 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 31' ' ' ARG . . . 53.27 69.24 1.27 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.677 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.408 ' CG2' ' HG2' ' A' ' 7' ' ' ARG . 17.5 t -88.49 107.52 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 120.923 0.392 . . . . 0.0 111.576 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -142.67 146.97 34.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.104 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.3 158.7 30.59 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.526 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.83 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.674 0.273 . . . . 0.0 110.761 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.46 124.45 50.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 110.749 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.1 t -93.74 136.5 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.219 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.422 ' HB3' ' HA3' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -83.17 109.15 16.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.114 179.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.44 135.59 27.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.286 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.26 111.0 2.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.259 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 t -113.59 102.89 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 0.0 111.458 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.63 107.18 19.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.667 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.12 146.21 60.56 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.532 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.88 156.41 30.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.77 2.314 . . . . 0.0 112.008 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -91.3 38.36 0.97 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.11 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -123.55 -38.65 2.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -83.39 156.74 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.822 0.344 . . . . 0.0 110.978 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -57.05 114.97 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.5 p -122.07 121.9 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.96 122.39 30.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.538 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -163.95 -77.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.03 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 5.8 mm-40 -155.07 131.47 10.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.57 -50.72 72.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.221 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 13.9 tt -63.17 -42.04 95.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.974 0.416 . . . . 0.0 111.166 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CD2' ' CD1' ' B' ' 4' ' ' LEU . 5.9 m-85 -50.9 -53.39 33.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.169 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -78.33 -21.7 49.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.137 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.452 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 4.9 mtt180 -72.92 -15.43 61.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.671 0.272 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.5 mt -109.82 -27.1 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.331 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -107.79 -54.54 2.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.796 0.331 . . . . 0.0 111.28 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.74 -73.62 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.277 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -111.85 123.72 50.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.785 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.504 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.286 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.59 102.82 10.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.421 ' O ' ' CG2' ' B' ' 3' ' ' ILE . 4.1 tt -92.86 105.74 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.335 0.588 . . . . 0.0 110.968 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.452 ' CD1' ' CD2' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -124.34 156.62 36.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.998 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.78 138.43 31.61 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.527 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.426 ' HB3' ' CG2' ' B' ' 22' ' ' VAL . 0.0 OUTLIER -150.93 146.0 25.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.285 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' B' ' 7' ' ' ARG . 0.6 OUTLIER -179.43 10.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.969 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.6 -41.21 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 122.18 -0.325 . . . . 0.0 111.483 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.71 94.48 0.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.803 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -97.11 -61.62 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.484 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m 64.99 98.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.432 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.447 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -120.4 154.36 35.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.147 179.204 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.95 100.08 5.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.973 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 8.2 tp -119.15 102.86 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.021 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.57 -108.14 0.35 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.307 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 11.8 t70 -129.09 -15.57 4.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 1.7 mt-10 164.29 61.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.033 0.444 . . . . 0.0 110.059 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 22.5 m -107.8 -168.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.631 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 1.1 t -175.3 103.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.758 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.447 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 21.5 t -102.77 106.9 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 9.4 t -91.59 111.9 23.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.508 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.426 ' CG2' ' HB3' ' B' ' 6' ' ' ARG . 29.9 m -84.0 62.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.551 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.41 -142.46 0.24 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.731 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' B' ' 31' ' ' ARG . . . 53.37 69.18 1.29 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.636 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.418 ' CG2' ' HG2' ' B' ' 7' ' ' ARG . 17.4 t -88.47 107.48 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 111.559 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -142.63 146.99 35.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.096 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.35 158.69 30.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.499 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.81 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.676 0.274 . . . . 0.0 110.776 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.45 124.41 50.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 110.744 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 29.6 t -93.68 136.5 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.426 ' HB3' ' HA3' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -83.17 109.12 16.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.129 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 mm -93.41 135.63 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.235 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.32 111.0 2.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.319 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 t -113.58 102.87 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 111.403 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.6 107.14 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.685 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.14 146.26 60.77 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.481 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.84 156.36 30.99 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.806 2.337 . . . . 0.0 112.016 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -91.3 38.38 0.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.139 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -123.56 -38.59 2.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.067 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -83.38 156.7 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -57.03 115.0 2.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.183 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.03 121.91 65.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.96 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.98 122.36 29.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.525 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -163.92 -77.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.729 0.299 . . . . 0.0 111.013 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.417 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 5.8 mm-40 -155.09 131.46 10.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.875 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.66 -50.63 72.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.179 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.453 ' HA ' ' HB2' ' B' ' 50' ' ' ARG . 13.9 tt -63.27 -42.0 94.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.454 ' CD2' ' CD1' ' A' ' 4' ' ' LEU . 5.9 m-85 -50.92 -53.36 33.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.185 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -78.32 -21.62 49.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.227 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 4.8 mtt180 -73.01 -15.34 61.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.296 . . . . 0.0 111.188 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 43.7 mt -109.94 -27.13 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.351 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -107.8 -54.52 2.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.291 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.68 -73.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -112.42 125.29 54.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.731 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.819 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.792 0.33 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.3 tt -122.18 116.12 23.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 3.6 tt -101.8 105.57 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.134 0.493 . . . . 0.0 110.535 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.408 ' HG ' ' CD2' ' B' ' 48' ' ' TYR . 0.2 OUTLIER -124.51 123.51 40.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.434 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.24 143.65 57.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.729 0.3 . . . . 0.0 110.414 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.488 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 10.6 mtt180 -153.18 148.24 26.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.969 0.414 . . . . 0.0 111.012 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 21.1 ttp180 175.48 -0.76 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.918 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -169.39 134.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.747 0.308 . . . . 0.0 110.831 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.05 47.83 89.09 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.514 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 11' ' ' THR . 18.2 mm-40 -112.46 167.57 10.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.514 0.197 . . . . 0.0 110.703 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.414 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER 163.54 105.53 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.245 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.438 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -115.82 154.14 30.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.247 179.086 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 ttt -130.27 100.88 5.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.007 0.432 . . . . 0.0 111.261 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.5 tp -113.06 121.77 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.465 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.35 -107.14 0.64 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.153 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 21.0 m-20 -154.96 6.95 0.26 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 2.0 tm-20 161.33 64.84 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 m -119.34 -158.53 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.47 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 171.39 102.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.438 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 22.4 t -117.36 110.91 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.808 0.337 . . . . 0.0 111.461 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.7 m -106.74 116.6 32.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.029 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 m -82.22 68.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.069 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.69 -141.64 0.07 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.622 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.32 74.26 0.36 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.364 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.5 t -85.68 107.75 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 120.974 0.416 . . . . 0.0 111.134 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.89 165.42 35.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.139 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.68 164.59 27.92 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.169 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 72.72 -62.51 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.607 0.242 . . . . 0.0 111.245 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.57 136.4 54.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.738 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.2 116.29 44.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 111.12 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 1.9 mtm105 -79.58 99.36 7.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.833 0.349 . . . . 0.0 110.697 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' B' ' 6' ' ' ARG . 16.2 mm -87.86 132.85 32.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.599 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.62 118.2 5.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.536 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 t -114.14 127.96 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.218 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 19' ' ' THR . 2.7 t-20 -123.68 107.48 11.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.312 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.98 142.76 22.76 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.715 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.9 156.62 27.09 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.797 2.332 . . . . 0.0 112.051 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -87.44 26.6 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.427 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.38 -41.66 6.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.837 0.351 . . . . 0.0 110.819 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.9 t -82.49 150.18 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.7 t -62.5 97.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.348 . . . . 0.0 111.018 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.39 120.61 61.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -128.39 136.22 50.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.594 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -178.3 -35.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.084 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.12 98.66 0.02 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.69 -26.45 63.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.818 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.2 mm -79.2 -44.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.415 ' CD2' ' HG ' ' B' ' 4' ' ' LEU . 3.3 m-85 -52.11 -44.91 64.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.84 -60.48 2.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.829 0.347 . . . . 0.0 111.683 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -54.95 -15.6 2.12 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.42 -52.75 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 122.284 -0.26 . . . . 0.0 111.591 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -72.53 -59.12 2.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.709 0.29 . . . . 0.0 111.153 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.06 -25.39 58.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.388 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -121.54 140.2 52.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.526 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.434 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.82 0.343 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 8.3 tt -122.24 116.21 23.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' B' ' 3' ' ' ILE . 3.6 tt -101.83 105.61 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.146 0.498 . . . . 0.0 110.524 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.415 ' HG ' ' CD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -124.58 123.5 40.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.423 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -63.16 143.69 57.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.38 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 10.6 mtt180 -153.23 148.26 26.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.952 0.406 . . . . 0.0 111.068 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 21.0 ttp180 175.44 -0.73 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.891 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -169.42 134.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.76 0.314 . . . . 0.0 110.797 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.04 47.79 89.29 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.486 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' B' ' 11' ' ' THR . 18.1 mm-40 -112.39 167.65 10.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.541 0.21 . . . . 0.0 110.711 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' THR . . . . . 0.423 ' CB ' ' O ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 163.51 105.51 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.263 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.427 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.9 OUTLIER -115.86 154.1 30.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.293 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 1.5 ttt -130.28 100.78 5.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.997 0.427 . . . . 0.0 111.23 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 2.5 tp -112.98 121.83 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.504 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.31 -107.09 0.64 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.147 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 21.1 m-20 -154.96 6.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 2.1 tm-20 161.32 64.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 m -119.36 -158.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.487 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.445 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 171.38 102.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 22.6 t -117.36 110.93 32.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.819 0.343 . . . . 0.0 111.399 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 16.7 m -106.74 116.68 32.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.005 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 m -82.29 68.5 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.064 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.68 -141.65 0.07 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.575 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.3 74.34 0.35 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.309 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.78 107.74 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.064 0.459 . . . . 0.0 111.149 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.84 165.47 35.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.186 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.73 164.62 27.87 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.141 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 72.75 -62.53 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.614 0.245 . . . . 0.0 111.253 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.62 136.46 54.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.703 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.22 116.24 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.703 0.287 . . . . 0.0 111.096 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 1.9 mtm105 -79.45 99.34 7.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.802 0.334 . . . . 0.0 110.791 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.412 HG13 ' HB2' ' A' ' 6' ' ' ARG . 16.2 mm -87.86 132.87 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.591 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.65 118.15 5.4 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.542 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 14.0 t -114.1 127.98 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.238 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' B' ' 19' ' ' THR . 2.7 t-20 -123.73 107.45 11.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.293 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.93 142.8 23.01 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.769 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.95 156.53 26.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.851 2.367 . . . . 0.0 111.989 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -87.32 26.51 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.465 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -101.42 -41.6 6.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.785 0.326 . . . . 0.0 110.779 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.9 t -82.55 150.22 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.624 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -62.47 97.93 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 111.101 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.38 120.6 61.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.1 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -128.37 136.26 50.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 3.7 ptt85 -178.28 -35.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.089 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.15 98.65 0.02 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -58.69 -26.55 63.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.767 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 32.8 mm -79.13 -44.25 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.408 ' CD2' ' HG ' ' A' ' 4' ' ' LEU . 3.3 m-85 -52.08 -44.95 64.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.291 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -60.51 2.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.851 0.358 . . . . 0.0 111.636 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -54.89 -15.77 2.2 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.26 -52.68 6.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.608 0.242 . . . . 0.0 111.587 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -72.58 -59.07 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.715 0.293 . . . . 0.0 111.133 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.09 -25.28 58.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.395 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -122.34 142.33 50.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 mttp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.876 -179.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.28 114.35 20.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.907 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' B' ' 31' ' ' ARG . 20.8 mm -96.2 105.03 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.027 0.441 . . . . 0.0 110.506 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.401 ' CD2' ' HG2' ' B' ' 52' ' ' GLN . 2.4 mm? -124.82 118.23 25.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.8 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.1 OUTLIER -55.68 139.83 43.5 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.43 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.44 ' HB3' ' CG2' ' A' ' 22' ' ' VAL . 3.8 mtp180 -151.37 148.4 28.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.029 0.442 . . . . 0.0 111.474 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 2.9 ttt180 175.91 -80.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.569 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t -32.75 -68.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.09 109.58 0.41 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.006 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.18 -173.63 2.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.553 0.216 . . . . 0.0 110.533 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 168.9 89.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.443 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.487 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 1.3 pt? -113.11 154.25 26.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.3 ttt -130.67 100.76 5.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.209 0.528 . . . . 0.0 111.348 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.421 ' HA ' HD11 ' A' ' 14' ' ' ILE . 2.6 tp -111.77 126.8 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.402 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.93 -104.56 0.68 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.965 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.9 p30 -162.34 8.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.405 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.9 mt-10 165.24 52.92 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.014 0.435 . . . . 0.0 110.316 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 m -115.27 -158.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.416 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER 167.05 106.86 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.487 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 3.1 t -117.43 114.27 45.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.769 0.319 . . . . 0.0 111.172 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -110.54 116.53 31.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.873 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 6' ' ' ARG . 34.2 m -81.16 71.16 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.42 HD11 ' N ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -88.97 -145.76 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.562 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.42 ' N ' HD11 ' A' ' 23' ' ' LEU . . . 56.7 79.76 0.09 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.326 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.8 t -85.93 107.82 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.904 0.383 . . . . 0.0 111.602 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.99 155.67 43.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.03 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.78 154.93 52.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.583 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 67.68 -88.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.464 0.173 . . . . 0.0 110.685 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -104.63 125.68 50.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.62 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 m -93.24 136.65 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.515 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 4.6 mtt180 -79.51 100.98 7.98 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.096 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.408 HG21 ' CG1' ' A' ' 22' ' ' VAL . 18.5 mm -87.35 133.79 29.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.66 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.96 119.02 6.32 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.266 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.3 t -109.55 129.61 64.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.929 0.395 . . . . 0.0 111.494 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 19' ' ' THR . 2.1 t30 -123.47 107.25 11.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.183 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.18 146.62 46.87 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.635 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -83.2 156.52 14.82 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.99 2.46 . . . . 0.0 112.278 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.92 15.59 4.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.352 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.29 -38.65 10.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.639 0.257 . . . . 0.0 110.973 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 t -87.95 142.21 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.835 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 m -55.85 98.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.027 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.4 p -122.2 120.82 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.222 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.19 136.09 50.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.442 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.413 ' NH2' ' NE ' ' B' ' 6' ' ' ARG . 24.4 ttt180 -156.69 -67.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 111.012 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.83 121.55 1.82 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.92 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.52 -42.43 82.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.61 -41.09 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.79 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -52.32 -46.71 66.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.701 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -86.71 -58.17 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 111.741 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.409 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 4.1 mtt180 -48.91 -20.29 0.49 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.9 mm -108.67 -52.67 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.632 0.253 . . . . 0.0 111.498 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -66.81 -63.5 1.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.721 0.296 . . . . 0.0 110.776 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.82 -32.13 69.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.982 0.42 . . . . 0.0 110.615 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -109.42 119.73 40.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.798 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm . . . . . 0 N--CA 1.448 -0.573 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.667 179.766 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.899 0.38 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 mp -122.26 114.41 20.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 31' ' ' ARG . 20.6 mm -96.25 104.95 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 0.0 110.566 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -124.76 118.43 26.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.781 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -55.78 139.83 44.06 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.378 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.447 ' HB3' ' CG2' ' B' ' 22' ' ' VAL . 3.8 mtp180 -151.38 148.37 28.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.048 0.452 . . . . 0.0 111.496 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 175.91 -80.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.591 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 25.1 t -32.76 -68.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.05 109.64 0.41 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.002 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.19 -173.59 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.548 0.213 . . . . 0.0 110.536 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 168.87 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.426 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.493 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 1.3 pt? -113.19 154.26 26.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 12.3 ttt -130.71 100.82 5.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.233 0.54 . . . . 0.0 111.403 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 2.6 tp -111.89 126.81 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.342 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.96 -104.66 0.69 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.913 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 2.9 p30 -162.31 9.01 0.06 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.9 mt-10 165.25 52.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.025 0.44 . . . . 0.0 110.284 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.8 m -115.26 -158.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.216 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.1 OUTLIER 167.05 106.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.493 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 3.1 t -117.45 114.28 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.753 0.311 . . . . 0.0 111.18 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -110.54 116.54 31.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.849 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' B' ' 6' ' ' ARG . 34.2 m -81.11 71.1 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.601 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.415 HD11 ' N ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -88.94 -145.72 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.576 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.415 ' N ' HD11 ' B' ' 23' ' ' LEU . . . 56.68 79.76 0.09 OUTLIER Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.363 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 20.9 t -86.0 107.83 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 120.96 0.41 . . . . 0.0 111.638 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.03 155.65 43.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.003 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.73 154.95 52.68 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.555 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 67.64 -88.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.492 0.187 . . . . 0.0 110.654 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -104.64 125.66 50.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.0 110.64 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 m -93.21 136.67 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.555 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.6 mtt180 -79.51 100.88 7.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.1 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 6' ' ' ARG . 18.6 mm -87.31 133.76 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.68 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.92 118.96 6.3 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.306 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 24.0 t -109.51 129.67 63.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.922 0.391 . . . . 0.0 111.556 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' B' ' 19' ' ' THR . 2.1 t30 -123.41 107.22 11.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.247 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.19 146.6 46.76 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.622 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -83.17 156.52 14.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.013 2.475 . . . . 0.0 112.271 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.95 15.57 4.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.303 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -38.6 10.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.662 0.268 . . . . 0.0 111.016 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 t -87.94 142.19 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.868 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 3.0 m -55.9 98.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.971 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 13.4 p -122.19 120.81 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.265 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.21 136.04 50.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.432 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.414 ' NH2' ' NE ' ' A' ' 6' ' ' ARG . 24.6 ttt180 -156.62 -67.17 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.939 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.77 121.61 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.42 -42.48 82.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -41.03 87.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.799 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -52.35 -46.65 66.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.634 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -86.84 -58.09 2.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.758 0.313 . . . . 0.0 111.804 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . 0.417 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 4.1 mtt180 -48.95 -20.16 0.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 36.6 mm -108.78 -52.63 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.629 0.252 . . . . 0.0 111.524 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.401 ' HG2' ' CD2' ' A' ' 4' ' ' LEU . 8.1 tp60 -66.87 -63.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.763 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.89 -32.2 69.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 110.589 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.417 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 0.5 OUTLIER -108.65 119.59 39.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.615 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.589 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttm . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.964 0.412 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -122.24 111.69 17.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.823 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.8 tt -106.06 116.66 50.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.1 0.476 . . . . 0.0 111.3 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.431 HD22 ' CD2' ' B' ' 48' ' ' TYR . 0.4 OUTLIER -123.9 123.4 40.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.336 179.354 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -63.61 80.07 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.888 0.375 . . . . 0.0 111.664 -179.17 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.45 ' HB2' HG13 ' B' ' 32' ' ' ILE . 23.5 mtt180 -78.79 143.22 36.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.126 0.489 . . . . 0.0 110.514 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.434 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 2.9 tmt_? -173.36 -13.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.864 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.61 -58.74 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.702 0.286 . . . . 0.0 111.175 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.57 105.55 0.21 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.803 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.2 -73.82 0.65 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.906 0.384 . . . . 0.0 110.723 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 m 69.53 102.39 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.49 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.426 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -109.94 154.59 22.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.626 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.3 ttt -127.2 100.07 5.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.98 0.419 . . . . 0.0 110.747 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.85 138.16 47.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.752 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 121.28 -106.01 1.08 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.104 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.4 t70 -159.57 7.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.7 mt-10 162.66 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.036 0.446 . . . . 0.0 110.151 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 m -116.38 -158.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.649 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 173.57 102.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.426 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 27.5 t -110.48 103.96 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.5 m -89.27 106.37 18.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.904 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.0 m -76.7 -168.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.899 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -173.38 141.3 0.89 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.103 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . -125.37 -24.54 1.58 Allowed Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.477 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.94 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.536 0.208 . . . . 0.0 110.63 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.91 165.5 0.13 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.747 0.308 . . . . 0.0 110.56 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.81 -99.98 0.01 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.569 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -101.36 -30.92 11.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 110.377 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.445 ' HB3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -119.82 136.65 54.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.955 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' B' ' 5' ' ' THR . 12.0 t -93.21 128.39 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 111.681 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 2.4 ttp180 -80.8 99.54 8.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.437 HG13 ' HB2' ' B' ' 6' ' ' ARG . 9.5 mm -88.77 127.43 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.931 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.03 109.99 3.4 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.486 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.73 102.93 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.936 0.398 . . . . 0.0 111.468 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -91.59 107.44 19.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.641 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.95 138.62 33.04 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.454 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.69 156.09 31.45 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.603 2.202 . . . . 0.0 112.102 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -82.01 2.25 31.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.564 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.84 -39.33 20.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.72 0.295 . . . . 0.0 111.267 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 t -86.78 146.85 5.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.885 0.374 . . . . 0.0 110.995 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.97 100.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.3 122.31 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -128.11 136.42 51.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.706 0.289 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.92 -175.78 4.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.489 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.3 145.78 30.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.843 0.354 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.67 -65.29 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.507 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.47 HG21 HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -52.08 -40.77 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.387 -179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.437 ' CE2' ' HB2' ' B' ' 4' ' ' LEU . 7.9 t80 -46.9 -67.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.436 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.413 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 48.5 mt-30 -71.96 -22.01 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.551 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -70.5 -15.95 62.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.649 0.261 . . . . 0.0 111.571 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.9 tt -112.15 -25.18 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.634 0.254 . . . . 0.0 111.5 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.79 -55.81 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.257 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.413 ' HB2' ' CB ' ' A' ' 49' ' ' GLN . . . -65.08 -71.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.1 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -108.0 116.61 32.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.772 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.558 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttm . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.88 0.371 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' B' ' 2' ' ' LEU . 0.0 OUTLIER -122.28 111.71 17.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 2.7 tt -106.11 116.69 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.167 0.508 . . . . 0.0 111.233 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -123.88 123.52 40.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.315 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -63.64 80.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.872 0.368 . . . . 0.0 111.623 -179.189 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.437 ' HB2' HG13 ' A' ' 32' ' ' ILE . 23.5 mtt180 -78.88 143.32 36.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.151 0.501 . . . . 0.0 110.503 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.43 ' HA ' ' HA3' ' B' ' 24' ' ' GLY . 2.9 tmt_? -173.37 -13.25 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.859 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 t -116.64 -58.68 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.674 0.273 . . . . 0.0 111.131 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.53 105.55 0.21 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.804 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.14 -73.89 0.65 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 110.77 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 8.8 m 69.61 102.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.436 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.418 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.4 OUTLIER -109.87 154.58 22.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.664 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 8.3 ttt -127.15 100.02 5.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.988 0.423 . . . . 0.0 110.769 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.76 138.2 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.734 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 121.28 -105.96 1.07 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.109 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.4 t70 -159.58 7.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.7 mt-10 162.69 59.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.981 0.42 . . . . 0.0 110.102 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 m -116.4 -158.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.632 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.403 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.1 OUTLIER 173.61 102.73 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.418 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 27.6 t -110.44 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 33.2 m -89.28 106.37 18.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.946 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 32.2 m -76.79 -168.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.905 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -173.38 141.32 0.9 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.095 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . -125.41 -24.43 1.59 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.97 130.79 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.525 0.202 . . . . 0.0 110.622 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.88 165.53 0.13 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 110.578 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.87 -100.01 0.01 OUTLIER Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.506 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -101.37 -30.88 11.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 110.372 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.447 ' HB3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -119.82 136.56 54.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.965 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 5' ' ' THR . 12.1 t -93.18 128.44 44.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.916 0.389 . . . . 0.0 111.636 -178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 2.4 ttp180 -80.8 99.52 8.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.45 HG13 ' HB2' ' A' ' 6' ' ' ARG . 9.6 mm -88.8 127.46 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.878 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.03 109.95 3.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.429 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.7 102.94 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 111.48 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' B' ' 19' ' ' THR . 1.8 t-20 -91.62 107.43 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.622 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.97 138.59 32.99 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.475 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.67 156.08 31.55 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.654 2.236 . . . . 0.0 112.134 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -82.03 2.28 31.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.603 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.88 -39.36 19.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.66 0.266 . . . . 0.0 111.187 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 t -86.67 146.8 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.042 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.01 100.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.3 122.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.752 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -128.1 136.4 51.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.684 0.278 . . . . 0.0 110.862 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.93 -175.79 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.491 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.31 145.7 31.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.86 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.62 -65.29 0.58 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.546 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.487 HD11 HG21 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -52.07 -40.8 30.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.37 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.431 ' CD2' HD22 ' A' ' 4' ' ' LEU . 8.0 t80 -46.86 -67.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.414 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.406 ' CB ' ' HB2' ' B' ' 53' ' ' ALA . 48.5 mt-30 -71.95 -21.95 61.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.632 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -70.57 -15.95 62.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.579 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 6.9 tt -112.17 -25.08 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.614 0.245 . . . . 0.0 111.501 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.82 -55.81 2.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 111.242 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.406 ' HB2' ' CB ' ' B' ' 49' ' ' GLN . . . -65.04 -71.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.168 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -108.33 116.97 32.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmm? . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.821 0.343 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mp -115.93 109.49 17.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.3 tt -84.52 111.35 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 0.0 111.443 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.18 156.25 23.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.729 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' B' ' 30' ' ' VAL . 0.2 OUTLIER -94.71 122.55 37.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 111.382 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.435 ' HB2' HG13 ' B' ' 32' ' ' ILE . 0.6 OUTLIER -95.6 148.97 21.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.645 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.469 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER 81.13 85.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.821 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 7' ' ' ARG . 47.3 t 80.72 56.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.287 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.51 -147.58 5.0 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.632 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.23 119.24 37.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 111.61 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 p -57.03 145.08 31.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.304 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.432 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -112.6 154.42 26.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.694 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.7 ttp -128.94 100.34 5.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.751 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.64 138.72 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.015 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.9 -106.27 0.95 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.151 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.4 p30 -158.58 7.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.6 OUTLIER 161.74 58.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.902 0.382 . . . . 0.0 110.044 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 m -114.37 -156.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.357 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.41 ' CG2' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 173.15 104.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.974 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.432 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 24.8 t -102.66 101.66 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.852 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -95.35 157.42 15.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.631 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 m -107.86 -172.39 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.309 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -124.05 -52.2 1.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 0.0 110.427 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' CA ' ' HG2' ' A' ' 7' ' ' ARG . . . 91.85 -43.47 2.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.996 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.56 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 4.0 t -85.65 149.91 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.525 0.202 . . . . 0.0 111.41 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 25' ' ' VAL . 28.1 tttp 99.07 122.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.068 0.547 . . . . 0.0 110.743 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.77 -179.51 37.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.762 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 63.63 -86.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -86.46 136.74 32.99 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.1 t -93.24 114.15 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.351 . . . . 0.0 110.874 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -89.28 99.87 12.77 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.888 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' B' ' 6' ' ' ARG . 24.0 mm -109.53 141.19 25.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.054 0.454 . . . . 0.0 111.667 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.82 107.48 2.58 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.919 -0.657 . . . . 0.0 111.987 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.8 103.41 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.904 0.383 . . . . 0.0 111.103 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.41 ' HB3' ' CG2' ' A' ' 19' ' ' THR . 1.2 t-20 -90.57 107.3 19.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.87 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.75 140.03 37.43 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.259 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.74 156.18 31.32 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.642 2.228 . . . . 0.0 112.28 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -80.32 0.16 34.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.355 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -78.01 -39.77 41.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.714 0.292 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 t -87.8 140.88 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.91 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 t -62.48 102.26 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.379 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.2 p -122.24 120.69 61.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -128.31 136.45 51.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.793 0.33 . . . . 0.0 111.199 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -139.62 -50.68 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.45 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 1.3 tp10 -178.29 141.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.514 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.51 -45.74 84.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.217 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -73.02 -38.51 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.67 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.409 ' O ' ' CB ' ' A' ' 52' ' ' GLN . 4.1 m-85 -51.54 -50.16 60.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -85.9 -52.81 5.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -16.35 12.62 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 mm -115.76 -57.92 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.409 ' CB ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -66.39 -48.07 71.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.104 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.85 -28.25 26.17 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 111.307 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -120.33 134.29 55.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.1 mttp . . . . . 0 N--CA 1.449 -0.514 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.147 -179.802 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmm? . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.804 0.335 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mp -115.96 109.5 17.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.847 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 18.3 tt -84.49 111.42 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.487 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.21 156.21 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.739 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.69 122.55 37.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.363 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.6 OUTLIER -95.65 148.97 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.635 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.468 ' O ' ' HB ' ' B' ' 8' ' ' VAL . 0.1 OUTLIER 81.22 85.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.767 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' B' ' 7' ' ' ARG . 47.3 t 80.64 56.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.287 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.5 -147.57 4.99 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.589 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.24 119.16 36.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.889 0.376 . . . . 0.0 111.614 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.5 p -57.04 145.04 31.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.263 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.438 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.2 OUTLIER -112.58 154.42 26.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.693 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 3.7 ttp -128.91 100.35 5.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.849 0.356 . . . . 0.0 110.723 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . 0.418 HG22 HD12 ' B' ' 14' ' ' ILE . 0.0 OUTLIER -114.66 138.77 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.981 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.83 -106.18 0.95 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.16 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.427 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.4 p30 -158.6 7.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.6 OUTLIER 161.77 58.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.018 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 m -114.31 -157.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.374 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.406 ' CG2' ' HB3' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 173.21 104.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.981 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.438 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 24.7 t -102.65 101.71 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.898 0.38 . . . . 0.0 110.807 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 9.9 t -95.36 157.41 15.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.609 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 m -107.81 -172.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.304 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -124.09 -52.19 1.76 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.83 0.347 . . . . 0.0 110.411 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.465 ' CA ' ' HG2' ' B' ' 7' ' ' ARG . . . 91.92 -43.41 2.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.989 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' B' ' 26' ' ' LYS . 4.0 t -85.77 149.94 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.492 0.187 . . . . 0.0 111.36 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' B' ' 25' ' ' VAL . 28.1 tttp 99.0 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.067 0.547 . . . . 0.0 110.799 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.78 -179.53 37.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.763 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 63.64 -86.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -86.46 136.71 33.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 5' ' ' THR . 4.1 t -93.19 114.1 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.351 . . . . 0.0 110.896 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -89.29 99.86 12.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.865 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 6' ' ' ARG . 24.0 mm -109.49 141.22 25.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.031 0.443 . . . . 0.0 111.719 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.85 107.53 2.58 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.979 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.85 103.43 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.926 0.393 . . . . 0.0 111.103 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.406 ' HB3' ' CG2' ' B' ' 19' ' ' THR . 1.2 t-20 -90.59 107.28 19.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.831 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.73 140.1 37.63 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.243 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.78 156.16 31.13 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.673 2.249 . . . . 0.0 112.268 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -80.31 0.23 33.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.428 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -78.07 -39.7 40.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.703 0.287 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 t -87.89 140.9 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.89 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -62.37 102.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.394 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.2 120.67 61.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.726 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -128.29 136.47 51.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.795 0.331 . . . . 0.0 111.147 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -139.62 -50.65 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.409 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.42 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 1.3 tp10 -178.3 141.34 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.543 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.51 -45.78 84.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.188 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.99 -38.52 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.651 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.42 ' HB2' ' HB3' ' B' ' 45' ' ' GLU . 4.1 m-85 -51.54 -50.15 60.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.75 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -85.92 -52.86 5.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.09 -16.21 12.24 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 17.1 mm -115.91 -57.88 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.413 ' CB ' ' O ' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -66.45 -48.06 71.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.09 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.84 -28.28 26.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 111.341 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' B' ' 55' ' ' LYS . 7.1 mt-10 -120.33 137.32 54.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.228 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' B' ' 54' ' ' GLU . 3.2 mtmp? . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.931 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.909 0.385 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mp -116.46 105.46 12.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.809 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 3.7 tt -84.8 108.99 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 tp -112.98 156.64 22.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.257 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.96 124.24 35.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.868 0.366 . . . . 0.0 111.021 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.497 ' HB2' ' CG1' ' B' ' 32' ' ' ILE . 0.0 OUTLIER -93.22 148.42 22.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.237 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER 83.34 90.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.401 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.406 ' CB ' ' O ' ' A' ' 7' ' ' ARG . 6.3 t 84.25 62.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.58 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.68 -146.9 4.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.383 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -113.26 118.17 33.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.845 0.355 . . . . 0.0 111.442 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.2 p -51.93 150.26 4.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.963 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.438 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -110.88 154.5 23.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.846 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.7 ttm -127.26 100.36 6.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.995 0.426 . . . . 0.0 110.906 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.401 ' HA ' HD11 ' A' ' 14' ' ' ILE . 3.8 tp -111.93 129.35 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.76 -102.76 0.61 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.165 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.565 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 5.4 p30 -166.24 8.41 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 31.6 tp10 167.29 57.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.98 -157.93 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.7 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 172.49 99.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.438 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 20.9 t -102.96 103.08 14.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.812 0.339 . . . . 0.0 111.77 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 m -87.22 146.84 25.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.242 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 22' ' ' VAL . 30.5 m -109.75 76.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.427 ' CG ' ' H ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -99.88 -151.11 0.39 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.307 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 31' ' ' ARG . . . 56.52 73.6 0.42 Allowed Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.098 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 7' ' ' ARG . 24.7 t -85.92 107.33 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.011 0.434 . . . . 0.0 111.627 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -137.21 142.82 42.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.906 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.53 -44.11 28.81 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.434 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -104.53 -86.25 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.939 0.369 . . . . 0.0 111.452 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -84.85 116.15 23.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.759 0.314 . . . . 0.0 111.172 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.0 m -93.81 136.51 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.189 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.528 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 4.9 mtt-85 -87.92 99.25 12.0 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.025 0.44 . . . . 0.0 110.1 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.495 ' CG1' ' HB2' ' B' ' 6' ' ' ARG . 27.3 mm -92.87 141.81 14.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.235 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.08 108.75 3.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.689 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 t -99.35 103.49 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.803 0.335 . . . . 0.0 111.049 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.1 t-20 -90.78 107.22 19.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.186 0.517 . . . . 0.0 110.62 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.43 141.32 38.57 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.247 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.99 156.19 30.38 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.615 2.21 . . . . 0.0 112.272 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -83.26 3.78 29.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.498 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -86.01 -36.87 19.5 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.695 0.283 . . . . 0.0 111.099 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 t -90.8 141.35 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.042 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -59.03 105.68 0.35 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.218 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.24 122.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.007 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.14 136.23 50.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.654 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.47 59.43 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 0.0 110.778 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.07 136.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -65.39 -41.85 93.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.834 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.7 mm -67.32 -54.43 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.129 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -47.19 -43.37 21.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.478 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.29 -55.01 5.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.353 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -56.93 -12.84 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.85 -57.3 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.715 0.293 . . . . 0.0 111.237 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -72.75 -57.99 3.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.892 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.29 -34.69 77.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 0.0 110.844 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -120.47 129.19 53.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.648 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? . . . . . 0 N--CA 1.453 -0.305 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.723 -179.345 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.871 0.367 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mp -116.47 105.5 12.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.76 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' B' ' 3' ' ' ILE . 3.7 tt -84.76 108.99 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.266 0.555 . . . . 0.0 111.143 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 tp -113.03 156.65 22.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.178 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.92 124.25 35.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.849 0.357 . . . . 0.0 111.028 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.495 ' HB2' ' CG1' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -93.21 148.34 22.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.243 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.454 ' CB ' ' O ' ' B' ' 6' ' ' ARG . 0.1 OUTLIER 83.32 90.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.402 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.419 ' CB ' ' O ' ' B' ' 7' ' ' ARG . 6.4 t 84.32 62.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.554 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.74 -146.96 4.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.394 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -113.22 118.14 33.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 111.44 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 19.2 p -51.92 150.22 4.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.991 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.436 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.2 OUTLIER -110.81 154.43 23.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.889 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 6.8 ttm -127.27 100.37 6.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.971 0.415 . . . . 0.0 110.872 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . 0.413 ' HA ' HD11 ' B' ' 14' ' ' ILE . 3.8 tp -111.9 129.32 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.78 -102.76 0.61 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.17 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 5.5 p30 -166.26 8.59 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 31.6 tp10 167.18 57.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.96 -157.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.729 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.419 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 172.48 99.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 21.0 t -102.94 103.04 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.791 0.329 . . . . 0.0 111.838 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 45.0 m -87.22 146.89 25.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.232 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.438 ' CG1' ' HG3' ' B' ' 6' ' ' ARG . 30.3 m -109.76 77.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.417 ' CG ' ' H ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -100.0 -151.09 0.39 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.28 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' B' ' 31' ' ' ARG . . . 56.56 73.56 0.43 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.112 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' B' ' 7' ' ' ARG . 24.5 t -85.9 107.39 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.01 0.433 . . . . 0.0 111.607 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -137.25 142.86 42.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.838 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.56 -44.14 29.02 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.42 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -104.53 -86.22 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.956 0.378 . . . . 0.0 111.478 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -84.92 116.1 23.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.789 0.328 . . . . 0.0 111.204 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 30.9 m -93.69 136.61 24.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.529 ' O ' ' HA3' ' B' ' 24' ' ' GLY . 4.9 mtt-85 -88.04 99.25 12.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.497 ' CG1' ' HB2' ' A' ' 6' ' ' ARG . 27.4 mm -92.81 141.74 14.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.24 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.06 108.74 3.01 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.719 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 27.0 t -99.33 103.5 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.843 0.354 . . . . 0.0 111.086 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' B' ' 19' ' ' THR . 1.1 t-20 -90.78 107.24 19.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 110.597 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.5 141.29 38.57 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.288 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.92 156.13 30.61 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.663 2.242 . . . . 0.0 112.221 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -83.19 3.75 29.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.524 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -85.98 -36.93 19.49 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.696 0.284 . . . . 0.0 111.091 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.0 t -90.65 141.29 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 111.055 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -59.06 105.69 0.35 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.184 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.28 122.55 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.11 136.25 50.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.734 0.302 . . . . 0.0 110.627 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.54 59.42 0.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.744 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.11 136.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -65.4 -41.86 93.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 36.4 mm -67.32 -54.48 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -47.15 -43.31 20.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.537 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.36 -54.98 5.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.331 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -56.97 -12.94 2.29 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.73 -57.33 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.676 0.274 . . . . 0.0 111.25 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -72.72 -57.88 3.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.954 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.41 -34.51 77.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.978 0.418 . . . . 0.0 110.847 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -121.77 133.58 54.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.795 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.626 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.793 0.33 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.6 tt -118.86 110.72 17.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 4.3 tt -96.86 105.36 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.143 0.497 . . . . 0.0 110.829 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.8 124.31 41.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.15 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -60.13 141.82 55.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.608 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -145.36 145.38 31.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.209 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 8.7 tmm_? 165.33 -10.86 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.224 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.6 t -149.38 1.31 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.93 -156.54 31.64 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.009 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.27 -163.91 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.764 0.316 . . . . 0.0 111.048 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 20' ' ' VAL . 17.6 p -107.53 163.14 13.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.426 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -112.24 154.68 25.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.264 179.574 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.63 100.16 5.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 111.251 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.434 ' HA ' HD11 ' A' ' 14' ' ' ILE . 6.9 tp -112.6 138.9 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.459 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.64 -104.54 1.11 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.3 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 4.2 t0 -153.51 1.0 0.25 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 3.2 mt-10 163.74 61.29 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.408 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 19' ' ' THR . 10.3 m -116.4 -157.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.308 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.409 ' N ' HG23 ' A' ' 18' ' ' VAL . 0.2 OUTLIER 174.53 106.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.426 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 13.2 t -102.87 106.09 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.93 0.395 . . . . 0.0 111.676 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.1 m -87.79 106.23 17.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.347 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 m -80.79 57.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.731 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 31' ' ' ARG . 32.0 tp -116.23 148.8 40.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.132 0.491 . . . . 0.0 110.692 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.99 65.0 0.11 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.36 107.78 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 121.168 0.509 . . . . 0.0 112.241 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.69 143.36 45.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.601 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.2 145.28 22.39 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.863 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.85 -82.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.636 0.255 . . . . 0.0 111.234 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -96.22 126.59 41.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.798 0.332 . . . . 0.0 111.091 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.3 t -93.58 134.35 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.07 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 6.4 mtm-85 -84.27 105.08 14.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.423 HG13 ' HB2' ' B' ' 6' ' ' ARG . 17.7 mm -91.89 133.91 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.331 . . . . 0.0 111.171 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.81 115.05 4.97 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.728 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.9 t -115.64 103.54 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.001 0.429 . . . . 0.0 111.814 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -97.44 107.44 19.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.219 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.71 150.07 72.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.783 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.74 156.48 13.8 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.081 2.521 . . . . 0.0 112.188 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 19.91 4.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.298 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.76 -38.81 5.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.662 0.267 . . . . 0.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 t -80.52 146.24 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.862 0.363 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.65 106.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.115 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.1 122.19 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.58 136.04 50.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.433 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -172.5 -69.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -164.49 121.29 1.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -65.38 -28.46 69.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.68 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.5 mm -70.95 -53.24 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.225 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -53.42 -42.55 67.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.405 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -78.12 -50.83 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.684 0.278 . . . . 0.0 111.51 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -61.03 -13.26 15.36 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 55.4 mt -112.39 -52.89 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.322 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.13 -57.54 5.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.081 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.31 -32.3 43.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 111.253 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.13 125.57 52.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? . . . . . 0 N--CA 1.451 -0.409 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.612 -179.52 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.795 0.331 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 9.6 tt -118.93 110.73 17.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 4.3 tt -96.91 105.39 17.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.136 0.494 . . . . 0.0 110.798 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.83 124.39 41.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.113 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -60.16 141.82 55.3 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.136 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.615 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -145.33 145.46 31.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.858 0.361 . . . . 0.0 111.156 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.615 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 8.7 tmm_? 165.31 -10.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.219 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 t -149.3 1.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.97 -156.47 31.59 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.982 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.32 -164.0 1.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.332 . . . . 0.0 111.057 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' B' ' 20' ' ' VAL . 17.6 p -107.47 163.18 13.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.2 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.422 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.1 OUTLIER -112.3 154.68 25.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.232 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -128.67 100.09 5.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 111.26 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 6.9 tp -112.55 138.89 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.536 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.65 -104.47 1.1 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.324 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 4.2 t0 -153.55 0.95 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.424 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 3.2 mt-10 163.73 61.27 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.966 0.413 . . . . 0.0 110.39 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.415 HG23 ' N ' ' B' ' 19' ' ' THR . 10.2 m -116.44 -157.08 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.327 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.415 ' N ' HG23 ' B' ' 18' ' ' VAL . 0.2 OUTLIER 174.53 106.43 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.422 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 13.2 t -102.92 106.13 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.978 0.418 . . . . 0.0 111.632 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 25.1 m -87.81 106.25 17.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.361 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 11.0 m -80.83 57.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.696 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 32.2 tp -116.34 148.84 40.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.157 0.503 . . . . 0.0 110.659 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.01 64.99 0.11 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.37 107.83 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.225 0.536 . . . . 0.0 112.215 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.78 143.29 45.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.595 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.11 145.21 22.16 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.986 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.92 -82.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.636 0.255 . . . . 0.0 111.196 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -96.3 126.62 41.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.842 0.353 . . . . 0.0 111.028 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 26.3 t -93.53 134.38 31.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 6.4 mtm-85 -84.27 105.08 14.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.761 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 6' ' ' ARG . 17.8 mm -91.97 134.03 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.349 . . . . 0.0 111.119 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.9 115.0 4.94 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.707 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 19.8 t -115.61 103.55 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 111.851 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -97.39 107.42 19.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.244 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.75 150.06 72.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.79 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.71 156.38 13.83 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.063 2.509 . . . . 0.0 112.229 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 19.93 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.346 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.77 -38.75 5.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.714 0.293 . . . . 0.0 111.125 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 t -80.53 146.21 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.981 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.54 106.31 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.196 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 10.2 p -122.15 122.24 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.811 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.6 136.12 50.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.368 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -172.64 -69.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 0.0 110.797 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 21.3 tp10 -164.49 121.24 1.59 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -65.32 -28.47 69.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.671 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.4 mm -70.92 -53.31 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' B' ' 45' ' ' GLU . 6.7 m-85 -53.32 -42.59 66.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.491 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -78.16 -50.82 11.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.527 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -61.02 -13.26 15.21 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 55.4 mt -112.38 -52.98 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.0 111.104 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.09 -57.58 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.105 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.26 -32.15 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.283 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -110.15 128.2 55.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.725 179.855 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.853 0.359 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 tt -116.3 114.09 23.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 mm -92.08 105.58 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.108 0.48 . . . . 0.0 110.625 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.421 HD11 ' CE1' ' B' ' 48' ' ' TYR . 0.2 OUTLIER -119.32 156.75 29.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.589 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.25 129.03 42.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.24 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.647 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 15.9 mtt180 -142.35 146.85 35.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.647 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.1 ttm180 165.33 -6.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.75 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.89 -62.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.808 0.337 . . . . 0.0 110.982 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.75 61.92 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.724 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -72.95 -69.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 110.625 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 m 71.75 101.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.483 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.431 ' HA ' ' HG2' ' B' ' 44' ' ' ARG . 1.1 pt? -111.26 154.77 23.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.075 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -127.61 100.06 5.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.016 0.436 . . . . 0.0 111.179 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.77 134.27 57.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.25 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.89 -104.91 0.86 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.061 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -150.19 1.6 0.48 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.3 mt-10 159.09 67.04 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.133 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 19' ' ' THR . 9.9 m -119.53 -155.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.723 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.42 ' N ' HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER 172.94 102.15 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 38.3 t -113.35 110.79 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -107.3 107.83 18.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.15 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 6' ' ' ARG . 29.9 m -80.28 74.87 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.062 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -156.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.06 71.9 1.3 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.92 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.401 ' HA ' ' CG ' ' A' ' 7' ' ' ARG . 10.7 t -86.19 107.68 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.083 0.468 . . . . 0.0 111.938 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.53 165.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -170.63 13.46 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.298 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.9 -28.57 14.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.882 0.372 . . . . 0.0 110.554 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -121.1 136.68 54.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -93.31 115.31 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.373 . . . . 0.0 111.553 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.51 98.84 7.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.874 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' B' ' 6' ' ' ARG . 4.6 mm -94.03 125.28 46.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.426 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.44 103.6 1.98 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.978 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.7 t -98.27 103.66 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.941 0.4 . . . . 0.0 111.893 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -92.63 107.46 19.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.077 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.8 147.71 55.38 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.017 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -79.66 156.55 24.57 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.966 2.444 . . . . 0.0 111.99 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -90.63 29.74 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.38 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.44 -40.32 5.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.669 0.271 . . . . 0.0 111.147 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.71 149.08 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.93 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.77 97.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.094 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.5 p -122.49 121.48 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.948 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.96 136.15 50.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.725 0.298 . . . . 0.0 110.404 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.428 ' HG2' ' HA ' ' B' ' 12' ' ' LEU . 0.0 OUTLIER -149.54 -62.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.719 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.47 133.49 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -65.36 -36.32 83.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.088 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 tp -74.28 -47.9 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.583 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.424 ' CE1' HD11 ' B' ' 4' ' ' LEU . 2.0 m-85 -55.84 -38.14 69.65 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -64.62 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -55.33 -15.86 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.9 mm -103.61 -56.55 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.653 0.263 . . . . 0.0 111.564 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.0 -56.97 4.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.678 0.275 . . . . 0.0 111.228 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.48 -25.27 63.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.297 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -131.6 146.75 52.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.916 0.388 . . . . 0.0 111.203 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.734 -179.708 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.774 0.321 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 tt -116.43 114.12 23.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 mm -92.06 105.53 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.052 0.453 . . . . 0.0 110.623 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.424 HD11 ' CE1' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -119.25 156.8 29.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.645 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.33 129.1 42.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.231 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.64 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 16.0 mtt180 -142.39 146.85 35.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.64 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 1.1 ttm180 165.29 -6.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.725 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.96 -62.9 2.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.782 0.325 . . . . 0.0 111.009 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.76 61.98 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.726 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -72.96 -69.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.612 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 5.7 m 71.75 101.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.551 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.428 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 1.1 pt? -111.11 154.74 23.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.154 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -127.64 100.11 5.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.062 0.458 . . . . 0.0 111.172 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.75 134.27 57.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.228 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.84 -104.88 0.86 Allowed Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.099 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 0.8 OUTLIER -150.2 1.59 0.47 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.3 mt-10 159.1 67.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.874 0.368 . . . . 0.0 110.175 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.413 HG23 ' N ' ' B' ' 19' ' ' THR . 10.0 m -119.53 -155.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 120.839 0.352 . . . . 0.0 111.703 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.413 ' N ' HG23 ' B' ' 18' ' ' VAL . 0.1 OUTLIER 172.92 102.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.425 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 38.4 t -113.37 110.86 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -107.34 107.79 18.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.23 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.42 ' CG2' ' HB2' ' B' ' 6' ' ' ARG . 30.5 m -80.24 74.98 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.019 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -156.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.731 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.13 71.87 1.3 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.921 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 t -86.22 107.66 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.083 0.468 . . . . 0.0 111.948 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.6 165.22 0.29 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.804 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.64 -170.64 13.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.324 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.88 -28.49 14.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.91 0.386 . . . . 0.0 110.579 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -121.19 136.7 54.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.97 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -93.35 115.37 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.948 0.404 . . . . 0.0 111.535 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.57 98.81 7.79 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.861 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.483 HD11 HG22 ' B' ' 32' ' ' ILE . 4.6 mm -93.98 125.28 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.417 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.51 103.56 1.97 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.964 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 17.5 t -98.15 103.63 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.937 0.399 . . . . 0.0 111.945 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -92.7 107.54 19.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.034 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.82 147.65 55.11 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.016 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.69 156.59 24.5 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.982 2.454 . . . . 0.0 112.0 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -90.71 29.81 1.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.328 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.43 -40.31 5.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.711 0.291 . . . . 0.0 111.159 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.0 t -81.7 149.1 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.78 97.8 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.076 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.56 121.46 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.91 136.15 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.676 0.274 . . . . 0.0 110.433 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.431 ' HG2' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -149.6 -62.72 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.952 0.406 . . . . 0.0 110.724 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.46 133.47 0.81 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.463 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.7 OUTLIER -65.28 -36.34 83.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 tp -74.31 -47.89 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.562 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.421 ' CE1' HD11 ' A' ' 4' ' ' LEU . 2.0 m-85 -55.66 -38.3 69.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -64.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' B' ' 46' ' ' GLU . 0.0 OUTLIER -55.28 -15.79 2.77 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.642 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 39.9 mm -103.65 -56.44 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.604 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.17 -56.86 4.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.758 0.313 . . . . 0.0 111.233 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.55 -25.17 62.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.203 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -132.32 146.05 51.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 0.0 111.179 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 mttm . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.337 179.454 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.888 0.375 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.8 tp -121.21 112.37 18.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 4.7 tt -99.79 105.74 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.222 0.535 . . . . 0.0 110.795 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.422 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 1.9 mm? -124.41 120.71 32.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.752 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -55.45 141.63 35.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.738 0.304 . . . . 0.0 110.806 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 5.3 mtt180 -150.95 143.94 24.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.058 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 5.7 ttp180 169.7 -4.17 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.756 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.44 -71.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.68 0.276 . . . . 0.0 111.199 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.88 90.48 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.697 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -110.15 -174.39 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.637 0.256 . . . . 0.0 110.56 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 170.82 101.28 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 111.041 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.462 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 1.2 pt? -115.31 154.1 29.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.397 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.1 ttm -129.53 100.7 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.096 0.474 . . . . 0.0 111.092 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 tp -114.73 123.29 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.531 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.23 -107.18 0.67 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.116 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -148.47 5.09 0.71 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 1.7 tt0 154.61 72.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.893 0.477 . . . . 0.0 109.969 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 m -122.31 -152.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.35 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.426 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 169.41 103.69 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.462 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 31.3 t -116.43 113.79 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.96 0.41 . . . . 0.0 111.858 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 t -110.88 112.9 25.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.33 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.421 ' CG2' ' CB ' ' A' ' 6' ' ' ARG . 26.9 m -80.81 75.55 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.802 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.61 -138.02 0.1 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.531 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.02 77.33 0.15 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.466 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.2 t -85.84 107.91 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 111.709 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.74 141.11 50.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.691 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.39 -50.39 5.58 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.57 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -101.57 -83.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.863 0.332 . . . . 0.0 111.262 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -87.18 118.99 26.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.0 111.126 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.4 m -93.33 136.34 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.186 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 5.0 mtm180 -78.13 106.44 10.01 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.483 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.5 mm -87.35 135.46 25.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.597 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.35 120.71 6.41 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.355 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -116.08 103.61 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.41 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.7 OUTLIER -98.08 107.67 20.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.571 179.641 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.35 142.36 26.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.503 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.29 156.35 25.67 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.724 2.283 . . . . 0.0 112.164 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.52 3.39 21.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.55 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -78.59 -41.91 30.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.71 0.291 . . . . 0.0 111.17 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 t -87.3 152.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.929 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 m -66.55 100.26 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.892 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.4 p -122.15 120.67 61.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.239 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.31 136.12 50.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.542 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.4 mtt85 -141.09 -64.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.437 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -168.88 136.15 1.9 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.748 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -55.0 -53.57 54.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.8 tt -65.08 -41.99 93.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.437 ' CG ' ' HB2' ' A' ' 45' ' ' GLU . 3.5 m-85 -45.46 -48.31 13.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.578 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -89.0 -49.33 6.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.463 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -53.59 -17.37 2.07 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 1.3 mp -111.52 -51.12 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.699 0.285 . . . . 0.0 111.013 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.18 -60.36 2.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.937 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.08 -36.61 77.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.895 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -114.31 123.8 50.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.289 -179.91 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.834 0.35 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 7.7 tp -121.18 112.31 18.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.414 ' CG2' ' O ' ' B' ' 3' ' ' ILE . 4.7 tt -99.77 105.73 17.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.146 0.498 . . . . 0.0 110.85 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.422 ' HG ' ' CD2' ' A' ' 48' ' ' TYR . 1.9 mm? -124.36 120.68 32.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.769 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -55.43 141.57 35.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.323 . . . . 0.0 110.735 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 5.3 mtt180 -150.95 143.95 24.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 5.7 ttp180 169.71 -4.13 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.758 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.45 -71.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.672 0.273 . . . . 0.0 111.171 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.88 90.4 0.13 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.703 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -110.09 -174.36 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.636 0.255 . . . . 0.0 110.591 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 170.79 101.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.082 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.457 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 1.2 pt? -115.33 154.08 29.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.427 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.1 ttm -129.46 100.73 5.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.057 0.456 . . . . 0.0 111.076 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 tp -114.83 123.31 70.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.493 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.2 -107.17 0.67 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.159 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 0.1 OUTLIER -148.4 5.09 0.71 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 1.7 tt0 154.65 72.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.895 0.478 . . . . 0.0 110.026 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 m -122.32 -152.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.305 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.425 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 169.45 103.74 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.457 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 31.9 t -116.47 113.82 44.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.931 0.396 . . . . 0.0 111.798 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.0 t -110.93 112.87 25.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.303 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.416 ' CG2' ' CB ' ' B' ' 6' ' ' ARG . 27.0 m -80.72 75.48 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.84 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.55 -138.03 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.565 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.96 77.35 0.14 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.481 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 37.2 t -85.9 107.9 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.037 0.446 . . . . 0.0 111.674 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.64 141.09 50.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.657 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.43 -50.37 5.62 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.267 -0.492 . . . . 0.0 113.587 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -101.61 -83.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.813 0.306 . . . . 0.0 111.235 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -87.22 118.99 27.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.915 0.388 . . . . 0.0 111.121 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 15.4 m -93.32 136.38 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.145 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 5.0 mtm180 -78.14 106.42 10.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.532 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 32.6 mm -87.33 135.4 25.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.002 0.429 . . . . 0.0 111.545 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.29 120.66 6.4 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.374 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -116.04 103.67 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 0.0 111.429 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' B' ' 19' ' ' THR . 0.7 OUTLIER -98.15 107.69 20.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.544 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.36 142.33 26.31 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.533 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -79.28 156.33 25.69 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.73 2.287 . . . . 0.0 112.195 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.51 3.45 21.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.537 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -78.69 -41.88 29.92 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.683 0.278 . . . . 0.0 111.129 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 t -87.26 152.07 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.987 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -66.62 100.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -122.16 120.66 61.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.233 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.35 136.06 50.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.74 0.305 . . . . 0.0 110.576 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 32.4 mtt85 -141.03 -64.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.899 0.38 . . . . 0.0 110.819 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.435 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 0.8 OUTLIER -168.85 136.21 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.738 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -55.02 -53.66 52.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.009 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 12.8 tt -64.98 -42.01 93.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.435 ' CG ' ' HB2' ' B' ' 45' ' ' GLU . 3.5 m-85 -45.4 -48.37 13.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.568 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -89.02 -49.34 6.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.464 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -53.56 -17.37 2.05 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.442 ' N ' ' CD1' ' B' ' 51' ' ' ILE . 1.3 mp -111.56 -50.98 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.708 0.289 . . . . 0.0 111.065 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.3 -60.32 2.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.896 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.63 77.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.886 0.374 . . . . 0.0 110.92 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -114.2 123.45 49.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.783 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.142 -179.779 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.839 0.352 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.1 105.39 13.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 3.9 tt -100.96 105.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.279 0.561 . . . . 0.0 111.08 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.22 119.71 29.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.85 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -58.02 149.55 22.99 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.724 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.19 144.32 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.978 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.431 ' HD3' ' CG1' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -163.93 25.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.561 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.52 -52.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.981 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.17 89.18 0.1 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.676 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.8 55.48 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.0 0.429 . . . . 0.0 110.674 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -61.45 101.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.457 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.405 ' CD2' ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -111.12 154.23 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.991 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -133.19 99.7 4.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.279 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.8 tp -118.04 138.7 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.723 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.06 -108.23 1.27 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.441 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -143.47 -5.41 0.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 3.2 tt0 163.31 65.28 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.5 m -117.28 -160.78 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.511 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.4 OUTLIER 175.74 104.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.405 ' CG2' ' CD2' ' A' ' 12' ' ' LEU . 27.2 m -115.54 106.87 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.65 109.51 21.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.361 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.84 70.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.602 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.81 -147.24 0.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.544 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 31' ' ' ARG . . . 63.19 79.67 0.14 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.165 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.431 ' CG1' ' HD3' ' A' ' 7' ' ' ARG . 85.9 t -85.91 107.36 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.001 0.429 . . . . 0.0 111.619 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.95 139.2 45.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.875 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.77 -50.66 7.15 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 113.753 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -101.36 -87.46 0.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.018 0.409 . . . . 0.0 111.452 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.403 ' HB3' HG22 ' B' ' 5' ' ' THR . 1.2 mp0 -84.87 119.63 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.5 m -93.3 136.83 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.631 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 4.8 mmt180 -76.99 103.76 7.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.944 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.405 HD11 HG21 ' A' ' 32' ' ' ILE . 8.4 mt -87.33 131.3 35.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.401 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 110.59 3.77 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.173 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.0 t -110.76 103.04 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.973 0.416 . . . . 0.0 111.565 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.8 t-20 -96.04 107.3 19.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.287 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.68 145.99 53.5 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.761 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.47 156.32 25.07 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.87 2.38 . . . . 0.0 112.145 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.35 35.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -119.17 -38.76 2.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.035 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 t -80.24 155.08 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.935 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -59.13 112.6 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.04 121.0 62.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -129.03 128.16 43.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.369 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.42 -69.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -157.03 116.66 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.78 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -60.92 -35.78 77.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.79 -43.34 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -51.5 -43.26 62.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.334 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -82.17 -41.74 19.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.255 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -72.62 0.17 11.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 tt -114.99 -45.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.756 0.312 . . . . 0.0 111.28 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -90.22 -50.07 6.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.732 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.23 -43.56 51.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.55 118.66 37.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.626 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.854 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.84 0.352 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.16 105.44 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.827 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' B' ' 3' ' ' ILE . 3.9 tt -100.98 105.16 17.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.22 0.533 . . . . 0.0 111.021 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.23 119.74 29.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.809 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -58.0 149.68 22.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.68 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.11 144.41 0.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.98 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.425 ' HD3' ' CG1' ' B' ' 25' ' ' VAL . 0.8 OUTLIER -164.03 25.93 0.07 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.638 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.51 -52.46 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.982 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.24 89.21 0.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.64 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.86 55.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.022 0.439 . . . . 0.0 110.648 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 25.7 m -61.53 101.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.522 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.412 ' CD2' ' CG2' ' B' ' 20' ' ' VAL . 0.1 OUTLIER -111.03 154.23 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.013 179.298 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -133.2 99.68 4.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.419 . . . . 0.0 111.289 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 8.7 tp -118.06 138.72 47.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.721 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.04 -108.11 1.26 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.528 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.8 OUTLIER -143.55 -5.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 3.3 tt0 163.23 65.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 11.6 m -117.22 -160.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.518 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.4 OUTLIER 175.71 104.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.412 ' CG2' ' CD2' ' B' ' 12' ' ' LEU . 27.7 m -115.51 106.78 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.57 109.46 21.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.376 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.81 70.4 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.582 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.95 -147.22 0.16 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.543 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' B' ' 31' ' ' ARG . . . 63.25 79.6 0.15 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.158 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.425 ' CG1' ' HD3' ' B' ' 7' ' ' ARG . 86.6 t -85.88 107.38 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.023 0.439 . . . . 0.0 111.614 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 139.22 45.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.814 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.76 -50.69 7.13 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.755 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -101.31 -87.51 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.984 0.392 . . . . 0.0 111.421 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.412 ' HB3' HG22 ' A' ' 5' ' ' THR . 1.2 mp0 -84.84 119.61 25.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.9 0.381 . . . . 0.0 110.865 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 18.4 m -93.3 136.88 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.624 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.8 mmt180 -77.03 103.7 7.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.049 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.404 HG21 HD11 ' B' ' 32' ' ' ILE . 8.5 mt -87.33 131.35 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.411 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.91 110.61 3.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.201 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 28.1 t -110.8 103.1 14.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.921 0.391 . . . . 0.0 111.524 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' B' ' 19' ' ' THR . 1.8 t-20 -96.08 107.29 19.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.279 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.67 145.92 53.25 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.815 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.43 156.36 25.22 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.863 2.375 . . . . 0.0 112.129 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.38 35.01 1.02 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.146 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -119.09 -38.9 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.741 0.305 . . . . 0.0 111.076 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 t -80.15 155.03 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.998 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -59.09 112.62 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.053 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.07 121.03 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -129.05 128.18 43.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.343 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 -69.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.72 0.295 . . . . 0.0 111.057 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -157.03 116.71 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.928 0.394 . . . . 0.0 110.734 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -60.94 -35.79 77.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.876 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.74 -43.38 47.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.111 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -51.35 -43.36 61.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.325 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -82.15 -41.83 19.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.229 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -72.54 0.17 11.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 tt -115.04 -45.66 4.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.755 0.312 . . . . 0.0 111.242 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -90.15 -50.05 6.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.714 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.25 -43.51 51.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.824 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.51 121.21 42.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.733 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.832 0.349 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.96 109.69 17.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 mm -97.2 105.34 17.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.09 0.471 . . . . 0.0 110.789 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.461 ' HG ' ' CG ' ' B' ' 48' ' ' TYR . 0.1 OUTLIER -124.23 110.42 14.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.2 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -62.9 77.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.961 0.41 . . . . 0.0 111.474 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.437 ' HB2' HG13 ' B' ' 32' ' ' ILE . 3.8 mtt-85 -80.12 143.68 33.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.321 0.581 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.453 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -170.59 -7.48 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.878 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.32 12.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.49 -139.25 9.36 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.864 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -107.08 -164.54 0.99 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.785 0.326 . . . . 0.0 111.178 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.3 p -110.02 169.34 8.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -109.35 154.31 22.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.597 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 ttp -129.73 100.29 5.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.07 0.462 . . . . 0.0 111.186 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.1 tp -114.32 124.69 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.486 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.11 -105.35 0.6 Allowed Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.058 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 2.2 t70 -160.81 11.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER 159.17 61.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.851 0.46 . . . . 0.0 109.781 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.8 m -118.3 -157.7 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.676 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.407 ' CG2' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 167.32 102.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.7 t -118.65 113.85 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.982 0.42 . . . . 0.0 111.951 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.0 m -96.03 113.08 24.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.549 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 24' ' ' GLY . 30.5 m -76.78 -19.0 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.862 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.89 -76.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.044 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . 92.41 -40.81 2.83 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.16 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 1.1 t -85.59 139.17 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.666 0.233 . . . . 0.0 110.938 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER 164.37 165.58 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.943 0.401 . . . . 0.0 110.715 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.71 105.59 2.05 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.151 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m120 64.45 -72.53 0.06 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 111.23 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.484 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -84.46 136.93 33.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.682 179.456 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.7 t -93.15 119.86 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.907 0.384 . . . . 0.0 111.794 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 0.1 OUTLIER -75.75 98.59 4.16 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.045 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' B' ' 6' ' ' ARG . 11.2 mm -92.18 123.42 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.39 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.77 119.24 6.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.26 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.74 103.73 15.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.922 0.391 . . . . 0.0 111.253 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.407 ' HB3' ' CG2' ' A' ' 19' ' ' THR . 3.6 t-20 -100.61 107.52 19.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.286 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.96 147.69 42.46 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.697 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.51 156.52 32.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.866 2.377 . . . . 0.0 112.126 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 30.35 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.25 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -106.08 -37.96 6.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.77 0.319 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.73 147.53 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -54.6 100.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.18 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.4 124.56 71.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.08 136.32 51.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.601 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -147.74 -176.85 5.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.57 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HB3' ' CG ' ' A' ' 48' ' ' TYR . 2.7 tt0 -59.32 137.99 57.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -61.29 2.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 tt -54.73 -42.05 59.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.349 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.467 ' CG ' ' HG ' ' B' ' 4' ' ' LEU . 4.5 m-30 -46.24 -58.85 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -75.97 -20.99 57.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.625 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -73.19 -13.84 61.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.596 0.236 . . . . 0.0 111.458 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.6 mt -108.91 -33.11 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.723 0.297 . . . . 0.0 111.361 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.93 -50.84 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.342 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.23 -69.03 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.924 0.393 . . . . 0.0 110.771 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -113.94 118.62 34.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.507 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.3 mttp . . . . . 0 N--CA 1.449 -0.493 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.643 179.779 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.815 0.34 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.87 109.65 17.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 13.0 mm -97.13 105.29 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.075 0.464 . . . . 0.0 110.861 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.467 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -124.22 110.45 14.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.178 179.064 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -62.95 77.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.011 0.434 . . . . 0.0 111.497 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' B' ' 4' ' ' LEU . 3.7 mtt-85 -80.06 143.67 33.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.329 0.585 . . . . 0.0 111.022 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.428 ' HA ' ' HA3' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -170.56 -7.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.905 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.24 12.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.43 -139.26 9.35 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.896 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -107.12 -164.5 0.99 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.159 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 8.5 p -110.07 169.37 8.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -109.39 154.36 22.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.519 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 1.6 ttp -129.76 100.26 5.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.462 . . . . 0.0 111.159 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . 0.405 ' HA ' HD11 ' B' ' 14' ' ' ILE . 3.1 tp -114.34 124.64 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.502 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.13 -105.46 0.61 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.127 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 2.2 t70 -160.67 12.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 0.2 OUTLIER 159.03 61.86 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.854 0.462 . . . . 0.0 109.77 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 8.8 m -118.41 -157.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.656 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.407 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 167.4 102.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 25.8 t -118.72 113.74 42.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.4 . . . . 0.0 111.946 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 4.0 m -95.96 113.16 24.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' B' ' 24' ' ' GLY . 31.0 m -76.75 -19.05 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.872 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.93 -76.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.02 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . 92.42 -40.85 2.82 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.165 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.423 ' O ' ' CB ' ' B' ' 26' ' ' LYS . 1.2 t -85.61 139.21 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.644 0.222 . . . . 0.0 110.943 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER 164.37 165.62 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.95 0.405 . . . . 0.0 110.736 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 29' ' ' GLN . . . -76.72 105.61 2.05 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.056 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m120 64.5 -72.63 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.903 0.382 . . . . 0.0 111.161 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 0.0 OUTLIER -84.47 136.98 33.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.631 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.14 119.82 41.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.847 0.356 . . . . 0.0 111.819 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -75.77 98.63 4.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.048 179.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.437 HG13 ' HB2' ' A' ' 6' ' ' ARG . 11.3 mm -92.18 123.33 44.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.334 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.71 119.23 6.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.332 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.73 103.7 15.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.878 0.371 . . . . 0.0 111.291 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' B' ' 19' ' ' THR . 3.6 t-20 -100.58 107.57 19.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.256 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.02 147.77 42.57 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.682 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -77.6 156.49 31.95 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.836 2.357 . . . . 0.0 112.161 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 30.22 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.233 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -106.01 -38.02 6.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.808 0.337 . . . . 0.0 110.89 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.63 147.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.947 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -54.58 100.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.204 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.34 124.54 71.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.09 136.29 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.631 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -147.74 -176.85 5.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.31 . . . . 0.0 110.631 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.433 ' HB3' ' CG ' ' B' ' 48' ' ' TYR . 2.7 tt0 -59.34 138.07 57.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 110.801 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -61.31 2.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 tt -54.72 -42.14 59.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.461 ' CG ' ' HG ' ' A' ' 4' ' ' LEU . 4.5 m-30 -46.2 -58.81 3.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -76.05 -20.93 57.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.609 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -73.28 -13.72 61.18 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 111.41 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 28.9 mt -109.09 -33.04 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.709 0.29 . . . . 0.0 111.357 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.98 -50.85 3.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.347 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.23 -69.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.969 0.414 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -114.05 119.59 37.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.402 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.733 179.955 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.789 0.328 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -122.22 116.69 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.805 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' A' ' 3' ' ' ILE . 4.2 tt -103.11 105.31 18.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.181 0.515 . . . . 0.0 110.786 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.414 HD21 ' CD1' ' B' ' 48' ' ' TYR . 4.1 tp -125.19 124.19 41.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.021 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -55.6 140.66 40.31 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.376 179.458 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 6.1 mtp85 -151.65 142.97 23.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.939 0.4 . . . . 0.0 111.426 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 172.82 -0.52 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.784 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.3 t -148.73 116.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.796 0.331 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.78 63.45 5.23 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.71 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 11' ' ' THR . 28.4 mm-40 -106.64 173.27 6.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.538 0.209 . . . . 0.0 110.723 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.415 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER 164.47 101.26 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.326 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.401 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -109.07 154.19 22.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.785 179.022 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -131.81 100.24 5.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.931 0.396 . . . . 0.0 111.307 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.2 tp -119.12 115.44 47.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.679 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.08 -106.76 0.51 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.912 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 11.8 t70 -150.74 8.64 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.1 mt-10 155.74 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.839 0.455 . . . . 0.0 109.879 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' MET . 16.6 m -135.58 131.41 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.861 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.1 m -116.09 117.05 29.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.401 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 4.9 t -108.89 110.84 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 111.784 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 t -102.24 104.61 15.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.239 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.88 71.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.241 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.11 -143.38 0.2 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.528 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.23 80.87 0.06 OUTLIER Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.797 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 t -110.28 108.28 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 120.844 0.354 . . . . 0.0 111.324 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -167.03 135.2 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.623 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.51 -153.33 19.26 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.765 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.65 -52.73 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -84.93 114.62 22.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 m -93.07 137.14 23.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 35.7 mtt180 -76.0 104.26 6.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.332 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.6 mm -87.22 137.38 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.901 0.381 . . . . 0.0 111.344 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.85 121.71 6.31 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.413 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 t -118.09 103.64 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.953 0.406 . . . . 0.0 111.431 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.25 107.59 19.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.299 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.07 144.82 22.6 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.822 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -83.0 156.27 15.17 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.85 2.367 . . . . 0.0 111.971 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 42.73 1.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.214 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -113.36 -43.72 3.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.715 0.293 . . . . 0.0 110.94 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.43 160.9 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.844 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.79 99.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.715 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.38 122.93 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.956 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.34 136.18 50.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.193 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.402 ' HD3' ' CD2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -161.76 -165.18 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.321 . . . . 0.0 110.766 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -64.26 136.71 57.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -55.08 -61.21 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 tt -55.95 -38.96 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.315 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.424 ' HB3' ' O ' ' A' ' 45' ' ' GLU . 43.3 t80 -46.71 -61.91 1.62 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -21.29 56.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.438 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 6.9 tpt180 -73.66 -10.94 60.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 52' ' ' GLN . 1.7 pt -114.29 -28.88 2.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.419 ' N ' HG13 ' A' ' 51' ' ' ILE . 13.1 mm-40 -104.83 -54.27 2.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.732 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.15 -66.01 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.699 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -110.26 117.52 33.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.648 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.484 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.818 0.342 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -122.26 116.63 24.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.879 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' B' ' 3' ' ' ILE . 4.2 tt -103.09 105.33 18.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.198 0.523 . . . . 0.0 110.774 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.417 HD21 ' CD1' ' A' ' 48' ' ' TYR . 4.1 tp -125.2 124.21 41.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.064 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -55.64 140.67 40.48 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.36 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 6.1 mtp85 -151.67 142.96 23.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.946 0.403 . . . . 0.0 111.427 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER 172.8 -0.54 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.821 179.438 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 17.3 t -148.66 116.75 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.781 0.324 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.7 63.47 5.21 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.705 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' B' ' 11' ' ' THR . 28.3 mm-40 -106.6 173.33 6.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.503 0.192 . . . . 0.0 110.768 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' THR . . . . . 0.416 ' CB ' ' O ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 164.47 101.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.409 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.0 154.19 22.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.789 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' B' ' 18' ' ' VAL . 0.5 OUTLIER -131.8 100.22 5.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 111.322 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 7.2 tp -119.06 115.45 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.708 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.08 -106.71 0.51 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.94 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 11.8 t70 -150.8 8.7 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.1 mt-10 155.7 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.811 0.444 . . . . 0.0 109.878 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' B' ' 13' ' ' MET . 16.5 m -135.64 131.42 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.827 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -116.05 117.04 29.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.86 110.82 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.868 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 1.4 t -102.22 104.62 15.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.216 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.88 71.04 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.291 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -143.35 0.2 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.476 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.19 80.79 0.06 OUTLIER Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.887 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 t -110.21 108.28 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 111.309 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -167.07 135.09 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.658 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.59 -153.36 19.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.806 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.67 -52.61 10.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 110.853 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -84.95 114.59 22.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.984 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 m -93.02 137.16 23.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.093 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 35.8 mtt180 -76.02 104.28 6.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.348 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 12.8 mm -87.29 137.37 21.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.933 0.396 . . . . 0.0 111.37 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.9 121.77 6.32 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.373 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 t -118.08 103.64 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 0.0 111.426 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.35 107.58 19.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.233 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.03 144.85 22.77 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.799 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -82.97 156.23 15.23 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.92 2.413 . . . . 0.0 111.979 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.81 42.67 1.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.218 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -113.26 -43.77 3.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.784 0.326 . . . . 0.0 110.971 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.46 160.93 3.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.769 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.71 99.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.758 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.4 122.89 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.954 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.34 136.16 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.402 ' HD3' ' CD2' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -161.76 -165.19 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.754 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.6 OUTLIER -64.32 136.67 57.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.966 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.7 OUTLIER -54.97 -61.27 2.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 tt -55.98 -38.91 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.299 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' B' ' 45' ' ' GLU . 43.1 t80 -46.74 -61.99 1.59 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -21.29 56.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.455 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' B' ' 46' ' ' GLU . 7.0 tpt180 -73.73 -10.9 60.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.572 0.225 . . . . 0.0 111.565 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.42 HG13 ' N ' ' B' ' 52' ' ' GLN . 1.7 pt -114.35 -28.62 2.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.797 0.332 . . . . 0.0 111.166 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.42 ' N ' HG13 ' B' ' 51' ' ' ILE . 13.0 mm-40 -104.95 -54.39 2.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.11 -65.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.726 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -110.5 117.82 34.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.546 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 tptm . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.453 179.736 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.753 0.311 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 mp -119.98 113.2 20.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 tt -105.04 107.86 23.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 110.737 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.428 ' HG ' ' CG ' ' B' ' 48' ' ' TYR . 1.4 mm? -124.09 126.03 45.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.095 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.76 145.2 46.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.409 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -155.89 146.28 21.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.164 0.507 . . . . 0.0 111.304 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.443 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 2.3 ttt180 175.92 74.31 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER 176.97 -60.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.663 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.74 82.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.73 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.17 -161.9 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.556 0.217 . . . . 0.0 110.569 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 172.35 89.43 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.633 0.254 . . . . 0.0 111.056 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.418 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -110.53 152.33 26.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.126 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.426 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -132.98 100.27 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.901 0.381 . . . . 0.0 111.546 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -111.35 127.07 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.258 179.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.52 -102.69 0.64 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.877 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.461 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.4 m-20 -165.77 17.39 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.4 OUTLIER 158.92 59.42 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.734 0.302 . . . . 0.0 110.884 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.426 ' CG2' ' HA ' ' A' ' 13' ' ' MET . 11.1 m -120.5 -157.37 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 120.638 0.256 . . . . 0.0 111.632 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.429 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 167.58 105.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.418 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 28.6 t -122.91 114.3 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.827 0.346 . . . . 0.0 111.737 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -104.4 118.4 36.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.513 ' O ' ' C ' ' A' ' 23' ' ' LEU . 17.1 m -91.85 63.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.427 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.513 ' C ' ' O ' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -13.16 -70.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.586 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . 90.74 -45.4 2.9 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.26 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -85.25 137.35 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 3.9 tptt 174.7 165.49 0.25 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.645 0.259 . . . . 0.0 110.383 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.37 -105.94 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.465 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.33 -41.5 11.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.069 0.461 . . . . 0.0 110.271 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -105.56 136.52 44.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.926 179.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.403 ' HA ' ' CB ' ' A' ' 26' ' ' LYS . 21.3 t -93.18 114.15 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 0.0 111.417 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.87 100.64 4.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.657 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.11 131.76 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.44 120.76 6.23 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.048 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -118.19 103.69 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.883 0.373 . . . . 0.0 111.199 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 19' ' ' THR . 3.0 t-20 -99.48 107.47 19.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.12 0.486 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.67 144.17 28.99 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.675 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.29 156.36 22.47 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.747 2.298 . . . . 0.0 112.129 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -93.25 34.6 1.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.103 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.42 -44.08 6.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.3 t -89.33 158.07 2.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.781 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.64 97.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.817 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.45 120.95 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.178 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -120.73 136.29 54.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -146.61 -176.32 5.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.69 0.281 . . . . 0.0 110.569 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.75 133.75 56.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 0.0 110.698 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -51.78 -60.27 3.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.31 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.419 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 1.3 tp -55.08 -42.86 67.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.482 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.435 ' CG ' ' HG ' ' B' ' 4' ' ' LEU . 2.7 m-85 -46.53 -68.08 0.22 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.443 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -70.52 -21.04 62.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.469 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 12.9 mtp85 -65.97 -23.02 66.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.677 0.275 . . . . 0.0 111.358 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.6 pt -109.91 -21.62 5.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -107.09 -58.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 111.441 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.44 -73.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.451 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.8 127.21 54.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.389 . . . . 0.0 111.12 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 93.49 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.027 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 t -48.32 -51.08 27.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.393 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -144.77 -71.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.04 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -179.24 167.12 1.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.918 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.1 p -146.13 151.34 37.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.769 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.8 t -97.99 120.96 39.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.944 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.787 0.327 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 mp -119.98 113.27 20.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 tt -105.05 107.84 23.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.09 0.472 . . . . 0.0 110.743 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.435 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 1.4 mm? -124.17 126.11 45.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.78 145.3 45.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.376 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -155.96 146.26 21.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.141 0.496 . . . . 0.0 111.27 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.439 ' HA ' ' HA3' ' B' ' 24' ' ' GLY . 2.3 ttt180 175.93 74.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.089 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER 176.87 -60.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.685 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.71 82.45 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.668 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.17 -161.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.547 0.213 . . . . 0.0 110.549 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 172.3 89.42 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.695 0.283 . . . . 0.0 111.095 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.417 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.2 OUTLIER -110.46 152.25 26.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.243 179.27 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.418 ' HA ' ' CG2' ' B' ' 18' ' ' VAL . 0.3 OUTLIER -132.96 100.36 4.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.4 . . . . 0.0 111.542 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.31 127.0 68.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.239 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.51 -102.64 0.64 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.888 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.4 m-20 -165.75 17.35 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.468 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.4 OUTLIER 158.9 59.55 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.747 0.308 . . . . 0.0 110.846 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.418 ' CG2' ' HA ' ' B' ' 13' ' ' MET . 11.2 m -120.6 -157.34 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.721 0.296 . . . . 0.0 111.55 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.424 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 167.61 105.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.417 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 28.9 t -122.94 114.34 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.32 . . . . 0.0 111.701 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 9.7 t -104.42 118.42 36.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.782 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.503 ' O ' ' C ' ' B' ' 23' ' ' LEU . 17.1 m -91.89 63.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.445 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.503 ' C ' ' O ' ' B' ' 22' ' ' VAL . 0.4 OUTLIER -13.19 -70.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.519 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . 90.75 -45.44 2.9 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.222 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -85.28 137.36 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.652 0.263 . . . . 0.0 110.831 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 3.9 tptt 174.69 165.52 0.25 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.64 0.257 . . . . 0.0 110.454 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.42 -105.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.445 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.32 -41.54 11.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.065 0.46 . . . . 0.0 110.265 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 0.2 OUTLIER -105.46 136.49 44.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.956 179.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.2 114.22 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 111.398 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.85 100.58 4.82 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.634 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 10.6 mm -87.11 131.76 34.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.42 120.72 6.22 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.091 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 16.2 t -118.17 103.72 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.899 0.38 . . . . 0.0 111.201 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' B' ' 19' ' ' THR . 3.0 t-20 -99.49 107.51 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.371 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.72 144.15 28.76 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.65 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.17 156.34 22.84 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.784 2.323 . . . . 0.0 112.152 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -93.29 34.67 1.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.44 -44.19 5.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 24.2 t -89.22 158.09 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.815 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.64 97.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.786 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.55 120.91 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.179 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -120.75 136.31 54.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.267 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -146.61 -176.3 5.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.522 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.73 133.75 56.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -51.8 -60.29 3.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.249 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.421 ' HA ' ' HB2' ' B' ' 50' ' ' ARG . 1.3 tp -55.05 -42.84 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.489 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.428 ' CG ' ' HG ' ' A' ' 4' ' ' LEU . 2.7 m-85 -46.57 -68.03 0.23 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.476 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -70.59 -21.03 62.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.498 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.421 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 13.0 mtp85 -65.96 -22.91 66.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.662 0.268 . . . . 0.0 111.35 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 18.6 pt -109.99 -21.76 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -107.04 -58.05 1.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.736 0.303 . . . . 0.0 111.468 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.47 -73.48 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.478 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.28 128.92 55.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.925 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.58 92.61 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.787 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 57.41 87.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.042 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -108.66 -47.54 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.967 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 63.22 -174.04 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.881 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -74.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.86 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.8 t -113.64 126.69 55.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.835 0.35 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 4.8 mp -119.87 116.07 25.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.707 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 mm -93.0 105.66 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.984 0.421 . . . . 0.0 110.58 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.41 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 2.5 mm? -116.77 156.79 26.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.666 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.01 133.63 41.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.951 0.405 . . . . 0.0 110.649 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -151.42 148.1 27.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.84 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 2.8 ttt180 177.39 -6.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.176 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.7 -57.29 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.768 0.318 . . . . 0.0 111.044 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.48 88.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.645 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.84 -70.55 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.732 0.301 . . . . 0.0 110.787 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m 75.87 103.45 0.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.529 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -108.94 154.46 22.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.967 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' B' ' 42' ' ' VAL . 24.5 ttp -128.12 100.54 5.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.097 0.475 . . . . 0.0 111.24 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.408 ' CD1' ' HB ' ' B' ' 42' ' ' VAL . 2.1 tp -112.78 122.97 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.423 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.8 -104.87 0.54 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.996 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.5 t70 -159.41 11.65 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 157.4 61.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.964 0.412 . . . . 0.0 109.954 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.7 m -118.48 -155.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.723 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.428 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 168.59 103.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.72 111.22 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 111.769 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.29 113.07 25.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.48 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.6 m -84.76 62.94 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.779 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.32 121.83 3.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . -99.52 -15.71 31.36 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.001 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.2 t -85.48 125.8 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.743 0.271 . . . . 0.0 110.473 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 1.3 tpmp? 176.9 165.29 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.814 0.34 . . . . 0.0 110.66 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 29' ' ' GLN . . . -90.96 108.42 3.58 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.539 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 65.68 -69.52 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.876 0.37 . . . . 0.0 110.796 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 1.8 mt-30 -84.82 136.57 33.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.62 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 t -93.0 119.69 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.044 0.45 . . . . 0.0 111.493 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -82.88 98.21 9.07 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.3 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' B' ' 6' ' ' ARG . 4.7 mm -93.05 127.66 45.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.61 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.08 112.38 4.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.328 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.0 t -106.35 103.68 15.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.871 0.367 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -98.37 107.33 19.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.368 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.16 146.08 52.85 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.677 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -83.44 156.22 14.33 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.005 2.47 . . . . 0.0 112.358 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -3.25 41.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.332 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -42.63 70.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.643 0.259 . . . . 0.0 111.171 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 t -91.0 152.53 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.803 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.3 t -76.09 106.08 7.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.966 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' B' ' 13' ' ' MET . 14.6 p -121.07 120.23 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.46 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -128.68 134.32 48.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.666 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.65 -49.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.706 0.288 . . . . 0.0 111.257 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.442 ' CB ' ' CG ' ' A' ' 48' ' ' TYR . 3.4 mm-40 -161.27 124.49 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.929 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.45 -59.07 5.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.101 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.1 -42.49 83.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.176 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.442 ' CG ' ' CB ' ' A' ' 45' ' ' GLU . 3.1 m-85 -44.25 -58.06 3.11 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.401 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . 11.6 pt20 -76.65 -21.62 55.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.793 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -67.38 -15.01 63.44 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.261 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.44 HG22 HD12 ' A' ' 51' ' ' ILE . 23.7 mm -116.05 -26.43 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.337 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.57 -58.66 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.909 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.401 ' CB ' ' HB2' ' A' ' 49' ' ' GLN . . . -60.78 -64.09 1.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.588 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -109.58 116.28 31.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.387 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER 149.67 -35.59 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.792 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m 64.56 176.88 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.224 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -177.46 -53.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -104.4 -174.51 2.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.803 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.2 p -121.0 158.94 26.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.8 m -110.2 133.6 53.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.82 0.343 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' B' ' 2' ' ' LEU . 4.8 mp -119.88 116.09 25.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 mm -93.05 105.73 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.994 0.426 . . . . 0.0 110.579 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' B' ' 4' ' ' LEU . 2.5 mm? -116.77 156.78 26.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.679 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.01 133.63 41.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.949 0.404 . . . . 0.0 110.653 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -151.44 148.11 27.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.796 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 2.8 ttt180 177.37 -6.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.13 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.67 -57.3 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.805 0.336 . . . . 0.0 111.044 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.47 88.34 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.601 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.88 -70.59 0.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.759 0.314 . . . . 0.0 110.735 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m 75.83 103.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.604 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -108.87 154.44 22.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.951 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 42' ' ' VAL . 24.4 ttp -128.09 100.47 5.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 111.227 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . 0.404 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 2.1 tp -112.74 122.93 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.87 -104.81 0.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.993 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.47 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.5 t70 -159.49 11.71 0.13 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.3 OUTLIER 157.35 61.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.699 0.399 . . . . 0.0 109.943 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.48 -155.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.705 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.429 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 168.66 103.13 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 25.3 t -119.71 111.21 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.866 0.365 . . . . 0.0 111.785 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.29 113.04 25.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.486 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.68 62.91 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.841 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.33 121.84 3.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . -99.57 -15.61 31.5 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.053 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' B' ' 26' ' ' LYS . 2.2 t -85.51 125.78 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.69 0.245 . . . . 0.0 110.465 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 1.3 tpmp? 176.91 165.3 0.5 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.626 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' B' ' 29' ' ' GLN . . . -91.0 108.34 3.57 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.55 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 65.77 -69.5 0.11 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.879 0.371 . . . . 0.0 110.739 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 1.8 mt-30 -84.8 136.57 33.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 5.3 t -92.99 119.78 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 0.0 111.497 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -82.95 98.26 9.13 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.281 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 6' ' ' ARG . 4.7 mm -93.08 127.7 45.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.636 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.08 112.33 4.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.384 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 27.0 t -106.3 103.67 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.846 0.355 . . . . 0.0 111.242 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' B' ' 19' ' ' THR . 0.1 OUTLIER -98.36 107.35 19.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.369 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.19 146.1 52.86 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.633 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -83.46 156.26 14.28 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.966 2.444 . . . . 0.0 112.356 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -3.36 41.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.35 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.49 -42.71 71.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.689 0.28 . . . . 0.0 111.184 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 t -90.98 152.58 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.802 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 39.4 t -76.08 105.98 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.982 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 13' ' ' MET . 14.6 p -121.0 120.17 61.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.494 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -128.63 134.3 48.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.665 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.66 -49.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 111.309 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.442 ' CB ' ' CG ' ' B' ' 48' ' ' TYR . 3.4 mm-40 -161.23 124.53 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.5 -59.04 5.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.1 -42.52 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.198 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.442 ' CG ' ' CB ' ' B' ' 45' ' ' GLU . 3.1 m-85 -44.22 -58.05 3.1 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.755 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.77 -21.52 55.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.782 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.411 ' HA ' ' HG2' ' B' ' 54' ' ' GLU . 0.8 OUTLIER -67.47 -14.75 63.21 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.34 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.402 HG22 HD12 ' B' ' 51' ' ' ILE . 23.6 mm -116.23 -26.76 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.311 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.24 -58.7 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.95 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.8 -63.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.629 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.411 ' HG2' ' HA ' ' B' ' 50' ' ' ARG . 0.0 OUTLIER -111.21 120.06 41.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.649 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.05 95.86 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.447 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.77 -166.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.505 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.47 29.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.757 0.313 . . . . 0.0 111.062 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.79 148.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 1.2 m -159.85 130.34 5.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.7 t -91.98 132.64 36.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.952 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.823 0.344 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.0 mp -122.03 107.39 12.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.1 tt -115.06 114.73 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.181 0.515 . . . . 0.0 110.967 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.45 ' HB3' ' CZ ' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -125.44 135.67 52.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.824 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -62.37 150.86 38.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -170.67 148.03 2.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.25 0.548 . . . . 0.0 111.474 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.402 ' CG ' ' HA3' ' A' ' 24' ' ' GLY . 2.2 ttp180 -176.69 7.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.782 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.62 -61.59 2.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.331 . . . . 0.0 111.011 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.6 86.05 0.16 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.494 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -82.02 171.68 14.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t 178.8 122.71 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.402 ' CD2' ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -144.39 141.36 29.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.402 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.0 ttt -133.0 99.73 4.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.419 . . . . 0.0 111.09 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.4 ' CG2' ' CG2' ' B' ' 14' ' ' ILE . 0.0 OUTLIER -116.3 129.27 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.484 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.8 -105.09 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.907 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.3 p30 -162.76 16.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 6.9 mt-10 158.2 60.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.849 0.357 . . . . 0.0 110.501 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.36 -159.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 120.766 0.317 . . . . 0.0 111.646 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 168.57 103.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.402 ' CG2' ' CD2' ' A' ' 12' ' ' LEU . 35.1 m -122.57 114.37 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.9 p -108.2 117.03 33.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.299 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.4 m -108.88 54.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.349 . . . . 0.0 111.693 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pp -47.94 151.17 0.97 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.863 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' HA3' ' CG ' ' A' ' 7' ' ' ARG . . . -107.7 2.56 34.11 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.601 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -85.21 120.66 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.928 0.364 . . . . 0.0 110.618 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER 174.73 165.34 0.25 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.76 0.315 . . . . 0.0 110.675 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.81 108.28 3.14 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.852 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.02 -74.41 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.859 0.362 . . . . 0.0 111.043 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 16.8 mt-30 -84.72 136.26 33.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.013 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.33 117.2 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 111.535 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.64 99.85 4.45 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.515 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.1 mm -87.08 124.5 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.165 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 118.43 6.09 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.569 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.7 t -117.79 103.53 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 0.0 111.396 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.4 OUTLIER -99.38 107.53 19.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.501 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.97 143.36 24.8 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.654 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.12 156.49 33.77 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.759 2.306 . . . . 0.0 112.078 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -89.17 30.08 1.0 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.278 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.58 -38.64 7.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 t -93.25 159.35 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.848 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.8 t -65.28 97.94 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.009 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.31 120.76 62.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.857 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.12 136.39 51.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.722 0.296 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -133.38 -176.12 4.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -64.17 147.79 51.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -50.96 -60.68 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.199 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 tp -55.07 -35.6 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.203 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' B' ' 4' ' ' LEU . 0.4 OUTLIER -53.04 -73.14 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.033 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . 5.3 pt20 -64.2 -17.28 63.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.542 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.48 -31.26 69.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.728 0.299 . . . . 0.0 111.328 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.0 mm -104.53 -12.84 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.917 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -114.88 -57.74 2.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.666 0.269 . . . . 0.0 111.716 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 49' ' ' GLN . . . -67.53 -71.69 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.383 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -118.18 117.82 30.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.003 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -55.34 111.32 0.85 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.993 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 m 55.43 -84.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.297 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -153.96 169.58 23.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.8 0.333 . . . . 0.0 110.82 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -163.47 86.84 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.43 159.42 16.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.68 136.51 52.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.937 179.986 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptt? . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.781 0.324 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 5.0 mp -122.06 107.39 12.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.971 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 3.0 tt -115.09 114.81 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.216 0.531 . . . . 0.0 110.942 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -125.49 135.73 52.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.763 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.39 150.9 38.44 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -170.69 148.04 2.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.268 0.556 . . . . 0.0 111.464 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -176.74 7.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.789 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.67 -61.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.848 0.356 . . . . 0.0 111.032 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.54 86.1 0.16 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -82.11 171.72 14.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.739 0.304 . . . . 0.0 110.944 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t 178.77 122.71 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.125 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.37 141.35 29.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.41 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 4.0 ttt -133.03 99.7 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . 0.4 ' CG2' ' CG2' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -116.29 129.33 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.478 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.76 -105.09 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.936 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.3 p30 -162.82 16.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 7.0 mt-10 158.19 60.84 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.857 0.361 . . . . 0.0 110.552 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 17.6 m -120.33 -159.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 120.807 0.337 . . . . 0.0 111.651 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 168.59 103.6 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.53 114.42 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.9 p -108.26 117.03 33.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.221 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 30.4 m -108.84 54.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.724 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pp -47.91 151.1 0.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.69 2.63 34.14 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.568 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -85.24 120.65 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.973 0.387 . . . . 0.0 110.588 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER 174.74 165.34 0.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.807 0.336 . . . . 0.0 110.634 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.8 108.22 3.13 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.813 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.03 -74.49 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 111.003 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 16.8 mt-30 -84.7 136.2 33.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.994 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.25 117.21 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.976 0.417 . . . . 0.0 111.532 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.61 99.8 4.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.543 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.05 124.51 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.114 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 118.39 6.08 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.558 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -117.75 103.57 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.41 . . . . 0.0 111.383 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' B' ' 19' ' ' THR . 0.4 OUTLIER -99.49 107.54 19.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.48 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.96 143.37 24.88 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.585 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.12 156.49 33.77 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.752 2.301 . . . . 0.0 112.066 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -89.14 29.95 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.281 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.47 -38.73 7.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.791 0.329 . . . . 0.0 110.816 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.19 159.31 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 5.8 t -65.21 97.89 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.029 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.29 120.79 62.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.866 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 136.38 51.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.752 0.311 . . . . 0.0 110.767 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -133.34 -176.07 4.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.693 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -64.27 147.81 51.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.03 -60.62 2.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 tp -55.0 -35.6 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.285 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -53.1 -73.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.039 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.404 ' HB2' ' CB ' ' B' ' 53' ' ' ALA . 5.3 pt20 -64.26 -17.32 63.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.531 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -31.17 69.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.734 0.302 . . . . 0.0 111.367 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 29.2 mm -104.64 -12.58 9.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.854 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -115.12 -57.85 2.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.709 0.29 . . . . 0.0 111.746 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.404 ' CB ' ' HB2' ' B' ' 49' ' ' GLN . . . -67.48 -71.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.33 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -117.81 116.94 27.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.706 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -60.2 109.8 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.18 -66.86 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.107 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? 78.0 -58.41 0.46 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -89.15 58.17 4.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 89.3 p -152.56 134.53 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -117.48 121.38 40.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.871 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.32 117.02 25.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.413 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 4.1 tt -97.97 104.76 16.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.221 0.534 . . . . 0.0 110.5 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.44 121.52 34.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.223 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -54.35 138.59 39.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.104 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 72.1 mtt180 -148.66 144.77 27.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.296 0.57 . . . . 0.0 111.787 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 174.98 -77.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.551 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.73 3.75 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.139 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.52 -139.49 4.4 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.907 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -108.61 -175.49 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.869 0.366 . . . . 0.0 111.218 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.5 p -102.17 165.53 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.028 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.447 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -110.53 154.63 23.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.525 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttt -130.67 100.06 5.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.072 0.463 . . . . 0.0 111.389 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.8 tp -115.9 125.52 73.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.505 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.49 -106.32 0.62 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.078 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.412 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.6 t0 -155.57 4.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 3.1 mt-10 163.37 61.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.017 0.436 . . . . 0.0 109.993 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.51 -159.91 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.824 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 171.49 99.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.447 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 42.9 t -106.42 107.52 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.827 0.346 . . . . 0.0 111.669 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 m -91.2 112.77 24.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.021 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.76 70.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.497 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.03 -152.76 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 31' ' ' ARG . . . 60.36 66.44 2.71 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.996 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -85.88 107.77 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 120.979 0.419 . . . . 0.0 111.049 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.1 165.41 36.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.136 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.98 156.45 47.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.512 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 70.03 -89.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.404 0.145 . . . . 0.0 110.985 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -110.48 124.56 52.02 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.906 0.384 . . . . 0.0 111.082 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.0 m -93.32 137.37 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.318 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 4.7 mtp180 -78.09 102.91 7.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.418 HG13 ' HB2' ' B' ' 6' ' ' ARG . 14.7 mm -87.32 134.52 27.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.137 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.53 115.79 4.99 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.512 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.12 103.34 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.944 0.402 . . . . 0.0 111.336 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -96.43 107.23 19.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.075 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.06 147.96 33.68 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.9 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.37 156.29 25.39 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.919 2.413 . . . . 0.0 111.984 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -91.38 41.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.114 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.15 -41.92 3.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.994 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 t -81.48 158.9 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.35 99.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.784 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 p -122.18 124.23 70.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.986 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -128.53 136.18 50.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.311 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -166.98 -170.67 1.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.719 0.295 . . . . 0.0 110.709 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 30.7 mm-40 -54.04 123.97 14.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.008 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.48 -54.91 41.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.115 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.0 tp -60.21 -41.18 85.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.026 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.418 ' CG ' ' HB2' ' A' ' 45' ' ' GLU . 4.4 m-85 -47.42 -55.51 8.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.237 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -80.0 -21.9 43.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.139 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -71.23 -13.33 61.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.285 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.4 tt -115.7 -36.39 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.877 0.37 . . . . 0.0 110.65 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -87.45 -58.3 2.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.098 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.51 -51.65 67.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.258 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -112.57 116.73 30.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.596 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.64 117.0 1.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.644 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.1 t -109.81 26.8 10.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.008 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -145.98 61.32 1.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.949 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.58 118.33 26.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 t -98.78 36.66 1.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.4 t -102.73 128.05 49.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.926 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.894 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttp . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.789 0.328 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 5.0 mp -122.35 117.02 25.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -98.03 104.81 16.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.219 0.533 . . . . 0.0 110.494 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.47 121.52 34.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.253 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -54.39 138.6 39.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.082 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 72.0 mtt180 -148.66 144.72 27.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.258 0.551 . . . . 0.0 111.802 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER 175.01 -77.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.491 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.72 3.73 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.211 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.5 -139.5 4.39 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.922 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -108.59 -175.52 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.923 0.392 . . . . 0.0 111.174 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 22.5 p -102.18 165.54 11.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.084 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.447 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -110.51 154.62 23.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.526 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttt -130.64 100.03 5.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.009 0.433 . . . . 0.0 111.395 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 5.8 tp -115.89 125.5 73.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.505 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.53 -106.32 0.62 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.065 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 2.6 t0 -155.61 4.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 3.1 mt-10 163.34 61.12 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.996 0.427 . . . . 0.0 110.0 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.48 -159.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.831 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 171.51 99.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.342 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.447 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 43.0 t -106.49 107.58 23.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.822 0.344 . . . . 0.0 111.602 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.2 m -91.22 112.89 24.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.979 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 26.3 m -76.9 70.55 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.457 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.07 -152.79 0.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.681 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' B' ' 31' ' ' ARG . . . 60.42 66.38 2.75 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.992 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 t -85.79 107.74 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.05 165.47 36.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.192 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.04 156.43 47.33 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.481 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 70.08 -89.51 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.041 0.136 . . . . 0.0 110.97 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -110.45 124.53 51.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.895 0.379 . . . . 0.0 111.158 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 m -93.26 137.41 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.381 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.8 mtp180 -78.19 102.94 7.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.424 HG13 ' HB2' ' A' ' 6' ' ' ARG . 14.9 mm -87.34 134.58 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.57 115.76 4.97 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.503 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.17 103.3 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 111.264 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -96.41 107.22 19.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.085 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.08 147.92 33.51 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.922 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.29 156.28 25.63 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.951 2.434 . . . . 0.0 112.007 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -91.34 41.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.166 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.14 -41.93 3.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 t -81.48 158.89 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.809 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.31 99.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.829 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 p -122.2 124.18 70.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.959 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -128.51 136.25 50.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.311 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -167.03 -170.71 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.722 0.296 . . . . 0.0 110.711 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.431 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 30.5 mm-40 -54.03 123.98 14.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 111.049 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.48 -54.93 41.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 8.0 tp -60.2 -41.17 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.059 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.431 ' CG ' ' HB2' ' B' ' 45' ' ' GLU . 4.4 m-85 -47.41 -55.49 8.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.256 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -79.91 -21.98 43.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.173 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -71.25 -13.3 61.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.252 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 1.4 tt -115.71 -36.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.657 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -87.45 -58.3 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.085 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.47 -51.67 67.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.309 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -112.61 116.75 30.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.522 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.52 105.47 0.53 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.951 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -75.28 -179.96 4.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.788 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 54.85 72.9 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.034 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -78.67 147.43 33.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 14.9 m -111.98 117.88 33.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 51.5 p -112.95 128.38 56.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.884 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.871 0.367 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -119.73 112.84 19.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.403 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 4.1 tt -99.97 105.03 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.179 0.514 . . . . 0.0 110.827 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.421 ' HG ' ' CD2' ' B' ' 48' ' ' TYR . 0.2 OUTLIER -124.76 121.49 34.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.036 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -56.16 140.59 43.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 0.0 110.618 179.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 66.8 mtt85 -155.84 145.33 20.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.422 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 0.0 OUTLIER 179.11 1.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.975 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 177.2 30.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 120.532 0.206 . . . . 0.0 111.356 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.93 -118.13 3.51 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.762 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -110.13 -178.31 3.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.912 0.387 . . . . 0.0 111.203 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.6 168.04 10.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.737 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.431 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -111.52 154.51 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -127.39 100.56 6.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.43 . . . . 0.0 110.873 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.1 tp -112.7 125.48 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.606 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.43 -105.44 0.65 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.195 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 12.0 m-20 -156.8 6.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 0.8 OUTLIER 161.15 61.89 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.23 -157.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.526 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 172.53 101.61 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.431 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 59.0 t -111.04 108.19 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.88 0.372 . . . . 0.0 111.697 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.1 p -105.08 110.43 22.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.011 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.2 m -77.4 72.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.61 -143.56 0.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.628 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.5 74.31 0.27 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.819 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.6 t -93.03 108.3 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.92 157.57 45.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.018 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.8 148.02 50.71 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.72 -79.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.634 0.254 . . . . 0.0 110.767 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -116.78 126.28 52.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.986 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.5 m -93.39 136.93 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.269 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 3.9 mtt85 -77.93 104.91 8.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.257 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.46 HG22 HD12 ' A' ' 32' ' ' ILE . 12.0 mm -87.37 137.75 20.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.848 0.356 . . . . 0.0 111.328 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.86 117.41 5.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.472 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 t -118.08 103.18 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.411 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.6 OUTLIER -95.74 107.17 19.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.378 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.11 145.49 55.85 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.588 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.28 156.32 29.33 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.834 2.356 . . . . 0.0 112.121 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.26 26.75 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.185 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -40.23 5.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.849 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -82.45 152.85 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.5 98.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.077 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.17 120.59 61.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.1 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -128.55 136.17 50.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.405 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -165.53 -40.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.685 0.279 . . . . 0.0 111.135 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' N ' ' HG3' ' A' ' 44' ' ' ARG . 1.2 mm-40 177.86 114.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.962 0.41 . . . . 0.0 110.882 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -58.48 -38.78 78.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.684 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.1 mm -69.33 -43.23 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.837 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.424 ' CD2' ' HG ' ' B' ' 4' ' ' LEU . 2.8 m-85 -51.36 -42.68 61.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.416 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -87.72 -58.9 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 111.534 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -52.2 -21.38 3.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.3 mm -106.07 -50.58 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.79 -58.79 3.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.668 0.271 . . . . 0.0 111.299 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.09 -29.71 69.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.343 . . . . 0.0 111.23 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.2 tt0 -137.97 157.53 46.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 54' ' ' GLU . 1.8 tttp 81.79 -56.5 0.25 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.879 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.68 159.3 15.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.709 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.7 -56.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.957 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -69.04 -30.87 69.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.5 t -116.66 80.76 1.52 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.7 p -122.2 120.97 35.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.886 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.833 0.349 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -119.75 112.85 19.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' B' ' 3' ' ' ILE . 4.1 tt -100.0 105.09 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.252 0.548 . . . . 0.0 110.79 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.424 ' HG ' ' CD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -124.81 121.55 34.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.019 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -56.24 140.66 43.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.369 . . . . 0.0 110.589 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 66.7 mtt85 -155.9 145.34 20.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.42 ' O ' ' CG1' ' B' ' 8' ' ' VAL . 0.0 OUTLIER 179.06 1.55 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.959 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER 177.13 30.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.573 0.225 . . . . 0.0 111.371 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.0 -118.18 3.5 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.685 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -110.15 -178.31 3.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.955 0.407 . . . . 0.0 111.178 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.57 168.04 10.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.805 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.415 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.8 OUTLIER -111.49 154.5 24.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.516 179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -127.42 100.46 6.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.022 0.439 . . . . 0.0 110.918 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 3.1 tp -112.69 125.5 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.563 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.46 -105.47 0.65 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.2 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 12.0 m-20 -156.89 6.97 0.17 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 0.8 OUTLIER 161.09 61.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.631 0.372 . . . . 0.0 110.023 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.23 -157.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.568 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 172.55 101.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.415 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 58.4 t -111.0 108.1 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.816 0.341 . . . . 0.0 111.747 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 5.0 p -104.98 110.45 22.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.03 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 30.7 m -77.5 72.56 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.56 -143.65 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.638 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.53 74.32 0.27 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.818 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 10.6 t -93.08 108.33 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 111.279 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.89 157.57 45.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.999 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.83 148.04 50.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.74 -80.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.642 0.258 . . . . 0.0 110.741 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -116.72 126.26 52.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.88 0.371 . . . . 0.0 110.96 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.5 m -93.4 136.98 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 3.9 mtt85 -77.95 104.93 8.81 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.254 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.454 HD12 HG22 ' B' ' 32' ' ' ILE . 12.2 mm -87.38 137.83 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.858 0.361 . . . . 0.0 111.305 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.94 117.44 5.14 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.458 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 t -118.03 103.14 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 111.489 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' B' ' 19' ' ' THR . 0.6 OUTLIER -95.8 107.22 19.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.17 145.5 55.79 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.597 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.28 156.34 29.32 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.814 2.343 . . . . 0.0 112.07 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.23 26.77 2.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.221 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.3 -40.28 5.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.753 0.311 . . . . 0.0 110.831 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -82.38 152.81 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.42 98.63 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.121 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.19 120.61 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.104 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -128.51 136.18 50.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.553 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' B' ' 45' ' ' GLU . 0.0 OUTLIER -165.57 -40.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 0.0 111.133 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.406 ' N ' ' HG3' ' B' ' 44' ' ' ARG . 1.2 mm-40 177.83 114.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.965 0.412 . . . . 0.0 110.918 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -58.52 -38.64 78.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.714 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 35.9 mm -69.38 -43.21 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.804 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.421 ' CD2' ' HG ' ' A' ' 4' ' ' LEU . 2.8 m-85 -51.38 -42.74 61.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.347 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -87.77 -58.82 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.771 0.319 . . . . 0.0 111.522 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -52.14 -21.54 3.39 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 40.2 mm -105.93 -50.51 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -58.8 3.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.713 0.292 . . . . 0.0 111.314 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.07 -29.71 69.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.342 . . . . 0.0 111.199 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -138.05 156.78 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -92.95 82.42 4.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.774 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 23.1 t -53.56 -35.32 60.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.209 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 65.08 72.57 0.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.88 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -132.63 -57.14 0.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 4.5 m -68.9 168.54 13.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.42 138.88 35.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.871 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.804 0.335 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.6 tt -116.55 103.15 10.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 4.1 tt -98.08 105.48 17.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.195 0.521 . . . . 0.0 110.785 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 tp -125.28 121.33 33.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.924 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -56.88 149.3 18.84 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.389 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.446 ' HG2' ' HB2' ' A' ' 10' ' ' GLU . 1.1 tpt180 -179.53 143.15 0.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.224 0.535 . . . . 0.0 111.399 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.41 ' NE ' ' CG1' ' A' ' 25' ' ' VAL . 36.4 ttt180 -170.1 23.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.063 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.08 -53.43 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.165 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.08 105.49 0.19 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.683 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . 0.7 OUTLIER -113.13 -58.25 2.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 0.0 110.869 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p 65.52 96.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.124 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.42 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 1.6 pt? -114.57 154.72 27.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.069 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 34.8 ttm -128.98 99.93 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.059 0.457 . . . . 0.0 111.015 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.412 ' HA ' HD11 ' A' ' 14' ' ' ILE . 6.1 tp -118.02 102.86 13.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.814 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.28 -107.33 0.32 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.972 -0.633 . . . . 0.0 111.887 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.36 -4.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 165.05 57.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.8 m -112.45 -161.58 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.816 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.5 OUTLIER 170.13 102.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 21.4 t -111.2 110.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.906 0.384 . . . . 0.0 111.894 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.4 m -98.35 111.65 23.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.767 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.5 m -77.01 68.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.347 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.45 -142.39 0.26 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.751 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 31' ' ' ARG . . . 53.82 70.77 0.84 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.566 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.41 ' CG1' ' NE ' ' A' ' 7' ' ' ARG . 40.5 t -85.94 107.66 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.909 0.385 . . . . 0.0 111.455 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -143.97 151.57 39.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.046 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.43 150.54 47.16 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.419 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 72.58 -75.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.606 0.241 . . . . 0.0 111.004 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -120.95 128.84 53.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.985 0.422 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 m -93.29 137.18 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.248 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 0.1 OUTLIER -75.77 104.63 6.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.28 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.3 mm -87.47 130.14 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.215 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.73 108.44 3.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.156 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.28 103.17 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 111.615 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 19' ' ' THR . 3.6 t-20 -96.19 107.22 19.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.384 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.9 146.84 58.53 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.715 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.58 156.36 21.55 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.961 2.441 . . . . 0.0 112.104 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -92.47 32.87 1.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.188 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.32 -41.26 3.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.739 0.304 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 t -77.9 160.68 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.79 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 t -66.75 106.68 1.92 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.838 0.352 . . . . 0.0 110.859 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.94 126.11 74.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -128.88 124.1 34.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.207 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -156.76 -65.82 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 110.461 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 5.3 tp10 -171.69 130.46 0.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.56 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -58.79 -38.75 79.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.047 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.1 mt -73.05 -43.56 58.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.302 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 3.2 m-85 -50.46 -46.63 56.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.651 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -58.09 3.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.401 ' HA ' ' CB ' ' A' ' 54' ' ' GLU . 3.6 mtp85 -55.05 -9.78 0.43 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.86 -55.45 4.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 O-C-N 122.258 -0.276 . . . . 0.0 111.728 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 7.2 mp0 -75.89 -54.3 7.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 110.999 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.04 -36.83 61.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.892 0.377 . . . . 0.0 110.962 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 50' ' ' ARG . 3.7 tp10 -103.56 122.42 44.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.753 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.59 96.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.877 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.4 t -62.74 157.23 21.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -94.9 125.55 39.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -64.37 129.61 40.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.1 -169.0 2.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.808 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.3 t -91.92 121.0 33.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.853 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.0 t80 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.86 -179.925 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.832 0.349 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 6.6 tt -116.58 103.12 10.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -98.04 105.56 17.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.26 0.552 . . . . 0.0 110.763 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 tp -125.32 121.37 33.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.831 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -56.97 149.27 19.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.397 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.457 ' HG2' ' HB2' ' B' ' 10' ' ' GLU . 1.1 tpt180 -179.53 143.17 0.19 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.253 0.549 . . . . 0.0 111.418 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.402 ' NE ' ' CG1' ' B' ' 25' ' ' VAL . 36.2 ttt180 -170.18 23.53 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.102 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.07 -53.51 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.161 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.13 105.52 0.19 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.703 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.457 ' HB2' ' HG2' ' B' ' 6' ' ' ARG . 0.7 OUTLIER -113.1 -58.33 2.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 110.854 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.9 p 65.53 96.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.165 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.425 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 1.6 pt? -114.48 154.76 27.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.121 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 34.8 ttm -129.04 99.96 5.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.01 0.433 . . . . 0.0 111.032 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 6.1 tp -117.97 102.85 13.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.854 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.3 -107.34 0.32 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.883 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.39 -4.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 165.07 57.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 m -112.42 -161.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.796 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.5 OUTLIER 170.09 102.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.443 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.425 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 21.4 t -111.22 110.16 31.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 111.948 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 6.4 m -98.35 111.65 23.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.794 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 17.5 m -76.98 68.42 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.312 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.52 -142.38 0.26 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.401 ' HA3' ' CB ' ' B' ' 31' ' ' ARG . . . 53.86 70.77 0.84 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.556 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.402 ' CG1' ' NE ' ' B' ' 7' ' ' ARG . 40.4 t -85.96 107.62 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.0 111.428 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -143.97 151.57 39.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.031 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.46 150.49 47.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.476 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 72.62 -75.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.585 0.231 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -121.05 128.78 52.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 111.089 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 m -93.23 137.16 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.266 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -75.77 104.6 6.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.289 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 9.3 mm -87.44 130.17 37.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.201 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.78 108.44 3.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.161 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.24 103.17 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.91 0.385 . . . . 0.0 111.577 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' B' ' 19' ' ' THR . 3.6 t-20 -96.13 107.15 19.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.402 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.85 146.78 58.38 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.751 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.57 156.34 21.56 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.963 2.442 . . . . 0.0 112.101 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -92.46 32.93 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.224 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.34 -41.21 3.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.78 0.324 . . . . 0.0 110.973 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 t -77.94 160.76 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.792 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 3.8 t -66.81 106.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 0.0 110.839 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.95 126.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.142 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -128.91 124.15 34.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.168 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -156.77 -65.84 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.441 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 5.3 tp10 -171.72 130.49 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.586 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -58.81 -38.73 79.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 mt -73.03 -43.49 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.307 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.402 ' HB2' ' HB3' ' B' ' 45' ' ' GLU . 3.2 m-85 -50.61 -46.47 58.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.635 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -58.11 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -55.13 -9.71 0.44 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.86 -55.53 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 7.2 mp0 -75.88 -54.32 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.684 0.278 . . . . 0.0 110.93 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.06 -36.72 61.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.945 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -103.79 124.01 48.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.1 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.09 -87.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.059 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 7.0 t 62.48 147.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.81 0.338 . . . . 0.0 110.742 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -130.92 -50.96 1.04 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -147.38 146.37 29.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.981 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -61.11 -53.96 50.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.9 p -121.94 124.4 43.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 11.4 t80 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.894 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mmm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.882 0.372 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 5.2 mp -116.7 104.74 11.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.682 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 mm -96.83 105.13 16.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 110.74 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.461 ' HG ' ' CG ' ' B' ' 48' ' ' TYR . 0.6 OUTLIER -124.63 116.7 22.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.976 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -54.7 140.22 36.45 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.394 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 24.3 mtt180 -154.76 141.13 18.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.184 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 179.11 4.3 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.299 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.24 -76.41 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 O-C-N 122.213 -0.304 . . . . 0.0 111.517 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.33 97.94 0.51 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.662 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 6' ' ' ARG . 6.6 mp0 -113.21 174.7 5.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.723 0.297 . . . . 0.0 111.034 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.402 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER 164.86 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.141 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.435 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -112.35 154.1 26.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.4 ttp -133.29 100.69 4.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.053 0.454 . . . . 0.0 111.755 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.405 ' HA ' HD11 ' A' ' 14' ' ' ILE . 5.1 tp -114.36 120.61 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.186 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.85 -106.92 0.59 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.058 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.466 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -152.55 6.43 0.41 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 4.6 mt-10 159.31 64.19 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.907 0.384 . . . . 0.0 110.29 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 m -118.85 -158.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 35' ' ' ASN . 0.1 OUTLIER 170.18 104.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 22.0 t -117.95 116.14 50.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.0 111.751 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.0 t -114.79 115.63 27.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.006 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.404 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 26.7 m -80.95 73.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.389 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.91 -136.04 0.1 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.472 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.05 74.7 0.21 Allowed Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.933 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.04 108.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.465 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -140.24 153.38 46.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.048 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.15 149.45 47.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.453 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 69.14 -83.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.638 0.256 . . . . 0.0 110.721 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -107.32 125.24 50.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.356 . . . . 0.0 110.947 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 m -93.13 136.89 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.283 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 28.8 mtt85 -75.96 104.39 6.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.491 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' B' ' 6' ' ' ARG . 28.4 mm -87.17 131.36 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.281 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.5 125.12 8.14 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.745 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.2 t -118.05 129.72 73.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.835 0.35 . . . . 0.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 19' ' ' THR . 2.4 t-20 -123.16 107.21 11.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.13 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.86 144.25 26.12 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.745 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.93 156.45 30.7 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.736 2.29 . . . . 0.0 112.081 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.08 38.01 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.398 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.73 -38.7 4.2 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.759 0.314 . . . . 0.0 110.803 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.3 t -89.58 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -57.49 97.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.943 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.35 120.71 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 136.11 50.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.674 0.274 . . . . 0.0 110.81 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -147.4 -172.6 4.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.54 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.42 ' HB3' ' CG ' ' A' ' 48' ' ' TYR . 1.5 tp10 -63.16 139.2 58.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.766 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -62.36 1.67 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.383 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.41 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 39.1 mm -56.82 -45.57 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.792 0.329 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.458 ' CG ' ' HG ' ' B' ' 4' ' ' LEU . 4.1 m-30 -41.5 -73.33 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.545 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.403 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . 13.8 pt20 -66.48 -19.26 65.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.54 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.41 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 6.0 mtm180 -69.0 -20.0 64.15 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.39 -23.87 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 4.3 pt20 -107.68 -52.38 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.623 0.249 . . . . 0.0 111.547 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.403 ' CB ' ' HB2' ' A' ' 49' ' ' GLN . . . -70.36 -72.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 111.224 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.5 118.81 37.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.727 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -56.72 95.42 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.138 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.9 p 49.05 95.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.222 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -84.03 57.82 4.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.955 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.3 151.45 51.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.6 151.3 38.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.734 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -122.39 120.67 34.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.912 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.7 mmm . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.87 0.367 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.436 ' N ' ' CD1' ' B' ' 2' ' ' LEU . 5.2 mp -116.76 104.74 11.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 mm -96.81 105.17 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.98 0.419 . . . . 0.0 110.725 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.458 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -124.66 116.67 22.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.961 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -54.72 140.24 36.54 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.413 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.494 ' HB3' ' HG2' ' B' ' 10' ' ' GLU . 24.4 mtt180 -154.74 141.13 18.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.205 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER 179.1 4.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.269 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.24 -76.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 O-C-N 122.167 -0.333 . . . . 0.0 111.544 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.33 97.89 0.51 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.666 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.494 ' HG2' ' HB3' ' B' ' 6' ' ' ARG . 6.6 mp0 -113.16 174.7 5.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.748 0.309 . . . . 0.0 111.051 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.403 ' CB ' ' O ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 164.81 91.71 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.14 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.443 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -112.31 154.05 26.27 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.4 ttp -133.26 100.58 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.999 0.428 . . . . 0.0 111.785 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . 0.439 ' HA ' HD11 ' B' ' 14' ' ' ILE . 5.1 tp -114.33 120.61 64.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.189 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.86 -106.92 0.59 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.086 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 0.4 OUTLIER -152.53 6.46 0.41 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.469 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 4.6 mt-10 159.32 64.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.957 0.408 . . . . 0.0 110.289 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 m -118.78 -158.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.417 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.459 ' O ' ' HB3' ' B' ' 35' ' ' ASN . 0.1 OUTLIER 170.18 104.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.443 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 21.9 t -117.9 116.1 50.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 0.0 111.741 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 3.0 t -114.75 115.62 27.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.005 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.402 ' CG1' HG21 ' B' ' 32' ' ' ILE . 26.8 m -80.97 73.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.0 0.429 . . . . 0.0 111.343 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.94 -136.08 0.1 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.483 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.08 74.67 0.22 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.975 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.99 108.15 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 0.0 111.47 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -140.27 153.34 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.058 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.11 149.45 47.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.465 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 69.06 -83.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.541 0.21 . . . . 0.0 110.701 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -107.35 125.24 50.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 110.941 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 m -93.14 136.91 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.32 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 28.6 mtt85 -76.0 104.35 6.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.454 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.412 HG13 ' HB2' ' A' ' 6' ' ' ARG . 28.4 mm -87.15 131.32 35.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.299 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.47 125.2 8.17 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.792 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 12.4 t -118.1 129.75 73.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.827 0.346 . . . . 0.0 111.063 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' B' ' 19' ' ' THR . 2.4 t-20 -123.23 107.26 11.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.074 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.89 144.22 25.91 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.75 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.83 156.45 31.08 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.797 2.331 . . . . 0.0 112.103 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.09 38.02 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.38 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.77 -38.69 4.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.79 0.329 . . . . 0.0 110.804 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 13.3 t -89.63 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.846 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -57.42 97.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.013 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.38 120.75 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 136.13 50.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.657 0.265 . . . . 0.0 110.816 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -147.41 -172.66 4.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.421 ' HB3' ' CD1' ' B' ' 48' ' ' TYR . 1.5 tp10 -63.01 139.19 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.824 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -62.33 1.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.421 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.415 ' HA ' ' HB2' ' B' ' 50' ' ' ARG . 39.2 mm -56.86 -45.53 83.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.78 0.324 . . . . 0.0 111.164 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.461 ' CG ' ' HG ' ' A' ' 4' ' ' LEU . 4.1 m-30 -41.52 -73.34 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.568 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.403 ' HB2' ' CB ' ' B' ' 53' ' ' ALA . 13.8 pt20 -66.48 -19.24 65.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.538 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.415 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 6.0 mtm180 -69.0 -19.92 64.14 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.57 -23.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' B' ' 48' ' ' TYR . 4.3 pt20 -107.82 -52.29 2.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.563 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.403 ' CB ' ' HB2' ' B' ' 49' ' ' GLN . . . -70.47 -72.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.807 0.337 . . . . 0.0 111.185 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.58 119.43 39.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.617 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.47 93.17 0.1 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.733 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 4.0 t 55.14 87.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.999 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -70.0 141.86 52.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -143.17 173.51 11.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 58.2 m -88.92 155.2 19.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -97.44 140.44 31.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.94 -179.92 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.799 0.333 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.419 ' HB3' ' CE2' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -118.11 108.48 15.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.2 tt -84.36 115.0 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.009 0.433 . . . . 0.0 111.535 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.405 HD12 ' CZ ' ' B' ' 48' ' ' TYR . 0.3 OUTLIER -115.1 156.24 25.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.653 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' B' ' 30' ' ' VAL . 0.3 OUTLIER -95.8 121.22 37.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 0.0 111.476 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.538 ' HB2' HG13 ' B' ' 32' ' ' ILE . 0.0 OUTLIER -92.21 149.16 21.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.475 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 6.6 mtp180 78.01 87.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.706 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 7' ' ' ARG . 56.2 t 80.74 55.49 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.193 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.89 -148.54 4.96 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.536 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.28 121.46 44.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 111.616 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -58.55 147.53 31.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.402 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.82 154.73 31.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.766 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.6 ttt -127.91 100.7 6.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 0.0 110.766 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 tp -115.42 137.7 48.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.952 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.71 -107.19 0.89 Allowed Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.339 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -153.39 -4.42 0.19 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 1.0 OUTLIER 171.38 57.43 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 m -111.31 -159.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.615 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 173.72 102.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.6 t -102.93 101.99 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.856 0.36 . . . . 0.0 111.172 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -93.17 157.3 16.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.22 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -106.86 -173.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.577 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.38 -53.52 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 0.0 110.291 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.464 ' CA ' ' HG2' ' A' ' 7' ' ' ARG . . . 93.64 -39.99 2.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.162 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 11.4 t -85.66 149.83 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.596 0.236 . . . . 0.0 111.495 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 25' ' ' VAL . 10.8 tttp 101.25 116.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.245 0.618 . . . . 0.0 110.85 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.81 174.74 46.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.683 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.83 -84.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.677 0.275 . . . . 0.0 110.301 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.9 136.95 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.423 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' B' ' 5' ' ' THR . 21.7 t -92.89 115.71 32.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.807 0.337 . . . . 0.0 110.888 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -86.44 99.46 11.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.99 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.536 HG13 ' HB2' ' B' ' 6' ' ' ARG . 33.0 mm -112.76 135.57 51.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.935 0.397 . . . . 0.0 111.425 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.37 112.72 4.19 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.302 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.07 103.17 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 111.103 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.7 107.29 19.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.638 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.02 145.52 56.06 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.431 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.24 156.55 19.65 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.93 2.42 . . . . 0.0 112.231 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -89.45 27.29 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.278 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -112.67 -37.17 4.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.757 0.313 . . . . 0.0 111.034 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.1 t -81.82 144.64 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.806 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -54.89 100.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.0 p -122.09 124.11 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.077 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.57 136.17 50.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.373 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -151.86 -60.69 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.931 0.396 . . . . 0.0 110.612 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 178.78 143.7 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.655 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -43.83 92.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.617 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.4 mm -64.56 -49.08 82.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.061 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' B' ' 2' ' ' LEU . 88.9 t80 -50.63 -45.84 57.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.55 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -75.55 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 111.729 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -51.44 -17.35 0.76 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.5 mt -108.89 -54.78 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.75 0.309 . . . . 0.0 111.205 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HG3' ' CD1' ' A' ' 48' ' ' TYR . 60.5 mm-40 -69.14 -62.05 1.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.922 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.3 -33.54 75.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.008 0.433 . . . . 0.0 110.731 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -118.19 124.06 47.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.606 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -52.69 110.45 0.51 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.267 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.1 t -72.28 177.19 4.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.747 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.5 114.84 4.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -176.99 114.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.83 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.4 160.44 6.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 p -115.95 134.78 54.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.826 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.825 0.345 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.422 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -118.07 108.44 15.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 5.3 tt -84.38 115.05 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 111.531 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.41 HD12 ' CZ ' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -115.12 156.15 25.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.686 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -95.7 121.19 37.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.018 0.437 . . . . 0.0 111.446 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.536 ' HB2' HG13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -92.21 149.12 21.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.53 179.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.476 ' O ' ' HB ' ' B' ' 8' ' ' VAL . 6.6 mtp180 78.02 87.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.691 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' B' ' 7' ' ' ARG . 55.3 t 80.67 55.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.188 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.88 -148.54 4.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.593 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.24 121.4 44.33 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.879 0.371 . . . . 0.0 111.614 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -58.48 147.57 31.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.413 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.83 154.76 31.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.728 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.6 ttt -127.97 100.59 5.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.856 0.36 . . . . 0.0 110.775 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . 0.4 ' HA ' HD11 ' B' ' 14' ' ' ILE . 4.6 tp -115.37 137.75 47.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.71 -107.22 0.89 Allowed Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.329 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.3 OUTLIER -153.41 -4.37 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 1.0 OUTLIER 171.27 57.42 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 m -111.33 -159.48 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.564 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 173.84 102.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.501 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 41.4 t -102.84 101.89 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.821 0.343 . . . . 0.0 111.227 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -93.1 157.25 16.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.237 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 34.9 m -106.81 -173.11 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.545 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.48 -53.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 110.3 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.47 ' CA ' ' HG2' ' B' ' 7' ' ' ARG . . . 93.61 -39.89 2.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.157 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.573 ' O ' ' CB ' ' B' ' 26' ' ' LYS . 11.4 t -85.66 149.82 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.543 0.211 . . . . 0.0 111.502 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' B' ' 25' ' ' VAL . 10.8 tttp 101.22 116.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.249 0.62 . . . . 0.0 110.804 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.84 174.78 46.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.644 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.75 -84.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.657 0.265 . . . . 0.0 110.319 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.89 136.96 33.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.437 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 5' ' ' THR . 21.6 t -92.89 115.7 32.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.361 . . . . 0.0 110.905 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -86.45 99.48 11.68 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.994 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.538 HG13 ' HB2' ' A' ' 6' ' ' ARG . 33.2 mm -112.77 135.63 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 111.395 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.44 112.72 4.18 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.294 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 25.4 t -98.11 103.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.093 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.66 107.25 19.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.659 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.98 145.51 56.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.476 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.29 156.46 19.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.891 2.394 . . . . 0.0 112.193 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -89.32 27.25 1.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.314 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -112.68 -37.22 4.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 110.995 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.1 t -81.69 144.63 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.825 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -54.96 100.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.128 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 13.1 p -122.13 124.07 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.062 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.48 136.2 50.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.407 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -151.88 -60.73 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.625 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 178.79 143.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.614 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.72 -43.86 92.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.932 0.396 . . . . 0.0 110.615 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 42.4 mm -64.59 -49.05 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.061 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 2' ' ' LEU . 88.8 t80 -50.68 -45.78 58.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.541 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -75.6 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.713 0.292 . . . . 0.0 111.715 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -51.47 -17.28 0.75 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 mt -109.0 -54.67 5.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.761 0.315 . . . . 0.0 111.221 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.417 ' HG3' ' CD1' ' B' ' 48' ' ' TYR . 60.6 mm-40 -69.16 -62.14 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.854 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.33 -33.36 75.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.97 0.414 . . . . 0.0 110.769 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -119.08 127.19 53.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.839 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 105.64 0.68 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.536 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -170.09 0.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.922 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -57.67 12.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.83 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -76.0 -66.89 0.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.814 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 29.1 t 58.22 100.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.041 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 82.6 p -97.6 145.15 26.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.801 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.92 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.805 0.336 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.51 102.83 10.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.034 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.42 ' CG2' ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -92.92 105.75 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.331 0.586 . . . . 0.0 110.949 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.454 ' CD1' ' CD2' ' B' ' 48' ' ' TYR . 0.1 OUTLIER -124.28 156.59 36.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.074 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.72 138.43 31.64 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.533 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.413 ' HB3' ' CG2' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -150.94 145.95 25.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.072 0.463 . . . . 0.0 111.324 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 7' ' ' ARG . 0.6 OUTLIER -179.37 10.98 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.89 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.54 -41.22 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 122.165 -0.334 . . . . 0.0 111.507 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.7 94.46 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.802 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -97.11 -61.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.458 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 m 64.94 98.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.385 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.442 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -120.44 154.37 35.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.086 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.98 100.05 5.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.939 0.4 . . . . 0.0 110.991 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.2 tp -119.15 102.85 13.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.037 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.54 -108.15 0.35 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.325 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.06 -15.51 4.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 164.29 61.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.993 0.425 . . . . 0.0 110.055 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.5 m -107.76 -168.62 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.64 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 t -175.33 103.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.751 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.442 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 21.5 t -102.76 106.9 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 t -91.57 111.85 23.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.569 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.413 ' CG2' ' HB3' ' A' ' 6' ' ' ARG . 30.1 m -84.01 62.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.569 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.43 -142.42 0.24 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.829 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 31' ' ' ARG . . . 53.27 69.24 1.27 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.677 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.408 ' CG2' ' HG2' ' A' ' 7' ' ' ARG . 17.5 t -88.49 107.52 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 120.923 0.392 . . . . 0.0 111.576 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -142.67 146.97 34.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.104 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.3 158.7 30.59 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.526 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.83 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.674 0.273 . . . . 0.0 110.761 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.46 124.45 50.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 110.749 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.1 t -93.74 136.5 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.219 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.422 ' HB3' ' HA3' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -83.17 109.15 16.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.114 179.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.44 135.59 27.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.286 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.26 111.0 2.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.259 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 t -113.59 102.89 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 0.0 111.458 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.63 107.18 19.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.667 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.12 146.21 60.56 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.532 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.88 156.41 30.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.77 2.314 . . . . 0.0 112.008 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -91.3 38.36 0.97 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.11 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -123.55 -38.65 2.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -83.39 156.74 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.822 0.344 . . . . 0.0 110.978 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -57.05 114.97 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.5 p -122.07 121.9 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.96 122.39 30.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.538 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -163.95 -77.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.03 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 5.8 mm-40 -155.07 131.47 10.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.57 -50.72 72.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.221 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 13.9 tt -63.17 -42.04 95.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.974 0.416 . . . . 0.0 111.166 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CD2' ' CD1' ' B' ' 4' ' ' LEU . 5.9 m-85 -50.9 -53.39 33.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.169 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -78.33 -21.7 49.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.137 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.452 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 4.9 mtt180 -72.92 -15.43 61.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.671 0.272 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.5 mt -109.82 -27.1 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.331 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -107.79 -54.54 2.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.796 0.331 . . . . 0.0 111.28 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.74 -73.62 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.277 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -111.85 123.72 50.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.785 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.03 90.34 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.286 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.28 -74.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.947 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.67 150.65 29.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -66.99 -57.61 6.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.2 p -164.89 -73.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -94.55 136.78 34.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.5 t80 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.879 -179.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.59 102.82 10.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.421 ' O ' ' CG2' ' B' ' 3' ' ' ILE . 4.1 tt -92.86 105.74 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.335 0.588 . . . . 0.0 110.968 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.452 ' CD1' ' CD2' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -124.34 156.62 36.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.998 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.78 138.43 31.61 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.527 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.426 ' HB3' ' CG2' ' B' ' 22' ' ' VAL . 0.0 OUTLIER -150.93 146.0 25.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.285 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' B' ' 7' ' ' ARG . 0.6 OUTLIER -179.43 10.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.969 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.6 -41.21 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 122.18 -0.325 . . . . 0.0 111.483 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.71 94.48 0.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.803 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -97.11 -61.62 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.484 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m 64.99 98.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.432 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.447 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -120.4 154.36 35.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.147 179.204 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.95 100.08 5.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.973 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 8.2 tp -119.15 102.86 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.021 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.57 -108.14 0.35 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.307 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 11.8 t70 -129.09 -15.57 4.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 1.7 mt-10 164.29 61.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.033 0.444 . . . . 0.0 110.059 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 22.5 m -107.8 -168.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.631 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 1.1 t -175.3 103.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.758 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.447 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 21.5 t -102.77 106.9 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 9.4 t -91.59 111.9 23.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.508 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.426 ' CG2' ' HB3' ' B' ' 6' ' ' ARG . 29.9 m -84.0 62.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.551 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.41 -142.46 0.24 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.731 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' B' ' 31' ' ' ARG . . . 53.37 69.18 1.29 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.636 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.418 ' CG2' ' HG2' ' B' ' 7' ' ' ARG . 17.4 t -88.47 107.48 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 111.559 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -142.63 146.99 35.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.096 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.35 158.69 30.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.499 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.81 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.676 0.274 . . . . 0.0 110.776 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.45 124.41 50.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 110.744 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 29.6 t -93.68 136.5 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.426 ' HB3' ' HA3' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -83.17 109.12 16.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.129 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 mm -93.41 135.63 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.235 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.32 111.0 2.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.319 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 t -113.58 102.87 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 111.403 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.6 107.14 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.685 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.14 146.26 60.77 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.481 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.84 156.36 30.99 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.806 2.337 . . . . 0.0 112.016 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -91.3 38.38 0.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.139 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -123.56 -38.59 2.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.067 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -83.38 156.7 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -57.03 115.0 2.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.183 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.03 121.91 65.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.96 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.98 122.36 29.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.525 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -163.92 -77.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.729 0.299 . . . . 0.0 111.013 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.417 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 5.8 mm-40 -155.09 131.46 10.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.875 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.66 -50.63 72.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.179 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.453 ' HA ' ' HB2' ' B' ' 50' ' ' ARG . 13.9 tt -63.27 -42.0 94.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.454 ' CD2' ' CD1' ' A' ' 4' ' ' LEU . 5.9 m-85 -50.92 -53.36 33.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.185 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -78.32 -21.62 49.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.227 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 4.8 mtt180 -73.01 -15.34 61.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.296 . . . . 0.0 111.188 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 43.7 mt -109.94 -27.13 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.351 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -107.8 -54.52 2.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.291 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.68 -73.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -112.42 125.29 54.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.731 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -64.79 89.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 45.5 m 61.97 -80.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.048 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 178.79 173.52 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.902 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -100.52 58.12 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.749 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.44 -81.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.07 126.93 49.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.792 0.33 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.3 tt -122.18 116.12 23.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 3.6 tt -101.8 105.57 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.134 0.493 . . . . 0.0 110.535 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.408 ' HG ' ' CD2' ' B' ' 48' ' ' TYR . 0.2 OUTLIER -124.51 123.51 40.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.434 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.24 143.65 57.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.729 0.3 . . . . 0.0 110.414 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.488 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 10.6 mtt180 -153.18 148.24 26.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.969 0.414 . . . . 0.0 111.012 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 21.1 ttp180 175.48 -0.76 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.918 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -169.39 134.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.747 0.308 . . . . 0.0 110.831 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.05 47.83 89.09 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.514 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 11' ' ' THR . 18.2 mm-40 -112.46 167.57 10.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.514 0.197 . . . . 0.0 110.703 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.414 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER 163.54 105.53 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.245 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.438 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -115.82 154.14 30.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.247 179.086 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 ttt -130.27 100.88 5.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.007 0.432 . . . . 0.0 111.261 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.5 tp -113.06 121.77 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.465 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.35 -107.14 0.64 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.153 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 21.0 m-20 -154.96 6.95 0.26 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 2.0 tm-20 161.33 64.84 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 m -119.34 -158.53 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.47 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 171.39 102.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.438 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 22.4 t -117.36 110.91 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.808 0.337 . . . . 0.0 111.461 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.7 m -106.74 116.6 32.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.029 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 m -82.22 68.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.069 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.69 -141.64 0.07 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.622 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.32 74.26 0.36 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.364 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.5 t -85.68 107.75 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 120.974 0.416 . . . . 0.0 111.134 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.89 165.42 35.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.139 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.68 164.59 27.92 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.169 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 72.72 -62.51 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.607 0.242 . . . . 0.0 111.245 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.57 136.4 54.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.738 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.2 116.29 44.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 111.12 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 1.9 mtm105 -79.58 99.36 7.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.833 0.349 . . . . 0.0 110.697 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' B' ' 6' ' ' ARG . 16.2 mm -87.86 132.85 32.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.599 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.62 118.2 5.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.536 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 t -114.14 127.96 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.218 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 19' ' ' THR . 2.7 t-20 -123.68 107.48 11.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.312 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.98 142.76 22.76 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.715 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.9 156.62 27.09 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.797 2.332 . . . . 0.0 112.051 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -87.44 26.6 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.427 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.38 -41.66 6.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.837 0.351 . . . . 0.0 110.819 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.9 t -82.49 150.18 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.7 t -62.5 97.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.348 . . . . 0.0 111.018 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.39 120.61 61.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -128.39 136.22 50.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.594 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -178.3 -35.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.084 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.12 98.66 0.02 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.69 -26.45 63.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.818 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.2 mm -79.2 -44.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.415 ' CD2' ' HG ' ' B' ' 4' ' ' LEU . 3.3 m-85 -52.11 -44.91 64.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.84 -60.48 2.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.829 0.347 . . . . 0.0 111.683 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -54.95 -15.6 2.12 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.42 -52.75 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 122.284 -0.26 . . . . 0.0 111.591 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -72.53 -59.12 2.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.709 0.29 . . . . 0.0 111.153 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.06 -25.39 58.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.388 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -121.54 140.2 52.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 74.99 0.06 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.434 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 m 55.56 -165.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.004 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -158.14 152.05 23.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.752 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.22 116.01 31.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 m -177.08 77.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 m -122.05 127.59 50.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 21.8 t80 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.93 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.82 0.343 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 8.3 tt -122.24 116.21 23.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' B' ' 3' ' ' ILE . 3.6 tt -101.83 105.61 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.146 0.498 . . . . 0.0 110.524 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.415 ' HG ' ' CD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -124.58 123.5 40.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.423 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -63.16 143.69 57.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.38 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 10.6 mtt180 -153.23 148.26 26.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.952 0.406 . . . . 0.0 111.068 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 21.0 ttp180 175.44 -0.73 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.891 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -169.42 134.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.76 0.314 . . . . 0.0 110.797 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.04 47.79 89.29 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.486 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' B' ' 11' ' ' THR . 18.1 mm-40 -112.39 167.65 10.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.541 0.21 . . . . 0.0 110.711 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.423 ' CB ' ' O ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 163.51 105.51 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.263 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.427 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.9 OUTLIER -115.86 154.1 30.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.293 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 1.5 ttt -130.28 100.78 5.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.997 0.427 . . . . 0.0 111.23 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 2.5 tp -112.98 121.83 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.504 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.31 -107.09 0.64 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.147 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 21.1 m-20 -154.96 6.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 2.1 tm-20 161.32 64.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 m -119.36 -158.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.487 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.445 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 171.38 102.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 22.6 t -117.36 110.93 32.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.819 0.343 . . . . 0.0 111.399 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 16.7 m -106.74 116.68 32.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.005 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 m -82.29 68.5 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.064 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.68 -141.65 0.07 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.575 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.3 74.34 0.35 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.309 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.78 107.74 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.064 0.459 . . . . 0.0 111.149 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.84 165.47 35.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.186 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.73 164.62 27.87 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.141 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 72.75 -62.53 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.614 0.245 . . . . 0.0 111.253 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.62 136.46 54.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.703 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.22 116.24 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.703 0.287 . . . . 0.0 111.096 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 1.9 mtm105 -79.45 99.34 7.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.802 0.334 . . . . 0.0 110.791 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.412 HG13 ' HB2' ' A' ' 6' ' ' ARG . 16.2 mm -87.86 132.87 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.591 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.65 118.15 5.4 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.542 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 14.0 t -114.1 127.98 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.238 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' B' ' 19' ' ' THR . 2.7 t-20 -123.73 107.45 11.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.293 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.93 142.8 23.01 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.769 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.95 156.53 26.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.851 2.367 . . . . 0.0 111.989 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -87.32 26.51 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.465 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -101.42 -41.6 6.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.785 0.326 . . . . 0.0 110.779 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.9 t -82.55 150.22 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.624 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -62.47 97.93 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 111.101 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.38 120.6 61.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.1 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -128.37 136.26 50.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 3.7 ptt85 -178.28 -35.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.089 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.15 98.65 0.02 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -58.69 -26.55 63.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.767 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 32.8 mm -79.13 -44.25 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.408 ' CD2' ' HG ' ' A' ' 4' ' ' LEU . 3.3 m-85 -52.08 -44.95 64.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.291 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -60.51 2.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.851 0.358 . . . . 0.0 111.636 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -54.89 -15.77 2.2 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.26 -52.68 6.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.608 0.242 . . . . 0.0 111.587 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -72.58 -59.07 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.715 0.293 . . . . 0.0 111.133 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.09 -25.28 58.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.395 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -122.34 142.33 50.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -73.23 74.45 1.3 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t 72.15 -67.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.41 72.46 0.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 110.918 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.13 139.5 28.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.827 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 4.3 t -140.0 142.38 36.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 7.3 m -96.83 136.49 37.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 20.4 t80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.894 179.969 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.28 114.35 20.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.907 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' B' ' 31' ' ' ARG . 20.8 mm -96.2 105.03 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.027 0.441 . . . . 0.0 110.506 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.401 ' CD2' ' HG2' ' B' ' 52' ' ' GLN . 2.4 mm? -124.82 118.23 25.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.8 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.1 OUTLIER -55.68 139.83 43.5 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.43 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.44 ' HB3' ' CG2' ' A' ' 22' ' ' VAL . 3.8 mtp180 -151.37 148.4 28.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.029 0.442 . . . . 0.0 111.474 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 2.9 ttt180 175.91 -80.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.569 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t -32.75 -68.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.09 109.58 0.41 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.006 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.18 -173.63 2.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.553 0.216 . . . . 0.0 110.533 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 168.9 89.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.443 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.487 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 1.3 pt? -113.11 154.25 26.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.3 ttt -130.67 100.76 5.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.209 0.528 . . . . 0.0 111.348 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.421 ' HA ' HD11 ' A' ' 14' ' ' ILE . 2.6 tp -111.77 126.8 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.402 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.93 -104.56 0.68 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.965 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.9 p30 -162.34 8.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.9 mt-10 165.24 52.92 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.014 0.435 . . . . 0.0 110.316 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 m -115.27 -158.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.416 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER 167.05 106.86 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.487 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 3.1 t -117.43 114.27 45.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.769 0.319 . . . . 0.0 111.172 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -110.54 116.53 31.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.873 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 6' ' ' ARG . 34.2 m -81.16 71.16 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.42 HD11 ' N ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -88.97 -145.76 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.562 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.42 ' N ' HD11 ' A' ' 23' ' ' LEU . . . 56.7 79.76 0.09 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.326 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.8 t -85.93 107.82 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.904 0.383 . . . . 0.0 111.602 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.99 155.67 43.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.03 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.78 154.93 52.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.583 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 67.68 -88.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.464 0.173 . . . . 0.0 110.685 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -104.63 125.68 50.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.62 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 m -93.24 136.65 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.515 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 4.6 mtt180 -79.51 100.98 7.98 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.096 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.408 HG21 ' CG1' ' A' ' 22' ' ' VAL . 18.5 mm -87.35 133.79 29.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.66 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.96 119.02 6.32 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.266 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.3 t -109.55 129.61 64.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.929 0.395 . . . . 0.0 111.494 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 19' ' ' THR . 2.1 t30 -123.47 107.25 11.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.183 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.18 146.62 46.87 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.635 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -83.2 156.52 14.82 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.99 2.46 . . . . 0.0 112.278 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.92 15.59 4.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.352 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.29 -38.65 10.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.639 0.257 . . . . 0.0 110.973 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 t -87.95 142.21 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.835 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 m -55.85 98.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.027 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.4 p -122.2 120.82 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.222 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.19 136.09 50.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.442 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.413 ' NH2' ' NE ' ' B' ' 6' ' ' ARG . 24.4 ttt180 -156.69 -67.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 111.012 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.83 121.55 1.82 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.92 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.52 -42.43 82.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.61 -41.09 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.79 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -52.32 -46.71 66.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.701 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -86.71 -58.17 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 111.741 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.409 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 4.1 mtt180 -48.91 -20.29 0.49 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.9 mm -108.67 -52.67 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.632 0.253 . . . . 0.0 111.498 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -66.81 -63.5 1.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.721 0.296 . . . . 0.0 110.776 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.82 -32.13 69.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.982 0.42 . . . . 0.0 110.615 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -109.42 119.73 40.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.798 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -62.87 92.62 0.05 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.667 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m 69.04 -65.94 0.27 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.348 . . . . 0.0 110.794 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.34 132.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.997 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -141.88 130.94 23.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.814 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.55 174.13 11.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.033 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.57 145.16 39.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.822 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 32.8 p90 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.893 179.935 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.899 0.38 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 mp -122.26 114.41 20.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 31' ' ' ARG . 20.6 mm -96.25 104.95 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 0.0 110.566 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -124.76 118.43 26.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.781 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -55.78 139.83 44.06 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.378 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.447 ' HB3' ' CG2' ' B' ' 22' ' ' VAL . 3.8 mtp180 -151.38 148.37 28.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.048 0.452 . . . . 0.0 111.496 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 175.91 -80.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.591 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 25.1 t -32.76 -68.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.05 109.64 0.41 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.002 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.19 -173.59 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.548 0.213 . . . . 0.0 110.536 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 168.87 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.426 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.493 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 1.3 pt? -113.19 154.26 26.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 12.3 ttt -130.71 100.82 5.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.233 0.54 . . . . 0.0 111.403 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 2.6 tp -111.89 126.81 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.342 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.96 -104.66 0.69 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.913 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 2.9 p30 -162.31 9.01 0.06 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.9 mt-10 165.25 52.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.025 0.44 . . . . 0.0 110.284 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.8 m -115.26 -158.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.216 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.1 OUTLIER 167.05 106.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.493 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 3.1 t -117.45 114.28 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.753 0.311 . . . . 0.0 111.18 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -110.54 116.54 31.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.849 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' B' ' 6' ' ' ARG . 34.2 m -81.11 71.1 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.601 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.415 HD11 ' N ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -88.94 -145.72 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.576 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.415 ' N ' HD11 ' B' ' 23' ' ' LEU . . . 56.68 79.76 0.09 OUTLIER Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.363 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 20.9 t -86.0 107.83 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 120.96 0.41 . . . . 0.0 111.638 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.03 155.65 43.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.003 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.73 154.95 52.68 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.555 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 67.64 -88.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.492 0.187 . . . . 0.0 110.654 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -104.64 125.66 50.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.0 110.64 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 m -93.21 136.67 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.555 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.6 mtt180 -79.51 100.88 7.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.1 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 6' ' ' ARG . 18.6 mm -87.31 133.76 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.68 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.92 118.96 6.3 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.306 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 24.0 t -109.51 129.67 63.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.922 0.391 . . . . 0.0 111.556 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' B' ' 19' ' ' THR . 2.1 t30 -123.41 107.22 11.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.247 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.19 146.6 46.76 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.622 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -83.17 156.52 14.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.013 2.475 . . . . 0.0 112.271 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.95 15.57 4.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.303 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -38.6 10.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.662 0.268 . . . . 0.0 111.016 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 t -87.94 142.19 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.868 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 3.0 m -55.9 98.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.971 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 13.4 p -122.19 120.81 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.265 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.21 136.04 50.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.432 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.414 ' NH2' ' NE ' ' A' ' 6' ' ' ARG . 24.6 ttt180 -156.62 -67.17 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.939 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.77 121.61 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.42 -42.48 82.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -41.03 87.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.799 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -52.35 -46.65 66.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.634 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -86.84 -58.09 2.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.758 0.313 . . . . 0.0 111.804 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.417 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 4.1 mtt180 -48.95 -20.16 0.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' B' ' 56' ' ' SER . 36.6 mm -108.78 -52.63 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.629 0.252 . . . . 0.0 111.524 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.401 ' HG2' ' CD2' ' A' ' 4' ' ' LEU . 8.1 tp60 -66.87 -63.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.763 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.89 -32.2 69.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 110.589 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.417 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 0.5 OUTLIER -108.65 119.59 39.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.615 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.35 103.0 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.589 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.413 ' HB2' ' CD1' ' B' ' 51' ' ' ILE . 35.7 t -67.66 171.29 6.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.038 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -148.9 110.81 4.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.624 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -90.63 -72.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.954 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 7.1 m -57.72 117.5 4.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 7.3 m -97.97 135.98 38.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.874 -179.961 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttm . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.964 0.412 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -122.24 111.69 17.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.823 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.8 tt -106.06 116.66 50.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.1 0.476 . . . . 0.0 111.3 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.431 HD22 ' CD2' ' B' ' 48' ' ' TYR . 0.4 OUTLIER -123.9 123.4 40.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.336 179.354 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -63.61 80.07 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.888 0.375 . . . . 0.0 111.664 -179.17 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.45 ' HB2' HG13 ' B' ' 32' ' ' ILE . 23.5 mtt180 -78.79 143.22 36.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.126 0.489 . . . . 0.0 110.514 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.434 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 2.9 tmt_? -173.36 -13.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.864 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.61 -58.74 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.702 0.286 . . . . 0.0 111.175 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.57 105.55 0.21 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.803 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.2 -73.82 0.65 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.906 0.384 . . . . 0.0 110.723 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 m 69.53 102.39 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.49 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.426 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -109.94 154.59 22.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.626 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.3 ttt -127.2 100.07 5.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.98 0.419 . . . . 0.0 110.747 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.85 138.16 47.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.752 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 121.28 -106.01 1.08 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.104 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.4 t70 -159.57 7.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.7 mt-10 162.66 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.036 0.446 . . . . 0.0 110.151 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 m -116.38 -158.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.649 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 173.57 102.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.426 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 27.5 t -110.48 103.96 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.5 m -89.27 106.37 18.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.904 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.0 m -76.7 -168.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.899 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -173.38 141.3 0.89 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.103 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . -125.37 -24.54 1.58 Allowed Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.477 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.94 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.536 0.208 . . . . 0.0 110.63 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.91 165.5 0.13 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.747 0.308 . . . . 0.0 110.56 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.81 -99.98 0.01 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.569 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -101.36 -30.92 11.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 110.377 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.445 ' HB3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -119.82 136.65 54.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.955 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' B' ' 5' ' ' THR . 12.0 t -93.21 128.39 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 111.681 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 2.4 ttp180 -80.8 99.54 8.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.437 HG13 ' HB2' ' B' ' 6' ' ' ARG . 9.5 mm -88.77 127.43 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.931 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.03 109.99 3.4 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.486 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.73 102.93 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.936 0.398 . . . . 0.0 111.468 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -91.59 107.44 19.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.641 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.95 138.62 33.04 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.454 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.69 156.09 31.45 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.603 2.202 . . . . 0.0 112.102 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -82.01 2.25 31.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.564 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.84 -39.33 20.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.72 0.295 . . . . 0.0 111.267 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 t -86.78 146.85 5.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.885 0.374 . . . . 0.0 110.995 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.97 100.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.3 122.31 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -128.11 136.42 51.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.706 0.289 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.92 -175.78 4.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.489 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.3 145.78 30.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.843 0.354 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.67 -65.29 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.507 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.47 HG21 HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -52.08 -40.77 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.387 -179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.437 ' CE2' ' HB2' ' B' ' 4' ' ' LEU . 7.9 t80 -46.9 -67.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.436 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.413 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 48.5 mt-30 -71.96 -22.01 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.551 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -70.5 -15.95 62.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.649 0.261 . . . . 0.0 111.571 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.9 tt -112.15 -25.18 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.634 0.254 . . . . 0.0 111.5 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.79 -55.81 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.257 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.413 ' HB2' ' CB ' ' A' ' 49' ' ' GLN . . . -65.08 -71.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.1 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -108.0 116.61 32.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.772 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.49 109.08 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.558 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 t -53.54 -65.01 0.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.761 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -92.9 91.8 7.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -67.36 153.92 42.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.987 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.1 t -110.0 95.9 5.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 m -116.38 134.51 54.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttm . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.88 0.371 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' B' ' 2' ' ' LEU . 0.0 OUTLIER -122.28 111.71 17.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 2.7 tt -106.11 116.69 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.167 0.508 . . . . 0.0 111.233 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -123.88 123.52 40.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.315 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -63.64 80.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.872 0.368 . . . . 0.0 111.623 -179.189 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.437 ' HB2' HG13 ' A' ' 32' ' ' ILE . 23.5 mtt180 -78.88 143.32 36.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.151 0.501 . . . . 0.0 110.503 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.43 ' HA ' ' HA3' ' B' ' 24' ' ' GLY . 2.9 tmt_? -173.37 -13.25 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.859 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 t -116.64 -58.68 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.674 0.273 . . . . 0.0 111.131 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.53 105.55 0.21 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.804 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.14 -73.89 0.65 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 110.77 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 8.8 m 69.61 102.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.436 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.418 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.4 OUTLIER -109.87 154.58 22.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.664 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 8.3 ttt -127.15 100.02 5.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.988 0.423 . . . . 0.0 110.769 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.76 138.2 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.734 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 121.28 -105.96 1.07 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.109 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.4 t70 -159.58 7.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.7 mt-10 162.69 59.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.981 0.42 . . . . 0.0 110.102 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 m -116.4 -158.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.632 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.403 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.1 OUTLIER 173.61 102.73 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.418 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 27.6 t -110.44 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 33.2 m -89.28 106.37 18.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.946 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 32.2 m -76.79 -168.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.905 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -173.38 141.32 0.9 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.095 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . -125.41 -24.43 1.59 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.97 130.79 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.525 0.202 . . . . 0.0 110.622 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.88 165.53 0.13 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 110.578 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.87 -100.01 0.01 OUTLIER Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.506 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -101.37 -30.88 11.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 110.372 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.447 ' HB3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -119.82 136.56 54.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.965 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 5' ' ' THR . 12.1 t -93.18 128.44 44.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.916 0.389 . . . . 0.0 111.636 -178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 2.4 ttp180 -80.8 99.52 8.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.45 HG13 ' HB2' ' A' ' 6' ' ' ARG . 9.6 mm -88.8 127.46 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.878 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.03 109.95 3.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.429 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.7 102.94 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 111.48 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' B' ' 19' ' ' THR . 1.8 t-20 -91.62 107.43 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.622 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.97 138.59 32.99 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.475 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.67 156.08 31.55 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.654 2.236 . . . . 0.0 112.134 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -82.03 2.28 31.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.603 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.88 -39.36 19.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.66 0.266 . . . . 0.0 111.187 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 t -86.67 146.8 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.042 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.01 100.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.3 122.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.752 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -128.1 136.4 51.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.684 0.278 . . . . 0.0 110.862 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.93 -175.79 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.491 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.31 145.7 31.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.86 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.62 -65.29 0.58 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.546 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.487 HD11 HG21 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -52.07 -40.8 30.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.37 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.431 ' CD2' HD22 ' A' ' 4' ' ' LEU . 8.0 t80 -46.86 -67.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.414 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.406 ' CB ' ' HB2' ' B' ' 53' ' ' ALA . 48.5 mt-30 -71.95 -21.95 61.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.632 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -70.57 -15.95 62.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.579 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 6.9 tt -112.17 -25.08 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.614 0.245 . . . . 0.0 111.501 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.82 -55.81 2.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 111.242 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.406 ' HB2' ' CB ' ' B' ' 49' ' ' GLN . . . -65.04 -71.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.168 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -108.33 116.97 32.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.35 103.68 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t -57.55 -71.29 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.014 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 61.74 176.8 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.818 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 67.11 -69.11 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.067 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 96.6 p -153.19 169.95 21.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.812 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.09 120.86 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.942 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmm? . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.821 0.343 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mp -115.93 109.49 17.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.3 tt -84.52 111.35 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 0.0 111.443 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.18 156.25 23.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.729 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' B' ' 30' ' ' VAL . 0.2 OUTLIER -94.71 122.55 37.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 111.382 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.435 ' HB2' HG13 ' B' ' 32' ' ' ILE . 0.6 OUTLIER -95.6 148.97 21.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.645 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.469 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER 81.13 85.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.821 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 7' ' ' ARG . 47.3 t 80.72 56.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.287 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.51 -147.58 5.0 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.632 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.23 119.24 37.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 111.61 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 p -57.03 145.08 31.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.304 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.432 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -112.6 154.42 26.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.694 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.7 ttp -128.94 100.34 5.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.751 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.64 138.72 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.015 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.9 -106.27 0.95 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.151 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.4 p30 -158.58 7.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.6 OUTLIER 161.74 58.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.902 0.382 . . . . 0.0 110.044 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 m -114.37 -156.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.357 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.41 ' CG2' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 173.15 104.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.974 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.432 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 24.8 t -102.66 101.66 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.852 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -95.35 157.42 15.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.631 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 m -107.86 -172.39 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.309 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -124.05 -52.2 1.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 0.0 110.427 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' CA ' ' HG2' ' A' ' 7' ' ' ARG . . . 91.85 -43.47 2.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.996 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.56 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 4.0 t -85.65 149.91 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.525 0.202 . . . . 0.0 111.41 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 25' ' ' VAL . 28.1 tttp 99.07 122.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.068 0.547 . . . . 0.0 110.743 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.77 -179.51 37.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.762 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 63.63 -86.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -86.46 136.74 32.99 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.1 t -93.24 114.15 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.351 . . . . 0.0 110.874 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -89.28 99.87 12.77 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.888 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' B' ' 6' ' ' ARG . 24.0 mm -109.53 141.19 25.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.054 0.454 . . . . 0.0 111.667 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.82 107.48 2.58 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.919 -0.657 . . . . 0.0 111.987 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.8 103.41 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.904 0.383 . . . . 0.0 111.103 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.41 ' HB3' ' CG2' ' A' ' 19' ' ' THR . 1.2 t-20 -90.57 107.3 19.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.87 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.75 140.03 37.43 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.259 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.74 156.18 31.32 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.642 2.228 . . . . 0.0 112.28 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -80.32 0.16 34.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.355 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -78.01 -39.77 41.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.714 0.292 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 t -87.8 140.88 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.91 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 t -62.48 102.26 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.379 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.2 p -122.24 120.69 61.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -128.31 136.45 51.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.793 0.33 . . . . 0.0 111.199 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -139.62 -50.68 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.45 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 1.3 tp10 -178.29 141.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.514 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.51 -45.74 84.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.217 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -73.02 -38.51 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.67 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.409 ' O ' ' CB ' ' A' ' 52' ' ' GLN . 4.1 m-85 -51.54 -50.16 60.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -85.9 -52.81 5.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -16.35 12.62 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 mm -115.76 -57.92 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.409 ' CB ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -66.39 -48.07 71.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.104 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.85 -28.25 26.17 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 111.307 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -120.33 134.29 55.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 57' ' ' GLN . 9.1 mttp -59.65 87.02 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.147 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.5 t 64.63 -72.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.176 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -147.88 164.36 33.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.832 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -94.81 87.23 4.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 p -170.75 -66.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 p -105.12 133.07 50.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.838 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmm? . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.804 0.335 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mp -115.96 109.5 17.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.847 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 18.3 tt -84.49 111.42 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.487 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.21 156.21 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.739 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.69 122.55 37.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.363 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.6 OUTLIER -95.65 148.97 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.635 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.468 ' O ' ' HB ' ' B' ' 8' ' ' VAL . 0.1 OUTLIER 81.22 85.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.767 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' B' ' 7' ' ' ARG . 47.3 t 80.64 56.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.287 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.5 -147.57 4.99 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.589 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.24 119.16 36.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.889 0.376 . . . . 0.0 111.614 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.5 p -57.04 145.04 31.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.263 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.438 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.2 OUTLIER -112.58 154.42 26.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.693 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 3.7 ttp -128.91 100.35 5.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.849 0.356 . . . . 0.0 110.723 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . 0.418 HG22 HD12 ' B' ' 14' ' ' ILE . 0.0 OUTLIER -114.66 138.77 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.981 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.83 -106.18 0.95 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.16 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.427 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.4 p30 -158.6 7.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.6 OUTLIER 161.77 58.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.018 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 m -114.31 -157.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.374 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.406 ' CG2' ' HB3' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 173.21 104.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.981 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.438 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 24.7 t -102.65 101.71 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.898 0.38 . . . . 0.0 110.807 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 9.9 t -95.36 157.41 15.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.609 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 m -107.81 -172.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.304 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -124.09 -52.19 1.76 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.83 0.347 . . . . 0.0 110.411 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.465 ' CA ' ' HG2' ' B' ' 7' ' ' ARG . . . 91.92 -43.41 2.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.989 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' B' ' 26' ' ' LYS . 4.0 t -85.77 149.94 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.492 0.187 . . . . 0.0 111.36 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' B' ' 25' ' ' VAL . 28.1 tttp 99.0 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.067 0.547 . . . . 0.0 110.799 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.78 -179.53 37.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.763 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 63.64 -86.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -86.46 136.71 33.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 5' ' ' THR . 4.1 t -93.19 114.1 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.351 . . . . 0.0 110.896 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -89.29 99.86 12.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.865 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 6' ' ' ARG . 24.0 mm -109.49 141.22 25.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.031 0.443 . . . . 0.0 111.719 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.85 107.53 2.58 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.979 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.85 103.43 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.926 0.393 . . . . 0.0 111.103 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.406 ' HB3' ' CG2' ' B' ' 19' ' ' THR . 1.2 t-20 -90.59 107.28 19.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.831 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.73 140.1 37.63 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.243 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.78 156.16 31.13 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.673 2.249 . . . . 0.0 112.268 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -80.31 0.23 33.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.428 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -78.07 -39.7 40.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.703 0.287 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 t -87.89 140.9 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.89 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -62.37 102.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.394 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.2 120.67 61.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.726 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -128.29 136.47 51.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.795 0.331 . . . . 0.0 111.147 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -139.62 -50.65 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.409 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.42 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 1.3 tp10 -178.3 141.34 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.543 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.51 -45.78 84.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.188 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.99 -38.52 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.651 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.42 ' HB2' ' HB3' ' B' ' 45' ' ' GLU . 4.1 m-85 -51.54 -50.15 60.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.75 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -85.92 -52.86 5.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.09 -16.21 12.24 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 17.1 mm -115.91 -57.88 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.413 ' CB ' ' O ' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -66.45 -48.06 71.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.09 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.84 -28.28 26.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 111.341 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' B' ' 55' ' ' LYS . 7.1 mt-10 -120.33 137.32 54.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.228 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' B' ' 54' ' ' GLU . 3.2 mtmp? 70.06 -97.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.931 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p 61.53 149.91 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.769 0.319 . . . . 0.0 110.756 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -153.69 -65.44 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.962 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.22 -148.56 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.688 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 1.8 m 78.22 108.42 0.07 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.904 0.383 . . . . 0.0 110.897 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.04 136.38 54.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.887 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.918 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.909 0.385 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mp -116.46 105.46 12.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.809 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 3.7 tt -84.8 108.99 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 tp -112.98 156.64 22.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.257 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.96 124.24 35.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.868 0.366 . . . . 0.0 111.021 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.497 ' HB2' ' CG1' ' B' ' 32' ' ' ILE . 0.0 OUTLIER -93.22 148.42 22.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.237 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER 83.34 90.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.401 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.406 ' CB ' ' O ' ' A' ' 7' ' ' ARG . 6.3 t 84.25 62.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.58 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.68 -146.9 4.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.383 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -113.26 118.17 33.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.845 0.355 . . . . 0.0 111.442 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.2 p -51.93 150.26 4.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.963 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.438 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -110.88 154.5 23.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.846 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.7 ttm -127.26 100.36 6.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.995 0.426 . . . . 0.0 110.906 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.401 ' HA ' HD11 ' A' ' 14' ' ' ILE . 3.8 tp -111.93 129.35 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.76 -102.76 0.61 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.165 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.565 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 5.4 p30 -166.24 8.41 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 31.6 tp10 167.29 57.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.98 -157.93 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.7 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 172.49 99.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.438 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 20.9 t -102.96 103.08 14.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.812 0.339 . . . . 0.0 111.77 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 m -87.22 146.84 25.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.242 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 22' ' ' VAL . 30.5 m -109.75 76.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' CG ' ' H ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -99.88 -151.11 0.39 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.307 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 31' ' ' ARG . . . 56.52 73.6 0.42 Allowed Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.098 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 7' ' ' ARG . 24.7 t -85.92 107.33 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.011 0.434 . . . . 0.0 111.627 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -137.21 142.82 42.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.906 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.53 -44.11 28.81 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.434 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -104.53 -86.25 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.939 0.369 . . . . 0.0 111.452 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -84.85 116.15 23.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.759 0.314 . . . . 0.0 111.172 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.0 m -93.81 136.51 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.189 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.528 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 4.9 mtt-85 -87.92 99.25 12.0 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.025 0.44 . . . . 0.0 110.1 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.495 ' CG1' ' HB2' ' B' ' 6' ' ' ARG . 27.3 mm -92.87 141.81 14.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.235 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.08 108.75 3.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.689 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 t -99.35 103.49 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.803 0.335 . . . . 0.0 111.049 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.1 t-20 -90.78 107.22 19.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.186 0.517 . . . . 0.0 110.62 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.43 141.32 38.57 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.247 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.99 156.19 30.38 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.615 2.21 . . . . 0.0 112.272 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -83.26 3.78 29.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.498 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -86.01 -36.87 19.5 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.695 0.283 . . . . 0.0 111.099 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 t -90.8 141.35 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.042 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -59.03 105.68 0.35 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.218 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.24 122.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.007 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.14 136.23 50.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.654 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.47 59.43 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 0.0 110.778 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.07 136.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -65.39 -41.85 93.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.834 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.7 mm -67.32 -54.43 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.129 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -47.19 -43.37 21.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.478 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.29 -55.01 5.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.353 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -56.93 -12.84 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.85 -57.3 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.715 0.293 . . . . 0.0 111.237 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -72.75 -57.99 3.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.892 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.29 -34.69 77.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 0.0 110.844 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -120.47 129.19 53.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.648 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -49.62 108.37 0.2 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.723 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 96.2 p -57.45 159.57 4.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.797 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -148.16 143.28 26.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.994 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.14 -178.88 5.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -134.18 120.98 20.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.34 134.34 54.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.924 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.895 -179.968 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.871 0.367 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mp -116.47 105.5 12.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.76 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' B' ' 3' ' ' ILE . 3.7 tt -84.76 108.99 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.266 0.555 . . . . 0.0 111.143 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 tp -113.03 156.65 22.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.178 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.92 124.25 35.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.849 0.357 . . . . 0.0 111.028 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.495 ' HB2' ' CG1' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -93.21 148.34 22.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.243 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.454 ' CB ' ' O ' ' B' ' 6' ' ' ARG . 0.1 OUTLIER 83.32 90.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.402 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.419 ' CB ' ' O ' ' B' ' 7' ' ' ARG . 6.4 t 84.32 62.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.554 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.74 -146.96 4.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.394 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -113.22 118.14 33.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 111.44 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 19.2 p -51.92 150.22 4.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.991 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.436 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.2 OUTLIER -110.81 154.43 23.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.889 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 6.8 ttm -127.27 100.37 6.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.971 0.415 . . . . 0.0 110.872 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . 0.413 ' HA ' HD11 ' B' ' 14' ' ' ILE . 3.8 tp -111.9 129.32 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.78 -102.76 0.61 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.17 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 5.5 p30 -166.26 8.59 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 31.6 tp10 167.18 57.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.96 -157.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.729 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.419 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 172.48 99.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 21.0 t -102.94 103.04 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.791 0.329 . . . . 0.0 111.838 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 45.0 m -87.22 146.89 25.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.232 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.438 ' CG1' ' HG3' ' B' ' 6' ' ' ARG . 30.3 m -109.76 77.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.417 ' CG ' ' H ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -100.0 -151.09 0.39 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.28 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' B' ' 31' ' ' ARG . . . 56.56 73.56 0.43 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.112 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' B' ' 7' ' ' ARG . 24.5 t -85.9 107.39 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.01 0.433 . . . . 0.0 111.607 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -137.25 142.86 42.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.838 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.56 -44.14 29.02 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.42 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -104.53 -86.22 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.956 0.378 . . . . 0.0 111.478 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -84.92 116.1 23.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.789 0.328 . . . . 0.0 111.204 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 30.9 m -93.69 136.61 24.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.529 ' O ' ' HA3' ' B' ' 24' ' ' GLY . 4.9 mtt-85 -88.04 99.25 12.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.497 ' CG1' ' HB2' ' A' ' 6' ' ' ARG . 27.4 mm -92.81 141.74 14.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.24 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.06 108.74 3.01 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.719 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 27.0 t -99.33 103.5 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.843 0.354 . . . . 0.0 111.086 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' B' ' 19' ' ' THR . 1.1 t-20 -90.78 107.24 19.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 110.597 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.5 141.29 38.57 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.288 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.92 156.13 30.61 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.663 2.242 . . . . 0.0 112.221 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -83.19 3.75 29.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.524 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -85.98 -36.93 19.49 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.696 0.284 . . . . 0.0 111.091 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.0 t -90.65 141.29 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 111.055 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -59.06 105.69 0.35 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.184 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.28 122.55 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.11 136.25 50.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.734 0.302 . . . . 0.0 110.627 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.54 59.42 0.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.744 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.11 136.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -65.4 -41.86 93.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 36.4 mm -67.32 -54.48 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -47.15 -43.31 20.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.537 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.36 -54.98 5.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.331 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -56.97 -12.94 2.29 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.73 -57.33 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.676 0.274 . . . . 0.0 111.25 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -72.72 -57.88 3.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.954 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.41 -34.51 77.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.978 0.418 . . . . 0.0 110.847 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -121.77 133.58 54.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.795 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.18 101.48 0.72 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.626 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.06 -66.32 0.26 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.98 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.68 166.92 19.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -177.04 110.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.799 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 35.4 t -58.77 106.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 10.8 m -96.56 120.95 37.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.955 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 t80 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.916 179.978 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.793 0.33 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.6 tt -118.86 110.72 17.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 4.3 tt -96.86 105.36 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.143 0.497 . . . . 0.0 110.829 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.8 124.31 41.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.15 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -60.13 141.82 55.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.608 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -145.36 145.38 31.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.209 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 8.7 tmm_? 165.33 -10.86 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.224 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.6 t -149.38 1.31 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.93 -156.54 31.64 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.009 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.27 -163.91 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.764 0.316 . . . . 0.0 111.048 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 20' ' ' VAL . 17.6 p -107.53 163.14 13.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.426 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -112.24 154.68 25.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.264 179.574 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.63 100.16 5.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 111.251 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.434 ' HA ' HD11 ' A' ' 14' ' ' ILE . 6.9 tp -112.6 138.9 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.459 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.64 -104.54 1.11 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.3 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 4.2 t0 -153.51 1.0 0.25 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 3.2 mt-10 163.74 61.29 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.408 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 19' ' ' THR . 10.3 m -116.4 -157.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.308 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.409 ' N ' HG23 ' A' ' 18' ' ' VAL . 0.2 OUTLIER 174.53 106.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.426 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 13.2 t -102.87 106.09 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.93 0.395 . . . . 0.0 111.676 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.1 m -87.79 106.23 17.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.347 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 m -80.79 57.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.731 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 31' ' ' ARG . 32.0 tp -116.23 148.8 40.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.132 0.491 . . . . 0.0 110.692 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.99 65.0 0.11 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.36 107.78 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 121.168 0.509 . . . . 0.0 112.241 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.69 143.36 45.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.601 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.2 145.28 22.39 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.863 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.85 -82.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.636 0.255 . . . . 0.0 111.234 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -96.22 126.59 41.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.798 0.332 . . . . 0.0 111.091 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.3 t -93.58 134.35 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.07 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 6.4 mtm-85 -84.27 105.08 14.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.423 HG13 ' HB2' ' B' ' 6' ' ' ARG . 17.7 mm -91.89 133.91 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.331 . . . . 0.0 111.171 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.81 115.05 4.97 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.728 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.9 t -115.64 103.54 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.001 0.429 . . . . 0.0 111.814 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -97.44 107.44 19.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.219 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.71 150.07 72.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.783 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.74 156.48 13.8 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.081 2.521 . . . . 0.0 112.188 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 19.91 4.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.298 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.76 -38.81 5.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.662 0.267 . . . . 0.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 t -80.52 146.24 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.862 0.363 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.65 106.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.115 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.1 122.19 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.58 136.04 50.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.433 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -172.5 -69.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -164.49 121.29 1.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -65.38 -28.46 69.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.68 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.5 mm -70.95 -53.24 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.225 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -53.42 -42.55 67.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.405 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -78.12 -50.83 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.684 0.278 . . . . 0.0 111.51 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -61.03 -13.26 15.36 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 55.4 mt -112.39 -52.89 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.322 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.13 -57.54 5.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.081 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.31 -32.3 43.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 111.253 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.13 125.57 52.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -55.62 92.35 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.612 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -68.6 0.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.783 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.79 -48.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.754 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -179.9 -67.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.753 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.41 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.82 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 m -100.3 143.11 30.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.4 t80 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.887 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.795 0.331 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 9.6 tt -118.93 110.73 17.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 4.3 tt -96.91 105.39 17.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.136 0.494 . . . . 0.0 110.798 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.83 124.39 41.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.113 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -60.16 141.82 55.3 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.136 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.615 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -145.33 145.46 31.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.858 0.361 . . . . 0.0 111.156 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.615 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 8.7 tmm_? 165.31 -10.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.219 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 t -149.3 1.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.97 -156.47 31.59 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.982 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.32 -164.0 1.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.332 . . . . 0.0 111.057 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' B' ' 20' ' ' VAL . 17.6 p -107.47 163.18 13.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.2 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.422 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.1 OUTLIER -112.3 154.68 25.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.232 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -128.67 100.09 5.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 111.26 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 6.9 tp -112.55 138.89 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.536 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.65 -104.47 1.1 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.324 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 4.2 t0 -153.55 0.95 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.424 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 3.2 mt-10 163.73 61.27 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.966 0.413 . . . . 0.0 110.39 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.415 HG23 ' N ' ' B' ' 19' ' ' THR . 10.2 m -116.44 -157.08 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.327 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.415 ' N ' HG23 ' B' ' 18' ' ' VAL . 0.2 OUTLIER 174.53 106.43 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.422 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 13.2 t -102.92 106.13 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.978 0.418 . . . . 0.0 111.632 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 25.1 m -87.81 106.25 17.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.361 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 11.0 m -80.83 57.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.696 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 32.2 tp -116.34 148.84 40.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.157 0.503 . . . . 0.0 110.659 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.01 64.99 0.11 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.37 107.83 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.225 0.536 . . . . 0.0 112.215 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.78 143.29 45.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.595 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.11 145.21 22.16 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.986 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.92 -82.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.636 0.255 . . . . 0.0 111.196 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -96.3 126.62 41.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.842 0.353 . . . . 0.0 111.028 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 26.3 t -93.53 134.38 31.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 6.4 mtm-85 -84.27 105.08 14.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.761 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 6' ' ' ARG . 17.8 mm -91.97 134.03 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.349 . . . . 0.0 111.119 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.9 115.0 4.94 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.707 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 19.8 t -115.61 103.55 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 111.851 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -97.39 107.42 19.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.244 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.75 150.06 72.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.79 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.71 156.38 13.83 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.063 2.509 . . . . 0.0 112.229 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 19.93 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.346 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.77 -38.75 5.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.714 0.293 . . . . 0.0 111.125 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 t -80.53 146.21 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.981 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.54 106.31 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.196 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 10.2 p -122.15 122.24 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.811 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.6 136.12 50.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.368 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -172.64 -69.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 0.0 110.797 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 21.3 tp10 -164.49 121.24 1.59 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -65.32 -28.47 69.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.671 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.4 mm -70.92 -53.31 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' B' ' 45' ' ' GLU . 6.7 m-85 -53.32 -42.59 66.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.491 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -78.16 -50.82 11.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.527 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -61.02 -13.26 15.21 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 55.4 mt -112.38 -52.98 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.0 111.104 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.09 -57.58 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.105 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.26 -32.15 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.283 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -110.15 128.2 55.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -68.07 86.56 0.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.725 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.44 -71.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.016 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -107.81 -70.89 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.04 111.74 7.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 55.0 m -108.84 101.6 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.6 p -98.94 127.05 44.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.843 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.853 0.359 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 tt -116.3 114.09 23.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 mm -92.08 105.58 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.108 0.48 . . . . 0.0 110.625 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.421 HD11 ' CE1' ' B' ' 48' ' ' TYR . 0.2 OUTLIER -119.32 156.75 29.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.589 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.25 129.03 42.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.24 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.647 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 15.9 mtt180 -142.35 146.85 35.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.647 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.1 ttm180 165.33 -6.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.75 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.89 -62.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.808 0.337 . . . . 0.0 110.982 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.75 61.92 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.724 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -72.95 -69.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 110.625 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 m 71.75 101.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.483 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.431 ' HA ' ' HG2' ' B' ' 44' ' ' ARG . 1.1 pt? -111.26 154.77 23.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.075 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -127.61 100.06 5.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.016 0.436 . . . . 0.0 111.179 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.77 134.27 57.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.25 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.89 -104.91 0.86 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.061 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -150.19 1.6 0.48 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.3 mt-10 159.09 67.04 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.133 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 19' ' ' THR . 9.9 m -119.53 -155.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.723 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.42 ' N ' HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER 172.94 102.15 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 38.3 t -113.35 110.79 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -107.3 107.83 18.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.15 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 6' ' ' ARG . 29.9 m -80.28 74.87 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.062 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -156.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.06 71.9 1.3 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.92 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.401 ' HA ' ' CG ' ' A' ' 7' ' ' ARG . 10.7 t -86.19 107.68 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.083 0.468 . . . . 0.0 111.938 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.53 165.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -170.63 13.46 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.298 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.9 -28.57 14.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.882 0.372 . . . . 0.0 110.554 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -121.1 136.68 54.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -93.31 115.31 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.373 . . . . 0.0 111.553 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.51 98.84 7.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.874 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' B' ' 6' ' ' ARG . 4.6 mm -94.03 125.28 46.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.426 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.44 103.6 1.98 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.978 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.7 t -98.27 103.66 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.941 0.4 . . . . 0.0 111.893 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -92.63 107.46 19.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.077 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.8 147.71 55.38 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.017 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -79.66 156.55 24.57 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.966 2.444 . . . . 0.0 111.99 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -90.63 29.74 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.38 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.44 -40.32 5.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.669 0.271 . . . . 0.0 111.147 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.71 149.08 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.93 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.77 97.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.094 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.5 p -122.49 121.48 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.948 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.96 136.15 50.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.725 0.298 . . . . 0.0 110.404 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.428 ' HG2' ' HA ' ' B' ' 12' ' ' LEU . 0.0 OUTLIER -149.54 -62.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.719 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.47 133.49 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -65.36 -36.32 83.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.088 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 tp -74.28 -47.9 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.583 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.424 ' CE1' HD11 ' B' ' 4' ' ' LEU . 2.0 m-85 -55.84 -38.14 69.65 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -64.62 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -55.33 -15.86 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.9 mm -103.61 -56.55 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.653 0.263 . . . . 0.0 111.564 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.0 -56.97 4.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.678 0.275 . . . . 0.0 111.228 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.48 -25.27 63.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.297 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -131.6 146.75 52.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.916 0.388 . . . . 0.0 111.203 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt 67.49 -99.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.734 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.95 161.31 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.861 0.363 . . . . 0.0 110.886 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -60.94 -169.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.774 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -106.12 -50.47 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.805 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.1 -68.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.3 t -122.03 140.18 52.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.774 0.321 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 tt -116.43 114.12 23.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 mm -92.06 105.53 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.052 0.453 . . . . 0.0 110.623 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.424 HD11 ' CE1' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -119.25 156.8 29.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.645 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.33 129.1 42.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.231 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.64 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 16.0 mtt180 -142.39 146.85 35.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.64 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 1.1 ttm180 165.29 -6.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.725 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.96 -62.9 2.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.782 0.325 . . . . 0.0 111.009 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.76 61.98 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.726 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -72.96 -69.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.612 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 5.7 m 71.75 101.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.551 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.428 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 1.1 pt? -111.11 154.74 23.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.154 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -127.64 100.11 5.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.062 0.458 . . . . 0.0 111.172 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.75 134.27 57.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.228 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.84 -104.88 0.86 Allowed Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.099 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 0.8 OUTLIER -150.2 1.59 0.47 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.3 mt-10 159.1 67.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.874 0.368 . . . . 0.0 110.175 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.413 HG23 ' N ' ' B' ' 19' ' ' THR . 10.0 m -119.53 -155.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 120.839 0.352 . . . . 0.0 111.703 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.413 ' N ' HG23 ' B' ' 18' ' ' VAL . 0.1 OUTLIER 172.92 102.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.425 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 38.4 t -113.37 110.86 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -107.34 107.79 18.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.23 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.42 ' CG2' ' HB2' ' B' ' 6' ' ' ARG . 30.5 m -80.24 74.98 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.019 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -156.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.731 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.13 71.87 1.3 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.921 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 t -86.22 107.66 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.083 0.468 . . . . 0.0 111.948 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.6 165.22 0.29 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.804 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.64 -170.64 13.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.324 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.88 -28.49 14.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.91 0.386 . . . . 0.0 110.579 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -121.19 136.7 54.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.97 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -93.35 115.37 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.948 0.404 . . . . 0.0 111.535 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.57 98.81 7.79 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.861 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.483 HD11 HG22 ' B' ' 32' ' ' ILE . 4.6 mm -93.98 125.28 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.417 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.51 103.56 1.97 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.964 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 17.5 t -98.15 103.63 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.937 0.399 . . . . 0.0 111.945 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -92.7 107.54 19.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.034 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.82 147.65 55.11 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.016 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.69 156.59 24.5 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.982 2.454 . . . . 0.0 112.0 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -90.71 29.81 1.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.328 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.43 -40.31 5.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.711 0.291 . . . . 0.0 111.159 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.0 t -81.7 149.1 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.78 97.8 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.076 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.56 121.46 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.91 136.15 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.676 0.274 . . . . 0.0 110.433 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.431 ' HG2' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -149.6 -62.72 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.952 0.406 . . . . 0.0 110.724 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.46 133.47 0.81 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.463 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.7 OUTLIER -65.28 -36.34 83.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 tp -74.31 -47.89 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.562 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.421 ' CE1' HD11 ' A' ' 4' ' ' LEU . 2.0 m-85 -55.66 -38.3 69.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -64.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' B' ' 46' ' ' GLU . 0.0 OUTLIER -55.28 -15.79 2.77 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.642 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 39.9 mm -103.65 -56.44 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.604 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.17 -56.86 4.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.758 0.313 . . . . 0.0 111.233 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.55 -25.17 62.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.203 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -132.32 146.05 51.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 0.0 111.179 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 mttm 52.04 19.23 0.97 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.337 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 2.1 t -68.25 155.43 39.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.776 0.322 . . . . 0.0 110.587 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.31 105.33 11.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.696 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -147.25 162.36 39.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.29 -25.46 10.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.068 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.15 127.82 38.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.876 0.369 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.888 0.375 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.8 tp -121.21 112.37 18.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 4.7 tt -99.79 105.74 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.222 0.535 . . . . 0.0 110.795 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.422 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 1.9 mm? -124.41 120.71 32.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.752 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -55.45 141.63 35.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.738 0.304 . . . . 0.0 110.806 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 5.3 mtt180 -150.95 143.94 24.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.058 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 5.7 ttp180 169.7 -4.17 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.756 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.44 -71.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.68 0.276 . . . . 0.0 111.199 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.88 90.48 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.697 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -110.15 -174.39 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.637 0.256 . . . . 0.0 110.56 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 170.82 101.28 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 111.041 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.462 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 1.2 pt? -115.31 154.1 29.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.397 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.1 ttm -129.53 100.7 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.096 0.474 . . . . 0.0 111.092 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 tp -114.73 123.29 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.531 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.23 -107.18 0.67 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.116 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -148.47 5.09 0.71 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 1.7 tt0 154.61 72.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.893 0.477 . . . . 0.0 109.969 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 m -122.31 -152.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.35 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.426 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 169.41 103.69 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.462 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 31.3 t -116.43 113.79 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.96 0.41 . . . . 0.0 111.858 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 t -110.88 112.9 25.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.33 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.421 ' CG2' ' CB ' ' A' ' 6' ' ' ARG . 26.9 m -80.81 75.55 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.802 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.61 -138.02 0.1 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.531 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.02 77.33 0.15 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.466 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.2 t -85.84 107.91 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 111.709 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.74 141.11 50.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.691 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.39 -50.39 5.58 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.57 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -101.57 -83.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.863 0.332 . . . . 0.0 111.262 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -87.18 118.99 26.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.0 111.126 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.4 m -93.33 136.34 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.186 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 5.0 mtm180 -78.13 106.44 10.01 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.483 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.5 mm -87.35 135.46 25.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.597 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.35 120.71 6.41 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.355 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -116.08 103.61 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.41 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.7 OUTLIER -98.08 107.67 20.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.571 179.641 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.35 142.36 26.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.503 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.29 156.35 25.67 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.724 2.283 . . . . 0.0 112.164 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.52 3.39 21.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.55 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -78.59 -41.91 30.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.71 0.291 . . . . 0.0 111.17 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 t -87.3 152.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.929 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 m -66.55 100.26 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.892 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.4 p -122.15 120.67 61.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.239 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.31 136.12 50.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.542 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.4 mtt85 -141.09 -64.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.437 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -168.88 136.15 1.9 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.748 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -55.0 -53.57 54.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.8 tt -65.08 -41.99 93.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.437 ' CG ' ' HB2' ' A' ' 45' ' ' GLU . 3.5 m-85 -45.46 -48.31 13.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.578 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -89.0 -49.33 6.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.463 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -53.59 -17.37 2.07 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 1.3 mp -111.52 -51.12 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.699 0.285 . . . . 0.0 111.013 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.18 -60.36 2.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.937 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.08 -36.61 77.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.895 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -114.31 123.8 50.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -46.38 107.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.289 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.6 p -63.59 163.41 11.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.987 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.52 91.71 4.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.67 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -129.1 161.62 29.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.024 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.3 p -149.0 82.96 1.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.722 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 m -91.94 127.17 37.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.834 0.35 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 7.7 tp -121.18 112.31 18.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.414 ' CG2' ' O ' ' B' ' 3' ' ' ILE . 4.7 tt -99.77 105.73 17.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.146 0.498 . . . . 0.0 110.85 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.422 ' HG ' ' CD2' ' A' ' 48' ' ' TYR . 1.9 mm? -124.36 120.68 32.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.769 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -55.43 141.57 35.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.323 . . . . 0.0 110.735 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 5.3 mtt180 -150.95 143.95 24.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 5.7 ttp180 169.71 -4.13 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.758 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.45 -71.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.672 0.273 . . . . 0.0 111.171 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.88 90.4 0.13 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.703 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -110.09 -174.36 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.636 0.255 . . . . 0.0 110.591 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 170.79 101.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.082 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.457 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 1.2 pt? -115.33 154.08 29.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.427 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.1 ttm -129.46 100.73 5.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.057 0.456 . . . . 0.0 111.076 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 tp -114.83 123.31 70.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.493 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.2 -107.17 0.67 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.159 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 0.1 OUTLIER -148.4 5.09 0.71 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 1.7 tt0 154.65 72.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.895 0.478 . . . . 0.0 110.026 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 m -122.32 -152.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.305 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.425 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 169.45 103.74 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.457 ' HB ' ' CD2' ' B' ' 12' ' ' LEU . 31.9 t -116.47 113.82 44.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.931 0.396 . . . . 0.0 111.798 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.0 t -110.93 112.87 25.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.303 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.416 ' CG2' ' CB ' ' B' ' 6' ' ' ARG . 27.0 m -80.72 75.48 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.84 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.55 -138.03 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.565 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.96 77.35 0.14 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.481 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 37.2 t -85.9 107.9 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.037 0.446 . . . . 0.0 111.674 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.64 141.09 50.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.657 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.43 -50.37 5.62 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.267 -0.492 . . . . 0.0 113.587 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -101.61 -83.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.813 0.306 . . . . 0.0 111.235 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -87.22 118.99 27.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.915 0.388 . . . . 0.0 111.121 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 15.4 m -93.32 136.38 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.145 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 5.0 mtm180 -78.14 106.42 10.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.532 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 32.6 mm -87.33 135.4 25.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.002 0.429 . . . . 0.0 111.545 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.29 120.66 6.4 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.374 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -116.04 103.67 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 0.0 111.429 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' B' ' 19' ' ' THR . 0.7 OUTLIER -98.15 107.69 20.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.544 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.36 142.33 26.31 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.533 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -79.28 156.33 25.69 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.73 2.287 . . . . 0.0 112.195 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.51 3.45 21.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.537 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -78.69 -41.88 29.92 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.683 0.278 . . . . 0.0 111.129 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 t -87.26 152.07 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.987 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -66.62 100.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -122.16 120.66 61.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.233 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.35 136.06 50.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.74 0.305 . . . . 0.0 110.576 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 32.4 mtt85 -141.03 -64.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.899 0.38 . . . . 0.0 110.819 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.435 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 0.8 OUTLIER -168.85 136.21 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.738 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -55.02 -53.66 52.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.009 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 12.8 tt -64.98 -42.01 93.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.435 ' CG ' ' HB2' ' B' ' 45' ' ' GLU . 3.5 m-85 -45.4 -48.37 13.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.568 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -89.02 -49.34 6.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.464 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -53.56 -17.37 2.05 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.442 ' N ' ' CD1' ' B' ' 51' ' ' ILE . 1.3 mp -111.56 -50.98 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.708 0.289 . . . . 0.0 111.065 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.3 -60.32 2.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.896 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.63 77.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.886 0.374 . . . . 0.0 110.92 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -114.2 123.45 49.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.783 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -56.87 104.28 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.142 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 21.5 t -96.89 -155.74 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.4 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.6 107.55 11.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.778 0.323 . . . . 0.0 110.626 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -137.56 -67.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.934 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 35.7 p -157.35 133.59 9.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.9 121.05 38.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.935 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.839 0.352 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.1 105.39 13.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 3.9 tt -100.96 105.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.279 0.561 . . . . 0.0 111.08 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.22 119.71 29.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.85 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -58.02 149.55 22.99 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.724 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.19 144.32 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.978 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.431 ' HD3' ' CG1' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -163.93 25.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.561 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.52 -52.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.981 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.17 89.18 0.1 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.676 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.8 55.48 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.0 0.429 . . . . 0.0 110.674 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -61.45 101.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.457 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.405 ' CD2' ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -111.12 154.23 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.991 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -133.19 99.7 4.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.279 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.8 tp -118.04 138.7 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.723 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.06 -108.23 1.27 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.441 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -143.47 -5.41 0.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 3.2 tt0 163.31 65.28 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.5 m -117.28 -160.78 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.511 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.4 OUTLIER 175.74 104.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.405 ' CG2' ' CD2' ' A' ' 12' ' ' LEU . 27.2 m -115.54 106.87 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.65 109.51 21.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.361 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.84 70.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.602 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.81 -147.24 0.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.544 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 31' ' ' ARG . . . 63.19 79.67 0.14 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.165 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.431 ' CG1' ' HD3' ' A' ' 7' ' ' ARG . 85.9 t -85.91 107.36 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.001 0.429 . . . . 0.0 111.619 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.95 139.2 45.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.875 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.77 -50.66 7.15 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 113.753 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -101.36 -87.46 0.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.018 0.409 . . . . 0.0 111.452 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.403 ' HB3' HG22 ' B' ' 5' ' ' THR . 1.2 mp0 -84.87 119.63 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.5 m -93.3 136.83 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.631 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 4.8 mmt180 -76.99 103.76 7.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.944 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.405 HD11 HG21 ' A' ' 32' ' ' ILE . 8.4 mt -87.33 131.3 35.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.401 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 110.59 3.77 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.173 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.0 t -110.76 103.04 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.973 0.416 . . . . 0.0 111.565 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.8 t-20 -96.04 107.3 19.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.287 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.68 145.99 53.5 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.761 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.47 156.32 25.07 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.87 2.38 . . . . 0.0 112.145 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.35 35.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -119.17 -38.76 2.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.035 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 t -80.24 155.08 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.935 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -59.13 112.6 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.04 121.0 62.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -129.03 128.16 43.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.369 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.42 -69.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -157.03 116.66 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.78 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -60.92 -35.78 77.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.79 -43.34 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -51.5 -43.26 62.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.334 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -82.17 -41.74 19.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.255 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -72.62 0.17 11.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.41 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 11.1 tt -114.99 -45.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.756 0.312 . . . . 0.0 111.28 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -90.22 -50.07 6.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.732 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.23 -43.56 51.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.55 118.66 37.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.626 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.23 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.854 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.41 ' HB2' ' HA ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -88.22 41.85 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.207 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 63.46 131.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.921 0.391 . . . . 0.0 111.118 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -133.25 -43.32 0.86 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.837 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 95.6 p -144.21 92.76 2.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.782 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 p -103.31 126.43 50.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.018 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.95 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.84 0.352 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.16 105.44 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.827 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' B' ' 3' ' ' ILE . 3.9 tt -100.98 105.16 17.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.22 0.533 . . . . 0.0 111.021 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.23 119.74 29.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.809 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -58.0 149.68 22.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.68 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.11 144.41 0.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.98 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.425 ' HD3' ' CG1' ' B' ' 25' ' ' VAL . 0.8 OUTLIER -164.03 25.93 0.07 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.638 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.51 -52.46 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.982 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.24 89.21 0.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.64 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.86 55.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.022 0.439 . . . . 0.0 110.648 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 25.7 m -61.53 101.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.522 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.412 ' CD2' ' CG2' ' B' ' 20' ' ' VAL . 0.1 OUTLIER -111.03 154.23 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.013 179.298 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -133.2 99.68 4.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.419 . . . . 0.0 111.289 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 8.7 tp -118.06 138.72 47.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.721 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.04 -108.11 1.26 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.528 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.8 OUTLIER -143.55 -5.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 3.3 tt0 163.23 65.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 11.6 m -117.22 -160.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.518 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.4 OUTLIER 175.71 104.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.412 ' CG2' ' CD2' ' B' ' 12' ' ' LEU . 27.7 m -115.51 106.78 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.57 109.46 21.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.376 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.81 70.4 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.582 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.95 -147.22 0.16 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.543 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' B' ' 31' ' ' ARG . . . 63.25 79.6 0.15 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.158 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.425 ' CG1' ' HD3' ' B' ' 7' ' ' ARG . 86.6 t -85.88 107.38 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.023 0.439 . . . . 0.0 111.614 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 139.22 45.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.814 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.76 -50.69 7.13 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.755 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -101.31 -87.51 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.984 0.392 . . . . 0.0 111.421 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.412 ' HB3' HG22 ' A' ' 5' ' ' THR . 1.2 mp0 -84.84 119.61 25.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.9 0.381 . . . . 0.0 110.865 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 18.4 m -93.3 136.88 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.624 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.8 mmt180 -77.03 103.7 7.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.049 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.404 HG21 HD11 ' B' ' 32' ' ' ILE . 8.5 mt -87.33 131.35 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.411 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.91 110.61 3.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.201 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 28.1 t -110.8 103.1 14.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.921 0.391 . . . . 0.0 111.524 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' B' ' 19' ' ' THR . 1.8 t-20 -96.08 107.29 19.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.279 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.67 145.92 53.25 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.815 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.43 156.36 25.22 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.863 2.375 . . . . 0.0 112.129 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.38 35.01 1.02 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.146 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -119.09 -38.9 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.741 0.305 . . . . 0.0 111.076 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 t -80.15 155.03 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.998 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -59.09 112.62 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.053 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.07 121.03 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -129.05 128.18 43.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.343 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 -69.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.72 0.295 . . . . 0.0 111.057 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -157.03 116.71 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.928 0.394 . . . . 0.0 110.734 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -60.94 -35.79 77.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.876 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.74 -43.38 47.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.111 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -51.35 -43.36 61.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.325 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -82.15 -41.83 19.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.229 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -72.54 0.17 11.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 tt -115.04 -45.66 4.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.755 0.312 . . . . 0.0 111.242 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -90.15 -50.05 6.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.714 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.25 -43.51 51.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.824 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.51 121.21 42.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.733 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 87.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 21.2 p -62.76 -176.06 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.028 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -172.77 171.3 4.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.804 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -57.97 -29.08 64.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.985 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 2.0 p -175.63 145.93 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.803 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.5 p -121.47 133.15 55.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 48.6 p90 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.897 179.975 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.832 0.349 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.96 109.69 17.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 mm -97.2 105.34 17.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.09 0.471 . . . . 0.0 110.789 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.461 ' HG ' ' CG ' ' B' ' 48' ' ' TYR . 0.1 OUTLIER -124.23 110.42 14.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.2 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -62.9 77.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.961 0.41 . . . . 0.0 111.474 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.437 ' HB2' HG13 ' B' ' 32' ' ' ILE . 3.8 mtt-85 -80.12 143.68 33.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.321 0.581 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.453 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -170.59 -7.48 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.878 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.32 12.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.49 -139.25 9.36 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.864 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -107.08 -164.54 0.99 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.785 0.326 . . . . 0.0 111.178 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.3 p -110.02 169.34 8.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -109.35 154.31 22.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.597 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 ttp -129.73 100.29 5.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.07 0.462 . . . . 0.0 111.186 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.1 tp -114.32 124.69 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.486 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.11 -105.35 0.6 Allowed Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.058 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 2.2 t70 -160.81 11.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER 159.17 61.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.851 0.46 . . . . 0.0 109.781 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.8 m -118.3 -157.7 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.676 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.407 ' CG2' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 167.32 102.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.7 t -118.65 113.85 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.982 0.42 . . . . 0.0 111.951 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.0 m -96.03 113.08 24.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.549 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 24' ' ' GLY . 30.5 m -76.78 -19.0 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.862 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.89 -76.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.044 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . 92.41 -40.81 2.83 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.16 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 1.1 t -85.59 139.17 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.666 0.233 . . . . 0.0 110.938 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER 164.37 165.58 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.943 0.401 . . . . 0.0 110.715 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.71 105.59 2.05 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.151 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m120 64.45 -72.53 0.06 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 111.23 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.484 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -84.46 136.93 33.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.682 179.456 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.7 t -93.15 119.86 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.907 0.384 . . . . 0.0 111.794 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 0.1 OUTLIER -75.75 98.59 4.16 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.045 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' B' ' 6' ' ' ARG . 11.2 mm -92.18 123.42 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.39 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.77 119.24 6.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.26 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.74 103.73 15.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.922 0.391 . . . . 0.0 111.253 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.407 ' HB3' ' CG2' ' A' ' 19' ' ' THR . 3.6 t-20 -100.61 107.52 19.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.286 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.96 147.69 42.46 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.697 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.51 156.52 32.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.866 2.377 . . . . 0.0 112.126 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 30.35 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.25 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -106.08 -37.96 6.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.77 0.319 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.73 147.53 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -54.6 100.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.18 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.4 124.56 71.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.08 136.32 51.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.601 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -147.74 -176.85 5.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.57 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HB3' ' CG ' ' A' ' 48' ' ' TYR . 2.7 tt0 -59.32 137.99 57.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -61.29 2.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 tt -54.73 -42.05 59.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.349 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.467 ' CG ' ' HG ' ' B' ' 4' ' ' LEU . 4.5 m-30 -46.24 -58.85 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -75.97 -20.99 57.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.625 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -73.19 -13.84 61.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.596 0.236 . . . . 0.0 111.458 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.6 mt -108.91 -33.11 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.723 0.297 . . . . 0.0 111.361 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.93 -50.84 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.342 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.23 -69.03 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.924 0.393 . . . . 0.0 110.771 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -113.94 118.62 34.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.507 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -57.25 101.73 0.07 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.643 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.82 -156.43 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -73.62 157.98 35.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.745 0.307 . . . . 0.0 110.701 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.03 -53.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.805 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.67 31.81 3.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.746 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.88 120.45 33.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.83 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.895 -179.945 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.815 0.34 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.87 109.65 17.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 13.0 mm -97.13 105.29 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.075 0.464 . . . . 0.0 110.861 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.467 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -124.22 110.45 14.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.178 179.064 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -62.95 77.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.011 0.434 . . . . 0.0 111.497 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' B' ' 4' ' ' LEU . 3.7 mtt-85 -80.06 143.67 33.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.329 0.585 . . . . 0.0 111.022 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.428 ' HA ' ' HA3' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -170.56 -7.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.905 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.24 12.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.43 -139.26 9.35 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.896 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -107.12 -164.5 0.99 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.159 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 8.5 p -110.07 169.37 8.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -109.39 154.36 22.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.519 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 1.6 ttp -129.76 100.26 5.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.462 . . . . 0.0 111.159 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . 0.405 ' HA ' HD11 ' B' ' 14' ' ' ILE . 3.1 tp -114.34 124.64 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.502 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.13 -105.46 0.61 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.127 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 2.2 t70 -160.67 12.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 0.2 OUTLIER 159.03 61.86 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.854 0.462 . . . . 0.0 109.77 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 8.8 m -118.41 -157.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.656 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.407 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 167.4 102.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 25.8 t -118.72 113.74 42.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.4 . . . . 0.0 111.946 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 4.0 m -95.96 113.16 24.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' B' ' 24' ' ' GLY . 31.0 m -76.75 -19.05 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.872 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.93 -76.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.02 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . 92.42 -40.85 2.82 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.165 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.423 ' O ' ' CB ' ' B' ' 26' ' ' LYS . 1.2 t -85.61 139.21 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.644 0.222 . . . . 0.0 110.943 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER 164.37 165.62 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.95 0.405 . . . . 0.0 110.736 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 29' ' ' GLN . . . -76.72 105.61 2.05 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.056 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m120 64.5 -72.63 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.903 0.382 . . . . 0.0 111.161 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 0.0 OUTLIER -84.47 136.98 33.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.631 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.14 119.82 41.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.847 0.356 . . . . 0.0 111.819 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -75.77 98.63 4.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.048 179.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.437 HG13 ' HB2' ' A' ' 6' ' ' ARG . 11.3 mm -92.18 123.33 44.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.334 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.71 119.23 6.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.332 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.73 103.7 15.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.878 0.371 . . . . 0.0 111.291 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' B' ' 19' ' ' THR . 3.6 t-20 -100.58 107.57 19.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.256 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.02 147.77 42.57 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.682 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -77.6 156.49 31.95 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.836 2.357 . . . . 0.0 112.161 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 30.22 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.233 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -106.01 -38.02 6.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.808 0.337 . . . . 0.0 110.89 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.63 147.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.947 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -54.58 100.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.204 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.34 124.54 71.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.09 136.29 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.631 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -147.74 -176.85 5.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.31 . . . . 0.0 110.631 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.433 ' HB3' ' CG ' ' B' ' 48' ' ' TYR . 2.7 tt0 -59.34 138.07 57.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 110.801 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -61.31 2.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 tt -54.72 -42.14 59.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.461 ' CG ' ' HG ' ' A' ' 4' ' ' LEU . 4.5 m-30 -46.2 -58.81 3.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -76.05 -20.93 57.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.609 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -73.28 -13.72 61.18 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 111.41 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 28.9 mt -109.09 -33.04 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.709 0.29 . . . . 0.0 111.357 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.98 -50.85 3.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.347 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.23 -69.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.969 0.414 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -114.05 119.59 37.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.402 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -57.66 103.64 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.733 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 77.0 p -160.03 71.18 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.994 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -59.93 -40.63 89.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 56.17 32.39 20.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.024 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 59.5 p -88.05 89.19 7.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.969 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.42 145.03 24.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 54.2 p90 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.939 -179.985 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.789 0.328 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -122.22 116.69 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.805 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' A' ' 3' ' ' ILE . 4.2 tt -103.11 105.31 18.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.181 0.515 . . . . 0.0 110.786 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.414 HD21 ' CD1' ' B' ' 48' ' ' TYR . 4.1 tp -125.19 124.19 41.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.021 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -55.6 140.66 40.31 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.376 179.458 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 6.1 mtp85 -151.65 142.97 23.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.939 0.4 . . . . 0.0 111.426 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 172.82 -0.52 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.784 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.3 t -148.73 116.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.796 0.331 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.78 63.45 5.23 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.71 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 11' ' ' THR . 28.4 mm-40 -106.64 173.27 6.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.538 0.209 . . . . 0.0 110.723 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.415 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER 164.47 101.26 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.326 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.401 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -109.07 154.19 22.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.785 179.022 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -131.81 100.24 5.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.931 0.396 . . . . 0.0 111.307 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.2 tp -119.12 115.44 47.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.679 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.08 -106.76 0.51 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.912 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 11.8 t70 -150.74 8.64 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.1 mt-10 155.74 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.839 0.455 . . . . 0.0 109.879 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' MET . 16.6 m -135.58 131.41 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.861 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.1 m -116.09 117.05 29.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.401 ' HB ' ' CD2' ' A' ' 12' ' ' LEU . 4.9 t -108.89 110.84 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 111.784 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 t -102.24 104.61 15.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.239 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.88 71.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.241 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.11 -143.38 0.2 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.528 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.23 80.87 0.06 OUTLIER Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.797 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 t -110.28 108.28 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 120.844 0.354 . . . . 0.0 111.324 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -167.03 135.2 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.623 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.51 -153.33 19.26 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.765 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.65 -52.73 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -84.93 114.62 22.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 m -93.07 137.14 23.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 35.7 mtt180 -76.0 104.26 6.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.332 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.6 mm -87.22 137.38 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.901 0.381 . . . . 0.0 111.344 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.85 121.71 6.31 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.413 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 t -118.09 103.64 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.953 0.406 . . . . 0.0 111.431 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.25 107.59 19.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.299 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.07 144.82 22.6 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.822 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -83.0 156.27 15.17 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.85 2.367 . . . . 0.0 111.971 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 42.73 1.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.214 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -113.36 -43.72 3.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.715 0.293 . . . . 0.0 110.94 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.43 160.9 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.844 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.79 99.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.715 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.38 122.93 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.956 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.34 136.18 50.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.193 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.402 ' HD3' ' CD2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -161.76 -165.18 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.321 . . . . 0.0 110.766 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -64.26 136.71 57.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -55.08 -61.21 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 tt -55.95 -38.96 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.315 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.424 ' HB3' ' O ' ' A' ' 45' ' ' GLU . 43.3 t80 -46.71 -61.91 1.62 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -21.29 56.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.438 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 6.9 tpt180 -73.66 -10.94 60.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 52' ' ' GLN . 1.7 pt -114.29 -28.88 2.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.419 ' N ' HG13 ' A' ' 51' ' ' ILE . 13.1 mm-40 -104.83 -54.27 2.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.732 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.15 -66.01 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.699 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -110.26 117.52 33.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.648 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.29 107.93 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.484 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.82 160.24 12.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.891 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -63.13 -66.48 0.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -82.54 147.17 28.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.814 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 p -144.74 29.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.067 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.9 m -93.25 145.03 24.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.805 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.917 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.818 0.342 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -122.26 116.63 24.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.879 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' B' ' 3' ' ' ILE . 4.2 tt -103.09 105.33 18.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.198 0.523 . . . . 0.0 110.774 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.417 HD21 ' CD1' ' A' ' 48' ' ' TYR . 4.1 tp -125.2 124.21 41.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.064 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -55.64 140.67 40.48 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.36 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 6.1 mtp85 -151.67 142.96 23.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.946 0.403 . . . . 0.0 111.427 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER 172.8 -0.54 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.821 179.438 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 17.3 t -148.66 116.75 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.781 0.324 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.7 63.47 5.21 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.705 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' B' ' 11' ' ' THR . 28.3 mm-40 -106.6 173.33 6.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.503 0.192 . . . . 0.0 110.768 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.416 ' CB ' ' O ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 164.47 101.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.409 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.0 154.19 22.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.789 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' B' ' 18' ' ' VAL . 0.5 OUTLIER -131.8 100.22 5.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 111.322 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 7.2 tp -119.06 115.45 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.708 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.08 -106.71 0.51 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.94 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 11.8 t70 -150.8 8.7 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.1 mt-10 155.7 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.811 0.444 . . . . 0.0 109.878 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' B' ' 13' ' ' MET . 16.5 m -135.64 131.42 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.827 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -116.05 117.04 29.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.86 110.82 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.868 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 1.4 t -102.22 104.62 15.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.216 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.88 71.04 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.291 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -143.35 0.2 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.476 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.19 80.79 0.06 OUTLIER Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.887 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 t -110.21 108.28 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 111.309 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -167.07 135.09 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.658 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.59 -153.36 19.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.806 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.67 -52.61 10.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 110.853 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -84.95 114.59 22.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.984 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 m -93.02 137.16 23.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.093 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 35.8 mtt180 -76.02 104.28 6.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.348 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 12.8 mm -87.29 137.37 21.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.933 0.396 . . . . 0.0 111.37 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.9 121.77 6.32 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.373 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 t -118.08 103.64 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 0.0 111.426 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.35 107.58 19.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.233 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.03 144.85 22.77 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.799 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -82.97 156.23 15.23 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.92 2.413 . . . . 0.0 111.979 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.81 42.67 1.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.218 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -113.26 -43.77 3.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.784 0.326 . . . . 0.0 110.971 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.46 160.93 3.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.769 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.71 99.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.758 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.4 122.89 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.954 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.34 136.16 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.402 ' HD3' ' CD2' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -161.76 -165.19 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.754 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.6 OUTLIER -64.32 136.67 57.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.966 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.7 OUTLIER -54.97 -61.27 2.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 tt -55.98 -38.91 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.299 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' B' ' 45' ' ' GLU . 43.1 t80 -46.74 -61.99 1.59 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -21.29 56.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.455 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' B' ' 46' ' ' GLU . 7.0 tpt180 -73.73 -10.9 60.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.572 0.225 . . . . 0.0 111.565 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.42 HG13 ' N ' ' B' ' 52' ' ' GLN . 1.7 pt -114.35 -28.62 2.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.797 0.332 . . . . 0.0 111.166 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.42 ' N ' HG13 ' B' ' 51' ' ' ILE . 13.0 mm-40 -104.95 -54.39 2.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.11 -65.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.726 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -110.5 117.82 34.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.546 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' B' ' 57' ' ' GLN . 1.5 tptm -64.73 95.23 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.453 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.56 -69.05 0.14 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.718 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' B' ' 55' ' ' LYS . 0.3 OUTLIER 68.12 61.44 0.4 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.091 179.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 70.25 129.16 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.04 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 55.0 p -161.65 122.55 2.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.727 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 95.5 p -91.81 127.31 37.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.073 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.906 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.753 0.311 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.76 HD21 ' HB2' ' B' ' 53' ' ' ALA . 5.4 mp -119.98 113.2 20.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.0 tt -105.04 107.86 23.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 110.737 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.436 ' HG ' ' CG ' ' B' ' 48' ' ' TYR . 1.4 mm? -124.09 126.03 45.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.095 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.412 HG21 ' HG2' ' B' ' 29' ' ' GLN . 0.3 OUTLIER -59.76 145.2 46.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.409 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.411 ' HB2' HG13 ' B' ' 32' ' ' ILE . 0.0 OUTLIER -155.89 146.28 21.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.164 0.507 . . . . 0.0 111.304 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.724 ' O ' HG13 ' A' ' 8' ' ' VAL . 2.3 ttt180 175.92 74.31 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 176.97 -60.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.663 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.74 82.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.73 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.409 ' O ' ' HB ' ' A' ' 11' ' ' THR . 1.3 tt0 -72.17 -161.9 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.556 0.217 . . . . 0.0 110.569 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER 172.35 89.43 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.633 0.254 . . . . 0.0 111.056 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.55 HD13 HG11 ' B' ' 34' ' ' VAL . 0.2 OUTLIER -110.53 152.33 26.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.126 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.505 ' HA ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -132.98 100.27 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.901 0.381 . . . . 0.0 111.546 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.622 ' C ' HD13 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -111.35 127.07 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.258 179.135 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.509 ' HA2' HG11 ' B' ' 40' ' ' VAL . . . 126.52 -102.69 0.64 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.877 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.461 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.4 m-20 -165.77 17.39 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.4 OUTLIER 158.92 59.42 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.734 0.302 . . . . 0.0 110.884 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.722 HG12 ' HD2' ' A' ' 37' ' ' PRO . 11.1 m -120.5 -157.37 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 120.638 0.256 . . . . 0.0 111.632 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 167.58 105.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 34' ' ' VAL . 28.6 t -122.91 114.3 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.827 0.346 . . . . 0.0 111.737 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 21' ' ' THR . 9.8 t -104.4 118.4 36.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.513 ' O ' ' C ' ' A' ' 23' ' ' LEU . 17.1 m -91.85 63.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.427 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.746 HD12 ' O ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -13.16 -70.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.586 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . 90.74 -45.4 2.9 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.26 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.746 ' O ' HD12 ' A' ' 23' ' ' LEU . 1.4 t -85.25 137.35 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' CB ' ' HA ' ' A' ' 30' ' ' VAL . 3.9 tptt 174.7 165.49 0.25 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.645 0.259 . . . . 0.0 110.383 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.37 -105.94 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.465 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.33 -41.5 11.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.069 0.461 . . . . 0.0 110.271 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -105.56 136.52 44.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.926 179.369 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.417 ' HA ' ' CB ' ' A' ' 26' ' ' LYS . 21.3 t -93.18 114.15 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 0.0 111.417 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.87 100.64 4.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.657 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.408 HG13 ' CB ' ' B' ' 6' ' ' ARG . 10.7 mm -87.11 131.76 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.44 120.76 6.23 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.048 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.734 ' HA ' HG13 ' A' ' 20' ' ' VAL . 16.3 t -118.19 103.69 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.883 0.373 . . . . 0.0 111.199 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 19' ' ' THR . 3.0 t-20 -99.48 107.47 19.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.12 0.486 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.67 144.17 28.99 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.675 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.722 ' HD2' HG12 ' A' ' 18' ' ' VAL . 85.7 Cg_endo -80.29 156.36 22.47 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.747 2.298 . . . . 0.0 112.129 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -93.25 34.6 1.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.103 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.42 -44.08 6.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.507 HG11 ' HA2' ' B' ' 15' ' ' GLY . 24.3 t -89.33 158.07 2.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.781 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -59.64 97.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.817 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.5 p -122.45 120.95 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.178 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -120.73 136.29 54.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -146.61 -176.32 5.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.69 0.281 . . . . 0.0 110.569 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.75 133.75 56.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 0.0 110.698 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -51.78 -60.27 3.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.31 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 48' ' ' TYR . 1.3 tp -55.08 -42.86 67.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.482 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 47' ' ' ILE . 2.7 m-85 -46.53 -68.08 0.22 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.443 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.703 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 2.5 pt20 -70.52 -21.04 62.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.469 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.45 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 12.9 mtp85 -65.97 -23.02 66.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.677 0.275 . . . . 0.0 111.358 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.6 pt -109.91 -21.62 5.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.417 ' HB3' HD23 ' B' ' 2' ' ' LEU . 1.2 tp60 -107.09 -58.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 111.441 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.791 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -66.44 -73.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.451 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.8 127.21 54.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.389 . . . . 0.0 111.12 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.529 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.027 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.787 0.327 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.4 mp -119.98 113.27 20.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.586 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.0 tt -105.05 107.84 23.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.09 0.472 . . . . 0.0 110.743 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.443 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 1.4 mm? -124.17 126.11 45.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -59.78 145.3 45.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.376 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -155.96 146.26 21.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.141 0.496 . . . . 0.0 111.27 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.729 ' O ' HG13 ' B' ' 8' ' ' VAL . 2.3 ttt180 175.93 74.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.089 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.729 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER 176.87 -60.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.685 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.71 82.45 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.668 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.17 -161.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.547 0.213 . . . . 0.0 110.549 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 172.3 89.42 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.695 0.283 . . . . 0.0 111.095 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.551 HD13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -110.46 152.25 26.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.243 179.27 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.519 ' HA ' HG23 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -132.96 100.36 4.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.4 . . . . 0.0 111.542 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.62 HD13 ' C ' ' B' ' 14' ' ' ILE . 0.0 OUTLIER -111.31 127.0 68.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.239 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.509 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 126.51 -102.64 0.64 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.888 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.4 m-20 -165.75 17.35 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.468 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.4 OUTLIER 158.9 59.55 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.747 0.308 . . . . 0.0 110.846 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.72 HG12 ' HD2' ' B' ' 37' ' ' PRO . 11.2 m -120.6 -157.34 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.721 0.296 . . . . 0.0 111.55 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.652 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 167.61 105.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.704 HG13 ' HA ' ' B' ' 34' ' ' VAL . 28.9 t -122.94 114.34 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.32 . . . . 0.0 111.701 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.431 HG23 ' O ' ' B' ' 21' ' ' THR . 9.7 t -104.42 118.42 36.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.782 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.503 ' O ' ' C ' ' B' ' 23' ' ' LEU . 17.1 m -91.89 63.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.445 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.757 HD12 ' O ' ' B' ' 25' ' ' VAL . 0.4 OUTLIER -13.19 -70.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.519 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . 90.75 -45.44 2.9 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.222 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.757 ' O ' HD12 ' B' ' 23' ' ' LEU . 1.4 t -85.28 137.36 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.652 0.263 . . . . 0.0 110.831 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 3.9 tptt 174.69 165.52 0.25 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.64 0.257 . . . . 0.0 110.454 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.42 -105.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.445 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.32 -41.54 11.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.065 0.46 . . . . 0.0 110.265 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 0.2 OUTLIER -105.46 136.49 44.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.956 179.344 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.406 ' HA ' ' CB ' ' B' ' 26' ' ' LYS . 21.3 t -93.2 114.22 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 111.398 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.85 100.58 4.82 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.634 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.411 HG13 ' HB2' ' A' ' 6' ' ' ARG . 10.6 mm -87.11 131.76 34.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.42 120.72 6.22 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.091 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.704 ' HA ' HG13 ' B' ' 20' ' ' VAL . 16.2 t -118.17 103.72 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.899 0.38 . . . . 0.0 111.201 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' B' ' 19' ' ' THR . 3.0 t-20 -99.49 107.51 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.371 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.72 144.15 28.76 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.65 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.72 ' HD2' HG12 ' B' ' 18' ' ' VAL . 85.0 Cg_endo -80.17 156.34 22.84 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.784 2.323 . . . . 0.0 112.152 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -93.29 34.67 1.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.44 -44.19 5.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.509 HG11 ' HA2' ' A' ' 15' ' ' GLY . 24.2 t -89.22 158.09 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.815 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.459 ' N ' HG12 ' B' ' 40' ' ' VAL . 1.0 OUTLIER -59.64 97.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.786 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.492 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.5 p -122.55 120.91 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.179 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -120.75 136.31 54.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.267 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -146.61 -176.3 5.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.522 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.73 133.75 56.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -51.8 -60.29 3.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.249 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.456 HG23 ' N ' ' B' ' 48' ' ' TYR . 1.3 tp -55.05 -42.84 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.489 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.456 ' N ' HG23 ' B' ' 47' ' ' ILE . 2.7 m-85 -46.57 -68.03 0.23 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.476 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 2.5 pt20 -70.59 -21.03 62.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.498 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 13.0 mtp85 -65.96 -22.91 66.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.662 0.268 . . . . 0.0 111.35 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 18.6 pt -109.99 -21.76 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.413 ' HB3' HD23 ' A' ' 2' ' ' LEU . 1.2 tp60 -107.04 -58.05 1.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.736 0.303 . . . . 0.0 111.468 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.76 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -66.47 -73.48 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.478 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.28 128.92 55.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.925 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.787 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.599 ' C ' HD12 ' A' ' 2' ' ' LEU . 2.0 ttt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.835 0.35 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 2' ' ' LEU . 4.8 mp -119.87 116.07 25.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.707 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.532 ' C ' HD22 ' A' ' 4' ' ' LEU . 14.2 mm -93.0 105.66 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.984 0.421 . . . . 0.0 110.58 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.619 ' N ' HD22 ' A' ' 4' ' ' LEU . 2.5 mm? -116.77 156.79 26.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.666 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' B' ' 29' ' ' GLN . 0.1 OUTLIER -97.01 133.63 41.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.951 0.405 . . . . 0.0 110.649 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.679 HH11 HG21 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -151.42 148.1 27.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.84 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 2.8 ttt180 177.39 -6.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.176 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.419 ' H ' ' H ' ' A' ' 7' ' ' ARG . 22.0 t -115.7 -57.29 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.768 0.318 . . . . 0.0 111.044 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.48 88.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.645 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.84 -70.55 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.732 0.301 . . . . 0.0 110.787 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m 75.87 103.45 0.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.529 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.492 ' CD1' HG11 ' B' ' 34' ' ' VAL . 1.3 pt? -108.94 154.46 22.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.967 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.488 ' HA ' HG23 ' A' ' 18' ' ' VAL . 24.5 ttp -128.12 100.54 5.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.097 0.475 . . . . 0.0 111.24 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.641 HD13 ' HB ' ' B' ' 42' ' ' VAL . 2.1 tp -112.78 122.97 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.423 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.619 ' HA2' HG11 ' B' ' 40' ' ' VAL . . . 133.8 -104.87 0.54 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.996 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.5 t70 -159.41 11.65 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 157.4 61.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.964 0.412 . . . . 0.0 109.954 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.662 HG12 ' HD2' ' A' ' 37' ' ' PRO . 17.7 m -118.48 -155.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.723 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 168.59 103.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.749 HG13 ' HA ' ' A' ' 34' ' ' VAL . 25.2 t -119.72 111.22 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 111.769 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.29 113.07 25.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.48 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.679 HG21 HH11 ' A' ' 6' ' ' ARG . 29.6 m -84.76 62.94 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.779 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.32 121.83 3.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . -99.52 -15.71 31.36 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.001 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.2 t -85.48 125.8 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.743 0.271 . . . . 0.0 110.473 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 1.3 tpmp? 176.9 165.29 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.814 0.34 . . . . 0.0 110.66 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 29' ' ' GLN . . . -90.96 108.42 3.58 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.539 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 65.68 -69.52 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.876 0.37 . . . . 0.0 110.796 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 1.8 mt-30 -84.82 136.57 33.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.62 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.538 HG12 ' CD1' ' A' ' 32' ' ' ILE . 5.4 t -93.0 119.69 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.044 0.45 . . . . 0.0 111.493 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -82.88 98.21 9.07 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.3 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.566 HG23 ' HA ' ' A' ' 22' ' ' VAL . 4.7 mm -93.05 127.66 45.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.61 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.08 112.38 4.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.328 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.749 ' HA ' HG13 ' A' ' 20' ' ' VAL . 28.0 t -106.35 103.68 15.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.871 0.367 . . . . 0.0 111.168 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -98.37 107.33 19.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.368 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.16 146.08 52.85 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.677 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.662 ' HD2' HG12 ' A' ' 18' ' ' VAL . 77.0 Cg_endo -83.44 156.22 14.33 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.005 2.47 . . . . 0.0 112.358 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -3.25 41.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.332 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -42.63 70.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.643 0.259 . . . . 0.0 111.171 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.632 HG11 ' HA2' ' B' ' 15' ' ' GLY . 11.6 t -91.0 152.53 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.803 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.3 t -76.09 106.08 7.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.966 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.648 ' HB ' HD13 ' B' ' 14' ' ' ILE . 14.6 p -121.07 120.23 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.46 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -128.68 134.32 48.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.666 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.516 HH21 HG21 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -154.65 -49.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.706 0.288 . . . . 0.0 111.257 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 3.4 mm-40 -161.27 124.49 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.929 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -56.45 -59.07 5.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.101 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.443 HG23 ' N ' ' A' ' 48' ' ' TYR . 17.6 tt -58.1 -42.49 83.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.176 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CG ' ' HB2' ' A' ' 45' ' ' GLU . 3.1 m-85 -44.25 -58.06 3.11 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 4.3 pt20 -76.65 -21.62 55.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.793 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -67.38 -15.01 63.44 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.261 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.623 HD13 ' HD2' ' A' ' 55' ' ' LYS . 23.7 mm -116.05 -26.43 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.337 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.57 -58.66 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.909 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . . . -60.78 -64.09 1.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.588 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -109.58 116.28 31.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.387 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.623 ' HD2' HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.465 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.792 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.593 ' C ' HD12 ' B' ' 2' ' ' LEU . 2.0 ttt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.82 0.343 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.616 ' HB3' HD21 ' B' ' 4' ' ' LEU . 4.8 mp -119.88 116.09 25.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.522 ' C ' HD22 ' B' ' 4' ' ' LEU . 14.2 mm -93.05 105.73 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.994 0.426 . . . . 0.0 110.579 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.629 HD22 ' N ' ' B' ' 4' ' ' LEU . 2.5 mm? -116.77 156.78 26.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.679 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.01 133.63 41.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.949 0.404 . . . . 0.0 110.653 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.68 HH11 HG21 ' B' ' 22' ' ' VAL . 0.1 OUTLIER -151.44 148.11 27.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.796 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 2.8 ttt180 177.37 -6.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.13 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.404 ' H ' ' H ' ' B' ' 7' ' ' ARG . 22.0 t -115.67 -57.3 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.805 0.336 . . . . 0.0 111.044 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.47 88.34 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.601 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.88 -70.59 0.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.759 0.314 . . . . 0.0 110.735 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m 75.83 103.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.604 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.486 ' CD1' HG11 ' A' ' 34' ' ' VAL . 1.3 pt? -108.87 154.44 22.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.951 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.489 ' HA ' HG23 ' B' ' 18' ' ' VAL . 24.4 ttp -128.09 100.47 5.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 111.227 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.648 HD13 ' HB ' ' A' ' 42' ' ' VAL . 2.1 tp -112.74 122.93 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.632 ' HA2' HG11 ' A' ' 40' ' ' VAL . . . 133.87 -104.81 0.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.993 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.47 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.5 t70 -159.49 11.71 0.13 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.3 OUTLIER 157.35 61.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.699 0.399 . . . . 0.0 109.943 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.648 HG12 ' HD2' ' B' ' 37' ' ' PRO . 17.6 m -118.48 -155.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.705 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.642 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 168.66 103.13 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.761 HG13 ' HA ' ' B' ' 34' ' ' VAL . 25.3 t -119.71 111.21 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.866 0.365 . . . . 0.0 111.785 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.29 113.04 25.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.486 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.68 HG21 HH11 ' B' ' 6' ' ' ARG . 29.3 m -84.68 62.91 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.841 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.33 121.84 3.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . -99.57 -15.61 31.5 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.053 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' B' ' 26' ' ' LYS . 2.2 t -85.51 125.78 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.69 0.245 . . . . 0.0 110.465 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' B' ' 25' ' ' VAL . 1.3 tpmp? 176.91 165.3 0.5 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.626 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' B' ' 29' ' ' GLN . . . -91.0 108.34 3.57 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.55 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 65.77 -69.5 0.11 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.879 0.371 . . . . 0.0 110.739 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' B' ' 27' ' ' GLY . 1.8 mt-30 -84.8 136.57 33.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.54 HG12 ' CD1' ' B' ' 32' ' ' ILE . 5.3 t -92.99 119.78 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 0.0 111.497 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -82.95 98.26 9.13 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.281 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.569 HG23 ' HA ' ' B' ' 22' ' ' VAL . 4.7 mm -93.08 127.7 45.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.636 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.08 112.33 4.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.384 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.761 ' HA ' HG13 ' B' ' 20' ' ' VAL . 27.0 t -106.3 103.67 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.846 0.355 . . . . 0.0 111.242 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' B' ' 19' ' ' THR . 0.1 OUTLIER -98.36 107.35 19.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.369 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.19 146.1 52.86 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.633 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.648 ' HD2' HG12 ' B' ' 18' ' ' VAL . 76.0 Cg_endo -83.46 156.26 14.28 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.966 2.444 . . . . 0.0 112.356 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -3.36 41.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.35 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.49 -42.71 71.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.689 0.28 . . . . 0.0 111.184 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.619 HG11 ' HA2' ' A' ' 15' ' ' GLY . 11.6 t -90.98 152.58 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.802 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 39.4 t -76.08 105.98 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.982 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.641 ' HB ' HD13 ' A' ' 14' ' ' ILE . 14.6 p -121.0 120.17 61.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.494 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -128.63 134.3 48.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.665 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.535 HH21 HG21 ' B' ' 42' ' ' VAL . 0.1 OUTLIER -154.66 -49.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 111.309 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.453 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 3.4 mm-40 -161.23 124.53 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.4 OUTLIER -56.5 -59.04 5.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.446 HG23 ' N ' ' B' ' 48' ' ' TYR . 17.6 tt -58.1 -42.52 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.198 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.453 ' CG ' ' HB2' ' B' ' 45' ' ' GLU . 3.1 m-85 -44.22 -58.05 3.1 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.755 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 4.3 pt20 -76.77 -21.52 55.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.782 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.446 ' HA ' ' HG2' ' B' ' 54' ' ' GLU . 0.8 OUTLIER -67.47 -14.75 63.21 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.34 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 23.6 mm -116.23 -26.76 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.311 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.24 -58.7 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.95 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' HB2' ' B' ' 49' ' ' GLN . . . -60.8 -63.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.629 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' B' ' 50' ' ' ARG . 0.0 OUTLIER -111.21 120.06 41.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.649 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.447 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.823 0.344 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' B' ' 53' ' ' ALA . 5.0 mp -122.03 107.39 12.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.1 tt -115.06 114.73 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.181 0.515 . . . . 0.0 110.967 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.466 ' HB3' ' CZ ' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -125.44 135.67 52.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.824 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.436 ' H ' HD13 ' A' ' 4' ' ' LEU . 0.2 OUTLIER -62.37 150.86 38.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.057 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -170.67 148.03 2.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.25 0.548 . . . . 0.0 111.474 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -176.69 7.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.782 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.62 -61.59 2.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.331 . . . . 0.0 111.011 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.6 86.05 0.16 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.494 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.732 ' OE1' HG22 ' A' ' 22' ' ' VAL . 4.3 tm-20 -82.02 171.68 14.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.897 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t 178.8 122.71 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -144.39 141.36 29.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.402 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.559 ' HA ' HG23 ' A' ' 18' ' ' VAL . 4.0 ttt -133.0 99.73 4.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.419 . . . . 0.0 111.09 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.792 HG23 HG23 ' B' ' 14' ' ' ILE . 0.0 OUTLIER -116.3 129.27 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.484 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.701 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 128.8 -105.09 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.907 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.3 p30 -162.76 16.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 6.9 mt-10 158.2 60.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.849 0.357 . . . . 0.0 110.501 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.702 HG12 ' HD2' ' A' ' 37' ' ' PRO . 17.5 m -120.36 -159.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 120.766 0.317 . . . . 0.0 111.646 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 168.57 103.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.629 ' CG1' HG13 ' A' ' 34' ' ' VAL . 35.1 m -122.57 114.37 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 10' ' ' GLU . 2.9 p -108.2 117.03 33.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.299 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.975 HG11 HG11 ' B' ' 22' ' ' VAL . 30.4 m -108.88 54.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.349 . . . . 0.0 111.693 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 25' ' ' VAL . 2.6 pp -47.94 151.17 0.97 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.863 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.423 ' HA2' HG11 ' A' ' 30' ' ' VAL . . . -107.7 2.56 34.11 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.601 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.431 ' N ' HD12 ' A' ' 23' ' ' LEU . 1.4 t -85.21 120.66 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.928 0.364 . . . . 0.0 110.618 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER 174.73 165.34 0.25 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.76 0.315 . . . . 0.0 110.675 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.81 108.28 3.14 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.852 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.02 -74.41 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.859 0.362 . . . . 0.0 111.043 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 16.8 mt-30 -84.72 136.26 33.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.013 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.423 HG11 ' HA2' ' A' ' 24' ' ' GLY . 22.0 t -93.33 117.2 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 111.535 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.404 ' HG2' HG12 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -75.64 99.85 4.45 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.515 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.852 ' CG2' HG12 ' A' ' 22' ' ' VAL . 11.1 mm -87.08 124.5 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.165 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 118.43 6.09 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.569 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.629 HG13 ' CG1' ' A' ' 20' ' ' VAL . 16.7 t -117.79 103.53 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 0.0 111.396 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.4 OUTLIER -99.38 107.53 19.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.501 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.97 143.36 24.8 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.654 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.702 ' HD2' HG12 ' A' ' 18' ' ' VAL . 78.5 Cg_endo -77.12 156.49 33.77 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.759 2.306 . . . . 0.0 112.078 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -89.17 30.08 1.0 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.278 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.58 -38.64 7.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 41' ' ' SER . 17.2 t -93.25 159.35 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.848 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.474 ' N ' HG12 ' A' ' 40' ' ' VAL . 5.8 t -65.28 97.94 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.009 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.9 p -122.31 120.76 62.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.857 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.12 136.39 51.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.722 0.296 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -133.38 -176.12 4.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -64.17 147.79 51.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -50.96 -60.68 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.199 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 tp -55.07 -35.6 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.203 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.473 ' CZ ' ' HB3' ' B' ' 4' ' ' LEU . 0.4 OUTLIER -53.04 -73.14 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.033 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.665 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 3.0 pt20 -64.2 -17.28 63.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.542 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.48 -31.26 69.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.728 0.299 . . . . 0.0 111.328 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.0 mm -104.53 -12.84 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.917 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -114.88 -57.74 2.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.666 0.269 . . . . 0.0 111.716 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . . . -67.53 -71.69 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.383 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -118.18 117.82 30.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.003 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.407 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.993 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptt? . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.781 0.324 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.0 mp -122.06 107.39 12.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.971 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.502 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.0 tt -115.09 114.81 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.216 0.531 . . . . 0.0 110.942 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -125.49 135.73 52.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.763 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.439 ' H ' HD13 ' B' ' 4' ' ' LEU . 0.2 OUTLIER -62.39 150.9 38.44 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.052 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -170.69 148.04 2.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.268 0.556 . . . . 0.0 111.464 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -176.74 7.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.789 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.67 -61.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.848 0.356 . . . . 0.0 111.032 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.54 86.1 0.16 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.704 ' OE1' HG22 ' B' ' 22' ' ' VAL . 4.3 tm-20 -82.11 171.72 14.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.739 0.304 . . . . 0.0 110.944 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t 178.77 122.71 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.125 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.534 ' HG ' HG22 ' B' ' 20' ' ' VAL . 0.1 OUTLIER -144.37 141.35 29.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.41 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.556 ' HA ' HG23 ' B' ' 18' ' ' VAL . 4.0 ttt -133.03 99.7 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.792 HG23 HG23 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -116.29 129.33 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.478 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.708 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 128.76 -105.09 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.936 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.3 p30 -162.82 16.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 7.0 mt-10 158.19 60.84 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.857 0.361 . . . . 0.0 110.552 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.702 HG12 ' HD2' ' B' ' 37' ' ' PRO . 17.6 m -120.33 -159.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 120.807 0.337 . . . . 0.0 111.651 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.653 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 168.59 103.6 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.639 HG12 HG13 ' B' ' 34' ' ' VAL . 35.1 m -122.53 114.42 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.549 HG22 ' O ' ' B' ' 10' ' ' GLU . 2.9 p -108.26 117.03 33.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.221 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.975 HG11 HG11 ' A' ' 22' ' ' VAL . 30.4 m -108.84 54.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.724 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.424 ' C ' HD12 ' B' ' 23' ' ' LEU . 2.6 pp -47.91 151.1 0.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.411 ' HA2' HG11 ' B' ' 30' ' ' VAL . . . -107.69 2.63 34.14 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.568 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.422 ' N ' HD12 ' B' ' 23' ' ' LEU . 1.4 t -85.24 120.65 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.973 0.387 . . . . 0.0 110.588 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER 174.74 165.34 0.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.807 0.336 . . . . 0.0 110.634 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.8 108.22 3.13 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.813 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.03 -74.49 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 111.003 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 16.8 mt-30 -84.7 136.2 33.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.994 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.411 HG11 ' HA2' ' B' ' 24' ' ' GLY . 22.0 t -93.25 117.21 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.976 0.417 . . . . 0.0 111.532 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.417 ' HG2' HG12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -75.61 99.8 4.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.543 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.852 ' CG2' HG12 ' B' ' 22' ' ' VAL . 11.0 mm -87.05 124.51 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.114 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 118.39 6.08 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.558 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.639 HG13 HG12 ' B' ' 20' ' ' VAL . 16.6 t -117.75 103.57 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.41 . . . . 0.0 111.383 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 19' ' ' THR . 0.4 OUTLIER -99.49 107.54 19.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.48 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.96 143.37 24.88 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.585 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.702 ' HD2' HG12 ' B' ' 18' ' ' VAL . 78.8 Cg_endo -77.12 156.49 33.77 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.752 2.301 . . . . 0.0 112.066 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -89.14 29.95 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.281 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.47 -38.73 7.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.791 0.329 . . . . 0.0 110.816 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.469 HG12 ' N ' ' B' ' 41' ' ' SER . 17.1 t -93.19 159.31 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.469 ' N ' HG12 ' B' ' 40' ' ' VAL . 5.8 t -65.21 97.89 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.029 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.485 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.9 p -122.29 120.79 62.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.866 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 136.38 51.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.752 0.311 . . . . 0.0 110.767 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -133.34 -176.07 4.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.693 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -64.27 147.81 51.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.03 -60.62 2.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 tp -55.0 -35.6 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.285 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -53.1 -73.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.039 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.669 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 3.0 pt20 -64.26 -17.32 63.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.531 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -31.17 69.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.734 0.302 . . . . 0.0 111.367 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.412 ' O ' HG22 ' B' ' 51' ' ' ILE . 29.2 mm -104.64 -12.58 9.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.854 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -115.12 -57.85 2.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.709 0.29 . . . . 0.0 111.746 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' B' ' 49' ' ' GLN . . . -67.48 -71.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.33 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -117.81 116.94 27.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.706 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.896 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.54 ' C ' HD12 ' A' ' 2' ' ' LEU . 2.8 ttp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 1.048 HD21 ' HB2' ' B' ' 53' ' ' ALA . 4.9 mp -122.32 117.02 25.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -97.97 104.76 16.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.221 0.534 . . . . 0.0 110.5 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.514 HD21 ' O ' ' B' ' 48' ' ' TYR . 0.8 OUTLIER -125.44 121.52 34.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.223 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -54.35 138.59 39.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.104 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.904 ' HB3' HG21 ' A' ' 22' ' ' VAL . 72.1 mtt180 -148.66 144.77 27.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.296 0.57 . . . . 0.0 111.787 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.646 ' NE ' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 174.98 -77.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.551 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.507 HG23 ' HD3' ' A' ' 7' ' ' ARG . 3.4 t -85.73 3.75 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.139 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.52 -139.49 4.4 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.907 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -108.61 -175.49 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.869 0.366 . . . . 0.0 111.218 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.719 HG22 ' HA ' ' A' ' 21' ' ' THR . 22.5 p -102.17 165.53 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.028 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.516 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -110.53 154.63 23.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.525 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.444 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.5 ttt -130.67 100.06 5.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.072 0.463 . . . . 0.0 111.389 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.853 HG23 HG23 ' B' ' 14' ' ' ILE . 5.8 tp -115.9 125.52 73.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.505 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.49 -106.32 0.62 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.078 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.412 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.6 t0 -155.57 4.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 3.1 mt-10 163.37 61.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.017 0.436 . . . . 0.0 109.993 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.641 ' O ' HG23 ' A' ' 19' ' ' THR . 5.3 m -115.51 -159.91 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.824 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 171.49 99.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.683 HG22 HG13 ' A' ' 34' ' ' VAL . 42.9 t -106.42 107.52 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.827 0.346 . . . . 0.0 111.669 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.719 ' HA ' HG22 ' A' ' 11' ' ' THR . 2.2 m -91.2 112.77 24.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.021 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.904 HG21 ' HB3' ' A' ' 6' ' ' ARG . 27.0 m -76.76 70.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.497 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.547 HD12 ' H ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -96.03 -152.76 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.547 ' H ' HD12 ' A' ' 23' ' ' LEU . . . 60.36 66.44 2.71 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.996 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.646 HG21 ' NE ' ' A' ' 7' ' ' ARG . 5.2 t -85.88 107.77 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 120.979 0.419 . . . . 0.0 111.049 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -155.1 165.41 36.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.136 -179.362 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.98 156.45 47.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.512 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 70.03 -89.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.404 0.145 . . . . 0.0 110.985 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.493 ' HB3' HG22 ' B' ' 5' ' ' THR . 14.7 mt-30 -110.48 124.56 52.02 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.906 0.384 . . . . 0.0 111.082 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.611 HG23 HD11 ' A' ' 32' ' ' ILE . 10.0 m -93.32 137.37 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.318 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 4.7 mtp180 -78.09 102.91 7.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.611 HD11 HG23 ' A' ' 30' ' ' VAL . 14.7 mm -87.32 134.52 27.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.137 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.53 115.79 4.99 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.512 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.683 HG13 HG22 ' A' ' 20' ' ' VAL . 21.4 t -111.12 103.34 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.944 0.402 . . . . 0.0 111.336 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -96.43 107.23 19.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.075 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.06 147.96 33.68 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.9 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.37 156.29 25.39 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.919 2.413 . . . . 0.0 111.984 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -91.38 41.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.114 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.15 -41.92 3.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.994 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 41' ' ' SER . 5.5 t -81.48 158.9 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.855 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -62.35 99.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.784 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.2 p -122.18 124.23 70.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -128.53 136.18 50.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.311 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -166.98 -170.67 1.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.719 0.295 . . . . 0.0 110.709 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.439 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 30.7 mm-40 -54.04 123.97 14.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.008 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.48 -54.91 41.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.115 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 51' ' ' ILE . 8.0 tp -60.21 -41.18 85.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.026 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.518 ' O ' HD21 ' B' ' 4' ' ' LEU . 4.4 m-85 -47.42 -55.51 8.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.237 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.703 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.6 pt20 -80.0 -21.9 43.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.139 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -71.23 -13.33 61.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.285 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 47' ' ' ILE . 1.4 tt -115.7 -36.39 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.877 0.37 . . . . 0.0 110.65 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -87.45 -58.3 2.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.098 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 1.044 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -61.51 -51.65 67.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.258 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -112.57 116.73 30.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.596 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.644 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.549 ' C ' HD12 ' B' ' 2' ' ' LEU . 2.8 ttp . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.789 0.328 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 1.044 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.0 mp -122.35 117.02 25.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.64 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -98.03 104.81 16.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.219 0.533 . . . . 0.0 110.494 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.518 HD21 ' O ' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -125.47 121.52 34.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.253 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -54.39 138.6 39.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.082 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.881 ' HB3' HG21 ' B' ' 22' ' ' VAL . 72.0 mtt180 -148.66 144.72 27.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.258 0.551 . . . . 0.0 111.802 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.63 ' NE ' HG21 ' B' ' 25' ' ' VAL . 0.0 OUTLIER 175.01 -77.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.491 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.509 HG23 ' HD3' ' B' ' 7' ' ' ARG . 3.4 t -85.72 3.73 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.211 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.5 -139.5 4.39 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.922 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -108.59 -175.52 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.923 0.392 . . . . 0.0 111.174 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.746 HG22 ' HA ' ' B' ' 21' ' ' THR . 22.5 p -102.18 165.54 11.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.084 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.525 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -110.51 154.62 23.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.526 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.429 ' HA ' HG23 ' B' ' 18' ' ' VAL . 2.5 ttt -130.64 100.03 5.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.009 0.433 . . . . 0.0 111.395 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.853 HG23 HG23 ' A' ' 14' ' ' ILE . 5.8 tp -115.89 125.5 73.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.505 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.53 -106.32 0.62 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.065 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 2.6 t0 -155.61 4.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 3.1 mt-10 163.34 61.12 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.996 0.427 . . . . 0.0 110.0 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.657 ' O ' HG23 ' B' ' 19' ' ' THR . 5.3 m -115.48 -159.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.831 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.657 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 171.51 99.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.342 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.689 HG22 HG13 ' B' ' 34' ' ' VAL . 43.0 t -106.49 107.58 23.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.822 0.344 . . . . 0.0 111.602 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.746 ' HA ' HG22 ' B' ' 11' ' ' THR . 2.2 m -91.22 112.89 24.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.979 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.881 HG21 ' HB3' ' B' ' 6' ' ' ARG . 26.3 m -76.9 70.55 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.457 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.537 HD12 ' H ' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -96.07 -152.79 0.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.681 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.537 ' H ' HD12 ' B' ' 23' ' ' LEU . . . 60.42 66.38 2.75 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.992 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.63 HG21 ' NE ' ' B' ' 7' ' ' ARG . 5.1 t -85.79 107.74 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.402 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.1 OUTLIER -155.05 165.47 36.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.192 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.04 156.43 47.33 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.481 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 70.08 -89.51 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.041 0.136 . . . . 0.0 110.97 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.487 ' HB3' HG22 ' A' ' 5' ' ' THR . 14.6 mt-30 -110.45 124.53 51.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.895 0.379 . . . . 0.0 111.158 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.62 HG23 HD11 ' B' ' 32' ' ' ILE . 10.2 m -93.26 137.41 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.381 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.8 mtp180 -78.19 102.94 7.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.62 HD11 HG23 ' B' ' 30' ' ' VAL . 14.9 mm -87.34 134.58 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.57 115.76 4.97 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.503 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.689 HG13 HG22 ' B' ' 20' ' ' VAL . 21.4 t -111.17 103.3 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 111.264 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -96.41 107.22 19.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.085 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.08 147.92 33.51 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.922 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.29 156.28 25.63 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.951 2.434 . . . . 0.0 112.007 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -91.34 41.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.166 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.14 -41.93 3.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.411 HG12 ' N ' ' B' ' 41' ' ' SER . 5.5 t -81.48 158.89 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.809 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.411 ' N ' HG12 ' B' ' 40' ' ' VAL . 0.3 OUTLIER -62.31 99.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.829 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.456 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.2 p -122.2 124.18 70.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.959 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -128.51 136.25 50.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.311 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -167.03 -170.71 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.722 0.296 . . . . 0.0 110.711 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.449 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 30.5 mm-40 -54.03 123.98 14.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 111.049 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.48 -54.93 41.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.428 HG23 ' N ' ' B' ' 48' ' ' TYR . 8.0 tp -60.2 -41.17 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.059 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.514 ' O ' HD21 ' A' ' 4' ' ' LEU . 4.4 m-85 -47.41 -55.49 8.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.256 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.703 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 4.5 pt20 -79.91 -21.98 43.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.173 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -71.25 -13.3 61.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.252 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.423 HG22 ' O ' ' B' ' 47' ' ' ILE . 1.4 tt -115.71 -36.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.657 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -87.45 -58.3 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.085 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 1.048 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -61.47 -51.67 67.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.309 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -112.61 116.75 30.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.522 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.951 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.437 ' C ' HD22 ' A' ' 2' ' ' LEU . 3.2 mtt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.871 0.367 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.961 HD11 ' HB2' ' B' ' 53' ' ' ALA . 4.4 mm? -119.73 112.84 19.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -99.97 105.03 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.179 0.514 . . . . 0.0 110.827 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.43 ' HG ' ' CD2' ' B' ' 48' ' ' TYR . 0.2 OUTLIER -124.76 121.49 34.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.036 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -56.16 140.59 43.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 0.0 110.618 179.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.458 ' HB3' HG21 ' A' ' 22' ' ' VAL . 66.8 mtt85 -155.84 145.33 20.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.785 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER 179.11 1.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.975 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 177.2 30.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 120.532 0.206 . . . . 0.0 111.356 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.93 -118.13 3.51 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.762 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -110.13 -178.31 3.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.912 0.387 . . . . 0.0 111.203 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.6 168.04 10.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.737 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.739 ' CD1' HG11 ' B' ' 34' ' ' VAL . 0.8 OUTLIER -111.52 154.51 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.569 ' HG3' HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -127.39 100.56 6.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.43 . . . . 0.0 110.873 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.627 HG23 HG23 ' B' ' 14' ' ' ILE . 3.1 tp -112.7 125.48 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.606 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.43 -105.44 0.65 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.195 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 12.0 m-20 -156.8 6.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 0.8 OUTLIER 161.15 61.89 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' ' 19' ' ' THR . 4.3 m -116.23 -157.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.526 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 172.53 101.61 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.692 HG22 HG13 ' A' ' 34' ' ' VAL . 59.0 t -111.04 108.19 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.88 0.372 . . . . 0.0 111.697 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.1 p -105.08 110.43 22.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.011 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 22' ' ' VAL . 31.2 m -77.4 72.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.61 -143.56 0.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.628 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.5 74.31 0.27 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.819 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.6 t -93.03 108.3 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.515 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -138.92 157.57 45.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.018 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.8 148.02 50.71 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.72 -79.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.634 0.254 . . . . 0.0 110.767 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.53 ' HB3' HG22 ' B' ' 5' ' ' THR . 8.9 mt-30 -116.78 126.28 52.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.986 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.682 HG23 HD11 ' A' ' 32' ' ' ILE . 17.5 m -93.39 136.93 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.269 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 3.9 mtt85 -77.93 104.91 8.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.257 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.682 HD11 HG23 ' A' ' 30' ' ' VAL . 12.0 mm -87.37 137.75 20.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.848 0.356 . . . . 0.0 111.328 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.86 117.41 5.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.472 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.744 HG11 ' CD1' ' B' ' 12' ' ' LEU . 15.6 t -118.08 103.18 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.411 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.6 OUTLIER -95.74 107.17 19.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.378 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.11 145.49 55.85 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.588 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HD2' HG12 ' A' ' 18' ' ' VAL . 92.2 Cg_endo -78.28 156.32 29.33 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.834 2.356 . . . . 0.0 112.121 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.26 26.75 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.185 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -40.23 5.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.849 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -82.45 152.85 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.5 98.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.077 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 42' ' ' VAL . 12.7 p -122.17 120.59 61.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.1 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -128.55 136.17 50.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.413 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -165.53 -40.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.685 0.279 . . . . 0.0 111.135 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.413 ' N ' ' HG3' ' A' ' 44' ' ' ARG . 1.2 mm-40 177.86 114.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.962 0.41 . . . . 0.0 110.882 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -58.48 -38.78 78.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.684 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.519 HG23 HG13 ' A' ' 51' ' ' ILE . 36.1 mm -69.33 -43.23 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.837 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.43 ' CD2' ' HG ' ' B' ' 4' ' ' LEU . 2.8 m-85 -51.36 -42.68 61.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.416 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -87.72 -58.9 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 111.534 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -52.2 -21.38 3.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.519 HG13 HG23 ' A' ' 47' ' ' ILE . 40.3 mm -106.07 -50.58 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.562 ' HB3' HD12 ' B' ' 2' ' ' LEU . 0.1 OUTLIER -75.79 -58.79 3.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.668 0.271 . . . . 0.0 111.299 -179.461 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.932 ' HB2' HD11 ' B' ' 2' ' ' LEU . . . -67.09 -29.71 69.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.343 . . . . 0.0 111.23 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.2 tt0 -137.97 157.53 46.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 54' ' ' GLU . 1.8 tttp . . . . . 0 N--CA 1.464 0.23 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.879 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.441 ' C ' HD22 ' B' ' 2' ' ' LEU . 3.2 mtt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.833 0.349 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.932 HD11 ' HB2' ' A' ' 53' ' ' ALA . 4.4 mm? -119.75 112.85 19.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.63 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -100.0 105.09 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.252 0.548 . . . . 0.0 110.79 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.43 ' HG ' ' CD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -124.81 121.55 34.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.019 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.53 HG22 ' HB3' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -56.24 140.66 43.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.369 . . . . 0.0 110.589 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.449 ' HB3' HG21 ' B' ' 22' ' ' VAL . 66.7 mtt85 -155.9 145.34 20.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.784 ' O ' HG13 ' B' ' 8' ' ' VAL . 0.0 OUTLIER 179.06 1.55 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.959 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.784 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER 177.13 30.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.573 0.225 . . . . 0.0 111.371 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.0 -118.18 3.5 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.685 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -110.15 -178.31 3.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.955 0.407 . . . . 0.0 111.178 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.57 168.04 10.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.805 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.744 ' CD1' HG11 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -111.49 154.5 24.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.516 179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.572 ' HG3' HG22 ' B' ' 18' ' ' VAL . 0.4 OUTLIER -127.42 100.46 6.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.022 0.439 . . . . 0.0 110.918 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.627 HG23 HG23 ' A' ' 14' ' ' ILE . 3.1 tp -112.69 125.5 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.563 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.46 -105.47 0.65 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.2 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 12.0 m-20 -156.89 6.97 0.17 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 0.8 OUTLIER 161.09 61.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.631 0.372 . . . . 0.0 110.023 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.671 ' O ' HG23 ' B' ' 19' ' ' THR . 4.3 m -116.23 -157.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.568 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.671 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 172.55 101.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.689 HG22 HG13 ' B' ' 34' ' ' VAL . 58.4 t -111.0 108.1 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.816 0.341 . . . . 0.0 111.747 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 5.0 p -104.98 110.45 22.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.03 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.564 ' O ' HG23 ' B' ' 22' ' ' VAL . 30.7 m -77.5 72.56 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.56 -143.65 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.638 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.53 74.32 0.27 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.818 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 10.6 t -93.08 108.33 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 111.279 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.513 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.0 OUTLIER -138.89 157.57 45.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.999 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.83 148.04 50.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.74 -80.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.642 0.258 . . . . 0.0 110.741 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.52 ' HB3' HG22 ' A' ' 5' ' ' THR . 8.9 mt-30 -116.72 126.26 52.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.88 0.371 . . . . 0.0 110.96 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.678 HG23 HD11 ' B' ' 32' ' ' ILE . 17.5 m -93.4 136.98 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 3.9 mtt85 -77.95 104.93 8.81 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.254 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.678 HD11 HG23 ' B' ' 30' ' ' VAL . 12.2 mm -87.38 137.83 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.858 0.361 . . . . 0.0 111.305 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.94 117.44 5.14 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.458 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.739 HG11 ' CD1' ' A' ' 12' ' ' LEU . 15.4 t -118.03 103.14 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 111.489 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' B' ' 19' ' ' THR . 0.6 OUTLIER -95.8 107.22 19.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.17 145.5 55.79 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.597 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.518 ' HD2' HG12 ' B' ' 18' ' ' VAL . 90.2 Cg_endo -78.28 156.34 29.32 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.814 2.343 . . . . 0.0 112.07 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.23 26.77 2.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.221 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.3 -40.28 5.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.753 0.311 . . . . 0.0 110.831 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -82.38 152.81 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.42 98.63 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.121 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.51 HG13 ' O ' ' B' ' 42' ' ' VAL . 12.7 p -122.19 120.61 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.104 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -128.51 136.18 50.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.553 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.414 ' HG3' ' N ' ' B' ' 45' ' ' GLU . 0.0 OUTLIER -165.57 -40.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 0.0 111.133 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' B' ' 44' ' ' ARG . 1.2 mm-40 177.83 114.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.965 0.412 . . . . 0.0 110.918 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -58.52 -38.64 78.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.714 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.522 HG23 HG13 ' B' ' 51' ' ' ILE . 35.9 mm -69.38 -43.21 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.804 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.43 ' CD2' ' HG ' ' A' ' 4' ' ' LEU . 2.8 m-85 -51.38 -42.74 61.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.347 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -87.77 -58.82 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.771 0.319 . . . . 0.0 111.522 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -52.14 -21.54 3.39 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.522 HG13 HG23 ' B' ' 47' ' ' ILE . 40.2 mm -105.93 -50.51 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.565 ' HB3' HD12 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -75.89 -58.8 3.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.713 0.292 . . . . 0.0 111.314 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.961 ' HB2' HD11 ' A' ' 2' ' ' LEU . . . -67.07 -29.71 69.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.342 . . . . 0.0 111.199 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -138.05 156.78 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.774 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.804 0.335 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.673 HD11 ' O ' ' B' ' 48' ' ' TYR . 6.6 tt -116.55 103.15 10.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -98.08 105.48 17.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.195 0.521 . . . . 0.0 110.785 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 4' ' ' LEU . 11.0 tp -125.28 121.33 33.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.924 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.593 HG22 ' HB3' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -56.88 149.3 18.84 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.389 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 10' ' ' GLU . 1.1 tpt180 -179.53 143.15 0.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.224 0.535 . . . . 0.0 111.399 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.931 ' NE ' HG13 ' A' ' 25' ' ' VAL . 36.4 ttt180 -170.1 23.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.063 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.08 -53.43 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.165 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.08 105.49 0.19 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.683 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.468 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . 0.7 OUTLIER -113.13 -58.25 2.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 0.0 110.869 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p 65.52 96.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.124 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.431 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 1.6 pt? -114.57 154.72 27.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.069 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.571 ' HA ' HG23 ' A' ' 18' ' ' VAL . 34.8 ttm -128.98 99.93 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.059 0.457 . . . . 0.0 111.015 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 14' ' ' ILE . 6.1 tp -118.02 102.86 13.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.814 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.28 -107.33 0.32 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.972 -0.633 . . . . 0.0 111.887 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.36 -4.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 165.05 57.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.762 HG12 ' HD2' ' A' ' 37' ' ' PRO . 12.8 m -112.45 -161.58 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.816 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.893 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.5 OUTLIER 170.13 102.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.844 HG13 ' HA ' ' A' ' 34' ' ' VAL . 21.4 t -111.2 110.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.906 0.384 . . . . 0.0 111.894 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.4 m -98.35 111.65 23.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.767 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 22' ' ' VAL . 17.5 m -77.01 68.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.347 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.45 -142.39 0.26 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.751 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 31' ' ' ARG . . . 53.82 70.77 0.84 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.566 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.931 HG13 ' NE ' ' A' ' 7' ' ' ARG . 40.5 t -85.94 107.66 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.909 0.385 . . . . 0.0 111.455 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -143.97 151.57 39.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.046 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.43 150.54 47.16 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.419 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 72.58 -75.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.606 0.241 . . . . 0.0 111.004 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.588 ' HB3' HG22 ' B' ' 5' ' ' THR . 9.0 mp0 -120.95 128.84 53.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.985 0.422 . . . . 0.0 111.115 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.654 HG23 HD11 ' A' ' 32' ' ' ILE . 11.0 m -93.29 137.18 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.248 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 0.1 OUTLIER -75.77 104.63 6.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.28 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.654 HD11 HG23 ' A' ' 30' ' ' VAL . 9.3 mm -87.47 130.14 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.215 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.73 108.44 3.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.156 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.844 ' HA ' HG13 ' A' ' 20' ' ' VAL . 12.7 t -107.28 103.17 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 111.615 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.893 ' HB3' HG23 ' A' ' 19' ' ' THR . 3.6 t-20 -96.19 107.22 19.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.384 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.9 146.84 58.53 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.715 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.762 ' HD2' HG12 ' A' ' 18' ' ' VAL . 86.5 Cg_endo -80.58 156.36 21.55 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.961 2.441 . . . . 0.0 112.104 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -92.47 32.87 1.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.188 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.32 -41.26 3.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.739 0.304 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 41' ' ' SER . 5.6 t -77.9 160.68 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.79 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.444 ' N ' HG12 ' A' ' 40' ' ' VAL . 3.8 t -66.75 106.68 1.92 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.838 0.352 . . . . 0.0 110.859 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 42' ' ' VAL . 12.7 p -121.94 126.11 74.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -128.88 124.1 34.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.207 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -156.76 -65.82 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 110.461 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 5.3 tp10 -171.69 130.46 0.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.56 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -58.79 -38.75 79.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.047 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.409 HG23 HG13 ' A' ' 51' ' ' ILE . 16.1 mt -73.05 -43.56 58.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.302 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.677 ' O ' HD11 ' B' ' 2' ' ' LEU . 3.2 m-85 -50.46 -46.63 56.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.651 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.622 ' HG2' ' HB3' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -83.1 -58.09 3.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.207 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.429 ' HA ' ' CB ' ' A' ' 54' ' ' GLU . 3.6 mtp85 -55.05 -9.78 0.43 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.409 HG13 HG23 ' A' ' 47' ' ' ILE . 49.3 mm -112.86 -55.45 4.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 O-C-N 122.258 -0.276 . . . . 0.0 111.728 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 7.2 mp0 -75.89 -54.3 7.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 110.999 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.622 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . . . -75.04 -36.83 61.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.892 0.377 . . . . 0.0 110.962 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' CB ' ' HA ' ' A' ' 50' ' ' ARG . 3.7 tp10 -103.56 122.42 44.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.753 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.877 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.832 0.349 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.677 HD11 ' O ' ' A' ' 48' ' ' TYR . 6.6 tt -116.58 103.12 10.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.637 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -98.04 105.56 17.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.26 0.552 . . . . 0.0 110.763 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 tp -125.32 121.37 33.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.831 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -56.97 149.27 19.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.397 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.476 ' HG2' ' HB2' ' B' ' 10' ' ' GLU . 1.1 tpt180 -179.53 143.17 0.19 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.253 0.549 . . . . 0.0 111.418 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.933 ' NE ' HG13 ' B' ' 25' ' ' VAL . 36.2 ttt180 -170.18 23.53 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.102 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.07 -53.51 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.161 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.13 105.52 0.19 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.703 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.476 ' HB2' ' HG2' ' B' ' 6' ' ' ARG . 0.7 OUTLIER -113.1 -58.33 2.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 110.854 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.9 p 65.53 96.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.165 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.438 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 1.6 pt? -114.48 154.76 27.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.121 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.562 ' HA ' HG23 ' B' ' 18' ' ' VAL . 34.8 ttm -129.04 99.96 5.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.01 0.433 . . . . 0.0 111.032 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.588 ' O ' HG23 ' B' ' 14' ' ' ILE . 6.1 tp -117.97 102.85 13.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.854 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.3 -107.34 0.32 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.883 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.39 -4.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 165.07 57.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.755 HG12 ' HD2' ' B' ' 37' ' ' PRO . 12.9 m -112.42 -161.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.796 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.911 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.5 OUTLIER 170.09 102.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.443 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' B' ' 34' ' ' VAL . 21.4 t -111.22 110.16 31.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 111.948 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 6.4 m -98.35 111.65 23.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.794 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 22' ' ' VAL . 17.5 m -76.98 68.42 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.312 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.52 -142.38 0.26 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' B' ' 31' ' ' ARG . . . 53.86 70.77 0.84 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.556 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.933 HG13 ' NE ' ' B' ' 7' ' ' ARG . 40.4 t -85.96 107.62 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.0 111.428 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -143.97 151.57 39.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.031 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.46 150.49 47.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.476 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 72.62 -75.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.585 0.231 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.593 ' HB3' HG22 ' A' ' 5' ' ' THR . 9.0 mp0 -121.05 128.78 52.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 111.089 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.647 HG23 HD11 ' B' ' 32' ' ' ILE . 11.0 m -93.23 137.16 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.266 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -75.77 104.6 6.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.289 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.647 HD11 HG23 ' B' ' 30' ' ' VAL . 9.3 mm -87.44 130.17 37.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.201 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.78 108.44 3.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.161 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.861 ' HA ' HG13 ' B' ' 20' ' ' VAL . 12.7 t -107.24 103.17 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.91 0.385 . . . . 0.0 111.577 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.911 ' HB3' HG23 ' B' ' 19' ' ' THR . 3.6 t-20 -96.13 107.15 19.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.402 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.85 146.78 58.38 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.751 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.755 ' HD2' HG12 ' B' ' 18' ' ' VAL . 86.1 Cg_endo -80.57 156.34 21.56 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.963 2.442 . . . . 0.0 112.101 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -92.46 32.93 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.224 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.34 -41.21 3.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.78 0.324 . . . . 0.0 110.973 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.437 HG12 ' N ' ' B' ' 41' ' ' SER . 5.6 t -77.94 160.76 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.792 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.437 ' N ' HG12 ' B' ' 40' ' ' VAL . 3.8 t -66.81 106.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 0.0 110.839 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.438 HG13 ' O ' ' B' ' 42' ' ' VAL . 12.7 p -121.95 126.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -128.91 124.15 34.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.168 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -156.77 -65.84 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.441 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 5.3 tp10 -171.72 130.49 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.586 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -58.81 -38.73 79.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.421 ' CG2' HG13 ' B' ' 51' ' ' ILE . 16.0 mt -73.03 -43.49 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.307 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.673 ' O ' HD11 ' A' ' 2' ' ' LEU . 3.2 m-85 -50.61 -46.47 58.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.635 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.623 ' HG2' ' HB3' ' B' ' 53' ' ' ALA . 0.3 OUTLIER -83.22 -58.11 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.427 ' HA ' ' CB ' ' B' ' 54' ' ' GLU . 3.6 mtp85 -55.13 -9.71 0.44 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.421 HG13 ' CG2' ' B' ' 47' ' ' ILE . 49.1 mm -112.86 -55.53 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 7.2 mp0 -75.88 -54.32 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.684 0.278 . . . . 0.0 110.93 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.623 ' HB3' ' HG2' ' B' ' 49' ' ' GLN . . . -75.06 -36.72 61.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.945 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' B' ' 50' ' ' ARG . 3.7 tp10 -103.79 124.01 48.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.1 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.059 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.659 ' C ' HD12 ' A' ' 2' ' ' LEU . 6.6 mmm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.882 0.372 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.659 HD12 ' C ' ' A' ' 1' ' ' MET . 5.2 mp -116.7 104.74 11.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.682 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.532 HG21 ' HD3' ' B' ' 31' ' ' ARG . 19.2 mm -96.83 105.13 16.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 110.74 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.468 ' HA ' HD22 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -124.63 116.7 22.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.976 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.549 HG22 ' HB3' ' B' ' 29' ' ' GLN . 0.3 OUTLIER -54.7 140.22 36.45 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.394 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.509 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 24.3 mtt180 -154.76 141.13 18.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.184 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 179.11 4.3 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.299 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.24 -76.41 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 O-C-N 122.213 -0.304 . . . . 0.0 111.517 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.33 97.94 0.51 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.662 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 6' ' ' ARG . 6.6 mp0 -113.21 174.7 5.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.723 0.297 . . . . 0.0 111.034 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER 164.86 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.141 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.446 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -112.35 154.1 26.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.528 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.4 ttp -133.29 100.69 4.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.053 0.454 . . . . 0.0 111.755 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.864 HG23 HG23 ' B' ' 14' ' ' ILE . 5.1 tp -114.36 120.61 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.186 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.472 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 135.85 -106.92 0.59 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.058 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.466 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -152.55 6.43 0.41 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 4.6 mt-10 159.31 64.19 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.907 0.384 . . . . 0.0 110.29 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.647 ' O ' HG23 ' A' ' 19' ' ' THR . 12.4 m -118.85 -158.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER 170.18 104.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.558 HG13 ' HA ' ' A' ' 34' ' ' VAL . 22.0 t -117.95 116.14 50.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.0 111.751 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.0 t -114.79 115.63 27.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.006 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.866 HG12 HG23 ' A' ' 32' ' ' ILE . 26.7 m -80.95 73.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.389 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.91 -136.04 0.1 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.472 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.05 74.7 0.21 Allowed Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.933 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.634 HG22 ' HG2' ' A' ' 7' ' ' ARG . 21.3 t -86.04 108.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.465 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -140.24 153.38 46.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.048 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.15 149.45 47.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.453 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 69.14 -83.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.638 0.256 . . . . 0.0 110.721 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.525 ' HB3' HG22 ' B' ' 5' ' ' THR . 42.5 mt-30 -107.32 125.24 50.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.356 . . . . 0.0 110.947 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.518 HG23 HD11 ' A' ' 32' ' ' ILE . 14.3 m -93.13 136.89 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.283 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.549 ' HD3' HG21 ' B' ' 3' ' ' ILE . 28.8 mtt85 -75.96 104.39 6.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.491 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.866 HG23 HG12 ' A' ' 22' ' ' VAL . 28.4 mm -87.17 131.36 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.281 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.5 125.12 8.14 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.745 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.558 ' HA ' HG13 ' A' ' 20' ' ' VAL . 12.2 t -118.05 129.72 73.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.835 0.35 . . . . 0.0 111.123 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 19' ' ' THR . 2.3 t30 -123.16 107.21 11.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.13 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.86 144.25 26.12 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.745 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HD2' HG12 ' A' ' 18' ' ' VAL . 82.2 Cg_endo -77.93 156.45 30.7 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.736 2.29 . . . . 0.0 112.081 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.08 38.01 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.398 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.73 -38.7 4.2 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.759 0.314 . . . . 0.0 110.803 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.477 HG12 ' O ' ' B' ' 15' ' ' GLY . 13.3 t -89.58 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -57.49 97.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.943 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.792 HG22 ' HD2' ' A' ' 44' ' ' ARG . 14.6 p -122.35 120.71 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 136.11 50.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.674 0.274 . . . . 0.0 110.81 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.792 ' HD2' HG22 ' A' ' 42' ' ' VAL . 1.9 mpp_? -147.4 -172.6 4.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.54 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.44 ' HB3' ' CG ' ' A' ' 48' ' ' TYR . 1.5 tp10 -63.16 139.2 58.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.766 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -62.36 1.67 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.383 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 39.1 mm -56.82 -45.57 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.792 0.329 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.461 ' CG ' ' HG ' ' B' ' 4' ' ' LEU . 4.1 m-30 -41.5 -73.33 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.545 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.699 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 13.8 pt20 -66.48 -19.26 65.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.54 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 6.0 mtm180 -69.0 -20.0 64.15 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 48' ' ' TYR . 3.5 pt -111.39 -23.87 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.48 ' HG3' HD23 ' B' ' 2' ' ' LEU . 4.3 pt20 -107.68 -52.38 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.623 0.249 . . . . 0.0 111.547 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.699 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . . . -70.36 -72.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 111.224 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.5 118.81 37.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.727 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.5 mttt . . . . . 0 N--CA 1.451 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.138 -179.904 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.65 ' C ' HD12 ' B' ' 2' ' ' LEU . 6.7 mmm . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.87 0.367 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.65 HD12 ' C ' ' B' ' 1' ' ' MET . 5.2 mp -116.76 104.74 11.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.549 HG21 ' HD3' ' A' ' 31' ' ' ARG . 19.2 mm -96.81 105.17 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.98 0.419 . . . . 0.0 110.725 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.461 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -124.66 116.67 22.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.961 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -54.72 140.24 36.54 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.413 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' B' ' 10' ' ' GLU . 24.4 mtt180 -154.74 141.13 18.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.205 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' B' ' 25' ' ' VAL . 0.0 OUTLIER 179.1 4.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.269 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.24 -76.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 O-C-N 122.167 -0.333 . . . . 0.0 111.544 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.33 97.89 0.51 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.666 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' B' ' 6' ' ' ARG . 6.6 mp0 -113.16 174.7 5.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.748 0.309 . . . . 0.0 111.051 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.47 HG22 ' C ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 164.81 91.71 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.14 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.454 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -112.31 154.05 26.27 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.512 ' HA ' HG23 ' B' ' 18' ' ' VAL . 2.4 ttp -133.26 100.58 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.999 0.428 . . . . 0.0 111.785 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.864 HG23 HG23 ' A' ' 14' ' ' ILE . 5.1 tp -114.33 120.61 64.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.189 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 135.86 -106.92 0.59 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.086 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 0.4 OUTLIER -152.53 6.46 0.41 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.469 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 4.6 mt-10 159.32 64.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.957 0.408 . . . . 0.0 110.289 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.642 ' O ' HG23 ' B' ' 19' ' ' THR . 12.3 m -118.78 -158.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.417 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.642 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.1 OUTLIER 170.18 104.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' B' ' 34' ' ' VAL . 21.9 t -117.9 116.1 50.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 0.0 111.741 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 3.0 t -114.75 115.62 27.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.005 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.86 HG12 HG23 ' B' ' 32' ' ' ILE . 26.8 m -80.97 73.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.0 0.429 . . . . 0.0 111.343 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.94 -136.08 0.1 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.483 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.08 74.67 0.22 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.975 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.634 HG22 ' HG2' ' B' ' 7' ' ' ARG . 21.3 t -85.99 108.15 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 0.0 111.47 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -140.27 153.34 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.058 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.11 149.45 47.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.465 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 69.06 -83.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.541 0.21 . . . . 0.0 110.701 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.549 ' HB3' HG22 ' A' ' 5' ' ' THR . 42.5 mt-30 -107.35 125.24 50.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 110.941 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.513 HG23 HD11 ' B' ' 32' ' ' ILE . 14.3 m -93.14 136.91 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.32 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.532 ' HD3' HG21 ' A' ' 3' ' ' ILE . 28.6 mtt85 -76.0 104.35 6.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.454 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.86 HG23 HG12 ' B' ' 22' ' ' VAL . 28.4 mm -87.15 131.32 35.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.299 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.47 125.2 8.17 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.792 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.567 ' HA ' HG13 ' B' ' 20' ' ' VAL . 12.4 t -118.1 129.75 73.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.827 0.346 . . . . 0.0 111.063 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' B' ' 19' ' ' THR . 2.3 t30 -123.23 107.26 11.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.074 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.89 144.22 25.91 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.75 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.42 ' HD2' HG12 ' B' ' 18' ' ' VAL . 84.1 Cg_endo -77.83 156.45 31.08 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.797 2.331 . . . . 0.0 112.103 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.09 38.02 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.38 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.77 -38.69 4.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.79 0.329 . . . . 0.0 110.804 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 15' ' ' GLY . 13.3 t -89.63 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.846 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -57.42 97.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.013 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.793 HG22 ' HD2' ' B' ' 44' ' ' ARG . 14.6 p -122.38 120.75 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 136.13 50.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.657 0.265 . . . . 0.0 110.816 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.793 ' HD2' HG22 ' B' ' 42' ' ' VAL . 1.9 mpp_? -147.41 -172.66 4.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.44 ' HB3' ' CG ' ' B' ' 48' ' ' TYR . 1.5 tp10 -63.01 139.19 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.824 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -62.33 1.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.421 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' B' ' 50' ' ' ARG . 39.2 mm -56.86 -45.53 83.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.78 0.324 . . . . 0.0 111.164 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.462 ' CG ' ' HG ' ' A' ' 4' ' ' LEU . 4.1 m-30 -41.52 -73.34 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.568 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.688 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 13.8 pt20 -66.48 -19.24 65.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.538 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 6.0 mtm180 -69.0 -19.92 64.14 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.416 HG13 ' O ' ' B' ' 48' ' ' TYR . 3.5 pt -111.57 -23.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.489 ' HG3' HD23 ' A' ' 2' ' ' LEU . 4.3 pt20 -107.82 -52.29 2.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.563 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.688 ' HB3' ' HB2' ' B' ' 49' ' ' GLN . . . -70.47 -72.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.807 0.337 . . . . 0.0 111.185 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.58 119.43 39.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.617 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.733 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.799 0.333 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.65 HD22 ' CE2' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -118.11 108.48 15.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 3' ' ' ILE . 5.2 tt -84.36 115.0 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.009 0.433 . . . . 0.0 111.535 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.767 HD12 ' CZ ' ' B' ' 48' ' ' TYR . 0.3 OUTLIER -115.1 156.24 25.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.653 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.476 ' H ' HD23 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -95.8 121.22 37.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 0.0 111.476 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.6 ' NH2' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -92.21 149.16 21.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.475 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.626 ' CG ' HG13 ' A' ' 30' ' ' VAL . 6.6 mtp180 78.01 87.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.706 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.647 HG23 ' CA ' ' A' ' 24' ' ' GLY . 56.2 t 80.74 55.49 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.193 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.525 ' H ' HG21 ' A' ' 22' ' ' VAL . . . -142.89 -148.54 4.96 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.536 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.28 121.46 44.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 111.616 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -58.55 147.53 31.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.402 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.741 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -117.82 154.73 31.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.766 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.6 ttt -127.91 100.7 6.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 0.0 110.766 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.62 HG23 HG23 ' B' ' 14' ' ' ILE . 4.6 tp -115.42 137.7 48.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.952 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.684 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 126.71 -107.19 0.89 Allowed Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.339 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -153.39 -4.42 0.19 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 1.0 OUTLIER 171.38 57.43 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 19' ' ' THR . 10.4 m -111.31 -159.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.615 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 173.72 102.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.741 ' HB ' HD23 ' A' ' 12' ' ' LEU . 41.6 t -102.93 101.99 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.856 0.36 . . . . 0.0 111.172 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -93.17 157.3 16.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.22 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.525 HG21 ' H ' ' A' ' 9' ' ' GLY . 34.8 m -106.86 -173.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.577 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -127.38 -53.52 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 0.0 110.291 179.689 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.647 ' CA ' HG23 ' A' ' 8' ' ' VAL . . . 93.64 -39.99 2.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.162 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 11.4 t -85.66 149.83 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.596 0.236 . . . . 0.0 111.495 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 25' ' ' VAL . 10.8 tttp 101.25 116.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.245 0.618 . . . . 0.0 110.85 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.81 174.74 46.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.683 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.83 -84.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.677 0.275 . . . . 0.0 110.301 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.9 136.95 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.423 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.741 ' CG1' HD11 ' A' ' 32' ' ' ILE . 21.7 t -92.89 115.71 32.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.807 0.337 . . . . 0.0 110.888 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -86.44 99.46 11.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.99 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.741 HD11 ' CG1' ' A' ' 30' ' ' VAL . 33.0 mm -112.76 135.57 51.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.935 0.397 . . . . 0.0 111.425 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.37 112.72 4.19 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.302 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.72 HG13 HG22 ' A' ' 20' ' ' VAL . 25.1 t -98.07 103.17 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.7 107.29 19.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.638 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.02 145.52 56.06 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.431 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HD2' HG12 ' A' ' 18' ' ' VAL . 88.4 Cg_endo -81.24 156.55 19.65 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.93 2.42 . . . . 0.0 112.231 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -89.45 27.29 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.278 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -112.67 -37.17 4.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.757 0.313 . . . . 0.0 111.034 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.689 HG12 ' O ' ' B' ' 15' ' ' GLY . 5.1 t -81.82 144.64 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.806 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -54.89 100.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.484 HG21 ' NH2' ' A' ' 44' ' ' ARG . 13.0 p -122.09 124.11 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.077 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.57 136.17 50.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.373 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.487 ' CZ ' HD13 ' B' ' 2' ' ' LEU . 7.1 mtt85 -151.86 -60.69 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.931 0.396 . . . . 0.0 110.612 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 178.78 143.7 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.655 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -43.83 92.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.617 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.525 HG22 HD12 ' A' ' 51' ' ' ILE . 42.4 mm -64.56 -49.08 82.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.061 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.771 ' CZ ' HD12 ' B' ' 4' ' ' LEU . 88.9 t80 -50.63 -45.84 57.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.55 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 53' ' ' ALA . 21.2 tt0 -75.55 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 111.729 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -51.44 -17.35 0.76 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.525 HD12 HG22 ' A' ' 47' ' ' ILE . 36.5 mt -108.89 -54.78 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.75 0.309 . . . . 0.0 111.205 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.63 ' HB2' HD23 ' B' ' 2' ' ' LEU . 60.5 mm-40 -69.14 -62.05 1.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.922 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.5 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . . . -67.3 -33.54 75.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.008 0.433 . . . . 0.0 110.731 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -118.19 124.06 47.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.606 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.5 tptp . . . . . 0 N--CA 1.451 -0.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.267 -179.631 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.825 0.345 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.657 HD22 ' CE2' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -118.07 108.44 15.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.558 HG23 ' O ' ' B' ' 3' ' ' ILE . 5.3 tt -84.38 115.05 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 111.531 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.771 HD12 ' CZ ' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -115.12 156.15 25.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.686 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.465 ' H ' HD23 ' B' ' 4' ' ' LEU . 0.3 OUTLIER -95.7 121.19 37.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.018 0.437 . . . . 0.0 111.446 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.602 ' NH2' HD22 ' B' ' 4' ' ' LEU . 0.0 OUTLIER -92.21 149.12 21.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.53 179.335 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.624 ' CG ' HG13 ' B' ' 30' ' ' VAL . 6.6 mtp180 78.02 87.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.691 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.657 HG23 ' CA ' ' B' ' 24' ' ' GLY . 55.3 t 80.67 55.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.188 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.524 ' H ' HG21 ' B' ' 22' ' ' VAL . . . -142.88 -148.54 4.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.593 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.24 121.4 44.33 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.879 0.371 . . . . 0.0 111.614 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -58.48 147.57 31.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.413 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.714 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.6 OUTLIER -117.83 154.76 31.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.728 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.6 ttt -127.97 100.59 5.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.856 0.36 . . . . 0.0 110.775 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.62 HG23 HG23 ' A' ' 14' ' ' ILE . 4.6 tp -115.37 137.75 47.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.689 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 126.71 -107.22 0.89 Allowed Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.329 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.3 OUTLIER -153.41 -4.37 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 1.0 OUTLIER 171.27 57.42 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.656 ' O ' HG23 ' B' ' 19' ' ' THR . 10.4 m -111.33 -159.48 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.564 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.656 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 173.84 102.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.501 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.757 HG22 HG13 ' B' ' 34' ' ' VAL . 41.4 t -102.84 101.89 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.821 0.343 . . . . 0.0 111.227 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -93.1 157.25 16.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.237 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.524 HG21 ' H ' ' B' ' 9' ' ' GLY . 34.9 m -106.81 -173.11 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.545 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' B' ' 23' ' ' LEU . 1.0 OUTLIER -127.48 -53.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 110.3 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.657 ' CA ' HG23 ' B' ' 8' ' ' VAL . . . 93.61 -39.89 2.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.157 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.573 ' O ' ' CB ' ' B' ' 26' ' ' LYS . 11.4 t -85.66 149.82 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.543 0.211 . . . . 0.0 111.502 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' B' ' 25' ' ' VAL . 10.8 tttp 101.22 116.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.249 0.62 . . . . 0.0 110.804 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.84 174.78 46.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.644 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.75 -84.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.657 0.265 . . . . 0.0 110.319 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.89 136.96 33.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.437 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.733 ' CG1' HD11 ' B' ' 32' ' ' ILE . 21.6 t -92.89 115.7 32.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.361 . . . . 0.0 110.905 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -86.45 99.48 11.68 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.994 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.733 HD11 ' CG1' ' B' ' 30' ' ' VAL . 33.2 mm -112.77 135.63 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 111.395 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.44 112.72 4.18 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.294 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.757 HG13 HG22 ' B' ' 20' ' ' VAL . 25.4 t -98.11 103.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.093 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.66 107.25 19.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.659 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.98 145.51 56.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.476 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.496 ' HD2' HG12 ' B' ' 18' ' ' VAL . 87.5 Cg_endo -81.29 156.46 19.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.891 2.394 . . . . 0.0 112.193 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -89.32 27.25 1.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.314 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -112.68 -37.22 4.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 110.995 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 15' ' ' GLY . 5.1 t -81.69 144.63 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.825 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -54.96 100.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.128 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.489 HG21 ' NH2' ' B' ' 44' ' ' ARG . 13.1 p -122.13 124.07 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.062 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.48 136.2 50.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.407 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.494 ' CZ ' HD13 ' A' ' 2' ' ' LEU . 7.1 mtt85 -151.88 -60.73 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.625 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 178.79 143.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.614 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.72 -43.86 92.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.932 0.396 . . . . 0.0 110.615 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.527 HG22 HD12 ' B' ' 51' ' ' ILE . 42.4 mm -64.59 -49.05 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.061 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.767 ' CZ ' HD12 ' A' ' 4' ' ' LEU . 88.8 t80 -50.68 -45.78 58.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.541 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.494 ' HG2' ' HB3' ' B' ' 53' ' ' ALA . 21.2 tt0 -75.6 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.713 0.292 . . . . 0.0 111.715 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -51.47 -17.28 0.75 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.527 HD12 HG22 ' B' ' 47' ' ' ILE . 36.0 mt -109.0 -54.67 5.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.761 0.315 . . . . 0.0 111.221 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.627 ' HB2' HD23 ' A' ' 2' ' ' LEU . 60.6 mm-40 -69.16 -62.14 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.854 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.495 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -67.33 -33.36 75.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.97 0.414 . . . . 0.0 110.769 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -119.08 127.19 53.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.839 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.536 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.805 0.336 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' B' ' 53' ' ' ALA . 0.5 OUTLIER -114.51 102.83 10.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.034 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -92.92 105.75 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.331 0.586 . . . . 0.0 110.949 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.831 HD13 ' CD2' ' B' ' 48' ' ' TYR . 0.1 OUTLIER -124.28 156.59 36.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.074 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.4 HG22 ' HB3' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -86.72 138.43 31.64 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.533 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.806 ' HB3' HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -150.94 145.95 25.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.072 0.463 . . . . 0.0 111.324 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -179.37 10.98 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.89 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.54 -41.22 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 122.165 -0.334 . . . . 0.0 111.507 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.7 94.46 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.802 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.403 ' CG ' ' HG2' ' A' ' 6' ' ' ARG . 2.2 tp10 -97.11 -61.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.458 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 m 64.94 98.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.385 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -120.44 154.37 35.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.086 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.667 ' HA ' HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -129.98 100.05 5.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.939 0.4 . . . . 0.0 110.991 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 14' ' ' ILE . 8.2 tp -119.15 102.85 13.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.037 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.545 ' HA2' HG11 ' B' ' 40' ' ' VAL . . . 156.54 -108.15 0.35 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.325 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.06 -15.51 4.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 164.29 61.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.993 0.425 . . . . 0.0 110.055 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.852 HG12 ' HD2' ' A' ' 37' ' ' PRO . 22.5 m -107.76 -168.62 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.64 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.872 HG23 ' HB3' ' A' ' 35' ' ' ASN . 1.1 t -175.33 103.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.751 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.675 HG13 ' HA ' ' A' ' 34' ' ' VAL . 21.5 t -102.76 106.9 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 21' ' ' THR . 9.4 t -91.57 111.85 23.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.569 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 6' ' ' ARG . 30.1 m -84.01 62.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.569 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.43 -142.42 0.24 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.829 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 31' ' ' ARG . . . 53.27 69.24 1.27 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.677 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' A' ' 7' ' ' ARG . 17.5 t -88.49 107.52 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 120.923 0.392 . . . . 0.0 111.576 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -142.67 146.97 34.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.104 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.3 158.7 30.59 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.526 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.83 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.674 0.273 . . . . 0.0 110.761 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.46 124.45 50.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 110.749 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.739 HG21 HG21 ' B' ' 30' ' ' VAL . 30.1 t -93.74 136.5 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.219 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.461 ' HB3' ' HA3' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -83.17 109.15 16.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.114 179.273 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.44 135.59 27.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.286 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.26 111.0 2.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.259 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.675 ' HA ' HG13 ' A' ' 20' ' ' VAL . 15.0 t -113.59 102.89 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 0.0 111.458 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.872 ' HB3' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER -91.63 107.18 19.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.667 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.435 ' HB1' HG12 ' B' ' 14' ' ' ILE . . . -130.12 146.21 60.56 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.532 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.852 ' HD2' HG12 ' A' ' 18' ' ' VAL . 86.9 Cg_endo -77.88 156.41 30.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.77 2.314 . . . . 0.0 112.008 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -91.3 38.36 0.97 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.11 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -123.55 -38.65 2.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.546 HG11 ' HA2' ' B' ' 15' ' ' GLY . 6.2 t -83.39 156.74 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.822 0.344 . . . . 0.0 110.978 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -57.05 114.97 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.5 p -122.07 121.9 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.96 122.39 30.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.538 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.565 HH21 HD13 ' B' ' 12' ' ' LEU . 17.5 ttm180 -163.95 -77.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.03 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.435 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 5.8 mm-40 -155.07 131.47 10.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.57 -50.72 72.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.221 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.471 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 13.9 tt -63.17 -42.04 95.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.974 0.416 . . . . 0.0 111.166 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.827 ' CD2' HD13 ' B' ' 4' ' ' LEU . 5.9 m-85 -50.9 -53.39 33.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.169 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.536 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 1.5 mt-30 -78.33 -21.7 49.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.137 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 4.9 mtt180 -72.92 -15.43 61.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.671 0.272 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.5 mt -109.82 -27.1 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.331 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.541 ' HB2' HD23 ' B' ' 2' ' ' LEU . 6.0 mp0 -107.79 -54.54 2.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.796 0.331 . . . . 0.0 111.28 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.651 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -64.74 -73.62 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.277 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -111.85 123.72 50.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.785 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.504 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.286 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.651 HD21 ' HB2' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -114.59 102.82 10.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.631 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -92.86 105.74 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.335 0.588 . . . . 0.0 110.968 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.827 HD13 ' CD2' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -124.34 156.62 36.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.998 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.78 138.43 31.61 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.527 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.834 ' HB3' HG21 ' B' ' 22' ' ' VAL . 0.0 OUTLIER -150.93 146.0 25.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.285 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.572 ' HG2' HG22 ' B' ' 25' ' ' VAL . 0.6 OUTLIER -179.43 10.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.969 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.6 -41.21 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 122.18 -0.325 . . . . 0.0 111.483 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.71 94.48 0.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.803 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -97.11 -61.62 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.484 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m 64.99 98.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.432 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.634 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -120.4 154.36 35.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.147 179.204 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.671 ' HA ' HG23 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -129.95 100.08 5.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.973 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.641 ' O ' HG23 ' B' ' 14' ' ' ILE . 8.2 tp -119.15 102.86 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.021 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.546 ' HA2' HG11 ' A' ' 40' ' ' VAL . . . 156.57 -108.14 0.35 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.307 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 11.8 t70 -129.09 -15.57 4.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 1.7 mt-10 164.29 61.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.033 0.444 . . . . 0.0 110.059 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.859 HG12 ' HD2' ' B' ' 37' ' ' PRO . 22.5 m -107.8 -168.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.631 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.874 HG23 ' HB3' ' B' ' 35' ' ' ASN . 1.1 t -175.3 103.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.758 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.692 HG13 ' HA ' ' B' ' 34' ' ' VAL . 21.5 t -102.77 106.9 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.511 HG23 ' O ' ' B' ' 21' ' ' THR . 9.4 t -91.59 111.9 23.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.508 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.834 HG21 ' HB3' ' B' ' 6' ' ' ARG . 29.9 m -84.0 62.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.551 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.41 -142.46 0.24 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.731 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' B' ' 31' ' ' ARG . . . 53.37 69.18 1.29 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.636 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.572 HG22 ' HG2' ' B' ' 7' ' ' ARG . 17.4 t -88.47 107.48 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 111.559 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -142.63 146.99 35.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.096 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.35 158.69 30.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.499 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.81 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.676 0.274 . . . . 0.0 110.776 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.4 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -108.45 124.41 50.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 110.744 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.739 HG21 HG21 ' A' ' 30' ' ' VAL . 29.6 t -93.68 136.5 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.464 ' HB3' ' HA3' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -83.17 109.12 16.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.129 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 mm -93.41 135.63 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.235 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.32 111.0 2.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.319 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.692 ' HA ' HG13 ' B' ' 20' ' ' VAL . 15.0 t -113.58 102.87 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 111.403 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.874 ' HB3' HG23 ' B' ' 19' ' ' THR . 0.2 OUTLIER -91.6 107.14 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.685 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.434 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -130.14 146.26 60.77 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.481 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.859 ' HD2' HG12 ' B' ' 18' ' ' VAL . 87.1 Cg_endo -77.84 156.36 30.99 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.806 2.337 . . . . 0.0 112.016 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -91.3 38.38 0.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.139 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -123.56 -38.59 2.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.067 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.545 HG11 ' HA2' ' A' ' 15' ' ' GLY . 6.2 t -83.38 156.7 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.006 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -57.03 115.0 2.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.183 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.472 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.7 p -122.03 121.91 65.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.96 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.98 122.36 29.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.525 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.567 HH21 HD13 ' A' ' 12' ' ' LEU . 17.5 ttm180 -163.92 -77.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.729 0.299 . . . . 0.0 111.013 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.433 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 5.8 mm-40 -155.09 131.46 10.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.875 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.66 -50.63 72.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.179 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.477 ' HA ' ' HB2' ' B' ' 50' ' ' ARG . 13.9 tt -63.27 -42.0 94.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.831 ' CD2' HD13 ' A' ' 4' ' ' LEU . 5.9 m-85 -50.92 -53.36 33.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.185 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.522 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 1.5 mt-30 -78.32 -21.62 49.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.227 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 4.8 mtt180 -73.01 -15.34 61.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.296 . . . . 0.0 111.188 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 43.7 mt -109.94 -27.13 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.351 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.538 ' HB2' HD23 ' A' ' 2' ' ' LEU . 6.0 mp0 -107.8 -54.52 2.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.291 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -64.68 -73.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -112.42 125.29 54.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.731 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.819 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.792 0.33 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' B' ' 53' ' ' ALA . 8.3 tt -122.18 116.12 23.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.6 tt -101.8 105.57 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.134 0.493 . . . . 0.0 110.535 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.467 HD23 ' HG3' ' B' ' 52' ' ' GLN . 0.2 OUTLIER -124.51 123.51 40.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.434 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -63.24 143.65 57.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.729 0.3 . . . . 0.0 110.414 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.704 ' HB2' HG21 ' A' ' 22' ' ' VAL . 10.6 mtt180 -153.18 148.24 26.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.969 0.414 . . . . 0.0 111.012 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.845 ' HD2' HG13 ' A' ' 25' ' ' VAL . 21.1 ttp180 175.48 -0.76 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.918 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -169.39 134.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.747 0.308 . . . . 0.0 110.831 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.05 47.83 89.09 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.514 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.486 ' C ' HG22 ' A' ' 11' ' ' THR . 18.2 mm-40 -112.46 167.57 10.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.514 0.197 . . . . 0.0 110.703 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.486 HG22 ' C ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER 163.54 105.53 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.245 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.449 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -115.82 154.14 30.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.247 179.086 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.482 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.5 ttt -130.27 100.88 5.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.007 0.432 . . . . 0.0 111.261 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.825 HG23 HG23 ' B' ' 14' ' ' ILE . 2.5 tp -113.06 121.77 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.465 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 134.35 -107.14 0.64 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.153 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.519 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 21.0 m-20 -154.96 6.95 0.26 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 2.0 tm-20 161.33 64.84 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 19' ' ' THR . 10.7 m -119.34 -158.53 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.47 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 171.39 102.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.653 HG13 ' HA ' ' A' ' 34' ' ' VAL . 22.4 t -117.36 110.91 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.808 0.337 . . . . 0.0 111.461 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.7 m -106.74 116.6 32.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.029 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.704 HG21 ' HB2' ' A' ' 6' ' ' ARG . 27.6 m -82.22 68.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.069 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.69 -141.64 0.07 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.622 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.32 74.26 0.36 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.364 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.845 HG13 ' HD2' ' A' ' 7' ' ' ARG . 41.5 t -85.68 107.75 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 120.974 0.416 . . . . 0.0 111.134 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.89 165.42 35.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.139 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.68 164.59 27.92 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.169 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 72.72 -62.51 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.607 0.242 . . . . 0.0 111.245 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.57 136.4 54.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.738 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.2 116.29 44.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 111.12 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 1.9 mtm105 -79.58 99.36 7.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.833 0.349 . . . . 0.0 110.697 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.65 HG23 HG12 ' A' ' 22' ' ' VAL . 16.2 mm -87.86 132.85 32.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.599 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.62 118.2 5.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.536 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.653 ' HA ' HG13 ' A' ' 20' ' ' VAL . 14.2 t -114.14 127.96 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.218 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 19' ' ' THR . 2.7 t-20 -123.68 107.48 11.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.312 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.98 142.76 22.76 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.715 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.9 156.62 27.09 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.797 2.332 . . . . 0.0 112.051 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -87.44 26.6 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.427 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.38 -41.66 6.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.837 0.351 . . . . 0.0 110.819 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.446 HG12 ' O ' ' B' ' 15' ' ' GLY . 3.9 t -82.49 150.18 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.7 t -62.5 97.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.348 . . . . 0.0 111.018 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.9 p -122.39 120.61 61.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -128.39 136.22 50.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.594 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -178.3 -35.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.084 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.12 98.66 0.02 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.69 -26.45 63.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.818 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.404 ' CG2' HG13 ' A' ' 51' ' ' ILE . 33.2 mm -79.2 -44.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' O ' HD11 ' B' ' 2' ' ' LEU . 3.3 m-85 -52.11 -44.91 64.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.84 -60.48 2.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.829 0.347 . . . . 0.0 111.683 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -54.95 -15.6 2.12 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.404 HG13 ' CG2' ' A' ' 47' ' ' ILE . 47.6 mm -108.42 -52.75 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 122.284 -0.26 . . . . 0.0 111.591 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.459 ' HG3' HD23 ' B' ' 4' ' ' LEU . 61.8 mm-40 -72.53 -59.12 2.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.709 0.29 . . . . 0.0 111.153 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.646 ' HB2' HD12 ' B' ' 2' ' ' LEU . . . -75.06 -25.39 58.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.388 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -121.54 140.2 52.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.526 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.434 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.82 0.343 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 53' ' ' ALA . 8.3 tt -122.24 116.21 23.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.629 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.6 tt -101.83 105.61 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.146 0.498 . . . . 0.0 110.524 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.459 HD23 ' HG3' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -124.58 123.5 40.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.423 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -63.16 143.69 57.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.38 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.705 ' HB2' HG21 ' B' ' 22' ' ' VAL . 10.6 mtt180 -153.23 148.26 26.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.952 0.406 . . . . 0.0 111.068 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.849 ' HD2' HG13 ' B' ' 25' ' ' VAL . 21.0 ttp180 175.44 -0.73 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.891 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.722 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -169.42 134.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.76 0.314 . . . . 0.0 110.797 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.04 47.79 89.29 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.486 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.484 ' C ' HG22 ' B' ' 11' ' ' THR . 18.1 mm-40 -112.39 167.65 10.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.541 0.21 . . . . 0.0 110.711 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.484 HG22 ' C ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 163.51 105.51 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.263 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.439 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.9 OUTLIER -115.86 154.1 30.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.293 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.467 ' HA ' HG23 ' B' ' 18' ' ' VAL . 1.5 ttt -130.28 100.78 5.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.997 0.427 . . . . 0.0 111.23 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.825 HG23 HG23 ' A' ' 14' ' ' ILE . 2.5 tp -112.98 121.83 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.504 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 134.31 -107.09 0.64 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.147 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 21.1 m-20 -154.96 6.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 2.1 tm-20 161.32 64.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.664 ' O ' HG23 ' B' ' 19' ' ' THR . 10.7 m -119.36 -158.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.487 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.664 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 171.38 102.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.657 HG13 ' HA ' ' B' ' 34' ' ' VAL . 22.6 t -117.36 110.93 32.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.819 0.343 . . . . 0.0 111.399 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 16.7 m -106.74 116.68 32.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.005 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' B' ' 6' ' ' ARG . 27.6 m -82.29 68.5 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.064 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.68 -141.65 0.07 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.575 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.3 74.34 0.35 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.309 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.849 HG13 ' HD2' ' B' ' 7' ' ' ARG . 41.4 t -85.78 107.74 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.064 0.459 . . . . 0.0 111.149 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.84 165.47 35.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.186 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.73 164.62 27.87 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.141 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 72.75 -62.53 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.614 0.245 . . . . 0.0 111.253 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.62 136.46 54.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.703 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.22 116.24 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.703 0.287 . . . . 0.0 111.096 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 1.9 mtm105 -79.45 99.34 7.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.802 0.334 . . . . 0.0 110.791 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.662 HG23 HG12 ' B' ' 22' ' ' VAL . 16.2 mm -87.86 132.87 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.591 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.65 118.15 5.4 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.542 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.657 ' HA ' HG13 ' B' ' 20' ' ' VAL . 14.0 t -114.1 127.98 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.238 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' B' ' 19' ' ' THR . 2.7 t-20 -123.73 107.45 11.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.293 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.93 142.8 23.01 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.769 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.95 156.53 26.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.851 2.367 . . . . 0.0 111.989 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -87.32 26.51 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.465 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -101.42 -41.6 6.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.785 0.326 . . . . 0.0 110.779 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 15' ' ' GLY . 3.9 t -82.55 150.22 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.624 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -62.47 97.93 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 111.101 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.504 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.8 p -122.38 120.6 61.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.1 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -128.37 136.26 50.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 3.7 ptt85 -178.28 -35.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.089 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.15 98.65 0.02 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -58.69 -26.55 63.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.767 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.416 ' CG2' HG13 ' B' ' 51' ' ' ILE . 32.8 mm -79.13 -44.25 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.415 ' O ' HD11 ' A' ' 2' ' ' LEU . 3.3 m-85 -52.08 -44.95 64.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.291 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -60.51 2.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.851 0.358 . . . . 0.0 111.636 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.406 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 5.3 mtp180 -54.89 -15.77 2.2 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.416 HG13 ' CG2' ' B' ' 47' ' ' ILE . 47.6 mm -108.26 -52.68 6.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.608 0.242 . . . . 0.0 111.587 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.467 ' HG3' HD23 ' A' ' 4' ' ' LEU . 61.7 mm-40 -72.58 -59.07 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.715 0.293 . . . . 0.0 111.133 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.655 ' HB2' HD12 ' A' ' 2' ' ' LEU . . . -75.09 -25.28 58.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.395 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 11.9 mm-40 -122.34 142.33 50.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 mttp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.876 -179.999 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' B' ' 53' ' ' ALA . 5.6 mp -122.28 114.35 20.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.907 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.423 ' CG2' ' HB3' ' B' ' 31' ' ' ARG . 20.8 mm -96.2 105.03 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.027 0.441 . . . . 0.0 110.506 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.41 ' CD2' ' HG2' ' B' ' 52' ' ' GLN . 2.4 mm? -124.82 118.23 25.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.8 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.1 OUTLIER -55.68 139.83 43.5 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.43 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.737 ' HB3' HG21 ' A' ' 22' ' ' VAL . 3.8 mtp180 -151.37 148.4 28.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.029 0.442 . . . . 0.0 111.474 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.738 ' NE ' HG13 ' A' ' 25' ' ' VAL . 2.9 ttt180 175.91 -80.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.569 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t -32.75 -68.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.09 109.58 0.41 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.006 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.859 ' HB2' HG22 ' A' ' 22' ' ' VAL . 8.2 mm-40 -113.18 -173.63 2.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.553 0.216 . . . . 0.0 110.533 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 10' ' ' GLU . 0.7 OUTLIER 168.9 89.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.443 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.52 HD21 ' HB ' ' A' ' 20' ' ' VAL . 1.3 pt? -113.11 154.25 26.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.3 ttt -130.67 100.76 5.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.209 0.528 . . . . 0.0 111.348 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.5 HD13 ' HB ' ' B' ' 42' ' ' VAL . 2.6 tp -111.77 126.8 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.402 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 127.93 -104.56 0.68 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.965 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.9 p30 -162.34 8.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.405 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.9 mt-10 165.24 52.92 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.014 0.435 . . . . 0.0 110.316 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.646 HG12 ' HD2' ' A' ' 37' ' ' PRO . 13.7 m -115.27 -158.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.934 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.1 OUTLIER 167.05 106.86 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 34' ' ' VAL . 3.1 t -117.43 114.27 45.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.769 0.319 . . . . 0.0 111.172 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.741 HG23 ' O ' ' A' ' 10' ' ' GLU . 5.0 m -110.54 116.53 31.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.873 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.859 HG22 ' HB2' ' A' ' 10' ' ' GLU . 34.2 m -81.16 71.16 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -88.97 -145.76 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.562 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 31' ' ' ARG . . . 56.7 79.76 0.09 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.326 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.738 HG13 ' NE ' ' A' ' 7' ' ' ARG . 20.8 t -85.93 107.82 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.904 0.383 . . . . 0.0 111.602 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.99 155.67 43.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.03 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.78 154.93 52.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.583 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 67.68 -88.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.464 0.173 . . . . 0.0 110.685 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -104.63 125.68 50.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.62 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.402 HG23 HD11 ' A' ' 32' ' ' ILE . 4.7 m -93.24 136.65 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.515 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 4.6 mtt180 -79.51 100.98 7.98 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.096 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.675 HG23 ' HA ' ' A' ' 22' ' ' VAL . 18.5 mm -87.35 133.79 29.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.66 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.96 119.02 6.32 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.266 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.649 ' HA ' HG13 ' A' ' 20' ' ' VAL . 24.3 t -109.55 129.61 64.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.929 0.395 . . . . 0.0 111.494 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.934 ' HB3' HG23 ' A' ' 19' ' ' THR . 2.1 t30 -123.47 107.25 11.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.183 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.18 146.62 46.87 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.635 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.646 ' HD2' HG12 ' A' ' 18' ' ' VAL . 82.8 Cg_endo -83.2 156.52 14.82 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.99 2.46 . . . . 0.0 112.278 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.92 15.59 4.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.352 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.29 -38.65 10.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.639 0.257 . . . . 0.0 110.973 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 15' ' ' GLY . 4.7 t -87.95 142.21 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.835 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 m -55.85 98.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.027 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 42' ' ' VAL . 13.4 p -122.2 120.82 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.222 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.19 136.09 50.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.442 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.413 ' NH2' ' NE ' ' B' ' 6' ' ' ARG . 24.4 ttt180 -156.69 -67.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 111.012 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.83 121.55 1.82 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.92 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.52 -42.43 82.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.61 -41.09 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.79 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -52.32 -46.71 66.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.701 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -86.71 -58.17 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 111.741 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.46 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 4.1 mtt180 -48.91 -20.29 0.49 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.9 mm -108.67 -52.67 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.632 0.253 . . . . 0.0 111.498 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.403 ' HG2' ' CD2' ' B' ' 4' ' ' LEU . 7.9 tp60 -66.81 -63.5 1.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.721 0.296 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.814 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -70.82 -32.13 69.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.982 0.42 . . . . 0.0 110.615 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -109.42 119.73 40.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.798 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm . . . . . 0 N--CA 1.448 -0.573 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.667 179.766 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.899 0.38 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.814 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.5 mp -122.26 114.41 20.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.425 ' CG2' ' HB3' ' A' ' 31' ' ' ARG . 20.6 mm -96.25 104.95 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 0.0 110.566 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.403 ' CD2' ' HG2' ' A' ' 52' ' ' GLN . 2.4 mm? -124.76 118.43 26.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.781 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -55.78 139.83 44.06 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.378 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.754 ' HB3' HG21 ' B' ' 22' ' ' VAL . 3.8 mtp180 -151.38 148.37 28.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.048 0.452 . . . . 0.0 111.496 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.741 ' NE ' HG13 ' B' ' 25' ' ' VAL . 2.9 ttt180 175.91 -80.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.591 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 25.1 t -32.76 -68.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.05 109.64 0.41 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.002 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.855 ' HB2' HG22 ' B' ' 22' ' ' VAL . 8.2 mm-40 -113.19 -173.59 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.548 0.213 . . . . 0.0 110.536 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' B' ' 10' ' ' GLU . 0.7 OUTLIER 168.87 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.426 179.663 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.522 HD21 ' HB ' ' B' ' 20' ' ' VAL . 1.3 pt? -113.19 154.26 26.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 12.3 ttt -130.71 100.82 5.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.233 0.54 . . . . 0.0 111.403 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.499 HD13 ' HB ' ' A' ' 42' ' ' VAL . 2.6 tp -111.89 126.81 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.342 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 127.96 -104.66 0.69 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.913 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 2.9 p30 -162.31 9.01 0.06 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.9 mt-10 165.25 52.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.025 0.44 . . . . 0.0 110.284 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.633 HG12 ' HD2' ' B' ' 37' ' ' PRO . 13.8 m -115.26 -158.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.216 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.944 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.1 OUTLIER 167.05 106.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.655 HG13 ' HA ' ' B' ' 34' ' ' VAL . 3.1 t -117.45 114.28 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.753 0.311 . . . . 0.0 111.18 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.752 HG23 ' O ' ' B' ' 10' ' ' GLU . 5.0 m -110.54 116.54 31.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.849 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.855 HG22 ' HB2' ' B' ' 10' ' ' GLU . 34.2 m -81.11 71.1 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.601 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.42 HD12 ' N ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -88.94 -145.72 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.576 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' B' ' 31' ' ' ARG . . . 56.68 79.76 0.09 OUTLIER Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.363 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.741 HG13 ' NE ' ' B' ' 7' ' ' ARG . 20.9 t -86.0 107.83 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 120.96 0.41 . . . . 0.0 111.638 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.03 155.65 43.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.003 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.73 154.95 52.68 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.555 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 67.64 -88.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.492 0.187 . . . . 0.0 110.654 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -104.64 125.66 50.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.0 110.64 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 m -93.21 136.67 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.555 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.6 mtt180 -79.51 100.88 7.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.1 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.668 HG23 ' HA ' ' B' ' 22' ' ' VAL . 18.6 mm -87.31 133.76 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.68 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.92 118.96 6.3 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.306 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.655 ' HA ' HG13 ' B' ' 20' ' ' VAL . 24.0 t -109.51 129.67 63.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.922 0.391 . . . . 0.0 111.556 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.944 ' HB3' HG23 ' B' ' 19' ' ' THR . 2.1 t30 -123.41 107.22 11.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.247 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.19 146.6 46.76 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.622 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.633 ' HD2' HG12 ' B' ' 18' ' ' VAL . 82.7 Cg_endo -83.17 156.52 14.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.013 2.475 . . . . 0.0 112.271 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.95 15.57 4.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.303 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -38.6 10.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.662 0.268 . . . . 0.0 111.016 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 15' ' ' GLY . 4.7 t -87.94 142.19 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.868 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 3.0 m -55.9 98.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.971 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.511 HG13 ' O ' ' B' ' 42' ' ' VAL . 13.4 p -122.19 120.81 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.265 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.21 136.04 50.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.432 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.414 ' NH2' ' NE ' ' A' ' 6' ' ' ARG . 24.6 ttt180 -156.62 -67.17 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.939 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.77 121.61 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.42 -42.48 82.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -41.03 87.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.799 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -52.35 -46.65 66.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.634 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -86.84 -58.09 2.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.758 0.313 . . . . 0.0 111.804 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.467 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 4.1 mtt180 -48.95 -20.16 0.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 36.6 mm -108.78 -52.63 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.629 0.252 . . . . 0.0 111.524 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.41 ' HG2' ' CD2' ' A' ' 4' ' ' LEU . 8.1 tp60 -66.87 -63.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.763 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.822 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -70.89 -32.2 69.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 110.589 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 0.5 OUTLIER -108.65 119.59 39.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.615 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.589 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.731 ' C ' HD13 ' A' ' 2' ' ' LEU . 1.7 ttm . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.964 0.412 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.731 HD13 ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -122.24 111.69 17.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.823 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 3' ' ' ILE . 2.8 tt -106.06 116.66 50.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.1 0.476 . . . . 0.0 111.3 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.87 HD22 ' CD2' ' B' ' 48' ' ' TYR . 0.4 OUTLIER -123.9 123.4 40.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.336 179.354 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -63.61 80.07 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.888 0.375 . . . . 0.0 111.664 -179.17 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.546 ' HD3' HG21 ' A' ' 22' ' ' VAL . 23.5 mtt180 -78.79 143.22 36.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.126 0.489 . . . . 0.0 110.514 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.435 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 2.9 tmt_? -173.36 -13.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.864 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.61 -58.74 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.702 0.286 . . . . 0.0 111.175 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.57 105.55 0.21 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.803 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.2 -73.82 0.65 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.906 0.384 . . . . 0.0 110.723 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 m 69.53 102.39 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.49 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.644 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -109.94 154.59 22.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.626 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.3 ttt -127.2 100.07 5.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.98 0.419 . . . . 0.0 110.747 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.644 HD13 ' N ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -115.85 138.16 47.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.752 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.644 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 121.28 -106.01 1.08 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.104 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.4 t70 -159.57 7.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.7 mt-10 162.66 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.036 0.446 . . . . 0.0 110.151 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.774 HG12 ' CD ' ' A' ' 37' ' ' PRO . 13.3 m -116.38 -158.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.649 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.951 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 173.57 102.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.644 ' HB ' HD23 ' A' ' 12' ' ' LEU . 27.5 t -110.48 103.96 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.5 m -89.27 106.37 18.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.904 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.546 HG21 ' HD3' ' A' ' 6' ' ' ARG . 32.0 m -76.7 -168.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.899 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.724 ' O ' HG11 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -173.38 141.3 0.89 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.103 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.481 ' H ' HD13 ' A' ' 23' ' ' LEU . . . -125.37 -24.54 1.58 Allowed Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.477 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.94 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.536 0.208 . . . . 0.0 110.63 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.91 165.5 0.13 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.747 0.308 . . . . 0.0 110.56 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.81 -99.98 0.01 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.569 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -101.36 -30.92 11.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 110.377 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.448 ' HB3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -119.82 136.65 54.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.955 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 23' ' ' LEU . 12.0 t -93.21 128.39 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 111.681 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 2.4 ttp180 -80.8 99.54 8.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.445 HG13 ' HB2' ' B' ' 6' ' ' ARG . 9.5 mm -88.77 127.43 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.931 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.03 109.99 3.4 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.486 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.574 ' HA ' HG13 ' A' ' 20' ' ' VAL . 21.5 t -111.73 102.93 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.936 0.398 . . . . 0.0 111.468 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.951 ' HB3' HG23 ' A' ' 19' ' ' THR . 1.8 t-20 -91.59 107.44 19.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.641 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.95 138.62 33.04 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.454 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.774 ' CD ' HG12 ' A' ' 18' ' ' VAL . 83.7 Cg_endo -77.69 156.09 31.45 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.603 2.202 . . . . 0.0 112.102 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -82.01 2.25 31.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.564 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.84 -39.33 20.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.72 0.295 . . . . 0.0 111.267 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 t -86.78 146.85 5.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.885 0.374 . . . . 0.0 110.995 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.97 100.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.5 p -122.3 122.31 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -128.11 136.42 51.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.706 0.289 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.668 HH22 HD23 ' B' ' 2' ' ' LEU . 0.5 OUTLIER -142.92 -175.78 4.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.489 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 1.9 mp0 -57.3 145.78 30.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.843 0.354 . . . . 0.0 110.874 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.67 -65.29 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.507 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -52.08 -40.77 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.387 -179.784 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.861 ' CD2' HD22 ' B' ' 4' ' ' LEU . 7.9 t80 -46.9 -67.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.436 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' A' ' 53' ' ' ALA . 48.5 mt-30 -71.96 -22.01 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.551 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -70.5 -15.95 62.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.649 0.261 . . . . 0.0 111.571 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.528 HG23 ' OE1' ' A' ' 52' ' ' GLN . 6.9 tt -112.15 -25.18 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.634 0.254 . . . . 0.0 111.5 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.562 ' HB3' HD12 ' B' ' 2' ' ' LEU . 0.6 OUTLIER -106.79 -55.81 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.257 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB2' ' HG2' ' A' ' 49' ' ' GLN . . . -65.08 -71.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.1 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -108.0 116.61 32.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.772 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.558 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.743 ' C ' HD13 ' B' ' 2' ' ' LEU . 1.7 ttm . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.88 0.371 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.743 HD13 ' C ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -122.28 111.71 17.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.45 HG23 ' O ' ' B' ' 3' ' ' ILE . 2.7 tt -106.11 116.69 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.167 0.508 . . . . 0.0 111.233 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.861 HD22 ' CD2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -123.88 123.52 40.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.315 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -63.64 80.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.872 0.368 . . . . 0.0 111.623 -179.189 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.558 ' HD3' HG21 ' B' ' 22' ' ' VAL . 23.5 mtt180 -78.88 143.32 36.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.151 0.501 . . . . 0.0 110.503 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.432 ' HA ' ' HA3' ' B' ' 24' ' ' GLY . 2.9 tmt_? -173.37 -13.25 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.859 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 t -116.64 -58.68 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.674 0.273 . . . . 0.0 111.131 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.53 105.55 0.21 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.804 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.14 -73.89 0.65 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 110.77 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 8.8 m 69.61 102.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.436 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.4 OUTLIER -109.87 154.58 22.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.664 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 8.3 ttt -127.15 100.02 5.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.988 0.423 . . . . 0.0 110.769 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.639 HD13 ' N ' ' B' ' 15' ' ' GLY . 0.0 OUTLIER -115.76 138.2 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.734 179.893 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.639 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 121.28 -105.96 1.07 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.109 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.4 t70 -159.58 7.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.7 mt-10 162.69 59.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.981 0.42 . . . . 0.0 110.102 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.776 HG12 ' CD ' ' B' ' 37' ' ' PRO . 13.4 m -116.4 -158.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.632 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.934 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.1 OUTLIER 173.61 102.73 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.642 ' HB ' HD23 ' B' ' 12' ' ' LEU . 27.6 t -110.44 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 33.2 m -89.28 106.37 18.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.946 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.558 HG21 ' HD3' ' B' ' 6' ' ' ARG . 32.2 m -76.79 -168.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.905 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.725 ' O ' HG11 ' B' ' 30' ' ' VAL . 0.2 OUTLIER -173.38 141.32 0.9 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.095 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.481 ' H ' HD13 ' B' ' 23' ' ' LEU . . . -125.41 -24.43 1.59 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.97 130.79 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.525 0.202 . . . . 0.0 110.622 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.88 165.53 0.13 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 110.578 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.87 -100.01 0.01 OUTLIER Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.506 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -101.37 -30.88 11.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 110.372 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.448 ' HB3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -119.82 136.56 54.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.965 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.725 HG11 ' O ' ' B' ' 23' ' ' LEU . 12.1 t -93.18 128.44 44.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.916 0.389 . . . . 0.0 111.636 -178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 2.4 ttp180 -80.8 99.52 8.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.46 HG13 ' HB2' ' A' ' 6' ' ' ARG . 9.6 mm -88.8 127.46 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.878 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.03 109.95 3.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.429 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.581 ' HA ' HG13 ' B' ' 20' ' ' VAL . 21.4 t -111.7 102.94 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 111.48 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.934 ' HB3' HG23 ' B' ' 19' ' ' THR . 1.8 t-20 -91.62 107.43 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.622 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.97 138.59 32.99 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.475 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.776 ' CD ' HG12 ' B' ' 18' ' ' VAL . 84.3 Cg_endo -77.67 156.08 31.55 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.654 2.236 . . . . 0.0 112.134 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -82.03 2.28 31.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.603 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.88 -39.36 19.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.66 0.266 . . . . 0.0 111.187 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 t -86.67 146.8 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.042 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.01 100.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.467 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.5 p -122.3 122.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.752 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -128.1 136.4 51.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.684 0.278 . . . . 0.0 110.862 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.672 HH22 HD23 ' A' ' 2' ' ' LEU . 0.5 OUTLIER -142.93 -175.79 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.491 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' B' ' 48' ' ' TYR . 1.9 mp0 -57.31 145.7 31.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.86 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.62 -65.29 0.58 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.546 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.665 HD13 ' O ' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -52.07 -40.8 30.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.37 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.87 ' CD2' HD22 ' A' ' 4' ' ' LEU . 8.0 t80 -46.86 -67.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.414 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.462 ' HG2' ' HB2' ' B' ' 53' ' ' ALA . 48.5 mt-30 -71.95 -21.95 61.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.632 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 61.0 mtt180 -70.57 -15.95 62.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.579 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.53 HG23 ' OE1' ' B' ' 52' ' ' GLN . 6.9 tt -112.17 -25.08 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.614 0.245 . . . . 0.0 111.501 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.536 ' HB3' HD12 ' A' ' 2' ' ' LEU . 0.6 OUTLIER -106.82 -55.81 2.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 111.242 -179.671 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.462 ' HB2' ' HG2' ' B' ' 49' ' ' GLN . . . -65.04 -71.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.168 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -108.33 116.97 32.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmm? . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.821 0.343 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.402 ' HB2' ' NH1' ' B' ' 44' ' ' ARG . 4.1 mp -115.93 109.49 17.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 3' ' ' ILE . 18.3 tt -84.52 111.35 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 0.0 111.443 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -113.18 156.25 23.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.729 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.551 ' N ' HD23 ' A' ' 4' ' ' LEU . 0.2 OUTLIER -94.71 122.55 37.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 111.382 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.442 ' HB2' HG13 ' B' ' 32' ' ' ILE . 0.6 OUTLIER -95.6 148.97 21.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.645 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.621 ' HG3' HG13 ' A' ' 30' ' ' VAL . 0.1 OUTLIER 81.13 85.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.821 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.653 HG23 ' HA2' ' A' ' 24' ' ' GLY . 47.3 t 80.72 56.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.287 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.43 ' H ' HG21 ' A' ' 22' ' ' VAL . . . -140.51 -147.58 5.0 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.632 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.23 119.24 37.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 111.61 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 21' ' ' THR . 14.4 p -57.03 145.08 31.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.304 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.798 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -112.6 154.42 26.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.694 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.7 ttp -128.94 100.34 5.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.751 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.498 HD11 HG11 ' B' ' 18' ' ' VAL . 0.0 OUTLIER -114.64 138.72 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.015 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.411 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 123.9 -106.27 0.95 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.151 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.588 ' OD2' HG22 ' A' ' 40' ' ' VAL . 1.4 p30 -158.58 7.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.6 OUTLIER 161.74 58.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.902 0.382 . . . . 0.0 110.044 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.796 HG12 ' HD2' ' A' ' 37' ' ' PRO . 10.7 m -114.37 -156.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.357 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.974 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 173.15 104.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.974 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.798 ' HB ' HD23 ' A' ' 12' ' ' LEU . 24.8 t -102.66 101.66 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.852 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.629 ' HA ' HG22 ' A' ' 11' ' ' THR . 9.8 t -95.35 157.42 15.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.631 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.43 HG21 ' H ' ' A' ' 9' ' ' GLY . 6.4 m -107.86 -172.39 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.309 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.2 tm? -124.05 -52.2 1.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 0.0 110.427 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.653 ' HA2' HG23 ' A' ' 8' ' ' VAL . . . 91.85 -43.47 2.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.996 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.56 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 4.0 t -85.65 149.91 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.525 0.202 . . . . 0.0 111.41 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 25' ' ' VAL . 28.1 tttp 99.07 122.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.068 0.547 . . . . 0.0 110.743 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.77 -179.51 37.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.762 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 63.63 -86.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -86.46 136.74 32.99 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.821 HG12 HD11 ' A' ' 32' ' ' ILE . 4.1 t -93.24 114.15 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.351 . . . . 0.0 110.874 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.56 ' HD2' HD11 ' B' ' 3' ' ' ILE . 8.9 mmt180 -89.28 99.87 12.77 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.888 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.821 HD11 HG12 ' A' ' 30' ' ' VAL . 24.0 mm -109.53 141.19 25.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.054 0.454 . . . . 0.0 111.667 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.82 107.48 2.58 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.919 -0.657 . . . . 0.0 111.987 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.587 HG13 HG22 ' A' ' 20' ' ' VAL . 21.4 t -97.8 103.41 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.904 0.383 . . . . 0.0 111.103 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.974 ' HB3' HG23 ' A' ' 19' ' ' THR . 1.2 t-20 -90.57 107.3 19.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.87 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.75 140.03 37.43 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.259 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.796 ' HD2' HG12 ' A' ' 18' ' ' VAL . 85.9 Cg_endo -77.74 156.18 31.32 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.642 2.228 . . . . 0.0 112.28 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -80.32 0.16 34.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.355 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -78.01 -39.77 41.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.714 0.292 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.588 HG22 ' OD2' ' A' ' 16' ' ' ASP . 5.5 t -87.8 140.88 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.91 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 t -62.48 102.26 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.379 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.2 p -122.24 120.69 61.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -128.31 136.45 51.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.793 0.33 . . . . 0.0 111.199 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.4 ' NH1' ' HB2' ' B' ' 2' ' ' LEU . 63.4 mtt180 -139.62 -50.68 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.45 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 1.3 tp10 -178.29 141.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.514 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.51 -45.74 84.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.217 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -73.02 -38.51 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.67 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 45' ' ' GLU . 4.1 m-85 -51.54 -50.16 60.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -85.9 -52.81 5.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -16.35 12.62 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 mm -115.76 -57.92 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.409 ' CB ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -66.39 -48.07 71.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.104 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.85 -28.25 26.17 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 111.307 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -120.33 134.29 55.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.1 mttp . . . . . 0 N--CA 1.449 -0.514 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.147 -179.802 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmm? . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.804 0.335 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.4 ' HB2' ' NH1' ' A' ' 44' ' ' ARG . 4.2 mp -115.96 109.5 17.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.847 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.58 HG23 ' O ' ' B' ' 3' ' ' ILE . 18.3 tt -84.49 111.42 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.487 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.564 HD23 ' N ' ' B' ' 5' ' ' THR . 1.0 OUTLIER -113.21 156.21 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.739 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.564 ' N ' HD23 ' B' ' 4' ' ' LEU . 0.2 OUTLIER -94.69 122.55 37.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.363 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.6 OUTLIER -95.65 148.97 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.635 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.61 ' HG3' HG13 ' B' ' 30' ' ' VAL . 0.1 OUTLIER 81.22 85.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.767 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.653 HG23 ' HA2' ' B' ' 24' ' ' GLY . 47.3 t 80.64 56.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.287 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.426 ' H ' HG21 ' B' ' 22' ' ' VAL . . . -140.5 -147.57 4.99 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.589 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.24 119.16 36.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.889 0.376 . . . . 0.0 111.614 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.632 HG22 ' HA ' ' B' ' 21' ' ' THR . 14.5 p -57.04 145.04 31.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.263 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.807 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.2 OUTLIER -112.58 154.42 26.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.693 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 3.7 ttp -128.91 100.35 5.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.849 0.356 . . . . 0.0 110.723 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.504 HD11 HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -114.66 138.77 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.981 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.407 ' HA2' HG11 ' A' ' 40' ' ' VAL . . . 123.83 -106.18 0.95 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.16 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.583 ' OD2' HG22 ' B' ' 40' ' ' VAL . 1.4 p30 -158.6 7.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.6 OUTLIER 161.77 58.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.018 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.782 HG12 ' HD2' ' B' ' 37' ' ' PRO . 10.6 m -114.31 -157.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.968 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 173.21 104.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.981 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.807 ' HB ' HD23 ' B' ' 12' ' ' LEU . 24.7 t -102.65 101.71 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.898 0.38 . . . . 0.0 110.807 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.632 ' HA ' HG22 ' B' ' 11' ' ' THR . 9.9 t -95.36 157.41 15.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.609 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.426 HG21 ' H ' ' B' ' 9' ' ' GLY . 6.4 m -107.81 -172.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.304 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.428 ' HA ' HD22 ' B' ' 23' ' ' LEU . 1.2 tm? -124.09 -52.19 1.76 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.83 0.347 . . . . 0.0 110.411 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.653 ' HA2' HG23 ' B' ' 8' ' ' VAL . . . 91.92 -43.41 2.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.989 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' B' ' 26' ' ' LYS . 4.0 t -85.77 149.94 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.492 0.187 . . . . 0.0 111.36 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' B' ' 25' ' ' VAL . 28.1 tttp 99.0 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.067 0.547 . . . . 0.0 110.799 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.78 -179.53 37.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.763 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 63.64 -86.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -86.46 136.71 33.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.793 HG12 HD11 ' B' ' 32' ' ' ILE . 4.1 t -93.19 114.1 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.351 . . . . 0.0 110.896 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.563 ' HD2' HD11 ' A' ' 3' ' ' ILE . 8.9 mmt180 -89.29 99.86 12.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.865 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.793 HD11 HG12 ' B' ' 30' ' ' VAL . 24.0 mm -109.49 141.22 25.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.031 0.443 . . . . 0.0 111.719 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.85 107.53 2.58 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.979 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.584 HG13 HG22 ' B' ' 20' ' ' VAL . 21.4 t -97.85 103.43 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.926 0.393 . . . . 0.0 111.103 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.968 ' HB3' HG23 ' B' ' 19' ' ' THR . 1.2 t-20 -90.59 107.28 19.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.831 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.73 140.1 37.63 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.243 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.782 ' HD2' HG12 ' B' ' 18' ' ' VAL . 86.0 Cg_endo -77.78 156.16 31.13 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.673 2.249 . . . . 0.0 112.268 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -80.31 0.23 33.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.428 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -78.07 -39.7 40.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.703 0.287 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.583 HG22 ' OD2' ' B' ' 16' ' ' ASP . 5.5 t -87.89 140.9 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.89 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -62.37 102.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.394 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.489 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.3 p -122.2 120.67 61.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.726 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -128.29 136.47 51.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.795 0.331 . . . . 0.0 111.147 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.402 ' NH1' ' HB2' ' A' ' 2' ' ' LEU . 63.7 mtt180 -139.62 -50.65 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.409 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 1.3 tp10 -178.3 141.34 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.543 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.51 -45.78 84.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.188 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.99 -38.52 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.651 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.421 ' HB2' ' HB3' ' B' ' 45' ' ' GLU . 4.1 m-85 -51.54 -50.15 60.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.75 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -85.92 -52.86 5.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.409 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 0.2 OUTLIER -58.09 -16.21 12.24 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.011 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 17.1 mm -115.91 -57.88 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.413 ' CB ' ' O ' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -66.45 -48.06 71.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.09 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.84 -28.28 26.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 111.341 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' B' ' 55' ' ' LYS . 7.1 mt-10 -120.33 137.32 54.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.228 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' B' ' 54' ' ' GLU . 3.2 mtmp? . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.931 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.909 0.385 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.734 ' HG ' ' HB2' ' B' ' 53' ' ' ALA . 1.7 mp -116.46 105.46 12.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.7 tt -84.8 108.99 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.673 HD13 ' NE ' ' B' ' 44' ' ' ARG . 1.9 tp -112.98 156.64 22.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.257 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.563 HG21 ' OE1' ' B' ' 29' ' ' GLN . 0.3 OUTLIER -90.96 124.24 35.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.868 0.366 . . . . 0.0 111.021 179.786 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.498 ' HB2' ' CG1' ' B' ' 32' ' ' ILE . 0.0 OUTLIER -93.22 148.42 22.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.237 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.716 ' HD3' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER 83.34 90.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.401 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.518 HG23 ' C ' ' A' ' 7' ' ' ARG . 6.3 t 84.25 62.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.58 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.68 -146.9 4.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.383 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.409 ' HB2' ' CZ ' ' B' ' 48' ' ' TYR . 3.8 tp10 -113.26 118.17 33.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.845 0.355 . . . . 0.0 111.442 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 21' ' ' THR . 19.2 p -51.93 150.26 4.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.963 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.746 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -110.88 154.5 23.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.846 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.661 ' HG2' HG22 ' A' ' 18' ' ' VAL . 6.7 ttm -127.26 100.36 6.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.995 0.426 . . . . 0.0 110.906 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.488 ' H ' HG21 ' A' ' 18' ' ' VAL . 3.8 tp -111.93 129.35 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.441 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 127.76 -102.76 0.61 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.165 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 5.4 p30 -166.24 8.41 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 31.6 tp10 167.29 57.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.661 HG22 ' HG2' ' A' ' 13' ' ' MET . 5.8 m -114.98 -157.93 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.7 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 172.49 99.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.746 ' HB ' HD23 ' A' ' 12' ' ' LEU . 20.9 t -102.96 103.08 14.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.812 0.339 . . . . 0.0 111.77 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.678 ' HA ' HG22 ' A' ' 11' ' ' THR . 44.4 m -87.22 146.84 25.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.242 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.825 ' HA ' HG23 ' A' ' 32' ' ' ILE . 30.5 m -109.75 76.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -99.88 -151.11 0.39 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.307 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 31' ' ' ARG . . . 56.52 73.6 0.42 Allowed Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.098 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.716 HG13 ' HD3' ' A' ' 7' ' ' ARG . 24.7 t -85.92 107.33 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.011 0.434 . . . . 0.0 111.627 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.58 ' H ' HG12 ' A' ' 30' ' ' VAL . 1.1 mttt -137.21 142.82 42.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.906 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.53 -44.11 28.81 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.434 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -104.53 -86.25 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.939 0.369 . . . . 0.0 111.452 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.558 ' OE1' HG21 ' B' ' 5' ' ' THR . 5.7 mt-30 -84.85 116.15 23.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.759 0.314 . . . . 0.0 111.172 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 26' ' ' LYS . 31.0 m -93.81 136.51 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.189 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.531 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 4.9 mtt-85 -87.92 99.25 12.0 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.025 0.44 . . . . 0.0 110.1 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.825 HG23 ' HA ' ' A' ' 22' ' ' VAL . 27.3 mm -92.87 141.81 14.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.235 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.08 108.75 3.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.689 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.486 ' HA ' HG13 ' A' ' 20' ' ' VAL . 27.1 t -99.35 103.49 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.803 0.335 . . . . 0.0 111.049 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 19' ' ' THR . 3.8 t30 -90.78 107.22 19.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.186 0.517 . . . . 0.0 110.62 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.43 141.32 38.57 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.247 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.641 ' CD ' HG12 ' A' ' 18' ' ' VAL . 86.0 Cg_endo -77.99 156.19 30.38 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.615 2.21 . . . . 0.0 112.272 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -83.26 3.78 29.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.498 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -86.01 -36.87 19.5 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.695 0.283 . . . . 0.0 111.099 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.44 HG12 ' O ' ' B' ' 15' ' ' GLY . 11.1 t -90.8 141.35 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.042 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -59.03 105.68 0.35 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.218 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.9 p -122.24 122.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.007 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.14 136.23 50.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.654 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.677 ' NE ' HD13 ' B' ' 4' ' ' LEU . 0.0 OUTLIER -154.47 59.43 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 0.0 110.778 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.07 136.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -65.39 -41.85 93.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.834 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.7 mm -67.32 -54.43 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.129 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.586 ' CD1' HD11 ' B' ' 4' ' ' LEU . 8.0 m-85 -47.19 -43.37 21.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.478 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.603 ' HG2' HD21 ' B' ' 2' ' ' LEU . 0.3 OUTLIER -78.29 -55.01 5.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.353 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 84.8 mmt-85 -56.93 -12.84 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.85 -57.3 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.715 0.293 . . . . 0.0 111.237 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.447 ' OE1' HD12 ' B' ' 4' ' ' LEU . 32.6 mt-30 -72.75 -57.99 3.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.892 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.725 ' HB2' ' HG ' ' B' ' 2' ' ' LEU . . . -67.29 -34.69 77.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 0.0 110.844 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 1.6 mt-10 -120.47 129.19 53.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.648 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? . . . . . 0 N--CA 1.453 -0.305 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.723 -179.345 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.871 0.367 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.725 ' HG ' ' HB2' ' A' ' 53' ' ' ALA . 1.7 mp -116.47 105.5 12.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.76 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.599 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.7 tt -84.76 108.99 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.266 0.555 . . . . 0.0 111.143 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.677 HD13 ' NE ' ' A' ' 44' ' ' ARG . 2.0 tp -113.03 156.65 22.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.178 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.558 HG21 ' OE1' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -90.92 124.25 35.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.849 0.357 . . . . 0.0 111.028 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.497 ' HB2' ' CG1' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -93.21 148.34 22.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.243 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.727 ' HD3' HG13 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 83.32 90.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.402 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.523 HG23 ' C ' ' B' ' 7' ' ' ARG . 6.4 t 84.32 62.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.554 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.74 -146.96 4.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.394 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 3.8 tp10 -113.22 118.14 33.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 111.44 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.667 HG22 ' HA ' ' B' ' 21' ' ' THR . 19.2 p -51.92 150.22 4.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.736 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.2 OUTLIER -110.81 154.43 23.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.889 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.68 ' HG2' HG22 ' B' ' 18' ' ' VAL . 6.8 ttm -127.27 100.37 6.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.971 0.415 . . . . 0.0 110.872 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.486 ' H ' HG21 ' B' ' 18' ' ' VAL . 3.8 tp -111.9 129.32 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.44 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 127.78 -102.76 0.61 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.17 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 5.5 p30 -166.26 8.59 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.579 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 31.6 tp10 167.18 57.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.68 HG22 ' HG2' ' B' ' 13' ' ' MET . 5.8 m -114.96 -157.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.729 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.648 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 172.48 99.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.736 ' HB ' HD23 ' B' ' 12' ' ' LEU . 21.0 t -102.94 103.04 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.791 0.329 . . . . 0.0 111.838 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.667 ' HA ' HG22 ' B' ' 11' ' ' THR . 45.0 m -87.22 146.89 25.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.232 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.809 ' HA ' HG23 ' B' ' 32' ' ' ILE . 30.3 m -109.76 77.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.421 HD12 ' N ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -100.0 -151.09 0.39 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.28 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' B' ' 31' ' ' ARG . . . 56.56 73.56 0.43 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.112 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.727 HG13 ' HD3' ' B' ' 7' ' ' ARG . 24.5 t -85.9 107.39 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.01 0.433 . . . . 0.0 111.607 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.591 ' H ' HG12 ' B' ' 30' ' ' VAL . 1.1 mttt -137.25 142.86 42.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.838 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.56 -44.14 29.02 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.42 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -104.53 -86.22 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.956 0.378 . . . . 0.0 111.478 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.563 ' OE1' HG21 ' A' ' 5' ' ' THR . 5.6 mt-30 -84.92 116.1 23.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.789 0.328 . . . . 0.0 111.204 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.591 HG12 ' H ' ' B' ' 26' ' ' LYS . 30.9 m -93.69 136.61 24.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.533 ' O ' ' HA3' ' B' ' 24' ' ' GLY . 4.9 mtt-85 -88.04 99.25 12.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.809 HG23 ' HA ' ' B' ' 22' ' ' VAL . 27.4 mm -92.81 141.74 14.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.24 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.06 108.74 3.01 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.719 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.474 ' HA ' HG13 ' B' ' 20' ' ' VAL . 27.0 t -99.33 103.5 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.843 0.354 . . . . 0.0 111.086 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' B' ' 19' ' ' THR . 3.8 t30 -90.78 107.24 19.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 110.597 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.5 141.29 38.57 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.288 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.638 ' CD ' HG12 ' B' ' 18' ' ' VAL . 84.7 Cg_endo -77.92 156.13 30.61 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.663 2.242 . . . . 0.0 112.221 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -83.19 3.75 29.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.524 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -85.98 -36.93 19.49 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.696 0.284 . . . . 0.0 111.091 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 15' ' ' GLY . 11.0 t -90.65 141.29 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 111.055 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -59.06 105.69 0.35 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.184 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.466 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.9 p -122.28 122.55 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.11 136.25 50.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.734 0.302 . . . . 0.0 110.627 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.673 ' NE ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -154.54 59.42 0.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.744 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.11 136.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -65.4 -41.86 93.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 36.4 mm -67.32 -54.48 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.581 ' CD1' HD11 ' A' ' 4' ' ' LEU . 8.2 m-85 -47.15 -43.31 20.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.537 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.596 ' HG2' HD21 ' A' ' 2' ' ' LEU . 0.3 OUTLIER -78.36 -54.98 5.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.331 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.42 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 84.8 mmt-85 -56.97 -12.94 2.29 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.73 -57.33 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.676 0.274 . . . . 0.0 111.25 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.439 ' OE1' HD12 ' A' ' 4' ' ' LEU . 32.5 mt-30 -72.72 -57.88 3.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.734 ' HB2' ' HG ' ' A' ' 2' ' ' LEU . . . -67.41 -34.51 77.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.978 0.418 . . . . 0.0 110.847 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 1.6 mt-10 -121.77 133.58 54.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.795 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.626 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.793 0.33 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.75 HD12 ' HB2' ' B' ' 53' ' ' ALA . 9.6 tt -118.86 110.72 17.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.3 tt -96.86 105.36 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.143 0.497 . . . . 0.0 110.829 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.8 124.31 41.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.15 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -60.13 141.82 55.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.618 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -145.36 145.38 31.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.209 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.618 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 8.7 tmm_? 165.33 -10.86 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.224 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 8' ' ' VAL . 17.6 t -149.38 1.31 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.93 -156.54 31.64 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.009 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.27 -163.91 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.764 0.316 . . . . 0.0 111.048 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.731 HG22 ' HA ' ' A' ' 21' ' ' THR . 17.6 p -107.53 163.14 13.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.746 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -112.24 154.68 25.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.264 179.574 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.63 100.16 5.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 111.251 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.517 HG23 HG23 ' B' ' 14' ' ' ILE . 6.9 tp -112.6 138.9 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.459 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.419 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 118.64 -104.54 1.11 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.3 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 4.2 t0 -153.51 1.0 0.25 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 3.2 mt-10 163.74 61.29 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.408 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.756 HG12 ' CD ' ' A' ' 37' ' ' PRO . 10.3 m -116.4 -157.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.308 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.953 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 174.53 106.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.746 ' HB ' HD23 ' A' ' 12' ' ' LEU . 13.2 t -102.87 106.09 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.93 0.395 . . . . 0.0 111.676 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.731 ' HA ' HG22 ' A' ' 11' ' ' THR . 25.1 m -87.79 106.23 17.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.347 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.477 HG21 ' HG2' ' A' ' 6' ' ' ARG . 11.1 m -80.79 57.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.731 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.525 HD12 ' H ' ' A' ' 24' ' ' GLY . 32.0 tp -116.23 148.8 40.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.132 0.491 . . . . 0.0 110.692 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.525 ' H ' HD12 ' A' ' 23' ' ' LEU . . . 128.99 65.0 0.11 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.4 HG22 ' HG2' ' A' ' 7' ' ' ARG . 2.5 t -85.36 107.78 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 121.168 0.509 . . . . 0.0 112.241 -177.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.69 143.36 45.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.601 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.2 145.28 22.39 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.863 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.85 -82.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.636 0.255 . . . . 0.0 111.234 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -96.22 126.59 41.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.798 0.332 . . . . 0.0 111.091 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.765 HG21 HG21 ' B' ' 30' ' ' VAL . 26.3 t -93.58 134.35 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.07 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 6.4 mtm-85 -84.27 105.08 14.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' B' ' 6' ' ' ARG . 17.7 mm -91.89 133.91 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.331 . . . . 0.0 111.171 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.81 115.05 4.97 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.728 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.475 ' HA ' HG13 ' A' ' 20' ' ' VAL . 19.9 t -115.64 103.54 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.001 0.429 . . . . 0.0 111.814 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.953 ' HB3' HG23 ' A' ' 19' ' ' THR . 4.9 t-20 -97.44 107.44 19.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.219 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.71 150.07 72.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.783 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.756 ' CD ' HG12 ' A' ' 18' ' ' VAL . 87.5 Cg_endo -83.74 156.48 13.8 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.081 2.521 . . . . 0.0 112.188 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 19.91 4.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.298 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.76 -38.81 5.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.662 0.267 . . . . 0.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.421 HG12 ' O ' ' B' ' 15' ' ' GLY . 11.6 t -80.52 146.24 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.862 0.363 . . . . 0.0 110.947 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.65 106.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.115 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.3 p -122.1 122.19 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.58 136.04 50.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.433 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -172.5 -69.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -164.49 121.29 1.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -65.38 -28.46 69.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.68 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.599 HG22 HD12 ' A' ' 51' ' ' ILE . 29.5 mm -70.95 -53.24 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.225 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -53.42 -42.55 67.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.405 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -78.12 -50.83 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.684 0.278 . . . . 0.0 111.51 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -61.03 -13.26 15.36 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.599 HD12 HG22 ' A' ' 47' ' ' ILE . 55.4 mt -112.39 -52.89 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.322 . . . . 0.0 111.151 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HG3' HD23 ' B' ' 4' ' ' LEU . 0.6 OUTLIER -69.13 -57.54 5.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.081 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.74 ' HB2' HD12 ' B' ' 2' ' ' LEU . . . -79.31 -32.3 43.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 111.253 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.13 125.57 52.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? . . . . . 0 N--CA 1.451 -0.409 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.612 -179.52 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.795 0.331 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.74 HD12 ' HB2' ' A' ' 53' ' ' ALA . 9.6 tt -118.93 110.73 17.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.616 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.3 tt -96.91 105.39 17.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.136 0.494 . . . . 0.0 110.798 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' B' ' 4' ' ' LEU . 0.2 OUTLIER -124.83 124.39 41.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.113 179.637 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -60.16 141.82 55.3 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.136 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.613 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -145.33 145.46 31.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.858 0.361 . . . . 0.0 111.156 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.613 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 8.7 tmm_? 165.31 -10.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.219 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.562 ' O ' HG12 ' B' ' 8' ' ' VAL . 17.7 t -149.3 1.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.97 -156.47 31.59 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.982 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.32 -164.0 1.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.332 . . . . 0.0 111.057 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.746 HG22 ' HA ' ' B' ' 21' ' ' THR . 17.6 p -107.47 163.18 13.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.2 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.771 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.1 OUTLIER -112.3 154.68 25.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.232 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -128.67 100.09 5.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 111.26 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.517 HG23 HG23 ' A' ' 14' ' ' ILE . 6.9 tp -112.55 138.89 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.536 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.421 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 118.65 -104.47 1.1 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.324 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 4.2 t0 -153.55 0.95 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.424 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 3.2 mt-10 163.73 61.27 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.966 0.413 . . . . 0.0 110.39 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.759 HG12 ' CD ' ' B' ' 37' ' ' PRO . 10.2 m -116.44 -157.08 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.327 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.935 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 174.53 106.43 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.771 ' HB ' HD23 ' B' ' 12' ' ' LEU . 13.2 t -102.92 106.13 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.978 0.418 . . . . 0.0 111.632 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.746 ' HA ' HG22 ' B' ' 11' ' ' THR . 25.1 m -87.81 106.25 17.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.361 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.477 HG21 ' HG2' ' B' ' 6' ' ' ARG . 11.0 m -80.83 57.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.696 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.517 HD12 ' H ' ' B' ' 24' ' ' GLY . 32.2 tp -116.34 148.84 40.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.157 0.503 . . . . 0.0 110.659 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.517 ' H ' HD12 ' B' ' 23' ' ' LEU . . . 129.01 64.99 0.11 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.37 107.83 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.225 0.536 . . . . 0.0 112.215 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.78 143.29 45.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.595 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.11 145.21 22.16 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.986 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.92 -82.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.636 0.255 . . . . 0.0 111.196 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -96.3 126.62 41.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.842 0.353 . . . . 0.0 111.028 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.765 HG21 HG21 ' A' ' 30' ' ' VAL . 26.3 t -93.53 134.38 31.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 6.4 mtm-85 -84.27 105.08 14.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.761 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.466 HG13 ' HB2' ' A' ' 6' ' ' ARG . 17.8 mm -91.97 134.03 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.349 . . . . 0.0 111.119 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.9 115.0 4.94 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.707 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.467 ' HA ' HG13 ' B' ' 20' ' ' VAL . 19.8 t -115.61 103.55 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 111.851 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.935 ' HB3' HG23 ' B' ' 19' ' ' THR . 4.9 t-20 -97.39 107.42 19.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.244 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.75 150.06 72.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.79 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.759 ' CD ' HG12 ' B' ' 18' ' ' VAL . 87.0 Cg_endo -83.71 156.38 13.83 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.063 2.509 . . . . 0.0 112.229 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 19.93 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.346 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.77 -38.75 5.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.714 0.293 . . . . 0.0 111.125 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 15' ' ' GLY . 11.6 t -80.53 146.21 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.981 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.54 106.31 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.196 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.461 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.2 p -122.15 122.24 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.811 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.6 136.12 50.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.368 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -172.64 -69.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 0.0 110.797 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 21.3 tp10 -164.49 121.24 1.59 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -65.32 -28.47 69.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.671 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.601 HG22 HD12 ' B' ' 51' ' ' ILE . 29.4 mm -70.92 -53.31 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' B' ' 45' ' ' GLU . 6.7 m-85 -53.32 -42.59 66.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.491 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -78.16 -50.82 11.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.527 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -61.02 -13.26 15.21 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.601 HD12 HG22 ' B' ' 47' ' ' ILE . 55.4 mt -112.38 -52.98 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.0 111.104 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.09 -57.58 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.105 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.75 ' HB2' HD12 ' A' ' 2' ' ' LEU . . . -79.26 -32.15 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.283 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -110.15 128.2 55.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.725 179.855 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.853 0.359 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.787 HD21 HD23 ' A' ' 4' ' ' LEU . 5.5 tt -116.3 114.09 23.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 mm -92.08 105.58 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.108 0.48 . . . . 0.0 110.625 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.933 HD11 ' CE1' ' B' ' 48' ' ' TYR . 0.2 OUTLIER -119.32 156.75 29.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.589 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.679 ' H ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -95.25 129.03 42.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.24 179.1 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.653 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 15.9 mtt180 -142.35 146.85 35.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.689 ' O ' HG22 ' A' ' 25' ' ' VAL . 1.1 ttm180 165.33 -6.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.75 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.89 -62.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.808 0.337 . . . . 0.0 110.982 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.75 61.92 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.724 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -72.95 -69.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 110.625 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 m 71.75 101.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.483 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.506 HD13 HH22 ' A' ' 6' ' ' ARG . 1.1 pt? -111.26 154.77 23.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.075 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -127.61 100.06 5.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.016 0.436 . . . . 0.0 111.179 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.779 HD11 HG11 ' B' ' 18' ' ' VAL . 0.0 OUTLIER -113.77 134.27 57.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.25 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.446 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 123.89 -104.91 0.86 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.061 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -150.19 1.6 0.48 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.3 mt-10 159.09 67.04 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.133 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.766 HG11 HD11 ' B' ' 14' ' ' ILE . 9.9 m -119.53 -155.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.723 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER 172.94 102.15 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.704 HG22 HG13 ' A' ' 34' ' ' VAL . 38.3 t -113.35 110.79 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -107.3 107.83 18.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.15 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.778 HG12 ' CG2' ' A' ' 32' ' ' ILE . 29.9 m -80.28 74.87 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.062 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.478 HD12 ' H ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -63.72 -156.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' H ' HD12 ' A' ' 23' ' ' LEU . . . 83.06 71.9 1.3 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.92 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 7' ' ' ARG . 10.7 t -86.19 107.68 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.083 0.468 . . . . 0.0 111.938 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.53 165.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -170.63 13.46 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.298 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.9 -28.57 14.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.882 0.372 . . . . 0.0 110.554 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -121.1 136.68 54.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.565 HG12 HD13 ' A' ' 32' ' ' ILE . 4.0 t -93.31 115.31 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.373 . . . . 0.0 111.553 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.51 98.84 7.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.874 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.778 ' CG2' HG12 ' A' ' 22' ' ' VAL . 4.6 mm -94.03 125.28 46.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.426 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.44 103.6 1.98 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.978 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.704 HG13 HG22 ' A' ' 20' ' ' VAL . 17.7 t -98.27 103.66 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.941 0.4 . . . . 0.0 111.893 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -92.63 107.46 19.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.077 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.8 147.71 55.38 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.017 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.655 ' HD2' HG12 ' A' ' 18' ' ' VAL . 88.4 Cg_endo -79.66 156.55 24.57 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.966 2.444 . . . . 0.0 111.99 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -90.63 29.74 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.38 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.44 -40.32 5.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.669 0.271 . . . . 0.0 111.147 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.71 149.08 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.93 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.77 97.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.094 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 42' ' ' VAL . 7.5 p -122.49 121.48 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.948 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.96 136.15 50.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.725 0.298 . . . . 0.0 110.404 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' B' ' 12' ' ' LEU . 0.0 OUTLIER -149.54 -62.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.719 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.418 ' OE2' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -171.47 133.49 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -65.36 -36.32 83.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.088 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 48' ' ' TYR . 1.7 tp -74.28 -47.9 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.583 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.931 ' CE1' HD11 ' B' ' 4' ' ' LEU . 2.0 m-85 -55.84 -38.14 69.65 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -64.62 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -55.33 -15.86 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.627 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.9 mm -103.61 -56.55 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.653 0.263 . . . . 0.0 111.564 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.495 ' OE1' HD22 ' B' ' 4' ' ' LEU . 2.5 mm-40 -77.0 -56.97 4.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.678 0.275 . . . . 0.0 111.228 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.771 ' HB2' ' CD1' ' B' ' 2' ' ' LEU . . . -70.48 -25.27 63.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.297 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 16.0 tt0 -131.6 146.75 52.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.916 0.388 . . . . 0.0 111.203 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 18.4 mtpt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.734 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.774 0.321 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.788 HD21 HD23 ' B' ' 4' ' ' LEU . 5.5 tt -116.43 114.12 23.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 mm -92.06 105.53 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.052 0.453 . . . . 0.0 110.623 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.931 HD11 ' CE1' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -119.25 156.8 29.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.645 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.677 ' H ' HD13 ' B' ' 4' ' ' LEU . 0.0 OUTLIER -95.33 129.1 42.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.231 179.128 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.645 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 16.0 mtt180 -142.39 146.85 35.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.691 ' O ' HG22 ' B' ' 25' ' ' VAL . 1.1 ttm180 165.29 -6.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.725 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.96 -62.9 2.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.782 0.325 . . . . 0.0 111.009 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.76 61.98 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.726 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -72.96 -69.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.612 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 5.7 m 71.75 101.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.551 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.513 HD13 HH22 ' B' ' 6' ' ' ARG . 1.1 pt? -111.11 154.74 23.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.154 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -127.64 100.11 5.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.062 0.458 . . . . 0.0 111.172 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.766 HD11 HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -113.75 134.27 57.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.228 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.443 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 123.84 -104.88 0.86 Allowed Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.099 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 0.8 OUTLIER -150.2 1.59 0.47 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.3 mt-10 159.1 67.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.874 0.368 . . . . 0.0 110.175 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.779 HG11 HD11 ' A' ' 14' ' ' ILE . 10.0 m -119.53 -155.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 120.839 0.352 . . . . 0.0 111.703 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.653 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.1 OUTLIER 172.92 102.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.711 HG22 HG13 ' B' ' 34' ' ' VAL . 38.4 t -113.37 110.86 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -107.34 107.79 18.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.23 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.764 HG12 ' CG2' ' B' ' 32' ' ' ILE . 30.5 m -80.24 74.98 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.019 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.486 HD12 ' H ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -63.8 -156.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.731 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.486 ' H ' HD12 ' B' ' 23' ' ' LEU . . . 83.13 71.87 1.3 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.921 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.691 HG22 ' O ' ' B' ' 7' ' ' ARG . 10.7 t -86.22 107.66 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.083 0.468 . . . . 0.0 111.948 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.6 165.22 0.29 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.804 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.64 -170.64 13.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.324 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.88 -28.49 14.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.91 0.386 . . . . 0.0 110.579 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -121.19 136.7 54.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.97 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.556 HG12 HD13 ' B' ' 32' ' ' ILE . 4.0 t -93.35 115.37 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.948 0.404 . . . . 0.0 111.535 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.57 98.81 7.79 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.861 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.764 ' CG2' HG12 ' B' ' 22' ' ' VAL . 4.6 mm -93.98 125.28 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.417 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.51 103.56 1.97 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.964 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.711 HG13 HG22 ' B' ' 20' ' ' VAL . 17.5 t -98.15 103.63 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.937 0.399 . . . . 0.0 111.945 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -92.7 107.54 19.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.034 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.82 147.65 55.11 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.016 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.668 ' HD2' HG12 ' B' ' 18' ' ' VAL . 88.8 Cg_endo -79.69 156.59 24.5 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.982 2.454 . . . . 0.0 112.0 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -90.71 29.81 1.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.328 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.43 -40.31 5.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.711 0.291 . . . . 0.0 111.159 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.0 t -81.7 149.1 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.78 97.8 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.076 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.457 HG13 ' O ' ' B' ' 42' ' ' VAL . 7.4 p -122.56 121.46 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.91 136.15 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.676 0.274 . . . . 0.0 110.433 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.462 ' HG2' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -149.6 -62.72 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.952 0.406 . . . . 0.0 110.724 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.417 ' OE2' HG22 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -171.46 133.47 0.81 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.463 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.7 OUTLIER -65.28 -36.34 83.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.52 HG23 ' N ' ' B' ' 48' ' ' TYR . 1.7 tp -74.31 -47.89 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.562 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.933 ' CE1' HD11 ' A' ' 4' ' ' LEU . 2.0 m-85 -55.66 -38.3 69.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -64.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' B' ' 46' ' ' GLU . 0.0 OUTLIER -55.28 -15.79 2.77 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.642 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 39.9 mm -103.65 -56.44 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.604 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.497 ' OE1' HD22 ' A' ' 4' ' ' LEU . 2.5 mm-40 -77.17 -56.86 4.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.758 0.313 . . . . 0.0 111.233 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.773 ' HB2' ' CD1' ' A' ' 2' ' ' LEU . . . -70.55 -25.17 62.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.203 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -132.32 146.05 51.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 0.0 111.179 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 mttm . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.337 179.454 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.888 0.375 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.783 HD13 ' HB2' ' B' ' 53' ' ' ALA . 7.8 tp -121.21 112.37 18.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.7 tt -99.79 105.74 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.222 0.535 . . . . 0.0 110.795 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.568 HD22 ' HG3' ' B' ' 52' ' ' GLN . 1.9 mm? -124.41 120.71 32.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.752 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -55.45 141.63 35.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.738 0.304 . . . . 0.0 110.806 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.739 ' HB2' HG21 ' A' ' 22' ' ' VAL . 5.3 mtt180 -150.95 143.94 24.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.058 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.716 ' HD2' HG13 ' A' ' 25' ' ' VAL . 5.7 ttp180 169.7 -4.17 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.756 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.44 -71.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.68 0.276 . . . . 0.0 111.199 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.88 90.48 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.697 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.637 ' O ' HG23 ' A' ' 11' ' ' THR . 57.9 mm-40 -110.15 -174.39 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.637 0.256 . . . . 0.0 110.56 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER 170.82 101.28 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 111.041 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.474 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 1.2 pt? -115.31 154.1 29.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.397 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.407 ' HG2' HG22 ' A' ' 18' ' ' VAL . 2.1 ttm -129.53 100.7 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.096 0.474 . . . . 0.0 111.092 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.86 HG23 HG23 ' B' ' 14' ' ' ILE . 2.4 tp -114.73 123.29 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.531 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.54 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 133.23 -107.18 0.67 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.116 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -148.47 5.09 0.71 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 1.7 tt0 154.61 72.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.893 0.477 . . . . 0.0 109.969 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.592 HG11 ' CG1' ' B' ' 14' ' ' ILE . 9.1 m -122.31 -152.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.35 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.898 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 169.41 103.69 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' A' ' 34' ' ' VAL . 31.3 t -116.43 113.79 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.96 0.41 . . . . 0.0 111.858 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 t -110.88 112.9 25.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.33 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.923 HG12 HG23 ' A' ' 32' ' ' ILE . 26.9 m -80.81 75.55 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.802 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.61 -138.02 0.1 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.531 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 31' ' ' ARG . . . 53.02 77.33 0.15 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.466 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.716 HG13 ' HD2' ' A' ' 7' ' ' ARG . 36.2 t -85.84 107.91 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 111.709 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.789 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -130.74 141.11 50.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.691 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.39 -50.39 5.58 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.57 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -101.57 -83.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.863 0.332 . . . . 0.0 111.262 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.438 ' HB3' HG22 ' B' ' 5' ' ' THR . 14.0 mp0 -87.18 118.99 26.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.0 111.126 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.789 HG12 ' H ' ' A' ' 26' ' ' LYS . 15.4 m -93.33 136.34 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.186 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.613 ' HB3' HD11 ' B' ' 3' ' ' ILE . 5.0 mtm180 -78.13 106.44 10.01 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.483 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.923 HG23 HG12 ' A' ' 22' ' ' VAL . 32.5 mm -87.35 135.46 25.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.597 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.35 120.71 6.41 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.355 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.751 ' HA ' HG13 ' A' ' 20' ' ' VAL . 17.4 t -116.08 103.61 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.41 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.898 ' HB3' HG23 ' A' ' 19' ' ' THR . 0.1 OUTLIER -98.08 107.67 20.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.571 179.641 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.35 142.36 26.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.503 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.486 ' HD2' HG12 ' A' ' 18' ' ' VAL . 95.0 Cg_endo -79.29 156.35 25.67 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.724 2.283 . . . . 0.0 112.164 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.52 3.39 21.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.55 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -78.59 -41.91 30.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.71 0.291 . . . . 0.0 111.17 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.534 HG12 ' O ' ' B' ' 15' ' ' GLY . 6.3 t -87.3 152.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.929 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 m -66.55 100.26 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.892 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.588 ' HB ' HD13 ' B' ' 14' ' ' ILE . 13.4 p -122.15 120.67 61.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.239 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.31 136.12 50.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.542 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.426 ' NH2' HG21 ' A' ' 42' ' ' VAL . 32.4 mtt85 -141.09 -64.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 0.0 110.805 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -168.88 136.15 1.9 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.748 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -55.0 -53.57 54.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.493 ' HA ' HD13 ' A' ' 51' ' ' ILE . 12.8 tt -65.08 -41.99 93.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.459 ' CG ' ' HB2' ' A' ' 45' ' ' GLU . 3.5 m-85 -45.46 -48.31 13.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.578 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -89.0 -49.33 6.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.463 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.637 ' C ' HD12 ' A' ' 51' ' ' ILE . 7.8 mtp180 -53.59 -17.37 2.07 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.637 HD12 ' C ' ' A' ' 50' ' ' ARG . 1.3 mp -111.52 -51.12 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.699 0.285 . . . . 0.0 111.013 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.565 ' HG3' HD22 ' B' ' 4' ' ' LEU . 0.5 OUTLIER -73.18 -60.36 2.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.937 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.777 ' HB2' HD13 ' B' ' 2' ' ' LEU . . . -69.08 -36.61 77.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.895 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 2.4 mt-10 -114.31 123.8 50.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.289 -179.91 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.834 0.35 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.777 HD13 ' HB2' ' A' ' 53' ' ' ALA . 7.7 tp -121.18 112.31 18.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.624 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.7 tt -99.77 105.73 17.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.146 0.498 . . . . 0.0 110.85 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.565 HD22 ' HG3' ' A' ' 52' ' ' GLN . 1.9 mm? -124.36 120.68 32.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.769 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -55.43 141.57 35.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.323 . . . . 0.0 110.735 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.744 ' HB2' HG21 ' B' ' 22' ' ' VAL . 5.3 mtt180 -150.95 143.95 24.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.707 ' HD2' HG13 ' B' ' 25' ' ' VAL . 5.7 ttp180 169.71 -4.13 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.758 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.45 -71.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.672 0.273 . . . . 0.0 111.171 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.88 90.4 0.13 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.703 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.625 ' O ' HG23 ' B' ' 11' ' ' THR . 58.0 mm-40 -110.09 -174.36 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.636 0.255 . . . . 0.0 110.591 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.625 HG23 ' O ' ' B' ' 10' ' ' GLU . 0.1 OUTLIER 170.79 101.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.082 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.469 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 1.2 pt? -115.33 154.08 29.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.427 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.413 ' HG2' HG22 ' B' ' 18' ' ' VAL . 2.1 ttm -129.46 100.73 5.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.057 0.456 . . . . 0.0 111.076 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.86 HG23 HG23 ' A' ' 14' ' ' ILE . 2.4 tp -114.83 123.31 70.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.493 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.534 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 133.2 -107.17 0.67 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.159 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.1 OUTLIER -148.4 5.09 0.71 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 1.7 tt0 154.65 72.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.895 0.478 . . . . 0.0 110.026 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.579 HG11 ' CG1' ' A' ' 14' ' ' ILE . 9.3 m -122.32 -152.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.305 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.925 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 169.45 103.74 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' B' ' 34' ' ' VAL . 31.9 t -116.47 113.82 44.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.931 0.396 . . . . 0.0 111.798 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.0 t -110.93 112.87 25.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.303 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.926 HG12 HG23 ' B' ' 32' ' ' ILE . 27.0 m -80.72 75.48 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.84 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.55 -138.03 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.565 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' B' ' 31' ' ' ARG . . . 52.96 77.35 0.14 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.481 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.707 HG13 ' HD2' ' B' ' 7' ' ' ARG . 37.2 t -85.9 107.9 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.037 0.446 . . . . 0.0 111.674 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.778 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.1 OUTLIER -130.64 141.09 50.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.657 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.43 -50.37 5.62 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.267 -0.492 . . . . 0.0 113.587 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -101.61 -83.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.813 0.306 . . . . 0.0 111.235 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.448 ' HB3' HG22 ' A' ' 5' ' ' THR . 14.0 mp0 -87.22 118.99 27.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.915 0.388 . . . . 0.0 111.121 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.778 HG12 ' H ' ' B' ' 26' ' ' LYS . 15.4 m -93.32 136.38 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.145 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.598 ' HB3' HD11 ' A' ' 3' ' ' ILE . 5.0 mtm180 -78.14 106.42 10.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.532 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.926 HG23 HG12 ' B' ' 22' ' ' VAL . 32.6 mm -87.33 135.4 25.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.002 0.429 . . . . 0.0 111.545 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.29 120.66 6.4 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.374 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.751 ' HA ' HG13 ' B' ' 20' ' ' VAL . 17.4 t -116.04 103.67 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 0.0 111.429 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.925 ' HB3' HG23 ' B' ' 19' ' ' THR . 0.1 OUTLIER -98.15 107.69 20.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.544 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.36 142.33 26.31 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.533 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.496 ' HD2' HG12 ' B' ' 18' ' ' VAL . 94.6 Cg_endo -79.28 156.33 25.69 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.73 2.287 . . . . 0.0 112.195 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.51 3.45 21.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.537 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -78.69 -41.88 29.92 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.683 0.278 . . . . 0.0 111.129 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 15' ' ' GLY . 6.3 t -87.26 152.07 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.987 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -66.62 100.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.585 ' HB ' HD13 ' A' ' 14' ' ' ILE . 13.3 p -122.16 120.66 61.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.233 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.35 136.06 50.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.74 0.305 . . . . 0.0 110.576 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.426 ' NH2' HG21 ' B' ' 42' ' ' VAL . 32.4 mtt85 -141.03 -64.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.899 0.38 . . . . 0.0 110.819 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.457 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 0.8 OUTLIER -168.85 136.21 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.738 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -55.02 -53.66 52.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.009 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.506 ' HA ' HD13 ' B' ' 51' ' ' ILE . 12.8 tt -64.98 -42.01 93.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.457 ' CG ' ' HB2' ' B' ' 45' ' ' GLU . 3.5 m-85 -45.4 -48.37 13.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.568 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -89.02 -49.34 6.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.464 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.635 ' C ' HD12 ' B' ' 51' ' ' ILE . 7.8 mtp180 -53.56 -17.37 2.05 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.635 HD12 ' C ' ' B' ' 50' ' ' ARG . 1.3 mp -111.56 -50.98 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.708 0.289 . . . . 0.0 111.065 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.568 ' HG3' HD22 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -73.3 -60.32 2.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.896 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.783 ' HB2' HD13 ' A' ' 2' ' ' LEU . . . -69.07 -36.63 77.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.886 0.374 . . . . 0.0 110.92 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 2.4 mt-10 -114.2 123.45 49.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.783 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.142 -179.779 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.839 0.352 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' B' ' 53' ' ' ALA . 7.4 tt -114.1 105.39 13.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.9 tt -100.96 105.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.279 0.561 . . . . 0.0 111.08 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.587 HD13 ' CD2' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -125.22 119.71 29.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.85 179.339 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.693 HG23 ' HG2' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -58.02 149.55 22.99 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.724 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.19 144.32 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.978 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.746 ' HD3' HG13 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -163.93 25.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.561 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.52 -52.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.981 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.17 89.18 0.1 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.676 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.8 55.48 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.0 0.429 . . . . 0.0 110.674 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -61.45 101.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.457 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.559 HD23 ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -111.12 154.23 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.991 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -133.19 99.7 4.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.279 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.779 HG23 HG23 ' B' ' 14' ' ' ILE . 8.8 tp -118.04 138.7 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.723 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.501 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 122.06 -108.23 1.27 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.441 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -143.47 -5.41 0.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 3.2 tt0 163.31 65.28 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.729 HG12 ' HD2' ' A' ' 37' ' ' PRO . 11.5 m -117.28 -160.78 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.511 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER 175.74 104.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.814 HG12 HG13 ' A' ' 34' ' ' VAL . 27.2 m -115.54 106.87 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.65 109.51 21.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.361 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.676 HG11 ' CD1' ' B' ' 32' ' ' ILE . 8.9 p -77.84 70.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.602 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.81 -147.24 0.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.544 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 31' ' ' ARG . . . 63.19 79.67 0.14 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.165 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.746 HG13 ' HD3' ' A' ' 7' ' ' ARG . 85.9 t -85.91 107.36 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.001 0.429 . . . . 0.0 111.619 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.662 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -133.95 139.2 45.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.875 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.77 -50.66 7.15 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 113.753 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -101.36 -87.46 0.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.018 0.409 . . . . 0.0 111.452 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.87 119.63 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 26' ' ' LYS . 18.5 m -93.3 136.83 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.631 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.696 ' HG2' HG23 ' B' ' 5' ' ' THR . 4.8 mmt180 -76.99 103.76 7.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.944 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.686 ' CD1' HG11 ' B' ' 22' ' ' VAL . 8.4 mt -87.33 131.3 35.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.401 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 110.59 3.77 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.173 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.814 HG13 HG12 ' A' ' 20' ' ' VAL . 28.0 t -110.76 103.04 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.973 0.416 . . . . 0.0 111.565 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -96.04 107.3 19.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.287 179.572 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.68 145.99 53.5 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.761 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.729 ' HD2' HG12 ' A' ' 18' ' ' VAL . 92.2 Cg_endo -79.47 156.32 25.07 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.87 2.38 . . . . 0.0 112.145 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.35 35.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -119.17 -38.76 2.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.035 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.49 HG12 ' O ' ' B' ' 15' ' ' GLY . 7.6 t -80.24 155.08 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.935 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -59.13 112.6 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.9 p -122.04 121.0 62.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -129.03 128.16 43.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.369 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.42 -69.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -157.03 116.66 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.78 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -60.92 -35.78 77.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 51' ' ' ILE . 1.2 tp -74.79 -43.34 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.601 ' CD2' HD13 ' B' ' 4' ' ' LEU . 6.4 m-85 -51.5 -43.26 62.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.334 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 8.7 pt20 -82.17 -41.74 19.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.255 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.417 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 7.3 mtm180 -72.62 0.17 11.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 47' ' ' ILE . 11.1 tt -114.99 -45.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.756 0.312 . . . . 0.0 111.28 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.493 ' N ' HG23 ' A' ' 51' ' ' ILE . 31.2 mm-40 -90.22 -50.07 6.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.732 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.489 ' HB2' HD12 ' B' ' 2' ' ' LEU . . . -75.23 -43.56 51.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -102.55 118.66 37.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.626 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.854 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.84 0.352 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 53' ' ' ALA . 7.4 tt -114.16 105.44 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.827 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.636 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.9 tt -100.98 105.16 17.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.22 0.533 . . . . 0.0 111.021 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.601 HD13 ' CD2' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -125.23 119.74 29.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.809 179.301 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.696 HG23 ' HG2' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -58.0 149.68 22.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.68 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.11 144.41 0.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.98 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.744 ' HD3' HG13 ' B' ' 25' ' ' VAL . 0.8 OUTLIER -164.03 25.93 0.07 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.638 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.51 -52.46 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.982 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.24 89.21 0.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.64 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.86 55.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.022 0.439 . . . . 0.0 110.648 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 25.7 m -61.53 101.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.522 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.565 HD23 ' CG2' ' B' ' 20' ' ' VAL . 0.1 OUTLIER -111.03 154.23 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.013 179.298 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -133.2 99.68 4.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.419 . . . . 0.0 111.289 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.779 HG23 HG23 ' A' ' 14' ' ' ILE . 8.7 tp -118.06 138.72 47.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.721 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.49 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 122.04 -108.11 1.26 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.528 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.8 OUTLIER -143.55 -5.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 3.3 tt0 163.23 65.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.755 HG12 ' HD2' ' B' ' 37' ' ' PRO . 11.6 m -117.22 -160.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.518 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.721 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.4 OUTLIER 175.71 104.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.798 HG12 HG13 ' B' ' 34' ' ' VAL . 27.7 m -115.51 106.78 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.57 109.46 21.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.376 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.686 HG11 ' CD1' ' A' ' 32' ' ' ILE . 8.9 p -77.81 70.4 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.582 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.95 -147.22 0.16 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.543 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.509 ' HA3' ' HB2' ' B' ' 31' ' ' ARG . . . 63.25 79.6 0.15 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.158 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.744 HG13 ' HD3' ' B' ' 7' ' ' ARG . 86.6 t -85.88 107.38 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.023 0.439 . . . . 0.0 111.614 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.657 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.0 OUTLIER -133.94 139.22 45.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.814 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.76 -50.69 7.13 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.755 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -101.31 -87.51 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.984 0.392 . . . . 0.0 111.421 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.84 119.61 25.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.9 0.381 . . . . 0.0 110.865 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.657 HG12 ' H ' ' B' ' 26' ' ' LYS . 18.4 m -93.3 136.88 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.624 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.693 ' HG2' HG23 ' A' ' 5' ' ' THR . 4.8 mmt180 -77.03 103.7 7.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.049 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.676 ' CD1' HG11 ' A' ' 22' ' ' VAL . 8.5 mt -87.33 131.35 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.411 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.91 110.61 3.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.201 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.798 HG13 HG12 ' B' ' 20' ' ' VAL . 28.1 t -110.8 103.1 14.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.921 0.391 . . . . 0.0 111.524 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' B' ' 19' ' ' THR . 0.1 OUTLIER -96.08 107.29 19.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.279 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.67 145.92 53.25 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.815 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.755 ' HD2' HG12 ' B' ' 18' ' ' VAL . 93.0 Cg_endo -79.43 156.36 25.22 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.863 2.375 . . . . 0.0 112.129 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.38 35.01 1.02 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.146 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -119.09 -38.9 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.741 0.305 . . . . 0.0 111.076 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 15' ' ' GLY . 7.5 t -80.15 155.03 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -59.09 112.62 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.053 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.498 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.9 p -122.07 121.03 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -129.05 128.18 43.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.343 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 -69.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.72 0.295 . . . . 0.0 111.057 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -157.03 116.71 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.928 0.394 . . . . 0.0 110.734 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -60.94 -35.79 77.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.876 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.637 ' O ' HG22 ' B' ' 51' ' ' ILE . 1.2 tp -74.74 -43.38 47.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.111 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.587 ' CD2' HD13 ' A' ' 4' ' ' LEU . 6.4 m-85 -51.35 -43.36 61.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.325 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 8.7 pt20 -82.15 -41.83 19.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.229 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -72.54 0.17 11.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.637 HG22 ' O ' ' B' ' 47' ' ' ILE . 11.1 tt -115.04 -45.66 4.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.755 0.312 . . . . 0.0 111.242 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.49 ' N ' HG23 ' B' ' 51' ' ' ILE . 31.3 mm-40 -90.15 -50.05 6.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.714 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' A' ' 2' ' ' LEU . . . -75.25 -43.51 51.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.824 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.51 121.21 42.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.733 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.832 0.349 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.451 HD22 HH21 ' B' ' 44' ' ' ARG . 0.7 OUTLIER -116.96 109.69 17.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 mm -97.2 105.34 17.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.09 0.471 . . . . 0.0 110.789 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.467 ' HG ' ' CG ' ' B' ' 48' ' ' TYR . 0.1 OUTLIER -124.23 110.42 14.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.2 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -62.9 77.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.961 0.41 . . . . 0.0 111.474 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.471 ' HB2' HG13 ' B' ' 32' ' ' ILE . 3.8 mtt-85 -80.12 143.68 33.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.321 0.581 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.637 ' HD3' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -170.59 -7.48 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.878 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -161.32 12.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.49 -139.25 9.36 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.864 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -107.08 -164.54 0.99 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.785 0.326 . . . . 0.0 111.178 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.612 HG22 HG23 ' A' ' 21' ' ' THR . 8.3 p -110.02 169.34 8.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 12' ' ' LEU . 1.6 pt? -109.35 154.31 22.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.597 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.564 ' HG2' HG22 ' A' ' 18' ' ' VAL . 1.6 ttp -129.73 100.29 5.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.07 0.462 . . . . 0.0 111.186 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.691 HG23 HG23 ' B' ' 14' ' ' ILE . 3.1 tp -114.32 124.69 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.486 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.52 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 132.11 -105.35 0.6 Allowed Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.058 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 2.2 t70 -160.81 11.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER 159.17 61.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.851 0.46 . . . . 0.0 109.781 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.564 HG22 ' HG2' ' A' ' 13' ' ' MET . 8.8 m -118.3 -157.7 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.676 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.935 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 167.32 102.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.77 HG13 ' HA ' ' A' ' 34' ' ' VAL . 25.7 t -118.65 113.85 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.982 0.42 . . . . 0.0 111.951 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.612 HG23 HG22 ' A' ' 11' ' ' THR . 4.0 m -96.03 113.08 24.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.549 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.786 HG11 HG21 ' B' ' 32' ' ' ILE . 30.5 m -76.78 -19.0 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.862 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER 62.89 -76.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.044 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . 92.41 -40.81 2.83 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.16 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.637 HG22 ' HD3' ' A' ' 7' ' ' ARG . 1.1 t -85.59 139.17 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.666 0.233 . . . . 0.0 110.938 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER 164.37 165.58 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.943 0.401 . . . . 0.0 110.715 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' GLN . . . -76.71 105.59 2.05 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.151 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m120 64.45 -72.53 0.06 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 111.23 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.505 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 1.3 tp60 -84.46 136.93 33.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.682 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.7 t -93.15 119.86 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.907 0.384 . . . . 0.0 111.794 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 0.1 OUTLIER -75.75 98.59 4.16 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.045 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.795 HG21 HG11 ' B' ' 22' ' ' VAL . 11.2 mm -92.18 123.42 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.39 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.77 119.24 6.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.26 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.77 ' HA ' HG13 ' A' ' 20' ' ' VAL . 22.0 t -109.74 103.73 15.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.922 0.391 . . . . 0.0 111.253 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.935 ' HB3' HG23 ' A' ' 19' ' ' THR . 3.6 t-20 -100.61 107.52 19.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.286 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.96 147.69 42.46 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.697 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.508 ' HD2' HG12 ' A' ' 18' ' ' VAL . 79.0 Cg_endo -77.51 156.52 32.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.866 2.377 . . . . 0.0 112.126 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 30.35 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.25 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -106.08 -37.96 6.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.77 0.319 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.509 HG12 ' O ' ' B' ' 15' ' ' GLY . 21.3 t -90.73 147.53 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -54.6 100.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.18 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.524 ' HB ' HD13 ' B' ' 14' ' ' ILE . 12.4 p -122.4 124.56 71.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.08 136.32 51.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.601 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.455 HH21 HD22 ' B' ' 2' ' ' LEU . 2.3 mpp_? -147.74 -176.85 5.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.57 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.455 ' HB3' ' CG ' ' A' ' 48' ' ' TYR . 2.7 tt0 -59.32 137.99 57.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -61.29 2.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.595 ' CG1' HD11 ' A' ' 51' ' ' ILE . 6.8 tt -54.73 -42.05 59.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.349 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.473 ' CG ' ' HG ' ' B' ' 4' ' ' LEU . 4.5 m-30 -46.24 -58.85 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.691 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 41.1 mt-30 -75.97 -20.99 57.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.625 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -73.19 -13.84 61.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.596 0.236 . . . . 0.0 111.458 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.595 HD11 ' CG1' ' A' ' 47' ' ' ILE . 28.6 mt -108.91 -33.11 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.723 0.297 . . . . 0.0 111.361 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.93 -50.84 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.342 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -62.23 -69.03 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.924 0.393 . . . . 0.0 110.771 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -113.94 118.62 34.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.507 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.3 mttp . . . . . 0 N--CA 1.449 -0.493 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.643 179.779 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.815 0.34 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.455 HD22 HH21 ' A' ' 44' ' ' ARG . 0.7 OUTLIER -116.87 109.65 17.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 13.0 mm -97.13 105.29 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.075 0.464 . . . . 0.0 110.861 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.473 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -124.22 110.45 14.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.178 179.064 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -62.95 77.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.011 0.434 . . . . 0.0 111.497 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.46 ' HB2' HG13 ' A' ' 32' ' ' ILE . 3.7 mtt-85 -80.06 143.67 33.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.329 0.585 . . . . 0.0 111.022 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.642 ' HD3' HG22 ' B' ' 25' ' ' VAL . 0.0 OUTLIER -170.56 -7.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.905 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.451 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -161.24 12.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.43 -139.26 9.35 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.896 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -107.12 -164.5 0.99 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.159 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.621 HG22 HG23 ' B' ' 21' ' ' THR . 8.5 p -110.07 169.37 8.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.481 HD23 ' H ' ' B' ' 12' ' ' LEU . 1.6 pt? -109.39 154.36 22.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.519 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.569 ' HG2' HG22 ' B' ' 18' ' ' VAL . 1.6 ttp -129.76 100.26 5.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.462 . . . . 0.0 111.159 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.691 HG23 HG23 ' A' ' 14' ' ' ILE . 3.1 tp -114.34 124.64 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.502 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.509 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 132.13 -105.46 0.61 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.127 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 2.2 t70 -160.67 12.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 0.2 OUTLIER 159.03 61.86 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.854 0.462 . . . . 0.0 109.77 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.569 HG22 ' HG2' ' B' ' 13' ' ' MET . 8.8 m -118.41 -157.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.656 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.946 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 167.4 102.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.748 HG13 ' HA ' ' B' ' 34' ' ' VAL . 25.8 t -118.72 113.74 42.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.4 . . . . 0.0 111.946 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.621 HG23 HG22 ' B' ' 11' ' ' THR . 4.0 m -95.96 113.16 24.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.795 HG11 HG21 ' A' ' 32' ' ' ILE . 31.0 m -76.75 -19.05 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.872 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.578 HD12 ' O ' ' B' ' 25' ' ' VAL . 0.2 OUTLIER 62.93 -76.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.02 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . 92.42 -40.85 2.82 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.165 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.642 HG22 ' HD3' ' B' ' 7' ' ' ARG . 1.2 t -85.61 139.21 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.644 0.222 . . . . 0.0 110.943 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER 164.37 165.62 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.95 0.405 . . . . 0.0 110.736 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 29' ' ' GLN . . . -76.72 105.61 2.05 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.056 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m120 64.5 -72.63 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.903 0.382 . . . . 0.0 111.161 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 1.3 tp60 -84.47 136.98 33.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.631 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.14 119.82 41.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.847 0.356 . . . . 0.0 111.819 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -75.77 98.63 4.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.048 179.488 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.786 HG21 HG11 ' A' ' 22' ' ' VAL . 11.3 mm -92.18 123.33 44.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.334 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.71 119.23 6.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.332 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.748 ' HA ' HG13 ' B' ' 20' ' ' VAL . 22.0 t -109.73 103.7 15.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.878 0.371 . . . . 0.0 111.291 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.946 ' HB3' HG23 ' B' ' 19' ' ' THR . 3.6 t-20 -100.58 107.57 19.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.256 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.02 147.77 42.57 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.682 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.49 ' HD2' HG12 ' B' ' 18' ' ' VAL . 79.5 Cg_endo -77.6 156.49 31.95 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.836 2.357 . . . . 0.0 112.161 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 30.22 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.233 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -106.01 -38.02 6.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.808 0.337 . . . . 0.0 110.89 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 15' ' ' GLY . 21.2 t -90.63 147.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.947 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -54.58 100.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.204 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.513 ' HB ' HD13 ' A' ' 14' ' ' ILE . 12.4 p -122.34 124.54 71.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.09 136.29 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.631 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.451 HH21 HD22 ' A' ' 2' ' ' LEU . 2.3 mpp_? -147.74 -176.85 5.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.31 . . . . 0.0 110.631 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.453 ' HB3' ' CG ' ' B' ' 48' ' ' TYR . 2.7 tt0 -59.34 138.07 57.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 110.801 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -61.31 2.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.589 ' CG1' HD11 ' B' ' 51' ' ' ILE . 6.8 tt -54.72 -42.14 59.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.481 ' HD1' HG23 ' B' ' 47' ' ' ILE . 4.5 m-30 -46.2 -58.81 3.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.687 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 41.1 mt-30 -76.05 -20.93 57.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.609 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -73.28 -13.72 61.18 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 111.41 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.589 HD11 ' CG1' ' B' ' 47' ' ' ILE . 28.9 mt -109.09 -33.04 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.709 0.29 . . . . 0.0 111.357 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.98 -50.85 3.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.347 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' B' ' 49' ' ' GLN . . . -62.23 -69.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.969 0.414 . . . . 0.0 110.791 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -114.05 119.59 37.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.402 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.733 179.955 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.789 0.328 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' B' ' 53' ' ' ALA . 2.0 mp -122.22 116.69 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.805 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.2 tt -103.11 105.31 18.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.181 0.515 . . . . 0.0 110.786 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.611 HD22 ' CD1' ' B' ' 48' ' ' TYR . 4.1 tp -125.19 124.19 41.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.021 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -55.6 140.66 40.31 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.376 179.458 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 6.1 mtp85 -151.65 142.97 23.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.939 0.4 . . . . 0.0 111.426 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 172.82 -0.52 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.784 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.3 t -148.73 116.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.796 0.331 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.78 63.45 5.23 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.71 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.479 ' C ' HG22 ' A' ' 11' ' ' THR . 28.4 mm-40 -106.64 173.27 6.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.538 0.209 . . . . 0.0 110.723 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.479 HG22 ' C ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER 164.47 101.26 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.326 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.869 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -109.07 154.19 22.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.785 179.022 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -131.81 100.24 5.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.931 0.396 . . . . 0.0 111.307 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.91 HG23 HG23 ' B' ' 14' ' ' ILE . 7.2 tp -119.12 115.44 47.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.679 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.08 -106.76 0.51 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.912 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 11.8 t70 -150.74 8.64 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.1 mt-10 155.74 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.839 0.455 . . . . 0.0 109.879 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.802 HG12 ' HD2' ' A' ' 37' ' ' PRO . 16.6 m -135.58 131.41 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.861 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.1 m -116.09 117.05 29.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.869 ' HB ' HD23 ' A' ' 12' ' ' LEU . 4.9 t -108.89 110.84 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 111.784 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 t -102.24 104.61 15.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.239 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.003 HG23 HD12 ' A' ' 32' ' ' ILE . 5.6 p -80.88 71.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.241 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.11 -143.38 0.2 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.528 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.23 80.87 0.06 OUTLIER Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.797 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 30' ' ' VAL . 14.2 t -110.28 108.28 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 120.844 0.354 . . . . 0.0 111.324 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -167.03 135.2 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.623 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.51 -153.33 19.26 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.765 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.65 -52.73 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.494 ' HB3' HG22 ' B' ' 5' ' ' THR . 43.5 mt-30 -84.93 114.62 22.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 32' ' ' ILE . 3.7 m -93.07 137.14 23.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 35.7 mtt180 -76.0 104.26 6.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.332 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.003 HD12 HG23 ' A' ' 22' ' ' VAL . 12.6 mm -87.22 137.38 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.901 0.381 . . . . 0.0 111.344 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.85 121.71 6.31 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.413 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.59 ' HA ' HG13 ' A' ' 20' ' ' VAL . 14.9 t -118.09 103.64 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.953 0.406 . . . . 0.0 111.431 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.25 107.59 19.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.299 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.07 144.82 22.6 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.822 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.802 ' HD2' HG12 ' A' ' 18' ' ' VAL . 93.0 Cg_endo -83.0 156.27 15.17 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.85 2.367 . . . . 0.0 111.971 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 42.73 1.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.214 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -113.36 -43.72 3.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.715 0.293 . . . . 0.0 110.94 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 41' ' ' SER . 5.1 t -83.43 160.9 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.844 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -59.79 99.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.715 -179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 42' ' ' VAL . 8.1 p -122.38 122.93 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.956 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.34 136.18 50.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.193 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.414 ' HD3' ' CD2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -161.76 -165.18 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.321 . . . . 0.0 110.766 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -64.26 136.71 57.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -55.08 -61.21 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 tt -55.95 -38.96 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.315 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.601 ' CD1' HD22 ' B' ' 4' ' ' LEU . 43.3 t80 -46.71 -61.91 1.62 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.657 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -76.35 -21.29 56.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.438 -179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 6.9 tpt180 -73.66 -10.94 60.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.424 HG13 ' N ' ' A' ' 52' ' ' GLN . 1.7 pt -114.29 -28.88 2.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.424 ' N ' HG13 ' A' ' 51' ' ' ILE . 13.1 mm-40 -104.83 -54.27 2.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.732 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -62.15 -66.01 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.699 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -110.26 117.52 33.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.648 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.484 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.818 0.342 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 53' ' ' ALA . 2.0 mp -122.26 116.63 24.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.879 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.636 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.2 tt -103.09 105.33 18.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.198 0.523 . . . . 0.0 110.774 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.601 HD22 ' CD1' ' A' ' 48' ' ' TYR . 4.1 tp -125.2 124.21 41.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.064 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -55.64 140.67 40.48 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.36 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 6.1 mtp85 -151.67 142.96 23.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.946 0.403 . . . . 0.0 111.427 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER 172.8 -0.54 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.821 179.438 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 17.3 t -148.66 116.75 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.781 0.324 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.7 63.47 5.21 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.705 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.472 ' C ' HG22 ' B' ' 11' ' ' THR . 28.3 mm-40 -106.6 173.33 6.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.503 0.192 . . . . 0.0 110.768 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.472 HG22 ' C ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 164.47 101.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.409 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.0 OUTLIER -109.0 154.19 22.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.789 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.504 ' HA ' ' O ' ' B' ' 18' ' ' VAL . 0.5 OUTLIER -131.8 100.22 5.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 111.322 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.91 HG23 HG23 ' A' ' 14' ' ' ILE . 7.2 tp -119.06 115.45 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.708 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.08 -106.71 0.51 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.94 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 11.8 t70 -150.8 8.7 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.1 mt-10 155.7 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.811 0.444 . . . . 0.0 109.878 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.801 HG12 ' HD2' ' B' ' 37' ' ' PRO . 16.5 m -135.64 131.42 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.827 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -116.05 117.04 29.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.858 ' HB ' HD23 ' B' ' 12' ' ' LEU . 4.8 t -108.86 110.82 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.868 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 1.4 t -102.22 104.62 15.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.216 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.97 HG23 HD12 ' B' ' 32' ' ' ILE . 5.6 p -80.88 71.04 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.291 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -143.35 0.2 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.476 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.19 80.79 0.06 OUTLIER Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.887 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' B' ' 30' ' ' VAL . 14.0 t -110.21 108.28 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 111.309 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -167.07 135.09 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.658 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.59 -153.36 19.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.806 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.67 -52.61 10.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 110.853 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.5 ' HB3' HG22 ' A' ' 5' ' ' THR . 43.5 mt-30 -84.95 114.59 22.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.984 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.712 HG23 HD11 ' B' ' 32' ' ' ILE . 3.7 m -93.02 137.16 23.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.093 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 35.8 mtt180 -76.02 104.28 6.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.348 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.97 HD12 HG23 ' B' ' 22' ' ' VAL . 12.8 mm -87.29 137.37 21.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.933 0.396 . . . . 0.0 111.37 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.9 121.77 6.32 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.373 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.592 ' HA ' HG13 ' B' ' 20' ' ' VAL . 15.0 t -118.08 103.64 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 0.0 111.426 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.35 107.58 19.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.233 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.03 144.85 22.77 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.799 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.801 ' HD2' HG12 ' B' ' 18' ' ' VAL . 93.0 Cg_endo -82.97 156.23 15.23 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.92 2.413 . . . . 0.0 111.979 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.81 42.67 1.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.218 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -113.26 -43.77 3.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.784 0.326 . . . . 0.0 110.971 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.445 HG12 ' N ' ' B' ' 41' ' ' SER . 5.1 t -83.46 160.93 3.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.769 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.445 ' N ' HG12 ' B' ' 40' ' ' VAL . 0.8 OUTLIER -59.71 99.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.758 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.455 HG13 ' O ' ' B' ' 42' ' ' VAL . 8.1 p -122.4 122.89 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.954 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.34 136.16 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.414 ' HD3' ' CD2' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -161.76 -165.19 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.754 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.6 OUTLIER -64.32 136.67 57.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.966 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.7 OUTLIER -54.97 -61.27 2.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 tt -55.98 -38.91 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.299 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.611 ' CD1' HD22 ' A' ' 4' ' ' LEU . 43.1 t80 -46.74 -61.99 1.59 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.645 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 0.0 OUTLIER -76.26 -21.29 56.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.455 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' B' ' 46' ' ' GLU . 7.0 tpt180 -73.73 -10.9 60.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.572 0.225 . . . . 0.0 111.565 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.425 HG13 ' N ' ' B' ' 52' ' ' GLN . 1.7 pt -114.35 -28.62 2.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.797 0.332 . . . . 0.0 111.166 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.425 ' N ' HG13 ' B' ' 51' ' ' ILE . 13.0 mm-40 -104.95 -54.39 2.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' B' ' 49' ' ' GLN . . . -62.11 -65.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.726 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -110.5 117.82 34.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.546 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 tptm . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.453 179.736 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.753 0.311 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.76 HD21 ' HB2' ' B' ' 53' ' ' ALA . 5.4 mp -119.98 113.2 20.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.0 tt -105.04 107.86 23.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 110.737 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.436 ' HG ' ' CG ' ' B' ' 48' ' ' TYR . 1.4 mm? -124.09 126.03 45.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.095 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.412 HG21 ' HG2' ' B' ' 29' ' ' GLN . 0.3 OUTLIER -59.76 145.2 46.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.409 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.411 ' HB2' HG13 ' B' ' 32' ' ' ILE . 0.0 OUTLIER -155.89 146.28 21.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.164 0.507 . . . . 0.0 111.304 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.724 ' O ' HG13 ' A' ' 8' ' ' VAL . 2.3 ttt180 175.92 74.31 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 176.97 -60.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.663 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.74 82.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.73 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.409 ' O ' ' HB ' ' A' ' 11' ' ' THR . 1.3 tt0 -72.17 -161.9 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.556 0.217 . . . . 0.0 110.569 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER 172.35 89.43 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.633 0.254 . . . . 0.0 111.056 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.55 HD13 HG11 ' B' ' 34' ' ' VAL . 0.2 OUTLIER -110.53 152.33 26.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.126 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.505 ' HA ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -132.98 100.27 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.901 0.381 . . . . 0.0 111.546 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.622 ' C ' HD13 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -111.35 127.07 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.258 179.135 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.509 ' HA2' HG11 ' B' ' 40' ' ' VAL . . . 126.52 -102.69 0.64 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.877 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.461 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.4 m-20 -165.77 17.39 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.4 OUTLIER 158.92 59.42 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.734 0.302 . . . . 0.0 110.884 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.722 HG12 ' HD2' ' A' ' 37' ' ' PRO . 11.1 m -120.5 -157.37 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 120.638 0.256 . . . . 0.0 111.632 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 167.58 105.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 34' ' ' VAL . 28.6 t -122.91 114.3 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.827 0.346 . . . . 0.0 111.737 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 21' ' ' THR . 9.8 t -104.4 118.4 36.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.513 ' O ' ' C ' ' A' ' 23' ' ' LEU . 17.1 m -91.85 63.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.427 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.746 HD12 ' O ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -13.16 -70.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.586 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . 90.74 -45.4 2.9 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.26 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.746 ' O ' HD12 ' A' ' 23' ' ' LEU . 1.4 t -85.25 137.35 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' CB ' ' HA ' ' A' ' 30' ' ' VAL . 3.9 tptt 174.7 165.49 0.25 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.645 0.259 . . . . 0.0 110.383 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.37 -105.94 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.465 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.33 -41.5 11.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.069 0.461 . . . . 0.0 110.271 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -105.56 136.52 44.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.926 179.369 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.417 ' HA ' ' CB ' ' A' ' 26' ' ' LYS . 21.3 t -93.18 114.15 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 0.0 111.417 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.87 100.64 4.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.657 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.408 HG13 ' CB ' ' B' ' 6' ' ' ARG . 10.7 mm -87.11 131.76 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.44 120.76 6.23 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.048 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.734 ' HA ' HG13 ' A' ' 20' ' ' VAL . 16.3 t -118.19 103.69 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.883 0.373 . . . . 0.0 111.199 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 19' ' ' THR . 3.0 t-20 -99.48 107.47 19.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.12 0.486 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.67 144.17 28.99 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.675 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.722 ' HD2' HG12 ' A' ' 18' ' ' VAL . 85.7 Cg_endo -80.29 156.36 22.47 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.747 2.298 . . . . 0.0 112.129 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -93.25 34.6 1.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.103 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.42 -44.08 6.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.507 HG11 ' HA2' ' B' ' 15' ' ' GLY . 24.3 t -89.33 158.07 2.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.781 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -59.64 97.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.817 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.5 p -122.45 120.95 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.178 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -120.73 136.29 54.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -146.61 -176.32 5.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.69 0.281 . . . . 0.0 110.569 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.75 133.75 56.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 0.0 110.698 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -51.78 -60.27 3.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.31 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 48' ' ' TYR . 1.3 tp -55.08 -42.86 67.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.482 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 47' ' ' ILE . 2.7 m-85 -46.53 -68.08 0.22 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.443 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.703 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 2.5 pt20 -70.52 -21.04 62.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.469 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.45 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 12.9 mtp85 -65.97 -23.02 66.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.677 0.275 . . . . 0.0 111.358 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.6 pt -109.91 -21.62 5.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.417 ' HB3' HD23 ' B' ' 2' ' ' LEU . 1.2 tp60 -107.09 -58.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 111.441 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.791 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -66.44 -73.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.451 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.8 127.21 54.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.389 . . . . 0.0 111.12 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 93.49 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.027 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 t -48.32 -51.08 27.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.393 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -144.77 -71.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.04 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -179.24 167.12 1.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.918 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.1 p -146.13 151.34 37.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.769 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.8 t -97.99 120.96 39.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.944 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.787 0.327 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.4 mp -119.98 113.27 20.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.586 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.0 tt -105.05 107.84 23.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.09 0.472 . . . . 0.0 110.743 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.443 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 1.4 mm? -124.17 126.11 45.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -59.78 145.3 45.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.376 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -155.96 146.26 21.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.141 0.496 . . . . 0.0 111.27 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.729 ' O ' HG13 ' B' ' 8' ' ' VAL . 2.3 ttt180 175.93 74.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.089 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.729 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER 176.87 -60.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.685 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.71 82.45 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.668 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.17 -161.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.547 0.213 . . . . 0.0 110.549 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 172.3 89.42 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.695 0.283 . . . . 0.0 111.095 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.551 HD13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -110.46 152.25 26.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.243 179.27 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.519 ' HA ' HG23 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -132.96 100.36 4.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.4 . . . . 0.0 111.542 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.62 HD13 ' C ' ' B' ' 14' ' ' ILE . 0.0 OUTLIER -111.31 127.0 68.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.239 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.509 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 126.51 -102.64 0.64 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.888 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.4 m-20 -165.75 17.35 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.468 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.4 OUTLIER 158.9 59.55 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.747 0.308 . . . . 0.0 110.846 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.72 HG12 ' HD2' ' B' ' 37' ' ' PRO . 11.2 m -120.6 -157.34 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.721 0.296 . . . . 0.0 111.55 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.652 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 167.61 105.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.704 HG13 ' HA ' ' B' ' 34' ' ' VAL . 28.9 t -122.94 114.34 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.32 . . . . 0.0 111.701 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.431 HG23 ' O ' ' B' ' 21' ' ' THR . 9.7 t -104.42 118.42 36.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.782 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.503 ' O ' ' C ' ' B' ' 23' ' ' LEU . 17.1 m -91.89 63.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.445 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.757 HD12 ' O ' ' B' ' 25' ' ' VAL . 0.4 OUTLIER -13.19 -70.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.519 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . 90.75 -45.44 2.9 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.222 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.757 ' O ' HD12 ' B' ' 23' ' ' LEU . 1.4 t -85.28 137.36 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.652 0.263 . . . . 0.0 110.831 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 3.9 tptt 174.69 165.52 0.25 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.64 0.257 . . . . 0.0 110.454 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.42 -105.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.445 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.32 -41.54 11.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.065 0.46 . . . . 0.0 110.265 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 0.2 OUTLIER -105.46 136.49 44.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.956 179.344 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.406 ' HA ' ' CB ' ' B' ' 26' ' ' LYS . 21.3 t -93.2 114.22 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 111.398 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.85 100.58 4.82 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.634 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.411 HG13 ' HB2' ' A' ' 6' ' ' ARG . 10.6 mm -87.11 131.76 34.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.42 120.72 6.22 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.091 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.704 ' HA ' HG13 ' B' ' 20' ' ' VAL . 16.2 t -118.17 103.72 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.899 0.38 . . . . 0.0 111.201 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' B' ' 19' ' ' THR . 3.0 t-20 -99.49 107.51 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.371 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.72 144.15 28.76 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.65 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.72 ' HD2' HG12 ' B' ' 18' ' ' VAL . 85.0 Cg_endo -80.17 156.34 22.84 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.784 2.323 . . . . 0.0 112.152 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -93.29 34.67 1.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.44 -44.19 5.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.509 HG11 ' HA2' ' A' ' 15' ' ' GLY . 24.2 t -89.22 158.09 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.815 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.459 ' N ' HG12 ' B' ' 40' ' ' VAL . 1.0 OUTLIER -59.64 97.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.786 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.492 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.5 p -122.55 120.91 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.179 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -120.75 136.31 54.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.267 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -146.61 -176.3 5.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.522 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.73 133.75 56.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -51.8 -60.29 3.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.249 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.456 HG23 ' N ' ' B' ' 48' ' ' TYR . 1.3 tp -55.05 -42.84 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.489 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.456 ' N ' HG23 ' B' ' 47' ' ' ILE . 2.7 m-85 -46.57 -68.03 0.23 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.476 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 2.5 pt20 -70.59 -21.03 62.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.498 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 13.0 mtp85 -65.96 -22.91 66.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.662 0.268 . . . . 0.0 111.35 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 18.6 pt -109.99 -21.76 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.413 ' HB3' HD23 ' A' ' 2' ' ' LEU . 1.2 tp60 -107.04 -58.05 1.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.736 0.303 . . . . 0.0 111.468 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.76 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -66.47 -73.48 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.478 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.28 128.92 55.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.925 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.58 92.61 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.787 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 57.41 87.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.042 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -108.66 -47.54 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.967 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 63.22 -174.04 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.881 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -74.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.86 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.8 t -113.64 126.69 55.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.599 ' C ' HD12 ' A' ' 2' ' ' LEU . 2.0 ttt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.835 0.35 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 2' ' ' LEU . 4.8 mp -119.87 116.07 25.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.707 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.532 ' C ' HD22 ' A' ' 4' ' ' LEU . 14.2 mm -93.0 105.66 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.984 0.421 . . . . 0.0 110.58 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.619 ' N ' HD22 ' A' ' 4' ' ' LEU . 2.5 mm? -116.77 156.79 26.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.666 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' B' ' 29' ' ' GLN . 0.1 OUTLIER -97.01 133.63 41.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.951 0.405 . . . . 0.0 110.649 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.679 HH11 HG21 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -151.42 148.1 27.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.84 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 2.8 ttt180 177.39 -6.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.176 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.419 ' H ' ' H ' ' A' ' 7' ' ' ARG . 22.0 t -115.7 -57.29 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.768 0.318 . . . . 0.0 111.044 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.48 88.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.645 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.84 -70.55 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.732 0.301 . . . . 0.0 110.787 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m 75.87 103.45 0.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.529 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.492 ' CD1' HG11 ' B' ' 34' ' ' VAL . 1.3 pt? -108.94 154.46 22.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.967 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.488 ' HA ' HG23 ' A' ' 18' ' ' VAL . 24.5 ttp -128.12 100.54 5.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.097 0.475 . . . . 0.0 111.24 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.641 HD13 ' HB ' ' B' ' 42' ' ' VAL . 2.1 tp -112.78 122.97 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.423 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.619 ' HA2' HG11 ' B' ' 40' ' ' VAL . . . 133.8 -104.87 0.54 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.996 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.5 t70 -159.41 11.65 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 157.4 61.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.964 0.412 . . . . 0.0 109.954 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.662 HG12 ' HD2' ' A' ' 37' ' ' PRO . 17.7 m -118.48 -155.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.723 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 168.59 103.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.749 HG13 ' HA ' ' A' ' 34' ' ' VAL . 25.2 t -119.72 111.22 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 111.769 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.29 113.07 25.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.48 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.679 HG21 HH11 ' A' ' 6' ' ' ARG . 29.6 m -84.76 62.94 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.779 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.32 121.83 3.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . -99.52 -15.71 31.36 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.001 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.2 t -85.48 125.8 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.743 0.271 . . . . 0.0 110.473 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 1.3 tpmp? 176.9 165.29 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.814 0.34 . . . . 0.0 110.66 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 29' ' ' GLN . . . -90.96 108.42 3.58 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.539 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 65.68 -69.52 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.876 0.37 . . . . 0.0 110.796 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 1.8 mt-30 -84.82 136.57 33.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.62 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.538 HG12 ' CD1' ' A' ' 32' ' ' ILE . 5.4 t -93.0 119.69 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.044 0.45 . . . . 0.0 111.493 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -82.88 98.21 9.07 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.3 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.566 HG23 ' HA ' ' A' ' 22' ' ' VAL . 4.7 mm -93.05 127.66 45.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.61 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.08 112.38 4.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.328 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.749 ' HA ' HG13 ' A' ' 20' ' ' VAL . 28.0 t -106.35 103.68 15.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.871 0.367 . . . . 0.0 111.168 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -98.37 107.33 19.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.368 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.16 146.08 52.85 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.677 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.662 ' HD2' HG12 ' A' ' 18' ' ' VAL . 77.0 Cg_endo -83.44 156.22 14.33 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.005 2.47 . . . . 0.0 112.358 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -3.25 41.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.332 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -42.63 70.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.643 0.259 . . . . 0.0 111.171 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.632 HG11 ' HA2' ' B' ' 15' ' ' GLY . 11.6 t -91.0 152.53 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.803 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.3 t -76.09 106.08 7.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.966 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.648 ' HB ' HD13 ' B' ' 14' ' ' ILE . 14.6 p -121.07 120.23 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.46 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -128.68 134.32 48.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.666 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.516 HH21 HG21 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -154.65 -49.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.706 0.288 . . . . 0.0 111.257 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 3.4 mm-40 -161.27 124.49 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.929 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -56.45 -59.07 5.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.101 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.443 HG23 ' N ' ' A' ' 48' ' ' TYR . 17.6 tt -58.1 -42.49 83.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.176 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CG ' ' HB2' ' A' ' 45' ' ' GLU . 3.1 m-85 -44.25 -58.06 3.11 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 4.3 pt20 -76.65 -21.62 55.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.793 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -67.38 -15.01 63.44 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.261 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.623 HD13 ' HD2' ' A' ' 55' ' ' LYS . 23.7 mm -116.05 -26.43 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.337 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.57 -58.66 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.909 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . . . -60.78 -64.09 1.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.588 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -109.58 116.28 31.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.387 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.623 ' HD2' HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER 149.67 -35.59 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.792 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m 64.56 176.88 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.224 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -177.46 -53.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -104.4 -174.51 2.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.803 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.2 p -121.0 158.94 26.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.8 m -110.2 133.6 53.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.593 ' C ' HD12 ' B' ' 2' ' ' LEU . 2.0 ttt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.82 0.343 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.616 ' HB3' HD21 ' B' ' 4' ' ' LEU . 4.8 mp -119.88 116.09 25.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.522 ' C ' HD22 ' B' ' 4' ' ' LEU . 14.2 mm -93.05 105.73 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.994 0.426 . . . . 0.0 110.579 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.629 HD22 ' N ' ' B' ' 4' ' ' LEU . 2.5 mm? -116.77 156.78 26.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.679 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.01 133.63 41.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.949 0.404 . . . . 0.0 110.653 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.68 HH11 HG21 ' B' ' 22' ' ' VAL . 0.1 OUTLIER -151.44 148.11 27.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.796 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 2.8 ttt180 177.37 -6.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.13 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.404 ' H ' ' H ' ' B' ' 7' ' ' ARG . 22.0 t -115.67 -57.3 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.805 0.336 . . . . 0.0 111.044 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.47 88.34 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.601 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.88 -70.59 0.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.759 0.314 . . . . 0.0 110.735 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m 75.83 103.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.604 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.486 ' CD1' HG11 ' A' ' 34' ' ' VAL . 1.3 pt? -108.87 154.44 22.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.951 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.489 ' HA ' HG23 ' B' ' 18' ' ' VAL . 24.4 ttp -128.09 100.47 5.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 111.227 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.648 HD13 ' HB ' ' A' ' 42' ' ' VAL . 2.1 tp -112.74 122.93 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.632 ' HA2' HG11 ' A' ' 40' ' ' VAL . . . 133.87 -104.81 0.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.993 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.47 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.5 t70 -159.49 11.71 0.13 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.3 OUTLIER 157.35 61.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.699 0.399 . . . . 0.0 109.943 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.648 HG12 ' HD2' ' B' ' 37' ' ' PRO . 17.6 m -118.48 -155.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.705 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.642 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 168.66 103.13 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.761 HG13 ' HA ' ' B' ' 34' ' ' VAL . 25.3 t -119.71 111.21 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.866 0.365 . . . . 0.0 111.785 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.29 113.04 25.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.486 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.68 HG21 HH11 ' B' ' 6' ' ' ARG . 29.3 m -84.68 62.91 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.841 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.33 121.84 3.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . -99.57 -15.61 31.5 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.053 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' B' ' 26' ' ' LYS . 2.2 t -85.51 125.78 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.69 0.245 . . . . 0.0 110.465 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' B' ' 25' ' ' VAL . 1.3 tpmp? 176.91 165.3 0.5 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.626 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' B' ' 29' ' ' GLN . . . -91.0 108.34 3.57 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.55 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 65.77 -69.5 0.11 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.879 0.371 . . . . 0.0 110.739 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' B' ' 27' ' ' GLY . 1.8 mt-30 -84.8 136.57 33.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.54 HG12 ' CD1' ' B' ' 32' ' ' ILE . 5.3 t -92.99 119.78 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 0.0 111.497 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -82.95 98.26 9.13 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.281 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.569 HG23 ' HA ' ' B' ' 22' ' ' VAL . 4.7 mm -93.08 127.7 45.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.636 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.08 112.33 4.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.384 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.761 ' HA ' HG13 ' B' ' 20' ' ' VAL . 27.0 t -106.3 103.67 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.846 0.355 . . . . 0.0 111.242 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' B' ' 19' ' ' THR . 0.1 OUTLIER -98.36 107.35 19.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.369 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.19 146.1 52.86 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.633 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.648 ' HD2' HG12 ' B' ' 18' ' ' VAL . 76.0 Cg_endo -83.46 156.26 14.28 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.966 2.444 . . . . 0.0 112.356 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -3.36 41.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.35 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.49 -42.71 71.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.689 0.28 . . . . 0.0 111.184 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.619 HG11 ' HA2' ' A' ' 15' ' ' GLY . 11.6 t -90.98 152.58 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.802 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 39.4 t -76.08 105.98 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.982 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.641 ' HB ' HD13 ' A' ' 14' ' ' ILE . 14.6 p -121.0 120.17 61.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.494 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -128.63 134.3 48.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.665 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.535 HH21 HG21 ' B' ' 42' ' ' VAL . 0.1 OUTLIER -154.66 -49.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 111.309 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.453 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 3.4 mm-40 -161.23 124.53 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.4 OUTLIER -56.5 -59.04 5.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.446 HG23 ' N ' ' B' ' 48' ' ' TYR . 17.6 tt -58.1 -42.52 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.198 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.453 ' CG ' ' HB2' ' B' ' 45' ' ' GLU . 3.1 m-85 -44.22 -58.05 3.1 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.755 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 4.3 pt20 -76.77 -21.52 55.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.782 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.446 ' HA ' ' HG2' ' B' ' 54' ' ' GLU . 0.8 OUTLIER -67.47 -14.75 63.21 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.34 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 23.6 mm -116.23 -26.76 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.311 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.24 -58.7 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.95 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' HB2' ' B' ' 49' ' ' GLN . . . -60.8 -63.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.629 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' B' ' 50' ' ' ARG . 0.0 OUTLIER -111.21 120.06 41.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.649 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.05 95.86 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.447 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.77 -166.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.505 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.47 29.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.757 0.313 . . . . 0.0 111.062 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.79 148.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 1.2 m -159.85 130.34 5.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.7 t -91.98 132.64 36.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.952 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.823 0.344 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' B' ' 53' ' ' ALA . 5.0 mp -122.03 107.39 12.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.1 tt -115.06 114.73 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.181 0.515 . . . . 0.0 110.967 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.466 ' HB3' ' CZ ' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -125.44 135.67 52.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.824 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.436 ' H ' HD13 ' A' ' 4' ' ' LEU . 0.2 OUTLIER -62.37 150.86 38.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.057 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -170.67 148.03 2.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.25 0.548 . . . . 0.0 111.474 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -176.69 7.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.782 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.62 -61.59 2.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.331 . . . . 0.0 111.011 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.6 86.05 0.16 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.494 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.732 ' OE1' HG22 ' A' ' 22' ' ' VAL . 4.3 tm-20 -82.02 171.68 14.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.897 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t 178.8 122.71 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -144.39 141.36 29.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.402 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.559 ' HA ' HG23 ' A' ' 18' ' ' VAL . 4.0 ttt -133.0 99.73 4.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.419 . . . . 0.0 111.09 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.792 HG23 HG23 ' B' ' 14' ' ' ILE . 0.0 OUTLIER -116.3 129.27 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.484 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.701 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 128.8 -105.09 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.907 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.3 p30 -162.76 16.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 6.9 mt-10 158.2 60.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.849 0.357 . . . . 0.0 110.501 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.702 HG12 ' HD2' ' A' ' 37' ' ' PRO . 17.5 m -120.36 -159.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 120.766 0.317 . . . . 0.0 111.646 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 168.57 103.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.629 ' CG1' HG13 ' A' ' 34' ' ' VAL . 35.1 m -122.57 114.37 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 10' ' ' GLU . 2.9 p -108.2 117.03 33.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.299 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.975 HG11 HG11 ' B' ' 22' ' ' VAL . 30.4 m -108.88 54.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.349 . . . . 0.0 111.693 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 25' ' ' VAL . 2.6 pp -47.94 151.17 0.97 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.863 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.423 ' HA2' HG11 ' A' ' 30' ' ' VAL . . . -107.7 2.56 34.11 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.601 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.431 ' N ' HD12 ' A' ' 23' ' ' LEU . 1.4 t -85.21 120.66 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.928 0.364 . . . . 0.0 110.618 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER 174.73 165.34 0.25 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.76 0.315 . . . . 0.0 110.675 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.81 108.28 3.14 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.852 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.02 -74.41 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.859 0.362 . . . . 0.0 111.043 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 16.8 mt-30 -84.72 136.26 33.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.013 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.423 HG11 ' HA2' ' A' ' 24' ' ' GLY . 22.0 t -93.33 117.2 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 111.535 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.404 ' HG2' HG12 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -75.64 99.85 4.45 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.515 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.852 ' CG2' HG12 ' A' ' 22' ' ' VAL . 11.1 mm -87.08 124.5 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.165 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 118.43 6.09 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.569 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.629 HG13 ' CG1' ' A' ' 20' ' ' VAL . 16.7 t -117.79 103.53 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 0.0 111.396 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.4 OUTLIER -99.38 107.53 19.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.501 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.97 143.36 24.8 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.654 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.702 ' HD2' HG12 ' A' ' 18' ' ' VAL . 78.5 Cg_endo -77.12 156.49 33.77 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.759 2.306 . . . . 0.0 112.078 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -89.17 30.08 1.0 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.278 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.58 -38.64 7.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 41' ' ' SER . 17.2 t -93.25 159.35 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.848 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.474 ' N ' HG12 ' A' ' 40' ' ' VAL . 5.8 t -65.28 97.94 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.009 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.9 p -122.31 120.76 62.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.857 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.12 136.39 51.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.722 0.296 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -133.38 -176.12 4.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -64.17 147.79 51.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -50.96 -60.68 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.199 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 tp -55.07 -35.6 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.203 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.473 ' CZ ' ' HB3' ' B' ' 4' ' ' LEU . 0.4 OUTLIER -53.04 -73.14 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.033 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.665 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 3.0 pt20 -64.2 -17.28 63.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.542 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.48 -31.26 69.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.728 0.299 . . . . 0.0 111.328 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.0 mm -104.53 -12.84 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.917 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -114.88 -57.74 2.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.666 0.269 . . . . 0.0 111.716 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . . . -67.53 -71.69 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.383 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -118.18 117.82 30.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.003 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -55.34 111.32 0.85 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.993 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 m 55.43 -84.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.297 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -153.96 169.58 23.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.8 0.333 . . . . 0.0 110.82 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -163.47 86.84 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.43 159.42 16.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.68 136.51 52.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.937 179.986 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptt? . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.781 0.324 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.0 mp -122.06 107.39 12.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.971 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.502 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.0 tt -115.09 114.81 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.216 0.531 . . . . 0.0 110.942 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -125.49 135.73 52.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.763 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.439 ' H ' HD13 ' B' ' 4' ' ' LEU . 0.2 OUTLIER -62.39 150.9 38.44 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.052 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -170.69 148.04 2.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.268 0.556 . . . . 0.0 111.464 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -176.74 7.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.789 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.67 -61.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.848 0.356 . . . . 0.0 111.032 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.54 86.1 0.16 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.704 ' OE1' HG22 ' B' ' 22' ' ' VAL . 4.3 tm-20 -82.11 171.72 14.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.739 0.304 . . . . 0.0 110.944 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t 178.77 122.71 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.125 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.534 ' HG ' HG22 ' B' ' 20' ' ' VAL . 0.1 OUTLIER -144.37 141.35 29.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.41 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.556 ' HA ' HG23 ' B' ' 18' ' ' VAL . 4.0 ttt -133.03 99.7 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.792 HG23 HG23 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -116.29 129.33 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.478 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.708 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 128.76 -105.09 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.936 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.3 p30 -162.82 16.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 7.0 mt-10 158.19 60.84 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.857 0.361 . . . . 0.0 110.552 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.702 HG12 ' HD2' ' B' ' 37' ' ' PRO . 17.6 m -120.33 -159.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 120.807 0.337 . . . . 0.0 111.651 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.653 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 168.59 103.6 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.639 HG12 HG13 ' B' ' 34' ' ' VAL . 35.1 m -122.53 114.42 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.549 HG22 ' O ' ' B' ' 10' ' ' GLU . 2.9 p -108.26 117.03 33.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.221 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.975 HG11 HG11 ' A' ' 22' ' ' VAL . 30.4 m -108.84 54.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.724 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.424 ' C ' HD12 ' B' ' 23' ' ' LEU . 2.6 pp -47.91 151.1 0.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.411 ' HA2' HG11 ' B' ' 30' ' ' VAL . . . -107.69 2.63 34.14 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.568 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.422 ' N ' HD12 ' B' ' 23' ' ' LEU . 1.4 t -85.24 120.65 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.973 0.387 . . . . 0.0 110.588 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER 174.74 165.34 0.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.807 0.336 . . . . 0.0 110.634 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.8 108.22 3.13 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.813 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.03 -74.49 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 111.003 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 16.8 mt-30 -84.7 136.2 33.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.994 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.411 HG11 ' HA2' ' B' ' 24' ' ' GLY . 22.0 t -93.25 117.21 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.976 0.417 . . . . 0.0 111.532 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.417 ' HG2' HG12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -75.61 99.8 4.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.543 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.852 ' CG2' HG12 ' B' ' 22' ' ' VAL . 11.0 mm -87.05 124.51 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.114 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 118.39 6.08 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.558 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.639 HG13 HG12 ' B' ' 20' ' ' VAL . 16.6 t -117.75 103.57 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.41 . . . . 0.0 111.383 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 19' ' ' THR . 0.4 OUTLIER -99.49 107.54 19.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.48 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.96 143.37 24.88 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.585 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.702 ' HD2' HG12 ' B' ' 18' ' ' VAL . 78.8 Cg_endo -77.12 156.49 33.77 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.752 2.301 . . . . 0.0 112.066 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -89.14 29.95 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.281 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.47 -38.73 7.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.791 0.329 . . . . 0.0 110.816 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.469 HG12 ' N ' ' B' ' 41' ' ' SER . 17.1 t -93.19 159.31 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.469 ' N ' HG12 ' B' ' 40' ' ' VAL . 5.8 t -65.21 97.89 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.029 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.485 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.9 p -122.29 120.79 62.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.866 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 136.38 51.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.752 0.311 . . . . 0.0 110.767 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -133.34 -176.07 4.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.693 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -64.27 147.81 51.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.03 -60.62 2.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 tp -55.0 -35.6 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.285 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -53.1 -73.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.039 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.669 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 3.0 pt20 -64.26 -17.32 63.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.531 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -31.17 69.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.734 0.302 . . . . 0.0 111.367 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.412 ' O ' HG22 ' B' ' 51' ' ' ILE . 29.2 mm -104.64 -12.58 9.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.854 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -115.12 -57.85 2.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.709 0.29 . . . . 0.0 111.746 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' B' ' 49' ' ' GLN . . . -67.48 -71.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.33 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -117.81 116.94 27.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.706 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' B' ' 57' ' ' GLN . 3.3 mtmp? -60.2 109.8 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.18 -66.86 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.107 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' B' ' 55' ' ' LYS . 6.7 tm0? 78.0 -58.41 0.46 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -89.15 58.17 4.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 89.3 p -152.56 134.53 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -117.48 121.38 40.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.871 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.54 ' C ' HD12 ' A' ' 2' ' ' LEU . 2.8 ttp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 1.048 HD21 ' HB2' ' B' ' 53' ' ' ALA . 4.9 mp -122.32 117.02 25.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -97.97 104.76 16.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.221 0.534 . . . . 0.0 110.5 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.514 HD21 ' O ' ' B' ' 48' ' ' TYR . 0.8 OUTLIER -125.44 121.52 34.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.223 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -54.35 138.59 39.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.104 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.904 ' HB3' HG21 ' A' ' 22' ' ' VAL . 72.1 mtt180 -148.66 144.77 27.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.296 0.57 . . . . 0.0 111.787 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.646 ' NE ' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 174.98 -77.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.551 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.507 HG23 ' HD3' ' A' ' 7' ' ' ARG . 3.4 t -85.73 3.75 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.139 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.52 -139.49 4.4 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.907 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -108.61 -175.49 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.869 0.366 . . . . 0.0 111.218 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.719 HG22 ' HA ' ' A' ' 21' ' ' THR . 22.5 p -102.17 165.53 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.028 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.516 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -110.53 154.63 23.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.525 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.444 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.5 ttt -130.67 100.06 5.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.072 0.463 . . . . 0.0 111.389 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.853 HG23 HG23 ' B' ' 14' ' ' ILE . 5.8 tp -115.9 125.52 73.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.505 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.49 -106.32 0.62 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.078 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.412 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.6 t0 -155.57 4.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 3.1 mt-10 163.37 61.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.017 0.436 . . . . 0.0 109.993 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.641 ' O ' HG23 ' A' ' 19' ' ' THR . 5.3 m -115.51 -159.91 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.824 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 171.49 99.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.683 HG22 HG13 ' A' ' 34' ' ' VAL . 42.9 t -106.42 107.52 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.827 0.346 . . . . 0.0 111.669 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.719 ' HA ' HG22 ' A' ' 11' ' ' THR . 2.2 m -91.2 112.77 24.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.021 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.904 HG21 ' HB3' ' A' ' 6' ' ' ARG . 27.0 m -76.76 70.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.497 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.547 HD12 ' H ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -96.03 -152.76 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.547 ' H ' HD12 ' A' ' 23' ' ' LEU . . . 60.36 66.44 2.71 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.996 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.646 HG21 ' NE ' ' A' ' 7' ' ' ARG . 5.2 t -85.88 107.77 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 120.979 0.419 . . . . 0.0 111.049 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -155.1 165.41 36.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.136 -179.362 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.98 156.45 47.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.512 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 70.03 -89.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.404 0.145 . . . . 0.0 110.985 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.493 ' HB3' HG22 ' B' ' 5' ' ' THR . 14.7 mt-30 -110.48 124.56 52.02 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.906 0.384 . . . . 0.0 111.082 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.611 HG23 HD11 ' A' ' 32' ' ' ILE . 10.0 m -93.32 137.37 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.318 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 4.7 mtp180 -78.09 102.91 7.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.611 HD11 HG23 ' A' ' 30' ' ' VAL . 14.7 mm -87.32 134.52 27.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.137 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.53 115.79 4.99 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.512 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.683 HG13 HG22 ' A' ' 20' ' ' VAL . 21.4 t -111.12 103.34 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.944 0.402 . . . . 0.0 111.336 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -96.43 107.23 19.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.075 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.06 147.96 33.68 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.9 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.37 156.29 25.39 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.919 2.413 . . . . 0.0 111.984 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -91.38 41.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.114 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.15 -41.92 3.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.994 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 41' ' ' SER . 5.5 t -81.48 158.9 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.855 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -62.35 99.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.784 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.2 p -122.18 124.23 70.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -128.53 136.18 50.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.311 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -166.98 -170.67 1.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.719 0.295 . . . . 0.0 110.709 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.439 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 30.7 mm-40 -54.04 123.97 14.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.008 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.48 -54.91 41.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.115 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 51' ' ' ILE . 8.0 tp -60.21 -41.18 85.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.026 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.518 ' O ' HD21 ' B' ' 4' ' ' LEU . 4.4 m-85 -47.42 -55.51 8.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.237 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.703 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.6 pt20 -80.0 -21.9 43.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.139 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -71.23 -13.33 61.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.285 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 47' ' ' ILE . 1.4 tt -115.7 -36.39 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.877 0.37 . . . . 0.0 110.65 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -87.45 -58.3 2.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.098 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 1.044 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -61.51 -51.65 67.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.258 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -112.57 116.73 30.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.596 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.64 117.0 1.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.644 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.1 t -109.81 26.8 10.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.008 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -145.98 61.32 1.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.949 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.58 118.33 26.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 t -98.78 36.66 1.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.4 t -102.73 128.05 49.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.926 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.894 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.549 ' C ' HD12 ' B' ' 2' ' ' LEU . 2.8 ttp . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.789 0.328 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 1.044 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.0 mp -122.35 117.02 25.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.64 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -98.03 104.81 16.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.219 0.533 . . . . 0.0 110.494 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.518 HD21 ' O ' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -125.47 121.52 34.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.253 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -54.39 138.6 39.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.082 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.881 ' HB3' HG21 ' B' ' 22' ' ' VAL . 72.0 mtt180 -148.66 144.72 27.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.258 0.551 . . . . 0.0 111.802 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.63 ' NE ' HG21 ' B' ' 25' ' ' VAL . 0.0 OUTLIER 175.01 -77.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.491 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.509 HG23 ' HD3' ' B' ' 7' ' ' ARG . 3.4 t -85.72 3.73 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.211 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.5 -139.5 4.39 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.922 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -108.59 -175.52 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.923 0.392 . . . . 0.0 111.174 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.746 HG22 ' HA ' ' B' ' 21' ' ' THR . 22.5 p -102.18 165.54 11.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.084 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.525 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -110.51 154.62 23.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.526 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.429 ' HA ' HG23 ' B' ' 18' ' ' VAL . 2.5 ttt -130.64 100.03 5.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.009 0.433 . . . . 0.0 111.395 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.853 HG23 HG23 ' A' ' 14' ' ' ILE . 5.8 tp -115.89 125.5 73.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.505 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.53 -106.32 0.62 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.065 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 2.6 t0 -155.61 4.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 3.1 mt-10 163.34 61.12 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.996 0.427 . . . . 0.0 110.0 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.657 ' O ' HG23 ' B' ' 19' ' ' THR . 5.3 m -115.48 -159.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.831 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.657 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 171.51 99.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.342 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.689 HG22 HG13 ' B' ' 34' ' ' VAL . 43.0 t -106.49 107.58 23.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.822 0.344 . . . . 0.0 111.602 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.746 ' HA ' HG22 ' B' ' 11' ' ' THR . 2.2 m -91.22 112.89 24.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.979 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.881 HG21 ' HB3' ' B' ' 6' ' ' ARG . 26.3 m -76.9 70.55 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.457 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.537 HD12 ' H ' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -96.07 -152.79 0.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.681 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.537 ' H ' HD12 ' B' ' 23' ' ' LEU . . . 60.42 66.38 2.75 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.992 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.63 HG21 ' NE ' ' B' ' 7' ' ' ARG . 5.1 t -85.79 107.74 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.402 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.1 OUTLIER -155.05 165.47 36.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.192 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.04 156.43 47.33 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.481 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 70.08 -89.51 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.041 0.136 . . . . 0.0 110.97 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.487 ' HB3' HG22 ' A' ' 5' ' ' THR . 14.6 mt-30 -110.45 124.53 51.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.895 0.379 . . . . 0.0 111.158 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.62 HG23 HD11 ' B' ' 32' ' ' ILE . 10.2 m -93.26 137.41 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.381 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.8 mtp180 -78.19 102.94 7.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.62 HD11 HG23 ' B' ' 30' ' ' VAL . 14.9 mm -87.34 134.58 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.57 115.76 4.97 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.503 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.689 HG13 HG22 ' B' ' 20' ' ' VAL . 21.4 t -111.17 103.3 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 111.264 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -96.41 107.22 19.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.085 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.08 147.92 33.51 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.922 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.29 156.28 25.63 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.951 2.434 . . . . 0.0 112.007 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -91.34 41.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.166 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.14 -41.93 3.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.411 HG12 ' N ' ' B' ' 41' ' ' SER . 5.5 t -81.48 158.89 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.809 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.411 ' N ' HG12 ' B' ' 40' ' ' VAL . 0.3 OUTLIER -62.31 99.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.829 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.456 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.2 p -122.2 124.18 70.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.959 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -128.51 136.25 50.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.311 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -167.03 -170.71 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.722 0.296 . . . . 0.0 110.711 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.449 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 30.5 mm-40 -54.03 123.98 14.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 111.049 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.48 -54.93 41.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.428 HG23 ' N ' ' B' ' 48' ' ' TYR . 8.0 tp -60.2 -41.17 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.059 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.514 ' O ' HD21 ' A' ' 4' ' ' LEU . 4.4 m-85 -47.41 -55.49 8.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.256 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.703 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 4.5 pt20 -79.91 -21.98 43.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.173 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -71.25 -13.3 61.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.252 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.423 HG22 ' O ' ' B' ' 47' ' ' ILE . 1.4 tt -115.71 -36.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.657 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -87.45 -58.3 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.085 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 1.048 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -61.47 -51.67 67.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.309 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -112.61 116.75 30.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.522 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.52 105.47 0.53 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.951 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -75.28 -179.96 4.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.788 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 54.85 72.9 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.034 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -78.67 147.43 33.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 14.9 m -111.98 117.88 33.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 51.5 p -112.95 128.38 56.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.884 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.437 ' C ' HD22 ' A' ' 2' ' ' LEU . 3.2 mtt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.871 0.367 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.961 HD11 ' HB2' ' B' ' 53' ' ' ALA . 4.4 mm? -119.73 112.84 19.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -99.97 105.03 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.179 0.514 . . . . 0.0 110.827 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.43 ' HG ' ' CD2' ' B' ' 48' ' ' TYR . 0.2 OUTLIER -124.76 121.49 34.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.036 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -56.16 140.59 43.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 0.0 110.618 179.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.458 ' HB3' HG21 ' A' ' 22' ' ' VAL . 66.8 mtt85 -155.84 145.33 20.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.785 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER 179.11 1.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.975 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 177.2 30.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 120.532 0.206 . . . . 0.0 111.356 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.93 -118.13 3.51 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.762 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -110.13 -178.31 3.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.912 0.387 . . . . 0.0 111.203 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.6 168.04 10.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.737 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.739 ' CD1' HG11 ' B' ' 34' ' ' VAL . 0.8 OUTLIER -111.52 154.51 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.569 ' HG3' HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -127.39 100.56 6.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.43 . . . . 0.0 110.873 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.627 HG23 HG23 ' B' ' 14' ' ' ILE . 3.1 tp -112.7 125.48 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.606 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.43 -105.44 0.65 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.195 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 12.0 m-20 -156.8 6.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 0.8 OUTLIER 161.15 61.89 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' ' 19' ' ' THR . 4.3 m -116.23 -157.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.526 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 172.53 101.61 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.692 HG22 HG13 ' A' ' 34' ' ' VAL . 59.0 t -111.04 108.19 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.88 0.372 . . . . 0.0 111.697 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.1 p -105.08 110.43 22.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.011 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 22' ' ' VAL . 31.2 m -77.4 72.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.61 -143.56 0.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.628 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.5 74.31 0.27 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.819 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.6 t -93.03 108.3 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.515 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -138.92 157.57 45.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.018 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.8 148.02 50.71 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.72 -79.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.634 0.254 . . . . 0.0 110.767 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.53 ' HB3' HG22 ' B' ' 5' ' ' THR . 8.9 mt-30 -116.78 126.28 52.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.986 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.682 HG23 HD11 ' A' ' 32' ' ' ILE . 17.5 m -93.39 136.93 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.269 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 3.9 mtt85 -77.93 104.91 8.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.257 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.682 HD11 HG23 ' A' ' 30' ' ' VAL . 12.0 mm -87.37 137.75 20.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.848 0.356 . . . . 0.0 111.328 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.86 117.41 5.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.472 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.744 HG11 ' CD1' ' B' ' 12' ' ' LEU . 15.6 t -118.08 103.18 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.411 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.6 OUTLIER -95.74 107.17 19.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.378 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.11 145.49 55.85 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.588 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HD2' HG12 ' A' ' 18' ' ' VAL . 92.2 Cg_endo -78.28 156.32 29.33 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.834 2.356 . . . . 0.0 112.121 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.26 26.75 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.185 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -40.23 5.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.849 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -82.45 152.85 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.5 98.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.077 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 42' ' ' VAL . 12.7 p -122.17 120.59 61.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.1 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -128.55 136.17 50.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.413 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -165.53 -40.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.685 0.279 . . . . 0.0 111.135 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.413 ' N ' ' HG3' ' A' ' 44' ' ' ARG . 1.2 mm-40 177.86 114.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.962 0.41 . . . . 0.0 110.882 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -58.48 -38.78 78.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.684 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.519 HG23 HG13 ' A' ' 51' ' ' ILE . 36.1 mm -69.33 -43.23 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.837 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.43 ' CD2' ' HG ' ' B' ' 4' ' ' LEU . 2.8 m-85 -51.36 -42.68 61.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.416 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -87.72 -58.9 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 111.534 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -52.2 -21.38 3.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.519 HG13 HG23 ' A' ' 47' ' ' ILE . 40.3 mm -106.07 -50.58 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.562 ' HB3' HD12 ' B' ' 2' ' ' LEU . 0.1 OUTLIER -75.79 -58.79 3.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.668 0.271 . . . . 0.0 111.299 -179.461 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.932 ' HB2' HD11 ' B' ' 2' ' ' LEU . . . -67.09 -29.71 69.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.343 . . . . 0.0 111.23 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.2 tt0 -137.97 157.53 46.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 54' ' ' GLU . 1.8 tttp 81.79 -56.5 0.25 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.879 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.68 159.3 15.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.709 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.7 -56.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.957 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -69.04 -30.87 69.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.5 t -116.66 80.76 1.52 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.7 p -122.2 120.97 35.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.886 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.441 ' C ' HD22 ' B' ' 2' ' ' LEU . 3.2 mtt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.833 0.349 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.932 HD11 ' HB2' ' A' ' 53' ' ' ALA . 4.4 mm? -119.75 112.85 19.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.63 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -100.0 105.09 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.252 0.548 . . . . 0.0 110.79 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.43 ' HG ' ' CD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -124.81 121.55 34.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.019 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.53 HG22 ' HB3' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -56.24 140.66 43.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.369 . . . . 0.0 110.589 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.449 ' HB3' HG21 ' B' ' 22' ' ' VAL . 66.7 mtt85 -155.9 145.34 20.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.784 ' O ' HG13 ' B' ' 8' ' ' VAL . 0.0 OUTLIER 179.06 1.55 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.959 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.784 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER 177.13 30.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.573 0.225 . . . . 0.0 111.371 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.0 -118.18 3.5 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.685 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -110.15 -178.31 3.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.955 0.407 . . . . 0.0 111.178 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.57 168.04 10.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.805 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.744 ' CD1' HG11 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -111.49 154.5 24.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.516 179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.572 ' HG3' HG22 ' B' ' 18' ' ' VAL . 0.4 OUTLIER -127.42 100.46 6.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.022 0.439 . . . . 0.0 110.918 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.627 HG23 HG23 ' A' ' 14' ' ' ILE . 3.1 tp -112.69 125.5 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.563 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.46 -105.47 0.65 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.2 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 12.0 m-20 -156.89 6.97 0.17 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 0.8 OUTLIER 161.09 61.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.631 0.372 . . . . 0.0 110.023 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.671 ' O ' HG23 ' B' ' 19' ' ' THR . 4.3 m -116.23 -157.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.568 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.671 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 172.55 101.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.689 HG22 HG13 ' B' ' 34' ' ' VAL . 58.4 t -111.0 108.1 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.816 0.341 . . . . 0.0 111.747 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 5.0 p -104.98 110.45 22.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.03 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.564 ' O ' HG23 ' B' ' 22' ' ' VAL . 30.7 m -77.5 72.56 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.56 -143.65 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.638 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.53 74.32 0.27 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.818 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 10.6 t -93.08 108.33 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 111.279 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.513 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.0 OUTLIER -138.89 157.57 45.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.999 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.83 148.04 50.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.74 -80.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.642 0.258 . . . . 0.0 110.741 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.52 ' HB3' HG22 ' A' ' 5' ' ' THR . 8.9 mt-30 -116.72 126.26 52.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.88 0.371 . . . . 0.0 110.96 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.678 HG23 HD11 ' B' ' 32' ' ' ILE . 17.5 m -93.4 136.98 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 3.9 mtt85 -77.95 104.93 8.81 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.254 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.678 HD11 HG23 ' B' ' 30' ' ' VAL . 12.2 mm -87.38 137.83 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.858 0.361 . . . . 0.0 111.305 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.94 117.44 5.14 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.458 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.739 HG11 ' CD1' ' A' ' 12' ' ' LEU . 15.4 t -118.03 103.14 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 111.489 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' B' ' 19' ' ' THR . 0.6 OUTLIER -95.8 107.22 19.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.17 145.5 55.79 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.597 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.518 ' HD2' HG12 ' B' ' 18' ' ' VAL . 90.2 Cg_endo -78.28 156.34 29.32 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.814 2.343 . . . . 0.0 112.07 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.23 26.77 2.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.221 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.3 -40.28 5.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.753 0.311 . . . . 0.0 110.831 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -82.38 152.81 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.42 98.63 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.121 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.51 HG13 ' O ' ' B' ' 42' ' ' VAL . 12.7 p -122.19 120.61 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.104 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -128.51 136.18 50.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.553 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.414 ' HG3' ' N ' ' B' ' 45' ' ' GLU . 0.0 OUTLIER -165.57 -40.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 0.0 111.133 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' B' ' 44' ' ' ARG . 1.2 mm-40 177.83 114.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.965 0.412 . . . . 0.0 110.918 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -58.52 -38.64 78.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.714 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.522 HG23 HG13 ' B' ' 51' ' ' ILE . 35.9 mm -69.38 -43.21 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.804 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.43 ' CD2' ' HG ' ' A' ' 4' ' ' LEU . 2.8 m-85 -51.38 -42.74 61.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.347 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -87.77 -58.82 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.771 0.319 . . . . 0.0 111.522 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -52.14 -21.54 3.39 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.522 HG13 HG23 ' B' ' 47' ' ' ILE . 40.2 mm -105.93 -50.51 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.565 ' HB3' HD12 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -75.89 -58.8 3.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.713 0.292 . . . . 0.0 111.314 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.961 ' HB2' HD11 ' A' ' 2' ' ' LEU . . . -67.07 -29.71 69.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.342 . . . . 0.0 111.199 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -138.05 156.78 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -92.95 82.42 4.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.774 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.411 ' CB ' HD13 ' B' ' 51' ' ' ILE . 23.1 t -53.56 -35.32 60.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.209 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 65.08 72.57 0.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.88 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -132.63 -57.14 0.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 4.5 m -68.9 168.54 13.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.42 138.88 35.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.871 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.804 0.335 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.673 HD11 ' O ' ' B' ' 48' ' ' TYR . 6.6 tt -116.55 103.15 10.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -98.08 105.48 17.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.195 0.521 . . . . 0.0 110.785 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 4' ' ' LEU . 11.0 tp -125.28 121.33 33.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.924 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.593 HG22 ' HB3' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -56.88 149.3 18.84 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.389 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 10' ' ' GLU . 1.1 tpt180 -179.53 143.15 0.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.224 0.535 . . . . 0.0 111.399 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.931 ' NE ' HG13 ' A' ' 25' ' ' VAL . 36.4 ttt180 -170.1 23.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.063 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.08 -53.43 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.165 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.08 105.49 0.19 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.683 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.468 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . 0.7 OUTLIER -113.13 -58.25 2.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 0.0 110.869 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p 65.52 96.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.124 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.431 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 1.6 pt? -114.57 154.72 27.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.069 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.571 ' HA ' HG23 ' A' ' 18' ' ' VAL . 34.8 ttm -128.98 99.93 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.059 0.457 . . . . 0.0 111.015 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 14' ' ' ILE . 6.1 tp -118.02 102.86 13.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.814 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.28 -107.33 0.32 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.972 -0.633 . . . . 0.0 111.887 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.36 -4.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 165.05 57.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.762 HG12 ' HD2' ' A' ' 37' ' ' PRO . 12.8 m -112.45 -161.58 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.816 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.893 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.5 OUTLIER 170.13 102.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.844 HG13 ' HA ' ' A' ' 34' ' ' VAL . 21.4 t -111.2 110.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.906 0.384 . . . . 0.0 111.894 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.4 m -98.35 111.65 23.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.767 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 22' ' ' VAL . 17.5 m -77.01 68.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.347 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.45 -142.39 0.26 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.751 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 31' ' ' ARG . . . 53.82 70.77 0.84 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.566 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.931 HG13 ' NE ' ' A' ' 7' ' ' ARG . 40.5 t -85.94 107.66 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.909 0.385 . . . . 0.0 111.455 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -143.97 151.57 39.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.046 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.43 150.54 47.16 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.419 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 72.58 -75.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.606 0.241 . . . . 0.0 111.004 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.588 ' HB3' HG22 ' B' ' 5' ' ' THR . 9.0 mp0 -120.95 128.84 53.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.985 0.422 . . . . 0.0 111.115 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.654 HG23 HD11 ' A' ' 32' ' ' ILE . 11.0 m -93.29 137.18 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.248 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 0.1 OUTLIER -75.77 104.63 6.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.28 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.654 HD11 HG23 ' A' ' 30' ' ' VAL . 9.3 mm -87.47 130.14 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.215 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.73 108.44 3.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.156 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.844 ' HA ' HG13 ' A' ' 20' ' ' VAL . 12.7 t -107.28 103.17 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 111.615 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.893 ' HB3' HG23 ' A' ' 19' ' ' THR . 3.6 t-20 -96.19 107.22 19.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.384 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.9 146.84 58.53 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.715 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.762 ' HD2' HG12 ' A' ' 18' ' ' VAL . 86.5 Cg_endo -80.58 156.36 21.55 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.961 2.441 . . . . 0.0 112.104 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -92.47 32.87 1.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.188 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.32 -41.26 3.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.739 0.304 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 41' ' ' SER . 5.6 t -77.9 160.68 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.79 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.444 ' N ' HG12 ' A' ' 40' ' ' VAL . 3.8 t -66.75 106.68 1.92 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.838 0.352 . . . . 0.0 110.859 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 42' ' ' VAL . 12.7 p -121.94 126.11 74.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -128.88 124.1 34.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.207 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -156.76 -65.82 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 110.461 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 5.3 tp10 -171.69 130.46 0.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.56 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -58.79 -38.75 79.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.047 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.409 HG23 HG13 ' A' ' 51' ' ' ILE . 16.1 mt -73.05 -43.56 58.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.302 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.677 ' O ' HD11 ' B' ' 2' ' ' LEU . 3.2 m-85 -50.46 -46.63 56.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.651 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.622 ' HG2' ' HB3' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -83.1 -58.09 3.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.207 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.429 ' HA ' ' CB ' ' A' ' 54' ' ' GLU . 3.6 mtp85 -55.05 -9.78 0.43 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.453 HG23 ' HB2' ' A' ' 56' ' ' SER . 49.3 mm -112.86 -55.45 4.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 O-C-N 122.258 -0.276 . . . . 0.0 111.728 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 7.2 mp0 -75.89 -54.3 7.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 110.999 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.622 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . . . -75.04 -36.83 61.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.892 0.377 . . . . 0.0 110.962 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' CB ' ' HA ' ' A' ' 50' ' ' ARG . 3.7 tp10 -103.56 122.42 44.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.753 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.59 96.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.877 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.453 ' HB2' HG23 ' A' ' 51' ' ' ILE . 22.4 t -62.74 157.23 21.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -94.9 125.55 39.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -64.37 129.61 40.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.1 -169.0 2.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.808 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.3 t -91.92 121.0 33.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.853 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.0 t80 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.86 -179.925 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.832 0.349 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.677 HD11 ' O ' ' A' ' 48' ' ' TYR . 6.6 tt -116.58 103.12 10.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.637 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -98.04 105.56 17.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.26 0.552 . . . . 0.0 110.763 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 tp -125.32 121.37 33.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.831 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -56.97 149.27 19.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.397 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.476 ' HG2' ' HB2' ' B' ' 10' ' ' GLU . 1.1 tpt180 -179.53 143.17 0.19 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.253 0.549 . . . . 0.0 111.418 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.933 ' NE ' HG13 ' B' ' 25' ' ' VAL . 36.2 ttt180 -170.18 23.53 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.102 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.07 -53.51 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.161 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.13 105.52 0.19 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.703 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.476 ' HB2' ' HG2' ' B' ' 6' ' ' ARG . 0.7 OUTLIER -113.1 -58.33 2.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 110.854 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.9 p 65.53 96.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.165 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.438 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 1.6 pt? -114.48 154.76 27.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.121 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.562 ' HA ' HG23 ' B' ' 18' ' ' VAL . 34.8 ttm -129.04 99.96 5.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.01 0.433 . . . . 0.0 111.032 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.588 ' O ' HG23 ' B' ' 14' ' ' ILE . 6.1 tp -117.97 102.85 13.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.854 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.3 -107.34 0.32 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.883 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.39 -4.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 165.07 57.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.755 HG12 ' HD2' ' B' ' 37' ' ' PRO . 12.9 m -112.42 -161.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.796 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.911 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.5 OUTLIER 170.09 102.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.443 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' B' ' 34' ' ' VAL . 21.4 t -111.22 110.16 31.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 111.948 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 6.4 m -98.35 111.65 23.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.794 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 22' ' ' VAL . 17.5 m -76.98 68.42 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.312 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.52 -142.38 0.26 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' B' ' 31' ' ' ARG . . . 53.86 70.77 0.84 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.556 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.933 HG13 ' NE ' ' B' ' 7' ' ' ARG . 40.4 t -85.96 107.62 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.0 111.428 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -143.97 151.57 39.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.031 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.46 150.49 47.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.476 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 72.62 -75.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.585 0.231 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.593 ' HB3' HG22 ' A' ' 5' ' ' THR . 9.0 mp0 -121.05 128.78 52.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 111.089 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.647 HG23 HD11 ' B' ' 32' ' ' ILE . 11.0 m -93.23 137.16 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.266 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -75.77 104.6 6.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.289 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.647 HD11 HG23 ' B' ' 30' ' ' VAL . 9.3 mm -87.44 130.17 37.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.201 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.78 108.44 3.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.161 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.861 ' HA ' HG13 ' B' ' 20' ' ' VAL . 12.7 t -107.24 103.17 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.91 0.385 . . . . 0.0 111.577 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.911 ' HB3' HG23 ' B' ' 19' ' ' THR . 3.6 t-20 -96.13 107.15 19.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.402 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.85 146.78 58.38 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.751 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.755 ' HD2' HG12 ' B' ' 18' ' ' VAL . 86.1 Cg_endo -80.57 156.34 21.56 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.963 2.442 . . . . 0.0 112.101 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -92.46 32.93 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.224 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.34 -41.21 3.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.78 0.324 . . . . 0.0 110.973 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.437 HG12 ' N ' ' B' ' 41' ' ' SER . 5.6 t -77.94 160.76 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.792 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.437 ' N ' HG12 ' B' ' 40' ' ' VAL . 3.8 t -66.81 106.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 0.0 110.839 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.438 HG13 ' O ' ' B' ' 42' ' ' VAL . 12.7 p -121.95 126.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -128.91 124.15 34.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.168 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -156.77 -65.84 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.441 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 5.3 tp10 -171.72 130.49 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.586 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -58.81 -38.73 79.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.421 ' CG2' HG13 ' B' ' 51' ' ' ILE . 16.0 mt -73.03 -43.49 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.307 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.673 ' O ' HD11 ' A' ' 2' ' ' LEU . 3.2 m-85 -50.61 -46.47 58.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.635 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.623 ' HG2' ' HB3' ' B' ' 53' ' ' ALA . 0.3 OUTLIER -83.22 -58.11 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.427 ' HA ' ' CB ' ' B' ' 54' ' ' GLU . 3.6 mtp85 -55.13 -9.71 0.44 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.421 HG13 ' CG2' ' B' ' 47' ' ' ILE . 49.1 mm -112.86 -55.53 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 7.2 mp0 -75.88 -54.32 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.684 0.278 . . . . 0.0 110.93 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.623 ' HB3' ' HG2' ' B' ' 49' ' ' GLN . . . -75.06 -36.72 61.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.945 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' B' ' 50' ' ' ARG . 3.7 tp10 -103.79 124.01 48.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.1 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.09 -87.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.059 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 7.0 t 62.48 147.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.81 0.338 . . . . 0.0 110.742 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -130.92 -50.96 1.04 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -147.38 146.37 29.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.981 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -61.11 -53.96 50.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.9 p -121.94 124.4 43.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 11.4 t80 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.894 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.659 ' C ' HD12 ' A' ' 2' ' ' LEU . 6.6 mmm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.882 0.372 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.659 HD12 ' C ' ' A' ' 1' ' ' MET . 5.2 mp -116.7 104.74 11.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.682 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.532 HG21 ' HD3' ' B' ' 31' ' ' ARG . 19.2 mm -96.83 105.13 16.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 110.74 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.468 ' HA ' HD22 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -124.63 116.7 22.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.976 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.549 HG22 ' HB3' ' B' ' 29' ' ' GLN . 0.3 OUTLIER -54.7 140.22 36.45 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.394 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.509 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 24.3 mtt180 -154.76 141.13 18.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.184 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 179.11 4.3 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.299 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.24 -76.41 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 O-C-N 122.213 -0.304 . . . . 0.0 111.517 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.33 97.94 0.51 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.662 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 6' ' ' ARG . 6.6 mp0 -113.21 174.7 5.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.723 0.297 . . . . 0.0 111.034 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER 164.86 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.141 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.446 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -112.35 154.1 26.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.528 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.4 ttp -133.29 100.69 4.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.053 0.454 . . . . 0.0 111.755 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.864 HG23 HG23 ' B' ' 14' ' ' ILE . 5.1 tp -114.36 120.61 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.186 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.472 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 135.85 -106.92 0.59 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.058 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.466 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -152.55 6.43 0.41 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 4.6 mt-10 159.31 64.19 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.907 0.384 . . . . 0.0 110.29 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.647 ' O ' HG23 ' A' ' 19' ' ' THR . 12.4 m -118.85 -158.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER 170.18 104.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.558 HG13 ' HA ' ' A' ' 34' ' ' VAL . 22.0 t -117.95 116.14 50.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.0 111.751 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.0 t -114.79 115.63 27.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.006 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.866 HG12 HG23 ' A' ' 32' ' ' ILE . 26.7 m -80.95 73.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.389 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.91 -136.04 0.1 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.472 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.05 74.7 0.21 Allowed Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.933 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.634 HG22 ' HG2' ' A' ' 7' ' ' ARG . 21.3 t -86.04 108.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.465 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -140.24 153.38 46.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.048 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.15 149.45 47.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.453 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 69.14 -83.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.638 0.256 . . . . 0.0 110.721 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.525 ' HB3' HG22 ' B' ' 5' ' ' THR . 42.5 mt-30 -107.32 125.24 50.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.356 . . . . 0.0 110.947 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.518 HG23 HD11 ' A' ' 32' ' ' ILE . 14.3 m -93.13 136.89 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.283 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.549 ' HD3' HG21 ' B' ' 3' ' ' ILE . 28.8 mtt85 -75.96 104.39 6.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.491 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.866 HG23 HG12 ' A' ' 22' ' ' VAL . 28.4 mm -87.17 131.36 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.281 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.5 125.12 8.14 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.745 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.558 ' HA ' HG13 ' A' ' 20' ' ' VAL . 12.2 t -118.05 129.72 73.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.835 0.35 . . . . 0.0 111.123 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 19' ' ' THR . 2.3 t30 -123.16 107.21 11.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.13 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.86 144.25 26.12 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.745 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HD2' HG12 ' A' ' 18' ' ' VAL . 82.2 Cg_endo -77.93 156.45 30.7 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.736 2.29 . . . . 0.0 112.081 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.08 38.01 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.398 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.73 -38.7 4.2 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.759 0.314 . . . . 0.0 110.803 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.477 HG12 ' O ' ' B' ' 15' ' ' GLY . 13.3 t -89.58 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -57.49 97.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.943 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.792 HG22 ' HD2' ' A' ' 44' ' ' ARG . 14.6 p -122.35 120.71 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 136.11 50.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.674 0.274 . . . . 0.0 110.81 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.792 ' HD2' HG22 ' A' ' 42' ' ' VAL . 1.9 mpp_? -147.4 -172.6 4.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.54 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.44 ' HB3' ' CG ' ' A' ' 48' ' ' TYR . 1.5 tp10 -63.16 139.2 58.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.766 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -62.36 1.67 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.383 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 39.1 mm -56.82 -45.57 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.792 0.329 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.461 ' CG ' ' HG ' ' B' ' 4' ' ' LEU . 4.1 m-30 -41.5 -73.33 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.545 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.699 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 13.8 pt20 -66.48 -19.26 65.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.54 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 6.0 mtm180 -69.0 -20.0 64.15 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 48' ' ' TYR . 3.5 pt -111.39 -23.87 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.48 ' HG3' HD23 ' B' ' 2' ' ' LEU . 4.3 pt20 -107.68 -52.38 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.623 0.249 . . . . 0.0 111.547 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.699 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . . . -70.36 -72.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 111.224 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.5 118.81 37.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.727 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -56.72 95.42 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.138 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.9 p 49.05 95.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.222 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -84.03 57.82 4.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.955 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.425 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -133.3 151.45 51.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.6 151.3 38.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.734 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -122.39 120.67 34.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.912 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.65 ' C ' HD12 ' B' ' 2' ' ' LEU . 6.7 mmm . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.87 0.367 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.65 HD12 ' C ' ' B' ' 1' ' ' MET . 5.2 mp -116.76 104.74 11.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.549 HG21 ' HD3' ' A' ' 31' ' ' ARG . 19.2 mm -96.81 105.17 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.98 0.419 . . . . 0.0 110.725 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.461 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -124.66 116.67 22.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.961 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -54.72 140.24 36.54 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.413 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' B' ' 10' ' ' GLU . 24.4 mtt180 -154.74 141.13 18.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.205 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' B' ' 25' ' ' VAL . 0.0 OUTLIER 179.1 4.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.269 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.24 -76.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 O-C-N 122.167 -0.333 . . . . 0.0 111.544 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.33 97.89 0.51 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.666 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' B' ' 6' ' ' ARG . 6.6 mp0 -113.16 174.7 5.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.748 0.309 . . . . 0.0 111.051 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.47 HG22 ' C ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 164.81 91.71 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.14 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.454 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -112.31 154.05 26.27 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.512 ' HA ' HG23 ' B' ' 18' ' ' VAL . 2.4 ttp -133.26 100.58 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.999 0.428 . . . . 0.0 111.785 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.864 HG23 HG23 ' A' ' 14' ' ' ILE . 5.1 tp -114.33 120.61 64.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.189 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 135.86 -106.92 0.59 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.086 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 0.4 OUTLIER -152.53 6.46 0.41 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.469 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 4.6 mt-10 159.32 64.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.957 0.408 . . . . 0.0 110.289 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.642 ' O ' HG23 ' B' ' 19' ' ' THR . 12.3 m -118.78 -158.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.417 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.642 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.1 OUTLIER 170.18 104.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' B' ' 34' ' ' VAL . 21.9 t -117.9 116.1 50.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 0.0 111.741 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 3.0 t -114.75 115.62 27.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.005 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.86 HG12 HG23 ' B' ' 32' ' ' ILE . 26.8 m -80.97 73.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.0 0.429 . . . . 0.0 111.343 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.94 -136.08 0.1 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.483 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.08 74.67 0.22 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.975 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.634 HG22 ' HG2' ' B' ' 7' ' ' ARG . 21.3 t -85.99 108.15 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 0.0 111.47 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -140.27 153.34 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.058 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.11 149.45 47.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.465 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 69.06 -83.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.541 0.21 . . . . 0.0 110.701 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.549 ' HB3' HG22 ' A' ' 5' ' ' THR . 42.5 mt-30 -107.35 125.24 50.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 110.941 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.513 HG23 HD11 ' B' ' 32' ' ' ILE . 14.3 m -93.14 136.91 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.32 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.532 ' HD3' HG21 ' A' ' 3' ' ' ILE . 28.6 mtt85 -76.0 104.35 6.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.454 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.86 HG23 HG12 ' B' ' 22' ' ' VAL . 28.4 mm -87.15 131.32 35.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.299 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.47 125.2 8.17 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.792 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.567 ' HA ' HG13 ' B' ' 20' ' ' VAL . 12.4 t -118.1 129.75 73.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.827 0.346 . . . . 0.0 111.063 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' B' ' 19' ' ' THR . 2.3 t30 -123.23 107.26 11.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.074 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.89 144.22 25.91 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.75 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.42 ' HD2' HG12 ' B' ' 18' ' ' VAL . 84.1 Cg_endo -77.83 156.45 31.08 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.797 2.331 . . . . 0.0 112.103 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.09 38.02 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.38 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.77 -38.69 4.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.79 0.329 . . . . 0.0 110.804 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 15' ' ' GLY . 13.3 t -89.63 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.846 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -57.42 97.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.013 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.793 HG22 ' HD2' ' B' ' 44' ' ' ARG . 14.6 p -122.38 120.75 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 136.13 50.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.657 0.265 . . . . 0.0 110.816 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.793 ' HD2' HG22 ' B' ' 42' ' ' VAL . 1.9 mpp_? -147.41 -172.66 4.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.44 ' HB3' ' CG ' ' B' ' 48' ' ' TYR . 1.5 tp10 -63.01 139.19 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.824 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -62.33 1.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.421 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' B' ' 50' ' ' ARG . 39.2 mm -56.86 -45.53 83.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.78 0.324 . . . . 0.0 111.164 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.462 ' CG ' ' HG ' ' A' ' 4' ' ' LEU . 4.1 m-30 -41.52 -73.34 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.568 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.688 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 13.8 pt20 -66.48 -19.24 65.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.538 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 6.0 mtm180 -69.0 -19.92 64.14 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.416 HG13 ' O ' ' B' ' 48' ' ' TYR . 3.5 pt -111.57 -23.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.489 ' HG3' HD23 ' A' ' 2' ' ' LEU . 4.3 pt20 -107.82 -52.29 2.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.563 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.688 ' HB3' ' HB2' ' B' ' 49' ' ' GLN . . . -70.47 -72.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.807 0.337 . . . . 0.0 111.185 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.58 119.43 39.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.617 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.47 93.17 0.1 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.733 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 4.0 t 55.14 87.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.999 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -70.0 141.86 52.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -143.17 173.51 11.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 58.2 m -88.92 155.2 19.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -97.44 140.44 31.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.94 -179.92 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.799 0.333 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.65 HD22 ' CE2' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -118.11 108.48 15.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 3' ' ' ILE . 5.2 tt -84.36 115.0 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.009 0.433 . . . . 0.0 111.535 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.767 HD12 ' CZ ' ' B' ' 48' ' ' TYR . 0.3 OUTLIER -115.1 156.24 25.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.653 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.476 ' H ' HD23 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -95.8 121.22 37.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 0.0 111.476 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.6 ' NH2' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -92.21 149.16 21.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.475 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.626 ' CG ' HG13 ' A' ' 30' ' ' VAL . 6.6 mtp180 78.01 87.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.706 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.647 HG23 ' CA ' ' A' ' 24' ' ' GLY . 56.2 t 80.74 55.49 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.193 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.525 ' H ' HG21 ' A' ' 22' ' ' VAL . . . -142.89 -148.54 4.96 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.536 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.28 121.46 44.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 111.616 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -58.55 147.53 31.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.402 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.741 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -117.82 154.73 31.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.766 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.6 ttt -127.91 100.7 6.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 0.0 110.766 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.62 HG23 HG23 ' B' ' 14' ' ' ILE . 4.6 tp -115.42 137.7 48.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.952 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.684 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 126.71 -107.19 0.89 Allowed Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.339 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -153.39 -4.42 0.19 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 1.0 OUTLIER 171.38 57.43 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 19' ' ' THR . 10.4 m -111.31 -159.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.615 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 173.72 102.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.741 ' HB ' HD23 ' A' ' 12' ' ' LEU . 41.6 t -102.93 101.99 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.856 0.36 . . . . 0.0 111.172 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -93.17 157.3 16.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.22 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.525 HG21 ' H ' ' A' ' 9' ' ' GLY . 34.8 m -106.86 -173.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.577 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -127.38 -53.52 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 0.0 110.291 179.689 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.647 ' CA ' HG23 ' A' ' 8' ' ' VAL . . . 93.64 -39.99 2.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.162 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 11.4 t -85.66 149.83 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.596 0.236 . . . . 0.0 111.495 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 25' ' ' VAL . 10.8 tttp 101.25 116.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.245 0.618 . . . . 0.0 110.85 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.81 174.74 46.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.683 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.83 -84.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.677 0.275 . . . . 0.0 110.301 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.9 136.95 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.423 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.741 ' CG1' HD11 ' A' ' 32' ' ' ILE . 21.7 t -92.89 115.71 32.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.807 0.337 . . . . 0.0 110.888 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -86.44 99.46 11.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.99 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.741 HD11 ' CG1' ' A' ' 30' ' ' VAL . 33.0 mm -112.76 135.57 51.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.935 0.397 . . . . 0.0 111.425 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.37 112.72 4.19 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.302 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.72 HG13 HG22 ' A' ' 20' ' ' VAL . 25.1 t -98.07 103.17 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.7 107.29 19.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.638 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.02 145.52 56.06 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.431 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HD2' HG12 ' A' ' 18' ' ' VAL . 88.4 Cg_endo -81.24 156.55 19.65 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.93 2.42 . . . . 0.0 112.231 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -89.45 27.29 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.278 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -112.67 -37.17 4.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.757 0.313 . . . . 0.0 111.034 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.689 HG12 ' O ' ' B' ' 15' ' ' GLY . 5.1 t -81.82 144.64 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.806 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -54.89 100.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.484 HG21 ' NH2' ' A' ' 44' ' ' ARG . 13.0 p -122.09 124.11 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.077 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.57 136.17 50.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.373 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.487 ' CZ ' HD13 ' B' ' 2' ' ' LEU . 7.1 mtt85 -151.86 -60.69 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.931 0.396 . . . . 0.0 110.612 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 178.78 143.7 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.655 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -43.83 92.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.617 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.525 HG22 HD12 ' A' ' 51' ' ' ILE . 42.4 mm -64.56 -49.08 82.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.061 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.771 ' CZ ' HD12 ' B' ' 4' ' ' LEU . 88.9 t80 -50.63 -45.84 57.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.55 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 53' ' ' ALA . 21.2 tt0 -75.55 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 111.729 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -51.44 -17.35 0.76 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.525 HD12 HG22 ' A' ' 47' ' ' ILE . 36.5 mt -108.89 -54.78 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.75 0.309 . . . . 0.0 111.205 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.63 ' HB2' HD23 ' B' ' 2' ' ' LEU . 60.5 mm-40 -69.14 -62.05 1.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.922 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.5 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . . . -67.3 -33.54 75.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.008 0.433 . . . . 0.0 110.731 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -118.19 124.06 47.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.606 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -52.69 110.45 0.51 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.267 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.1 t -72.28 177.19 4.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.747 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.5 114.84 4.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -176.99 114.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.83 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.4 160.44 6.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 p -115.95 134.78 54.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.826 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.825 0.345 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.657 HD22 ' CE2' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -118.07 108.44 15.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.558 HG23 ' O ' ' B' ' 3' ' ' ILE . 5.3 tt -84.38 115.05 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 111.531 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.771 HD12 ' CZ ' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -115.12 156.15 25.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.686 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.465 ' H ' HD23 ' B' ' 4' ' ' LEU . 0.3 OUTLIER -95.7 121.19 37.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.018 0.437 . . . . 0.0 111.446 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.602 ' NH2' HD22 ' B' ' 4' ' ' LEU . 0.0 OUTLIER -92.21 149.12 21.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.53 179.335 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.624 ' CG ' HG13 ' B' ' 30' ' ' VAL . 6.6 mtp180 78.02 87.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.691 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.657 HG23 ' CA ' ' B' ' 24' ' ' GLY . 55.3 t 80.67 55.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.188 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.524 ' H ' HG21 ' B' ' 22' ' ' VAL . . . -142.88 -148.54 4.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.593 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.24 121.4 44.33 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.879 0.371 . . . . 0.0 111.614 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -58.48 147.57 31.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.413 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.714 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.6 OUTLIER -117.83 154.76 31.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.728 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.6 ttt -127.97 100.59 5.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.856 0.36 . . . . 0.0 110.775 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.62 HG23 HG23 ' A' ' 14' ' ' ILE . 4.6 tp -115.37 137.75 47.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.689 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 126.71 -107.22 0.89 Allowed Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.329 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.3 OUTLIER -153.41 -4.37 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 1.0 OUTLIER 171.27 57.42 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.656 ' O ' HG23 ' B' ' 19' ' ' THR . 10.4 m -111.33 -159.48 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.564 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.656 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 173.84 102.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.501 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.757 HG22 HG13 ' B' ' 34' ' ' VAL . 41.4 t -102.84 101.89 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.821 0.343 . . . . 0.0 111.227 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -93.1 157.25 16.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.237 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.524 HG21 ' H ' ' B' ' 9' ' ' GLY . 34.9 m -106.81 -173.11 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.545 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' B' ' 23' ' ' LEU . 1.0 OUTLIER -127.48 -53.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 110.3 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.657 ' CA ' HG23 ' B' ' 8' ' ' VAL . . . 93.61 -39.89 2.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.157 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.573 ' O ' ' CB ' ' B' ' 26' ' ' LYS . 11.4 t -85.66 149.82 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.543 0.211 . . . . 0.0 111.502 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' B' ' 25' ' ' VAL . 10.8 tttp 101.22 116.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.249 0.62 . . . . 0.0 110.804 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.84 174.78 46.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.644 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.75 -84.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.657 0.265 . . . . 0.0 110.319 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.89 136.96 33.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.437 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.733 ' CG1' HD11 ' B' ' 32' ' ' ILE . 21.6 t -92.89 115.7 32.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.361 . . . . 0.0 110.905 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -86.45 99.48 11.68 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.994 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.733 HD11 ' CG1' ' B' ' 30' ' ' VAL . 33.2 mm -112.77 135.63 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 111.395 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.44 112.72 4.18 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.294 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.757 HG13 HG22 ' B' ' 20' ' ' VAL . 25.4 t -98.11 103.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.093 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.66 107.25 19.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.659 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.98 145.51 56.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.476 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.496 ' HD2' HG12 ' B' ' 18' ' ' VAL . 87.5 Cg_endo -81.29 156.46 19.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.891 2.394 . . . . 0.0 112.193 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -89.32 27.25 1.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.314 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -112.68 -37.22 4.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 110.995 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 15' ' ' GLY . 5.1 t -81.69 144.63 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.825 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -54.96 100.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.128 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.489 HG21 ' NH2' ' B' ' 44' ' ' ARG . 13.1 p -122.13 124.07 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.062 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.48 136.2 50.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.407 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.494 ' CZ ' HD13 ' A' ' 2' ' ' LEU . 7.1 mtt85 -151.88 -60.73 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.625 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 178.79 143.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.614 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.72 -43.86 92.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.932 0.396 . . . . 0.0 110.615 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.527 HG22 HD12 ' B' ' 51' ' ' ILE . 42.4 mm -64.59 -49.05 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.061 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.767 ' CZ ' HD12 ' A' ' 4' ' ' LEU . 88.8 t80 -50.68 -45.78 58.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.541 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.494 ' HG2' ' HB3' ' B' ' 53' ' ' ALA . 21.2 tt0 -75.6 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.713 0.292 . . . . 0.0 111.715 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -51.47 -17.28 0.75 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.527 HD12 HG22 ' B' ' 47' ' ' ILE . 36.0 mt -109.0 -54.67 5.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.761 0.315 . . . . 0.0 111.221 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.627 ' HB2' HD23 ' A' ' 2' ' ' LEU . 60.6 mm-40 -69.16 -62.14 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.854 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.495 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -67.33 -33.36 75.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.97 0.414 . . . . 0.0 110.769 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -119.08 127.19 53.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.839 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 105.64 0.68 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.536 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -170.09 0.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.922 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -57.67 12.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.83 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -76.0 -66.89 0.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.814 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 29.1 t 58.22 100.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.041 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 82.6 p -97.6 145.15 26.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.801 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.92 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.805 0.336 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' B' ' 53' ' ' ALA . 0.5 OUTLIER -114.51 102.83 10.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.034 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -92.92 105.75 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.331 0.586 . . . . 0.0 110.949 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.831 HD13 ' CD2' ' B' ' 48' ' ' TYR . 0.1 OUTLIER -124.28 156.59 36.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.074 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.4 HG22 ' HB3' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -86.72 138.43 31.64 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.533 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.806 ' HB3' HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -150.94 145.95 25.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.072 0.463 . . . . 0.0 111.324 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -179.37 10.98 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.89 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.54 -41.22 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 122.165 -0.334 . . . . 0.0 111.507 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.7 94.46 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.802 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.403 ' CG ' ' HG2' ' A' ' 6' ' ' ARG . 2.2 tp10 -97.11 -61.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.458 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 m 64.94 98.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.385 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -120.44 154.37 35.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.086 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.667 ' HA ' HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -129.98 100.05 5.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.939 0.4 . . . . 0.0 110.991 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 14' ' ' ILE . 8.2 tp -119.15 102.85 13.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.037 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.545 ' HA2' HG11 ' B' ' 40' ' ' VAL . . . 156.54 -108.15 0.35 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.325 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.06 -15.51 4.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 164.29 61.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.993 0.425 . . . . 0.0 110.055 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.852 HG12 ' HD2' ' A' ' 37' ' ' PRO . 22.5 m -107.76 -168.62 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.64 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.872 HG23 ' HB3' ' A' ' 35' ' ' ASN . 1.1 t -175.33 103.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.751 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.675 HG13 ' HA ' ' A' ' 34' ' ' VAL . 21.5 t -102.76 106.9 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 21' ' ' THR . 9.4 t -91.57 111.85 23.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.569 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 6' ' ' ARG . 30.1 m -84.01 62.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.569 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.43 -142.42 0.24 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.829 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 31' ' ' ARG . . . 53.27 69.24 1.27 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.677 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' A' ' 7' ' ' ARG . 17.5 t -88.49 107.52 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 120.923 0.392 . . . . 0.0 111.576 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -142.67 146.97 34.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.104 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.3 158.7 30.59 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.526 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.83 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.674 0.273 . . . . 0.0 110.761 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.46 124.45 50.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 110.749 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.739 HG21 HG21 ' B' ' 30' ' ' VAL . 30.1 t -93.74 136.5 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.219 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.461 ' HB3' ' HA3' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -83.17 109.15 16.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.114 179.273 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.44 135.59 27.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.286 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.26 111.0 2.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.259 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.675 ' HA ' HG13 ' A' ' 20' ' ' VAL . 15.0 t -113.59 102.89 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 0.0 111.458 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.872 ' HB3' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER -91.63 107.18 19.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.667 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.435 ' HB1' HG12 ' B' ' 14' ' ' ILE . . . -130.12 146.21 60.56 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.532 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.852 ' HD2' HG12 ' A' ' 18' ' ' VAL . 86.9 Cg_endo -77.88 156.41 30.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.77 2.314 . . . . 0.0 112.008 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -91.3 38.36 0.97 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.11 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -123.55 -38.65 2.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.546 HG11 ' HA2' ' B' ' 15' ' ' GLY . 6.2 t -83.39 156.74 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.822 0.344 . . . . 0.0 110.978 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -57.05 114.97 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.5 p -122.07 121.9 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.96 122.39 30.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.538 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.565 HH21 HD13 ' B' ' 12' ' ' LEU . 17.5 ttm180 -163.95 -77.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.03 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 5.8 mm-40 -155.07 131.47 10.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.57 -50.72 72.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.221 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.471 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 13.9 tt -63.17 -42.04 95.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.974 0.416 . . . . 0.0 111.166 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.827 ' CD2' HD13 ' B' ' 4' ' ' LEU . 5.9 m-85 -50.9 -53.39 33.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.169 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.536 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 1.5 mt-30 -78.33 -21.7 49.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.137 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 4.9 mtt180 -72.92 -15.43 61.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.671 0.272 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.5 mt -109.82 -27.1 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.331 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.541 ' HB2' HD23 ' B' ' 2' ' ' LEU . 6.0 mp0 -107.79 -54.54 2.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.796 0.331 . . . . 0.0 111.28 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.651 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -64.74 -73.62 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.277 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -111.85 123.72 50.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.785 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.03 90.34 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.286 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.28 -74.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.947 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.67 150.65 29.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -66.99 -57.61 6.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.2 p -164.89 -73.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -94.55 136.78 34.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.5 t80 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.879 -179.984 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.651 HD21 ' HB2' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -114.59 102.82 10.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.631 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -92.86 105.74 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.335 0.588 . . . . 0.0 110.968 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.827 HD13 ' CD2' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -124.34 156.62 36.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.998 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.78 138.43 31.61 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.527 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.834 ' HB3' HG21 ' B' ' 22' ' ' VAL . 0.0 OUTLIER -150.93 146.0 25.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.285 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.572 ' HG2' HG22 ' B' ' 25' ' ' VAL . 0.6 OUTLIER -179.43 10.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.969 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.6 -41.21 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 122.18 -0.325 . . . . 0.0 111.483 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.71 94.48 0.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.803 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -97.11 -61.62 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.484 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m 64.99 98.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.432 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.634 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -120.4 154.36 35.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.147 179.204 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.671 ' HA ' HG23 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -129.95 100.08 5.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.973 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.641 ' O ' HG23 ' B' ' 14' ' ' ILE . 8.2 tp -119.15 102.86 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.021 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.546 ' HA2' HG11 ' A' ' 40' ' ' VAL . . . 156.57 -108.14 0.35 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.307 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 11.8 t70 -129.09 -15.57 4.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 1.7 mt-10 164.29 61.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.033 0.444 . . . . 0.0 110.059 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.859 HG12 ' HD2' ' B' ' 37' ' ' PRO . 22.5 m -107.8 -168.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.631 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.874 HG23 ' HB3' ' B' ' 35' ' ' ASN . 1.1 t -175.3 103.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.758 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.692 HG13 ' HA ' ' B' ' 34' ' ' VAL . 21.5 t -102.77 106.9 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.511 HG23 ' O ' ' B' ' 21' ' ' THR . 9.4 t -91.59 111.9 23.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.508 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.834 HG21 ' HB3' ' B' ' 6' ' ' ARG . 29.9 m -84.0 62.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.551 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.41 -142.46 0.24 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.731 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' B' ' 31' ' ' ARG . . . 53.37 69.18 1.29 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.636 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.572 HG22 ' HG2' ' B' ' 7' ' ' ARG . 17.4 t -88.47 107.48 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 111.559 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -142.63 146.99 35.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.096 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.35 158.69 30.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.499 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.81 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.676 0.274 . . . . 0.0 110.776 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.4 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -108.45 124.41 50.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 110.744 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.739 HG21 HG21 ' A' ' 30' ' ' VAL . 29.6 t -93.68 136.5 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.464 ' HB3' ' HA3' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -83.17 109.12 16.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.129 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 mm -93.41 135.63 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.235 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.32 111.0 2.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.319 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.692 ' HA ' HG13 ' B' ' 20' ' ' VAL . 15.0 t -113.58 102.87 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 111.403 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.874 ' HB3' HG23 ' B' ' 19' ' ' THR . 0.2 OUTLIER -91.6 107.14 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.685 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.434 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -130.14 146.26 60.77 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.481 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.859 ' HD2' HG12 ' B' ' 18' ' ' VAL . 87.1 Cg_endo -77.84 156.36 30.99 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.806 2.337 . . . . 0.0 112.016 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -91.3 38.38 0.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.139 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -123.56 -38.59 2.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.067 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.545 HG11 ' HA2' ' A' ' 15' ' ' GLY . 6.2 t -83.38 156.7 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.006 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -57.03 115.0 2.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.183 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.472 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.7 p -122.03 121.91 65.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.96 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.98 122.36 29.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.525 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.567 HH21 HD13 ' A' ' 12' ' ' LEU . 17.5 ttm180 -163.92 -77.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.729 0.299 . . . . 0.0 111.013 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.433 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 5.8 mm-40 -155.09 131.46 10.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.875 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.66 -50.63 72.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.179 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.477 ' HA ' ' HB2' ' B' ' 50' ' ' ARG . 13.9 tt -63.27 -42.0 94.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.831 ' CD2' HD13 ' A' ' 4' ' ' LEU . 5.9 m-85 -50.92 -53.36 33.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.185 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.522 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 1.5 mt-30 -78.32 -21.62 49.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.227 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 4.8 mtt180 -73.01 -15.34 61.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.296 . . . . 0.0 111.188 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 43.7 mt -109.94 -27.13 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.351 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.538 ' HB2' HD23 ' A' ' 2' ' ' LEU . 6.0 mp0 -107.8 -54.52 2.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.291 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -64.68 -73.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -112.42 125.29 54.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.731 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -64.79 89.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 45.5 m 61.97 -80.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.048 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 178.79 173.52 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.902 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -100.52 58.12 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.749 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.44 -81.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.07 126.93 49.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.792 0.33 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' B' ' 53' ' ' ALA . 8.3 tt -122.18 116.12 23.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.6 tt -101.8 105.57 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.134 0.493 . . . . 0.0 110.535 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.467 HD23 ' HG3' ' B' ' 52' ' ' GLN . 0.2 OUTLIER -124.51 123.51 40.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.434 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -63.24 143.65 57.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.729 0.3 . . . . 0.0 110.414 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.704 ' HB2' HG21 ' A' ' 22' ' ' VAL . 10.6 mtt180 -153.18 148.24 26.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.969 0.414 . . . . 0.0 111.012 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.845 ' HD2' HG13 ' A' ' 25' ' ' VAL . 21.1 ttp180 175.48 -0.76 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.918 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -169.39 134.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.747 0.308 . . . . 0.0 110.831 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.05 47.83 89.09 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.514 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.486 ' C ' HG22 ' A' ' 11' ' ' THR . 18.2 mm-40 -112.46 167.57 10.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.514 0.197 . . . . 0.0 110.703 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.486 HG22 ' C ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER 163.54 105.53 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.245 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.449 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -115.82 154.14 30.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.247 179.086 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.482 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.5 ttt -130.27 100.88 5.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.007 0.432 . . . . 0.0 111.261 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.825 HG23 HG23 ' B' ' 14' ' ' ILE . 2.5 tp -113.06 121.77 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.465 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 134.35 -107.14 0.64 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.153 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.519 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 21.0 m-20 -154.96 6.95 0.26 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 2.0 tm-20 161.33 64.84 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 19' ' ' THR . 10.7 m -119.34 -158.53 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.47 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 171.39 102.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.653 HG13 ' HA ' ' A' ' 34' ' ' VAL . 22.4 t -117.36 110.91 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.808 0.337 . . . . 0.0 111.461 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.7 m -106.74 116.6 32.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.029 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.704 HG21 ' HB2' ' A' ' 6' ' ' ARG . 27.6 m -82.22 68.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.069 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.69 -141.64 0.07 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.622 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.32 74.26 0.36 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.364 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.845 HG13 ' HD2' ' A' ' 7' ' ' ARG . 41.5 t -85.68 107.75 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 120.974 0.416 . . . . 0.0 111.134 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.89 165.42 35.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.139 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.68 164.59 27.92 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.169 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 72.72 -62.51 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.607 0.242 . . . . 0.0 111.245 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.57 136.4 54.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.738 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.2 116.29 44.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 111.12 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 1.9 mtm105 -79.58 99.36 7.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.833 0.349 . . . . 0.0 110.697 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.65 HG23 HG12 ' A' ' 22' ' ' VAL . 16.2 mm -87.86 132.85 32.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.599 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.62 118.2 5.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.536 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.653 ' HA ' HG13 ' A' ' 20' ' ' VAL . 14.2 t -114.14 127.96 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.218 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 19' ' ' THR . 2.7 t-20 -123.68 107.48 11.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.312 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.98 142.76 22.76 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.715 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.9 156.62 27.09 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.797 2.332 . . . . 0.0 112.051 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -87.44 26.6 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.427 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.38 -41.66 6.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.837 0.351 . . . . 0.0 110.819 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.446 HG12 ' O ' ' B' ' 15' ' ' GLY . 3.9 t -82.49 150.18 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.7 t -62.5 97.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.348 . . . . 0.0 111.018 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.9 p -122.39 120.61 61.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -128.39 136.22 50.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.594 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -178.3 -35.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.084 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.12 98.66 0.02 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.69 -26.45 63.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.818 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.404 ' CG2' HG13 ' A' ' 51' ' ' ILE . 33.2 mm -79.2 -44.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' O ' HD11 ' B' ' 2' ' ' LEU . 3.3 m-85 -52.11 -44.91 64.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.84 -60.48 2.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.829 0.347 . . . . 0.0 111.683 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -54.95 -15.6 2.12 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' A' ' 56' ' ' SER . 47.6 mm -108.42 -52.75 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 122.284 -0.26 . . . . 0.0 111.591 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.459 ' HG3' HD23 ' B' ' 4' ' ' LEU . 61.8 mm-40 -72.53 -59.12 2.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.709 0.29 . . . . 0.0 111.153 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.646 ' HB2' HD12 ' B' ' 2' ' ' LEU . . . -75.06 -25.39 58.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.388 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -121.54 140.2 52.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 74.99 0.06 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.434 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.697 ' HA ' HD13 ' A' ' 51' ' ' ILE . 3.7 m 55.56 -165.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.004 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -158.14 152.05 23.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.752 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.22 116.01 31.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 m -177.08 77.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 m -122.05 127.59 50.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 21.8 t80 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.93 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.82 0.343 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 53' ' ' ALA . 8.3 tt -122.24 116.21 23.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.629 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.6 tt -101.83 105.61 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.146 0.498 . . . . 0.0 110.524 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.459 HD23 ' HG3' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -124.58 123.5 40.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.423 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -63.16 143.69 57.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.38 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.705 ' HB2' HG21 ' B' ' 22' ' ' VAL . 10.6 mtt180 -153.23 148.26 26.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.952 0.406 . . . . 0.0 111.068 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.849 ' HD2' HG13 ' B' ' 25' ' ' VAL . 21.0 ttp180 175.44 -0.73 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.891 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.722 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -169.42 134.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.76 0.314 . . . . 0.0 110.797 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.04 47.79 89.29 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.486 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.484 ' C ' HG22 ' B' ' 11' ' ' THR . 18.1 mm-40 -112.39 167.65 10.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.541 0.21 . . . . 0.0 110.711 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.484 HG22 ' C ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 163.51 105.51 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.263 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.439 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.9 OUTLIER -115.86 154.1 30.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.293 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.467 ' HA ' HG23 ' B' ' 18' ' ' VAL . 1.5 ttt -130.28 100.78 5.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.997 0.427 . . . . 0.0 111.23 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.825 HG23 HG23 ' A' ' 14' ' ' ILE . 2.5 tp -112.98 121.83 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.504 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 134.31 -107.09 0.64 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.147 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 21.1 m-20 -154.96 6.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 2.1 tm-20 161.32 64.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.664 ' O ' HG23 ' B' ' 19' ' ' THR . 10.7 m -119.36 -158.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.487 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.664 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 171.38 102.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.657 HG13 ' HA ' ' B' ' 34' ' ' VAL . 22.6 t -117.36 110.93 32.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.819 0.343 . . . . 0.0 111.399 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 16.7 m -106.74 116.68 32.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.005 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' B' ' 6' ' ' ARG . 27.6 m -82.29 68.5 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.064 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.68 -141.65 0.07 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.575 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.3 74.34 0.35 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.309 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.849 HG13 ' HD2' ' B' ' 7' ' ' ARG . 41.4 t -85.78 107.74 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.064 0.459 . . . . 0.0 111.149 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.84 165.47 35.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.186 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.73 164.62 27.87 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.141 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 72.75 -62.53 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.614 0.245 . . . . 0.0 111.253 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.62 136.46 54.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.703 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.22 116.24 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.703 0.287 . . . . 0.0 111.096 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 1.9 mtm105 -79.45 99.34 7.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.802 0.334 . . . . 0.0 110.791 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.662 HG23 HG12 ' B' ' 22' ' ' VAL . 16.2 mm -87.86 132.87 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.591 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.65 118.15 5.4 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.542 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.657 ' HA ' HG13 ' B' ' 20' ' ' VAL . 14.0 t -114.1 127.98 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.238 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' B' ' 19' ' ' THR . 2.7 t-20 -123.73 107.45 11.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.293 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.93 142.8 23.01 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.769 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.95 156.53 26.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.851 2.367 . . . . 0.0 111.989 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -87.32 26.51 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.465 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -101.42 -41.6 6.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.785 0.326 . . . . 0.0 110.779 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 15' ' ' GLY . 3.9 t -82.55 150.22 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.624 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -62.47 97.93 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 111.101 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.504 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.8 p -122.38 120.6 61.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.1 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -128.37 136.26 50.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 3.7 ptt85 -178.28 -35.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.089 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.15 98.65 0.02 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -58.69 -26.55 63.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.767 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.416 ' CG2' HG13 ' B' ' 51' ' ' ILE . 32.8 mm -79.13 -44.25 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.415 ' O ' HD11 ' A' ' 2' ' ' LEU . 3.3 m-85 -52.08 -44.95 64.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.291 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -60.51 2.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.851 0.358 . . . . 0.0 111.636 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.406 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 5.3 mtp180 -54.89 -15.77 2.2 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' B' ' 56' ' ' SER . 47.6 mm -108.26 -52.68 6.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.608 0.242 . . . . 0.0 111.587 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.467 ' HG3' HD23 ' A' ' 4' ' ' LEU . 61.7 mm-40 -72.58 -59.07 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.715 0.293 . . . . 0.0 111.133 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.655 ' HB2' HD12 ' A' ' 2' ' ' LEU . . . -75.09 -25.28 58.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.395 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 11.9 mm-40 -122.34 142.33 50.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -73.23 74.45 1.3 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.473 ' HA ' HD13 ' B' ' 51' ' ' ILE . 5.6 t 72.15 -67.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.41 72.46 0.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 110.918 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.13 139.5 28.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.827 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 4.3 t -140.0 142.38 36.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 7.3 m -96.83 136.49 37.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 20.4 t80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.894 179.969 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' B' ' 53' ' ' ALA . 5.6 mp -122.28 114.35 20.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.907 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.423 ' CG2' ' HB3' ' B' ' 31' ' ' ARG . 20.8 mm -96.2 105.03 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.027 0.441 . . . . 0.0 110.506 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.41 ' CD2' ' HG2' ' B' ' 52' ' ' GLN . 2.4 mm? -124.82 118.23 25.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.8 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.1 OUTLIER -55.68 139.83 43.5 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.43 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.737 ' HB3' HG21 ' A' ' 22' ' ' VAL . 3.8 mtp180 -151.37 148.4 28.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.029 0.442 . . . . 0.0 111.474 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.738 ' NE ' HG13 ' A' ' 25' ' ' VAL . 2.9 ttt180 175.91 -80.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.569 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t -32.75 -68.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.09 109.58 0.41 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.006 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.859 ' HB2' HG22 ' A' ' 22' ' ' VAL . 8.2 mm-40 -113.18 -173.63 2.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.553 0.216 . . . . 0.0 110.533 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 10' ' ' GLU . 0.7 OUTLIER 168.9 89.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.443 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.52 HD21 ' HB ' ' A' ' 20' ' ' VAL . 1.3 pt? -113.11 154.25 26.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.3 ttt -130.67 100.76 5.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.209 0.528 . . . . 0.0 111.348 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.5 HD13 ' HB ' ' B' ' 42' ' ' VAL . 2.6 tp -111.77 126.8 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.402 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 127.93 -104.56 0.68 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.965 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.9 p30 -162.34 8.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.9 mt-10 165.24 52.92 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.014 0.435 . . . . 0.0 110.316 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.646 HG12 ' HD2' ' A' ' 37' ' ' PRO . 13.7 m -115.27 -158.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.934 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.1 OUTLIER 167.05 106.86 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 34' ' ' VAL . 3.1 t -117.43 114.27 45.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.769 0.319 . . . . 0.0 111.172 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.741 HG23 ' O ' ' A' ' 10' ' ' GLU . 5.0 m -110.54 116.53 31.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.873 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.859 HG22 ' HB2' ' A' ' 10' ' ' GLU . 34.2 m -81.16 71.16 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -88.97 -145.76 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.562 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 31' ' ' ARG . . . 56.7 79.76 0.09 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.326 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.738 HG13 ' NE ' ' A' ' 7' ' ' ARG . 20.8 t -85.93 107.82 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.904 0.383 . . . . 0.0 111.602 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.99 155.67 43.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.03 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.78 154.93 52.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.583 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 67.68 -88.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.464 0.173 . . . . 0.0 110.685 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -104.63 125.68 50.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.62 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.402 HG23 HD11 ' A' ' 32' ' ' ILE . 4.7 m -93.24 136.65 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.515 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 4.6 mtt180 -79.51 100.98 7.98 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.096 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.675 HG23 ' HA ' ' A' ' 22' ' ' VAL . 18.5 mm -87.35 133.79 29.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.66 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.96 119.02 6.32 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.266 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.649 ' HA ' HG13 ' A' ' 20' ' ' VAL . 24.3 t -109.55 129.61 64.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.929 0.395 . . . . 0.0 111.494 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.934 ' HB3' HG23 ' A' ' 19' ' ' THR . 2.1 t30 -123.47 107.25 11.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.183 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.18 146.62 46.87 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.635 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.646 ' HD2' HG12 ' A' ' 18' ' ' VAL . 82.8 Cg_endo -83.2 156.52 14.82 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.99 2.46 . . . . 0.0 112.278 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.92 15.59 4.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.352 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.29 -38.65 10.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.639 0.257 . . . . 0.0 110.973 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 15' ' ' GLY . 4.7 t -87.95 142.21 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.835 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 m -55.85 98.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.027 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 42' ' ' VAL . 13.4 p -122.2 120.82 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.222 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.19 136.09 50.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.442 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.413 ' NH2' ' NE ' ' B' ' 6' ' ' ARG . 24.4 ttt180 -156.69 -67.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 111.012 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.83 121.55 1.82 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.92 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.52 -42.43 82.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.61 -41.09 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.79 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -52.32 -46.71 66.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.701 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -86.71 -58.17 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 111.741 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.46 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 4.1 mtt180 -48.91 -20.29 0.49 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.9 mm -108.67 -52.67 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.632 0.253 . . . . 0.0 111.498 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.403 ' HG2' ' CD2' ' B' ' 4' ' ' LEU . 7.9 tp60 -66.81 -63.5 1.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.721 0.296 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.814 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -70.82 -32.13 69.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.982 0.42 . . . . 0.0 110.615 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -109.42 119.73 40.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.798 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -62.87 92.62 0.05 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.667 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m 69.04 -65.94 0.27 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.348 . . . . 0.0 110.794 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.34 132.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.997 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -141.88 130.94 23.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.814 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.55 174.13 11.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.033 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.57 145.16 39.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.822 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 32.8 p90 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.893 179.935 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.899 0.38 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.814 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.5 mp -122.26 114.41 20.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.425 ' CG2' ' HB3' ' A' ' 31' ' ' ARG . 20.6 mm -96.25 104.95 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 0.0 110.566 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.403 ' CD2' ' HG2' ' A' ' 52' ' ' GLN . 2.4 mm? -124.76 118.43 26.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.781 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -55.78 139.83 44.06 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.378 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.754 ' HB3' HG21 ' B' ' 22' ' ' VAL . 3.8 mtp180 -151.38 148.37 28.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.048 0.452 . . . . 0.0 111.496 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.741 ' NE ' HG13 ' B' ' 25' ' ' VAL . 2.9 ttt180 175.91 -80.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.591 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 25.1 t -32.76 -68.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.05 109.64 0.41 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.002 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.855 ' HB2' HG22 ' B' ' 22' ' ' VAL . 8.2 mm-40 -113.19 -173.59 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.548 0.213 . . . . 0.0 110.536 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' B' ' 10' ' ' GLU . 0.7 OUTLIER 168.87 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.426 179.663 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.522 HD21 ' HB ' ' B' ' 20' ' ' VAL . 1.3 pt? -113.19 154.26 26.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 12.3 ttt -130.71 100.82 5.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.233 0.54 . . . . 0.0 111.403 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.499 HD13 ' HB ' ' A' ' 42' ' ' VAL . 2.6 tp -111.89 126.81 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.342 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 127.96 -104.66 0.69 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.913 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 2.9 p30 -162.31 9.01 0.06 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.9 mt-10 165.25 52.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.025 0.44 . . . . 0.0 110.284 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.633 HG12 ' HD2' ' B' ' 37' ' ' PRO . 13.8 m -115.26 -158.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.216 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.944 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.1 OUTLIER 167.05 106.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.655 HG13 ' HA ' ' B' ' 34' ' ' VAL . 3.1 t -117.45 114.28 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.753 0.311 . . . . 0.0 111.18 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.752 HG23 ' O ' ' B' ' 10' ' ' GLU . 5.0 m -110.54 116.54 31.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.849 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.855 HG22 ' HB2' ' B' ' 10' ' ' GLU . 34.2 m -81.11 71.1 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.601 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.42 HD12 ' N ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -88.94 -145.72 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.576 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' B' ' 31' ' ' ARG . . . 56.68 79.76 0.09 OUTLIER Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.363 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.741 HG13 ' NE ' ' B' ' 7' ' ' ARG . 20.9 t -86.0 107.83 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 120.96 0.41 . . . . 0.0 111.638 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.03 155.65 43.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.003 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.73 154.95 52.68 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.555 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 67.64 -88.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.492 0.187 . . . . 0.0 110.654 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -104.64 125.66 50.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.0 110.64 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 m -93.21 136.67 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.555 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.6 mtt180 -79.51 100.88 7.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.1 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.668 HG23 ' HA ' ' B' ' 22' ' ' VAL . 18.6 mm -87.31 133.76 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.68 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.92 118.96 6.3 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.306 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.655 ' HA ' HG13 ' B' ' 20' ' ' VAL . 24.0 t -109.51 129.67 63.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.922 0.391 . . . . 0.0 111.556 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.944 ' HB3' HG23 ' B' ' 19' ' ' THR . 2.1 t30 -123.41 107.22 11.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.247 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.19 146.6 46.76 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.622 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.633 ' HD2' HG12 ' B' ' 18' ' ' VAL . 82.7 Cg_endo -83.17 156.52 14.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.013 2.475 . . . . 0.0 112.271 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.95 15.57 4.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.303 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -38.6 10.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.662 0.268 . . . . 0.0 111.016 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 15' ' ' GLY . 4.7 t -87.94 142.19 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.868 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 3.0 m -55.9 98.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.971 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.511 HG13 ' O ' ' B' ' 42' ' ' VAL . 13.4 p -122.19 120.81 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.265 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.21 136.04 50.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.432 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.414 ' NH2' ' NE ' ' A' ' 6' ' ' ARG . 24.6 ttt180 -156.62 -67.17 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.939 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.77 121.61 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.42 -42.48 82.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -41.03 87.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.799 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -52.35 -46.65 66.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.634 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -86.84 -58.09 2.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.758 0.313 . . . . 0.0 111.804 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.467 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 4.1 mtt180 -48.95 -20.16 0.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.821 HG23 ' HB2' ' B' ' 56' ' ' SER . 36.6 mm -108.78 -52.63 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.629 0.252 . . . . 0.0 111.524 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.41 ' HG2' ' CD2' ' A' ' 4' ' ' LEU . 8.1 tp60 -66.87 -63.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.763 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.822 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -70.89 -32.2 69.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 110.589 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 0.5 OUTLIER -108.65 119.59 39.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.615 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.35 103.0 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.589 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.821 ' HB2' HG23 ' B' ' 51' ' ' ILE . 35.7 t -67.66 171.29 6.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.038 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -148.9 110.81 4.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.624 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -90.63 -72.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.954 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 7.1 m -57.72 117.5 4.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 7.3 m -97.97 135.98 38.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.874 -179.961 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.731 ' C ' HD13 ' A' ' 2' ' ' LEU . 1.7 ttm . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.964 0.412 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.731 HD13 ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -122.24 111.69 17.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.823 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 3' ' ' ILE . 2.8 tt -106.06 116.66 50.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.1 0.476 . . . . 0.0 111.3 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.87 HD22 ' CD2' ' B' ' 48' ' ' TYR . 0.4 OUTLIER -123.9 123.4 40.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.336 179.354 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -63.61 80.07 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.888 0.375 . . . . 0.0 111.664 -179.17 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.546 ' HD3' HG21 ' A' ' 22' ' ' VAL . 23.5 mtt180 -78.79 143.22 36.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.126 0.489 . . . . 0.0 110.514 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.435 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 2.9 tmt_? -173.36 -13.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.864 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.61 -58.74 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.702 0.286 . . . . 0.0 111.175 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.57 105.55 0.21 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.803 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.2 -73.82 0.65 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.906 0.384 . . . . 0.0 110.723 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 m 69.53 102.39 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.49 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.644 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -109.94 154.59 22.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.626 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.3 ttt -127.2 100.07 5.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.98 0.419 . . . . 0.0 110.747 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.644 HD13 ' N ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -115.85 138.16 47.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.752 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.644 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 121.28 -106.01 1.08 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.104 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.4 t70 -159.57 7.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.7 mt-10 162.66 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.036 0.446 . . . . 0.0 110.151 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.774 HG12 ' CD ' ' A' ' 37' ' ' PRO . 13.3 m -116.38 -158.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.649 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.951 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 173.57 102.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.644 ' HB ' HD23 ' A' ' 12' ' ' LEU . 27.5 t -110.48 103.96 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.5 m -89.27 106.37 18.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.904 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.546 HG21 ' HD3' ' A' ' 6' ' ' ARG . 32.0 m -76.7 -168.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.899 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.724 ' O ' HG11 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -173.38 141.3 0.89 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.103 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.481 ' H ' HD13 ' A' ' 23' ' ' LEU . . . -125.37 -24.54 1.58 Allowed Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.477 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.94 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.536 0.208 . . . . 0.0 110.63 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.91 165.5 0.13 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.747 0.308 . . . . 0.0 110.56 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.81 -99.98 0.01 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.569 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -101.36 -30.92 11.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 110.377 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.448 ' HB3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -119.82 136.65 54.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.955 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 23' ' ' LEU . 12.0 t -93.21 128.39 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 111.681 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 2.4 ttp180 -80.8 99.54 8.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.445 HG13 ' HB2' ' B' ' 6' ' ' ARG . 9.5 mm -88.77 127.43 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.931 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.03 109.99 3.4 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.486 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.574 ' HA ' HG13 ' A' ' 20' ' ' VAL . 21.5 t -111.73 102.93 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.936 0.398 . . . . 0.0 111.468 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.951 ' HB3' HG23 ' A' ' 19' ' ' THR . 1.8 t-20 -91.59 107.44 19.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.641 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.95 138.62 33.04 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.454 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.774 ' CD ' HG12 ' A' ' 18' ' ' VAL . 83.7 Cg_endo -77.69 156.09 31.45 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.603 2.202 . . . . 0.0 112.102 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -82.01 2.25 31.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.564 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.84 -39.33 20.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.72 0.295 . . . . 0.0 111.267 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 t -86.78 146.85 5.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.885 0.374 . . . . 0.0 110.995 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.97 100.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.5 p -122.3 122.31 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -128.11 136.42 51.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.706 0.289 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.668 HH22 HD23 ' B' ' 2' ' ' LEU . 0.5 OUTLIER -142.92 -175.78 4.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.489 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 1.9 mp0 -57.3 145.78 30.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.843 0.354 . . . . 0.0 110.874 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.67 -65.29 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.507 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -52.08 -40.77 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.387 -179.784 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.861 ' CD2' HD22 ' B' ' 4' ' ' LEU . 7.9 t80 -46.9 -67.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.436 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' A' ' 53' ' ' ALA . 48.5 mt-30 -71.96 -22.01 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.551 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -70.5 -15.95 62.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.649 0.261 . . . . 0.0 111.571 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.528 HG23 ' OE1' ' A' ' 52' ' ' GLN . 6.9 tt -112.15 -25.18 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.634 0.254 . . . . 0.0 111.5 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.562 ' HB3' HD12 ' B' ' 2' ' ' LEU . 0.6 OUTLIER -106.79 -55.81 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.257 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB2' ' HG2' ' A' ' 49' ' ' GLN . . . -65.08 -71.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.1 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -108.0 116.61 32.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.772 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.49 109.08 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.558 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 t -53.54 -65.01 0.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.761 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -92.9 91.8 7.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -67.36 153.92 42.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.987 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.1 t -110.0 95.9 5.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 m -116.38 134.51 54.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.743 ' C ' HD13 ' B' ' 2' ' ' LEU . 1.7 ttm . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.88 0.371 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.743 HD13 ' C ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -122.28 111.71 17.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.45 HG23 ' O ' ' B' ' 3' ' ' ILE . 2.7 tt -106.11 116.69 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.167 0.508 . . . . 0.0 111.233 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.861 HD22 ' CD2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -123.88 123.52 40.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.315 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -63.64 80.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.872 0.368 . . . . 0.0 111.623 -179.189 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.558 ' HD3' HG21 ' B' ' 22' ' ' VAL . 23.5 mtt180 -78.88 143.32 36.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.151 0.501 . . . . 0.0 110.503 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.432 ' HA ' ' HA3' ' B' ' 24' ' ' GLY . 2.9 tmt_? -173.37 -13.25 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.859 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 t -116.64 -58.68 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.674 0.273 . . . . 0.0 111.131 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.53 105.55 0.21 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.804 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.14 -73.89 0.65 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 110.77 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 8.8 m 69.61 102.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.436 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.4 OUTLIER -109.87 154.58 22.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.664 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 8.3 ttt -127.15 100.02 5.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.988 0.423 . . . . 0.0 110.769 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.639 HD13 ' N ' ' B' ' 15' ' ' GLY . 0.0 OUTLIER -115.76 138.2 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.734 179.893 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.639 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 121.28 -105.96 1.07 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.109 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.4 t70 -159.58 7.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.7 mt-10 162.69 59.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.981 0.42 . . . . 0.0 110.102 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.776 HG12 ' CD ' ' B' ' 37' ' ' PRO . 13.4 m -116.4 -158.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.632 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.934 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.1 OUTLIER 173.61 102.73 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.642 ' HB ' HD23 ' B' ' 12' ' ' LEU . 27.6 t -110.44 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 33.2 m -89.28 106.37 18.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.946 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.558 HG21 ' HD3' ' B' ' 6' ' ' ARG . 32.2 m -76.79 -168.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.905 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.725 ' O ' HG11 ' B' ' 30' ' ' VAL . 0.2 OUTLIER -173.38 141.32 0.9 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.095 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.481 ' H ' HD13 ' B' ' 23' ' ' LEU . . . -125.41 -24.43 1.59 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.97 130.79 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.525 0.202 . . . . 0.0 110.622 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.88 165.53 0.13 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 110.578 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.87 -100.01 0.01 OUTLIER Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.506 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -101.37 -30.88 11.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 110.372 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.448 ' HB3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -119.82 136.56 54.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.965 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.725 HG11 ' O ' ' B' ' 23' ' ' LEU . 12.1 t -93.18 128.44 44.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.916 0.389 . . . . 0.0 111.636 -178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 2.4 ttp180 -80.8 99.52 8.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.46 HG13 ' HB2' ' A' ' 6' ' ' ARG . 9.6 mm -88.8 127.46 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.878 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.03 109.95 3.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.429 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.581 ' HA ' HG13 ' B' ' 20' ' ' VAL . 21.4 t -111.7 102.94 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 111.48 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.934 ' HB3' HG23 ' B' ' 19' ' ' THR . 1.8 t-20 -91.62 107.43 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.622 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.97 138.59 32.99 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.475 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.776 ' CD ' HG12 ' B' ' 18' ' ' VAL . 84.3 Cg_endo -77.67 156.08 31.55 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.654 2.236 . . . . 0.0 112.134 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -82.03 2.28 31.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.603 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.88 -39.36 19.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.66 0.266 . . . . 0.0 111.187 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 t -86.67 146.8 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.042 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.01 100.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.467 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.5 p -122.3 122.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.752 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -128.1 136.4 51.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.684 0.278 . . . . 0.0 110.862 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.672 HH22 HD23 ' A' ' 2' ' ' LEU . 0.5 OUTLIER -142.93 -175.79 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.491 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' B' ' 48' ' ' TYR . 1.9 mp0 -57.31 145.7 31.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.86 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.62 -65.29 0.58 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.546 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.665 HD13 ' O ' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -52.07 -40.8 30.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.37 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.87 ' CD2' HD22 ' A' ' 4' ' ' LEU . 8.0 t80 -46.86 -67.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.414 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.462 ' HG2' ' HB2' ' B' ' 53' ' ' ALA . 48.5 mt-30 -71.95 -21.95 61.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.632 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 61.0 mtt180 -70.57 -15.95 62.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.579 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.53 HG23 ' OE1' ' B' ' 52' ' ' GLN . 6.9 tt -112.17 -25.08 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.614 0.245 . . . . 0.0 111.501 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.536 ' HB3' HD12 ' A' ' 2' ' ' LEU . 0.6 OUTLIER -106.82 -55.81 2.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 111.242 -179.671 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.462 ' HB2' ' HG2' ' B' ' 49' ' ' GLN . . . -65.04 -71.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.168 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -108.33 116.97 32.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.35 103.68 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t -57.55 -71.29 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.014 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 61.74 176.8 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.818 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 67.11 -69.11 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.067 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 96.6 p -153.19 169.95 21.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.812 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.09 120.86 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.942 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmm? . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.821 0.343 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.402 ' HB2' ' NH1' ' B' ' 44' ' ' ARG . 4.1 mp -115.93 109.49 17.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 3' ' ' ILE . 18.3 tt -84.52 111.35 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 0.0 111.443 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -113.18 156.25 23.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.729 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.551 ' N ' HD23 ' A' ' 4' ' ' LEU . 0.2 OUTLIER -94.71 122.55 37.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 111.382 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.442 ' HB2' HG13 ' B' ' 32' ' ' ILE . 0.6 OUTLIER -95.6 148.97 21.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.645 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.621 ' HG3' HG13 ' A' ' 30' ' ' VAL . 0.1 OUTLIER 81.13 85.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.821 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.653 HG23 ' HA2' ' A' ' 24' ' ' GLY . 47.3 t 80.72 56.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.287 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.43 ' H ' HG21 ' A' ' 22' ' ' VAL . . . -140.51 -147.58 5.0 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.632 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.23 119.24 37.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 111.61 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 21' ' ' THR . 14.4 p -57.03 145.08 31.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.304 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.798 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -112.6 154.42 26.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.694 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.7 ttp -128.94 100.34 5.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.751 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.498 HD11 HG11 ' B' ' 18' ' ' VAL . 0.0 OUTLIER -114.64 138.72 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.015 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.411 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 123.9 -106.27 0.95 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.151 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.588 ' OD2' HG22 ' A' ' 40' ' ' VAL . 1.4 p30 -158.58 7.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.6 OUTLIER 161.74 58.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.902 0.382 . . . . 0.0 110.044 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.796 HG12 ' HD2' ' A' ' 37' ' ' PRO . 10.7 m -114.37 -156.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.357 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.974 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 173.15 104.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.974 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.798 ' HB ' HD23 ' A' ' 12' ' ' LEU . 24.8 t -102.66 101.66 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.852 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.629 ' HA ' HG22 ' A' ' 11' ' ' THR . 9.8 t -95.35 157.42 15.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.631 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.43 HG21 ' H ' ' A' ' 9' ' ' GLY . 6.4 m -107.86 -172.39 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.309 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.2 tm? -124.05 -52.2 1.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 0.0 110.427 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.653 ' HA2' HG23 ' A' ' 8' ' ' VAL . . . 91.85 -43.47 2.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.996 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.56 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 4.0 t -85.65 149.91 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.525 0.202 . . . . 0.0 111.41 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 25' ' ' VAL . 28.1 tttp 99.07 122.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.068 0.547 . . . . 0.0 110.743 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.77 -179.51 37.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.762 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 63.63 -86.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -86.46 136.74 32.99 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.821 HG12 HD11 ' A' ' 32' ' ' ILE . 4.1 t -93.24 114.15 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.351 . . . . 0.0 110.874 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.56 ' HD2' HD11 ' B' ' 3' ' ' ILE . 8.9 mmt180 -89.28 99.87 12.77 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.888 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.821 HD11 HG12 ' A' ' 30' ' ' VAL . 24.0 mm -109.53 141.19 25.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.054 0.454 . . . . 0.0 111.667 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.82 107.48 2.58 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.919 -0.657 . . . . 0.0 111.987 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.587 HG13 HG22 ' A' ' 20' ' ' VAL . 21.4 t -97.8 103.41 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.904 0.383 . . . . 0.0 111.103 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.974 ' HB3' HG23 ' A' ' 19' ' ' THR . 1.2 t-20 -90.57 107.3 19.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.87 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.75 140.03 37.43 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.259 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.796 ' HD2' HG12 ' A' ' 18' ' ' VAL . 85.9 Cg_endo -77.74 156.18 31.32 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.642 2.228 . . . . 0.0 112.28 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -80.32 0.16 34.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.355 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -78.01 -39.77 41.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.714 0.292 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.588 HG22 ' OD2' ' A' ' 16' ' ' ASP . 5.5 t -87.8 140.88 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.91 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 t -62.48 102.26 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.379 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.2 p -122.24 120.69 61.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -128.31 136.45 51.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.793 0.33 . . . . 0.0 111.199 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.4 ' NH1' ' HB2' ' B' ' 2' ' ' LEU . 63.4 mtt180 -139.62 -50.68 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.45 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 1.3 tp10 -178.29 141.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.514 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.51 -45.74 84.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.217 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -73.02 -38.51 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.67 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 45' ' ' GLU . 4.1 m-85 -51.54 -50.16 60.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -85.9 -52.81 5.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -16.35 12.62 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 mm -115.76 -57.92 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.409 ' CB ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -66.39 -48.07 71.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.104 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.85 -28.25 26.17 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 111.307 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -120.33 134.29 55.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 57' ' ' GLN . 9.1 mttp -59.65 87.02 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.147 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.5 t 64.63 -72.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.176 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -147.88 164.36 33.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.832 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -94.81 87.23 4.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 p -170.75 -66.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 p -105.12 133.07 50.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.838 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmm? . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.804 0.335 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.4 ' HB2' ' NH1' ' A' ' 44' ' ' ARG . 4.2 mp -115.96 109.5 17.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.847 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.58 HG23 ' O ' ' B' ' 3' ' ' ILE . 18.3 tt -84.49 111.42 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.487 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.564 HD23 ' N ' ' B' ' 5' ' ' THR . 1.0 OUTLIER -113.21 156.21 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.739 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.564 ' N ' HD23 ' B' ' 4' ' ' LEU . 0.2 OUTLIER -94.69 122.55 37.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.363 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.6 OUTLIER -95.65 148.97 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.635 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.61 ' HG3' HG13 ' B' ' 30' ' ' VAL . 0.1 OUTLIER 81.22 85.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.767 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.653 HG23 ' HA2' ' B' ' 24' ' ' GLY . 47.3 t 80.64 56.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.287 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.426 ' H ' HG21 ' B' ' 22' ' ' VAL . . . -140.5 -147.57 4.99 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.589 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.24 119.16 36.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.889 0.376 . . . . 0.0 111.614 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.632 HG22 ' HA ' ' B' ' 21' ' ' THR . 14.5 p -57.04 145.04 31.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.263 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.807 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.2 OUTLIER -112.58 154.42 26.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.693 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 3.7 ttp -128.91 100.35 5.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.849 0.356 . . . . 0.0 110.723 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.504 HD11 HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -114.66 138.77 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.981 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.407 ' HA2' HG11 ' A' ' 40' ' ' VAL . . . 123.83 -106.18 0.95 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.16 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.583 ' OD2' HG22 ' B' ' 40' ' ' VAL . 1.4 p30 -158.6 7.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.6 OUTLIER 161.77 58.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.018 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.782 HG12 ' HD2' ' B' ' 37' ' ' PRO . 10.6 m -114.31 -157.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.968 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 173.21 104.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.981 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.807 ' HB ' HD23 ' B' ' 12' ' ' LEU . 24.7 t -102.65 101.71 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.898 0.38 . . . . 0.0 110.807 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.632 ' HA ' HG22 ' B' ' 11' ' ' THR . 9.9 t -95.36 157.41 15.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.609 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.426 HG21 ' H ' ' B' ' 9' ' ' GLY . 6.4 m -107.81 -172.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.304 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.428 ' HA ' HD22 ' B' ' 23' ' ' LEU . 1.2 tm? -124.09 -52.19 1.76 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.83 0.347 . . . . 0.0 110.411 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.653 ' HA2' HG23 ' B' ' 8' ' ' VAL . . . 91.92 -43.41 2.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.989 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' B' ' 26' ' ' LYS . 4.0 t -85.77 149.94 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.492 0.187 . . . . 0.0 111.36 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' B' ' 25' ' ' VAL . 28.1 tttp 99.0 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.067 0.547 . . . . 0.0 110.799 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.78 -179.53 37.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.763 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 63.64 -86.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -86.46 136.71 33.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.793 HG12 HD11 ' B' ' 32' ' ' ILE . 4.1 t -93.19 114.1 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.351 . . . . 0.0 110.896 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.563 ' HD2' HD11 ' A' ' 3' ' ' ILE . 8.9 mmt180 -89.29 99.86 12.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.865 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.793 HD11 HG12 ' B' ' 30' ' ' VAL . 24.0 mm -109.49 141.22 25.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.031 0.443 . . . . 0.0 111.719 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.85 107.53 2.58 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.979 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.584 HG13 HG22 ' B' ' 20' ' ' VAL . 21.4 t -97.85 103.43 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.926 0.393 . . . . 0.0 111.103 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.968 ' HB3' HG23 ' B' ' 19' ' ' THR . 1.2 t-20 -90.59 107.28 19.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.831 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.73 140.1 37.63 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.243 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.782 ' HD2' HG12 ' B' ' 18' ' ' VAL . 86.0 Cg_endo -77.78 156.16 31.13 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.673 2.249 . . . . 0.0 112.268 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -80.31 0.23 33.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.428 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -78.07 -39.7 40.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.703 0.287 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.583 HG22 ' OD2' ' B' ' 16' ' ' ASP . 5.5 t -87.89 140.9 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.89 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -62.37 102.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.394 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.489 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.3 p -122.2 120.67 61.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.726 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -128.29 136.47 51.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.795 0.331 . . . . 0.0 111.147 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.402 ' NH1' ' HB2' ' A' ' 2' ' ' LEU . 63.7 mtt180 -139.62 -50.65 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.409 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 1.3 tp10 -178.3 141.34 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.543 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.51 -45.78 84.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.188 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.99 -38.52 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.651 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.421 ' HB2' ' HB3' ' B' ' 45' ' ' GLU . 4.1 m-85 -51.54 -50.15 60.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.75 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -85.92 -52.86 5.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.409 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 0.2 OUTLIER -58.09 -16.21 12.24 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.011 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 17.1 mm -115.91 -57.88 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.413 ' CB ' ' O ' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -66.45 -48.06 71.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.09 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.84 -28.28 26.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 111.341 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' B' ' 55' ' ' LYS . 7.1 mt-10 -120.33 137.32 54.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.228 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' B' ' 54' ' ' GLU . 3.2 mtmp? 70.06 -97.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.931 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p 61.53 149.91 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.769 0.319 . . . . 0.0 110.756 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -153.69 -65.44 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.962 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.22 -148.56 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.688 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 1.8 m 78.22 108.42 0.07 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.904 0.383 . . . . 0.0 110.897 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.04 136.38 54.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.887 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.918 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.909 0.385 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.734 ' HG ' ' HB2' ' B' ' 53' ' ' ALA . 1.7 mp -116.46 105.46 12.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.7 tt -84.8 108.99 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.673 HD13 ' NE ' ' B' ' 44' ' ' ARG . 1.9 tp -112.98 156.64 22.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.257 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.563 HG21 ' OE1' ' B' ' 29' ' ' GLN . 0.3 OUTLIER -90.96 124.24 35.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.868 0.366 . . . . 0.0 111.021 179.786 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.498 ' HB2' ' CG1' ' B' ' 32' ' ' ILE . 0.0 OUTLIER -93.22 148.42 22.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.237 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.716 ' HD3' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER 83.34 90.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.401 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.518 HG23 ' C ' ' A' ' 7' ' ' ARG . 6.3 t 84.25 62.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.58 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.68 -146.9 4.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.383 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.409 ' HB2' ' CZ ' ' B' ' 48' ' ' TYR . 3.8 tp10 -113.26 118.17 33.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.845 0.355 . . . . 0.0 111.442 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 21' ' ' THR . 19.2 p -51.93 150.26 4.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.963 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.746 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -110.88 154.5 23.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.846 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.661 ' HG2' HG22 ' A' ' 18' ' ' VAL . 6.7 ttm -127.26 100.36 6.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.995 0.426 . . . . 0.0 110.906 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.488 ' H ' HG21 ' A' ' 18' ' ' VAL . 3.8 tp -111.93 129.35 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.441 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 127.76 -102.76 0.61 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.165 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 5.4 p30 -166.24 8.41 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 31.6 tp10 167.29 57.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.661 HG22 ' HG2' ' A' ' 13' ' ' MET . 5.8 m -114.98 -157.93 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.7 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 172.49 99.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.746 ' HB ' HD23 ' A' ' 12' ' ' LEU . 20.9 t -102.96 103.08 14.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.812 0.339 . . . . 0.0 111.77 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.678 ' HA ' HG22 ' A' ' 11' ' ' THR . 44.4 m -87.22 146.84 25.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.242 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.825 ' HA ' HG23 ' A' ' 32' ' ' ILE . 30.5 m -109.75 76.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -99.88 -151.11 0.39 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.307 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 31' ' ' ARG . . . 56.52 73.6 0.42 Allowed Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.098 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.716 HG13 ' HD3' ' A' ' 7' ' ' ARG . 24.7 t -85.92 107.33 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.011 0.434 . . . . 0.0 111.627 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.58 ' H ' HG12 ' A' ' 30' ' ' VAL . 1.1 mttt -137.21 142.82 42.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.906 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.53 -44.11 28.81 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.434 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -104.53 -86.25 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.939 0.369 . . . . 0.0 111.452 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.558 ' OE1' HG21 ' B' ' 5' ' ' THR . 5.7 mt-30 -84.85 116.15 23.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.759 0.314 . . . . 0.0 111.172 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 26' ' ' LYS . 31.0 m -93.81 136.51 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.189 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.531 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 4.9 mtt-85 -87.92 99.25 12.0 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.025 0.44 . . . . 0.0 110.1 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.825 HG23 ' HA ' ' A' ' 22' ' ' VAL . 27.3 mm -92.87 141.81 14.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.235 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.08 108.75 3.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.689 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.486 ' HA ' HG13 ' A' ' 20' ' ' VAL . 27.1 t -99.35 103.49 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.803 0.335 . . . . 0.0 111.049 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 19' ' ' THR . 3.8 t30 -90.78 107.22 19.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.186 0.517 . . . . 0.0 110.62 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.43 141.32 38.57 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.247 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.641 ' CD ' HG12 ' A' ' 18' ' ' VAL . 86.0 Cg_endo -77.99 156.19 30.38 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.615 2.21 . . . . 0.0 112.272 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -83.26 3.78 29.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.498 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -86.01 -36.87 19.5 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.695 0.283 . . . . 0.0 111.099 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.44 HG12 ' O ' ' B' ' 15' ' ' GLY . 11.1 t -90.8 141.35 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.042 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -59.03 105.68 0.35 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.218 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.9 p -122.24 122.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.007 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.14 136.23 50.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.654 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.677 ' NE ' HD13 ' B' ' 4' ' ' LEU . 0.0 OUTLIER -154.47 59.43 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 0.0 110.778 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.07 136.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -65.39 -41.85 93.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.834 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.7 mm -67.32 -54.43 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.129 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.586 ' CD1' HD11 ' B' ' 4' ' ' LEU . 8.0 m-85 -47.19 -43.37 21.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.478 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.603 ' HG2' HD21 ' B' ' 2' ' ' LEU . 0.3 OUTLIER -78.29 -55.01 5.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.353 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 84.8 mmt-85 -56.93 -12.84 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.692 HG23 ' HB3' ' A' ' 56' ' ' SER . 30.1 mm -107.85 -57.3 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.715 0.293 . . . . 0.0 111.237 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.447 ' OE1' HD12 ' B' ' 4' ' ' LEU . 32.6 mt-30 -72.75 -57.99 3.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.892 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.725 ' HB2' ' HG ' ' B' ' 2' ' ' LEU . . . -67.29 -34.69 77.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 0.0 110.844 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 1.6 mt-10 -120.47 129.19 53.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.648 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -49.62 108.37 0.2 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.723 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.692 ' HB3' HG23 ' A' ' 51' ' ' ILE . 96.2 p -57.45 159.57 4.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.797 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -148.16 143.28 26.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.994 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.14 -178.88 5.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -134.18 120.98 20.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.34 134.34 54.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.924 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.895 -179.968 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.871 0.367 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.725 ' HG ' ' HB2' ' A' ' 53' ' ' ALA . 1.7 mp -116.47 105.5 12.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.76 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.599 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.7 tt -84.76 108.99 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.266 0.555 . . . . 0.0 111.143 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.677 HD13 ' NE ' ' A' ' 44' ' ' ARG . 2.0 tp -113.03 156.65 22.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.178 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.558 HG21 ' OE1' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -90.92 124.25 35.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.849 0.357 . . . . 0.0 111.028 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.497 ' HB2' ' CG1' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -93.21 148.34 22.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.243 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.727 ' HD3' HG13 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 83.32 90.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.402 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.523 HG23 ' C ' ' B' ' 7' ' ' ARG . 6.4 t 84.32 62.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.554 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.74 -146.96 4.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.394 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 3.8 tp10 -113.22 118.14 33.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 111.44 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.667 HG22 ' HA ' ' B' ' 21' ' ' THR . 19.2 p -51.92 150.22 4.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.736 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.2 OUTLIER -110.81 154.43 23.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.889 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.68 ' HG2' HG22 ' B' ' 18' ' ' VAL . 6.8 ttm -127.27 100.37 6.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.971 0.415 . . . . 0.0 110.872 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.486 ' H ' HG21 ' B' ' 18' ' ' VAL . 3.8 tp -111.9 129.32 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.44 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 127.78 -102.76 0.61 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.17 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 5.5 p30 -166.26 8.59 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.579 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 31.6 tp10 167.18 57.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.68 HG22 ' HG2' ' B' ' 13' ' ' MET . 5.8 m -114.96 -157.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.729 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.648 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 172.48 99.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.736 ' HB ' HD23 ' B' ' 12' ' ' LEU . 21.0 t -102.94 103.04 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.791 0.329 . . . . 0.0 111.838 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.667 ' HA ' HG22 ' B' ' 11' ' ' THR . 45.0 m -87.22 146.89 25.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.232 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.809 ' HA ' HG23 ' B' ' 32' ' ' ILE . 30.3 m -109.76 77.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.421 HD12 ' N ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -100.0 -151.09 0.39 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.28 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' B' ' 31' ' ' ARG . . . 56.56 73.56 0.43 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.112 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.727 HG13 ' HD3' ' B' ' 7' ' ' ARG . 24.5 t -85.9 107.39 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.01 0.433 . . . . 0.0 111.607 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.591 ' H ' HG12 ' B' ' 30' ' ' VAL . 1.1 mttt -137.25 142.86 42.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.838 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.56 -44.14 29.02 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.42 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -104.53 -86.22 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.956 0.378 . . . . 0.0 111.478 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.563 ' OE1' HG21 ' A' ' 5' ' ' THR . 5.6 mt-30 -84.92 116.1 23.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.789 0.328 . . . . 0.0 111.204 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.591 HG12 ' H ' ' B' ' 26' ' ' LYS . 30.9 m -93.69 136.61 24.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.533 ' O ' ' HA3' ' B' ' 24' ' ' GLY . 4.9 mtt-85 -88.04 99.25 12.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.809 HG23 ' HA ' ' B' ' 22' ' ' VAL . 27.4 mm -92.81 141.74 14.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.24 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.06 108.74 3.01 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.719 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.474 ' HA ' HG13 ' B' ' 20' ' ' VAL . 27.0 t -99.33 103.5 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.843 0.354 . . . . 0.0 111.086 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' B' ' 19' ' ' THR . 3.8 t30 -90.78 107.24 19.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 110.597 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.5 141.29 38.57 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.288 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.638 ' CD ' HG12 ' B' ' 18' ' ' VAL . 84.7 Cg_endo -77.92 156.13 30.61 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.663 2.242 . . . . 0.0 112.221 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -83.19 3.75 29.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.524 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -85.98 -36.93 19.49 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.696 0.284 . . . . 0.0 111.091 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 15' ' ' GLY . 11.0 t -90.65 141.29 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 111.055 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -59.06 105.69 0.35 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.184 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.466 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.9 p -122.28 122.55 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.11 136.25 50.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.734 0.302 . . . . 0.0 110.627 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.673 ' NE ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -154.54 59.42 0.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.744 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.11 136.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -65.4 -41.86 93.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 36.4 mm -67.32 -54.48 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.581 ' CD1' HD11 ' A' ' 4' ' ' LEU . 8.2 m-85 -47.15 -43.31 20.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.537 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.596 ' HG2' HD21 ' A' ' 2' ' ' LEU . 0.3 OUTLIER -78.36 -54.98 5.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.331 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.42 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 84.8 mmt-85 -56.97 -12.94 2.29 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.73 -57.33 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.676 0.274 . . . . 0.0 111.25 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.439 ' OE1' HD12 ' A' ' 4' ' ' LEU . 32.5 mt-30 -72.72 -57.88 3.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.734 ' HB2' ' HG ' ' A' ' 2' ' ' LEU . . . -67.41 -34.51 77.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.978 0.418 . . . . 0.0 110.847 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 1.6 mt-10 -121.77 133.58 54.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.795 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.18 101.48 0.72 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.626 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.06 -66.32 0.26 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.98 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.68 166.92 19.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -177.04 110.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.799 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 35.4 t -58.77 106.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 10.8 m -96.56 120.95 37.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.955 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 t80 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.916 179.978 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.793 0.33 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.75 HD12 ' HB2' ' B' ' 53' ' ' ALA . 9.6 tt -118.86 110.72 17.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.3 tt -96.86 105.36 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.143 0.497 . . . . 0.0 110.829 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.8 124.31 41.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.15 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -60.13 141.82 55.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.618 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -145.36 145.38 31.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.209 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.618 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 8.7 tmm_? 165.33 -10.86 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.224 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 8' ' ' VAL . 17.6 t -149.38 1.31 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.93 -156.54 31.64 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.009 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.27 -163.91 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.764 0.316 . . . . 0.0 111.048 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.731 HG22 ' HA ' ' A' ' 21' ' ' THR . 17.6 p -107.53 163.14 13.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.746 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -112.24 154.68 25.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.264 179.574 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.63 100.16 5.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 111.251 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.517 HG23 HG23 ' B' ' 14' ' ' ILE . 6.9 tp -112.6 138.9 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.459 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.419 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 118.64 -104.54 1.11 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.3 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 4.2 t0 -153.51 1.0 0.25 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 3.2 mt-10 163.74 61.29 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.408 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.756 HG12 ' CD ' ' A' ' 37' ' ' PRO . 10.3 m -116.4 -157.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.308 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.953 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 174.53 106.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.746 ' HB ' HD23 ' A' ' 12' ' ' LEU . 13.2 t -102.87 106.09 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.93 0.395 . . . . 0.0 111.676 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.731 ' HA ' HG22 ' A' ' 11' ' ' THR . 25.1 m -87.79 106.23 17.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.347 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.477 HG21 ' HG2' ' A' ' 6' ' ' ARG . 11.1 m -80.79 57.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.731 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.525 HD12 ' H ' ' A' ' 24' ' ' GLY . 32.0 tp -116.23 148.8 40.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.132 0.491 . . . . 0.0 110.692 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.525 ' H ' HD12 ' A' ' 23' ' ' LEU . . . 128.99 65.0 0.11 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.4 HG22 ' HG2' ' A' ' 7' ' ' ARG . 2.5 t -85.36 107.78 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 121.168 0.509 . . . . 0.0 112.241 -177.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.69 143.36 45.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.601 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.2 145.28 22.39 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.863 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.85 -82.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.636 0.255 . . . . 0.0 111.234 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -96.22 126.59 41.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.798 0.332 . . . . 0.0 111.091 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.765 HG21 HG21 ' B' ' 30' ' ' VAL . 26.3 t -93.58 134.35 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.07 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 6.4 mtm-85 -84.27 105.08 14.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' B' ' 6' ' ' ARG . 17.7 mm -91.89 133.91 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.331 . . . . 0.0 111.171 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.81 115.05 4.97 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.728 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.475 ' HA ' HG13 ' A' ' 20' ' ' VAL . 19.9 t -115.64 103.54 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.001 0.429 . . . . 0.0 111.814 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.953 ' HB3' HG23 ' A' ' 19' ' ' THR . 4.9 t-20 -97.44 107.44 19.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.219 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.71 150.07 72.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.783 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.756 ' CD ' HG12 ' A' ' 18' ' ' VAL . 87.5 Cg_endo -83.74 156.48 13.8 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.081 2.521 . . . . 0.0 112.188 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 19.91 4.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.298 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.76 -38.81 5.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.662 0.267 . . . . 0.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.421 HG12 ' O ' ' B' ' 15' ' ' GLY . 11.6 t -80.52 146.24 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.862 0.363 . . . . 0.0 110.947 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.65 106.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.115 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.3 p -122.1 122.19 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.58 136.04 50.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.433 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -172.5 -69.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -164.49 121.29 1.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -65.38 -28.46 69.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.68 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.599 HG22 HD12 ' A' ' 51' ' ' ILE . 29.5 mm -70.95 -53.24 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.225 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -53.42 -42.55 67.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.405 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -78.12 -50.83 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.684 0.278 . . . . 0.0 111.51 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -61.03 -13.26 15.36 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.599 HD12 HG22 ' A' ' 47' ' ' ILE . 55.4 mt -112.39 -52.89 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.322 . . . . 0.0 111.151 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HG3' HD23 ' B' ' 4' ' ' LEU . 0.6 OUTLIER -69.13 -57.54 5.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.081 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.74 ' HB2' HD12 ' B' ' 2' ' ' LEU . . . -79.31 -32.3 43.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 111.253 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.13 125.57 52.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -55.62 92.35 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.612 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -68.6 0.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.783 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.79 -48.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.754 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -179.9 -67.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.753 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.41 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.82 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 m -100.3 143.11 30.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.4 t80 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.887 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.795 0.331 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.74 HD12 ' HB2' ' A' ' 53' ' ' ALA . 9.6 tt -118.93 110.73 17.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.616 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.3 tt -96.91 105.39 17.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.136 0.494 . . . . 0.0 110.798 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' B' ' 4' ' ' LEU . 0.2 OUTLIER -124.83 124.39 41.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.113 179.637 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -60.16 141.82 55.3 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.136 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.613 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -145.33 145.46 31.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.858 0.361 . . . . 0.0 111.156 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.613 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 8.7 tmm_? 165.31 -10.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.219 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.562 ' O ' HG12 ' B' ' 8' ' ' VAL . 17.7 t -149.3 1.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.97 -156.47 31.59 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.982 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.32 -164.0 1.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.332 . . . . 0.0 111.057 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.746 HG22 ' HA ' ' B' ' 21' ' ' THR . 17.6 p -107.47 163.18 13.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.2 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.771 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.1 OUTLIER -112.3 154.68 25.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.232 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -128.67 100.09 5.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 111.26 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.517 HG23 HG23 ' A' ' 14' ' ' ILE . 6.9 tp -112.55 138.89 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.536 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.421 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 118.65 -104.47 1.1 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.324 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 4.2 t0 -153.55 0.95 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.424 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 3.2 mt-10 163.73 61.27 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.966 0.413 . . . . 0.0 110.39 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.759 HG12 ' CD ' ' B' ' 37' ' ' PRO . 10.2 m -116.44 -157.08 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.327 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.935 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 174.53 106.43 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.771 ' HB ' HD23 ' B' ' 12' ' ' LEU . 13.2 t -102.92 106.13 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.978 0.418 . . . . 0.0 111.632 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.746 ' HA ' HG22 ' B' ' 11' ' ' THR . 25.1 m -87.81 106.25 17.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.361 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.477 HG21 ' HG2' ' B' ' 6' ' ' ARG . 11.0 m -80.83 57.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.696 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.517 HD12 ' H ' ' B' ' 24' ' ' GLY . 32.2 tp -116.34 148.84 40.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.157 0.503 . . . . 0.0 110.659 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.517 ' H ' HD12 ' B' ' 23' ' ' LEU . . . 129.01 64.99 0.11 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.37 107.83 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.225 0.536 . . . . 0.0 112.215 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.78 143.29 45.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.595 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.11 145.21 22.16 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.986 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.92 -82.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.636 0.255 . . . . 0.0 111.196 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -96.3 126.62 41.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.842 0.353 . . . . 0.0 111.028 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.765 HG21 HG21 ' A' ' 30' ' ' VAL . 26.3 t -93.53 134.38 31.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 6.4 mtm-85 -84.27 105.08 14.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.761 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.466 HG13 ' HB2' ' A' ' 6' ' ' ARG . 17.8 mm -91.97 134.03 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.349 . . . . 0.0 111.119 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.9 115.0 4.94 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.707 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.467 ' HA ' HG13 ' B' ' 20' ' ' VAL . 19.8 t -115.61 103.55 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 111.851 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.935 ' HB3' HG23 ' B' ' 19' ' ' THR . 4.9 t-20 -97.39 107.42 19.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.244 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.75 150.06 72.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.79 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.759 ' CD ' HG12 ' B' ' 18' ' ' VAL . 87.0 Cg_endo -83.71 156.38 13.83 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.063 2.509 . . . . 0.0 112.229 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 19.93 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.346 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.77 -38.75 5.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.714 0.293 . . . . 0.0 111.125 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 15' ' ' GLY . 11.6 t -80.53 146.21 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.981 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.54 106.31 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.196 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.461 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.2 p -122.15 122.24 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.811 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.6 136.12 50.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.368 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -172.64 -69.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 0.0 110.797 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 21.3 tp10 -164.49 121.24 1.59 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -65.32 -28.47 69.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.671 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.601 HG22 HD12 ' B' ' 51' ' ' ILE . 29.4 mm -70.92 -53.31 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' B' ' 45' ' ' GLU . 6.7 m-85 -53.32 -42.59 66.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.491 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -78.16 -50.82 11.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.527 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -61.02 -13.26 15.21 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.601 HD12 HG22 ' B' ' 47' ' ' ILE . 55.4 mt -112.38 -52.98 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.0 111.104 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.09 -57.58 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.105 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.75 ' HB2' HD12 ' A' ' 2' ' ' LEU . . . -79.26 -32.15 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.283 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -110.15 128.2 55.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -68.07 86.56 0.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.725 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.44 -71.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.016 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -107.81 -70.89 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.04 111.74 7.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 55.0 m -108.84 101.6 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.6 p -98.94 127.05 44.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.843 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.853 0.359 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.787 HD21 HD23 ' A' ' 4' ' ' LEU . 5.5 tt -116.3 114.09 23.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 mm -92.08 105.58 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.108 0.48 . . . . 0.0 110.625 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.933 HD11 ' CE1' ' B' ' 48' ' ' TYR . 0.2 OUTLIER -119.32 156.75 29.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.589 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.679 ' H ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -95.25 129.03 42.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.24 179.1 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.653 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 15.9 mtt180 -142.35 146.85 35.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.689 ' O ' HG22 ' A' ' 25' ' ' VAL . 1.1 ttm180 165.33 -6.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.75 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.89 -62.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.808 0.337 . . . . 0.0 110.982 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.75 61.92 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.724 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -72.95 -69.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 110.625 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 m 71.75 101.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.483 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.506 HD13 HH22 ' A' ' 6' ' ' ARG . 1.1 pt? -111.26 154.77 23.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.075 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -127.61 100.06 5.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.016 0.436 . . . . 0.0 111.179 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.779 HD11 HG11 ' B' ' 18' ' ' VAL . 0.0 OUTLIER -113.77 134.27 57.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.25 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.446 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 123.89 -104.91 0.86 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.061 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -150.19 1.6 0.48 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.3 mt-10 159.09 67.04 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.133 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.766 HG11 HD11 ' B' ' 14' ' ' ILE . 9.9 m -119.53 -155.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.723 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER 172.94 102.15 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.704 HG22 HG13 ' A' ' 34' ' ' VAL . 38.3 t -113.35 110.79 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -107.3 107.83 18.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.15 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.778 HG12 ' CG2' ' A' ' 32' ' ' ILE . 29.9 m -80.28 74.87 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.062 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.478 HD12 ' H ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -63.72 -156.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' H ' HD12 ' A' ' 23' ' ' LEU . . . 83.06 71.9 1.3 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.92 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 7' ' ' ARG . 10.7 t -86.19 107.68 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.083 0.468 . . . . 0.0 111.938 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.53 165.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -170.63 13.46 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.298 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.9 -28.57 14.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.882 0.372 . . . . 0.0 110.554 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -121.1 136.68 54.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.565 HG12 HD13 ' A' ' 32' ' ' ILE . 4.0 t -93.31 115.31 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.373 . . . . 0.0 111.553 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.51 98.84 7.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.874 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.778 ' CG2' HG12 ' A' ' 22' ' ' VAL . 4.6 mm -94.03 125.28 46.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.426 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.44 103.6 1.98 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.978 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.704 HG13 HG22 ' A' ' 20' ' ' VAL . 17.7 t -98.27 103.66 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.941 0.4 . . . . 0.0 111.893 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -92.63 107.46 19.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.077 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.8 147.71 55.38 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.017 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.655 ' HD2' HG12 ' A' ' 18' ' ' VAL . 88.4 Cg_endo -79.66 156.55 24.57 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.966 2.444 . . . . 0.0 111.99 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -90.63 29.74 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.38 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.44 -40.32 5.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.669 0.271 . . . . 0.0 111.147 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.71 149.08 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.93 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.77 97.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.094 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 42' ' ' VAL . 7.5 p -122.49 121.48 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.948 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.96 136.15 50.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.725 0.298 . . . . 0.0 110.404 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' B' ' 12' ' ' LEU . 0.0 OUTLIER -149.54 -62.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.719 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' OE2' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -171.47 133.49 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -65.36 -36.32 83.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.088 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 48' ' ' TYR . 1.7 tp -74.28 -47.9 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.583 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.931 ' CE1' HD11 ' B' ' 4' ' ' LEU . 2.0 m-85 -55.84 -38.14 69.65 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -64.62 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -55.33 -15.86 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.627 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.9 mm -103.61 -56.55 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.653 0.263 . . . . 0.0 111.564 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.495 ' OE1' HD22 ' B' ' 4' ' ' LEU . 2.5 mm-40 -77.0 -56.97 4.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.678 0.275 . . . . 0.0 111.228 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.771 ' HB2' ' CD1' ' B' ' 2' ' ' LEU . . . -70.48 -25.27 63.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.297 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 16.0 tt0 -131.6 146.75 52.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.916 0.388 . . . . 0.0 111.203 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 18.4 mtpt 67.49 -99.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.734 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.95 161.31 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.861 0.363 . . . . 0.0 110.886 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -60.94 -169.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.774 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -106.12 -50.47 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.805 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.1 -68.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.3 t -122.03 140.18 52.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.774 0.321 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.788 HD21 HD23 ' B' ' 4' ' ' LEU . 5.5 tt -116.43 114.12 23.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 mm -92.06 105.53 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.052 0.453 . . . . 0.0 110.623 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.931 HD11 ' CE1' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -119.25 156.8 29.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.645 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.677 ' H ' HD13 ' B' ' 4' ' ' LEU . 0.0 OUTLIER -95.33 129.1 42.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.231 179.128 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.645 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 16.0 mtt180 -142.39 146.85 35.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.691 ' O ' HG22 ' B' ' 25' ' ' VAL . 1.1 ttm180 165.29 -6.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.725 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.96 -62.9 2.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.782 0.325 . . . . 0.0 111.009 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.76 61.98 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.726 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -72.96 -69.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.612 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 5.7 m 71.75 101.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.551 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.513 HD13 HH22 ' B' ' 6' ' ' ARG . 1.1 pt? -111.11 154.74 23.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.154 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -127.64 100.11 5.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.062 0.458 . . . . 0.0 111.172 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.766 HD11 HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -113.75 134.27 57.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.228 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.443 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 123.84 -104.88 0.86 Allowed Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.099 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 0.8 OUTLIER -150.2 1.59 0.47 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.3 mt-10 159.1 67.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.874 0.368 . . . . 0.0 110.175 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.779 HG11 HD11 ' A' ' 14' ' ' ILE . 10.0 m -119.53 -155.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 120.839 0.352 . . . . 0.0 111.703 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.653 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.1 OUTLIER 172.92 102.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.711 HG22 HG13 ' B' ' 34' ' ' VAL . 38.4 t -113.37 110.86 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -107.34 107.79 18.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.23 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.764 HG12 ' CG2' ' B' ' 32' ' ' ILE . 30.5 m -80.24 74.98 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.019 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.486 HD12 ' H ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -63.8 -156.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.731 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.486 ' H ' HD12 ' B' ' 23' ' ' LEU . . . 83.13 71.87 1.3 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.921 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.691 HG22 ' O ' ' B' ' 7' ' ' ARG . 10.7 t -86.22 107.66 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.083 0.468 . . . . 0.0 111.948 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.6 165.22 0.29 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.804 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.64 -170.64 13.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.324 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.88 -28.49 14.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.91 0.386 . . . . 0.0 110.579 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -121.19 136.7 54.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.97 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.556 HG12 HD13 ' B' ' 32' ' ' ILE . 4.0 t -93.35 115.37 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.948 0.404 . . . . 0.0 111.535 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.57 98.81 7.79 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.861 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.764 ' CG2' HG12 ' B' ' 22' ' ' VAL . 4.6 mm -93.98 125.28 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.417 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.51 103.56 1.97 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.964 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.711 HG13 HG22 ' B' ' 20' ' ' VAL . 17.5 t -98.15 103.63 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.937 0.399 . . . . 0.0 111.945 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -92.7 107.54 19.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.034 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.82 147.65 55.11 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.016 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.668 ' HD2' HG12 ' B' ' 18' ' ' VAL . 88.8 Cg_endo -79.69 156.59 24.5 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.982 2.454 . . . . 0.0 112.0 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -90.71 29.81 1.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.328 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.43 -40.31 5.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.711 0.291 . . . . 0.0 111.159 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.0 t -81.7 149.1 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.78 97.8 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.076 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.457 HG13 ' O ' ' B' ' 42' ' ' VAL . 7.4 p -122.56 121.46 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.91 136.15 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.676 0.274 . . . . 0.0 110.433 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.462 ' HG2' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -149.6 -62.72 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.952 0.406 . . . . 0.0 110.724 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.417 ' OE2' HG22 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -171.46 133.47 0.81 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.463 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.7 OUTLIER -65.28 -36.34 83.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.52 HG23 ' N ' ' B' ' 48' ' ' TYR . 1.7 tp -74.31 -47.89 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.562 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.933 ' CE1' HD11 ' A' ' 4' ' ' LEU . 2.0 m-85 -55.66 -38.3 69.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -64.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' B' ' 46' ' ' GLU . 0.0 OUTLIER -55.28 -15.79 2.77 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.642 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 39.9 mm -103.65 -56.44 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.604 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.497 ' OE1' HD22 ' A' ' 4' ' ' LEU . 2.5 mm-40 -77.17 -56.86 4.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.758 0.313 . . . . 0.0 111.233 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.773 ' HB2' ' CD1' ' A' ' 2' ' ' LEU . . . -70.55 -25.17 62.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.203 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -132.32 146.05 51.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 0.0 111.179 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 mttm 52.04 19.23 0.97 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.337 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 2.1 t -68.25 155.43 39.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.776 0.322 . . . . 0.0 110.587 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.31 105.33 11.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.696 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -147.25 162.36 39.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.29 -25.46 10.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.068 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.15 127.82 38.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.876 0.369 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.888 0.375 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.783 HD13 ' HB2' ' B' ' 53' ' ' ALA . 7.8 tp -121.21 112.37 18.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.7 tt -99.79 105.74 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.222 0.535 . . . . 0.0 110.795 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.568 HD22 ' HG3' ' B' ' 52' ' ' GLN . 1.9 mm? -124.41 120.71 32.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.752 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -55.45 141.63 35.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.738 0.304 . . . . 0.0 110.806 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.739 ' HB2' HG21 ' A' ' 22' ' ' VAL . 5.3 mtt180 -150.95 143.94 24.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.058 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.716 ' HD2' HG13 ' A' ' 25' ' ' VAL . 5.7 ttp180 169.7 -4.17 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.756 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.44 -71.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.68 0.276 . . . . 0.0 111.199 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.88 90.48 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.697 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.637 ' O ' HG23 ' A' ' 11' ' ' THR . 57.9 mm-40 -110.15 -174.39 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.637 0.256 . . . . 0.0 110.56 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER 170.82 101.28 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 111.041 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.474 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 1.2 pt? -115.31 154.1 29.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.397 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.407 ' HG2' HG22 ' A' ' 18' ' ' VAL . 2.1 ttm -129.53 100.7 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.096 0.474 . . . . 0.0 111.092 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.86 HG23 HG23 ' B' ' 14' ' ' ILE . 2.4 tp -114.73 123.29 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.531 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.54 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 133.23 -107.18 0.67 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.116 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -148.47 5.09 0.71 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 1.7 tt0 154.61 72.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.893 0.477 . . . . 0.0 109.969 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.592 HG11 ' CG1' ' B' ' 14' ' ' ILE . 9.1 m -122.31 -152.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.35 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.898 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 169.41 103.69 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' A' ' 34' ' ' VAL . 31.3 t -116.43 113.79 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.96 0.41 . . . . 0.0 111.858 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 t -110.88 112.9 25.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.33 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.923 HG12 HG23 ' A' ' 32' ' ' ILE . 26.9 m -80.81 75.55 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.802 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.61 -138.02 0.1 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.531 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 31' ' ' ARG . . . 53.02 77.33 0.15 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.466 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.716 HG13 ' HD2' ' A' ' 7' ' ' ARG . 36.2 t -85.84 107.91 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 111.709 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.789 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -130.74 141.11 50.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.691 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.39 -50.39 5.58 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.57 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -101.57 -83.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.863 0.332 . . . . 0.0 111.262 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.438 ' HB3' HG22 ' B' ' 5' ' ' THR . 14.0 mp0 -87.18 118.99 26.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.0 111.126 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.789 HG12 ' H ' ' A' ' 26' ' ' LYS . 15.4 m -93.33 136.34 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.186 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.613 ' HB3' HD11 ' B' ' 3' ' ' ILE . 5.0 mtm180 -78.13 106.44 10.01 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.483 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.923 HG23 HG12 ' A' ' 22' ' ' VAL . 32.5 mm -87.35 135.46 25.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.597 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.35 120.71 6.41 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.355 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.751 ' HA ' HG13 ' A' ' 20' ' ' VAL . 17.4 t -116.08 103.61 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.41 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.898 ' HB3' HG23 ' A' ' 19' ' ' THR . 0.1 OUTLIER -98.08 107.67 20.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.571 179.641 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.35 142.36 26.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.503 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.486 ' HD2' HG12 ' A' ' 18' ' ' VAL . 95.0 Cg_endo -79.29 156.35 25.67 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.724 2.283 . . . . 0.0 112.164 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.52 3.39 21.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.55 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -78.59 -41.91 30.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.71 0.291 . . . . 0.0 111.17 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.534 HG12 ' O ' ' B' ' 15' ' ' GLY . 6.3 t -87.3 152.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.929 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 m -66.55 100.26 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.892 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.588 ' HB ' HD13 ' B' ' 14' ' ' ILE . 13.4 p -122.15 120.67 61.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.239 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.31 136.12 50.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.542 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' NH2' HG21 ' A' ' 42' ' ' VAL . 32.4 mtt85 -141.09 -64.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 0.0 110.805 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -168.88 136.15 1.9 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.748 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -55.0 -53.57 54.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.493 ' HA ' HD13 ' A' ' 51' ' ' ILE . 12.8 tt -65.08 -41.99 93.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.459 ' CG ' ' HB2' ' A' ' 45' ' ' GLU . 3.5 m-85 -45.46 -48.31 13.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.578 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -89.0 -49.33 6.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.463 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.637 ' C ' HD12 ' A' ' 51' ' ' ILE . 7.8 mtp180 -53.59 -17.37 2.07 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.637 HD12 ' C ' ' A' ' 50' ' ' ARG . 1.3 mp -111.52 -51.12 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.699 0.285 . . . . 0.0 111.013 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.565 ' HG3' HD22 ' B' ' 4' ' ' LEU . 0.5 OUTLIER -73.18 -60.36 2.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.937 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.777 ' HB2' HD13 ' B' ' 2' ' ' LEU . . . -69.08 -36.61 77.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.895 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 2.4 mt-10 -114.31 123.8 50.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -46.38 107.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.289 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.411 ' HB3' HG23 ' A' ' 51' ' ' ILE . 24.6 p -63.59 163.41 11.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.987 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.52 91.71 4.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.67 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -129.1 161.62 29.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.024 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.3 p -149.0 82.96 1.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.722 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 m -91.94 127.17 37.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.834 0.35 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.777 HD13 ' HB2' ' A' ' 53' ' ' ALA . 7.7 tp -121.18 112.31 18.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.624 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.7 tt -99.77 105.73 17.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.146 0.498 . . . . 0.0 110.85 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.565 HD22 ' HG3' ' A' ' 52' ' ' GLN . 1.9 mm? -124.36 120.68 32.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.769 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -55.43 141.57 35.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.323 . . . . 0.0 110.735 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.744 ' HB2' HG21 ' B' ' 22' ' ' VAL . 5.3 mtt180 -150.95 143.95 24.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.707 ' HD2' HG13 ' B' ' 25' ' ' VAL . 5.7 ttp180 169.71 -4.13 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.758 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.45 -71.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.672 0.273 . . . . 0.0 111.171 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.88 90.4 0.13 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.703 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.625 ' O ' HG23 ' B' ' 11' ' ' THR . 58.0 mm-40 -110.09 -174.36 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.636 0.255 . . . . 0.0 110.591 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.625 HG23 ' O ' ' B' ' 10' ' ' GLU . 0.1 OUTLIER 170.79 101.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.082 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.469 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 1.2 pt? -115.33 154.08 29.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.427 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.413 ' HG2' HG22 ' B' ' 18' ' ' VAL . 2.1 ttm -129.46 100.73 5.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.057 0.456 . . . . 0.0 111.076 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.86 HG23 HG23 ' A' ' 14' ' ' ILE . 2.4 tp -114.83 123.31 70.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.493 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.534 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 133.2 -107.17 0.67 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.159 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.1 OUTLIER -148.4 5.09 0.71 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 1.7 tt0 154.65 72.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.895 0.478 . . . . 0.0 110.026 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.579 HG11 ' CG1' ' A' ' 14' ' ' ILE . 9.3 m -122.32 -152.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.305 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.925 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 169.45 103.74 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' B' ' 34' ' ' VAL . 31.9 t -116.47 113.82 44.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.931 0.396 . . . . 0.0 111.798 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.0 t -110.93 112.87 25.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.303 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.926 HG12 HG23 ' B' ' 32' ' ' ILE . 27.0 m -80.72 75.48 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.84 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.55 -138.03 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.565 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' B' ' 31' ' ' ARG . . . 52.96 77.35 0.14 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.481 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.707 HG13 ' HD2' ' B' ' 7' ' ' ARG . 37.2 t -85.9 107.9 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.037 0.446 . . . . 0.0 111.674 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.778 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.1 OUTLIER -130.64 141.09 50.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.657 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.43 -50.37 5.62 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.267 -0.492 . . . . 0.0 113.587 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -101.61 -83.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.813 0.306 . . . . 0.0 111.235 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.448 ' HB3' HG22 ' A' ' 5' ' ' THR . 14.0 mp0 -87.22 118.99 27.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.915 0.388 . . . . 0.0 111.121 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.778 HG12 ' H ' ' B' ' 26' ' ' LYS . 15.4 m -93.32 136.38 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.145 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.598 ' HB3' HD11 ' A' ' 3' ' ' ILE . 5.0 mtm180 -78.14 106.42 10.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.532 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.926 HG23 HG12 ' B' ' 22' ' ' VAL . 32.6 mm -87.33 135.4 25.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.002 0.429 . . . . 0.0 111.545 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.29 120.66 6.4 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.374 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.751 ' HA ' HG13 ' B' ' 20' ' ' VAL . 17.4 t -116.04 103.67 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 0.0 111.429 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.925 ' HB3' HG23 ' B' ' 19' ' ' THR . 0.1 OUTLIER -98.15 107.69 20.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.544 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.36 142.33 26.31 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.533 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.496 ' HD2' HG12 ' B' ' 18' ' ' VAL . 94.6 Cg_endo -79.28 156.33 25.69 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.73 2.287 . . . . 0.0 112.195 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.51 3.45 21.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.537 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -78.69 -41.88 29.92 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.683 0.278 . . . . 0.0 111.129 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 15' ' ' GLY . 6.3 t -87.26 152.07 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.987 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -66.62 100.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.585 ' HB ' HD13 ' A' ' 14' ' ' ILE . 13.3 p -122.16 120.66 61.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.233 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.35 136.06 50.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.74 0.305 . . . . 0.0 110.576 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.426 ' NH2' HG21 ' B' ' 42' ' ' VAL . 32.4 mtt85 -141.03 -64.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.899 0.38 . . . . 0.0 110.819 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.457 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 0.8 OUTLIER -168.85 136.21 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.738 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -55.02 -53.66 52.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.009 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.506 ' HA ' HD13 ' B' ' 51' ' ' ILE . 12.8 tt -64.98 -42.01 93.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.457 ' CG ' ' HB2' ' B' ' 45' ' ' GLU . 3.5 m-85 -45.4 -48.37 13.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.568 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -89.02 -49.34 6.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.464 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.635 ' C ' HD12 ' B' ' 51' ' ' ILE . 7.8 mtp180 -53.56 -17.37 2.05 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.635 HD12 ' C ' ' B' ' 50' ' ' ARG . 1.3 mp -111.56 -50.98 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.708 0.289 . . . . 0.0 111.065 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.568 ' HG3' HD22 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -73.3 -60.32 2.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.896 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.783 ' HB2' HD13 ' A' ' 2' ' ' LEU . . . -69.07 -36.63 77.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.886 0.374 . . . . 0.0 110.92 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 2.4 mt-10 -114.2 123.45 49.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.783 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -56.87 104.28 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.142 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 21.5 t -96.89 -155.74 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.4 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.6 107.55 11.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.778 0.323 . . . . 0.0 110.626 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -137.56 -67.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.934 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 35.7 p -157.35 133.59 9.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.9 121.05 38.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.935 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.839 0.352 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' B' ' 53' ' ' ALA . 7.4 tt -114.1 105.39 13.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.9 tt -100.96 105.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.279 0.561 . . . . 0.0 111.08 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.587 HD13 ' CD2' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -125.22 119.71 29.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.85 179.339 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.693 HG23 ' HG2' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -58.02 149.55 22.99 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.724 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.19 144.32 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.978 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.746 ' HD3' HG13 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -163.93 25.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.561 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.52 -52.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.981 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.17 89.18 0.1 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.676 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.8 55.48 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.0 0.429 . . . . 0.0 110.674 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -61.45 101.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.457 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.559 HD23 ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -111.12 154.23 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.991 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -133.19 99.7 4.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.279 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.779 HG23 HG23 ' B' ' 14' ' ' ILE . 8.8 tp -118.04 138.7 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.723 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.501 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 122.06 -108.23 1.27 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.441 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -143.47 -5.41 0.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 3.2 tt0 163.31 65.28 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.729 HG12 ' HD2' ' A' ' 37' ' ' PRO . 11.5 m -117.28 -160.78 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.511 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER 175.74 104.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.814 HG12 HG13 ' A' ' 34' ' ' VAL . 27.2 m -115.54 106.87 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.65 109.51 21.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.361 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.676 HG11 ' CD1' ' B' ' 32' ' ' ILE . 8.9 p -77.84 70.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.602 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.81 -147.24 0.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.544 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 31' ' ' ARG . . . 63.19 79.67 0.14 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.165 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.746 HG13 ' HD3' ' A' ' 7' ' ' ARG . 85.9 t -85.91 107.36 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.001 0.429 . . . . 0.0 111.619 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.662 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -133.95 139.2 45.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.875 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.77 -50.66 7.15 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 113.753 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -101.36 -87.46 0.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.018 0.409 . . . . 0.0 111.452 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.87 119.63 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 26' ' ' LYS . 18.5 m -93.3 136.83 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.631 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.696 ' HG2' HG23 ' B' ' 5' ' ' THR . 4.8 mmt180 -76.99 103.76 7.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.944 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.686 ' CD1' HG11 ' B' ' 22' ' ' VAL . 8.4 mt -87.33 131.3 35.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.401 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 110.59 3.77 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.173 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.814 HG13 HG12 ' A' ' 20' ' ' VAL . 28.0 t -110.76 103.04 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.973 0.416 . . . . 0.0 111.565 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -96.04 107.3 19.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.287 179.572 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.68 145.99 53.5 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.761 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.729 ' HD2' HG12 ' A' ' 18' ' ' VAL . 92.2 Cg_endo -79.47 156.32 25.07 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.87 2.38 . . . . 0.0 112.145 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.35 35.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -119.17 -38.76 2.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.035 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.49 HG12 ' O ' ' B' ' 15' ' ' GLY . 7.6 t -80.24 155.08 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.935 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -59.13 112.6 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.9 p -122.04 121.0 62.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -129.03 128.16 43.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.369 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.42 -69.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -157.03 116.66 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.78 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -60.92 -35.78 77.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 51' ' ' ILE . 1.2 tp -74.79 -43.34 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.601 ' CD2' HD13 ' B' ' 4' ' ' LEU . 6.4 m-85 -51.5 -43.26 62.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.334 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 8.7 pt20 -82.17 -41.74 19.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.255 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.417 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 7.3 mtm180 -72.62 0.17 11.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 47' ' ' ILE . 11.1 tt -114.99 -45.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.756 0.312 . . . . 0.0 111.28 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.493 ' N ' HG23 ' A' ' 51' ' ' ILE . 31.2 mm-40 -90.22 -50.07 6.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.732 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.489 ' HB2' HD12 ' B' ' 2' ' ' LEU . . . -75.23 -43.56 51.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -102.55 118.66 37.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.626 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.23 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.854 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.446 ' HB2' ' HA ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -88.22 41.85 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.207 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 63.46 131.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.921 0.391 . . . . 0.0 111.118 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -133.25 -43.32 0.86 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.837 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 95.6 p -144.21 92.76 2.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.782 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 p -103.31 126.43 50.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.018 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.95 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.84 0.352 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 53' ' ' ALA . 7.4 tt -114.16 105.44 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.827 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.636 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.9 tt -100.98 105.16 17.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.22 0.533 . . . . 0.0 111.021 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.601 HD13 ' CD2' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -125.23 119.74 29.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.809 179.301 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.696 HG23 ' HG2' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -58.0 149.68 22.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.68 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.11 144.41 0.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.98 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.744 ' HD3' HG13 ' B' ' 25' ' ' VAL . 0.8 OUTLIER -164.03 25.93 0.07 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.638 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.51 -52.46 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.982 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.24 89.21 0.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.64 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.86 55.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.022 0.439 . . . . 0.0 110.648 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 25.7 m -61.53 101.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.522 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.565 HD23 ' CG2' ' B' ' 20' ' ' VAL . 0.1 OUTLIER -111.03 154.23 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.013 179.298 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -133.2 99.68 4.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.419 . . . . 0.0 111.289 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.779 HG23 HG23 ' A' ' 14' ' ' ILE . 8.7 tp -118.06 138.72 47.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.721 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.49 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 122.04 -108.11 1.26 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.528 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.8 OUTLIER -143.55 -5.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 3.3 tt0 163.23 65.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.755 HG12 ' HD2' ' B' ' 37' ' ' PRO . 11.6 m -117.22 -160.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.518 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.721 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.4 OUTLIER 175.71 104.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.798 HG12 HG13 ' B' ' 34' ' ' VAL . 27.7 m -115.51 106.78 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.57 109.46 21.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.376 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.686 HG11 ' CD1' ' A' ' 32' ' ' ILE . 8.9 p -77.81 70.4 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.582 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.95 -147.22 0.16 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.543 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.509 ' HA3' ' HB2' ' B' ' 31' ' ' ARG . . . 63.25 79.6 0.15 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.158 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.744 HG13 ' HD3' ' B' ' 7' ' ' ARG . 86.6 t -85.88 107.38 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.023 0.439 . . . . 0.0 111.614 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.657 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.0 OUTLIER -133.94 139.22 45.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.814 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.76 -50.69 7.13 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.755 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -101.31 -87.51 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.984 0.392 . . . . 0.0 111.421 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.84 119.61 25.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.9 0.381 . . . . 0.0 110.865 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.657 HG12 ' H ' ' B' ' 26' ' ' LYS . 18.4 m -93.3 136.88 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.624 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.693 ' HG2' HG23 ' A' ' 5' ' ' THR . 4.8 mmt180 -77.03 103.7 7.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.049 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.676 ' CD1' HG11 ' A' ' 22' ' ' VAL . 8.5 mt -87.33 131.35 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.411 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.91 110.61 3.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.201 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.798 HG13 HG12 ' B' ' 20' ' ' VAL . 28.1 t -110.8 103.1 14.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.921 0.391 . . . . 0.0 111.524 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' B' ' 19' ' ' THR . 0.1 OUTLIER -96.08 107.29 19.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.279 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.67 145.92 53.25 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.815 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.755 ' HD2' HG12 ' B' ' 18' ' ' VAL . 93.0 Cg_endo -79.43 156.36 25.22 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.863 2.375 . . . . 0.0 112.129 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.38 35.01 1.02 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.146 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -119.09 -38.9 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.741 0.305 . . . . 0.0 111.076 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 15' ' ' GLY . 7.5 t -80.15 155.03 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -59.09 112.62 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.053 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.498 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.9 p -122.07 121.03 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -129.05 128.18 43.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.343 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 -69.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.72 0.295 . . . . 0.0 111.057 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -157.03 116.71 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.928 0.394 . . . . 0.0 110.734 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -60.94 -35.79 77.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.876 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.637 ' O ' HG22 ' B' ' 51' ' ' ILE . 1.2 tp -74.74 -43.38 47.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.111 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.587 ' CD2' HD13 ' A' ' 4' ' ' LEU . 6.4 m-85 -51.35 -43.36 61.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.325 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 8.7 pt20 -82.15 -41.83 19.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.229 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -72.54 0.17 11.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.637 HG22 ' O ' ' B' ' 47' ' ' ILE . 11.1 tt -115.04 -45.66 4.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.755 0.312 . . . . 0.0 111.242 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.49 ' N ' HG23 ' B' ' 51' ' ' ILE . 31.3 mm-40 -90.15 -50.05 6.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.714 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' A' ' 2' ' ' LEU . . . -75.25 -43.51 51.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.824 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.51 121.21 42.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.733 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 87.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 21.2 p -62.76 -176.06 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.028 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -172.77 171.3 4.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.804 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -57.97 -29.08 64.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.985 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 2.0 p -175.63 145.93 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.803 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.5 p -121.47 133.15 55.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 48.6 p90 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.897 179.975 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.832 0.349 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.451 HD22 HH21 ' B' ' 44' ' ' ARG . 0.7 OUTLIER -116.96 109.69 17.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 mm -97.2 105.34 17.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.09 0.471 . . . . 0.0 110.789 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.467 ' HG ' ' CG ' ' B' ' 48' ' ' TYR . 0.1 OUTLIER -124.23 110.42 14.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.2 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -62.9 77.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.961 0.41 . . . . 0.0 111.474 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.471 ' HB2' HG13 ' B' ' 32' ' ' ILE . 3.8 mtt-85 -80.12 143.68 33.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.321 0.581 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.637 ' HD3' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -170.59 -7.48 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.878 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -161.32 12.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.49 -139.25 9.36 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.864 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -107.08 -164.54 0.99 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.785 0.326 . . . . 0.0 111.178 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.612 HG22 HG23 ' A' ' 21' ' ' THR . 8.3 p -110.02 169.34 8.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 12' ' ' LEU . 1.6 pt? -109.35 154.31 22.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.597 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.564 ' HG2' HG22 ' A' ' 18' ' ' VAL . 1.6 ttp -129.73 100.29 5.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.07 0.462 . . . . 0.0 111.186 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.691 HG23 HG23 ' B' ' 14' ' ' ILE . 3.1 tp -114.32 124.69 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.486 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.52 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 132.11 -105.35 0.6 Allowed Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.058 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 2.2 t70 -160.81 11.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER 159.17 61.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.851 0.46 . . . . 0.0 109.781 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.564 HG22 ' HG2' ' A' ' 13' ' ' MET . 8.8 m -118.3 -157.7 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.676 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.935 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 167.32 102.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.77 HG13 ' HA ' ' A' ' 34' ' ' VAL . 25.7 t -118.65 113.85 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.982 0.42 . . . . 0.0 111.951 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.612 HG23 HG22 ' A' ' 11' ' ' THR . 4.0 m -96.03 113.08 24.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.549 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.786 HG11 HG21 ' B' ' 32' ' ' ILE . 30.5 m -76.78 -19.0 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.862 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER 62.89 -76.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.044 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . 92.41 -40.81 2.83 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.16 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.637 HG22 ' HD3' ' A' ' 7' ' ' ARG . 1.1 t -85.59 139.17 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.666 0.233 . . . . 0.0 110.938 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER 164.37 165.58 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.943 0.401 . . . . 0.0 110.715 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' GLN . . . -76.71 105.59 2.05 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.151 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m120 64.45 -72.53 0.06 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 111.23 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.505 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 1.3 tp60 -84.46 136.93 33.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.682 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.7 t -93.15 119.86 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.907 0.384 . . . . 0.0 111.794 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 0.1 OUTLIER -75.75 98.59 4.16 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.045 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.795 HG21 HG11 ' B' ' 22' ' ' VAL . 11.2 mm -92.18 123.42 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.39 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.77 119.24 6.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.26 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.77 ' HA ' HG13 ' A' ' 20' ' ' VAL . 22.0 t -109.74 103.73 15.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.922 0.391 . . . . 0.0 111.253 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.935 ' HB3' HG23 ' A' ' 19' ' ' THR . 3.6 t-20 -100.61 107.52 19.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.286 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.96 147.69 42.46 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.697 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.508 ' HD2' HG12 ' A' ' 18' ' ' VAL . 79.0 Cg_endo -77.51 156.52 32.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.866 2.377 . . . . 0.0 112.126 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 30.35 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.25 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -106.08 -37.96 6.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.77 0.319 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.509 HG12 ' O ' ' B' ' 15' ' ' GLY . 21.3 t -90.73 147.53 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -54.6 100.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.18 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.524 ' HB ' HD13 ' B' ' 14' ' ' ILE . 12.4 p -122.4 124.56 71.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.08 136.32 51.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.601 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.455 HH21 HD22 ' B' ' 2' ' ' LEU . 2.3 mpp_? -147.74 -176.85 5.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.57 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.455 ' HB3' ' CG ' ' A' ' 48' ' ' TYR . 2.7 tt0 -59.32 137.99 57.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -61.29 2.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.595 ' CG1' HD11 ' A' ' 51' ' ' ILE . 6.8 tt -54.73 -42.05 59.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.349 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.473 ' CG ' ' HG ' ' B' ' 4' ' ' LEU . 4.5 m-30 -46.24 -58.85 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.691 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 41.1 mt-30 -75.97 -20.99 57.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.625 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -73.19 -13.84 61.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.596 0.236 . . . . 0.0 111.458 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.595 HD11 ' CG1' ' A' ' 47' ' ' ILE . 28.6 mt -108.91 -33.11 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.723 0.297 . . . . 0.0 111.361 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.93 -50.84 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.342 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -62.23 -69.03 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.924 0.393 . . . . 0.0 110.771 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -113.94 118.62 34.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.507 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -57.25 101.73 0.07 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.643 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.82 -156.43 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -73.62 157.98 35.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.745 0.307 . . . . 0.0 110.701 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.03 -53.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.805 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.67 31.81 3.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.746 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.88 120.45 33.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.83 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.895 -179.945 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.815 0.34 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.455 HD22 HH21 ' A' ' 44' ' ' ARG . 0.7 OUTLIER -116.87 109.65 17.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 13.0 mm -97.13 105.29 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.075 0.464 . . . . 0.0 110.861 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.473 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -124.22 110.45 14.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.178 179.064 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -62.95 77.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.011 0.434 . . . . 0.0 111.497 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.46 ' HB2' HG13 ' A' ' 32' ' ' ILE . 3.7 mtt-85 -80.06 143.67 33.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.329 0.585 . . . . 0.0 111.022 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.642 ' HD3' HG22 ' B' ' 25' ' ' VAL . 0.0 OUTLIER -170.56 -7.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.905 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.451 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -161.24 12.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.43 -139.26 9.35 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.896 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -107.12 -164.5 0.99 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.159 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.621 HG22 HG23 ' B' ' 21' ' ' THR . 8.5 p -110.07 169.37 8.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.481 HD23 ' H ' ' B' ' 12' ' ' LEU . 1.6 pt? -109.39 154.36 22.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.519 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.569 ' HG2' HG22 ' B' ' 18' ' ' VAL . 1.6 ttp -129.76 100.26 5.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.462 . . . . 0.0 111.159 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.691 HG23 HG23 ' A' ' 14' ' ' ILE . 3.1 tp -114.34 124.64 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.502 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.509 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 132.13 -105.46 0.61 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.127 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 2.2 t70 -160.67 12.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 0.2 OUTLIER 159.03 61.86 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.854 0.462 . . . . 0.0 109.77 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.569 HG22 ' HG2' ' B' ' 13' ' ' MET . 8.8 m -118.41 -157.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.656 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.946 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 167.4 102.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.748 HG13 ' HA ' ' B' ' 34' ' ' VAL . 25.8 t -118.72 113.74 42.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.4 . . . . 0.0 111.946 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.621 HG23 HG22 ' B' ' 11' ' ' THR . 4.0 m -95.96 113.16 24.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.795 HG11 HG21 ' A' ' 32' ' ' ILE . 31.0 m -76.75 -19.05 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.872 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.578 HD12 ' O ' ' B' ' 25' ' ' VAL . 0.2 OUTLIER 62.93 -76.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.02 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . 92.42 -40.85 2.82 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.165 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.642 HG22 ' HD3' ' B' ' 7' ' ' ARG . 1.2 t -85.61 139.21 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.644 0.222 . . . . 0.0 110.943 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER 164.37 165.62 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.95 0.405 . . . . 0.0 110.736 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 29' ' ' GLN . . . -76.72 105.61 2.05 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.056 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m120 64.5 -72.63 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.903 0.382 . . . . 0.0 111.161 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 1.3 tp60 -84.47 136.98 33.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.631 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.14 119.82 41.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.847 0.356 . . . . 0.0 111.819 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -75.77 98.63 4.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.048 179.488 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.786 HG21 HG11 ' A' ' 22' ' ' VAL . 11.3 mm -92.18 123.33 44.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.334 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.71 119.23 6.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.332 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.748 ' HA ' HG13 ' B' ' 20' ' ' VAL . 22.0 t -109.73 103.7 15.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.878 0.371 . . . . 0.0 111.291 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.946 ' HB3' HG23 ' B' ' 19' ' ' THR . 3.6 t-20 -100.58 107.57 19.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.256 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.02 147.77 42.57 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.682 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.49 ' HD2' HG12 ' B' ' 18' ' ' VAL . 79.5 Cg_endo -77.6 156.49 31.95 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.836 2.357 . . . . 0.0 112.161 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 30.22 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.233 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -106.01 -38.02 6.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.808 0.337 . . . . 0.0 110.89 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 15' ' ' GLY . 21.2 t -90.63 147.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.947 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -54.58 100.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.204 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.513 ' HB ' HD13 ' A' ' 14' ' ' ILE . 12.4 p -122.34 124.54 71.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.09 136.29 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.631 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.451 HH21 HD22 ' A' ' 2' ' ' LEU . 2.3 mpp_? -147.74 -176.85 5.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.31 . . . . 0.0 110.631 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.453 ' HB3' ' CG ' ' B' ' 48' ' ' TYR . 2.7 tt0 -59.34 138.07 57.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 110.801 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -61.31 2.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.589 ' CG1' HD11 ' B' ' 51' ' ' ILE . 6.8 tt -54.72 -42.14 59.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.481 ' HD1' HG23 ' B' ' 47' ' ' ILE . 4.5 m-30 -46.2 -58.81 3.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.687 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 41.1 mt-30 -76.05 -20.93 57.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.609 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -73.28 -13.72 61.18 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 111.41 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.589 HD11 ' CG1' ' B' ' 47' ' ' ILE . 28.9 mt -109.09 -33.04 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.709 0.29 . . . . 0.0 111.357 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.98 -50.85 3.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.347 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' B' ' 49' ' ' GLN . . . -62.23 -69.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.969 0.414 . . . . 0.0 110.791 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -114.05 119.59 37.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.402 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -57.66 103.64 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.733 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 77.0 p -160.03 71.18 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.994 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -59.93 -40.63 89.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 56.17 32.39 20.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.024 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 59.5 p -88.05 89.19 7.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.969 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.42 145.03 24.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 54.2 p90 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.939 -179.985 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.789 0.328 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' B' ' 53' ' ' ALA . 2.0 mp -122.22 116.69 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.805 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.2 tt -103.11 105.31 18.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.181 0.515 . . . . 0.0 110.786 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.611 HD22 ' CD1' ' B' ' 48' ' ' TYR . 4.1 tp -125.19 124.19 41.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.021 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -55.6 140.66 40.31 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.376 179.458 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 6.1 mtp85 -151.65 142.97 23.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.939 0.4 . . . . 0.0 111.426 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 172.82 -0.52 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.784 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.3 t -148.73 116.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.796 0.331 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.78 63.45 5.23 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.71 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.479 ' C ' HG22 ' A' ' 11' ' ' THR . 28.4 mm-40 -106.64 173.27 6.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.538 0.209 . . . . 0.0 110.723 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.479 HG22 ' C ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER 164.47 101.26 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.326 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.869 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -109.07 154.19 22.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.785 179.022 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -131.81 100.24 5.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.931 0.396 . . . . 0.0 111.307 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.91 HG23 HG23 ' B' ' 14' ' ' ILE . 7.2 tp -119.12 115.44 47.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.679 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.08 -106.76 0.51 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.912 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 11.8 t70 -150.74 8.64 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.1 mt-10 155.74 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.839 0.455 . . . . 0.0 109.879 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.802 HG12 ' HD2' ' A' ' 37' ' ' PRO . 16.6 m -135.58 131.41 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.861 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.1 m -116.09 117.05 29.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.869 ' HB ' HD23 ' A' ' 12' ' ' LEU . 4.9 t -108.89 110.84 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 111.784 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 t -102.24 104.61 15.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.239 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.003 HG23 HD12 ' A' ' 32' ' ' ILE . 5.6 p -80.88 71.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.241 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.11 -143.38 0.2 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.528 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.23 80.87 0.06 OUTLIER Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.797 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 30' ' ' VAL . 14.2 t -110.28 108.28 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 120.844 0.354 . . . . 0.0 111.324 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -167.03 135.2 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.623 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.51 -153.33 19.26 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.765 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.65 -52.73 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.494 ' HB3' HG22 ' B' ' 5' ' ' THR . 43.5 mt-30 -84.93 114.62 22.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 32' ' ' ILE . 3.7 m -93.07 137.14 23.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 35.7 mtt180 -76.0 104.26 6.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.332 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.003 HD12 HG23 ' A' ' 22' ' ' VAL . 12.6 mm -87.22 137.38 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.901 0.381 . . . . 0.0 111.344 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.85 121.71 6.31 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.413 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.59 ' HA ' HG13 ' A' ' 20' ' ' VAL . 14.9 t -118.09 103.64 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.953 0.406 . . . . 0.0 111.431 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.25 107.59 19.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.299 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.07 144.82 22.6 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.822 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.802 ' HD2' HG12 ' A' ' 18' ' ' VAL . 93.0 Cg_endo -83.0 156.27 15.17 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.85 2.367 . . . . 0.0 111.971 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 42.73 1.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.214 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -113.36 -43.72 3.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.715 0.293 . . . . 0.0 110.94 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 41' ' ' SER . 5.1 t -83.43 160.9 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.844 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -59.79 99.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.715 -179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 42' ' ' VAL . 8.1 p -122.38 122.93 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.956 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.34 136.18 50.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.193 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.414 ' HD3' ' CD2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -161.76 -165.18 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.321 . . . . 0.0 110.766 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -64.26 136.71 57.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -55.08 -61.21 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 tt -55.95 -38.96 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.315 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.601 ' CD1' HD22 ' B' ' 4' ' ' LEU . 43.3 t80 -46.71 -61.91 1.62 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.657 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -76.35 -21.29 56.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.438 -179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 6.9 tpt180 -73.66 -10.94 60.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.424 HG13 ' N ' ' A' ' 52' ' ' GLN . 1.7 pt -114.29 -28.88 2.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.424 ' N ' HG13 ' A' ' 51' ' ' ILE . 13.1 mm-40 -104.83 -54.27 2.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.732 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -62.15 -66.01 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.699 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -110.26 117.52 33.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.648 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.29 107.93 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.484 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.82 160.24 12.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.891 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -63.13 -66.48 0.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -82.54 147.17 28.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.814 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 p -144.74 29.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.067 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.9 m -93.25 145.03 24.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.805 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.917 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.818 0.342 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 53' ' ' ALA . 2.0 mp -122.26 116.63 24.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.879 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.636 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.2 tt -103.09 105.33 18.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.198 0.523 . . . . 0.0 110.774 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.601 HD22 ' CD1' ' A' ' 48' ' ' TYR . 4.1 tp -125.2 124.21 41.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.064 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -55.64 140.67 40.48 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.36 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 6.1 mtp85 -151.67 142.96 23.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.946 0.403 . . . . 0.0 111.427 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER 172.8 -0.54 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.821 179.438 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 17.3 t -148.66 116.75 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.781 0.324 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.7 63.47 5.21 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.705 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.472 ' C ' HG22 ' B' ' 11' ' ' THR . 28.3 mm-40 -106.6 173.33 6.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.503 0.192 . . . . 0.0 110.768 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.472 HG22 ' C ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 164.47 101.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.409 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.0 OUTLIER -109.0 154.19 22.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.789 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.504 ' HA ' ' O ' ' B' ' 18' ' ' VAL . 0.5 OUTLIER -131.8 100.22 5.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 111.322 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.91 HG23 HG23 ' A' ' 14' ' ' ILE . 7.2 tp -119.06 115.45 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.708 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.08 -106.71 0.51 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.94 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 11.8 t70 -150.8 8.7 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.1 mt-10 155.7 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.811 0.444 . . . . 0.0 109.878 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.801 HG12 ' HD2' ' B' ' 37' ' ' PRO . 16.5 m -135.64 131.42 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.827 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -116.05 117.04 29.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.858 ' HB ' HD23 ' B' ' 12' ' ' LEU . 4.8 t -108.86 110.82 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.868 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 1.4 t -102.22 104.62 15.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.216 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.97 HG23 HD12 ' B' ' 32' ' ' ILE . 5.6 p -80.88 71.04 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.291 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -143.35 0.2 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.476 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.19 80.79 0.06 OUTLIER Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.887 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' B' ' 30' ' ' VAL . 14.0 t -110.21 108.28 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 111.309 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -167.07 135.09 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.658 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.59 -153.36 19.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.806 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.67 -52.61 10.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 110.853 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.5 ' HB3' HG22 ' A' ' 5' ' ' THR . 43.5 mt-30 -84.95 114.59 22.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.984 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.712 HG23 HD11 ' B' ' 32' ' ' ILE . 3.7 m -93.02 137.16 23.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.093 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 35.8 mtt180 -76.02 104.28 6.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.348 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.97 HD12 HG23 ' B' ' 22' ' ' VAL . 12.8 mm -87.29 137.37 21.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.933 0.396 . . . . 0.0 111.37 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.9 121.77 6.32 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.373 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.592 ' HA ' HG13 ' B' ' 20' ' ' VAL . 15.0 t -118.08 103.64 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 0.0 111.426 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.35 107.58 19.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.233 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.03 144.85 22.77 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.799 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.801 ' HD2' HG12 ' B' ' 18' ' ' VAL . 93.0 Cg_endo -82.97 156.23 15.23 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.92 2.413 . . . . 0.0 111.979 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.81 42.67 1.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.218 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -113.26 -43.77 3.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.784 0.326 . . . . 0.0 110.971 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.445 HG12 ' N ' ' B' ' 41' ' ' SER . 5.1 t -83.46 160.93 3.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.769 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.445 ' N ' HG12 ' B' ' 40' ' ' VAL . 0.8 OUTLIER -59.71 99.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.758 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.455 HG13 ' O ' ' B' ' 42' ' ' VAL . 8.1 p -122.4 122.89 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.954 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.34 136.16 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.414 ' HD3' ' CD2' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -161.76 -165.19 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.754 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.6 OUTLIER -64.32 136.67 57.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.966 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.7 OUTLIER -54.97 -61.27 2.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 tt -55.98 -38.91 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.299 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.611 ' CD1' HD22 ' A' ' 4' ' ' LEU . 43.1 t80 -46.74 -61.99 1.59 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.645 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 0.0 OUTLIER -76.26 -21.29 56.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.455 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' B' ' 46' ' ' GLU . 7.0 tpt180 -73.73 -10.9 60.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.572 0.225 . . . . 0.0 111.565 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.425 HG13 ' N ' ' B' ' 52' ' ' GLN . 1.7 pt -114.35 -28.62 2.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.797 0.332 . . . . 0.0 111.166 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.425 ' N ' HG13 ' B' ' 51' ' ' ILE . 13.0 mm-40 -104.95 -54.39 2.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' B' ' 49' ' ' GLN . . . -62.11 -65.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.726 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -110.5 117.82 34.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.546 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' B' ' 57' ' ' GLN . 1.5 tptm -64.73 95.23 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.453 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.56 -69.05 0.14 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.718 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' B' ' 55' ' ' LYS . 0.3 OUTLIER 68.12 61.44 0.4 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.091 179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 70.25 129.16 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.04 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 55.0 p -161.65 122.55 2.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.727 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 95.5 p -91.81 127.31 37.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.073 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.906 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.753 0.311 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.76 HD21 ' HB2' ' B' ' 53' ' ' ALA . 5.4 mp -119.98 113.2 20.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.0 tt -105.04 107.86 23.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 110.737 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.436 ' HG ' ' CG ' ' B' ' 48' ' ' TYR . 1.4 mm? -124.09 126.03 45.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.095 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.412 HG21 ' HG2' ' B' ' 29' ' ' GLN . 0.3 OUTLIER -59.76 145.2 46.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.409 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.411 ' HB2' HG13 ' B' ' 32' ' ' ILE . 0.0 OUTLIER -155.89 146.28 21.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.164 0.507 . . . . 0.0 111.304 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.724 ' O ' HG13 ' A' ' 8' ' ' VAL . 2.3 ttt180 175.92 74.31 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 176.97 -60.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.663 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.74 82.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.73 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.409 ' O ' ' HB ' ' A' ' 11' ' ' THR . 1.3 tt0 -72.17 -161.9 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.556 0.217 . . . . 0.0 110.569 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER 172.35 89.43 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.633 0.254 . . . . 0.0 111.056 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.55 HD13 HG11 ' B' ' 34' ' ' VAL . 0.2 OUTLIER -110.53 152.33 26.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.126 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.505 ' HA ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -132.98 100.27 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.901 0.381 . . . . 0.0 111.546 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.622 ' C ' HD13 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -111.35 127.07 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.258 179.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.509 ' HA2' HG11 ' B' ' 40' ' ' VAL . . . 126.52 -102.69 0.64 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.877 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.461 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.4 m-20 -165.77 17.39 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.4 OUTLIER 158.92 59.42 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.734 0.302 . . . . 0.0 110.884 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.722 HG12 ' HD2' ' A' ' 37' ' ' PRO . 11.1 m -120.5 -157.37 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 120.638 0.256 . . . . 0.0 111.632 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 167.58 105.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 34' ' ' VAL . 28.6 t -122.91 114.3 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.827 0.346 . . . . 0.0 111.737 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 21' ' ' THR . 9.8 t -104.4 118.4 36.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.513 ' O ' ' C ' ' A' ' 23' ' ' LEU . 17.1 m -91.85 63.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.427 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.746 HD12 ' O ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -13.16 -70.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.586 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . 90.74 -45.4 2.9 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.26 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.746 ' O ' HD12 ' A' ' 23' ' ' LEU . 1.4 t -85.25 137.35 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' CB ' ' HA ' ' A' ' 30' ' ' VAL . 3.9 tptt 174.7 165.49 0.25 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.645 0.259 . . . . 0.0 110.383 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.37 -105.94 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.465 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.33 -41.5 11.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.069 0.461 . . . . 0.0 110.271 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -105.56 136.52 44.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.926 179.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.417 ' HA ' ' CB ' ' A' ' 26' ' ' LYS . 21.3 t -93.18 114.15 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 0.0 111.417 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.87 100.64 4.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.657 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.408 HG13 ' CB ' ' B' ' 6' ' ' ARG . 10.7 mm -87.11 131.76 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.44 120.76 6.23 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.048 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.734 ' HA ' HG13 ' A' ' 20' ' ' VAL . 16.3 t -118.19 103.69 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.883 0.373 . . . . 0.0 111.199 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 19' ' ' THR . 3.0 t-20 -99.48 107.47 19.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.12 0.486 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.67 144.17 28.99 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.675 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.722 ' HD2' HG12 ' A' ' 18' ' ' VAL . 85.7 Cg_endo -80.29 156.36 22.47 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.747 2.298 . . . . 0.0 112.129 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -93.25 34.6 1.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.103 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.42 -44.08 6.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.507 HG11 ' HA2' ' B' ' 15' ' ' GLY . 24.3 t -89.33 158.07 2.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.781 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -59.64 97.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.817 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.5 p -122.45 120.95 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.178 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -120.73 136.29 54.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -146.61 -176.32 5.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.69 0.281 . . . . 0.0 110.569 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.75 133.75 56.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 0.0 110.698 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -51.78 -60.27 3.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.31 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 48' ' ' TYR . 1.3 tp -55.08 -42.86 67.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.482 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 47' ' ' ILE . 2.7 m-85 -46.53 -68.08 0.22 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.443 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.703 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 2.5 pt20 -70.52 -21.04 62.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.469 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.45 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 12.9 mtp85 -65.97 -23.02 66.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.677 0.275 . . . . 0.0 111.358 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.6 pt -109.91 -21.62 5.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.417 ' HB3' HD23 ' B' ' 2' ' ' LEU . 1.2 tp60 -107.09 -58.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 111.441 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.791 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -66.44 -73.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.451 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.8 127.21 54.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.389 . . . . 0.0 111.12 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.529 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.027 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.787 0.327 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.4 mp -119.98 113.27 20.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.586 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.0 tt -105.05 107.84 23.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.09 0.472 . . . . 0.0 110.743 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.443 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 1.4 mm? -124.17 126.11 45.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -59.78 145.3 45.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.376 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -155.96 146.26 21.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.141 0.496 . . . . 0.0 111.27 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.729 ' O ' HG13 ' B' ' 8' ' ' VAL . 2.3 ttt180 175.93 74.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.089 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.729 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER 176.87 -60.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.685 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.71 82.45 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.668 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.17 -161.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.547 0.213 . . . . 0.0 110.549 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 172.3 89.42 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.695 0.283 . . . . 0.0 111.095 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.551 HD13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -110.46 152.25 26.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.243 179.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.519 ' HA ' HG23 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -132.96 100.36 4.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.4 . . . . 0.0 111.542 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.62 HD13 ' C ' ' B' ' 14' ' ' ILE . 0.0 OUTLIER -111.31 127.0 68.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.239 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.509 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 126.51 -102.64 0.64 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.888 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.4 m-20 -165.75 17.35 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.468 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.4 OUTLIER 158.9 59.55 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.747 0.308 . . . . 0.0 110.846 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.72 HG12 ' HD2' ' B' ' 37' ' ' PRO . 11.2 m -120.6 -157.34 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.721 0.296 . . . . 0.0 111.55 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.652 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 167.61 105.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.704 HG13 ' HA ' ' B' ' 34' ' ' VAL . 28.9 t -122.94 114.34 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.32 . . . . 0.0 111.701 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.431 HG23 ' O ' ' B' ' 21' ' ' THR . 9.7 t -104.42 118.42 36.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.782 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.503 ' O ' ' C ' ' B' ' 23' ' ' LEU . 17.1 m -91.89 63.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.445 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.757 HD12 ' O ' ' B' ' 25' ' ' VAL . 0.4 OUTLIER -13.19 -70.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.519 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . 90.75 -45.44 2.9 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.222 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.757 ' O ' HD12 ' B' ' 23' ' ' LEU . 1.4 t -85.28 137.36 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.652 0.263 . . . . 0.0 110.831 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 3.9 tptt 174.69 165.52 0.25 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.64 0.257 . . . . 0.0 110.454 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.42 -105.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.445 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.32 -41.54 11.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.065 0.46 . . . . 0.0 110.265 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 0.2 OUTLIER -105.46 136.49 44.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.956 179.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.406 ' HA ' ' CB ' ' B' ' 26' ' ' LYS . 21.3 t -93.2 114.22 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 111.398 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.85 100.58 4.82 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.634 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.411 HG13 ' HB2' ' A' ' 6' ' ' ARG . 10.6 mm -87.11 131.76 34.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.42 120.72 6.22 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.091 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.704 ' HA ' HG13 ' B' ' 20' ' ' VAL . 16.2 t -118.17 103.72 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.899 0.38 . . . . 0.0 111.201 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' B' ' 19' ' ' THR . 3.0 t-20 -99.49 107.51 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.371 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.72 144.15 28.76 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.65 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.72 ' HD2' HG12 ' B' ' 18' ' ' VAL . 85.0 Cg_endo -80.17 156.34 22.84 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.784 2.323 . . . . 0.0 112.152 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -93.29 34.67 1.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.44 -44.19 5.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.509 HG11 ' HA2' ' A' ' 15' ' ' GLY . 24.2 t -89.22 158.09 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.815 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.459 ' N ' HG12 ' B' ' 40' ' ' VAL . 1.0 OUTLIER -59.64 97.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.786 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.492 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.5 p -122.55 120.91 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.179 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -120.75 136.31 54.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.267 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -146.61 -176.3 5.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.522 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.73 133.75 56.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -51.8 -60.29 3.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.249 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.456 HG23 ' N ' ' B' ' 48' ' ' TYR . 1.3 tp -55.05 -42.84 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.489 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.456 ' N ' HG23 ' B' ' 47' ' ' ILE . 2.7 m-85 -46.57 -68.03 0.23 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.476 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 2.5 pt20 -70.59 -21.03 62.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.498 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 13.0 mtp85 -65.96 -22.91 66.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.662 0.268 . . . . 0.0 111.35 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 18.6 pt -109.99 -21.76 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.413 ' HB3' HD23 ' A' ' 2' ' ' LEU . 1.2 tp60 -107.04 -58.05 1.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.736 0.303 . . . . 0.0 111.468 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.76 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -66.47 -73.48 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.478 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.28 128.92 55.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.925 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.787 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.599 ' C ' HD12 ' A' ' 2' ' ' LEU . 2.0 ttt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.835 0.35 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 2' ' ' LEU . 4.8 mp -119.87 116.07 25.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.707 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.532 ' C ' HD22 ' A' ' 4' ' ' LEU . 14.2 mm -93.0 105.66 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.984 0.421 . . . . 0.0 110.58 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.619 ' N ' HD22 ' A' ' 4' ' ' LEU . 2.5 mm? -116.77 156.79 26.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.666 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' B' ' 29' ' ' GLN . 0.1 OUTLIER -97.01 133.63 41.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.951 0.405 . . . . 0.0 110.649 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.679 HH11 HG21 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -151.42 148.1 27.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.84 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 2.8 ttt180 177.39 -6.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.176 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.419 ' H ' ' H ' ' A' ' 7' ' ' ARG . 22.0 t -115.7 -57.29 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.768 0.318 . . . . 0.0 111.044 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.48 88.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.645 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.84 -70.55 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.732 0.301 . . . . 0.0 110.787 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m 75.87 103.45 0.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.529 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.492 ' CD1' HG11 ' B' ' 34' ' ' VAL . 1.3 pt? -108.94 154.46 22.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.967 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.488 ' HA ' HG23 ' A' ' 18' ' ' VAL . 24.5 ttp -128.12 100.54 5.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.097 0.475 . . . . 0.0 111.24 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.641 HD13 ' HB ' ' B' ' 42' ' ' VAL . 2.1 tp -112.78 122.97 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.423 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.619 ' HA2' HG11 ' B' ' 40' ' ' VAL . . . 133.8 -104.87 0.54 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.996 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.5 t70 -159.41 11.65 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 157.4 61.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.964 0.412 . . . . 0.0 109.954 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.662 HG12 ' HD2' ' A' ' 37' ' ' PRO . 17.7 m -118.48 -155.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.723 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 168.59 103.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.749 HG13 ' HA ' ' A' ' 34' ' ' VAL . 25.2 t -119.72 111.22 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 111.769 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.29 113.07 25.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.48 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.679 HG21 HH11 ' A' ' 6' ' ' ARG . 29.6 m -84.76 62.94 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.779 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.32 121.83 3.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . -99.52 -15.71 31.36 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.001 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.2 t -85.48 125.8 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.743 0.271 . . . . 0.0 110.473 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 1.3 tpmp? 176.9 165.29 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.814 0.34 . . . . 0.0 110.66 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 29' ' ' GLN . . . -90.96 108.42 3.58 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.539 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 65.68 -69.52 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.876 0.37 . . . . 0.0 110.796 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 1.8 mt-30 -84.82 136.57 33.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.62 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.538 HG12 ' CD1' ' A' ' 32' ' ' ILE . 5.4 t -93.0 119.69 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.044 0.45 . . . . 0.0 111.493 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -82.88 98.21 9.07 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.3 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.566 HG23 ' HA ' ' A' ' 22' ' ' VAL . 4.7 mm -93.05 127.66 45.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.61 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.08 112.38 4.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.328 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.749 ' HA ' HG13 ' A' ' 20' ' ' VAL . 28.0 t -106.35 103.68 15.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.871 0.367 . . . . 0.0 111.168 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -98.37 107.33 19.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.368 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.16 146.08 52.85 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.677 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.662 ' HD2' HG12 ' A' ' 18' ' ' VAL . 77.0 Cg_endo -83.44 156.22 14.33 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.005 2.47 . . . . 0.0 112.358 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -3.25 41.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.332 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -42.63 70.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.643 0.259 . . . . 0.0 111.171 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.632 HG11 ' HA2' ' B' ' 15' ' ' GLY . 11.6 t -91.0 152.53 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.803 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.3 t -76.09 106.08 7.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.966 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.648 ' HB ' HD13 ' B' ' 14' ' ' ILE . 14.6 p -121.07 120.23 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.46 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -128.68 134.32 48.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.666 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.516 HH21 HG21 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -154.65 -49.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.706 0.288 . . . . 0.0 111.257 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 3.4 mm-40 -161.27 124.49 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.929 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -56.45 -59.07 5.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.101 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.443 HG23 ' N ' ' A' ' 48' ' ' TYR . 17.6 tt -58.1 -42.49 83.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.176 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CG ' ' HB2' ' A' ' 45' ' ' GLU . 3.1 m-85 -44.25 -58.06 3.11 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 11.6 pt20 -76.65 -21.62 55.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.793 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -67.38 -15.01 63.44 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.261 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.623 HD13 ' HD2' ' A' ' 55' ' ' LYS . 23.7 mm -116.05 -26.43 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.337 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.57 -58.66 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.909 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . . . -60.78 -64.09 1.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.588 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -109.58 116.28 31.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.387 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.623 ' HD2' HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.465 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.792 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.593 ' C ' HD12 ' B' ' 2' ' ' LEU . 2.0 ttt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.82 0.343 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.616 ' HB3' HD21 ' B' ' 4' ' ' LEU . 4.8 mp -119.88 116.09 25.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.522 ' C ' HD22 ' B' ' 4' ' ' LEU . 14.2 mm -93.05 105.73 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.994 0.426 . . . . 0.0 110.579 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.629 HD22 ' N ' ' B' ' 4' ' ' LEU . 2.5 mm? -116.77 156.78 26.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.679 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.01 133.63 41.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.949 0.404 . . . . 0.0 110.653 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.68 HH11 HG21 ' B' ' 22' ' ' VAL . 0.1 OUTLIER -151.44 148.11 27.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.796 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 2.8 ttt180 177.37 -6.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.13 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.404 ' H ' ' H ' ' B' ' 7' ' ' ARG . 22.0 t -115.67 -57.3 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.805 0.336 . . . . 0.0 111.044 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.47 88.34 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.601 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.88 -70.59 0.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.759 0.314 . . . . 0.0 110.735 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m 75.83 103.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.604 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.486 ' CD1' HG11 ' A' ' 34' ' ' VAL . 1.3 pt? -108.87 154.44 22.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.951 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.489 ' HA ' HG23 ' B' ' 18' ' ' VAL . 24.4 ttp -128.09 100.47 5.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 111.227 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.648 HD13 ' HB ' ' A' ' 42' ' ' VAL . 2.1 tp -112.74 122.93 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.632 ' HA2' HG11 ' A' ' 40' ' ' VAL . . . 133.87 -104.81 0.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.993 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.47 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.5 t70 -159.49 11.71 0.13 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.3 OUTLIER 157.35 61.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.699 0.399 . . . . 0.0 109.943 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.648 HG12 ' HD2' ' B' ' 37' ' ' PRO . 17.6 m -118.48 -155.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.705 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.642 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 168.66 103.13 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.761 HG13 ' HA ' ' B' ' 34' ' ' VAL . 25.3 t -119.71 111.21 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.866 0.365 . . . . 0.0 111.785 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.29 113.04 25.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.486 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.68 HG21 HH11 ' B' ' 6' ' ' ARG . 29.3 m -84.68 62.91 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.841 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.33 121.84 3.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . -99.57 -15.61 31.5 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.053 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' B' ' 26' ' ' LYS . 2.2 t -85.51 125.78 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.69 0.245 . . . . 0.0 110.465 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' B' ' 25' ' ' VAL . 1.3 tpmp? 176.91 165.3 0.5 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.626 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' B' ' 29' ' ' GLN . . . -91.0 108.34 3.57 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.55 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 65.77 -69.5 0.11 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.879 0.371 . . . . 0.0 110.739 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' B' ' 27' ' ' GLY . 1.8 mt-30 -84.8 136.57 33.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.54 HG12 ' CD1' ' B' ' 32' ' ' ILE . 5.3 t -92.99 119.78 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 0.0 111.497 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -82.95 98.26 9.13 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.281 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.569 HG23 ' HA ' ' B' ' 22' ' ' VAL . 4.7 mm -93.08 127.7 45.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.636 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.08 112.33 4.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.384 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.761 ' HA ' HG13 ' B' ' 20' ' ' VAL . 27.0 t -106.3 103.67 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.846 0.355 . . . . 0.0 111.242 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' B' ' 19' ' ' THR . 0.1 OUTLIER -98.36 107.35 19.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.369 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.19 146.1 52.86 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.633 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.648 ' HD2' HG12 ' B' ' 18' ' ' VAL . 76.0 Cg_endo -83.46 156.26 14.28 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.966 2.444 . . . . 0.0 112.356 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -3.36 41.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.35 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.49 -42.71 71.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.689 0.28 . . . . 0.0 111.184 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.619 HG11 ' HA2' ' A' ' 15' ' ' GLY . 11.6 t -90.98 152.58 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.802 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 39.4 t -76.08 105.98 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.982 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.641 ' HB ' HD13 ' A' ' 14' ' ' ILE . 14.6 p -121.0 120.17 61.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.494 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -128.63 134.3 48.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.665 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.535 HH21 HG21 ' B' ' 42' ' ' VAL . 0.1 OUTLIER -154.66 -49.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 111.309 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.453 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 3.4 mm-40 -161.23 124.53 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.4 OUTLIER -56.5 -59.04 5.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.446 HG23 ' N ' ' B' ' 48' ' ' TYR . 17.6 tt -58.1 -42.52 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.198 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.453 ' CG ' ' HB2' ' B' ' 45' ' ' GLU . 3.1 m-85 -44.22 -58.05 3.1 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.755 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 11.6 pt20 -76.77 -21.52 55.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.782 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.446 ' HA ' ' HG2' ' B' ' 54' ' ' GLU . 0.8 OUTLIER -67.47 -14.75 63.21 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.34 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 23.6 mm -116.23 -26.76 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.311 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.24 -58.7 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.95 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' HB2' ' B' ' 49' ' ' GLN . . . -60.8 -63.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.629 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' B' ' 50' ' ' ARG . 0.0 OUTLIER -111.21 120.06 41.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.649 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.447 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.823 0.344 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' B' ' 53' ' ' ALA . 5.0 mp -122.03 107.39 12.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.1 tt -115.06 114.73 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.181 0.515 . . . . 0.0 110.967 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.466 ' HB3' ' CZ ' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -125.44 135.67 52.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.824 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.436 ' H ' HD13 ' A' ' 4' ' ' LEU . 0.2 OUTLIER -62.37 150.86 38.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -170.67 148.03 2.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.25 0.548 . . . . 0.0 111.474 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -176.69 7.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.782 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.62 -61.59 2.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.331 . . . . 0.0 111.011 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.6 86.05 0.16 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.494 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.732 ' OE1' HG22 ' A' ' 22' ' ' VAL . 4.3 tm-20 -82.02 171.68 14.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.897 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t 178.8 122.71 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -144.39 141.36 29.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.402 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.559 ' HA ' HG23 ' A' ' 18' ' ' VAL . 4.0 ttt -133.0 99.73 4.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.419 . . . . 0.0 111.09 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.792 HG23 HG23 ' B' ' 14' ' ' ILE . 0.0 OUTLIER -116.3 129.27 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.484 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.701 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 128.8 -105.09 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.907 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.3 p30 -162.76 16.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 6.9 mt-10 158.2 60.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.849 0.357 . . . . 0.0 110.501 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.702 HG12 ' HD2' ' A' ' 37' ' ' PRO . 17.5 m -120.36 -159.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 120.766 0.317 . . . . 0.0 111.646 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 168.57 103.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.629 ' CG1' HG13 ' A' ' 34' ' ' VAL . 35.1 m -122.57 114.37 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 10' ' ' GLU . 2.9 p -108.2 117.03 33.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.299 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.975 HG11 HG11 ' B' ' 22' ' ' VAL . 30.4 m -108.88 54.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.349 . . . . 0.0 111.693 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 25' ' ' VAL . 2.6 pp -47.94 151.17 0.97 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.863 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.423 ' HA2' HG11 ' A' ' 30' ' ' VAL . . . -107.7 2.56 34.11 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.601 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.431 ' N ' HD12 ' A' ' 23' ' ' LEU . 1.4 t -85.21 120.66 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.928 0.364 . . . . 0.0 110.618 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER 174.73 165.34 0.25 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.76 0.315 . . . . 0.0 110.675 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.81 108.28 3.14 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.852 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.02 -74.41 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.859 0.362 . . . . 0.0 111.043 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 16.8 mt-30 -84.72 136.26 33.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.013 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.423 HG11 ' HA2' ' A' ' 24' ' ' GLY . 22.0 t -93.33 117.2 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 111.535 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.404 ' HG2' HG12 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -75.64 99.85 4.45 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.515 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.852 ' CG2' HG12 ' A' ' 22' ' ' VAL . 11.1 mm -87.08 124.5 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.165 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 118.43 6.09 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.569 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.629 HG13 ' CG1' ' A' ' 20' ' ' VAL . 16.7 t -117.79 103.53 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 0.0 111.396 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.4 OUTLIER -99.38 107.53 19.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.501 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.97 143.36 24.8 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.654 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.702 ' HD2' HG12 ' A' ' 18' ' ' VAL . 78.5 Cg_endo -77.12 156.49 33.77 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.759 2.306 . . . . 0.0 112.078 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -89.17 30.08 1.0 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.278 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.58 -38.64 7.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 41' ' ' SER . 17.2 t -93.25 159.35 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.848 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.474 ' N ' HG12 ' A' ' 40' ' ' VAL . 5.8 t -65.28 97.94 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.009 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.9 p -122.31 120.76 62.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.857 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.12 136.39 51.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.722 0.296 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -133.38 -176.12 4.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -64.17 147.79 51.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -50.96 -60.68 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.199 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 tp -55.07 -35.6 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.203 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.473 ' CZ ' ' HB3' ' B' ' 4' ' ' LEU . 0.4 OUTLIER -53.04 -73.14 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.033 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.665 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 5.3 pt20 -64.2 -17.28 63.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.542 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.48 -31.26 69.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.728 0.299 . . . . 0.0 111.328 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.0 mm -104.53 -12.84 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.917 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -114.88 -57.74 2.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.666 0.269 . . . . 0.0 111.716 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . . . -67.53 -71.69 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.383 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -118.18 117.82 30.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.003 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.407 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.993 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptt? . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.781 0.324 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.0 mp -122.06 107.39 12.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.971 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.502 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.0 tt -115.09 114.81 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.216 0.531 . . . . 0.0 110.942 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -125.49 135.73 52.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.763 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.439 ' H ' HD13 ' B' ' 4' ' ' LEU . 0.2 OUTLIER -62.39 150.9 38.44 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -170.69 148.04 2.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.268 0.556 . . . . 0.0 111.464 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -176.74 7.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.789 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.67 -61.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.848 0.356 . . . . 0.0 111.032 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.54 86.1 0.16 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.704 ' OE1' HG22 ' B' ' 22' ' ' VAL . 4.3 tm-20 -82.11 171.72 14.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.739 0.304 . . . . 0.0 110.944 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t 178.77 122.71 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.125 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.534 ' HG ' HG22 ' B' ' 20' ' ' VAL . 0.1 OUTLIER -144.37 141.35 29.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.41 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.556 ' HA ' HG23 ' B' ' 18' ' ' VAL . 4.0 ttt -133.03 99.7 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.792 HG23 HG23 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -116.29 129.33 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.478 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.708 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 128.76 -105.09 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.936 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.3 p30 -162.82 16.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 7.0 mt-10 158.19 60.84 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.857 0.361 . . . . 0.0 110.552 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.702 HG12 ' HD2' ' B' ' 37' ' ' PRO . 17.6 m -120.33 -159.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 120.807 0.337 . . . . 0.0 111.651 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.653 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 168.59 103.6 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.639 HG12 HG13 ' B' ' 34' ' ' VAL . 35.1 m -122.53 114.42 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.549 HG22 ' O ' ' B' ' 10' ' ' GLU . 2.9 p -108.26 117.03 33.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.221 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.975 HG11 HG11 ' A' ' 22' ' ' VAL . 30.4 m -108.84 54.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.724 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.424 ' C ' HD12 ' B' ' 23' ' ' LEU . 2.6 pp -47.91 151.1 0.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.411 ' HA2' HG11 ' B' ' 30' ' ' VAL . . . -107.69 2.63 34.14 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.568 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.422 ' N ' HD12 ' B' ' 23' ' ' LEU . 1.4 t -85.24 120.65 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.973 0.387 . . . . 0.0 110.588 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER 174.74 165.34 0.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.807 0.336 . . . . 0.0 110.634 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.8 108.22 3.13 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.813 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.03 -74.49 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 111.003 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 16.8 mt-30 -84.7 136.2 33.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.994 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.411 HG11 ' HA2' ' B' ' 24' ' ' GLY . 22.0 t -93.25 117.21 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.976 0.417 . . . . 0.0 111.532 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.417 ' HG2' HG12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -75.61 99.8 4.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.543 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.852 ' CG2' HG12 ' B' ' 22' ' ' VAL . 11.0 mm -87.05 124.51 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.114 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 118.39 6.08 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.558 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.639 HG13 HG12 ' B' ' 20' ' ' VAL . 16.6 t -117.75 103.57 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.41 . . . . 0.0 111.383 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 19' ' ' THR . 0.4 OUTLIER -99.49 107.54 19.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.48 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.96 143.37 24.88 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.585 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.702 ' HD2' HG12 ' B' ' 18' ' ' VAL . 78.8 Cg_endo -77.12 156.49 33.77 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.752 2.301 . . . . 0.0 112.066 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -89.14 29.95 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.281 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.47 -38.73 7.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.791 0.329 . . . . 0.0 110.816 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.469 HG12 ' N ' ' B' ' 41' ' ' SER . 17.1 t -93.19 159.31 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.469 ' N ' HG12 ' B' ' 40' ' ' VAL . 5.8 t -65.21 97.89 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.029 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.485 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.9 p -122.29 120.79 62.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.866 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 136.38 51.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.752 0.311 . . . . 0.0 110.767 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -133.34 -176.07 4.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.693 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -64.27 147.81 51.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.03 -60.62 2.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 tp -55.0 -35.6 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.285 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -53.1 -73.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.039 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.669 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 5.3 pt20 -64.26 -17.32 63.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.531 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -31.17 69.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.734 0.302 . . . . 0.0 111.367 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.412 ' O ' HG22 ' B' ' 51' ' ' ILE . 29.2 mm -104.64 -12.58 9.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.854 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -115.12 -57.85 2.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.709 0.29 . . . . 0.0 111.746 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' B' ' 49' ' ' GLN . . . -67.48 -71.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.33 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -117.81 116.94 27.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.706 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.896 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.54 ' C ' HD12 ' A' ' 2' ' ' LEU . 2.8 ttp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 1.048 HD21 ' HB2' ' B' ' 53' ' ' ALA . 4.9 mp -122.32 117.02 25.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -97.97 104.76 16.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.221 0.534 . . . . 0.0 110.5 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.514 HD21 ' O ' ' B' ' 48' ' ' TYR . 0.8 OUTLIER -125.44 121.52 34.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.223 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -54.35 138.59 39.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.104 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.904 ' HB3' HG21 ' A' ' 22' ' ' VAL . 72.1 mtt180 -148.66 144.77 27.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.296 0.57 . . . . 0.0 111.787 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.646 ' NE ' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 174.98 -77.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.551 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.507 HG23 ' HD3' ' A' ' 7' ' ' ARG . 3.4 t -85.73 3.75 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.139 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.52 -139.49 4.4 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.907 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -108.61 -175.49 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.869 0.366 . . . . 0.0 111.218 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.719 HG22 ' HA ' ' A' ' 21' ' ' THR . 22.5 p -102.17 165.53 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.028 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.516 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -110.53 154.63 23.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.525 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.444 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.5 ttt -130.67 100.06 5.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.072 0.463 . . . . 0.0 111.389 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.853 HG23 HG23 ' B' ' 14' ' ' ILE . 5.8 tp -115.9 125.52 73.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.505 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.49 -106.32 0.62 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.078 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.412 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.6 t0 -155.57 4.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 3.1 mt-10 163.37 61.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.017 0.436 . . . . 0.0 109.993 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.641 ' O ' HG23 ' A' ' 19' ' ' THR . 5.3 m -115.51 -159.91 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.824 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 171.49 99.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.683 HG22 HG13 ' A' ' 34' ' ' VAL . 42.9 t -106.42 107.52 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.827 0.346 . . . . 0.0 111.669 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.719 ' HA ' HG22 ' A' ' 11' ' ' THR . 2.2 m -91.2 112.77 24.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.021 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.904 HG21 ' HB3' ' A' ' 6' ' ' ARG . 27.0 m -76.76 70.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.497 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.547 HD12 ' H ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -96.03 -152.76 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.547 ' H ' HD12 ' A' ' 23' ' ' LEU . . . 60.36 66.44 2.71 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.996 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.646 HG21 ' NE ' ' A' ' 7' ' ' ARG . 5.2 t -85.88 107.77 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 120.979 0.419 . . . . 0.0 111.049 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -155.1 165.41 36.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.136 -179.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.98 156.45 47.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.512 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 70.03 -89.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.404 0.145 . . . . 0.0 110.985 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.493 ' HB3' HG22 ' B' ' 5' ' ' THR . 14.7 mt-30 -110.48 124.56 52.02 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.906 0.384 . . . . 0.0 111.082 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.611 HG23 HD11 ' A' ' 32' ' ' ILE . 10.0 m -93.32 137.37 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.318 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 4.7 mtp180 -78.09 102.91 7.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.611 HD11 HG23 ' A' ' 30' ' ' VAL . 14.7 mm -87.32 134.52 27.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.137 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.53 115.79 4.99 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.512 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.683 HG13 HG22 ' A' ' 20' ' ' VAL . 21.4 t -111.12 103.34 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.944 0.402 . . . . 0.0 111.336 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -96.43 107.23 19.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.075 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.06 147.96 33.68 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.9 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.37 156.29 25.39 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.919 2.413 . . . . 0.0 111.984 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -91.38 41.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.114 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.15 -41.92 3.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.994 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 41' ' ' SER . 5.5 t -81.48 158.9 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.855 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -62.35 99.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.784 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.2 p -122.18 124.23 70.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -128.53 136.18 50.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.311 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -166.98 -170.67 1.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.719 0.295 . . . . 0.0 110.709 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.439 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 30.7 mm-40 -54.04 123.97 14.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.008 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.48 -54.91 41.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.115 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 51' ' ' ILE . 8.0 tp -60.21 -41.18 85.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.026 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.518 ' O ' HD21 ' B' ' 4' ' ' LEU . 4.4 m-85 -47.42 -55.51 8.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.237 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.703 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.6 pt20 -80.0 -21.9 43.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.139 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -71.23 -13.33 61.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.285 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 47' ' ' ILE . 1.4 tt -115.7 -36.39 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.877 0.37 . . . . 0.0 110.65 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -87.45 -58.3 2.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.098 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 1.044 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -61.51 -51.65 67.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.258 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -112.57 116.73 30.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.596 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.644 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.549 ' C ' HD12 ' B' ' 2' ' ' LEU . 2.8 ttp . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.789 0.328 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 1.044 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.0 mp -122.35 117.02 25.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.64 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -98.03 104.81 16.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.219 0.533 . . . . 0.0 110.494 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.518 HD21 ' O ' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -125.47 121.52 34.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.253 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -54.39 138.6 39.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.082 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.881 ' HB3' HG21 ' B' ' 22' ' ' VAL . 72.0 mtt180 -148.66 144.72 27.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.258 0.551 . . . . 0.0 111.802 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.63 ' NE ' HG21 ' B' ' 25' ' ' VAL . 0.0 OUTLIER 175.01 -77.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.491 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.509 HG23 ' HD3' ' B' ' 7' ' ' ARG . 3.4 t -85.72 3.73 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.211 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.5 -139.5 4.39 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.922 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -108.59 -175.52 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.923 0.392 . . . . 0.0 111.174 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.746 HG22 ' HA ' ' B' ' 21' ' ' THR . 22.5 p -102.18 165.54 11.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.084 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.525 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -110.51 154.62 23.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.526 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.429 ' HA ' HG23 ' B' ' 18' ' ' VAL . 2.5 ttt -130.64 100.03 5.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.009 0.433 . . . . 0.0 111.395 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.853 HG23 HG23 ' A' ' 14' ' ' ILE . 5.8 tp -115.89 125.5 73.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.505 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.53 -106.32 0.62 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.065 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 2.6 t0 -155.61 4.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 3.1 mt-10 163.34 61.12 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.996 0.427 . . . . 0.0 110.0 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.657 ' O ' HG23 ' B' ' 19' ' ' THR . 5.3 m -115.48 -159.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.831 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.657 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 171.51 99.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.342 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.689 HG22 HG13 ' B' ' 34' ' ' VAL . 43.0 t -106.49 107.58 23.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.822 0.344 . . . . 0.0 111.602 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.746 ' HA ' HG22 ' B' ' 11' ' ' THR . 2.2 m -91.22 112.89 24.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.979 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.881 HG21 ' HB3' ' B' ' 6' ' ' ARG . 26.3 m -76.9 70.55 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.457 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.537 HD12 ' H ' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -96.07 -152.79 0.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.681 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.537 ' H ' HD12 ' B' ' 23' ' ' LEU . . . 60.42 66.38 2.75 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.992 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.63 HG21 ' NE ' ' B' ' 7' ' ' ARG . 5.1 t -85.79 107.74 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.402 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.1 OUTLIER -155.05 165.47 36.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.192 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.04 156.43 47.33 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.481 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 70.08 -89.51 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.041 0.136 . . . . 0.0 110.97 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.487 ' HB3' HG22 ' A' ' 5' ' ' THR . 14.6 mt-30 -110.45 124.53 51.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.895 0.379 . . . . 0.0 111.158 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.62 HG23 HD11 ' B' ' 32' ' ' ILE . 10.2 m -93.26 137.41 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.381 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.8 mtp180 -78.19 102.94 7.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.62 HD11 HG23 ' B' ' 30' ' ' VAL . 14.9 mm -87.34 134.58 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.57 115.76 4.97 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.503 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.689 HG13 HG22 ' B' ' 20' ' ' VAL . 21.4 t -111.17 103.3 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 111.264 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -96.41 107.22 19.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.085 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.08 147.92 33.51 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.922 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.29 156.28 25.63 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.951 2.434 . . . . 0.0 112.007 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -91.34 41.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.166 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.14 -41.93 3.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.411 HG12 ' N ' ' B' ' 41' ' ' SER . 5.5 t -81.48 158.89 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.809 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.411 ' N ' HG12 ' B' ' 40' ' ' VAL . 0.3 OUTLIER -62.31 99.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.829 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.456 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.2 p -122.2 124.18 70.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.959 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -128.51 136.25 50.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.311 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -167.03 -170.71 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.722 0.296 . . . . 0.0 110.711 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.449 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 30.5 mm-40 -54.03 123.98 14.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 111.049 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.48 -54.93 41.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.428 HG23 ' N ' ' B' ' 48' ' ' TYR . 8.0 tp -60.2 -41.17 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.059 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.514 ' O ' HD21 ' A' ' 4' ' ' LEU . 4.4 m-85 -47.41 -55.49 8.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.256 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.703 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 4.5 pt20 -79.91 -21.98 43.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.173 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -71.25 -13.3 61.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.252 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.423 HG22 ' O ' ' B' ' 47' ' ' ILE . 1.4 tt -115.71 -36.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.657 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -87.45 -58.3 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.085 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 1.048 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -61.47 -51.67 67.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.309 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -112.61 116.75 30.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.522 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.951 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.437 ' C ' HD22 ' A' ' 2' ' ' LEU . 3.2 mtt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.871 0.367 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.961 HD11 ' HB2' ' B' ' 53' ' ' ALA . 4.4 mm? -119.73 112.84 19.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -99.97 105.03 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.179 0.514 . . . . 0.0 110.827 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.43 ' HG ' ' CD2' ' B' ' 48' ' ' TYR . 0.2 OUTLIER -124.76 121.49 34.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.036 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -56.16 140.59 43.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 0.0 110.618 179.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.458 ' HB3' HG21 ' A' ' 22' ' ' VAL . 66.8 mtt85 -155.84 145.33 20.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.785 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER 179.11 1.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.975 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 177.2 30.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 120.532 0.206 . . . . 0.0 111.356 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.93 -118.13 3.51 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.762 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -110.13 -178.31 3.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.912 0.387 . . . . 0.0 111.203 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.6 168.04 10.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.737 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.739 ' CD1' HG11 ' B' ' 34' ' ' VAL . 0.8 OUTLIER -111.52 154.51 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.569 ' HG3' HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -127.39 100.56 6.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.43 . . . . 0.0 110.873 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.627 HG23 HG23 ' B' ' 14' ' ' ILE . 3.1 tp -112.7 125.48 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.606 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.43 -105.44 0.65 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.195 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 12.0 m-20 -156.8 6.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 0.8 OUTLIER 161.15 61.89 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' ' 19' ' ' THR . 4.3 m -116.23 -157.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.526 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 172.53 101.61 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.692 HG22 HG13 ' A' ' 34' ' ' VAL . 59.0 t -111.04 108.19 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.88 0.372 . . . . 0.0 111.697 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.1 p -105.08 110.43 22.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.011 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 22' ' ' VAL . 31.2 m -77.4 72.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.61 -143.56 0.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.628 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.5 74.31 0.27 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.819 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.6 t -93.03 108.3 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.515 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -138.92 157.57 45.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.018 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.8 148.02 50.71 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.72 -79.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.634 0.254 . . . . 0.0 110.767 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.53 ' HB3' HG22 ' B' ' 5' ' ' THR . 8.9 mt-30 -116.78 126.28 52.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.986 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.682 HG23 HD11 ' A' ' 32' ' ' ILE . 17.5 m -93.39 136.93 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.269 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 3.9 mtt85 -77.93 104.91 8.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.257 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.682 HD11 HG23 ' A' ' 30' ' ' VAL . 12.0 mm -87.37 137.75 20.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.848 0.356 . . . . 0.0 111.328 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.86 117.41 5.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.472 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.744 HG11 ' CD1' ' B' ' 12' ' ' LEU . 15.6 t -118.08 103.18 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.411 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.6 OUTLIER -95.74 107.17 19.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.378 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.11 145.49 55.85 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.588 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HD2' HG12 ' A' ' 18' ' ' VAL . 92.2 Cg_endo -78.28 156.32 29.33 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.834 2.356 . . . . 0.0 112.121 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.26 26.75 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.185 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -40.23 5.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.849 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -82.45 152.85 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.5 98.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.077 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 42' ' ' VAL . 12.7 p -122.17 120.59 61.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.1 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -128.55 136.17 50.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.413 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -165.53 -40.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.685 0.279 . . . . 0.0 111.135 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.413 ' N ' ' HG3' ' A' ' 44' ' ' ARG . 1.2 mm-40 177.86 114.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.962 0.41 . . . . 0.0 110.882 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -58.48 -38.78 78.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.684 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.519 HG23 HG13 ' A' ' 51' ' ' ILE . 36.1 mm -69.33 -43.23 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.837 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.43 ' CD2' ' HG ' ' B' ' 4' ' ' LEU . 2.8 m-85 -51.36 -42.68 61.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.416 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -87.72 -58.9 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 111.534 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -52.2 -21.38 3.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.519 HG13 HG23 ' A' ' 47' ' ' ILE . 40.3 mm -106.07 -50.58 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.562 ' HB3' HD12 ' B' ' 2' ' ' LEU . 0.1 OUTLIER -75.79 -58.79 3.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.668 0.271 . . . . 0.0 111.299 -179.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.932 ' HB2' HD11 ' B' ' 2' ' ' LEU . . . -67.09 -29.71 69.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.343 . . . . 0.0 111.23 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.2 tt0 -137.97 157.53 46.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 54' ' ' GLU . 1.8 tttp . . . . . 0 N--CA 1.464 0.23 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.879 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.441 ' C ' HD22 ' B' ' 2' ' ' LEU . 3.2 mtt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.833 0.349 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.932 HD11 ' HB2' ' A' ' 53' ' ' ALA . 4.4 mm? -119.75 112.85 19.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.63 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -100.0 105.09 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.252 0.548 . . . . 0.0 110.79 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.43 ' HG ' ' CD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -124.81 121.55 34.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.019 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.53 HG22 ' HB3' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -56.24 140.66 43.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.369 . . . . 0.0 110.589 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.449 ' HB3' HG21 ' B' ' 22' ' ' VAL . 66.7 mtt85 -155.9 145.34 20.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.784 ' O ' HG13 ' B' ' 8' ' ' VAL . 0.0 OUTLIER 179.06 1.55 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.959 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.784 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER 177.13 30.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.573 0.225 . . . . 0.0 111.371 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.0 -118.18 3.5 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.685 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -110.15 -178.31 3.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.955 0.407 . . . . 0.0 111.178 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.57 168.04 10.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.805 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.744 ' CD1' HG11 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -111.49 154.5 24.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.516 179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.572 ' HG3' HG22 ' B' ' 18' ' ' VAL . 0.4 OUTLIER -127.42 100.46 6.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.022 0.439 . . . . 0.0 110.918 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.627 HG23 HG23 ' A' ' 14' ' ' ILE . 3.1 tp -112.69 125.5 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.563 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.46 -105.47 0.65 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.2 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 12.0 m-20 -156.89 6.97 0.17 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 0.8 OUTLIER 161.09 61.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.631 0.372 . . . . 0.0 110.023 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.671 ' O ' HG23 ' B' ' 19' ' ' THR . 4.3 m -116.23 -157.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.568 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.671 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 172.55 101.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.689 HG22 HG13 ' B' ' 34' ' ' VAL . 58.4 t -111.0 108.1 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.816 0.341 . . . . 0.0 111.747 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 5.0 p -104.98 110.45 22.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.03 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.564 ' O ' HG23 ' B' ' 22' ' ' VAL . 30.7 m -77.5 72.56 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.56 -143.65 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.638 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.53 74.32 0.27 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.818 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 10.6 t -93.08 108.33 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 111.279 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.513 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.0 OUTLIER -138.89 157.57 45.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.999 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.83 148.04 50.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.74 -80.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.642 0.258 . . . . 0.0 110.741 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.52 ' HB3' HG22 ' A' ' 5' ' ' THR . 8.9 mt-30 -116.72 126.26 52.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.88 0.371 . . . . 0.0 110.96 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.678 HG23 HD11 ' B' ' 32' ' ' ILE . 17.5 m -93.4 136.98 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 3.9 mtt85 -77.95 104.93 8.81 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.254 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.678 HD11 HG23 ' B' ' 30' ' ' VAL . 12.2 mm -87.38 137.83 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.858 0.361 . . . . 0.0 111.305 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.94 117.44 5.14 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.458 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.739 HG11 ' CD1' ' A' ' 12' ' ' LEU . 15.4 t -118.03 103.14 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 111.489 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' B' ' 19' ' ' THR . 0.6 OUTLIER -95.8 107.22 19.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.17 145.5 55.79 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.597 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.518 ' HD2' HG12 ' B' ' 18' ' ' VAL . 90.2 Cg_endo -78.28 156.34 29.32 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.814 2.343 . . . . 0.0 112.07 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.23 26.77 2.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.221 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.3 -40.28 5.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.753 0.311 . . . . 0.0 110.831 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -82.38 152.81 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.42 98.63 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.121 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.51 HG13 ' O ' ' B' ' 42' ' ' VAL . 12.7 p -122.19 120.61 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.104 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -128.51 136.18 50.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.553 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.414 ' HG3' ' N ' ' B' ' 45' ' ' GLU . 0.0 OUTLIER -165.57 -40.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 0.0 111.133 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' B' ' 44' ' ' ARG . 1.2 mm-40 177.83 114.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.965 0.412 . . . . 0.0 110.918 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -58.52 -38.64 78.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.714 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.522 HG23 HG13 ' B' ' 51' ' ' ILE . 35.9 mm -69.38 -43.21 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.804 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.43 ' CD2' ' HG ' ' A' ' 4' ' ' LEU . 2.8 m-85 -51.38 -42.74 61.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.347 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -87.77 -58.82 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.771 0.319 . . . . 0.0 111.522 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -52.14 -21.54 3.39 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.522 HG13 HG23 ' B' ' 47' ' ' ILE . 40.2 mm -105.93 -50.51 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.565 ' HB3' HD12 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -75.89 -58.8 3.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.713 0.292 . . . . 0.0 111.314 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.961 ' HB2' HD11 ' A' ' 2' ' ' LEU . . . -67.07 -29.71 69.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.342 . . . . 0.0 111.199 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -138.05 156.78 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.774 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.804 0.335 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.673 HD11 ' O ' ' B' ' 48' ' ' TYR . 6.6 tt -116.55 103.15 10.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -98.08 105.48 17.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.195 0.521 . . . . 0.0 110.785 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 4' ' ' LEU . 11.0 tp -125.28 121.33 33.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.924 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.593 HG22 ' HB3' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -56.88 149.3 18.84 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.389 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 10' ' ' GLU . 1.1 tpt180 -179.53 143.15 0.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.224 0.535 . . . . 0.0 111.399 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.931 ' NE ' HG13 ' A' ' 25' ' ' VAL . 36.4 ttt180 -170.1 23.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.063 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.08 -53.43 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.165 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.08 105.49 0.19 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.683 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.468 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . 0.7 OUTLIER -113.13 -58.25 2.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 0.0 110.869 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p 65.52 96.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.124 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.431 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 1.6 pt? -114.57 154.72 27.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.069 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.571 ' HA ' HG23 ' A' ' 18' ' ' VAL . 34.8 ttm -128.98 99.93 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.059 0.457 . . . . 0.0 111.015 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 14' ' ' ILE . 6.1 tp -118.02 102.86 13.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.814 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.28 -107.33 0.32 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.972 -0.633 . . . . 0.0 111.887 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.36 -4.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 165.05 57.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.762 HG12 ' HD2' ' A' ' 37' ' ' PRO . 12.8 m -112.45 -161.58 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.816 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.893 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.5 OUTLIER 170.13 102.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.844 HG13 ' HA ' ' A' ' 34' ' ' VAL . 21.4 t -111.2 110.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.906 0.384 . . . . 0.0 111.894 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.4 m -98.35 111.65 23.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.767 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 22' ' ' VAL . 17.5 m -77.01 68.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.347 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.45 -142.39 0.26 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.751 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 31' ' ' ARG . . . 53.82 70.77 0.84 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.566 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.931 HG13 ' NE ' ' A' ' 7' ' ' ARG . 40.5 t -85.94 107.66 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.909 0.385 . . . . 0.0 111.455 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -143.97 151.57 39.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.046 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.43 150.54 47.16 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.419 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 72.58 -75.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.606 0.241 . . . . 0.0 111.004 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.588 ' HB3' HG22 ' B' ' 5' ' ' THR . 9.0 mp0 -120.95 128.84 53.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.985 0.422 . . . . 0.0 111.115 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.654 HG23 HD11 ' A' ' 32' ' ' ILE . 11.0 m -93.29 137.18 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.248 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 0.1 OUTLIER -75.77 104.63 6.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.28 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.654 HD11 HG23 ' A' ' 30' ' ' VAL . 9.3 mm -87.47 130.14 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.215 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.73 108.44 3.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.156 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.844 ' HA ' HG13 ' A' ' 20' ' ' VAL . 12.7 t -107.28 103.17 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 111.615 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.893 ' HB3' HG23 ' A' ' 19' ' ' THR . 3.6 t-20 -96.19 107.22 19.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.384 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.9 146.84 58.53 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.715 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.762 ' HD2' HG12 ' A' ' 18' ' ' VAL . 86.5 Cg_endo -80.58 156.36 21.55 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.961 2.441 . . . . 0.0 112.104 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -92.47 32.87 1.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.188 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.32 -41.26 3.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.739 0.304 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 41' ' ' SER . 5.6 t -77.9 160.68 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.79 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.444 ' N ' HG12 ' A' ' 40' ' ' VAL . 3.8 t -66.75 106.68 1.92 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.838 0.352 . . . . 0.0 110.859 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 42' ' ' VAL . 12.7 p -121.94 126.11 74.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -128.88 124.1 34.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.207 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -156.76 -65.82 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 110.461 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 5.3 tp10 -171.69 130.46 0.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.56 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -58.79 -38.75 79.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.047 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.409 HG23 HG13 ' A' ' 51' ' ' ILE . 16.1 mt -73.05 -43.56 58.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.302 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.677 ' O ' HD11 ' B' ' 2' ' ' LEU . 3.2 m-85 -50.46 -46.63 56.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.651 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.622 ' HG2' ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -83.1 -58.09 3.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.207 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.429 ' HA ' ' CB ' ' A' ' 54' ' ' GLU . 3.6 mtp85 -55.05 -9.78 0.43 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.409 HG13 HG23 ' A' ' 47' ' ' ILE . 49.3 mm -112.86 -55.45 4.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 O-C-N 122.258 -0.276 . . . . 0.0 111.728 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 7.2 mp0 -75.89 -54.3 7.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 110.999 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.622 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . . . -75.04 -36.83 61.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.892 0.377 . . . . 0.0 110.962 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' CB ' ' HA ' ' A' ' 50' ' ' ARG . 3.7 tp10 -103.56 122.42 44.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.753 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.877 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.832 0.349 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.677 HD11 ' O ' ' A' ' 48' ' ' TYR . 6.6 tt -116.58 103.12 10.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.637 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -98.04 105.56 17.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.26 0.552 . . . . 0.0 110.763 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 tp -125.32 121.37 33.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.831 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -56.97 149.27 19.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.397 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.476 ' HG2' ' HB2' ' B' ' 10' ' ' GLU . 1.1 tpt180 -179.53 143.17 0.19 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.253 0.549 . . . . 0.0 111.418 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.933 ' NE ' HG13 ' B' ' 25' ' ' VAL . 36.2 ttt180 -170.18 23.53 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.102 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.07 -53.51 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.161 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.13 105.52 0.19 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.703 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.476 ' HB2' ' HG2' ' B' ' 6' ' ' ARG . 0.7 OUTLIER -113.1 -58.33 2.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 110.854 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.9 p 65.53 96.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.165 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.438 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 1.6 pt? -114.48 154.76 27.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.121 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.562 ' HA ' HG23 ' B' ' 18' ' ' VAL . 34.8 ttm -129.04 99.96 5.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.01 0.433 . . . . 0.0 111.032 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.588 ' O ' HG23 ' B' ' 14' ' ' ILE . 6.1 tp -117.97 102.85 13.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.854 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.3 -107.34 0.32 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.883 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.39 -4.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 165.07 57.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.755 HG12 ' HD2' ' B' ' 37' ' ' PRO . 12.9 m -112.42 -161.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.796 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.911 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.5 OUTLIER 170.09 102.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.443 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' B' ' 34' ' ' VAL . 21.4 t -111.22 110.16 31.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 111.948 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 6.4 m -98.35 111.65 23.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.794 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 22' ' ' VAL . 17.5 m -76.98 68.42 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.312 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.52 -142.38 0.26 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' B' ' 31' ' ' ARG . . . 53.86 70.77 0.84 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.556 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.933 HG13 ' NE ' ' B' ' 7' ' ' ARG . 40.4 t -85.96 107.62 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.0 111.428 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -143.97 151.57 39.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.031 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.46 150.49 47.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.476 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 72.62 -75.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.585 0.231 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.593 ' HB3' HG22 ' A' ' 5' ' ' THR . 9.0 mp0 -121.05 128.78 52.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 111.089 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.647 HG23 HD11 ' B' ' 32' ' ' ILE . 11.0 m -93.23 137.16 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.266 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -75.77 104.6 6.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.289 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.647 HD11 HG23 ' B' ' 30' ' ' VAL . 9.3 mm -87.44 130.17 37.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.201 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.78 108.44 3.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.161 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.861 ' HA ' HG13 ' B' ' 20' ' ' VAL . 12.7 t -107.24 103.17 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.91 0.385 . . . . 0.0 111.577 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.911 ' HB3' HG23 ' B' ' 19' ' ' THR . 3.6 t-20 -96.13 107.15 19.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.402 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.85 146.78 58.38 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.751 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.755 ' HD2' HG12 ' B' ' 18' ' ' VAL . 86.1 Cg_endo -80.57 156.34 21.56 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.963 2.442 . . . . 0.0 112.101 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -92.46 32.93 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.224 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.34 -41.21 3.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.78 0.324 . . . . 0.0 110.973 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.437 HG12 ' N ' ' B' ' 41' ' ' SER . 5.6 t -77.94 160.76 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.792 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.437 ' N ' HG12 ' B' ' 40' ' ' VAL . 3.8 t -66.81 106.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 0.0 110.839 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.438 HG13 ' O ' ' B' ' 42' ' ' VAL . 12.7 p -121.95 126.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -128.91 124.15 34.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.168 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -156.77 -65.84 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.441 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 5.3 tp10 -171.72 130.49 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.586 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -58.81 -38.73 79.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.421 ' CG2' HG13 ' B' ' 51' ' ' ILE . 16.0 mt -73.03 -43.49 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.307 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.673 ' O ' HD11 ' A' ' 2' ' ' LEU . 3.2 m-85 -50.61 -46.47 58.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.635 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.623 ' HG2' ' HB3' ' B' ' 53' ' ' ALA . 0.0 OUTLIER -83.22 -58.11 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.427 ' HA ' ' CB ' ' B' ' 54' ' ' GLU . 3.6 mtp85 -55.13 -9.71 0.44 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.421 HG13 ' CG2' ' B' ' 47' ' ' ILE . 49.1 mm -112.86 -55.53 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 7.2 mp0 -75.88 -54.32 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.684 0.278 . . . . 0.0 110.93 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.623 ' HB3' ' HG2' ' B' ' 49' ' ' GLN . . . -75.06 -36.72 61.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.945 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' B' ' 50' ' ' ARG . 3.7 tp10 -103.79 124.01 48.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.1 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.059 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.659 ' C ' HD12 ' A' ' 2' ' ' LEU . 6.6 mmm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.882 0.372 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.659 HD12 ' C ' ' A' ' 1' ' ' MET . 5.2 mp -116.7 104.74 11.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.682 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.532 HG21 ' HD3' ' B' ' 31' ' ' ARG . 19.2 mm -96.83 105.13 16.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 110.74 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.468 ' HA ' HD22 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -124.63 116.7 22.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.976 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.549 HG22 ' HB3' ' B' ' 29' ' ' GLN . 0.3 OUTLIER -54.7 140.22 36.45 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.394 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.509 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 24.3 mtt180 -154.76 141.13 18.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.184 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 179.11 4.3 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.299 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.24 -76.41 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 O-C-N 122.213 -0.304 . . . . 0.0 111.517 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.33 97.94 0.51 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.662 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 6' ' ' ARG . 6.6 mp0 -113.21 174.7 5.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.723 0.297 . . . . 0.0 111.034 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER 164.86 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.141 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.446 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -112.35 154.1 26.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.528 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.4 ttp -133.29 100.69 4.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.053 0.454 . . . . 0.0 111.755 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.864 HG23 HG23 ' B' ' 14' ' ' ILE . 5.1 tp -114.36 120.61 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.186 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.472 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 135.85 -106.92 0.59 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.058 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.466 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -152.55 6.43 0.41 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 4.6 mt-10 159.31 64.19 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.907 0.384 . . . . 0.0 110.29 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.647 ' O ' HG23 ' A' ' 19' ' ' THR . 12.4 m -118.85 -158.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER 170.18 104.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.558 HG13 ' HA ' ' A' ' 34' ' ' VAL . 22.0 t -117.95 116.14 50.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.0 111.751 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.0 t -114.79 115.63 27.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.006 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.866 HG12 HG23 ' A' ' 32' ' ' ILE . 26.7 m -80.95 73.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.389 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.91 -136.04 0.1 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.472 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.05 74.7 0.21 Allowed Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.933 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.634 HG22 ' HG2' ' A' ' 7' ' ' ARG . 21.3 t -86.04 108.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.465 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -140.24 153.38 46.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.048 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.15 149.45 47.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.453 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 69.14 -83.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.638 0.256 . . . . 0.0 110.721 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.525 ' HB3' HG22 ' B' ' 5' ' ' THR . 42.5 mt-30 -107.32 125.24 50.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.356 . . . . 0.0 110.947 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.518 HG23 HD11 ' A' ' 32' ' ' ILE . 14.3 m -93.13 136.89 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.283 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.549 ' HD3' HG21 ' B' ' 3' ' ' ILE . 28.8 mtt85 -75.96 104.39 6.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.491 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.866 HG23 HG12 ' A' ' 22' ' ' VAL . 28.4 mm -87.17 131.36 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.281 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.5 125.12 8.14 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.745 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.558 ' HA ' HG13 ' A' ' 20' ' ' VAL . 12.2 t -118.05 129.72 73.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.835 0.35 . . . . 0.0 111.123 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 19' ' ' THR . 2.4 t-20 -123.16 107.21 11.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.13 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.86 144.25 26.12 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.745 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HD2' HG12 ' A' ' 18' ' ' VAL . 82.2 Cg_endo -77.93 156.45 30.7 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.736 2.29 . . . . 0.0 112.081 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.08 38.01 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.398 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.73 -38.7 4.2 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.759 0.314 . . . . 0.0 110.803 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.477 HG12 ' O ' ' B' ' 15' ' ' GLY . 13.3 t -89.58 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -57.49 97.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.943 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.792 HG22 ' HD2' ' A' ' 44' ' ' ARG . 14.6 p -122.35 120.71 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 136.11 50.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.674 0.274 . . . . 0.0 110.81 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.792 ' HD2' HG22 ' A' ' 42' ' ' VAL . 1.9 mpp_? -147.4 -172.6 4.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.54 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.44 ' HB3' ' CG ' ' A' ' 48' ' ' TYR . 1.5 tp10 -63.16 139.2 58.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.766 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -62.36 1.67 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.383 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 39.1 mm -56.82 -45.57 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.792 0.329 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.461 ' CG ' ' HG ' ' B' ' 4' ' ' LEU . 4.1 m-30 -41.5 -73.33 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.545 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.699 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 13.8 pt20 -66.48 -19.26 65.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.54 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 6.0 mtm180 -69.0 -20.0 64.15 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 48' ' ' TYR . 3.5 pt -111.39 -23.87 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.48 ' HG3' HD23 ' B' ' 2' ' ' LEU . 4.3 pt20 -107.68 -52.38 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.623 0.249 . . . . 0.0 111.547 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.699 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . . . -70.36 -72.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 111.224 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.5 118.81 37.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.727 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.5 mttt . . . . . 0 N--CA 1.451 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.138 -179.904 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.65 ' C ' HD12 ' B' ' 2' ' ' LEU . 6.7 mmm . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.87 0.367 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.65 HD12 ' C ' ' B' ' 1' ' ' MET . 5.2 mp -116.76 104.74 11.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.549 HG21 ' HD3' ' A' ' 31' ' ' ARG . 19.2 mm -96.81 105.17 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.98 0.419 . . . . 0.0 110.725 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.461 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -124.66 116.67 22.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.961 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -54.72 140.24 36.54 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.413 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' B' ' 10' ' ' GLU . 24.4 mtt180 -154.74 141.13 18.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.205 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' B' ' 25' ' ' VAL . 0.0 OUTLIER 179.1 4.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.269 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.24 -76.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 O-C-N 122.167 -0.333 . . . . 0.0 111.544 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.33 97.89 0.51 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.666 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' B' ' 6' ' ' ARG . 6.6 mp0 -113.16 174.7 5.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.748 0.309 . . . . 0.0 111.051 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.47 HG22 ' C ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 164.81 91.71 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.14 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.454 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -112.31 154.05 26.27 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.512 ' HA ' HG23 ' B' ' 18' ' ' VAL . 2.4 ttp -133.26 100.58 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.999 0.428 . . . . 0.0 111.785 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.864 HG23 HG23 ' A' ' 14' ' ' ILE . 5.1 tp -114.33 120.61 64.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.189 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 135.86 -106.92 0.59 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.086 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 0.4 OUTLIER -152.53 6.46 0.41 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.469 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 4.6 mt-10 159.32 64.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.957 0.408 . . . . 0.0 110.289 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.642 ' O ' HG23 ' B' ' 19' ' ' THR . 12.3 m -118.78 -158.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.417 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.642 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.1 OUTLIER 170.18 104.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' B' ' 34' ' ' VAL . 21.9 t -117.9 116.1 50.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 0.0 111.741 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 3.0 t -114.75 115.62 27.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.005 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.86 HG12 HG23 ' B' ' 32' ' ' ILE . 26.8 m -80.97 73.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.0 0.429 . . . . 0.0 111.343 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.94 -136.08 0.1 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.483 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.08 74.67 0.22 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.975 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.634 HG22 ' HG2' ' B' ' 7' ' ' ARG . 21.3 t -85.99 108.15 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 0.0 111.47 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -140.27 153.34 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.058 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.11 149.45 47.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.465 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 69.06 -83.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.541 0.21 . . . . 0.0 110.701 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.549 ' HB3' HG22 ' A' ' 5' ' ' THR . 42.5 mt-30 -107.35 125.24 50.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 110.941 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.513 HG23 HD11 ' B' ' 32' ' ' ILE . 14.3 m -93.14 136.91 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.32 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.532 ' HD3' HG21 ' A' ' 3' ' ' ILE . 28.6 mtt85 -76.0 104.35 6.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.454 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.86 HG23 HG12 ' B' ' 22' ' ' VAL . 28.4 mm -87.15 131.32 35.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.299 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.47 125.2 8.17 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.792 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.567 ' HA ' HG13 ' B' ' 20' ' ' VAL . 12.4 t -118.1 129.75 73.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.827 0.346 . . . . 0.0 111.063 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' B' ' 19' ' ' THR . 2.4 t-20 -123.23 107.26 11.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.074 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.89 144.22 25.91 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.75 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.42 ' HD2' HG12 ' B' ' 18' ' ' VAL . 84.1 Cg_endo -77.83 156.45 31.08 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.797 2.331 . . . . 0.0 112.103 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.09 38.02 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.38 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.77 -38.69 4.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.79 0.329 . . . . 0.0 110.804 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 15' ' ' GLY . 13.3 t -89.63 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.846 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -57.42 97.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.013 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.793 HG22 ' HD2' ' B' ' 44' ' ' ARG . 14.6 p -122.38 120.75 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 136.13 50.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.657 0.265 . . . . 0.0 110.816 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.793 ' HD2' HG22 ' B' ' 42' ' ' VAL . 1.9 mpp_? -147.41 -172.66 4.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.44 ' HB3' ' CG ' ' B' ' 48' ' ' TYR . 1.5 tp10 -63.01 139.19 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.824 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -62.33 1.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.421 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' B' ' 50' ' ' ARG . 39.2 mm -56.86 -45.53 83.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.78 0.324 . . . . 0.0 111.164 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.462 ' CG ' ' HG ' ' A' ' 4' ' ' LEU . 4.1 m-30 -41.52 -73.34 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.568 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.688 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 13.8 pt20 -66.48 -19.24 65.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.538 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 6.0 mtm180 -69.0 -19.92 64.14 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.416 HG13 ' O ' ' B' ' 48' ' ' TYR . 3.5 pt -111.57 -23.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.489 ' HG3' HD23 ' A' ' 2' ' ' LEU . 4.3 pt20 -107.82 -52.29 2.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.563 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.688 ' HB3' ' HB2' ' B' ' 49' ' ' GLN . . . -70.47 -72.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.807 0.337 . . . . 0.0 111.185 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.58 119.43 39.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.617 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.733 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.799 0.333 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.65 HD22 ' CE2' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -118.11 108.48 15.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 3' ' ' ILE . 5.2 tt -84.36 115.0 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.009 0.433 . . . . 0.0 111.535 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.767 HD12 ' CZ ' ' B' ' 48' ' ' TYR . 0.3 OUTLIER -115.1 156.24 25.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.653 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.476 ' H ' HD23 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -95.8 121.22 37.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 0.0 111.476 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.6 ' NH2' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -92.21 149.16 21.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.475 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.626 ' CG ' HG13 ' A' ' 30' ' ' VAL . 6.6 mtp180 78.01 87.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.706 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.647 HG23 ' CA ' ' A' ' 24' ' ' GLY . 56.2 t 80.74 55.49 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.193 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.525 ' H ' HG21 ' A' ' 22' ' ' VAL . . . -142.89 -148.54 4.96 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.536 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.28 121.46 44.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 111.616 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -58.55 147.53 31.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.402 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.741 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -117.82 154.73 31.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.766 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.6 ttt -127.91 100.7 6.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 0.0 110.766 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.62 HG23 HG23 ' B' ' 14' ' ' ILE . 4.6 tp -115.42 137.7 48.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.952 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.684 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 126.71 -107.19 0.89 Allowed Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.339 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -153.39 -4.42 0.19 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 1.0 OUTLIER 171.38 57.43 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 19' ' ' THR . 10.4 m -111.31 -159.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.615 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 173.72 102.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.741 ' HB ' HD23 ' A' ' 12' ' ' LEU . 41.6 t -102.93 101.99 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.856 0.36 . . . . 0.0 111.172 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -93.17 157.3 16.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.22 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.525 HG21 ' H ' ' A' ' 9' ' ' GLY . 34.8 m -106.86 -173.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.577 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -127.38 -53.52 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 0.0 110.291 179.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.647 ' CA ' HG23 ' A' ' 8' ' ' VAL . . . 93.64 -39.99 2.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.162 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 11.4 t -85.66 149.83 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.596 0.236 . . . . 0.0 111.495 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 25' ' ' VAL . 10.8 tttp 101.25 116.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.245 0.618 . . . . 0.0 110.85 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.81 174.74 46.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.683 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.83 -84.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.677 0.275 . . . . 0.0 110.301 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.9 136.95 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.423 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.741 ' CG1' HD11 ' A' ' 32' ' ' ILE . 21.7 t -92.89 115.71 32.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.807 0.337 . . . . 0.0 110.888 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -86.44 99.46 11.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.99 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.741 HD11 ' CG1' ' A' ' 30' ' ' VAL . 33.0 mm -112.76 135.57 51.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.935 0.397 . . . . 0.0 111.425 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.37 112.72 4.19 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.302 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.72 HG13 HG22 ' A' ' 20' ' ' VAL . 25.1 t -98.07 103.17 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.7 107.29 19.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.638 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.02 145.52 56.06 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.431 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HD2' HG12 ' A' ' 18' ' ' VAL . 88.4 Cg_endo -81.24 156.55 19.65 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.93 2.42 . . . . 0.0 112.231 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -89.45 27.29 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.278 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -112.67 -37.17 4.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.757 0.313 . . . . 0.0 111.034 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.689 HG12 ' O ' ' B' ' 15' ' ' GLY . 5.1 t -81.82 144.64 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.806 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -54.89 100.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.484 HG21 ' NH2' ' A' ' 44' ' ' ARG . 13.0 p -122.09 124.11 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.077 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.57 136.17 50.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.373 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.487 ' CZ ' HD13 ' B' ' 2' ' ' LEU . 7.1 mtt85 -151.86 -60.69 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.931 0.396 . . . . 0.0 110.612 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 178.78 143.7 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.655 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -43.83 92.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.617 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.525 HG22 HD12 ' A' ' 51' ' ' ILE . 42.4 mm -64.56 -49.08 82.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.061 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.771 ' CZ ' HD12 ' B' ' 4' ' ' LEU . 88.9 t80 -50.63 -45.84 57.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.55 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 53' ' ' ALA . 21.2 tt0 -75.55 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 111.729 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -51.44 -17.35 0.76 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.525 HD12 HG22 ' A' ' 47' ' ' ILE . 36.5 mt -108.89 -54.78 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.75 0.309 . . . . 0.0 111.205 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.63 ' HB2' HD23 ' B' ' 2' ' ' LEU . 60.5 mm-40 -69.14 -62.05 1.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.922 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.5 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . . . -67.3 -33.54 75.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.008 0.433 . . . . 0.0 110.731 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -118.19 124.06 47.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.606 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.5 tptp . . . . . 0 N--CA 1.451 -0.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.267 -179.631 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.825 0.345 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.657 HD22 ' CE2' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -118.07 108.44 15.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.558 HG23 ' O ' ' B' ' 3' ' ' ILE . 5.3 tt -84.38 115.05 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 111.531 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.771 HD12 ' CZ ' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -115.12 156.15 25.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.686 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.465 ' H ' HD23 ' B' ' 4' ' ' LEU . 0.3 OUTLIER -95.7 121.19 37.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.018 0.437 . . . . 0.0 111.446 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.602 ' NH2' HD22 ' B' ' 4' ' ' LEU . 0.0 OUTLIER -92.21 149.12 21.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.53 179.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.624 ' CG ' HG13 ' B' ' 30' ' ' VAL . 6.6 mtp180 78.02 87.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.691 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.657 HG23 ' CA ' ' B' ' 24' ' ' GLY . 55.3 t 80.67 55.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.188 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.524 ' H ' HG21 ' B' ' 22' ' ' VAL . . . -142.88 -148.54 4.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.593 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.24 121.4 44.33 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.879 0.371 . . . . 0.0 111.614 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -58.48 147.57 31.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.413 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.714 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.6 OUTLIER -117.83 154.76 31.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.728 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.6 ttt -127.97 100.59 5.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.856 0.36 . . . . 0.0 110.775 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.62 HG23 HG23 ' A' ' 14' ' ' ILE . 4.6 tp -115.37 137.75 47.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.689 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 126.71 -107.22 0.89 Allowed Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.329 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.3 OUTLIER -153.41 -4.37 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 1.0 OUTLIER 171.27 57.42 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.656 ' O ' HG23 ' B' ' 19' ' ' THR . 10.4 m -111.33 -159.48 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.564 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.656 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 173.84 102.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.501 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.757 HG22 HG13 ' B' ' 34' ' ' VAL . 41.4 t -102.84 101.89 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.821 0.343 . . . . 0.0 111.227 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -93.1 157.25 16.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.237 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.524 HG21 ' H ' ' B' ' 9' ' ' GLY . 34.9 m -106.81 -173.11 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.545 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' B' ' 23' ' ' LEU . 1.0 OUTLIER -127.48 -53.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 110.3 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.657 ' CA ' HG23 ' B' ' 8' ' ' VAL . . . 93.61 -39.89 2.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.157 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.573 ' O ' ' CB ' ' B' ' 26' ' ' LYS . 11.4 t -85.66 149.82 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.543 0.211 . . . . 0.0 111.502 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' B' ' 25' ' ' VAL . 10.8 tttp 101.22 116.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.249 0.62 . . . . 0.0 110.804 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.84 174.78 46.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.644 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.75 -84.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.657 0.265 . . . . 0.0 110.319 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.89 136.96 33.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.437 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.733 ' CG1' HD11 ' B' ' 32' ' ' ILE . 21.6 t -92.89 115.7 32.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.361 . . . . 0.0 110.905 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -86.45 99.48 11.68 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.994 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.733 HD11 ' CG1' ' B' ' 30' ' ' VAL . 33.2 mm -112.77 135.63 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 111.395 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.44 112.72 4.18 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.294 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.757 HG13 HG22 ' B' ' 20' ' ' VAL . 25.4 t -98.11 103.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.093 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.66 107.25 19.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.659 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.98 145.51 56.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.476 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.496 ' HD2' HG12 ' B' ' 18' ' ' VAL . 87.5 Cg_endo -81.29 156.46 19.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.891 2.394 . . . . 0.0 112.193 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -89.32 27.25 1.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.314 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -112.68 -37.22 4.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 110.995 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 15' ' ' GLY . 5.1 t -81.69 144.63 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.825 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -54.96 100.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.128 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.489 HG21 ' NH2' ' B' ' 44' ' ' ARG . 13.1 p -122.13 124.07 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.062 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.48 136.2 50.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.407 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.494 ' CZ ' HD13 ' A' ' 2' ' ' LEU . 7.1 mtt85 -151.88 -60.73 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.625 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 178.79 143.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.614 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.72 -43.86 92.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.932 0.396 . . . . 0.0 110.615 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.527 HG22 HD12 ' B' ' 51' ' ' ILE . 42.4 mm -64.59 -49.05 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.061 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.767 ' CZ ' HD12 ' A' ' 4' ' ' LEU . 88.8 t80 -50.68 -45.78 58.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.541 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.494 ' HG2' ' HB3' ' B' ' 53' ' ' ALA . 21.2 tt0 -75.6 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.713 0.292 . . . . 0.0 111.715 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -51.47 -17.28 0.75 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.527 HD12 HG22 ' B' ' 47' ' ' ILE . 36.0 mt -109.0 -54.67 5.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.761 0.315 . . . . 0.0 111.221 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.627 ' HB2' HD23 ' A' ' 2' ' ' LEU . 60.6 mm-40 -69.16 -62.14 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.854 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.495 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -67.33 -33.36 75.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.97 0.414 . . . . 0.0 110.769 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -119.08 127.19 53.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.839 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.536 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.805 0.336 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' B' ' 53' ' ' ALA . 0.5 OUTLIER -114.51 102.83 10.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.034 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -92.92 105.75 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.331 0.586 . . . . 0.0 110.949 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.831 HD13 ' CD2' ' B' ' 48' ' ' TYR . 0.1 OUTLIER -124.28 156.59 36.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.074 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.4 HG22 ' HB3' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -86.72 138.43 31.64 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.533 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.806 ' HB3' HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -150.94 145.95 25.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.072 0.463 . . . . 0.0 111.324 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -179.37 10.98 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.89 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.54 -41.22 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 122.165 -0.334 . . . . 0.0 111.507 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.7 94.46 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.802 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.403 ' CG ' ' HG2' ' A' ' 6' ' ' ARG . 2.2 tp10 -97.11 -61.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.458 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 m 64.94 98.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.385 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -120.44 154.37 35.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.086 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.667 ' HA ' HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -129.98 100.05 5.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.939 0.4 . . . . 0.0 110.991 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 14' ' ' ILE . 8.2 tp -119.15 102.85 13.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.037 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.545 ' HA2' HG11 ' B' ' 40' ' ' VAL . . . 156.54 -108.15 0.35 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.325 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.06 -15.51 4.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 164.29 61.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.993 0.425 . . . . 0.0 110.055 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.852 HG12 ' HD2' ' A' ' 37' ' ' PRO . 22.5 m -107.76 -168.62 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.64 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.872 HG23 ' HB3' ' A' ' 35' ' ' ASN . 1.1 t -175.33 103.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.751 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.675 HG13 ' HA ' ' A' ' 34' ' ' VAL . 21.5 t -102.76 106.9 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 21' ' ' THR . 9.4 t -91.57 111.85 23.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.569 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 6' ' ' ARG . 30.1 m -84.01 62.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.569 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.43 -142.42 0.24 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.829 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 31' ' ' ARG . . . 53.27 69.24 1.27 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.677 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' A' ' 7' ' ' ARG . 17.5 t -88.49 107.52 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 120.923 0.392 . . . . 0.0 111.576 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -142.67 146.97 34.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.104 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.3 158.7 30.59 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.526 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.83 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.674 0.273 . . . . 0.0 110.761 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.46 124.45 50.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 110.749 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.739 HG21 HG21 ' B' ' 30' ' ' VAL . 30.1 t -93.74 136.5 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.219 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.461 ' HB3' ' HA3' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -83.17 109.15 16.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.114 179.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.44 135.59 27.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.286 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.26 111.0 2.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.259 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.675 ' HA ' HG13 ' A' ' 20' ' ' VAL . 15.0 t -113.59 102.89 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 0.0 111.458 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.872 ' HB3' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER -91.63 107.18 19.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.667 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.435 ' HB1' HG12 ' B' ' 14' ' ' ILE . . . -130.12 146.21 60.56 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.532 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.852 ' HD2' HG12 ' A' ' 18' ' ' VAL . 86.9 Cg_endo -77.88 156.41 30.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.77 2.314 . . . . 0.0 112.008 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -91.3 38.36 0.97 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.11 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -123.55 -38.65 2.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.546 HG11 ' HA2' ' B' ' 15' ' ' GLY . 6.2 t -83.39 156.74 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.822 0.344 . . . . 0.0 110.978 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -57.05 114.97 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.5 p -122.07 121.9 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.96 122.39 30.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.538 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.565 HH21 HD13 ' B' ' 12' ' ' LEU . 17.5 ttm180 -163.95 -77.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.03 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.435 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 5.8 mm-40 -155.07 131.47 10.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.57 -50.72 72.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.221 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.471 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 13.9 tt -63.17 -42.04 95.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.974 0.416 . . . . 0.0 111.166 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.827 ' CD2' HD13 ' B' ' 4' ' ' LEU . 5.9 m-85 -50.9 -53.39 33.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.169 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.536 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 1.5 mt-30 -78.33 -21.7 49.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.137 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 4.9 mtt180 -72.92 -15.43 61.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.671 0.272 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.5 mt -109.82 -27.1 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.331 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.541 ' HB2' HD23 ' B' ' 2' ' ' LEU . 6.0 mp0 -107.79 -54.54 2.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.796 0.331 . . . . 0.0 111.28 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.651 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -64.74 -73.62 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.277 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -111.85 123.72 50.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.785 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.504 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.286 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.651 HD21 ' HB2' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -114.59 102.82 10.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.631 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -92.86 105.74 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.335 0.588 . . . . 0.0 110.968 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.827 HD13 ' CD2' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -124.34 156.62 36.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.998 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.78 138.43 31.61 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.527 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.834 ' HB3' HG21 ' B' ' 22' ' ' VAL . 0.0 OUTLIER -150.93 146.0 25.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.285 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.572 ' HG2' HG22 ' B' ' 25' ' ' VAL . 0.6 OUTLIER -179.43 10.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.969 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.6 -41.21 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 122.18 -0.325 . . . . 0.0 111.483 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.71 94.48 0.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.803 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -97.11 -61.62 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.484 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m 64.99 98.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.432 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.634 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -120.4 154.36 35.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.147 179.204 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.671 ' HA ' HG23 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -129.95 100.08 5.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.973 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.641 ' O ' HG23 ' B' ' 14' ' ' ILE . 8.2 tp -119.15 102.86 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.021 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.546 ' HA2' HG11 ' A' ' 40' ' ' VAL . . . 156.57 -108.14 0.35 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.307 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 11.8 t70 -129.09 -15.57 4.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 1.7 mt-10 164.29 61.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.033 0.444 . . . . 0.0 110.059 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.859 HG12 ' HD2' ' B' ' 37' ' ' PRO . 22.5 m -107.8 -168.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.631 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.874 HG23 ' HB3' ' B' ' 35' ' ' ASN . 1.1 t -175.3 103.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.758 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.692 HG13 ' HA ' ' B' ' 34' ' ' VAL . 21.5 t -102.77 106.9 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.511 HG23 ' O ' ' B' ' 21' ' ' THR . 9.4 t -91.59 111.9 23.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.508 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.834 HG21 ' HB3' ' B' ' 6' ' ' ARG . 29.9 m -84.0 62.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.551 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.41 -142.46 0.24 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.731 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' B' ' 31' ' ' ARG . . . 53.37 69.18 1.29 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.636 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.572 HG22 ' HG2' ' B' ' 7' ' ' ARG . 17.4 t -88.47 107.48 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 111.559 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -142.63 146.99 35.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.096 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.35 158.69 30.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.499 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.81 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.676 0.274 . . . . 0.0 110.776 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.4 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -108.45 124.41 50.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 110.744 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.739 HG21 HG21 ' A' ' 30' ' ' VAL . 29.6 t -93.68 136.5 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.464 ' HB3' ' HA3' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -83.17 109.12 16.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.129 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 mm -93.41 135.63 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.235 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.32 111.0 2.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.319 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.692 ' HA ' HG13 ' B' ' 20' ' ' VAL . 15.0 t -113.58 102.87 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 111.403 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.874 ' HB3' HG23 ' B' ' 19' ' ' THR . 0.2 OUTLIER -91.6 107.14 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.685 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.434 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -130.14 146.26 60.77 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.481 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.859 ' HD2' HG12 ' B' ' 18' ' ' VAL . 87.1 Cg_endo -77.84 156.36 30.99 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.806 2.337 . . . . 0.0 112.016 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -91.3 38.38 0.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.139 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -123.56 -38.59 2.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.067 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.545 HG11 ' HA2' ' A' ' 15' ' ' GLY . 6.2 t -83.38 156.7 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.006 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -57.03 115.0 2.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.183 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.472 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.7 p -122.03 121.91 65.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.96 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.98 122.36 29.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.525 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.567 HH21 HD13 ' A' ' 12' ' ' LEU . 17.5 ttm180 -163.92 -77.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.729 0.299 . . . . 0.0 111.013 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.433 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 5.8 mm-40 -155.09 131.46 10.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.875 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.66 -50.63 72.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.179 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.477 ' HA ' ' HB2' ' B' ' 50' ' ' ARG . 13.9 tt -63.27 -42.0 94.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.831 ' CD2' HD13 ' A' ' 4' ' ' LEU . 5.9 m-85 -50.92 -53.36 33.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.185 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.522 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 1.5 mt-30 -78.32 -21.62 49.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.227 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 4.8 mtt180 -73.01 -15.34 61.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.296 . . . . 0.0 111.188 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 43.7 mt -109.94 -27.13 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.351 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.538 ' HB2' HD23 ' A' ' 2' ' ' LEU . 6.0 mp0 -107.8 -54.52 2.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.291 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -64.68 -73.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -112.42 125.29 54.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.731 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.819 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.792 0.33 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' B' ' 53' ' ' ALA . 8.3 tt -122.18 116.12 23.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.6 tt -101.8 105.57 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.134 0.493 . . . . 0.0 110.535 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.467 HD23 ' HG3' ' B' ' 52' ' ' GLN . 0.2 OUTLIER -124.51 123.51 40.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.434 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -63.24 143.65 57.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.729 0.3 . . . . 0.0 110.414 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.704 ' HB2' HG21 ' A' ' 22' ' ' VAL . 10.6 mtt180 -153.18 148.24 26.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.969 0.414 . . . . 0.0 111.012 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.845 ' HD2' HG13 ' A' ' 25' ' ' VAL . 21.1 ttp180 175.48 -0.76 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.918 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -169.39 134.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.747 0.308 . . . . 0.0 110.831 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.05 47.83 89.09 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.514 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.486 ' C ' HG22 ' A' ' 11' ' ' THR . 18.2 mm-40 -112.46 167.57 10.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.514 0.197 . . . . 0.0 110.703 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.486 HG22 ' C ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER 163.54 105.53 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.245 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.449 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -115.82 154.14 30.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.247 179.086 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.482 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.5 ttt -130.27 100.88 5.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.007 0.432 . . . . 0.0 111.261 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.825 HG23 HG23 ' B' ' 14' ' ' ILE . 2.5 tp -113.06 121.77 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.465 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 134.35 -107.14 0.64 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.153 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.519 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 21.0 m-20 -154.96 6.95 0.26 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 2.0 tm-20 161.33 64.84 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 19' ' ' THR . 10.7 m -119.34 -158.53 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.47 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 171.39 102.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.653 HG13 ' HA ' ' A' ' 34' ' ' VAL . 22.4 t -117.36 110.91 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.808 0.337 . . . . 0.0 111.461 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.7 m -106.74 116.6 32.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.029 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.704 HG21 ' HB2' ' A' ' 6' ' ' ARG . 27.6 m -82.22 68.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.069 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.69 -141.64 0.07 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.622 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.32 74.26 0.36 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.364 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.845 HG13 ' HD2' ' A' ' 7' ' ' ARG . 41.5 t -85.68 107.75 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 120.974 0.416 . . . . 0.0 111.134 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.89 165.42 35.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.139 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.68 164.59 27.92 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.169 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 72.72 -62.51 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.607 0.242 . . . . 0.0 111.245 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.57 136.4 54.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.738 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.2 116.29 44.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 111.12 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 1.9 mtm105 -79.58 99.36 7.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.833 0.349 . . . . 0.0 110.697 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.65 HG23 HG12 ' A' ' 22' ' ' VAL . 16.2 mm -87.86 132.85 32.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.599 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.62 118.2 5.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.536 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.653 ' HA ' HG13 ' A' ' 20' ' ' VAL . 14.2 t -114.14 127.96 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.218 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 19' ' ' THR . 2.7 t-20 -123.68 107.48 11.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.312 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.98 142.76 22.76 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.715 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.9 156.62 27.09 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.797 2.332 . . . . 0.0 112.051 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -87.44 26.6 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.427 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.38 -41.66 6.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.837 0.351 . . . . 0.0 110.819 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.446 HG12 ' O ' ' B' ' 15' ' ' GLY . 3.9 t -82.49 150.18 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.7 t -62.5 97.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.348 . . . . 0.0 111.018 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.9 p -122.39 120.61 61.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -128.39 136.22 50.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.594 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -178.3 -35.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.084 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.12 98.66 0.02 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.69 -26.45 63.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.818 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.404 ' CG2' HG13 ' A' ' 51' ' ' ILE . 33.2 mm -79.2 -44.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' O ' HD11 ' B' ' 2' ' ' LEU . 3.3 m-85 -52.11 -44.91 64.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.84 -60.48 2.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.829 0.347 . . . . 0.0 111.683 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -54.95 -15.6 2.12 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.404 HG13 ' CG2' ' A' ' 47' ' ' ILE . 47.6 mm -108.42 -52.75 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 122.284 -0.26 . . . . 0.0 111.591 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.459 ' HG3' HD23 ' B' ' 4' ' ' LEU . 61.8 mm-40 -72.53 -59.12 2.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.709 0.29 . . . . 0.0 111.153 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.646 ' HB2' HD12 ' B' ' 2' ' ' LEU . . . -75.06 -25.39 58.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.388 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -121.54 140.2 52.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.526 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.434 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.82 0.343 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 53' ' ' ALA . 8.3 tt -122.24 116.21 23.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.629 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.6 tt -101.83 105.61 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.146 0.498 . . . . 0.0 110.524 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.459 HD23 ' HG3' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -124.58 123.5 40.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.423 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -63.16 143.69 57.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.38 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.705 ' HB2' HG21 ' B' ' 22' ' ' VAL . 10.6 mtt180 -153.23 148.26 26.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.952 0.406 . . . . 0.0 111.068 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.849 ' HD2' HG13 ' B' ' 25' ' ' VAL . 21.0 ttp180 175.44 -0.73 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.891 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.722 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -169.42 134.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.76 0.314 . . . . 0.0 110.797 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.04 47.79 89.29 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.486 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.484 ' C ' HG22 ' B' ' 11' ' ' THR . 18.1 mm-40 -112.39 167.65 10.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.541 0.21 . . . . 0.0 110.711 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.484 HG22 ' C ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 163.51 105.51 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.263 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.439 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.9 OUTLIER -115.86 154.1 30.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.293 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.467 ' HA ' HG23 ' B' ' 18' ' ' VAL . 1.5 ttt -130.28 100.78 5.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.997 0.427 . . . . 0.0 111.23 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.825 HG23 HG23 ' A' ' 14' ' ' ILE . 2.5 tp -112.98 121.83 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.504 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 134.31 -107.09 0.64 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.147 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 21.1 m-20 -154.96 6.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 2.1 tm-20 161.32 64.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.664 ' O ' HG23 ' B' ' 19' ' ' THR . 10.7 m -119.36 -158.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.487 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.664 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 171.38 102.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.657 HG13 ' HA ' ' B' ' 34' ' ' VAL . 22.6 t -117.36 110.93 32.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.819 0.343 . . . . 0.0 111.399 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 16.7 m -106.74 116.68 32.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.005 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' B' ' 6' ' ' ARG . 27.6 m -82.29 68.5 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.064 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.68 -141.65 0.07 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.575 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.3 74.34 0.35 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.309 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.849 HG13 ' HD2' ' B' ' 7' ' ' ARG . 41.4 t -85.78 107.74 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.064 0.459 . . . . 0.0 111.149 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.84 165.47 35.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.186 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.73 164.62 27.87 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.141 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 72.75 -62.53 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.614 0.245 . . . . 0.0 111.253 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.62 136.46 54.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.703 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.22 116.24 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.703 0.287 . . . . 0.0 111.096 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 1.9 mtm105 -79.45 99.34 7.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.802 0.334 . . . . 0.0 110.791 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.662 HG23 HG12 ' B' ' 22' ' ' VAL . 16.2 mm -87.86 132.87 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.591 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.65 118.15 5.4 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.542 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.657 ' HA ' HG13 ' B' ' 20' ' ' VAL . 14.0 t -114.1 127.98 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.238 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' B' ' 19' ' ' THR . 2.7 t-20 -123.73 107.45 11.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.293 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.93 142.8 23.01 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.769 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.95 156.53 26.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.851 2.367 . . . . 0.0 111.989 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -87.32 26.51 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.465 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -101.42 -41.6 6.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.785 0.326 . . . . 0.0 110.779 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 15' ' ' GLY . 3.9 t -82.55 150.22 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.624 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -62.47 97.93 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 111.101 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.504 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.8 p -122.38 120.6 61.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.1 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -128.37 136.26 50.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 3.7 ptt85 -178.28 -35.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.089 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.15 98.65 0.02 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -58.69 -26.55 63.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.767 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.416 ' CG2' HG13 ' B' ' 51' ' ' ILE . 32.8 mm -79.13 -44.25 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.415 ' O ' HD11 ' A' ' 2' ' ' LEU . 3.3 m-85 -52.08 -44.95 64.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.291 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -60.51 2.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.851 0.358 . . . . 0.0 111.636 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.406 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 5.3 mtp180 -54.89 -15.77 2.2 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.416 HG13 ' CG2' ' B' ' 47' ' ' ILE . 47.6 mm -108.26 -52.68 6.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.608 0.242 . . . . 0.0 111.587 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.467 ' HG3' HD23 ' A' ' 4' ' ' LEU . 61.7 mm-40 -72.58 -59.07 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.715 0.293 . . . . 0.0 111.133 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.655 ' HB2' HD12 ' A' ' 2' ' ' LEU . . . -75.09 -25.28 58.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.395 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 11.9 mm-40 -122.34 142.33 50.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 mttp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.876 -179.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' B' ' 53' ' ' ALA . 5.6 mp -122.28 114.35 20.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.907 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.423 ' CG2' ' HB3' ' B' ' 31' ' ' ARG . 20.8 mm -96.2 105.03 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.027 0.441 . . . . 0.0 110.506 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.41 ' CD2' ' HG2' ' B' ' 52' ' ' GLN . 2.4 mm? -124.82 118.23 25.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.8 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.1 OUTLIER -55.68 139.83 43.5 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.43 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.737 ' HB3' HG21 ' A' ' 22' ' ' VAL . 3.8 mtp180 -151.37 148.4 28.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.029 0.442 . . . . 0.0 111.474 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.738 ' NE ' HG13 ' A' ' 25' ' ' VAL . 2.9 ttt180 175.91 -80.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.569 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t -32.75 -68.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.09 109.58 0.41 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.006 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.859 ' HB2' HG22 ' A' ' 22' ' ' VAL . 8.2 mm-40 -113.18 -173.63 2.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.553 0.216 . . . . 0.0 110.533 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 10' ' ' GLU . 0.7 OUTLIER 168.9 89.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.443 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.52 HD21 ' HB ' ' A' ' 20' ' ' VAL . 1.3 pt? -113.11 154.25 26.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.3 ttt -130.67 100.76 5.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.209 0.528 . . . . 0.0 111.348 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.5 HD13 ' HB ' ' B' ' 42' ' ' VAL . 2.6 tp -111.77 126.8 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.402 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 127.93 -104.56 0.68 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.965 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.9 p30 -162.34 8.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.405 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.9 mt-10 165.24 52.92 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.014 0.435 . . . . 0.0 110.316 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.646 HG12 ' HD2' ' A' ' 37' ' ' PRO . 13.7 m -115.27 -158.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.934 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.1 OUTLIER 167.05 106.86 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 34' ' ' VAL . 3.1 t -117.43 114.27 45.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.769 0.319 . . . . 0.0 111.172 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.741 HG23 ' O ' ' A' ' 10' ' ' GLU . 5.0 m -110.54 116.53 31.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.873 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.859 HG22 ' HB2' ' A' ' 10' ' ' GLU . 34.2 m -81.16 71.16 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -88.97 -145.76 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.562 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 31' ' ' ARG . . . 56.7 79.76 0.09 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.326 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.738 HG13 ' NE ' ' A' ' 7' ' ' ARG . 20.8 t -85.93 107.82 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.904 0.383 . . . . 0.0 111.602 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.99 155.67 43.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.03 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.78 154.93 52.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.583 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 67.68 -88.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.464 0.173 . . . . 0.0 110.685 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -104.63 125.68 50.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.62 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.402 HG23 HD11 ' A' ' 32' ' ' ILE . 4.7 m -93.24 136.65 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.515 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 4.6 mtt180 -79.51 100.98 7.98 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.096 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.675 HG23 ' HA ' ' A' ' 22' ' ' VAL . 18.5 mm -87.35 133.79 29.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.66 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.96 119.02 6.32 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.266 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.649 ' HA ' HG13 ' A' ' 20' ' ' VAL . 24.3 t -109.55 129.61 64.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.929 0.395 . . . . 0.0 111.494 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.934 ' HB3' HG23 ' A' ' 19' ' ' THR . 2.1 t30 -123.47 107.25 11.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.183 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.18 146.62 46.87 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.635 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.646 ' HD2' HG12 ' A' ' 18' ' ' VAL . 82.8 Cg_endo -83.2 156.52 14.82 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.99 2.46 . . . . 0.0 112.278 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.92 15.59 4.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.352 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.29 -38.65 10.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.639 0.257 . . . . 0.0 110.973 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 15' ' ' GLY . 4.7 t -87.95 142.21 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.835 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 m -55.85 98.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.027 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 42' ' ' VAL . 13.4 p -122.2 120.82 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.222 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.19 136.09 50.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.442 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.413 ' NH2' ' NE ' ' B' ' 6' ' ' ARG . 24.4 ttt180 -156.69 -67.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 111.012 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.83 121.55 1.82 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.92 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.52 -42.43 82.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.61 -41.09 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.79 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -52.32 -46.71 66.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.701 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -86.71 -58.17 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 111.741 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.46 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 4.1 mtt180 -48.91 -20.29 0.49 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.9 mm -108.67 -52.67 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.632 0.253 . . . . 0.0 111.498 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.403 ' HG2' ' CD2' ' B' ' 4' ' ' LEU . 7.9 tp60 -66.81 -63.5 1.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.721 0.296 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.814 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -70.82 -32.13 69.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.982 0.42 . . . . 0.0 110.615 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -109.42 119.73 40.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.798 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm . . . . . 0 N--CA 1.448 -0.573 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.667 179.766 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.899 0.38 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.814 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.5 mp -122.26 114.41 20.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.425 ' CG2' ' HB3' ' A' ' 31' ' ' ARG . 20.6 mm -96.25 104.95 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 0.0 110.566 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.403 ' CD2' ' HG2' ' A' ' 52' ' ' GLN . 2.4 mm? -124.76 118.43 26.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.781 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -55.78 139.83 44.06 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.378 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.754 ' HB3' HG21 ' B' ' 22' ' ' VAL . 3.8 mtp180 -151.38 148.37 28.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.048 0.452 . . . . 0.0 111.496 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.741 ' NE ' HG13 ' B' ' 25' ' ' VAL . 2.9 ttt180 175.91 -80.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.591 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 25.1 t -32.76 -68.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.05 109.64 0.41 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.002 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.855 ' HB2' HG22 ' B' ' 22' ' ' VAL . 8.2 mm-40 -113.19 -173.59 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.548 0.213 . . . . 0.0 110.536 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' B' ' 10' ' ' GLU . 0.7 OUTLIER 168.87 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.426 179.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.522 HD21 ' HB ' ' B' ' 20' ' ' VAL . 1.3 pt? -113.19 154.26 26.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 12.3 ttt -130.71 100.82 5.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.233 0.54 . . . . 0.0 111.403 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.499 HD13 ' HB ' ' A' ' 42' ' ' VAL . 2.6 tp -111.89 126.81 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.342 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 127.96 -104.66 0.69 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.913 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 2.9 p30 -162.31 9.01 0.06 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.9 mt-10 165.25 52.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.025 0.44 . . . . 0.0 110.284 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.633 HG12 ' HD2' ' B' ' 37' ' ' PRO . 13.8 m -115.26 -158.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.216 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.944 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.1 OUTLIER 167.05 106.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.655 HG13 ' HA ' ' B' ' 34' ' ' VAL . 3.1 t -117.45 114.28 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.753 0.311 . . . . 0.0 111.18 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.752 HG23 ' O ' ' B' ' 10' ' ' GLU . 5.0 m -110.54 116.54 31.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.849 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.855 HG22 ' HB2' ' B' ' 10' ' ' GLU . 34.2 m -81.11 71.1 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.601 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.42 HD12 ' N ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -88.94 -145.72 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.576 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' B' ' 31' ' ' ARG . . . 56.68 79.76 0.09 OUTLIER Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.363 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.741 HG13 ' NE ' ' B' ' 7' ' ' ARG . 20.9 t -86.0 107.83 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 120.96 0.41 . . . . 0.0 111.638 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.03 155.65 43.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.003 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.73 154.95 52.68 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.555 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 67.64 -88.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.492 0.187 . . . . 0.0 110.654 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -104.64 125.66 50.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.0 110.64 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 m -93.21 136.67 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.555 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.6 mtt180 -79.51 100.88 7.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.1 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.668 HG23 ' HA ' ' B' ' 22' ' ' VAL . 18.6 mm -87.31 133.76 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.68 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.92 118.96 6.3 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.306 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.655 ' HA ' HG13 ' B' ' 20' ' ' VAL . 24.0 t -109.51 129.67 63.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.922 0.391 . . . . 0.0 111.556 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.944 ' HB3' HG23 ' B' ' 19' ' ' THR . 2.1 t30 -123.41 107.22 11.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.247 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.19 146.6 46.76 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.622 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.633 ' HD2' HG12 ' B' ' 18' ' ' VAL . 82.7 Cg_endo -83.17 156.52 14.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.013 2.475 . . . . 0.0 112.271 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.95 15.57 4.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.303 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -38.6 10.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.662 0.268 . . . . 0.0 111.016 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 15' ' ' GLY . 4.7 t -87.94 142.19 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.868 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 3.0 m -55.9 98.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.971 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.511 HG13 ' O ' ' B' ' 42' ' ' VAL . 13.4 p -122.19 120.81 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.265 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.21 136.04 50.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.432 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.414 ' NH2' ' NE ' ' A' ' 6' ' ' ARG . 24.6 ttt180 -156.62 -67.17 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.939 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.77 121.61 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.42 -42.48 82.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -41.03 87.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.799 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -52.35 -46.65 66.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.634 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -86.84 -58.09 2.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.758 0.313 . . . . 0.0 111.804 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.467 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 4.1 mtt180 -48.95 -20.16 0.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 36.6 mm -108.78 -52.63 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.629 0.252 . . . . 0.0 111.524 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.41 ' HG2' ' CD2' ' A' ' 4' ' ' LEU . 8.1 tp60 -66.87 -63.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.763 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.822 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -70.89 -32.2 69.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 110.589 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 0.5 OUTLIER -108.65 119.59 39.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.615 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.589 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.731 ' C ' HD13 ' A' ' 2' ' ' LEU . 1.7 ttm . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.964 0.412 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.731 HD13 ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -122.24 111.69 17.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.823 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 3' ' ' ILE . 2.8 tt -106.06 116.66 50.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.1 0.476 . . . . 0.0 111.3 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.87 HD22 ' CD2' ' B' ' 48' ' ' TYR . 0.4 OUTLIER -123.9 123.4 40.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.336 179.354 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -63.61 80.07 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.888 0.375 . . . . 0.0 111.664 -179.17 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.546 ' HD3' HG21 ' A' ' 22' ' ' VAL . 23.5 mtt180 -78.79 143.22 36.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.126 0.489 . . . . 0.0 110.514 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.435 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 2.9 tmt_? -173.36 -13.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.864 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.61 -58.74 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.702 0.286 . . . . 0.0 111.175 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.57 105.55 0.21 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.803 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.2 -73.82 0.65 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.906 0.384 . . . . 0.0 110.723 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 m 69.53 102.39 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.49 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.644 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -109.94 154.59 22.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.626 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.3 ttt -127.2 100.07 5.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.98 0.419 . . . . 0.0 110.747 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.644 HD13 ' N ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -115.85 138.16 47.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.752 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.644 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 121.28 -106.01 1.08 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.104 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.4 t70 -159.57 7.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.7 mt-10 162.66 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.036 0.446 . . . . 0.0 110.151 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.774 HG12 ' CD ' ' A' ' 37' ' ' PRO . 13.3 m -116.38 -158.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.649 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.951 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 173.57 102.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.644 ' HB ' HD23 ' A' ' 12' ' ' LEU . 27.5 t -110.48 103.96 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.5 m -89.27 106.37 18.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.904 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.546 HG21 ' HD3' ' A' ' 6' ' ' ARG . 32.0 m -76.7 -168.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.899 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.724 ' O ' HG11 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -173.38 141.3 0.89 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.103 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.481 ' H ' HD13 ' A' ' 23' ' ' LEU . . . -125.37 -24.54 1.58 Allowed Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.477 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.94 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.536 0.208 . . . . 0.0 110.63 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.91 165.5 0.13 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.747 0.308 . . . . 0.0 110.56 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.81 -99.98 0.01 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.569 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -101.36 -30.92 11.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 110.377 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.448 ' HB3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -119.82 136.65 54.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.955 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 23' ' ' LEU . 12.0 t -93.21 128.39 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 111.681 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 2.4 ttp180 -80.8 99.54 8.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.445 HG13 ' HB2' ' B' ' 6' ' ' ARG . 9.5 mm -88.77 127.43 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.931 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.03 109.99 3.4 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.486 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.574 ' HA ' HG13 ' A' ' 20' ' ' VAL . 21.5 t -111.73 102.93 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.936 0.398 . . . . 0.0 111.468 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.951 ' HB3' HG23 ' A' ' 19' ' ' THR . 1.8 t-20 -91.59 107.44 19.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.641 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.95 138.62 33.04 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.454 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.774 ' CD ' HG12 ' A' ' 18' ' ' VAL . 83.7 Cg_endo -77.69 156.09 31.45 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.603 2.202 . . . . 0.0 112.102 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -82.01 2.25 31.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.564 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.84 -39.33 20.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.72 0.295 . . . . 0.0 111.267 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 t -86.78 146.85 5.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.885 0.374 . . . . 0.0 110.995 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.97 100.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.5 p -122.3 122.31 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -128.11 136.42 51.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.706 0.289 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.668 HH22 HD23 ' B' ' 2' ' ' LEU . 0.5 OUTLIER -142.92 -175.78 4.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.489 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 1.9 mp0 -57.3 145.78 30.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.843 0.354 . . . . 0.0 110.874 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.67 -65.29 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.507 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -52.08 -40.77 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.387 -179.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.861 ' CD2' HD22 ' B' ' 4' ' ' LEU . 7.9 t80 -46.9 -67.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.436 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' A' ' 53' ' ' ALA . 48.5 mt-30 -71.96 -22.01 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.551 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -70.5 -15.95 62.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.649 0.261 . . . . 0.0 111.571 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.528 HG23 ' OE1' ' A' ' 52' ' ' GLN . 6.9 tt -112.15 -25.18 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.634 0.254 . . . . 0.0 111.5 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.562 ' HB3' HD12 ' B' ' 2' ' ' LEU . 0.6 OUTLIER -106.79 -55.81 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.257 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB2' ' HG2' ' A' ' 49' ' ' GLN . . . -65.08 -71.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.1 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -108.0 116.61 32.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.772 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.558 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.743 ' C ' HD13 ' B' ' 2' ' ' LEU . 1.7 ttm . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.88 0.371 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.743 HD13 ' C ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -122.28 111.71 17.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.45 HG23 ' O ' ' B' ' 3' ' ' ILE . 2.7 tt -106.11 116.69 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.167 0.508 . . . . 0.0 111.233 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.861 HD22 ' CD2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -123.88 123.52 40.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.315 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -63.64 80.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.872 0.368 . . . . 0.0 111.623 -179.189 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.558 ' HD3' HG21 ' B' ' 22' ' ' VAL . 23.5 mtt180 -78.88 143.32 36.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.151 0.501 . . . . 0.0 110.503 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.432 ' HA ' ' HA3' ' B' ' 24' ' ' GLY . 2.9 tmt_? -173.37 -13.25 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.859 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 t -116.64 -58.68 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.674 0.273 . . . . 0.0 111.131 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.53 105.55 0.21 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.804 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.14 -73.89 0.65 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 110.77 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 8.8 m 69.61 102.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.436 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.4 OUTLIER -109.87 154.58 22.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.664 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 8.3 ttt -127.15 100.02 5.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.988 0.423 . . . . 0.0 110.769 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.639 HD13 ' N ' ' B' ' 15' ' ' GLY . 0.0 OUTLIER -115.76 138.2 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.734 179.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.639 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 121.28 -105.96 1.07 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.109 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.4 t70 -159.58 7.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.7 mt-10 162.69 59.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.981 0.42 . . . . 0.0 110.102 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.776 HG12 ' CD ' ' B' ' 37' ' ' PRO . 13.4 m -116.4 -158.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.632 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.934 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.1 OUTLIER 173.61 102.73 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.642 ' HB ' HD23 ' B' ' 12' ' ' LEU . 27.6 t -110.44 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 33.2 m -89.28 106.37 18.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.946 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.558 HG21 ' HD3' ' B' ' 6' ' ' ARG . 32.2 m -76.79 -168.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.905 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.725 ' O ' HG11 ' B' ' 30' ' ' VAL . 0.2 OUTLIER -173.38 141.32 0.9 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.095 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.481 ' H ' HD13 ' B' ' 23' ' ' LEU . . . -125.41 -24.43 1.59 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.97 130.79 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.525 0.202 . . . . 0.0 110.622 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.88 165.53 0.13 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 110.578 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.87 -100.01 0.01 OUTLIER Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.506 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -101.37 -30.88 11.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 110.372 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.448 ' HB3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -119.82 136.56 54.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.965 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.725 HG11 ' O ' ' B' ' 23' ' ' LEU . 12.1 t -93.18 128.44 44.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.916 0.389 . . . . 0.0 111.636 -178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 2.4 ttp180 -80.8 99.52 8.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.46 HG13 ' HB2' ' A' ' 6' ' ' ARG . 9.6 mm -88.8 127.46 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.878 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.03 109.95 3.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.429 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.581 ' HA ' HG13 ' B' ' 20' ' ' VAL . 21.4 t -111.7 102.94 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 111.48 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.934 ' HB3' HG23 ' B' ' 19' ' ' THR . 1.8 t-20 -91.62 107.43 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.622 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.97 138.59 32.99 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.475 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.776 ' CD ' HG12 ' B' ' 18' ' ' VAL . 84.3 Cg_endo -77.67 156.08 31.55 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.654 2.236 . . . . 0.0 112.134 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -82.03 2.28 31.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.603 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.88 -39.36 19.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.66 0.266 . . . . 0.0 111.187 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 t -86.67 146.8 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.042 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.01 100.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.467 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.5 p -122.3 122.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.752 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -128.1 136.4 51.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.684 0.278 . . . . 0.0 110.862 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.672 HH22 HD23 ' A' ' 2' ' ' LEU . 0.5 OUTLIER -142.93 -175.79 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.491 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' B' ' 48' ' ' TYR . 1.9 mp0 -57.31 145.7 31.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.86 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.62 -65.29 0.58 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.546 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.665 HD13 ' O ' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -52.07 -40.8 30.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.37 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.87 ' CD2' HD22 ' A' ' 4' ' ' LEU . 8.0 t80 -46.86 -67.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.414 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.462 ' HG2' ' HB2' ' B' ' 53' ' ' ALA . 48.5 mt-30 -71.95 -21.95 61.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.632 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 61.0 mtt180 -70.57 -15.95 62.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.579 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.53 HG23 ' OE1' ' B' ' 52' ' ' GLN . 6.9 tt -112.17 -25.08 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.614 0.245 . . . . 0.0 111.501 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.536 ' HB3' HD12 ' A' ' 2' ' ' LEU . 0.6 OUTLIER -106.82 -55.81 2.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 111.242 -179.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.462 ' HB2' ' HG2' ' B' ' 49' ' ' GLN . . . -65.04 -71.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.168 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -108.33 116.97 32.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmm? . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.821 0.343 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.402 ' HB2' ' NH1' ' B' ' 44' ' ' ARG . 4.1 mp -115.93 109.49 17.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 3' ' ' ILE . 18.3 tt -84.52 111.35 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 0.0 111.443 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -113.18 156.25 23.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.729 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.551 ' N ' HD23 ' A' ' 4' ' ' LEU . 0.2 OUTLIER -94.71 122.55 37.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 111.382 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.442 ' HB2' HG13 ' B' ' 32' ' ' ILE . 0.6 OUTLIER -95.6 148.97 21.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.645 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.621 ' HG3' HG13 ' A' ' 30' ' ' VAL . 0.1 OUTLIER 81.13 85.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.821 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.653 HG23 ' HA2' ' A' ' 24' ' ' GLY . 47.3 t 80.72 56.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.287 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.43 ' H ' HG21 ' A' ' 22' ' ' VAL . . . -140.51 -147.58 5.0 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.632 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.23 119.24 37.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 111.61 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 21' ' ' THR . 14.4 p -57.03 145.08 31.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.304 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.798 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -112.6 154.42 26.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.694 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.7 ttp -128.94 100.34 5.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.751 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.498 HD11 HG11 ' B' ' 18' ' ' VAL . 0.0 OUTLIER -114.64 138.72 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.015 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.411 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 123.9 -106.27 0.95 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.151 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.588 ' OD2' HG22 ' A' ' 40' ' ' VAL . 1.4 p30 -158.58 7.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.6 OUTLIER 161.74 58.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.902 0.382 . . . . 0.0 110.044 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.796 HG12 ' HD2' ' A' ' 37' ' ' PRO . 10.7 m -114.37 -156.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.357 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.974 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 173.15 104.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.974 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.798 ' HB ' HD23 ' A' ' 12' ' ' LEU . 24.8 t -102.66 101.66 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.852 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.629 ' HA ' HG22 ' A' ' 11' ' ' THR . 9.8 t -95.35 157.42 15.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.631 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.43 HG21 ' H ' ' A' ' 9' ' ' GLY . 6.4 m -107.86 -172.39 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.309 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.2 tm? -124.05 -52.2 1.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 0.0 110.427 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.653 ' HA2' HG23 ' A' ' 8' ' ' VAL . . . 91.85 -43.47 2.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.996 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.56 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 4.0 t -85.65 149.91 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.525 0.202 . . . . 0.0 111.41 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 25' ' ' VAL . 28.1 tttp 99.07 122.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.068 0.547 . . . . 0.0 110.743 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.77 -179.51 37.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.762 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 63.63 -86.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -86.46 136.74 32.99 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.821 HG12 HD11 ' A' ' 32' ' ' ILE . 4.1 t -93.24 114.15 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.351 . . . . 0.0 110.874 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.56 ' HD2' HD11 ' B' ' 3' ' ' ILE . 8.9 mmt180 -89.28 99.87 12.77 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.888 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.821 HD11 HG12 ' A' ' 30' ' ' VAL . 24.0 mm -109.53 141.19 25.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.054 0.454 . . . . 0.0 111.667 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.82 107.48 2.58 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.919 -0.657 . . . . 0.0 111.987 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.587 HG13 HG22 ' A' ' 20' ' ' VAL . 21.4 t -97.8 103.41 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.904 0.383 . . . . 0.0 111.103 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.974 ' HB3' HG23 ' A' ' 19' ' ' THR . 1.2 t-20 -90.57 107.3 19.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.87 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.75 140.03 37.43 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.259 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.796 ' HD2' HG12 ' A' ' 18' ' ' VAL . 85.9 Cg_endo -77.74 156.18 31.32 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.642 2.228 . . . . 0.0 112.28 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -80.32 0.16 34.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.355 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -78.01 -39.77 41.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.714 0.292 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.588 HG22 ' OD2' ' A' ' 16' ' ' ASP . 5.5 t -87.8 140.88 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.91 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 t -62.48 102.26 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.379 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.2 p -122.24 120.69 61.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -128.31 136.45 51.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.793 0.33 . . . . 0.0 111.199 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.4 ' NH1' ' HB2' ' B' ' 2' ' ' LEU . 63.4 mtt180 -139.62 -50.68 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.45 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 1.3 tp10 -178.29 141.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.514 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.51 -45.74 84.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.217 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -73.02 -38.51 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.67 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 45' ' ' GLU . 4.1 m-85 -51.54 -50.16 60.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -85.9 -52.81 5.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -16.35 12.62 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 mm -115.76 -57.92 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.409 ' CB ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -66.39 -48.07 71.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.104 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.85 -28.25 26.17 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 111.307 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -120.33 134.29 55.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.1 mttp . . . . . 0 N--CA 1.449 -0.514 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.147 -179.802 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmm? . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.804 0.335 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.4 ' HB2' ' NH1' ' A' ' 44' ' ' ARG . 4.2 mp -115.96 109.5 17.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.847 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.58 HG23 ' O ' ' B' ' 3' ' ' ILE . 18.3 tt -84.49 111.42 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.487 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.564 HD23 ' N ' ' B' ' 5' ' ' THR . 1.0 OUTLIER -113.21 156.21 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.739 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.564 ' N ' HD23 ' B' ' 4' ' ' LEU . 0.2 OUTLIER -94.69 122.55 37.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.363 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.6 OUTLIER -95.65 148.97 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.635 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.61 ' HG3' HG13 ' B' ' 30' ' ' VAL . 0.1 OUTLIER 81.22 85.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.767 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.653 HG23 ' HA2' ' B' ' 24' ' ' GLY . 47.3 t 80.64 56.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.287 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.426 ' H ' HG21 ' B' ' 22' ' ' VAL . . . -140.5 -147.57 4.99 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.589 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.24 119.16 36.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.889 0.376 . . . . 0.0 111.614 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.632 HG22 ' HA ' ' B' ' 21' ' ' THR . 14.5 p -57.04 145.04 31.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.263 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.807 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.2 OUTLIER -112.58 154.42 26.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.693 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 3.7 ttp -128.91 100.35 5.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.849 0.356 . . . . 0.0 110.723 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.504 HD11 HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -114.66 138.77 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.981 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.407 ' HA2' HG11 ' A' ' 40' ' ' VAL . . . 123.83 -106.18 0.95 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.16 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.583 ' OD2' HG22 ' B' ' 40' ' ' VAL . 1.4 p30 -158.6 7.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.6 OUTLIER 161.77 58.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.018 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.782 HG12 ' HD2' ' B' ' 37' ' ' PRO . 10.6 m -114.31 -157.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.968 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 173.21 104.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.981 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.807 ' HB ' HD23 ' B' ' 12' ' ' LEU . 24.7 t -102.65 101.71 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.898 0.38 . . . . 0.0 110.807 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.632 ' HA ' HG22 ' B' ' 11' ' ' THR . 9.9 t -95.36 157.41 15.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.609 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.426 HG21 ' H ' ' B' ' 9' ' ' GLY . 6.4 m -107.81 -172.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.304 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.428 ' HA ' HD22 ' B' ' 23' ' ' LEU . 1.2 tm? -124.09 -52.19 1.76 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.83 0.347 . . . . 0.0 110.411 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.653 ' HA2' HG23 ' B' ' 8' ' ' VAL . . . 91.92 -43.41 2.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.989 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' B' ' 26' ' ' LYS . 4.0 t -85.77 149.94 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.492 0.187 . . . . 0.0 111.36 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' B' ' 25' ' ' VAL . 28.1 tttp 99.0 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.067 0.547 . . . . 0.0 110.799 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.78 -179.53 37.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.763 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 63.64 -86.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -86.46 136.71 33.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.793 HG12 HD11 ' B' ' 32' ' ' ILE . 4.1 t -93.19 114.1 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.351 . . . . 0.0 110.896 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.563 ' HD2' HD11 ' A' ' 3' ' ' ILE . 8.9 mmt180 -89.29 99.86 12.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.865 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.793 HD11 HG12 ' B' ' 30' ' ' VAL . 24.0 mm -109.49 141.22 25.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.031 0.443 . . . . 0.0 111.719 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.85 107.53 2.58 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.979 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.584 HG13 HG22 ' B' ' 20' ' ' VAL . 21.4 t -97.85 103.43 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.926 0.393 . . . . 0.0 111.103 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.968 ' HB3' HG23 ' B' ' 19' ' ' THR . 1.2 t-20 -90.59 107.28 19.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.831 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.73 140.1 37.63 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.243 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.782 ' HD2' HG12 ' B' ' 18' ' ' VAL . 86.0 Cg_endo -77.78 156.16 31.13 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.673 2.249 . . . . 0.0 112.268 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -80.31 0.23 33.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.428 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -78.07 -39.7 40.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.703 0.287 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.583 HG22 ' OD2' ' B' ' 16' ' ' ASP . 5.5 t -87.89 140.9 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.89 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -62.37 102.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.394 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.489 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.3 p -122.2 120.67 61.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.726 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -128.29 136.47 51.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.795 0.331 . . . . 0.0 111.147 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.402 ' NH1' ' HB2' ' A' ' 2' ' ' LEU . 63.7 mtt180 -139.62 -50.65 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.409 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 1.3 tp10 -178.3 141.34 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.543 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.51 -45.78 84.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.188 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.99 -38.52 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.651 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.421 ' HB2' ' HB3' ' B' ' 45' ' ' GLU . 4.1 m-85 -51.54 -50.15 60.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.75 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -85.92 -52.86 5.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.409 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 0.2 OUTLIER -58.09 -16.21 12.24 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.011 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 17.1 mm -115.91 -57.88 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.413 ' CB ' ' O ' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -66.45 -48.06 71.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.09 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.84 -28.28 26.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 111.341 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' B' ' 55' ' ' LYS . 7.1 mt-10 -120.33 137.32 54.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.228 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' B' ' 54' ' ' GLU . 3.2 mtmp? . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.931 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.909 0.385 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.734 ' HG ' ' HB2' ' B' ' 53' ' ' ALA . 1.7 mp -116.46 105.46 12.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.7 tt -84.8 108.99 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.673 HD13 ' NE ' ' B' ' 44' ' ' ARG . 1.9 tp -112.98 156.64 22.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.257 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.563 HG21 ' OE1' ' B' ' 29' ' ' GLN . 0.3 OUTLIER -90.96 124.24 35.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.868 0.366 . . . . 0.0 111.021 179.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.498 ' HB2' ' CG1' ' B' ' 32' ' ' ILE . 0.0 OUTLIER -93.22 148.42 22.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.237 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.716 ' HD3' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER 83.34 90.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.401 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.518 HG23 ' C ' ' A' ' 7' ' ' ARG . 6.3 t 84.25 62.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.58 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.68 -146.9 4.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.383 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.409 ' HB2' ' CZ ' ' B' ' 48' ' ' TYR . 3.8 tp10 -113.26 118.17 33.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.845 0.355 . . . . 0.0 111.442 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 21' ' ' THR . 19.2 p -51.93 150.26 4.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.963 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.746 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -110.88 154.5 23.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.846 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.661 ' HG2' HG22 ' A' ' 18' ' ' VAL . 6.7 ttm -127.26 100.36 6.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.995 0.426 . . . . 0.0 110.906 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.488 ' H ' HG21 ' A' ' 18' ' ' VAL . 3.8 tp -111.93 129.35 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.441 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 127.76 -102.76 0.61 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.165 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 5.4 p30 -166.24 8.41 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 31.6 tp10 167.29 57.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.661 HG22 ' HG2' ' A' ' 13' ' ' MET . 5.8 m -114.98 -157.93 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.7 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 172.49 99.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.746 ' HB ' HD23 ' A' ' 12' ' ' LEU . 20.9 t -102.96 103.08 14.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.812 0.339 . . . . 0.0 111.77 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.678 ' HA ' HG22 ' A' ' 11' ' ' THR . 44.4 m -87.22 146.84 25.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.242 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.825 ' HA ' HG23 ' A' ' 32' ' ' ILE . 30.5 m -109.75 76.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -99.88 -151.11 0.39 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.307 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 31' ' ' ARG . . . 56.52 73.6 0.42 Allowed Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.098 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.716 HG13 ' HD3' ' A' ' 7' ' ' ARG . 24.7 t -85.92 107.33 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.011 0.434 . . . . 0.0 111.627 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.58 ' H ' HG12 ' A' ' 30' ' ' VAL . 1.1 mttt -137.21 142.82 42.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.906 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.53 -44.11 28.81 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.434 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -104.53 -86.25 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.939 0.369 . . . . 0.0 111.452 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.558 ' OE1' HG21 ' B' ' 5' ' ' THR . 5.7 mt-30 -84.85 116.15 23.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.759 0.314 . . . . 0.0 111.172 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 26' ' ' LYS . 31.0 m -93.81 136.51 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.189 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.531 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 4.9 mtt-85 -87.92 99.25 12.0 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.025 0.44 . . . . 0.0 110.1 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.825 HG23 ' HA ' ' A' ' 22' ' ' VAL . 27.3 mm -92.87 141.81 14.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.235 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.08 108.75 3.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.689 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.486 ' HA ' HG13 ' A' ' 20' ' ' VAL . 27.1 t -99.35 103.49 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.803 0.335 . . . . 0.0 111.049 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.1 t-20 -90.78 107.22 19.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.186 0.517 . . . . 0.0 110.62 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.43 141.32 38.57 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.247 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.641 ' CD ' HG12 ' A' ' 18' ' ' VAL . 86.0 Cg_endo -77.99 156.19 30.38 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.615 2.21 . . . . 0.0 112.272 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -83.26 3.78 29.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.498 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -86.01 -36.87 19.5 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.695 0.283 . . . . 0.0 111.099 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.44 HG12 ' O ' ' B' ' 15' ' ' GLY . 11.1 t -90.8 141.35 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.042 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -59.03 105.68 0.35 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.218 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.9 p -122.24 122.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.007 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.14 136.23 50.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.654 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.677 ' NE ' HD13 ' B' ' 4' ' ' LEU . 0.0 OUTLIER -154.47 59.43 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 0.0 110.778 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.07 136.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -65.39 -41.85 93.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.834 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.7 mm -67.32 -54.43 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.129 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.586 ' CD1' HD11 ' B' ' 4' ' ' LEU . 8.0 m-85 -47.19 -43.37 21.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.478 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.603 ' HG2' HD21 ' B' ' 2' ' ' LEU . 0.3 OUTLIER -78.29 -55.01 5.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.353 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 84.8 mmt-85 -56.93 -12.84 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.85 -57.3 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.715 0.293 . . . . 0.0 111.237 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.447 ' OE1' HD12 ' B' ' 4' ' ' LEU . 32.6 mt-30 -72.75 -57.99 3.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.892 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.725 ' HB2' ' HG ' ' B' ' 2' ' ' LEU . . . -67.29 -34.69 77.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 0.0 110.844 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 1.6 mt-10 -120.47 129.19 53.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.648 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? . . . . . 0 N--CA 1.453 -0.305 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.723 -179.345 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.871 0.367 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.725 ' HG ' ' HB2' ' A' ' 53' ' ' ALA . 1.7 mp -116.47 105.5 12.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.76 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.599 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.7 tt -84.76 108.99 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.266 0.555 . . . . 0.0 111.143 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.677 HD13 ' NE ' ' A' ' 44' ' ' ARG . 2.0 tp -113.03 156.65 22.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.178 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.558 HG21 ' OE1' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -90.92 124.25 35.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.849 0.357 . . . . 0.0 111.028 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.497 ' HB2' ' CG1' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -93.21 148.34 22.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.243 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.727 ' HD3' HG13 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 83.32 90.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.402 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.523 HG23 ' C ' ' B' ' 7' ' ' ARG . 6.4 t 84.32 62.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.554 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.74 -146.96 4.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.394 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 3.8 tp10 -113.22 118.14 33.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 111.44 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.667 HG22 ' HA ' ' B' ' 21' ' ' THR . 19.2 p -51.92 150.22 4.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.736 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.2 OUTLIER -110.81 154.43 23.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.889 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.68 ' HG2' HG22 ' B' ' 18' ' ' VAL . 6.8 ttm -127.27 100.37 6.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.971 0.415 . . . . 0.0 110.872 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.486 ' H ' HG21 ' B' ' 18' ' ' VAL . 3.8 tp -111.9 129.32 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.44 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 127.78 -102.76 0.61 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.17 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 5.5 p30 -166.26 8.59 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.579 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 31.6 tp10 167.18 57.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.68 HG22 ' HG2' ' B' ' 13' ' ' MET . 5.8 m -114.96 -157.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.729 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.648 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 172.48 99.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.736 ' HB ' HD23 ' B' ' 12' ' ' LEU . 21.0 t -102.94 103.04 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.791 0.329 . . . . 0.0 111.838 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.667 ' HA ' HG22 ' B' ' 11' ' ' THR . 45.0 m -87.22 146.89 25.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.232 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.809 ' HA ' HG23 ' B' ' 32' ' ' ILE . 30.3 m -109.76 77.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.421 HD12 ' N ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -100.0 -151.09 0.39 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.28 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' B' ' 31' ' ' ARG . . . 56.56 73.56 0.43 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.112 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.727 HG13 ' HD3' ' B' ' 7' ' ' ARG . 24.5 t -85.9 107.39 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.01 0.433 . . . . 0.0 111.607 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.591 ' H ' HG12 ' B' ' 30' ' ' VAL . 1.1 mttt -137.25 142.86 42.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.838 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.56 -44.14 29.02 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.42 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -104.53 -86.22 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.956 0.378 . . . . 0.0 111.478 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.563 ' OE1' HG21 ' A' ' 5' ' ' THR . 5.6 mt-30 -84.92 116.1 23.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.789 0.328 . . . . 0.0 111.204 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.591 HG12 ' H ' ' B' ' 26' ' ' LYS . 30.9 m -93.69 136.61 24.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.533 ' O ' ' HA3' ' B' ' 24' ' ' GLY . 4.9 mtt-85 -88.04 99.25 12.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.809 HG23 ' HA ' ' B' ' 22' ' ' VAL . 27.4 mm -92.81 141.74 14.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.24 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.06 108.74 3.01 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.719 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.474 ' HA ' HG13 ' B' ' 20' ' ' VAL . 27.0 t -99.33 103.5 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.843 0.354 . . . . 0.0 111.086 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' B' ' 19' ' ' THR . 1.1 t-20 -90.78 107.24 19.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 110.597 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.5 141.29 38.57 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.288 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.638 ' CD ' HG12 ' B' ' 18' ' ' VAL . 84.7 Cg_endo -77.92 156.13 30.61 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.663 2.242 . . . . 0.0 112.221 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -83.19 3.75 29.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.524 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -85.98 -36.93 19.49 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.696 0.284 . . . . 0.0 111.091 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 15' ' ' GLY . 11.0 t -90.65 141.29 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 111.055 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -59.06 105.69 0.35 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.184 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.466 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.9 p -122.28 122.55 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.11 136.25 50.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.734 0.302 . . . . 0.0 110.627 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.673 ' NE ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -154.54 59.42 0.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.744 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.11 136.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -65.4 -41.86 93.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 36.4 mm -67.32 -54.48 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.581 ' CD1' HD11 ' A' ' 4' ' ' LEU . 8.2 m-85 -47.15 -43.31 20.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.537 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.596 ' HG2' HD21 ' A' ' 2' ' ' LEU . 0.3 OUTLIER -78.36 -54.98 5.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.331 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.42 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 84.8 mmt-85 -56.97 -12.94 2.29 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.73 -57.33 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.676 0.274 . . . . 0.0 111.25 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.439 ' OE1' HD12 ' A' ' 4' ' ' LEU . 32.5 mt-30 -72.72 -57.88 3.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.734 ' HB2' ' HG ' ' A' ' 2' ' ' LEU . . . -67.41 -34.51 77.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.978 0.418 . . . . 0.0 110.847 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 1.6 mt-10 -121.77 133.58 54.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.795 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.626 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.793 0.33 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.75 HD12 ' HB2' ' B' ' 53' ' ' ALA . 9.6 tt -118.86 110.72 17.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.3 tt -96.86 105.36 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.143 0.497 . . . . 0.0 110.829 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.8 124.31 41.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.15 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -60.13 141.82 55.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.618 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -145.36 145.38 31.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.209 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.618 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 8.7 tmm_? 165.33 -10.86 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.224 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 8' ' ' VAL . 17.6 t -149.38 1.31 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.93 -156.54 31.64 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.009 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.27 -163.91 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.764 0.316 . . . . 0.0 111.048 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.731 HG22 ' HA ' ' A' ' 21' ' ' THR . 17.6 p -107.53 163.14 13.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.746 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -112.24 154.68 25.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.264 179.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.63 100.16 5.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 111.251 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.517 HG23 HG23 ' B' ' 14' ' ' ILE . 6.9 tp -112.6 138.9 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.459 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.419 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 118.64 -104.54 1.11 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.3 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 4.2 t0 -153.51 1.0 0.25 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 3.2 mt-10 163.74 61.29 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.408 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.756 HG12 ' CD ' ' A' ' 37' ' ' PRO . 10.3 m -116.4 -157.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.308 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.953 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 174.53 106.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.746 ' HB ' HD23 ' A' ' 12' ' ' LEU . 13.2 t -102.87 106.09 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.93 0.395 . . . . 0.0 111.676 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.731 ' HA ' HG22 ' A' ' 11' ' ' THR . 25.1 m -87.79 106.23 17.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.347 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.477 HG21 ' HG2' ' A' ' 6' ' ' ARG . 11.1 m -80.79 57.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.731 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.525 HD12 ' H ' ' A' ' 24' ' ' GLY . 32.0 tp -116.23 148.8 40.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.132 0.491 . . . . 0.0 110.692 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.525 ' H ' HD12 ' A' ' 23' ' ' LEU . . . 128.99 65.0 0.11 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.4 HG22 ' HG2' ' A' ' 7' ' ' ARG . 2.5 t -85.36 107.78 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 121.168 0.509 . . . . 0.0 112.241 -177.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.69 143.36 45.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.601 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.2 145.28 22.39 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.863 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.85 -82.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.636 0.255 . . . . 0.0 111.234 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -96.22 126.59 41.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.798 0.332 . . . . 0.0 111.091 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.765 HG21 HG21 ' B' ' 30' ' ' VAL . 26.3 t -93.58 134.35 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.07 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 6.4 mtm-85 -84.27 105.08 14.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' B' ' 6' ' ' ARG . 17.7 mm -91.89 133.91 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.331 . . . . 0.0 111.171 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.81 115.05 4.97 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.728 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.475 ' HA ' HG13 ' A' ' 20' ' ' VAL . 19.9 t -115.64 103.54 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.001 0.429 . . . . 0.0 111.814 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.953 ' HB3' HG23 ' A' ' 19' ' ' THR . 4.9 t-20 -97.44 107.44 19.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.219 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.71 150.07 72.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.783 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.756 ' CD ' HG12 ' A' ' 18' ' ' VAL . 87.5 Cg_endo -83.74 156.48 13.8 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.081 2.521 . . . . 0.0 112.188 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 19.91 4.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.298 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.76 -38.81 5.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.662 0.267 . . . . 0.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.421 HG12 ' O ' ' B' ' 15' ' ' GLY . 11.6 t -80.52 146.24 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.862 0.363 . . . . 0.0 110.947 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.65 106.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.115 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.3 p -122.1 122.19 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.58 136.04 50.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.433 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -172.5 -69.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -164.49 121.29 1.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -65.38 -28.46 69.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.68 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.599 HG22 HD12 ' A' ' 51' ' ' ILE . 29.5 mm -70.95 -53.24 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.225 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -53.42 -42.55 67.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.405 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -78.12 -50.83 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.684 0.278 . . . . 0.0 111.51 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -61.03 -13.26 15.36 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.599 HD12 HG22 ' A' ' 47' ' ' ILE . 55.4 mt -112.39 -52.89 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.322 . . . . 0.0 111.151 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HG3' HD23 ' B' ' 4' ' ' LEU . 0.6 OUTLIER -69.13 -57.54 5.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.081 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.74 ' HB2' HD12 ' B' ' 2' ' ' LEU . . . -79.31 -32.3 43.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 111.253 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.13 125.57 52.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? . . . . . 0 N--CA 1.451 -0.409 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.612 -179.52 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.795 0.331 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.74 HD12 ' HB2' ' A' ' 53' ' ' ALA . 9.6 tt -118.93 110.73 17.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.616 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.3 tt -96.91 105.39 17.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.136 0.494 . . . . 0.0 110.798 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' B' ' 4' ' ' LEU . 0.2 OUTLIER -124.83 124.39 41.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.113 179.637 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -60.16 141.82 55.3 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.136 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.613 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -145.33 145.46 31.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.858 0.361 . . . . 0.0 111.156 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.613 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 8.7 tmm_? 165.31 -10.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.219 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.562 ' O ' HG12 ' B' ' 8' ' ' VAL . 17.7 t -149.3 1.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.97 -156.47 31.59 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.982 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.32 -164.0 1.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.332 . . . . 0.0 111.057 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.746 HG22 ' HA ' ' B' ' 21' ' ' THR . 17.6 p -107.47 163.18 13.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.2 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.771 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.1 OUTLIER -112.3 154.68 25.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.232 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -128.67 100.09 5.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 111.26 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.517 HG23 HG23 ' A' ' 14' ' ' ILE . 6.9 tp -112.55 138.89 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.536 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.421 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 118.65 -104.47 1.1 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.324 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 4.2 t0 -153.55 0.95 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.424 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 3.2 mt-10 163.73 61.27 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.966 0.413 . . . . 0.0 110.39 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.759 HG12 ' CD ' ' B' ' 37' ' ' PRO . 10.2 m -116.44 -157.08 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.327 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.935 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 174.53 106.43 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.771 ' HB ' HD23 ' B' ' 12' ' ' LEU . 13.2 t -102.92 106.13 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.978 0.418 . . . . 0.0 111.632 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.746 ' HA ' HG22 ' B' ' 11' ' ' THR . 25.1 m -87.81 106.25 17.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.361 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.477 HG21 ' HG2' ' B' ' 6' ' ' ARG . 11.0 m -80.83 57.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.696 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.517 HD12 ' H ' ' B' ' 24' ' ' GLY . 32.2 tp -116.34 148.84 40.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.157 0.503 . . . . 0.0 110.659 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.517 ' H ' HD12 ' B' ' 23' ' ' LEU . . . 129.01 64.99 0.11 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.37 107.83 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.225 0.536 . . . . 0.0 112.215 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.78 143.29 45.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.595 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.11 145.21 22.16 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.986 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.92 -82.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.636 0.255 . . . . 0.0 111.196 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -96.3 126.62 41.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.842 0.353 . . . . 0.0 111.028 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.765 HG21 HG21 ' A' ' 30' ' ' VAL . 26.3 t -93.53 134.38 31.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 6.4 mtm-85 -84.27 105.08 14.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.761 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.466 HG13 ' HB2' ' A' ' 6' ' ' ARG . 17.8 mm -91.97 134.03 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.349 . . . . 0.0 111.119 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.9 115.0 4.94 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.707 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.467 ' HA ' HG13 ' B' ' 20' ' ' VAL . 19.8 t -115.61 103.55 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 111.851 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.935 ' HB3' HG23 ' B' ' 19' ' ' THR . 4.9 t-20 -97.39 107.42 19.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.244 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.75 150.06 72.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.79 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.759 ' CD ' HG12 ' B' ' 18' ' ' VAL . 87.0 Cg_endo -83.71 156.38 13.83 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.063 2.509 . . . . 0.0 112.229 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 19.93 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.346 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.77 -38.75 5.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.714 0.293 . . . . 0.0 111.125 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 15' ' ' GLY . 11.6 t -80.53 146.21 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.981 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.54 106.31 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.196 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.461 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.2 p -122.15 122.24 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.811 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.6 136.12 50.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.368 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -172.64 -69.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 0.0 110.797 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 21.3 tp10 -164.49 121.24 1.59 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -65.32 -28.47 69.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.671 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.601 HG22 HD12 ' B' ' 51' ' ' ILE . 29.4 mm -70.92 -53.31 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' B' ' 45' ' ' GLU . 6.7 m-85 -53.32 -42.59 66.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.491 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -78.16 -50.82 11.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.527 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -61.02 -13.26 15.21 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.601 HD12 HG22 ' B' ' 47' ' ' ILE . 55.4 mt -112.38 -52.98 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.0 111.104 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.09 -57.58 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.105 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.75 ' HB2' HD12 ' A' ' 2' ' ' LEU . . . -79.26 -32.15 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.283 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -110.15 128.2 55.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.725 179.855 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.853 0.359 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.787 HD21 HD23 ' A' ' 4' ' ' LEU . 5.5 tt -116.3 114.09 23.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 mm -92.08 105.58 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.108 0.48 . . . . 0.0 110.625 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.933 HD11 ' CE1' ' B' ' 48' ' ' TYR . 0.2 OUTLIER -119.32 156.75 29.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.589 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.679 ' H ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -95.25 129.03 42.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.24 179.1 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.653 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 15.9 mtt180 -142.35 146.85 35.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.689 ' O ' HG22 ' A' ' 25' ' ' VAL . 1.1 ttm180 165.33 -6.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.75 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.89 -62.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.808 0.337 . . . . 0.0 110.982 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.75 61.92 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.724 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -72.95 -69.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 110.625 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 m 71.75 101.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.483 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.506 HD13 HH22 ' A' ' 6' ' ' ARG . 1.1 pt? -111.26 154.77 23.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.075 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -127.61 100.06 5.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.016 0.436 . . . . 0.0 111.179 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.779 HD11 HG11 ' B' ' 18' ' ' VAL . 0.0 OUTLIER -113.77 134.27 57.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.25 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.446 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 123.89 -104.91 0.86 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.061 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -150.19 1.6 0.48 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.3 mt-10 159.09 67.04 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.133 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.766 HG11 HD11 ' B' ' 14' ' ' ILE . 9.9 m -119.53 -155.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.723 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER 172.94 102.15 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.704 HG22 HG13 ' A' ' 34' ' ' VAL . 38.3 t -113.35 110.79 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -107.3 107.83 18.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.15 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.778 HG12 ' CG2' ' A' ' 32' ' ' ILE . 29.9 m -80.28 74.87 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.062 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.478 HD12 ' H ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -63.72 -156.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' H ' HD12 ' A' ' 23' ' ' LEU . . . 83.06 71.9 1.3 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.92 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 7' ' ' ARG . 10.7 t -86.19 107.68 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.083 0.468 . . . . 0.0 111.938 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.53 165.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -170.63 13.46 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.298 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.9 -28.57 14.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.882 0.372 . . . . 0.0 110.554 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -121.1 136.68 54.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.565 HG12 HD13 ' A' ' 32' ' ' ILE . 4.0 t -93.31 115.31 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.373 . . . . 0.0 111.553 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.51 98.84 7.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.874 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.778 ' CG2' HG12 ' A' ' 22' ' ' VAL . 4.6 mm -94.03 125.28 46.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.426 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.44 103.6 1.98 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.978 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.704 HG13 HG22 ' A' ' 20' ' ' VAL . 17.7 t -98.27 103.66 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.941 0.4 . . . . 0.0 111.893 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -92.63 107.46 19.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.077 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.8 147.71 55.38 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.017 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.655 ' HD2' HG12 ' A' ' 18' ' ' VAL . 88.4 Cg_endo -79.66 156.55 24.57 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.966 2.444 . . . . 0.0 111.99 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -90.63 29.74 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.38 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.44 -40.32 5.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.669 0.271 . . . . 0.0 111.147 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.71 149.08 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.93 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.77 97.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.094 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 42' ' ' VAL . 7.5 p -122.49 121.48 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.948 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.96 136.15 50.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.725 0.298 . . . . 0.0 110.404 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' B' ' 12' ' ' LEU . 0.0 OUTLIER -149.54 -62.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.719 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.418 ' OE2' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -171.47 133.49 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -65.36 -36.32 83.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.088 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 48' ' ' TYR . 1.7 tp -74.28 -47.9 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.583 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.931 ' CE1' HD11 ' B' ' 4' ' ' LEU . 2.0 m-85 -55.84 -38.14 69.65 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -64.62 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -55.33 -15.86 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.9 mm -103.61 -56.55 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.653 0.263 . . . . 0.0 111.564 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.495 ' OE1' HD22 ' B' ' 4' ' ' LEU . 2.5 mm-40 -77.0 -56.97 4.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.678 0.275 . . . . 0.0 111.228 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.771 ' HB2' ' CD1' ' B' ' 2' ' ' LEU . . . -70.48 -25.27 63.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.297 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 16.0 tt0 -131.6 146.75 52.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.916 0.388 . . . . 0.0 111.203 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 18.4 mtpt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.734 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.774 0.321 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.788 HD21 HD23 ' B' ' 4' ' ' LEU . 5.5 tt -116.43 114.12 23.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 mm -92.06 105.53 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.052 0.453 . . . . 0.0 110.623 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.931 HD11 ' CE1' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -119.25 156.8 29.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.645 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.677 ' H ' HD13 ' B' ' 4' ' ' LEU . 0.0 OUTLIER -95.33 129.1 42.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.231 179.128 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.645 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 16.0 mtt180 -142.39 146.85 35.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.691 ' O ' HG22 ' B' ' 25' ' ' VAL . 1.1 ttm180 165.29 -6.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.725 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.96 -62.9 2.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.782 0.325 . . . . 0.0 111.009 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.76 61.98 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.726 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -72.96 -69.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.612 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 5.7 m 71.75 101.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.551 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.513 HD13 HH22 ' B' ' 6' ' ' ARG . 1.1 pt? -111.11 154.74 23.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.154 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -127.64 100.11 5.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.062 0.458 . . . . 0.0 111.172 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.766 HD11 HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -113.75 134.27 57.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.228 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.443 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 123.84 -104.88 0.86 Allowed Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.099 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 0.8 OUTLIER -150.2 1.59 0.47 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.3 mt-10 159.1 67.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.874 0.368 . . . . 0.0 110.175 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.779 HG11 HD11 ' A' ' 14' ' ' ILE . 10.0 m -119.53 -155.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 120.839 0.352 . . . . 0.0 111.703 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.653 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.1 OUTLIER 172.92 102.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.711 HG22 HG13 ' B' ' 34' ' ' VAL . 38.4 t -113.37 110.86 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -107.34 107.79 18.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.23 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.764 HG12 ' CG2' ' B' ' 32' ' ' ILE . 30.5 m -80.24 74.98 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.019 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.486 HD12 ' H ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -63.8 -156.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.731 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.486 ' H ' HD12 ' B' ' 23' ' ' LEU . . . 83.13 71.87 1.3 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.921 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.691 HG22 ' O ' ' B' ' 7' ' ' ARG . 10.7 t -86.22 107.66 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.083 0.468 . . . . 0.0 111.948 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.6 165.22 0.29 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.804 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.64 -170.64 13.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.324 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.88 -28.49 14.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.91 0.386 . . . . 0.0 110.579 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -121.19 136.7 54.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.97 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.556 HG12 HD13 ' B' ' 32' ' ' ILE . 4.0 t -93.35 115.37 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.948 0.404 . . . . 0.0 111.535 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.57 98.81 7.79 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.861 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.764 ' CG2' HG12 ' B' ' 22' ' ' VAL . 4.6 mm -93.98 125.28 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.417 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.51 103.56 1.97 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.964 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.711 HG13 HG22 ' B' ' 20' ' ' VAL . 17.5 t -98.15 103.63 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.937 0.399 . . . . 0.0 111.945 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -92.7 107.54 19.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.034 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.82 147.65 55.11 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.016 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.668 ' HD2' HG12 ' B' ' 18' ' ' VAL . 88.8 Cg_endo -79.69 156.59 24.5 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.982 2.454 . . . . 0.0 112.0 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -90.71 29.81 1.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.328 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.43 -40.31 5.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.711 0.291 . . . . 0.0 111.159 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.0 t -81.7 149.1 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.78 97.8 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.076 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.457 HG13 ' O ' ' B' ' 42' ' ' VAL . 7.4 p -122.56 121.46 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.91 136.15 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.676 0.274 . . . . 0.0 110.433 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.462 ' HG2' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -149.6 -62.72 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.952 0.406 . . . . 0.0 110.724 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.417 ' OE2' HG22 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -171.46 133.47 0.81 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.463 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.7 OUTLIER -65.28 -36.34 83.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.52 HG23 ' N ' ' B' ' 48' ' ' TYR . 1.7 tp -74.31 -47.89 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.562 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.933 ' CE1' HD11 ' A' ' 4' ' ' LEU . 2.0 m-85 -55.66 -38.3 69.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -64.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' B' ' 46' ' ' GLU . 0.0 OUTLIER -55.28 -15.79 2.77 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.642 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 39.9 mm -103.65 -56.44 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.604 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.497 ' OE1' HD22 ' A' ' 4' ' ' LEU . 2.5 mm-40 -77.17 -56.86 4.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.758 0.313 . . . . 0.0 111.233 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.773 ' HB2' ' CD1' ' A' ' 2' ' ' LEU . . . -70.55 -25.17 62.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.203 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -132.32 146.05 51.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 0.0 111.179 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 mttm . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.337 179.454 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.888 0.375 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.783 HD13 ' HB2' ' B' ' 53' ' ' ALA . 7.8 tp -121.21 112.37 18.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.7 tt -99.79 105.74 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.222 0.535 . . . . 0.0 110.795 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.568 HD22 ' HG3' ' B' ' 52' ' ' GLN . 1.9 mm? -124.41 120.71 32.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.752 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -55.45 141.63 35.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.738 0.304 . . . . 0.0 110.806 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.739 ' HB2' HG21 ' A' ' 22' ' ' VAL . 5.3 mtt180 -150.95 143.94 24.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.058 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.716 ' HD2' HG13 ' A' ' 25' ' ' VAL . 5.7 ttp180 169.7 -4.17 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.756 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.44 -71.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.68 0.276 . . . . 0.0 111.199 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.88 90.48 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.697 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.637 ' O ' HG23 ' A' ' 11' ' ' THR . 57.9 mm-40 -110.15 -174.39 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.637 0.256 . . . . 0.0 110.56 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER 170.82 101.28 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 111.041 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.474 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 1.2 pt? -115.31 154.1 29.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.397 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.407 ' HG2' HG22 ' A' ' 18' ' ' VAL . 2.1 ttm -129.53 100.7 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.096 0.474 . . . . 0.0 111.092 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.86 HG23 HG23 ' B' ' 14' ' ' ILE . 2.4 tp -114.73 123.29 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.531 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.54 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 133.23 -107.18 0.67 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.116 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -148.47 5.09 0.71 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 1.7 tt0 154.61 72.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.893 0.477 . . . . 0.0 109.969 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.592 HG11 ' CG1' ' B' ' 14' ' ' ILE . 9.1 m -122.31 -152.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.35 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.898 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 169.41 103.69 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' A' ' 34' ' ' VAL . 31.3 t -116.43 113.79 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.96 0.41 . . . . 0.0 111.858 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 t -110.88 112.9 25.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.33 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.923 HG12 HG23 ' A' ' 32' ' ' ILE . 26.9 m -80.81 75.55 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.802 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.61 -138.02 0.1 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.531 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 31' ' ' ARG . . . 53.02 77.33 0.15 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.466 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.716 HG13 ' HD2' ' A' ' 7' ' ' ARG . 36.2 t -85.84 107.91 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 111.709 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.789 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -130.74 141.11 50.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.691 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.39 -50.39 5.58 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.57 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -101.57 -83.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.863 0.332 . . . . 0.0 111.262 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.438 ' HB3' HG22 ' B' ' 5' ' ' THR . 14.0 mp0 -87.18 118.99 26.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.0 111.126 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.789 HG12 ' H ' ' A' ' 26' ' ' LYS . 15.4 m -93.33 136.34 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.186 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.613 ' HB3' HD11 ' B' ' 3' ' ' ILE . 5.0 mtm180 -78.13 106.44 10.01 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.483 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.923 HG23 HG12 ' A' ' 22' ' ' VAL . 32.5 mm -87.35 135.46 25.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.597 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.35 120.71 6.41 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.355 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.751 ' HA ' HG13 ' A' ' 20' ' ' VAL . 17.4 t -116.08 103.61 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.41 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.898 ' HB3' HG23 ' A' ' 19' ' ' THR . 0.7 OUTLIER -98.08 107.67 20.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.571 179.641 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.35 142.36 26.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.503 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.486 ' HD2' HG12 ' A' ' 18' ' ' VAL . 95.0 Cg_endo -79.29 156.35 25.67 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.724 2.283 . . . . 0.0 112.164 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.52 3.39 21.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.55 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -78.59 -41.91 30.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.71 0.291 . . . . 0.0 111.17 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.534 HG12 ' O ' ' B' ' 15' ' ' GLY . 6.3 t -87.3 152.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.929 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 m -66.55 100.26 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.892 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.588 ' HB ' HD13 ' B' ' 14' ' ' ILE . 13.4 p -122.15 120.67 61.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.239 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.31 136.12 50.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.542 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.426 ' NH2' HG21 ' A' ' 42' ' ' VAL . 32.4 mtt85 -141.09 -64.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 0.0 110.805 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -168.88 136.15 1.9 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.748 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -55.0 -53.57 54.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.493 ' HA ' HD13 ' A' ' 51' ' ' ILE . 12.8 tt -65.08 -41.99 93.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.459 ' CG ' ' HB2' ' A' ' 45' ' ' GLU . 3.5 m-85 -45.46 -48.31 13.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.578 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -89.0 -49.33 6.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.463 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.637 ' C ' HD12 ' A' ' 51' ' ' ILE . 7.8 mtp180 -53.59 -17.37 2.07 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.637 HD12 ' C ' ' A' ' 50' ' ' ARG . 1.3 mp -111.52 -51.12 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.699 0.285 . . . . 0.0 111.013 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.565 ' HG3' HD22 ' B' ' 4' ' ' LEU . 0.5 OUTLIER -73.18 -60.36 2.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.937 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.777 ' HB2' HD13 ' B' ' 2' ' ' LEU . . . -69.08 -36.61 77.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.895 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 2.4 mt-10 -114.31 123.8 50.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.289 -179.91 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.834 0.35 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.777 HD13 ' HB2' ' A' ' 53' ' ' ALA . 7.7 tp -121.18 112.31 18.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.624 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.7 tt -99.77 105.73 17.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.146 0.498 . . . . 0.0 110.85 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.565 HD22 ' HG3' ' A' ' 52' ' ' GLN . 1.9 mm? -124.36 120.68 32.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.769 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -55.43 141.57 35.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.323 . . . . 0.0 110.735 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.744 ' HB2' HG21 ' B' ' 22' ' ' VAL . 5.3 mtt180 -150.95 143.95 24.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.707 ' HD2' HG13 ' B' ' 25' ' ' VAL . 5.7 ttp180 169.71 -4.13 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.758 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.45 -71.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.672 0.273 . . . . 0.0 111.171 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.88 90.4 0.13 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.703 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.625 ' O ' HG23 ' B' ' 11' ' ' THR . 58.0 mm-40 -110.09 -174.36 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.636 0.255 . . . . 0.0 110.591 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.625 HG23 ' O ' ' B' ' 10' ' ' GLU . 0.1 OUTLIER 170.79 101.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.082 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.469 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 1.2 pt? -115.33 154.08 29.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.427 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.413 ' HG2' HG22 ' B' ' 18' ' ' VAL . 2.1 ttm -129.46 100.73 5.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.057 0.456 . . . . 0.0 111.076 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.86 HG23 HG23 ' A' ' 14' ' ' ILE . 2.4 tp -114.83 123.31 70.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.493 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.534 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 133.2 -107.17 0.67 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.159 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.1 OUTLIER -148.4 5.09 0.71 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 1.7 tt0 154.65 72.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.895 0.478 . . . . 0.0 110.026 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.579 HG11 ' CG1' ' A' ' 14' ' ' ILE . 9.3 m -122.32 -152.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.305 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.925 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 169.45 103.74 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' B' ' 34' ' ' VAL . 31.9 t -116.47 113.82 44.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.931 0.396 . . . . 0.0 111.798 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.0 t -110.93 112.87 25.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.303 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.926 HG12 HG23 ' B' ' 32' ' ' ILE . 27.0 m -80.72 75.48 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.84 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.55 -138.03 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.565 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' B' ' 31' ' ' ARG . . . 52.96 77.35 0.14 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.481 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.707 HG13 ' HD2' ' B' ' 7' ' ' ARG . 37.2 t -85.9 107.9 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.037 0.446 . . . . 0.0 111.674 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.778 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.1 OUTLIER -130.64 141.09 50.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.657 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.43 -50.37 5.62 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.267 -0.492 . . . . 0.0 113.587 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -101.61 -83.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.813 0.306 . . . . 0.0 111.235 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.448 ' HB3' HG22 ' A' ' 5' ' ' THR . 14.0 mp0 -87.22 118.99 27.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.915 0.388 . . . . 0.0 111.121 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.778 HG12 ' H ' ' B' ' 26' ' ' LYS . 15.4 m -93.32 136.38 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.145 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.598 ' HB3' HD11 ' A' ' 3' ' ' ILE . 5.0 mtm180 -78.14 106.42 10.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.532 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.926 HG23 HG12 ' B' ' 22' ' ' VAL . 32.6 mm -87.33 135.4 25.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.002 0.429 . . . . 0.0 111.545 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.29 120.66 6.4 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.374 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.751 ' HA ' HG13 ' B' ' 20' ' ' VAL . 17.4 t -116.04 103.67 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 0.0 111.429 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.925 ' HB3' HG23 ' B' ' 19' ' ' THR . 0.7 OUTLIER -98.15 107.69 20.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.544 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.36 142.33 26.31 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.533 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.496 ' HD2' HG12 ' B' ' 18' ' ' VAL . 94.6 Cg_endo -79.28 156.33 25.69 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.73 2.287 . . . . 0.0 112.195 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.51 3.45 21.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.537 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -78.69 -41.88 29.92 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.683 0.278 . . . . 0.0 111.129 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 15' ' ' GLY . 6.3 t -87.26 152.07 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.987 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -66.62 100.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.585 ' HB ' HD13 ' A' ' 14' ' ' ILE . 13.3 p -122.16 120.66 61.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.233 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.35 136.06 50.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.74 0.305 . . . . 0.0 110.576 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.426 ' NH2' HG21 ' B' ' 42' ' ' VAL . 32.4 mtt85 -141.03 -64.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.899 0.38 . . . . 0.0 110.819 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.457 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 0.8 OUTLIER -168.85 136.21 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.738 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -55.02 -53.66 52.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.009 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.506 ' HA ' HD13 ' B' ' 51' ' ' ILE . 12.8 tt -64.98 -42.01 93.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.457 ' CG ' ' HB2' ' B' ' 45' ' ' GLU . 3.5 m-85 -45.4 -48.37 13.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.568 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -89.02 -49.34 6.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.464 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.635 ' C ' HD12 ' B' ' 51' ' ' ILE . 7.8 mtp180 -53.56 -17.37 2.05 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.635 HD12 ' C ' ' B' ' 50' ' ' ARG . 1.3 mp -111.56 -50.98 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.708 0.289 . . . . 0.0 111.065 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.568 ' HG3' HD22 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -73.3 -60.32 2.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.896 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.783 ' HB2' HD13 ' A' ' 2' ' ' LEU . . . -69.07 -36.63 77.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.886 0.374 . . . . 0.0 110.92 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 2.4 mt-10 -114.2 123.45 49.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.783 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.142 -179.779 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.839 0.352 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' B' ' 53' ' ' ALA . 7.4 tt -114.1 105.39 13.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.9 tt -100.96 105.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.279 0.561 . . . . 0.0 111.08 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.587 HD13 ' CD2' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -125.22 119.71 29.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.85 179.339 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.693 HG23 ' HG2' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -58.02 149.55 22.99 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.724 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.19 144.32 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.978 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.746 ' HD3' HG13 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -163.93 25.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.561 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.52 -52.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.981 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.17 89.18 0.1 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.676 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.8 55.48 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.0 0.429 . . . . 0.0 110.674 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -61.45 101.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.457 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.559 HD23 ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -111.12 154.23 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.991 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -133.19 99.7 4.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.279 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.779 HG23 HG23 ' B' ' 14' ' ' ILE . 8.8 tp -118.04 138.7 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.723 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.501 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 122.06 -108.23 1.27 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.441 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -143.47 -5.41 0.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 3.2 tt0 163.31 65.28 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.729 HG12 ' HD2' ' A' ' 37' ' ' PRO . 11.5 m -117.28 -160.78 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.511 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER 175.74 104.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.814 HG12 HG13 ' A' ' 34' ' ' VAL . 27.2 m -115.54 106.87 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.65 109.51 21.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.361 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.676 HG11 ' CD1' ' B' ' 32' ' ' ILE . 8.9 p -77.84 70.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.602 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.81 -147.24 0.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.544 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 31' ' ' ARG . . . 63.19 79.67 0.14 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.165 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.746 HG13 ' HD3' ' A' ' 7' ' ' ARG . 85.9 t -85.91 107.36 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.001 0.429 . . . . 0.0 111.619 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.662 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -133.95 139.2 45.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.875 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.77 -50.66 7.15 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 113.753 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -101.36 -87.46 0.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.018 0.409 . . . . 0.0 111.452 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.87 119.63 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 26' ' ' LYS . 18.5 m -93.3 136.83 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.631 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.696 ' HG2' HG23 ' B' ' 5' ' ' THR . 4.8 mmt180 -76.99 103.76 7.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.944 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.686 ' CD1' HG11 ' B' ' 22' ' ' VAL . 8.4 mt -87.33 131.3 35.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.401 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 110.59 3.77 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.173 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.814 HG13 HG12 ' A' ' 20' ' ' VAL . 28.0 t -110.76 103.04 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.973 0.416 . . . . 0.0 111.565 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.8 t-20 -96.04 107.3 19.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.287 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.68 145.99 53.5 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.761 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.729 ' HD2' HG12 ' A' ' 18' ' ' VAL . 92.2 Cg_endo -79.47 156.32 25.07 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.87 2.38 . . . . 0.0 112.145 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.35 35.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -119.17 -38.76 2.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.035 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.49 HG12 ' O ' ' B' ' 15' ' ' GLY . 7.6 t -80.24 155.08 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.935 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -59.13 112.6 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.9 p -122.04 121.0 62.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -129.03 128.16 43.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.369 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.42 -69.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -157.03 116.66 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.78 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -60.92 -35.78 77.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 51' ' ' ILE . 1.2 tp -74.79 -43.34 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.601 ' CD2' HD13 ' B' ' 4' ' ' LEU . 6.4 m-85 -51.5 -43.26 62.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.334 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 8.7 pt20 -82.17 -41.74 19.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.255 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.417 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 7.3 mtm180 -72.62 0.17 11.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 47' ' ' ILE . 11.1 tt -114.99 -45.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.756 0.312 . . . . 0.0 111.28 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.493 ' N ' HG23 ' A' ' 51' ' ' ILE . 31.2 mm-40 -90.22 -50.07 6.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.732 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.489 ' HB2' HD12 ' B' ' 2' ' ' LEU . . . -75.23 -43.56 51.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -102.55 118.66 37.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.626 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.854 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.84 0.352 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 53' ' ' ALA . 7.4 tt -114.16 105.44 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.827 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.636 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.9 tt -100.98 105.16 17.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.22 0.533 . . . . 0.0 111.021 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.601 HD13 ' CD2' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -125.23 119.74 29.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.809 179.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.696 HG23 ' HG2' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -58.0 149.68 22.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.68 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.11 144.41 0.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.98 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.744 ' HD3' HG13 ' B' ' 25' ' ' VAL . 0.8 OUTLIER -164.03 25.93 0.07 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.638 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.51 -52.46 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.982 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.24 89.21 0.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.64 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.86 55.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.022 0.439 . . . . 0.0 110.648 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 25.7 m -61.53 101.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.522 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.565 HD23 ' CG2' ' B' ' 20' ' ' VAL . 0.1 OUTLIER -111.03 154.23 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.013 179.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -133.2 99.68 4.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.419 . . . . 0.0 111.289 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.779 HG23 HG23 ' A' ' 14' ' ' ILE . 8.7 tp -118.06 138.72 47.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.721 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.49 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 122.04 -108.11 1.26 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.528 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.8 OUTLIER -143.55 -5.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 3.3 tt0 163.23 65.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.755 HG12 ' HD2' ' B' ' 37' ' ' PRO . 11.6 m -117.22 -160.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.518 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.721 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.4 OUTLIER 175.71 104.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.798 HG12 HG13 ' B' ' 34' ' ' VAL . 27.7 m -115.51 106.78 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.57 109.46 21.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.376 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.686 HG11 ' CD1' ' A' ' 32' ' ' ILE . 8.9 p -77.81 70.4 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.582 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.95 -147.22 0.16 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.543 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.509 ' HA3' ' HB2' ' B' ' 31' ' ' ARG . . . 63.25 79.6 0.15 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.158 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.744 HG13 ' HD3' ' B' ' 7' ' ' ARG . 86.6 t -85.88 107.38 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.023 0.439 . . . . 0.0 111.614 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.657 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.0 OUTLIER -133.94 139.22 45.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.814 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.76 -50.69 7.13 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.755 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -101.31 -87.51 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.984 0.392 . . . . 0.0 111.421 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.84 119.61 25.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.9 0.381 . . . . 0.0 110.865 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.657 HG12 ' H ' ' B' ' 26' ' ' LYS . 18.4 m -93.3 136.88 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.624 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.693 ' HG2' HG23 ' A' ' 5' ' ' THR . 4.8 mmt180 -77.03 103.7 7.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.049 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.676 ' CD1' HG11 ' A' ' 22' ' ' VAL . 8.5 mt -87.33 131.35 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.411 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.91 110.61 3.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.201 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.798 HG13 HG12 ' B' ' 20' ' ' VAL . 28.1 t -110.8 103.1 14.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.921 0.391 . . . . 0.0 111.524 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' B' ' 19' ' ' THR . 1.8 t-20 -96.08 107.29 19.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.279 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.67 145.92 53.25 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.815 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.755 ' HD2' HG12 ' B' ' 18' ' ' VAL . 93.0 Cg_endo -79.43 156.36 25.22 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.863 2.375 . . . . 0.0 112.129 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.38 35.01 1.02 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.146 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -119.09 -38.9 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.741 0.305 . . . . 0.0 111.076 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 15' ' ' GLY . 7.5 t -80.15 155.03 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -59.09 112.62 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.053 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.498 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.9 p -122.07 121.03 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -129.05 128.18 43.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.343 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 -69.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.72 0.295 . . . . 0.0 111.057 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -157.03 116.71 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.928 0.394 . . . . 0.0 110.734 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -60.94 -35.79 77.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.876 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.637 ' O ' HG22 ' B' ' 51' ' ' ILE . 1.2 tp -74.74 -43.38 47.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.111 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.587 ' CD2' HD13 ' A' ' 4' ' ' LEU . 6.4 m-85 -51.35 -43.36 61.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.325 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 8.7 pt20 -82.15 -41.83 19.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.229 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -72.54 0.17 11.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.637 HG22 ' O ' ' B' ' 47' ' ' ILE . 11.1 tt -115.04 -45.66 4.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.755 0.312 . . . . 0.0 111.242 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.49 ' N ' HG23 ' B' ' 51' ' ' ILE . 31.3 mm-40 -90.15 -50.05 6.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.714 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' A' ' 2' ' ' LEU . . . -75.25 -43.51 51.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.824 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.51 121.21 42.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.733 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.832 0.349 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.451 HD22 HH21 ' B' ' 44' ' ' ARG . 0.7 OUTLIER -116.96 109.69 17.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 mm -97.2 105.34 17.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.09 0.471 . . . . 0.0 110.789 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.467 ' HG ' ' CG ' ' B' ' 48' ' ' TYR . 0.1 OUTLIER -124.23 110.42 14.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.2 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -62.9 77.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.961 0.41 . . . . 0.0 111.474 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.471 ' HB2' HG13 ' B' ' 32' ' ' ILE . 3.8 mtt-85 -80.12 143.68 33.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.321 0.581 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.637 ' HD3' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -170.59 -7.48 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.878 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -161.32 12.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.49 -139.25 9.36 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.864 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -107.08 -164.54 0.99 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.785 0.326 . . . . 0.0 111.178 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.612 HG22 HG23 ' A' ' 21' ' ' THR . 8.3 p -110.02 169.34 8.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 12' ' ' LEU . 1.6 pt? -109.35 154.31 22.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.597 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.564 ' HG2' HG22 ' A' ' 18' ' ' VAL . 1.6 ttp -129.73 100.29 5.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.07 0.462 . . . . 0.0 111.186 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.691 HG23 HG23 ' B' ' 14' ' ' ILE . 3.1 tp -114.32 124.69 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.486 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.52 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 132.11 -105.35 0.6 Allowed Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.058 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 2.2 t70 -160.81 11.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER 159.17 61.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.851 0.46 . . . . 0.0 109.781 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.564 HG22 ' HG2' ' A' ' 13' ' ' MET . 8.8 m -118.3 -157.7 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.676 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.935 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 167.32 102.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.77 HG13 ' HA ' ' A' ' 34' ' ' VAL . 25.7 t -118.65 113.85 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.982 0.42 . . . . 0.0 111.951 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.612 HG23 HG22 ' A' ' 11' ' ' THR . 4.0 m -96.03 113.08 24.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.549 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.786 HG11 HG21 ' B' ' 32' ' ' ILE . 30.5 m -76.78 -19.0 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.862 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER 62.89 -76.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.044 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . 92.41 -40.81 2.83 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.16 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.637 HG22 ' HD3' ' A' ' 7' ' ' ARG . 1.1 t -85.59 139.17 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.666 0.233 . . . . 0.0 110.938 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER 164.37 165.58 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.943 0.401 . . . . 0.0 110.715 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' GLN . . . -76.71 105.59 2.05 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.151 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m120 64.45 -72.53 0.06 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 111.23 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.505 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -84.46 136.93 33.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.682 179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.7 t -93.15 119.86 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.907 0.384 . . . . 0.0 111.794 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 0.1 OUTLIER -75.75 98.59 4.16 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.045 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.795 HG21 HG11 ' B' ' 22' ' ' VAL . 11.2 mm -92.18 123.42 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.39 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.77 119.24 6.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.26 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.77 ' HA ' HG13 ' A' ' 20' ' ' VAL . 22.0 t -109.74 103.73 15.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.922 0.391 . . . . 0.0 111.253 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.935 ' HB3' HG23 ' A' ' 19' ' ' THR . 3.6 t-20 -100.61 107.52 19.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.286 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.96 147.69 42.46 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.697 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.508 ' HD2' HG12 ' A' ' 18' ' ' VAL . 79.0 Cg_endo -77.51 156.52 32.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.866 2.377 . . . . 0.0 112.126 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 30.35 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.25 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -106.08 -37.96 6.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.77 0.319 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.509 HG12 ' O ' ' B' ' 15' ' ' GLY . 21.3 t -90.73 147.53 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -54.6 100.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.18 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.524 ' HB ' HD13 ' B' ' 14' ' ' ILE . 12.4 p -122.4 124.56 71.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.08 136.32 51.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.601 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.455 HH21 HD22 ' B' ' 2' ' ' LEU . 2.3 mpp_? -147.74 -176.85 5.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.57 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.455 ' HB3' ' CG ' ' A' ' 48' ' ' TYR . 2.7 tt0 -59.32 137.99 57.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -61.29 2.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.595 ' CG1' HD11 ' A' ' 51' ' ' ILE . 6.8 tt -54.73 -42.05 59.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.349 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.473 ' CG ' ' HG ' ' B' ' 4' ' ' LEU . 4.5 m-30 -46.24 -58.85 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.691 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 41.1 mt-30 -75.97 -20.99 57.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.625 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -73.19 -13.84 61.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.596 0.236 . . . . 0.0 111.458 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.595 HD11 ' CG1' ' A' ' 47' ' ' ILE . 28.6 mt -108.91 -33.11 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.723 0.297 . . . . 0.0 111.361 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.93 -50.84 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.342 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -62.23 -69.03 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.924 0.393 . . . . 0.0 110.771 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -113.94 118.62 34.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.507 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.3 mttp . . . . . 0 N--CA 1.449 -0.493 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.643 179.779 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.815 0.34 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.455 HD22 HH21 ' A' ' 44' ' ' ARG . 0.7 OUTLIER -116.87 109.65 17.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 13.0 mm -97.13 105.29 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.075 0.464 . . . . 0.0 110.861 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.473 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -124.22 110.45 14.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.178 179.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -62.95 77.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.011 0.434 . . . . 0.0 111.497 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.46 ' HB2' HG13 ' A' ' 32' ' ' ILE . 3.7 mtt-85 -80.06 143.67 33.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.329 0.585 . . . . 0.0 111.022 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.642 ' HD3' HG22 ' B' ' 25' ' ' VAL . 0.0 OUTLIER -170.56 -7.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.905 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.451 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -161.24 12.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.43 -139.26 9.35 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.896 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -107.12 -164.5 0.99 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.159 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.621 HG22 HG23 ' B' ' 21' ' ' THR . 8.5 p -110.07 169.37 8.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.481 HD23 ' H ' ' B' ' 12' ' ' LEU . 1.6 pt? -109.39 154.36 22.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.519 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.569 ' HG2' HG22 ' B' ' 18' ' ' VAL . 1.6 ttp -129.76 100.26 5.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.462 . . . . 0.0 111.159 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.691 HG23 HG23 ' A' ' 14' ' ' ILE . 3.1 tp -114.34 124.64 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.502 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.509 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 132.13 -105.46 0.61 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.127 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 2.2 t70 -160.67 12.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 0.2 OUTLIER 159.03 61.86 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.854 0.462 . . . . 0.0 109.77 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.569 HG22 ' HG2' ' B' ' 13' ' ' MET . 8.8 m -118.41 -157.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.656 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.946 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 167.4 102.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.748 HG13 ' HA ' ' B' ' 34' ' ' VAL . 25.8 t -118.72 113.74 42.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.4 . . . . 0.0 111.946 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.621 HG23 HG22 ' B' ' 11' ' ' THR . 4.0 m -95.96 113.16 24.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.795 HG11 HG21 ' A' ' 32' ' ' ILE . 31.0 m -76.75 -19.05 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.872 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.578 HD12 ' O ' ' B' ' 25' ' ' VAL . 0.2 OUTLIER 62.93 -76.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.02 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . 92.42 -40.85 2.82 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.165 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.642 HG22 ' HD3' ' B' ' 7' ' ' ARG . 1.2 t -85.61 139.21 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.644 0.222 . . . . 0.0 110.943 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER 164.37 165.62 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.95 0.405 . . . . 0.0 110.736 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 29' ' ' GLN . . . -76.72 105.61 2.05 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.056 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m120 64.5 -72.63 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.903 0.382 . . . . 0.0 111.161 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 0.0 OUTLIER -84.47 136.98 33.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.631 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.14 119.82 41.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.847 0.356 . . . . 0.0 111.819 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -75.77 98.63 4.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.048 179.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.786 HG21 HG11 ' A' ' 22' ' ' VAL . 11.3 mm -92.18 123.33 44.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.334 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.71 119.23 6.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.332 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.748 ' HA ' HG13 ' B' ' 20' ' ' VAL . 22.0 t -109.73 103.7 15.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.878 0.371 . . . . 0.0 111.291 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.946 ' HB3' HG23 ' B' ' 19' ' ' THR . 3.6 t-20 -100.58 107.57 19.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.256 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.02 147.77 42.57 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.682 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.49 ' HD2' HG12 ' B' ' 18' ' ' VAL . 79.5 Cg_endo -77.6 156.49 31.95 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.836 2.357 . . . . 0.0 112.161 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 30.22 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.233 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -106.01 -38.02 6.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.808 0.337 . . . . 0.0 110.89 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 15' ' ' GLY . 21.2 t -90.63 147.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.947 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -54.58 100.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.204 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.513 ' HB ' HD13 ' A' ' 14' ' ' ILE . 12.4 p -122.34 124.54 71.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.09 136.29 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.631 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.451 HH21 HD22 ' A' ' 2' ' ' LEU . 2.3 mpp_? -147.74 -176.85 5.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.31 . . . . 0.0 110.631 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.453 ' HB3' ' CG ' ' B' ' 48' ' ' TYR . 2.7 tt0 -59.34 138.07 57.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 110.801 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -61.31 2.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.589 ' CG1' HD11 ' B' ' 51' ' ' ILE . 6.8 tt -54.72 -42.14 59.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.481 ' HD1' HG23 ' B' ' 47' ' ' ILE . 4.5 m-30 -46.2 -58.81 3.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.687 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 41.1 mt-30 -76.05 -20.93 57.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.609 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -73.28 -13.72 61.18 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 111.41 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.589 HD11 ' CG1' ' B' ' 47' ' ' ILE . 28.9 mt -109.09 -33.04 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.709 0.29 . . . . 0.0 111.357 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.98 -50.85 3.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.347 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' B' ' 49' ' ' GLN . . . -62.23 -69.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.969 0.414 . . . . 0.0 110.791 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -114.05 119.59 37.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.402 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.733 179.955 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.789 0.328 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' B' ' 53' ' ' ALA . 2.0 mp -122.22 116.69 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.805 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.2 tt -103.11 105.31 18.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.181 0.515 . . . . 0.0 110.786 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.611 HD22 ' CD1' ' B' ' 48' ' ' TYR . 4.1 tp -125.19 124.19 41.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.021 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -55.6 140.66 40.31 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.376 179.458 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 6.1 mtp85 -151.65 142.97 23.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.939 0.4 . . . . 0.0 111.426 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 172.82 -0.52 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.784 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.3 t -148.73 116.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.796 0.331 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.78 63.45 5.23 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.71 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.479 ' C ' HG22 ' A' ' 11' ' ' THR . 28.4 mm-40 -106.64 173.27 6.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.538 0.209 . . . . 0.0 110.723 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.479 HG22 ' C ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER 164.47 101.26 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.326 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.869 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -109.07 154.19 22.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.785 179.022 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -131.81 100.24 5.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.931 0.396 . . . . 0.0 111.307 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.91 HG23 HG23 ' B' ' 14' ' ' ILE . 7.2 tp -119.12 115.44 47.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.679 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.08 -106.76 0.51 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.912 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 11.8 t70 -150.74 8.64 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.1 mt-10 155.74 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.839 0.455 . . . . 0.0 109.879 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.802 HG12 ' HD2' ' A' ' 37' ' ' PRO . 16.6 m -135.58 131.41 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.861 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.1 m -116.09 117.05 29.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.869 ' HB ' HD23 ' A' ' 12' ' ' LEU . 4.9 t -108.89 110.84 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 111.784 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 t -102.24 104.61 15.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.239 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.003 HG23 HD12 ' A' ' 32' ' ' ILE . 5.6 p -80.88 71.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.241 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.11 -143.38 0.2 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.528 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.23 80.87 0.06 OUTLIER Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.797 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 30' ' ' VAL . 14.2 t -110.28 108.28 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 120.844 0.354 . . . . 0.0 111.324 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -167.03 135.2 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.623 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.51 -153.33 19.26 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.765 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.65 -52.73 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.494 ' HB3' HG22 ' B' ' 5' ' ' THR . 43.5 mt-30 -84.93 114.62 22.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 32' ' ' ILE . 3.7 m -93.07 137.14 23.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 35.7 mtt180 -76.0 104.26 6.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.332 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.003 HD12 HG23 ' A' ' 22' ' ' VAL . 12.6 mm -87.22 137.38 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.901 0.381 . . . . 0.0 111.344 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.85 121.71 6.31 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.413 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.59 ' HA ' HG13 ' A' ' 20' ' ' VAL . 14.9 t -118.09 103.64 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.953 0.406 . . . . 0.0 111.431 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.25 107.59 19.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.299 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.07 144.82 22.6 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.822 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.802 ' HD2' HG12 ' A' ' 18' ' ' VAL . 93.0 Cg_endo -83.0 156.27 15.17 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.85 2.367 . . . . 0.0 111.971 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 42.73 1.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.214 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -113.36 -43.72 3.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.715 0.293 . . . . 0.0 110.94 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 41' ' ' SER . 5.1 t -83.43 160.9 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.844 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -59.79 99.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.715 -179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 42' ' ' VAL . 8.1 p -122.38 122.93 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.956 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.34 136.18 50.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.193 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.414 ' HD3' ' CD2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -161.76 -165.18 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.321 . . . . 0.0 110.766 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -64.26 136.71 57.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -55.08 -61.21 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 tt -55.95 -38.96 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.315 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.601 ' CD1' HD22 ' B' ' 4' ' ' LEU . 43.3 t80 -46.71 -61.91 1.62 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.657 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -76.35 -21.29 56.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.438 -179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 6.9 tpt180 -73.66 -10.94 60.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.424 HG13 ' N ' ' A' ' 52' ' ' GLN . 1.7 pt -114.29 -28.88 2.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.424 ' N ' HG13 ' A' ' 51' ' ' ILE . 13.1 mm-40 -104.83 -54.27 2.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.732 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -62.15 -66.01 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.699 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -110.26 117.52 33.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.648 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.484 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.818 0.342 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 53' ' ' ALA . 2.0 mp -122.26 116.63 24.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.879 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.636 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.2 tt -103.09 105.33 18.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.198 0.523 . . . . 0.0 110.774 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.601 HD22 ' CD1' ' A' ' 48' ' ' TYR . 4.1 tp -125.2 124.21 41.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.064 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -55.64 140.67 40.48 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.36 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 6.1 mtp85 -151.67 142.96 23.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.946 0.403 . . . . 0.0 111.427 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER 172.8 -0.54 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.821 179.438 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 17.3 t -148.66 116.75 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.781 0.324 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.7 63.47 5.21 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.705 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.472 ' C ' HG22 ' B' ' 11' ' ' THR . 28.3 mm-40 -106.6 173.33 6.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.503 0.192 . . . . 0.0 110.768 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.472 HG22 ' C ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 164.47 101.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.409 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.0 OUTLIER -109.0 154.19 22.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.789 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.504 ' HA ' ' O ' ' B' ' 18' ' ' VAL . 0.5 OUTLIER -131.8 100.22 5.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 111.322 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.91 HG23 HG23 ' A' ' 14' ' ' ILE . 7.2 tp -119.06 115.45 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.708 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.08 -106.71 0.51 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.94 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 11.8 t70 -150.8 8.7 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.1 mt-10 155.7 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.811 0.444 . . . . 0.0 109.878 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.801 HG12 ' HD2' ' B' ' 37' ' ' PRO . 16.5 m -135.64 131.42 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.827 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -116.05 117.04 29.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.858 ' HB ' HD23 ' B' ' 12' ' ' LEU . 4.8 t -108.86 110.82 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.868 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 1.4 t -102.22 104.62 15.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.216 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.97 HG23 HD12 ' B' ' 32' ' ' ILE . 5.6 p -80.88 71.04 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.291 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -143.35 0.2 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.476 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.19 80.79 0.06 OUTLIER Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.887 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' B' ' 30' ' ' VAL . 14.0 t -110.21 108.28 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 111.309 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -167.07 135.09 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.658 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.59 -153.36 19.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.806 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.67 -52.61 10.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 110.853 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.5 ' HB3' HG22 ' A' ' 5' ' ' THR . 43.5 mt-30 -84.95 114.59 22.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.984 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.712 HG23 HD11 ' B' ' 32' ' ' ILE . 3.7 m -93.02 137.16 23.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.093 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 35.8 mtt180 -76.02 104.28 6.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.348 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.97 HD12 HG23 ' B' ' 22' ' ' VAL . 12.8 mm -87.29 137.37 21.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.933 0.396 . . . . 0.0 111.37 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.9 121.77 6.32 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.373 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.592 ' HA ' HG13 ' B' ' 20' ' ' VAL . 15.0 t -118.08 103.64 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 0.0 111.426 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.35 107.58 19.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.233 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.03 144.85 22.77 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.799 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.801 ' HD2' HG12 ' B' ' 18' ' ' VAL . 93.0 Cg_endo -82.97 156.23 15.23 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.92 2.413 . . . . 0.0 111.979 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.81 42.67 1.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.218 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -113.26 -43.77 3.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.784 0.326 . . . . 0.0 110.971 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.445 HG12 ' N ' ' B' ' 41' ' ' SER . 5.1 t -83.46 160.93 3.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.769 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.445 ' N ' HG12 ' B' ' 40' ' ' VAL . 0.8 OUTLIER -59.71 99.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.758 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.455 HG13 ' O ' ' B' ' 42' ' ' VAL . 8.1 p -122.4 122.89 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.954 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.34 136.16 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.414 ' HD3' ' CD2' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -161.76 -165.19 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.754 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.6 OUTLIER -64.32 136.67 57.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.966 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.7 OUTLIER -54.97 -61.27 2.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 tt -55.98 -38.91 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.299 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.611 ' CD1' HD22 ' A' ' 4' ' ' LEU . 43.1 t80 -46.74 -61.99 1.59 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.645 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 0.0 OUTLIER -76.26 -21.29 56.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.455 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' B' ' 46' ' ' GLU . 7.0 tpt180 -73.73 -10.9 60.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.572 0.225 . . . . 0.0 111.565 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.425 HG13 ' N ' ' B' ' 52' ' ' GLN . 1.7 pt -114.35 -28.62 2.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.797 0.332 . . . . 0.0 111.166 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.425 ' N ' HG13 ' B' ' 51' ' ' ILE . 13.0 mm-40 -104.95 -54.39 2.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' B' ' 49' ' ' GLN . . . -62.11 -65.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.726 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -110.5 117.82 34.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.546 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 tptm . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.453 179.736 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.753 0.311 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.76 HD21 ' HB2' ' B' ' 53' ' ' ALA . 5.4 mp -119.98 113.2 20.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.0 tt -105.04 107.86 23.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 110.737 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.436 ' HG ' ' CG ' ' B' ' 48' ' ' TYR . 1.4 mm? -124.09 126.03 45.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.095 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.412 HG21 ' HG2' ' B' ' 29' ' ' GLN . 0.3 OUTLIER -59.76 145.2 46.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.409 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.411 ' HB2' HG13 ' B' ' 32' ' ' ILE . 0.0 OUTLIER -155.89 146.28 21.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.164 0.507 . . . . 0.0 111.304 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.724 ' O ' HG13 ' A' ' 8' ' ' VAL . 2.3 ttt180 175.92 74.31 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 176.97 -60.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.663 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.74 82.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.73 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.409 ' O ' ' HB ' ' A' ' 11' ' ' THR . 1.3 tt0 -72.17 -161.9 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.556 0.217 . . . . 0.0 110.569 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER 172.35 89.43 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.633 0.254 . . . . 0.0 111.056 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.55 HD13 HG11 ' B' ' 34' ' ' VAL . 0.2 OUTLIER -110.53 152.33 26.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.126 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.505 ' HA ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -132.98 100.27 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.901 0.381 . . . . 0.0 111.546 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.622 ' C ' HD13 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -111.35 127.07 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.258 179.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.509 ' HA2' HG11 ' B' ' 40' ' ' VAL . . . 126.52 -102.69 0.64 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.877 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.461 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.4 m-20 -165.77 17.39 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.4 OUTLIER 158.92 59.42 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.734 0.302 . . . . 0.0 110.884 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.722 HG12 ' HD2' ' A' ' 37' ' ' PRO . 11.1 m -120.5 -157.37 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 120.638 0.256 . . . . 0.0 111.632 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 167.58 105.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 34' ' ' VAL . 28.6 t -122.91 114.3 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.827 0.346 . . . . 0.0 111.737 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 21' ' ' THR . 9.8 t -104.4 118.4 36.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.513 ' O ' ' C ' ' A' ' 23' ' ' LEU . 17.1 m -91.85 63.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.427 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.746 HD12 ' O ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -13.16 -70.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.586 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . 90.74 -45.4 2.9 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.26 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.746 ' O ' HD12 ' A' ' 23' ' ' LEU . 1.4 t -85.25 137.35 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' CB ' ' HA ' ' A' ' 30' ' ' VAL . 3.9 tptt 174.7 165.49 0.25 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.645 0.259 . . . . 0.0 110.383 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.37 -105.94 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.465 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.33 -41.5 11.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.069 0.461 . . . . 0.0 110.271 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -105.56 136.52 44.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.926 179.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.417 ' HA ' ' CB ' ' A' ' 26' ' ' LYS . 21.3 t -93.18 114.15 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 0.0 111.417 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.87 100.64 4.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.657 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.408 HG13 ' CB ' ' B' ' 6' ' ' ARG . 10.7 mm -87.11 131.76 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.44 120.76 6.23 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.048 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.734 ' HA ' HG13 ' A' ' 20' ' ' VAL . 16.3 t -118.19 103.69 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.883 0.373 . . . . 0.0 111.199 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 19' ' ' THR . 3.0 t-20 -99.48 107.47 19.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.12 0.486 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.67 144.17 28.99 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.675 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.722 ' HD2' HG12 ' A' ' 18' ' ' VAL . 85.7 Cg_endo -80.29 156.36 22.47 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.747 2.298 . . . . 0.0 112.129 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -93.25 34.6 1.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.103 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.42 -44.08 6.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.507 HG11 ' HA2' ' B' ' 15' ' ' GLY . 24.3 t -89.33 158.07 2.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.781 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -59.64 97.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.817 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.5 p -122.45 120.95 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.178 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -120.73 136.29 54.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -146.61 -176.32 5.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.69 0.281 . . . . 0.0 110.569 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.75 133.75 56.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 0.0 110.698 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -51.78 -60.27 3.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.31 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 48' ' ' TYR . 1.3 tp -55.08 -42.86 67.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.482 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 47' ' ' ILE . 2.7 m-85 -46.53 -68.08 0.22 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.443 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.703 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 2.5 pt20 -70.52 -21.04 62.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.469 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.45 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 12.9 mtp85 -65.97 -23.02 66.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.677 0.275 . . . . 0.0 111.358 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.6 pt -109.91 -21.62 5.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.417 ' HB3' HD23 ' B' ' 2' ' ' LEU . 1.2 tp60 -107.09 -58.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 111.441 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.791 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -66.44 -73.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.451 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.8 127.21 54.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.389 . . . . 0.0 111.12 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 93.49 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.027 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 t -48.32 -51.08 27.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.393 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -144.77 -71.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.04 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -179.24 167.12 1.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.918 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.1 p -146.13 151.34 37.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.769 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.8 t -97.99 120.96 39.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.944 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.787 0.327 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.4 mp -119.98 113.27 20.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.586 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.0 tt -105.05 107.84 23.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.09 0.472 . . . . 0.0 110.743 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.443 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 1.4 mm? -124.17 126.11 45.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -59.78 145.3 45.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.376 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -155.96 146.26 21.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.141 0.496 . . . . 0.0 111.27 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.729 ' O ' HG13 ' B' ' 8' ' ' VAL . 2.3 ttt180 175.93 74.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.089 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.729 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER 176.87 -60.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.685 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.71 82.45 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.668 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.17 -161.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.547 0.213 . . . . 0.0 110.549 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 172.3 89.42 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.695 0.283 . . . . 0.0 111.095 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.551 HD13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -110.46 152.25 26.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.243 179.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.519 ' HA ' HG23 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -132.96 100.36 4.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.4 . . . . 0.0 111.542 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.62 HD13 ' C ' ' B' ' 14' ' ' ILE . 0.0 OUTLIER -111.31 127.0 68.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.239 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.509 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 126.51 -102.64 0.64 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.888 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.4 m-20 -165.75 17.35 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.468 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.4 OUTLIER 158.9 59.55 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.747 0.308 . . . . 0.0 110.846 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.72 HG12 ' HD2' ' B' ' 37' ' ' PRO . 11.2 m -120.6 -157.34 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.721 0.296 . . . . 0.0 111.55 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.652 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 167.61 105.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.704 HG13 ' HA ' ' B' ' 34' ' ' VAL . 28.9 t -122.94 114.34 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.32 . . . . 0.0 111.701 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.431 HG23 ' O ' ' B' ' 21' ' ' THR . 9.7 t -104.42 118.42 36.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.782 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.503 ' O ' ' C ' ' B' ' 23' ' ' LEU . 17.1 m -91.89 63.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.445 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.757 HD12 ' O ' ' B' ' 25' ' ' VAL . 0.4 OUTLIER -13.19 -70.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.519 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . 90.75 -45.44 2.9 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.222 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.757 ' O ' HD12 ' B' ' 23' ' ' LEU . 1.4 t -85.28 137.36 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.652 0.263 . . . . 0.0 110.831 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 3.9 tptt 174.69 165.52 0.25 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.64 0.257 . . . . 0.0 110.454 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.42 -105.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.445 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -90.32 -41.54 11.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.065 0.46 . . . . 0.0 110.265 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 0.2 OUTLIER -105.46 136.49 44.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.956 179.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.406 ' HA ' ' CB ' ' B' ' 26' ' ' LYS . 21.3 t -93.2 114.22 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 111.398 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.85 100.58 4.82 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.634 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.411 HG13 ' HB2' ' A' ' 6' ' ' ARG . 10.6 mm -87.11 131.76 34.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.42 120.72 6.22 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.091 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.704 ' HA ' HG13 ' B' ' 20' ' ' VAL . 16.2 t -118.17 103.72 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.899 0.38 . . . . 0.0 111.201 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' B' ' 19' ' ' THR . 3.0 t-20 -99.49 107.51 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.371 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.72 144.15 28.76 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.65 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.72 ' HD2' HG12 ' B' ' 18' ' ' VAL . 85.0 Cg_endo -80.17 156.34 22.84 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.784 2.323 . . . . 0.0 112.152 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -93.29 34.67 1.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.44 -44.19 5.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.509 HG11 ' HA2' ' A' ' 15' ' ' GLY . 24.2 t -89.22 158.09 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.815 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.459 ' N ' HG12 ' B' ' 40' ' ' VAL . 1.0 OUTLIER -59.64 97.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.786 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.492 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.5 p -122.55 120.91 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.179 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -120.75 136.31 54.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.267 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -146.61 -176.3 5.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.522 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.73 133.75 56.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -51.8 -60.29 3.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.249 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.456 HG23 ' N ' ' B' ' 48' ' ' TYR . 1.3 tp -55.05 -42.84 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.489 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.456 ' N ' HG23 ' B' ' 47' ' ' ILE . 2.7 m-85 -46.57 -68.03 0.23 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.476 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 2.5 pt20 -70.59 -21.03 62.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.498 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 13.0 mtp85 -65.96 -22.91 66.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.662 0.268 . . . . 0.0 111.35 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 18.6 pt -109.99 -21.76 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.413 ' HB3' HD23 ' A' ' 2' ' ' LEU . 1.2 tp60 -107.04 -58.05 1.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.736 0.303 . . . . 0.0 111.468 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.76 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -66.47 -73.48 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.478 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.28 128.92 55.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.925 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.58 92.61 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.787 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 57.41 87.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.042 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -108.66 -47.54 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.967 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 63.22 -174.04 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.881 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -74.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.86 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.8 t -113.64 126.69 55.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.599 ' C ' HD12 ' A' ' 2' ' ' LEU . 2.0 ttt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.835 0.35 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 2' ' ' LEU . 4.8 mp -119.87 116.07 25.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.707 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.532 ' C ' HD22 ' A' ' 4' ' ' LEU . 14.2 mm -93.0 105.66 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.984 0.421 . . . . 0.0 110.58 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.619 ' N ' HD22 ' A' ' 4' ' ' LEU . 2.5 mm? -116.77 156.79 26.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.666 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' B' ' 29' ' ' GLN . 0.1 OUTLIER -97.01 133.63 41.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.951 0.405 . . . . 0.0 110.649 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.679 HH11 HG21 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -151.42 148.1 27.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.84 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 2.8 ttt180 177.39 -6.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.176 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.419 ' H ' ' H ' ' A' ' 7' ' ' ARG . 22.0 t -115.7 -57.29 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.768 0.318 . . . . 0.0 111.044 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.48 88.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.645 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.84 -70.55 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.732 0.301 . . . . 0.0 110.787 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m 75.87 103.45 0.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.529 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.492 ' CD1' HG11 ' B' ' 34' ' ' VAL . 1.3 pt? -108.94 154.46 22.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.967 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.488 ' HA ' HG23 ' A' ' 18' ' ' VAL . 24.5 ttp -128.12 100.54 5.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.097 0.475 . . . . 0.0 111.24 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.641 HD13 ' HB ' ' B' ' 42' ' ' VAL . 2.1 tp -112.78 122.97 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.423 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.619 ' HA2' HG11 ' B' ' 40' ' ' VAL . . . 133.8 -104.87 0.54 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.996 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.5 t70 -159.41 11.65 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 157.4 61.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.964 0.412 . . . . 0.0 109.954 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.662 HG12 ' HD2' ' A' ' 37' ' ' PRO . 17.7 m -118.48 -155.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.723 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 168.59 103.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.749 HG13 ' HA ' ' A' ' 34' ' ' VAL . 25.2 t -119.72 111.22 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 111.769 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.29 113.07 25.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.48 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.679 HG21 HH11 ' A' ' 6' ' ' ARG . 29.6 m -84.76 62.94 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.779 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.32 121.83 3.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . -99.52 -15.71 31.36 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.001 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.2 t -85.48 125.8 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.743 0.271 . . . . 0.0 110.473 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 1.3 tpmp? 176.9 165.29 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.814 0.34 . . . . 0.0 110.66 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 29' ' ' GLN . . . -90.96 108.42 3.58 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.539 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 65.68 -69.52 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.876 0.37 . . . . 0.0 110.796 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 1.8 mt-30 -84.82 136.57 33.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.62 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.538 HG12 ' CD1' ' A' ' 32' ' ' ILE . 5.4 t -93.0 119.69 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.044 0.45 . . . . 0.0 111.493 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -82.88 98.21 9.07 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.3 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.566 HG23 ' HA ' ' A' ' 22' ' ' VAL . 4.7 mm -93.05 127.66 45.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.61 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.08 112.38 4.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.328 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.749 ' HA ' HG13 ' A' ' 20' ' ' VAL . 28.0 t -106.35 103.68 15.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.871 0.367 . . . . 0.0 111.168 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -98.37 107.33 19.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.368 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.16 146.08 52.85 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.677 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.662 ' HD2' HG12 ' A' ' 18' ' ' VAL . 77.0 Cg_endo -83.44 156.22 14.33 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.005 2.47 . . . . 0.0 112.358 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -3.25 41.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.332 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -42.63 70.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.643 0.259 . . . . 0.0 111.171 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.632 HG11 ' HA2' ' B' ' 15' ' ' GLY . 11.6 t -91.0 152.53 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.803 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.3 t -76.09 106.08 7.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.966 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.648 ' HB ' HD13 ' B' ' 14' ' ' ILE . 14.6 p -121.07 120.23 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.46 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -128.68 134.32 48.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.666 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.516 HH21 HG21 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -154.65 -49.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.706 0.288 . . . . 0.0 111.257 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 3.4 mm-40 -161.27 124.49 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.929 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -56.45 -59.07 5.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.101 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.443 HG23 ' N ' ' A' ' 48' ' ' TYR . 17.6 tt -58.1 -42.49 83.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.176 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CG ' ' HB2' ' A' ' 45' ' ' GLU . 3.1 m-85 -44.25 -58.06 3.11 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 11.6 pt20 -76.65 -21.62 55.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.793 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -67.38 -15.01 63.44 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.261 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.623 HD13 ' HD2' ' A' ' 55' ' ' LYS . 23.7 mm -116.05 -26.43 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.337 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.57 -58.66 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.909 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . . . -60.78 -64.09 1.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.588 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -109.58 116.28 31.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.387 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.623 ' HD2' HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER 149.67 -35.59 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.792 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m 64.56 176.88 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.224 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -177.46 -53.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -104.4 -174.51 2.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.803 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.2 p -121.0 158.94 26.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.8 m -110.2 133.6 53.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.593 ' C ' HD12 ' B' ' 2' ' ' LEU . 2.0 ttt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.82 0.343 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.616 ' HB3' HD21 ' B' ' 4' ' ' LEU . 4.8 mp -119.88 116.09 25.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.522 ' C ' HD22 ' B' ' 4' ' ' LEU . 14.2 mm -93.05 105.73 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.994 0.426 . . . . 0.0 110.579 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.629 HD22 ' N ' ' B' ' 4' ' ' LEU . 2.5 mm? -116.77 156.78 26.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.679 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.01 133.63 41.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.949 0.404 . . . . 0.0 110.653 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.68 HH11 HG21 ' B' ' 22' ' ' VAL . 0.1 OUTLIER -151.44 148.11 27.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.796 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 2.8 ttt180 177.37 -6.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.13 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.404 ' H ' ' H ' ' B' ' 7' ' ' ARG . 22.0 t -115.67 -57.3 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.805 0.336 . . . . 0.0 111.044 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.47 88.34 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.601 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.88 -70.59 0.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.759 0.314 . . . . 0.0 110.735 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m 75.83 103.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.604 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.486 ' CD1' HG11 ' A' ' 34' ' ' VAL . 1.3 pt? -108.87 154.44 22.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.951 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.489 ' HA ' HG23 ' B' ' 18' ' ' VAL . 24.4 ttp -128.09 100.47 5.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 111.227 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.648 HD13 ' HB ' ' A' ' 42' ' ' VAL . 2.1 tp -112.74 122.93 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.632 ' HA2' HG11 ' A' ' 40' ' ' VAL . . . 133.87 -104.81 0.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.993 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.47 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.5 t70 -159.49 11.71 0.13 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.3 OUTLIER 157.35 61.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.699 0.399 . . . . 0.0 109.943 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.648 HG12 ' HD2' ' B' ' 37' ' ' PRO . 17.6 m -118.48 -155.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.705 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.642 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 168.66 103.13 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.761 HG13 ' HA ' ' B' ' 34' ' ' VAL . 25.3 t -119.71 111.21 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.866 0.365 . . . . 0.0 111.785 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.29 113.04 25.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.486 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.68 HG21 HH11 ' B' ' 6' ' ' ARG . 29.3 m -84.68 62.91 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.841 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.33 121.84 3.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . -99.57 -15.61 31.5 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.053 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' B' ' 26' ' ' LYS . 2.2 t -85.51 125.78 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.69 0.245 . . . . 0.0 110.465 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' B' ' 25' ' ' VAL . 1.3 tpmp? 176.91 165.3 0.5 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.626 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' B' ' 29' ' ' GLN . . . -91.0 108.34 3.57 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.55 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 65.77 -69.5 0.11 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.879 0.371 . . . . 0.0 110.739 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' B' ' 27' ' ' GLY . 1.8 mt-30 -84.8 136.57 33.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.54 HG12 ' CD1' ' B' ' 32' ' ' ILE . 5.3 t -92.99 119.78 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 0.0 111.497 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -82.95 98.26 9.13 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.281 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.569 HG23 ' HA ' ' B' ' 22' ' ' VAL . 4.7 mm -93.08 127.7 45.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.636 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.08 112.33 4.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.384 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.761 ' HA ' HG13 ' B' ' 20' ' ' VAL . 27.0 t -106.3 103.67 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.846 0.355 . . . . 0.0 111.242 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' B' ' 19' ' ' THR . 0.1 OUTLIER -98.36 107.35 19.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.369 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.19 146.1 52.86 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.633 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.648 ' HD2' HG12 ' B' ' 18' ' ' VAL . 76.0 Cg_endo -83.46 156.26 14.28 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.966 2.444 . . . . 0.0 112.356 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -3.36 41.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.35 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.49 -42.71 71.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.689 0.28 . . . . 0.0 111.184 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.619 HG11 ' HA2' ' A' ' 15' ' ' GLY . 11.6 t -90.98 152.58 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.802 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 39.4 t -76.08 105.98 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.982 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.641 ' HB ' HD13 ' A' ' 14' ' ' ILE . 14.6 p -121.0 120.17 61.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.494 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -128.63 134.3 48.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.665 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.535 HH21 HG21 ' B' ' 42' ' ' VAL . 0.1 OUTLIER -154.66 -49.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 111.309 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.453 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 3.4 mm-40 -161.23 124.53 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.4 OUTLIER -56.5 -59.04 5.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.446 HG23 ' N ' ' B' ' 48' ' ' TYR . 17.6 tt -58.1 -42.52 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.198 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.453 ' CG ' ' HB2' ' B' ' 45' ' ' GLU . 3.1 m-85 -44.22 -58.05 3.1 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.755 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 11.6 pt20 -76.77 -21.52 55.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.782 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.446 ' HA ' ' HG2' ' B' ' 54' ' ' GLU . 0.8 OUTLIER -67.47 -14.75 63.21 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.34 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 23.6 mm -116.23 -26.76 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.311 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.24 -58.7 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.95 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' HB2' ' B' ' 49' ' ' GLN . . . -60.8 -63.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.629 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' B' ' 50' ' ' ARG . 0.0 OUTLIER -111.21 120.06 41.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.649 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.05 95.86 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.447 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.77 -166.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.505 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.47 29.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.757 0.313 . . . . 0.0 111.062 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.79 148.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 1.2 m -159.85 130.34 5.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.7 t -91.98 132.64 36.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.952 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.823 0.344 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' B' ' 53' ' ' ALA . 5.0 mp -122.03 107.39 12.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.1 tt -115.06 114.73 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.181 0.515 . . . . 0.0 110.967 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.466 ' HB3' ' CZ ' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -125.44 135.67 52.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.824 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.436 ' H ' HD13 ' A' ' 4' ' ' LEU . 0.2 OUTLIER -62.37 150.86 38.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -170.67 148.03 2.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.25 0.548 . . . . 0.0 111.474 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -176.69 7.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.782 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.62 -61.59 2.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.331 . . . . 0.0 111.011 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.6 86.05 0.16 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.494 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.732 ' OE1' HG22 ' A' ' 22' ' ' VAL . 4.3 tm-20 -82.02 171.68 14.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.897 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t 178.8 122.71 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -144.39 141.36 29.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.402 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.559 ' HA ' HG23 ' A' ' 18' ' ' VAL . 4.0 ttt -133.0 99.73 4.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.419 . . . . 0.0 111.09 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.792 HG23 HG23 ' B' ' 14' ' ' ILE . 0.0 OUTLIER -116.3 129.27 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.484 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.701 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 128.8 -105.09 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.907 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.3 p30 -162.76 16.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 6.9 mt-10 158.2 60.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.849 0.357 . . . . 0.0 110.501 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.702 HG12 ' HD2' ' A' ' 37' ' ' PRO . 17.5 m -120.36 -159.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 120.766 0.317 . . . . 0.0 111.646 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 168.57 103.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.629 ' CG1' HG13 ' A' ' 34' ' ' VAL . 35.1 m -122.57 114.37 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 10' ' ' GLU . 2.9 p -108.2 117.03 33.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.299 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.975 HG11 HG11 ' B' ' 22' ' ' VAL . 30.4 m -108.88 54.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.349 . . . . 0.0 111.693 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 25' ' ' VAL . 2.6 pp -47.94 151.17 0.97 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.863 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.423 ' HA2' HG11 ' A' ' 30' ' ' VAL . . . -107.7 2.56 34.11 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.601 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.431 ' N ' HD12 ' A' ' 23' ' ' LEU . 1.4 t -85.21 120.66 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.928 0.364 . . . . 0.0 110.618 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER 174.73 165.34 0.25 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.76 0.315 . . . . 0.0 110.675 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.81 108.28 3.14 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.852 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.02 -74.41 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.859 0.362 . . . . 0.0 111.043 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 16.8 mt-30 -84.72 136.26 33.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.013 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.423 HG11 ' HA2' ' A' ' 24' ' ' GLY . 22.0 t -93.33 117.2 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 111.535 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.404 ' HG2' HG12 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -75.64 99.85 4.45 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.515 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.852 ' CG2' HG12 ' A' ' 22' ' ' VAL . 11.1 mm -87.08 124.5 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.165 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 118.43 6.09 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.569 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.629 HG13 ' CG1' ' A' ' 20' ' ' VAL . 16.7 t -117.79 103.53 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 0.0 111.396 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.4 OUTLIER -99.38 107.53 19.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.501 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.97 143.36 24.8 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.654 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.702 ' HD2' HG12 ' A' ' 18' ' ' VAL . 78.5 Cg_endo -77.12 156.49 33.77 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.759 2.306 . . . . 0.0 112.078 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -89.17 30.08 1.0 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.278 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.58 -38.64 7.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 41' ' ' SER . 17.2 t -93.25 159.35 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.848 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.474 ' N ' HG12 ' A' ' 40' ' ' VAL . 5.8 t -65.28 97.94 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.009 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.9 p -122.31 120.76 62.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.857 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.12 136.39 51.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.722 0.296 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -133.38 -176.12 4.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -64.17 147.79 51.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -50.96 -60.68 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.199 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 tp -55.07 -35.6 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.203 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.473 ' CZ ' ' HB3' ' B' ' 4' ' ' LEU . 0.4 OUTLIER -53.04 -73.14 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.033 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.665 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 5.3 pt20 -64.2 -17.28 63.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.542 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.48 -31.26 69.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.728 0.299 . . . . 0.0 111.328 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.0 mm -104.53 -12.84 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.917 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -114.88 -57.74 2.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.666 0.269 . . . . 0.0 111.716 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . . . -67.53 -71.69 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.383 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -118.18 117.82 30.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.003 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -55.34 111.32 0.85 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.993 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 m 55.43 -84.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.297 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -153.96 169.58 23.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.8 0.333 . . . . 0.0 110.82 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -163.47 86.84 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.43 159.42 16.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.68 136.51 52.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.937 179.986 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptt? . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.781 0.324 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.0 mp -122.06 107.39 12.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.971 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.502 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.0 tt -115.09 114.81 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.216 0.531 . . . . 0.0 110.942 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -125.49 135.73 52.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.763 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.439 ' H ' HD13 ' B' ' 4' ' ' LEU . 0.2 OUTLIER -62.39 150.9 38.44 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -170.69 148.04 2.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.268 0.556 . . . . 0.0 111.464 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -176.74 7.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.789 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.67 -61.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.848 0.356 . . . . 0.0 111.032 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.54 86.1 0.16 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.704 ' OE1' HG22 ' B' ' 22' ' ' VAL . 4.3 tm-20 -82.11 171.72 14.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.739 0.304 . . . . 0.0 110.944 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t 178.77 122.71 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.125 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.534 ' HG ' HG22 ' B' ' 20' ' ' VAL . 0.1 OUTLIER -144.37 141.35 29.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.41 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.556 ' HA ' HG23 ' B' ' 18' ' ' VAL . 4.0 ttt -133.03 99.7 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.792 HG23 HG23 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -116.29 129.33 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.478 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.708 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 128.76 -105.09 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.936 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.3 p30 -162.82 16.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 7.0 mt-10 158.19 60.84 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.857 0.361 . . . . 0.0 110.552 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.702 HG12 ' HD2' ' B' ' 37' ' ' PRO . 17.6 m -120.33 -159.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 120.807 0.337 . . . . 0.0 111.651 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.653 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 168.59 103.6 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.639 HG12 HG13 ' B' ' 34' ' ' VAL . 35.1 m -122.53 114.42 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.549 HG22 ' O ' ' B' ' 10' ' ' GLU . 2.9 p -108.26 117.03 33.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.221 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.975 HG11 HG11 ' A' ' 22' ' ' VAL . 30.4 m -108.84 54.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.724 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.424 ' C ' HD12 ' B' ' 23' ' ' LEU . 2.6 pp -47.91 151.1 0.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.411 ' HA2' HG11 ' B' ' 30' ' ' VAL . . . -107.69 2.63 34.14 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.568 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.422 ' N ' HD12 ' B' ' 23' ' ' LEU . 1.4 t -85.24 120.65 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.973 0.387 . . . . 0.0 110.588 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER 174.74 165.34 0.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.807 0.336 . . . . 0.0 110.634 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.8 108.22 3.13 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.813 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.03 -74.49 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 111.003 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 16.8 mt-30 -84.7 136.2 33.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.994 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.411 HG11 ' HA2' ' B' ' 24' ' ' GLY . 22.0 t -93.25 117.21 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.976 0.417 . . . . 0.0 111.532 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.417 ' HG2' HG12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -75.61 99.8 4.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.543 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.852 ' CG2' HG12 ' B' ' 22' ' ' VAL . 11.0 mm -87.05 124.51 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.114 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 118.39 6.08 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.558 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.639 HG13 HG12 ' B' ' 20' ' ' VAL . 16.6 t -117.75 103.57 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.41 . . . . 0.0 111.383 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 19' ' ' THR . 0.4 OUTLIER -99.49 107.54 19.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.48 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.96 143.37 24.88 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.585 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.702 ' HD2' HG12 ' B' ' 18' ' ' VAL . 78.8 Cg_endo -77.12 156.49 33.77 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.752 2.301 . . . . 0.0 112.066 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -89.14 29.95 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.281 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.47 -38.73 7.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.791 0.329 . . . . 0.0 110.816 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.469 HG12 ' N ' ' B' ' 41' ' ' SER . 17.1 t -93.19 159.31 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.469 ' N ' HG12 ' B' ' 40' ' ' VAL . 5.8 t -65.21 97.89 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.029 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.485 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.9 p -122.29 120.79 62.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.866 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 136.38 51.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.752 0.311 . . . . 0.0 110.767 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -133.34 -176.07 4.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.693 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -64.27 147.81 51.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.03 -60.62 2.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 tp -55.0 -35.6 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.285 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -53.1 -73.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.039 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.669 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 5.3 pt20 -64.26 -17.32 63.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.531 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -31.17 69.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.734 0.302 . . . . 0.0 111.367 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.412 ' O ' HG22 ' B' ' 51' ' ' ILE . 29.2 mm -104.64 -12.58 9.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.854 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -115.12 -57.85 2.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.709 0.29 . . . . 0.0 111.746 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' B' ' 49' ' ' GLN . . . -67.48 -71.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.33 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -117.81 116.94 27.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.706 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' B' ' 57' ' ' GLN . 3.3 mtmp? -60.2 109.8 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.18 -66.86 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.107 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' B' ' 55' ' ' LYS . 6.7 tm0? 78.0 -58.41 0.46 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -89.15 58.17 4.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 89.3 p -152.56 134.53 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -117.48 121.38 40.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.871 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.54 ' C ' HD12 ' A' ' 2' ' ' LEU . 2.8 ttp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 1.048 HD21 ' HB2' ' B' ' 53' ' ' ALA . 4.9 mp -122.32 117.02 25.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -97.97 104.76 16.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.221 0.534 . . . . 0.0 110.5 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.514 HD21 ' O ' ' B' ' 48' ' ' TYR . 0.8 OUTLIER -125.44 121.52 34.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.223 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -54.35 138.59 39.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.104 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.904 ' HB3' HG21 ' A' ' 22' ' ' VAL . 72.1 mtt180 -148.66 144.77 27.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.296 0.57 . . . . 0.0 111.787 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.646 ' NE ' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 174.98 -77.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.551 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.507 HG23 ' HD3' ' A' ' 7' ' ' ARG . 3.4 t -85.73 3.75 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.139 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.52 -139.49 4.4 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.907 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -108.61 -175.49 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.869 0.366 . . . . 0.0 111.218 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.719 HG22 ' HA ' ' A' ' 21' ' ' THR . 22.5 p -102.17 165.53 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.028 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.516 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -110.53 154.63 23.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.525 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.444 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.5 ttt -130.67 100.06 5.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.072 0.463 . . . . 0.0 111.389 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.853 HG23 HG23 ' B' ' 14' ' ' ILE . 5.8 tp -115.9 125.52 73.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.505 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.49 -106.32 0.62 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.078 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.412 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.6 t0 -155.57 4.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 3.1 mt-10 163.37 61.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.017 0.436 . . . . 0.0 109.993 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.641 ' O ' HG23 ' A' ' 19' ' ' THR . 5.3 m -115.51 -159.91 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.824 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 171.49 99.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.683 HG22 HG13 ' A' ' 34' ' ' VAL . 42.9 t -106.42 107.52 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.827 0.346 . . . . 0.0 111.669 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.719 ' HA ' HG22 ' A' ' 11' ' ' THR . 2.2 m -91.2 112.77 24.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.021 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.904 HG21 ' HB3' ' A' ' 6' ' ' ARG . 27.0 m -76.76 70.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.497 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.547 HD12 ' H ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -96.03 -152.76 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.547 ' H ' HD12 ' A' ' 23' ' ' LEU . . . 60.36 66.44 2.71 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.996 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.646 HG21 ' NE ' ' A' ' 7' ' ' ARG . 5.2 t -85.88 107.77 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 120.979 0.419 . . . . 0.0 111.049 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -155.1 165.41 36.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.136 -179.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.98 156.45 47.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.512 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 70.03 -89.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.404 0.145 . . . . 0.0 110.985 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.493 ' HB3' HG22 ' B' ' 5' ' ' THR . 14.7 mt-30 -110.48 124.56 52.02 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.906 0.384 . . . . 0.0 111.082 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.611 HG23 HD11 ' A' ' 32' ' ' ILE . 10.0 m -93.32 137.37 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.318 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 4.7 mtp180 -78.09 102.91 7.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.611 HD11 HG23 ' A' ' 30' ' ' VAL . 14.7 mm -87.32 134.52 27.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.137 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.53 115.79 4.99 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.512 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.683 HG13 HG22 ' A' ' 20' ' ' VAL . 21.4 t -111.12 103.34 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.944 0.402 . . . . 0.0 111.336 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -96.43 107.23 19.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.075 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.06 147.96 33.68 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.9 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.37 156.29 25.39 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.919 2.413 . . . . 0.0 111.984 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -91.38 41.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.114 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.15 -41.92 3.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.994 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 41' ' ' SER . 5.5 t -81.48 158.9 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.855 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -62.35 99.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.784 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.2 p -122.18 124.23 70.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -128.53 136.18 50.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.311 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -166.98 -170.67 1.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.719 0.295 . . . . 0.0 110.709 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.439 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 30.7 mm-40 -54.04 123.97 14.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.008 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.48 -54.91 41.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.115 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 51' ' ' ILE . 8.0 tp -60.21 -41.18 85.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.026 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.518 ' O ' HD21 ' B' ' 4' ' ' LEU . 4.4 m-85 -47.42 -55.51 8.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.237 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.703 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.6 pt20 -80.0 -21.9 43.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.139 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -71.23 -13.33 61.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.285 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 47' ' ' ILE . 1.4 tt -115.7 -36.39 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.877 0.37 . . . . 0.0 110.65 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -87.45 -58.3 2.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.098 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 1.044 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -61.51 -51.65 67.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.258 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -112.57 116.73 30.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.596 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.64 117.0 1.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.644 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.1 t -109.81 26.8 10.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.008 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -145.98 61.32 1.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.949 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.58 118.33 26.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 t -98.78 36.66 1.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.4 t -102.73 128.05 49.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.926 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.894 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.549 ' C ' HD12 ' B' ' 2' ' ' LEU . 2.8 ttp . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.789 0.328 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 1.044 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.0 mp -122.35 117.02 25.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.64 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -98.03 104.81 16.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.219 0.533 . . . . 0.0 110.494 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.518 HD21 ' O ' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -125.47 121.52 34.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.253 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -54.39 138.6 39.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.082 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.881 ' HB3' HG21 ' B' ' 22' ' ' VAL . 72.0 mtt180 -148.66 144.72 27.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.258 0.551 . . . . 0.0 111.802 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.63 ' NE ' HG21 ' B' ' 25' ' ' VAL . 0.0 OUTLIER 175.01 -77.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.491 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.509 HG23 ' HD3' ' B' ' 7' ' ' ARG . 3.4 t -85.72 3.73 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.211 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.5 -139.5 4.39 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.922 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -108.59 -175.52 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.923 0.392 . . . . 0.0 111.174 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.746 HG22 ' HA ' ' B' ' 21' ' ' THR . 22.5 p -102.18 165.54 11.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.084 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.525 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -110.51 154.62 23.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.526 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.429 ' HA ' HG23 ' B' ' 18' ' ' VAL . 2.5 ttt -130.64 100.03 5.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.009 0.433 . . . . 0.0 111.395 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.853 HG23 HG23 ' A' ' 14' ' ' ILE . 5.8 tp -115.89 125.5 73.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.505 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.53 -106.32 0.62 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.065 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 2.6 t0 -155.61 4.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 3.1 mt-10 163.34 61.12 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.996 0.427 . . . . 0.0 110.0 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.657 ' O ' HG23 ' B' ' 19' ' ' THR . 5.3 m -115.48 -159.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.831 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.657 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 171.51 99.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.342 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.689 HG22 HG13 ' B' ' 34' ' ' VAL . 43.0 t -106.49 107.58 23.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.822 0.344 . . . . 0.0 111.602 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.746 ' HA ' HG22 ' B' ' 11' ' ' THR . 2.2 m -91.22 112.89 24.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.979 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.881 HG21 ' HB3' ' B' ' 6' ' ' ARG . 26.3 m -76.9 70.55 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.457 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.537 HD12 ' H ' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -96.07 -152.79 0.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.681 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.537 ' H ' HD12 ' B' ' 23' ' ' LEU . . . 60.42 66.38 2.75 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.992 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.63 HG21 ' NE ' ' B' ' 7' ' ' ARG . 5.1 t -85.79 107.74 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.402 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.1 OUTLIER -155.05 165.47 36.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.192 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.04 156.43 47.33 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.481 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 70.08 -89.51 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.041 0.136 . . . . 0.0 110.97 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.487 ' HB3' HG22 ' A' ' 5' ' ' THR . 14.6 mt-30 -110.45 124.53 51.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.895 0.379 . . . . 0.0 111.158 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.62 HG23 HD11 ' B' ' 32' ' ' ILE . 10.2 m -93.26 137.41 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.381 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.8 mtp180 -78.19 102.94 7.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.62 HD11 HG23 ' B' ' 30' ' ' VAL . 14.9 mm -87.34 134.58 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.57 115.76 4.97 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.503 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.689 HG13 HG22 ' B' ' 20' ' ' VAL . 21.4 t -111.17 103.3 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 111.264 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -96.41 107.22 19.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.085 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.08 147.92 33.51 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.922 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.29 156.28 25.63 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.951 2.434 . . . . 0.0 112.007 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -91.34 41.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.166 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.14 -41.93 3.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.411 HG12 ' N ' ' B' ' 41' ' ' SER . 5.5 t -81.48 158.89 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.809 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.411 ' N ' HG12 ' B' ' 40' ' ' VAL . 0.3 OUTLIER -62.31 99.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.829 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.456 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.2 p -122.2 124.18 70.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.959 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -128.51 136.25 50.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.311 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -167.03 -170.71 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.722 0.296 . . . . 0.0 110.711 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.449 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 30.5 mm-40 -54.03 123.98 14.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 111.049 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.48 -54.93 41.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.428 HG23 ' N ' ' B' ' 48' ' ' TYR . 8.0 tp -60.2 -41.17 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.059 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.514 ' O ' HD21 ' A' ' 4' ' ' LEU . 4.4 m-85 -47.41 -55.49 8.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.256 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.703 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 4.5 pt20 -79.91 -21.98 43.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.173 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -71.25 -13.3 61.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.252 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.423 HG22 ' O ' ' B' ' 47' ' ' ILE . 1.4 tt -115.71 -36.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.657 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -87.45 -58.3 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.085 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 1.048 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -61.47 -51.67 67.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.309 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -112.61 116.75 30.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.522 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.52 105.47 0.53 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.951 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -75.28 -179.96 4.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.788 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 54.85 72.9 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.034 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -78.67 147.43 33.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 14.9 m -111.98 117.88 33.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 51.5 p -112.95 128.38 56.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.884 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.437 ' C ' HD22 ' A' ' 2' ' ' LEU . 3.2 mtt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.871 0.367 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.961 HD11 ' HB2' ' B' ' 53' ' ' ALA . 4.4 mm? -119.73 112.84 19.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -99.97 105.03 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.179 0.514 . . . . 0.0 110.827 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.43 ' HG ' ' CD2' ' B' ' 48' ' ' TYR . 0.2 OUTLIER -124.76 121.49 34.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.036 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -56.16 140.59 43.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 0.0 110.618 179.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.458 ' HB3' HG21 ' A' ' 22' ' ' VAL . 66.8 mtt85 -155.84 145.33 20.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.785 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER 179.11 1.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.975 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 177.2 30.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 120.532 0.206 . . . . 0.0 111.356 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.93 -118.13 3.51 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.762 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -110.13 -178.31 3.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.912 0.387 . . . . 0.0 111.203 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.6 168.04 10.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.737 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.739 ' CD1' HG11 ' B' ' 34' ' ' VAL . 0.8 OUTLIER -111.52 154.51 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.569 ' HG3' HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -127.39 100.56 6.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.43 . . . . 0.0 110.873 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.627 HG23 HG23 ' B' ' 14' ' ' ILE . 3.1 tp -112.7 125.48 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.606 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.43 -105.44 0.65 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.195 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 12.0 m-20 -156.8 6.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 0.8 OUTLIER 161.15 61.89 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' ' 19' ' ' THR . 4.3 m -116.23 -157.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.526 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 172.53 101.61 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.692 HG22 HG13 ' A' ' 34' ' ' VAL . 59.0 t -111.04 108.19 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.88 0.372 . . . . 0.0 111.697 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.1 p -105.08 110.43 22.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.011 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 22' ' ' VAL . 31.2 m -77.4 72.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.61 -143.56 0.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.628 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.5 74.31 0.27 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.819 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.6 t -93.03 108.3 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.515 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -138.92 157.57 45.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.018 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.8 148.02 50.71 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.72 -79.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.634 0.254 . . . . 0.0 110.767 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.53 ' HB3' HG22 ' B' ' 5' ' ' THR . 8.9 mt-30 -116.78 126.28 52.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.986 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.682 HG23 HD11 ' A' ' 32' ' ' ILE . 17.5 m -93.39 136.93 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.269 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 3.9 mtt85 -77.93 104.91 8.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.257 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.682 HD11 HG23 ' A' ' 30' ' ' VAL . 12.0 mm -87.37 137.75 20.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.848 0.356 . . . . 0.0 111.328 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.86 117.41 5.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.472 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.744 HG11 ' CD1' ' B' ' 12' ' ' LEU . 15.6 t -118.08 103.18 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.411 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.6 OUTLIER -95.74 107.17 19.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.378 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.11 145.49 55.85 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.588 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HD2' HG12 ' A' ' 18' ' ' VAL . 92.2 Cg_endo -78.28 156.32 29.33 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.834 2.356 . . . . 0.0 112.121 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.26 26.75 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.185 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -40.23 5.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.849 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -82.45 152.85 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.5 98.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.077 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 42' ' ' VAL . 12.7 p -122.17 120.59 61.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.1 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -128.55 136.17 50.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.413 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -165.53 -40.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.685 0.279 . . . . 0.0 111.135 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.413 ' N ' ' HG3' ' A' ' 44' ' ' ARG . 1.2 mm-40 177.86 114.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.962 0.41 . . . . 0.0 110.882 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -58.48 -38.78 78.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.684 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.519 HG23 HG13 ' A' ' 51' ' ' ILE . 36.1 mm -69.33 -43.23 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.837 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.43 ' CD2' ' HG ' ' B' ' 4' ' ' LEU . 2.8 m-85 -51.36 -42.68 61.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.416 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -87.72 -58.9 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 111.534 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -52.2 -21.38 3.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.519 HG13 HG23 ' A' ' 47' ' ' ILE . 40.3 mm -106.07 -50.58 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.562 ' HB3' HD12 ' B' ' 2' ' ' LEU . 0.1 OUTLIER -75.79 -58.79 3.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.668 0.271 . . . . 0.0 111.299 -179.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.932 ' HB2' HD11 ' B' ' 2' ' ' LEU . . . -67.09 -29.71 69.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.343 . . . . 0.0 111.23 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 1.2 tt0 -137.97 157.53 46.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 54' ' ' GLU . 1.8 tttp 81.79 -56.5 0.25 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.879 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.68 159.3 15.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.709 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.7 -56.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.957 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -69.04 -30.87 69.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.5 t -116.66 80.76 1.52 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.7 p -122.2 120.97 35.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.886 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.441 ' C ' HD22 ' B' ' 2' ' ' LEU . 3.2 mtt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.833 0.349 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.932 HD11 ' HB2' ' A' ' 53' ' ' ALA . 4.4 mm? -119.75 112.85 19.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.63 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -100.0 105.09 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.252 0.548 . . . . 0.0 110.79 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.43 ' HG ' ' CD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -124.81 121.55 34.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.019 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.53 HG22 ' HB3' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -56.24 140.66 43.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.369 . . . . 0.0 110.589 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.449 ' HB3' HG21 ' B' ' 22' ' ' VAL . 66.7 mtt85 -155.9 145.34 20.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.784 ' O ' HG13 ' B' ' 8' ' ' VAL . 0.0 OUTLIER 179.06 1.55 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.959 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.784 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER 177.13 30.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.573 0.225 . . . . 0.0 111.371 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.0 -118.18 3.5 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.685 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -110.15 -178.31 3.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.955 0.407 . . . . 0.0 111.178 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.57 168.04 10.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.805 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.744 ' CD1' HG11 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -111.49 154.5 24.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.516 179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.572 ' HG3' HG22 ' B' ' 18' ' ' VAL . 0.4 OUTLIER -127.42 100.46 6.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.022 0.439 . . . . 0.0 110.918 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.627 HG23 HG23 ' A' ' 14' ' ' ILE . 3.1 tp -112.69 125.5 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.563 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.46 -105.47 0.65 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.2 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 12.0 m-20 -156.89 6.97 0.17 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 0.8 OUTLIER 161.09 61.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.631 0.372 . . . . 0.0 110.023 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.671 ' O ' HG23 ' B' ' 19' ' ' THR . 4.3 m -116.23 -157.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.568 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.671 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 172.55 101.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.689 HG22 HG13 ' B' ' 34' ' ' VAL . 58.4 t -111.0 108.1 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.816 0.341 . . . . 0.0 111.747 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 5.0 p -104.98 110.45 22.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.03 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.564 ' O ' HG23 ' B' ' 22' ' ' VAL . 30.7 m -77.5 72.56 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.56 -143.65 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.638 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.53 74.32 0.27 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.818 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 10.6 t -93.08 108.33 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 111.279 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.513 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.0 OUTLIER -138.89 157.57 45.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.999 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.83 148.04 50.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.74 -80.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.642 0.258 . . . . 0.0 110.741 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.52 ' HB3' HG22 ' A' ' 5' ' ' THR . 8.9 mt-30 -116.72 126.26 52.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.88 0.371 . . . . 0.0 110.96 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.678 HG23 HD11 ' B' ' 32' ' ' ILE . 17.5 m -93.4 136.98 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 3.9 mtt85 -77.95 104.93 8.81 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.254 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.678 HD11 HG23 ' B' ' 30' ' ' VAL . 12.2 mm -87.38 137.83 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.858 0.361 . . . . 0.0 111.305 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.94 117.44 5.14 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.458 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.739 HG11 ' CD1' ' A' ' 12' ' ' LEU . 15.4 t -118.03 103.14 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 111.489 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' B' ' 19' ' ' THR . 0.6 OUTLIER -95.8 107.22 19.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.17 145.5 55.79 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.597 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.518 ' HD2' HG12 ' B' ' 18' ' ' VAL . 90.2 Cg_endo -78.28 156.34 29.32 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.814 2.343 . . . . 0.0 112.07 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.23 26.77 2.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.221 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.3 -40.28 5.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.753 0.311 . . . . 0.0 110.831 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 t -82.38 152.81 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.42 98.63 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.121 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.51 HG13 ' O ' ' B' ' 42' ' ' VAL . 12.7 p -122.19 120.61 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.104 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -128.51 136.18 50.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.553 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.414 ' HG3' ' N ' ' B' ' 45' ' ' GLU . 0.0 OUTLIER -165.57 -40.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 0.0 111.133 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' B' ' 44' ' ' ARG . 1.2 mm-40 177.83 114.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.965 0.412 . . . . 0.0 110.918 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -58.52 -38.64 78.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.714 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.522 HG23 HG13 ' B' ' 51' ' ' ILE . 35.9 mm -69.38 -43.21 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.804 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.43 ' CD2' ' HG ' ' A' ' 4' ' ' LEU . 2.8 m-85 -51.38 -42.74 61.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.347 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -87.77 -58.82 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.771 0.319 . . . . 0.0 111.522 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -52.14 -21.54 3.39 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.522 HG13 HG23 ' B' ' 47' ' ' ILE . 40.2 mm -105.93 -50.51 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.565 ' HB3' HD12 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -75.89 -58.8 3.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.713 0.292 . . . . 0.0 111.314 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.961 ' HB2' HD11 ' A' ' 2' ' ' LEU . . . -67.07 -29.71 69.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.342 . . . . 0.0 111.199 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -138.05 156.78 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -92.95 82.42 4.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.774 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.411 ' CB ' HD13 ' B' ' 51' ' ' ILE . 23.1 t -53.56 -35.32 60.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.209 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 65.08 72.57 0.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.88 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -132.63 -57.14 0.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 4.5 m -68.9 168.54 13.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.42 138.88 35.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.871 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.804 0.335 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.673 HD11 ' O ' ' B' ' 48' ' ' TYR . 6.6 tt -116.55 103.15 10.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -98.08 105.48 17.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.195 0.521 . . . . 0.0 110.785 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 4' ' ' LEU . 11.0 tp -125.28 121.33 33.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.924 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.593 HG22 ' HB3' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -56.88 149.3 18.84 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.389 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 10' ' ' GLU . 1.1 tpt180 -179.53 143.15 0.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.224 0.535 . . . . 0.0 111.399 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.931 ' NE ' HG13 ' A' ' 25' ' ' VAL . 36.4 ttt180 -170.1 23.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.063 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.08 -53.43 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.165 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.08 105.49 0.19 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.683 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.468 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . 0.7 OUTLIER -113.13 -58.25 2.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 0.0 110.869 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p 65.52 96.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.124 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.431 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 1.6 pt? -114.57 154.72 27.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.069 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.571 ' HA ' HG23 ' A' ' 18' ' ' VAL . 34.8 ttm -128.98 99.93 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.059 0.457 . . . . 0.0 111.015 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 14' ' ' ILE . 6.1 tp -118.02 102.86 13.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.814 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.28 -107.33 0.32 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.972 -0.633 . . . . 0.0 111.887 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.36 -4.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 165.05 57.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.762 HG12 ' HD2' ' A' ' 37' ' ' PRO . 12.8 m -112.45 -161.58 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.816 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.893 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.5 OUTLIER 170.13 102.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.844 HG13 ' HA ' ' A' ' 34' ' ' VAL . 21.4 t -111.2 110.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.906 0.384 . . . . 0.0 111.894 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.4 m -98.35 111.65 23.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.767 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 22' ' ' VAL . 17.5 m -77.01 68.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.347 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.45 -142.39 0.26 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.751 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 31' ' ' ARG . . . 53.82 70.77 0.84 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.566 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.931 HG13 ' NE ' ' A' ' 7' ' ' ARG . 40.5 t -85.94 107.66 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.909 0.385 . . . . 0.0 111.455 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -143.97 151.57 39.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.046 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.43 150.54 47.16 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.419 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 72.58 -75.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.606 0.241 . . . . 0.0 111.004 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.588 ' HB3' HG22 ' B' ' 5' ' ' THR . 9.0 mp0 -120.95 128.84 53.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.985 0.422 . . . . 0.0 111.115 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.654 HG23 HD11 ' A' ' 32' ' ' ILE . 11.0 m -93.29 137.18 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.248 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 0.1 OUTLIER -75.77 104.63 6.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.28 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.654 HD11 HG23 ' A' ' 30' ' ' VAL . 9.3 mm -87.47 130.14 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.215 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.73 108.44 3.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.156 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.844 ' HA ' HG13 ' A' ' 20' ' ' VAL . 12.7 t -107.28 103.17 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 111.615 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.893 ' HB3' HG23 ' A' ' 19' ' ' THR . 3.6 t-20 -96.19 107.22 19.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.384 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.9 146.84 58.53 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.715 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.762 ' HD2' HG12 ' A' ' 18' ' ' VAL . 86.5 Cg_endo -80.58 156.36 21.55 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.961 2.441 . . . . 0.0 112.104 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -92.47 32.87 1.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.188 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.32 -41.26 3.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.739 0.304 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 41' ' ' SER . 5.6 t -77.9 160.68 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.79 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.444 ' N ' HG12 ' A' ' 40' ' ' VAL . 3.8 t -66.75 106.68 1.92 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.838 0.352 . . . . 0.0 110.859 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 42' ' ' VAL . 12.7 p -121.94 126.11 74.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -128.88 124.1 34.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.207 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -156.76 -65.82 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 110.461 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 5.3 tp10 -171.69 130.46 0.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.56 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -58.79 -38.75 79.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.047 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.409 HG23 HG13 ' A' ' 51' ' ' ILE . 16.1 mt -73.05 -43.56 58.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.302 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.677 ' O ' HD11 ' B' ' 2' ' ' LEU . 3.2 m-85 -50.46 -46.63 56.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.651 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.622 ' HG2' ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -83.1 -58.09 3.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.207 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.429 ' HA ' ' CB ' ' A' ' 54' ' ' GLU . 3.6 mtp85 -55.05 -9.78 0.43 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.453 HG23 ' HB2' ' A' ' 56' ' ' SER . 49.3 mm -112.86 -55.45 4.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 O-C-N 122.258 -0.276 . . . . 0.0 111.728 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 7.2 mp0 -75.89 -54.3 7.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 110.999 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.622 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . . . -75.04 -36.83 61.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.892 0.377 . . . . 0.0 110.962 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' CB ' ' HA ' ' A' ' 50' ' ' ARG . 3.7 tp10 -103.56 122.42 44.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.753 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.59 96.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.877 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.453 ' HB2' HG23 ' A' ' 51' ' ' ILE . 22.4 t -62.74 157.23 21.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -94.9 125.55 39.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -64.37 129.61 40.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.1 -169.0 2.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.808 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.3 t -91.92 121.0 33.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.853 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.0 t80 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.86 -179.925 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.832 0.349 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.677 HD11 ' O ' ' A' ' 48' ' ' TYR . 6.6 tt -116.58 103.12 10.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.637 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -98.04 105.56 17.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.26 0.552 . . . . 0.0 110.763 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 tp -125.32 121.37 33.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.831 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -56.97 149.27 19.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.397 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.476 ' HG2' ' HB2' ' B' ' 10' ' ' GLU . 1.1 tpt180 -179.53 143.17 0.19 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.253 0.549 . . . . 0.0 111.418 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.933 ' NE ' HG13 ' B' ' 25' ' ' VAL . 36.2 ttt180 -170.18 23.53 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.102 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.07 -53.51 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.161 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.13 105.52 0.19 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.703 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.476 ' HB2' ' HG2' ' B' ' 6' ' ' ARG . 0.7 OUTLIER -113.1 -58.33 2.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 110.854 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.9 p 65.53 96.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.165 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.438 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 1.6 pt? -114.48 154.76 27.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.121 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.562 ' HA ' HG23 ' B' ' 18' ' ' VAL . 34.8 ttm -129.04 99.96 5.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.01 0.433 . . . . 0.0 111.032 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.588 ' O ' HG23 ' B' ' 14' ' ' ILE . 6.1 tp -117.97 102.85 13.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.854 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.3 -107.34 0.32 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.883 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.39 -4.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 165.07 57.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.755 HG12 ' HD2' ' B' ' 37' ' ' PRO . 12.9 m -112.42 -161.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.796 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.911 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.5 OUTLIER 170.09 102.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.443 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' B' ' 34' ' ' VAL . 21.4 t -111.22 110.16 31.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 111.948 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 6.4 m -98.35 111.65 23.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.794 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 22' ' ' VAL . 17.5 m -76.98 68.42 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.312 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.52 -142.38 0.26 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' B' ' 31' ' ' ARG . . . 53.86 70.77 0.84 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.556 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.933 HG13 ' NE ' ' B' ' 7' ' ' ARG . 40.4 t -85.96 107.62 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.0 111.428 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -143.97 151.57 39.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.031 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.46 150.49 47.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.476 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 72.62 -75.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.585 0.231 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.593 ' HB3' HG22 ' A' ' 5' ' ' THR . 9.0 mp0 -121.05 128.78 52.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 111.089 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.647 HG23 HD11 ' B' ' 32' ' ' ILE . 11.0 m -93.23 137.16 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.266 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -75.77 104.6 6.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.289 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.647 HD11 HG23 ' B' ' 30' ' ' VAL . 9.3 mm -87.44 130.17 37.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.201 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.78 108.44 3.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.161 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.861 ' HA ' HG13 ' B' ' 20' ' ' VAL . 12.7 t -107.24 103.17 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.91 0.385 . . . . 0.0 111.577 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.911 ' HB3' HG23 ' B' ' 19' ' ' THR . 3.6 t-20 -96.13 107.15 19.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.402 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.85 146.78 58.38 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.751 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.755 ' HD2' HG12 ' B' ' 18' ' ' VAL . 86.1 Cg_endo -80.57 156.34 21.56 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.963 2.442 . . . . 0.0 112.101 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -92.46 32.93 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.224 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.34 -41.21 3.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.78 0.324 . . . . 0.0 110.973 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.437 HG12 ' N ' ' B' ' 41' ' ' SER . 5.6 t -77.94 160.76 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.792 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.437 ' N ' HG12 ' B' ' 40' ' ' VAL . 3.8 t -66.81 106.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 0.0 110.839 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.438 HG13 ' O ' ' B' ' 42' ' ' VAL . 12.7 p -121.95 126.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -128.91 124.15 34.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.168 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -156.77 -65.84 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.441 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 5.3 tp10 -171.72 130.49 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.586 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -58.81 -38.73 79.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.421 ' CG2' HG13 ' B' ' 51' ' ' ILE . 16.0 mt -73.03 -43.49 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.307 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.673 ' O ' HD11 ' A' ' 2' ' ' LEU . 3.2 m-85 -50.61 -46.47 58.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.635 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.623 ' HG2' ' HB3' ' B' ' 53' ' ' ALA . 0.0 OUTLIER -83.22 -58.11 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.427 ' HA ' ' CB ' ' B' ' 54' ' ' GLU . 3.6 mtp85 -55.13 -9.71 0.44 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.421 HG13 ' CG2' ' B' ' 47' ' ' ILE . 49.1 mm -112.86 -55.53 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 7.2 mp0 -75.88 -54.32 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.684 0.278 . . . . 0.0 110.93 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.623 ' HB3' ' HG2' ' B' ' 49' ' ' GLN . . . -75.06 -36.72 61.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.945 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' B' ' 50' ' ' ARG . 3.7 tp10 -103.79 124.01 48.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.1 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.09 -87.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.059 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 7.0 t 62.48 147.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.81 0.338 . . . . 0.0 110.742 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -130.92 -50.96 1.04 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -147.38 146.37 29.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.981 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -61.11 -53.96 50.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.9 p -121.94 124.4 43.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 11.4 t80 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.894 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.659 ' C ' HD12 ' A' ' 2' ' ' LEU . 6.6 mmm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.882 0.372 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.659 HD12 ' C ' ' A' ' 1' ' ' MET . 5.2 mp -116.7 104.74 11.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.682 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.532 HG21 ' HD3' ' B' ' 31' ' ' ARG . 19.2 mm -96.83 105.13 16.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 110.74 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.468 ' HA ' HD22 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -124.63 116.7 22.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.976 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.549 HG22 ' HB3' ' B' ' 29' ' ' GLN . 0.3 OUTLIER -54.7 140.22 36.45 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.394 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.509 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 24.3 mtt180 -154.76 141.13 18.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.184 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 179.11 4.3 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.299 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.24 -76.41 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 O-C-N 122.213 -0.304 . . . . 0.0 111.517 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.33 97.94 0.51 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.662 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 6' ' ' ARG . 6.6 mp0 -113.21 174.7 5.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.723 0.297 . . . . 0.0 111.034 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER 164.86 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.141 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.446 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -112.35 154.1 26.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.528 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.4 ttp -133.29 100.69 4.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.053 0.454 . . . . 0.0 111.755 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.864 HG23 HG23 ' B' ' 14' ' ' ILE . 5.1 tp -114.36 120.61 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.186 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.472 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 135.85 -106.92 0.59 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.058 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.466 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -152.55 6.43 0.41 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 4.6 mt-10 159.31 64.19 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.907 0.384 . . . . 0.0 110.29 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.647 ' O ' HG23 ' A' ' 19' ' ' THR . 12.4 m -118.85 -158.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER 170.18 104.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.558 HG13 ' HA ' ' A' ' 34' ' ' VAL . 22.0 t -117.95 116.14 50.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.0 111.751 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.0 t -114.79 115.63 27.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.006 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.866 HG12 HG23 ' A' ' 32' ' ' ILE . 26.7 m -80.95 73.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.389 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.91 -136.04 0.1 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.472 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.05 74.7 0.21 Allowed Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.933 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.634 HG22 ' HG2' ' A' ' 7' ' ' ARG . 21.3 t -86.04 108.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.465 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -140.24 153.38 46.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.048 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.15 149.45 47.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.453 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 69.14 -83.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.638 0.256 . . . . 0.0 110.721 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.525 ' HB3' HG22 ' B' ' 5' ' ' THR . 42.5 mt-30 -107.32 125.24 50.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.356 . . . . 0.0 110.947 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.518 HG23 HD11 ' A' ' 32' ' ' ILE . 14.3 m -93.13 136.89 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.283 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.549 ' HD3' HG21 ' B' ' 3' ' ' ILE . 28.8 mtt85 -75.96 104.39 6.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.491 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.866 HG23 HG12 ' A' ' 22' ' ' VAL . 28.4 mm -87.17 131.36 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.281 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.5 125.12 8.14 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.745 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.558 ' HA ' HG13 ' A' ' 20' ' ' VAL . 12.2 t -118.05 129.72 73.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.835 0.35 . . . . 0.0 111.123 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 19' ' ' THR . 2.4 t-20 -123.16 107.21 11.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.13 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.86 144.25 26.12 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.745 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HD2' HG12 ' A' ' 18' ' ' VAL . 82.2 Cg_endo -77.93 156.45 30.7 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.736 2.29 . . . . 0.0 112.081 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.08 38.01 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.398 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.73 -38.7 4.2 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.759 0.314 . . . . 0.0 110.803 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.477 HG12 ' O ' ' B' ' 15' ' ' GLY . 13.3 t -89.58 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -57.49 97.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.943 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.792 HG22 ' HD2' ' A' ' 44' ' ' ARG . 14.6 p -122.35 120.71 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 136.11 50.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.674 0.274 . . . . 0.0 110.81 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.792 ' HD2' HG22 ' A' ' 42' ' ' VAL . 1.9 mpp_? -147.4 -172.6 4.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.54 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.44 ' HB3' ' CG ' ' A' ' 48' ' ' TYR . 1.5 tp10 -63.16 139.2 58.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.766 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -62.36 1.67 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.383 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 39.1 mm -56.82 -45.57 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.792 0.329 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.461 ' CG ' ' HG ' ' B' ' 4' ' ' LEU . 4.1 m-30 -41.5 -73.33 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.545 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.699 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 13.8 pt20 -66.48 -19.26 65.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.54 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 6.0 mtm180 -69.0 -20.0 64.15 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 48' ' ' TYR . 3.5 pt -111.39 -23.87 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.48 ' HG3' HD23 ' B' ' 2' ' ' LEU . 4.3 pt20 -107.68 -52.38 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.623 0.249 . . . . 0.0 111.547 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.699 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . . . -70.36 -72.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 111.224 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.5 118.81 37.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.727 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -56.72 95.42 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.138 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.9 p 49.05 95.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.222 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -84.03 57.82 4.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.955 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.3 151.45 51.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.6 151.3 38.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.734 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -122.39 120.67 34.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.912 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.65 ' C ' HD12 ' B' ' 2' ' ' LEU . 6.7 mmm . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.87 0.367 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.65 HD12 ' C ' ' B' ' 1' ' ' MET . 5.2 mp -116.76 104.74 11.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.549 HG21 ' HD3' ' A' ' 31' ' ' ARG . 19.2 mm -96.81 105.17 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.98 0.419 . . . . 0.0 110.725 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.461 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -124.66 116.67 22.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.961 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -54.72 140.24 36.54 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.413 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' B' ' 10' ' ' GLU . 24.4 mtt180 -154.74 141.13 18.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.205 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' B' ' 25' ' ' VAL . 0.0 OUTLIER 179.1 4.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.269 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.24 -76.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 O-C-N 122.167 -0.333 . . . . 0.0 111.544 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.33 97.89 0.51 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.666 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' B' ' 6' ' ' ARG . 6.6 mp0 -113.16 174.7 5.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.748 0.309 . . . . 0.0 111.051 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.47 HG22 ' C ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 164.81 91.71 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.14 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.454 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -112.31 154.05 26.27 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.512 ' HA ' HG23 ' B' ' 18' ' ' VAL . 2.4 ttp -133.26 100.58 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.999 0.428 . . . . 0.0 111.785 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.864 HG23 HG23 ' A' ' 14' ' ' ILE . 5.1 tp -114.33 120.61 64.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.189 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 135.86 -106.92 0.59 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.086 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 0.4 OUTLIER -152.53 6.46 0.41 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.469 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 4.6 mt-10 159.32 64.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.957 0.408 . . . . 0.0 110.289 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.642 ' O ' HG23 ' B' ' 19' ' ' THR . 12.3 m -118.78 -158.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.417 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.642 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.1 OUTLIER 170.18 104.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' B' ' 34' ' ' VAL . 21.9 t -117.9 116.1 50.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 0.0 111.741 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 3.0 t -114.75 115.62 27.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.005 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.86 HG12 HG23 ' B' ' 32' ' ' ILE . 26.8 m -80.97 73.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.0 0.429 . . . . 0.0 111.343 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.94 -136.08 0.1 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.483 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.08 74.67 0.22 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.975 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.634 HG22 ' HG2' ' B' ' 7' ' ' ARG . 21.3 t -85.99 108.15 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 0.0 111.47 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -140.27 153.34 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.058 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.11 149.45 47.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.465 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 69.06 -83.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.541 0.21 . . . . 0.0 110.701 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.549 ' HB3' HG22 ' A' ' 5' ' ' THR . 42.5 mt-30 -107.35 125.24 50.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 110.941 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.513 HG23 HD11 ' B' ' 32' ' ' ILE . 14.3 m -93.14 136.91 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.32 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.532 ' HD3' HG21 ' A' ' 3' ' ' ILE . 28.6 mtt85 -76.0 104.35 6.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.454 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.86 HG23 HG12 ' B' ' 22' ' ' VAL . 28.4 mm -87.15 131.32 35.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.299 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.47 125.2 8.17 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.792 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.567 ' HA ' HG13 ' B' ' 20' ' ' VAL . 12.4 t -118.1 129.75 73.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.827 0.346 . . . . 0.0 111.063 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' B' ' 19' ' ' THR . 2.4 t-20 -123.23 107.26 11.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.074 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.89 144.22 25.91 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.75 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.42 ' HD2' HG12 ' B' ' 18' ' ' VAL . 84.1 Cg_endo -77.83 156.45 31.08 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.797 2.331 . . . . 0.0 112.103 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.09 38.02 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.38 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.77 -38.69 4.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.79 0.329 . . . . 0.0 110.804 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 15' ' ' GLY . 13.3 t -89.63 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.846 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -57.42 97.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.013 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.793 HG22 ' HD2' ' B' ' 44' ' ' ARG . 14.6 p -122.38 120.75 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 136.13 50.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.657 0.265 . . . . 0.0 110.816 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.793 ' HD2' HG22 ' B' ' 42' ' ' VAL . 1.9 mpp_? -147.41 -172.66 4.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.44 ' HB3' ' CG ' ' B' ' 48' ' ' TYR . 1.5 tp10 -63.01 139.19 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.824 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -62.33 1.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.421 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' B' ' 50' ' ' ARG . 39.2 mm -56.86 -45.53 83.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.78 0.324 . . . . 0.0 111.164 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.462 ' CG ' ' HG ' ' A' ' 4' ' ' LEU . 4.1 m-30 -41.52 -73.34 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.568 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.688 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 13.8 pt20 -66.48 -19.24 65.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.538 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 6.0 mtm180 -69.0 -19.92 64.14 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.416 HG13 ' O ' ' B' ' 48' ' ' TYR . 3.5 pt -111.57 -23.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.489 ' HG3' HD23 ' A' ' 2' ' ' LEU . 4.3 pt20 -107.82 -52.29 2.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.563 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.688 ' HB3' ' HB2' ' B' ' 49' ' ' GLN . . . -70.47 -72.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.807 0.337 . . . . 0.0 111.185 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.58 119.43 39.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.617 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.47 93.17 0.1 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.733 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 4.0 t 55.14 87.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.999 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -70.0 141.86 52.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -143.17 173.51 11.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 58.2 m -88.92 155.2 19.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -97.44 140.44 31.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.94 -179.92 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.799 0.333 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.65 HD22 ' CE2' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -118.11 108.48 15.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 3' ' ' ILE . 5.2 tt -84.36 115.0 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.009 0.433 . . . . 0.0 111.535 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.767 HD12 ' CZ ' ' B' ' 48' ' ' TYR . 0.3 OUTLIER -115.1 156.24 25.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.653 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.476 ' H ' HD23 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -95.8 121.22 37.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 0.0 111.476 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.6 ' NH2' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -92.21 149.16 21.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.475 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.626 ' CG ' HG13 ' A' ' 30' ' ' VAL . 6.6 mtp180 78.01 87.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.706 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.647 HG23 ' CA ' ' A' ' 24' ' ' GLY . 56.2 t 80.74 55.49 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.193 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.525 ' H ' HG21 ' A' ' 22' ' ' VAL . . . -142.89 -148.54 4.96 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.536 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.28 121.46 44.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 111.616 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -58.55 147.53 31.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.402 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.741 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -117.82 154.73 31.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.766 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.6 ttt -127.91 100.7 6.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 0.0 110.766 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.62 HG23 HG23 ' B' ' 14' ' ' ILE . 4.6 tp -115.42 137.7 48.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.952 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.684 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 126.71 -107.19 0.89 Allowed Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.339 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -153.39 -4.42 0.19 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 1.0 OUTLIER 171.38 57.43 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 19' ' ' THR . 10.4 m -111.31 -159.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.615 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 173.72 102.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.741 ' HB ' HD23 ' A' ' 12' ' ' LEU . 41.6 t -102.93 101.99 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.856 0.36 . . . . 0.0 111.172 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -93.17 157.3 16.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.22 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.525 HG21 ' H ' ' A' ' 9' ' ' GLY . 34.8 m -106.86 -173.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.577 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -127.38 -53.52 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 0.0 110.291 179.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.647 ' CA ' HG23 ' A' ' 8' ' ' VAL . . . 93.64 -39.99 2.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.162 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 11.4 t -85.66 149.83 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.596 0.236 . . . . 0.0 111.495 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 25' ' ' VAL . 10.8 tttp 101.25 116.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.245 0.618 . . . . 0.0 110.85 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.81 174.74 46.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.683 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.83 -84.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.677 0.275 . . . . 0.0 110.301 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.9 136.95 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.423 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.741 ' CG1' HD11 ' A' ' 32' ' ' ILE . 21.7 t -92.89 115.71 32.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.807 0.337 . . . . 0.0 110.888 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -86.44 99.46 11.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.99 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.741 HD11 ' CG1' ' A' ' 30' ' ' VAL . 33.0 mm -112.76 135.57 51.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.935 0.397 . . . . 0.0 111.425 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.37 112.72 4.19 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.302 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.72 HG13 HG22 ' A' ' 20' ' ' VAL . 25.1 t -98.07 103.17 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.7 107.29 19.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.638 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.02 145.52 56.06 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.431 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HD2' HG12 ' A' ' 18' ' ' VAL . 88.4 Cg_endo -81.24 156.55 19.65 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.93 2.42 . . . . 0.0 112.231 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -89.45 27.29 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.278 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -112.67 -37.17 4.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.757 0.313 . . . . 0.0 111.034 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.689 HG12 ' O ' ' B' ' 15' ' ' GLY . 5.1 t -81.82 144.64 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.806 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -54.89 100.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.484 HG21 ' NH2' ' A' ' 44' ' ' ARG . 13.0 p -122.09 124.11 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.077 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.57 136.17 50.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.373 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.487 ' CZ ' HD13 ' B' ' 2' ' ' LEU . 7.1 mtt85 -151.86 -60.69 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.931 0.396 . . . . 0.0 110.612 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 178.78 143.7 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.655 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -43.83 92.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.617 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.525 HG22 HD12 ' A' ' 51' ' ' ILE . 42.4 mm -64.56 -49.08 82.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.061 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.771 ' CZ ' HD12 ' B' ' 4' ' ' LEU . 88.9 t80 -50.63 -45.84 57.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.55 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 53' ' ' ALA . 21.2 tt0 -75.55 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 111.729 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -51.44 -17.35 0.76 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.525 HD12 HG22 ' A' ' 47' ' ' ILE . 36.5 mt -108.89 -54.78 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.75 0.309 . . . . 0.0 111.205 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.63 ' HB2' HD23 ' B' ' 2' ' ' LEU . 60.5 mm-40 -69.14 -62.05 1.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.922 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.5 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . . . -67.3 -33.54 75.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.008 0.433 . . . . 0.0 110.731 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -118.19 124.06 47.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.606 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -52.69 110.45 0.51 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.267 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.1 t -72.28 177.19 4.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.747 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.5 114.84 4.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -176.99 114.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.83 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.4 160.44 6.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 p -115.95 134.78 54.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.826 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.825 0.345 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.657 HD22 ' CE2' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -118.07 108.44 15.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.558 HG23 ' O ' ' B' ' 3' ' ' ILE . 5.3 tt -84.38 115.05 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 111.531 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.771 HD12 ' CZ ' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -115.12 156.15 25.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.686 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.465 ' H ' HD23 ' B' ' 4' ' ' LEU . 0.3 OUTLIER -95.7 121.19 37.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.018 0.437 . . . . 0.0 111.446 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.602 ' NH2' HD22 ' B' ' 4' ' ' LEU . 0.0 OUTLIER -92.21 149.12 21.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.53 179.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.624 ' CG ' HG13 ' B' ' 30' ' ' VAL . 6.6 mtp180 78.02 87.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.691 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.657 HG23 ' CA ' ' B' ' 24' ' ' GLY . 55.3 t 80.67 55.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.188 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.524 ' H ' HG21 ' B' ' 22' ' ' VAL . . . -142.88 -148.54 4.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.593 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.24 121.4 44.33 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.879 0.371 . . . . 0.0 111.614 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -58.48 147.57 31.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.413 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.714 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.6 OUTLIER -117.83 154.76 31.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.728 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.6 ttt -127.97 100.59 5.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.856 0.36 . . . . 0.0 110.775 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.62 HG23 HG23 ' A' ' 14' ' ' ILE . 4.6 tp -115.37 137.75 47.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.689 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 126.71 -107.22 0.89 Allowed Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.329 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.3 OUTLIER -153.41 -4.37 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 1.0 OUTLIER 171.27 57.42 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.656 ' O ' HG23 ' B' ' 19' ' ' THR . 10.4 m -111.33 -159.48 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.564 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.656 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 173.84 102.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.501 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.757 HG22 HG13 ' B' ' 34' ' ' VAL . 41.4 t -102.84 101.89 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.821 0.343 . . . . 0.0 111.227 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -93.1 157.25 16.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.237 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.524 HG21 ' H ' ' B' ' 9' ' ' GLY . 34.9 m -106.81 -173.11 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.545 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' B' ' 23' ' ' LEU . 1.0 OUTLIER -127.48 -53.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 110.3 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.657 ' CA ' HG23 ' B' ' 8' ' ' VAL . . . 93.61 -39.89 2.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.157 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.573 ' O ' ' CB ' ' B' ' 26' ' ' LYS . 11.4 t -85.66 149.82 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.543 0.211 . . . . 0.0 111.502 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' B' ' 25' ' ' VAL . 10.8 tttp 101.22 116.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.249 0.62 . . . . 0.0 110.804 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.84 174.78 46.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.644 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.75 -84.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.657 0.265 . . . . 0.0 110.319 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -84.89 136.96 33.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.437 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.733 ' CG1' HD11 ' B' ' 32' ' ' ILE . 21.6 t -92.89 115.7 32.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.361 . . . . 0.0 110.905 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -86.45 99.48 11.68 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.994 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.733 HD11 ' CG1' ' B' ' 30' ' ' VAL . 33.2 mm -112.77 135.63 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 111.395 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.44 112.72 4.18 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.294 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.757 HG13 HG22 ' B' ' 20' ' ' VAL . 25.4 t -98.11 103.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.093 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.66 107.25 19.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.659 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.98 145.51 56.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.476 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.496 ' HD2' HG12 ' B' ' 18' ' ' VAL . 87.5 Cg_endo -81.29 156.46 19.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.891 2.394 . . . . 0.0 112.193 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -89.32 27.25 1.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.314 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -112.68 -37.22 4.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 110.995 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 15' ' ' GLY . 5.1 t -81.69 144.63 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.825 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -54.96 100.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.128 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.489 HG21 ' NH2' ' B' ' 44' ' ' ARG . 13.1 p -122.13 124.07 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.062 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.48 136.2 50.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.407 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.494 ' CZ ' HD13 ' A' ' 2' ' ' LEU . 7.1 mtt85 -151.88 -60.73 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.625 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 178.79 143.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.614 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.72 -43.86 92.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.932 0.396 . . . . 0.0 110.615 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.527 HG22 HD12 ' B' ' 51' ' ' ILE . 42.4 mm -64.59 -49.05 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.061 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.767 ' CZ ' HD12 ' A' ' 4' ' ' LEU . 88.8 t80 -50.68 -45.78 58.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.541 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.494 ' HG2' ' HB3' ' B' ' 53' ' ' ALA . 21.2 tt0 -75.6 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.713 0.292 . . . . 0.0 111.715 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -51.47 -17.28 0.75 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.527 HD12 HG22 ' B' ' 47' ' ' ILE . 36.0 mt -109.0 -54.67 5.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.761 0.315 . . . . 0.0 111.221 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.627 ' HB2' HD23 ' A' ' 2' ' ' LEU . 60.6 mm-40 -69.16 -62.14 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.854 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.495 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -67.33 -33.36 75.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.97 0.414 . . . . 0.0 110.769 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -119.08 127.19 53.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.839 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 105.64 0.68 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.536 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -170.09 0.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.922 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -57.67 12.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.83 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -76.0 -66.89 0.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.814 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 29.1 t 58.22 100.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.041 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 82.6 p -97.6 145.15 26.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.801 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.92 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.805 0.336 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' B' ' 53' ' ' ALA . 0.5 OUTLIER -114.51 102.83 10.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.034 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.1 tt -92.92 105.75 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.331 0.586 . . . . 0.0 110.949 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.831 HD13 ' CD2' ' B' ' 48' ' ' TYR . 0.1 OUTLIER -124.28 156.59 36.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.074 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.4 HG22 ' HB3' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -86.72 138.43 31.64 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.533 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.806 ' HB3' HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -150.94 145.95 25.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.072 0.463 . . . . 0.0 111.324 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -179.37 10.98 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.89 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.54 -41.22 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 122.165 -0.334 . . . . 0.0 111.507 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.7 94.46 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.802 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.403 ' CG ' ' HG2' ' A' ' 6' ' ' ARG . 2.2 tp10 -97.11 -61.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.458 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 m 64.94 98.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.385 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -120.44 154.37 35.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.086 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.667 ' HA ' HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -129.98 100.05 5.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.939 0.4 . . . . 0.0 110.991 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 14' ' ' ILE . 8.2 tp -119.15 102.85 13.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.037 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.545 ' HA2' HG11 ' B' ' 40' ' ' VAL . . . 156.54 -108.15 0.35 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.325 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.06 -15.51 4.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 164.29 61.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.993 0.425 . . . . 0.0 110.055 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.852 HG12 ' HD2' ' A' ' 37' ' ' PRO . 22.5 m -107.76 -168.62 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.64 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.872 HG23 ' HB3' ' A' ' 35' ' ' ASN . 1.1 t -175.33 103.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.751 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.675 HG13 ' HA ' ' A' ' 34' ' ' VAL . 21.5 t -102.76 106.9 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 21' ' ' THR . 9.4 t -91.57 111.85 23.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.569 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 6' ' ' ARG . 30.1 m -84.01 62.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.569 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.43 -142.42 0.24 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.829 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 31' ' ' ARG . . . 53.27 69.24 1.27 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.677 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' A' ' 7' ' ' ARG . 17.5 t -88.49 107.52 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 120.923 0.392 . . . . 0.0 111.576 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -142.67 146.97 34.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.104 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.3 158.7 30.59 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.526 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.83 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.674 0.273 . . . . 0.0 110.761 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.46 124.45 50.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 110.749 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.739 HG21 HG21 ' B' ' 30' ' ' VAL . 30.1 t -93.74 136.5 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.219 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.461 ' HB3' ' HA3' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -83.17 109.15 16.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.114 179.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.44 135.59 27.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.286 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.26 111.0 2.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.259 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.675 ' HA ' HG13 ' A' ' 20' ' ' VAL . 15.0 t -113.59 102.89 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 0.0 111.458 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.872 ' HB3' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER -91.63 107.18 19.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.667 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.435 ' HB1' HG12 ' B' ' 14' ' ' ILE . . . -130.12 146.21 60.56 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.532 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.852 ' HD2' HG12 ' A' ' 18' ' ' VAL . 86.9 Cg_endo -77.88 156.41 30.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.77 2.314 . . . . 0.0 112.008 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -91.3 38.36 0.97 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.11 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -123.55 -38.65 2.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.546 HG11 ' HA2' ' B' ' 15' ' ' GLY . 6.2 t -83.39 156.74 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.822 0.344 . . . . 0.0 110.978 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -57.05 114.97 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.5 p -122.07 121.9 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.96 122.39 30.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.538 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.565 HH21 HD13 ' B' ' 12' ' ' LEU . 17.5 ttm180 -163.95 -77.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.03 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 5.8 mm-40 -155.07 131.47 10.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.57 -50.72 72.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.221 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.471 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 13.9 tt -63.17 -42.04 95.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.974 0.416 . . . . 0.0 111.166 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.827 ' CD2' HD13 ' B' ' 4' ' ' LEU . 5.9 m-85 -50.9 -53.39 33.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.169 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.536 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 1.5 mt-30 -78.33 -21.7 49.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.137 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . 4.9 mtt180 -72.92 -15.43 61.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.671 0.272 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.5 mt -109.82 -27.1 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.331 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.541 ' HB2' HD23 ' B' ' 2' ' ' LEU . 6.0 mp0 -107.79 -54.54 2.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.796 0.331 . . . . 0.0 111.28 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.651 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -64.74 -73.62 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.277 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -111.85 123.72 50.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.785 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.03 90.34 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.286 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.28 -74.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.947 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.67 150.65 29.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -66.99 -57.61 6.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.2 p -164.89 -73.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -94.55 136.78 34.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.5 t80 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.879 -179.984 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.651 HD21 ' HB2' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -114.59 102.82 10.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.631 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.1 tt -92.86 105.74 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.335 0.588 . . . . 0.0 110.968 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.827 HD13 ' CD2' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -124.34 156.62 36.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.998 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.78 138.43 31.61 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.527 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.834 ' HB3' HG21 ' B' ' 22' ' ' VAL . 0.0 OUTLIER -150.93 146.0 25.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.285 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.572 ' HG2' HG22 ' B' ' 25' ' ' VAL . 0.6 OUTLIER -179.43 10.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.969 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.6 -41.21 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 122.18 -0.325 . . . . 0.0 111.483 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.71 94.48 0.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.803 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -97.11 -61.62 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.484 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m 64.99 98.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.432 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.634 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -120.4 154.36 35.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.147 179.204 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.671 ' HA ' HG23 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -129.95 100.08 5.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.973 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.641 ' O ' HG23 ' B' ' 14' ' ' ILE . 8.2 tp -119.15 102.86 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.021 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.546 ' HA2' HG11 ' A' ' 40' ' ' VAL . . . 156.57 -108.14 0.35 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.307 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 11.8 t70 -129.09 -15.57 4.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 1.7 mt-10 164.29 61.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.033 0.444 . . . . 0.0 110.059 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.859 HG12 ' HD2' ' B' ' 37' ' ' PRO . 22.5 m -107.8 -168.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.631 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.874 HG23 ' HB3' ' B' ' 35' ' ' ASN . 1.1 t -175.3 103.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.758 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.692 HG13 ' HA ' ' B' ' 34' ' ' VAL . 21.5 t -102.77 106.9 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.511 HG23 ' O ' ' B' ' 21' ' ' THR . 9.4 t -91.59 111.9 23.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.508 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.834 HG21 ' HB3' ' B' ' 6' ' ' ARG . 29.9 m -84.0 62.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.551 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.41 -142.46 0.24 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.731 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' B' ' 31' ' ' ARG . . . 53.37 69.18 1.29 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.636 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.572 HG22 ' HG2' ' B' ' 7' ' ' ARG . 17.4 t -88.47 107.48 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 111.559 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -142.63 146.99 35.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.096 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.35 158.69 30.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.499 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.81 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.676 0.274 . . . . 0.0 110.776 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.4 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -108.45 124.41 50.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 110.744 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.739 HG21 HG21 ' A' ' 30' ' ' VAL . 29.6 t -93.68 136.5 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.464 ' HB3' ' HA3' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -83.17 109.12 16.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.129 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 mm -93.41 135.63 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.235 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.32 111.0 2.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.319 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.692 ' HA ' HG13 ' B' ' 20' ' ' VAL . 15.0 t -113.58 102.87 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 111.403 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.874 ' HB3' HG23 ' B' ' 19' ' ' THR . 0.2 OUTLIER -91.6 107.14 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.685 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.434 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -130.14 146.26 60.77 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.481 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.859 ' HD2' HG12 ' B' ' 18' ' ' VAL . 87.1 Cg_endo -77.84 156.36 30.99 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.806 2.337 . . . . 0.0 112.016 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -91.3 38.38 0.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.139 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -123.56 -38.59 2.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.067 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.545 HG11 ' HA2' ' A' ' 15' ' ' GLY . 6.2 t -83.38 156.7 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.006 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -57.03 115.0 2.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.183 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.472 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.7 p -122.03 121.91 65.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.96 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.98 122.36 29.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.525 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.567 HH21 HD13 ' A' ' 12' ' ' LEU . 17.5 ttm180 -163.92 -77.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.729 0.299 . . . . 0.0 111.013 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.433 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 5.8 mm-40 -155.09 131.46 10.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.875 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.66 -50.63 72.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.179 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.477 ' HA ' ' HB2' ' B' ' 50' ' ' ARG . 13.9 tt -63.27 -42.0 94.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.831 ' CD2' HD13 ' A' ' 4' ' ' LEU . 5.9 m-85 -50.92 -53.36 33.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.185 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.522 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 1.5 mt-30 -78.32 -21.62 49.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.227 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 4.8 mtt180 -73.01 -15.34 61.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.296 . . . . 0.0 111.188 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 43.7 mt -109.94 -27.13 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.351 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.538 ' HB2' HD23 ' A' ' 2' ' ' LEU . 6.0 mp0 -107.8 -54.52 2.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.291 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -64.68 -73.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -112.42 125.29 54.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.731 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -64.79 89.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 45.5 m 61.97 -80.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.048 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 178.79 173.52 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.902 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -100.52 58.12 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.749 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.44 -81.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.07 126.93 49.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.792 0.33 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' B' ' 53' ' ' ALA . 8.3 tt -122.18 116.12 23.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.6 tt -101.8 105.57 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.134 0.493 . . . . 0.0 110.535 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.467 HD23 ' HG3' ' B' ' 52' ' ' GLN . 0.2 OUTLIER -124.51 123.51 40.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.434 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -63.24 143.65 57.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.729 0.3 . . . . 0.0 110.414 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.704 ' HB2' HG21 ' A' ' 22' ' ' VAL . 10.6 mtt180 -153.18 148.24 26.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.969 0.414 . . . . 0.0 111.012 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.845 ' HD2' HG13 ' A' ' 25' ' ' VAL . 21.1 ttp180 175.48 -0.76 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.918 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -169.39 134.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.747 0.308 . . . . 0.0 110.831 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.05 47.83 89.09 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.514 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.486 ' C ' HG22 ' A' ' 11' ' ' THR . 18.2 mm-40 -112.46 167.57 10.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.514 0.197 . . . . 0.0 110.703 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.486 HG22 ' C ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER 163.54 105.53 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.245 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.449 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -115.82 154.14 30.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.247 179.086 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.482 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.5 ttt -130.27 100.88 5.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.007 0.432 . . . . 0.0 111.261 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.825 HG23 HG23 ' B' ' 14' ' ' ILE . 2.5 tp -113.06 121.77 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.465 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 134.35 -107.14 0.64 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.153 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.519 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 21.0 m-20 -154.96 6.95 0.26 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 2.0 tm-20 161.33 64.84 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 19' ' ' THR . 10.7 m -119.34 -158.53 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.47 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 171.39 102.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.653 HG13 ' HA ' ' A' ' 34' ' ' VAL . 22.4 t -117.36 110.91 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.808 0.337 . . . . 0.0 111.461 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.7 m -106.74 116.6 32.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.029 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.704 HG21 ' HB2' ' A' ' 6' ' ' ARG . 27.6 m -82.22 68.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.069 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.69 -141.64 0.07 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.622 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.32 74.26 0.36 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.364 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.845 HG13 ' HD2' ' A' ' 7' ' ' ARG . 41.5 t -85.68 107.75 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 120.974 0.416 . . . . 0.0 111.134 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.89 165.42 35.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.139 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.68 164.59 27.92 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.169 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 72.72 -62.51 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.607 0.242 . . . . 0.0 111.245 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.57 136.4 54.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.738 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.2 116.29 44.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 111.12 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 1.9 mtm105 -79.58 99.36 7.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.833 0.349 . . . . 0.0 110.697 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.65 HG23 HG12 ' A' ' 22' ' ' VAL . 16.2 mm -87.86 132.85 32.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.599 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.62 118.2 5.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.536 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.653 ' HA ' HG13 ' A' ' 20' ' ' VAL . 14.2 t -114.14 127.96 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.218 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 19' ' ' THR . 2.7 t-20 -123.68 107.48 11.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.312 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.98 142.76 22.76 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.715 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.9 156.62 27.09 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.797 2.332 . . . . 0.0 112.051 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -87.44 26.6 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.427 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.38 -41.66 6.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.837 0.351 . . . . 0.0 110.819 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.446 HG12 ' O ' ' B' ' 15' ' ' GLY . 3.9 t -82.49 150.18 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.7 t -62.5 97.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.348 . . . . 0.0 111.018 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.9 p -122.39 120.61 61.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -128.39 136.22 50.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.594 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -178.3 -35.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.084 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.12 98.66 0.02 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.69 -26.45 63.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.818 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.404 ' CG2' HG13 ' A' ' 51' ' ' ILE . 33.2 mm -79.2 -44.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' O ' HD11 ' B' ' 2' ' ' LEU . 3.3 m-85 -52.11 -44.91 64.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.84 -60.48 2.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.829 0.347 . . . . 0.0 111.683 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -54.95 -15.6 2.12 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' A' ' 56' ' ' SER . 47.6 mm -108.42 -52.75 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 122.284 -0.26 . . . . 0.0 111.591 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.459 ' HG3' HD23 ' B' ' 4' ' ' LEU . 61.8 mm-40 -72.53 -59.12 2.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.709 0.29 . . . . 0.0 111.153 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.646 ' HB2' HD12 ' B' ' 2' ' ' LEU . . . -75.06 -25.39 58.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.388 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -121.54 140.2 52.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 74.99 0.06 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.434 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.697 ' HA ' HD13 ' A' ' 51' ' ' ILE . 3.7 m 55.56 -165.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.004 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -158.14 152.05 23.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.752 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.22 116.01 31.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 m -177.08 77.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 m -122.05 127.59 50.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 21.8 t80 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.93 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.82 0.343 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 53' ' ' ALA . 8.3 tt -122.24 116.21 23.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.629 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.6 tt -101.83 105.61 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.146 0.498 . . . . 0.0 110.524 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.459 HD23 ' HG3' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -124.58 123.5 40.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.423 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -63.16 143.69 57.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.38 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.705 ' HB2' HG21 ' B' ' 22' ' ' VAL . 10.6 mtt180 -153.23 148.26 26.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.952 0.406 . . . . 0.0 111.068 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.849 ' HD2' HG13 ' B' ' 25' ' ' VAL . 21.0 ttp180 175.44 -0.73 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.891 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.722 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -169.42 134.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.76 0.314 . . . . 0.0 110.797 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.04 47.79 89.29 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.486 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.484 ' C ' HG22 ' B' ' 11' ' ' THR . 18.1 mm-40 -112.39 167.65 10.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.541 0.21 . . . . 0.0 110.711 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.484 HG22 ' C ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 163.51 105.51 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.263 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.439 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 0.9 OUTLIER -115.86 154.1 30.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.293 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.467 ' HA ' HG23 ' B' ' 18' ' ' VAL . 1.5 ttt -130.28 100.78 5.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.997 0.427 . . . . 0.0 111.23 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.825 HG23 HG23 ' A' ' 14' ' ' ILE . 2.5 tp -112.98 121.83 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.504 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 134.31 -107.09 0.64 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.147 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 21.1 m-20 -154.96 6.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 2.1 tm-20 161.32 64.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.664 ' O ' HG23 ' B' ' 19' ' ' THR . 10.7 m -119.36 -158.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.487 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.664 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 171.38 102.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.657 HG13 ' HA ' ' B' ' 34' ' ' VAL . 22.6 t -117.36 110.93 32.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.819 0.343 . . . . 0.0 111.399 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 16.7 m -106.74 116.68 32.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.005 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' B' ' 6' ' ' ARG . 27.6 m -82.29 68.5 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.064 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.68 -141.65 0.07 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.575 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.3 74.34 0.35 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.309 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.849 HG13 ' HD2' ' B' ' 7' ' ' ARG . 41.4 t -85.78 107.74 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.064 0.459 . . . . 0.0 111.149 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.84 165.47 35.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.186 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.73 164.62 27.87 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.141 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 72.75 -62.53 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.614 0.245 . . . . 0.0 111.253 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.62 136.46 54.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.703 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.22 116.24 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.703 0.287 . . . . 0.0 111.096 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 1.9 mtm105 -79.45 99.34 7.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.802 0.334 . . . . 0.0 110.791 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.662 HG23 HG12 ' B' ' 22' ' ' VAL . 16.2 mm -87.86 132.87 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.591 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.65 118.15 5.4 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.542 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.657 ' HA ' HG13 ' B' ' 20' ' ' VAL . 14.0 t -114.1 127.98 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.238 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' B' ' 19' ' ' THR . 2.7 t-20 -123.73 107.45 11.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.293 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.93 142.8 23.01 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.769 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.95 156.53 26.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.851 2.367 . . . . 0.0 111.989 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -87.32 26.51 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.465 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -101.42 -41.6 6.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.785 0.326 . . . . 0.0 110.779 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 15' ' ' GLY . 3.9 t -82.55 150.22 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.624 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -62.47 97.93 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 111.101 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.504 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.8 p -122.38 120.6 61.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.1 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -128.37 136.26 50.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 3.7 ptt85 -178.28 -35.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.089 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.15 98.65 0.02 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -58.69 -26.55 63.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.767 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.416 ' CG2' HG13 ' B' ' 51' ' ' ILE . 32.8 mm -79.13 -44.25 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.415 ' O ' HD11 ' A' ' 2' ' ' LEU . 3.3 m-85 -52.08 -44.95 64.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.291 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -60.51 2.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.851 0.358 . . . . 0.0 111.636 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.406 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 5.3 mtp180 -54.89 -15.77 2.2 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' B' ' 56' ' ' SER . 47.6 mm -108.26 -52.68 6.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.608 0.242 . . . . 0.0 111.587 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.467 ' HG3' HD23 ' A' ' 4' ' ' LEU . 61.7 mm-40 -72.58 -59.07 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.715 0.293 . . . . 0.0 111.133 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.655 ' HB2' HD12 ' A' ' 2' ' ' LEU . . . -75.09 -25.28 58.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.395 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 11.9 mm-40 -122.34 142.33 50.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -73.23 74.45 1.3 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.473 ' HA ' HD13 ' B' ' 51' ' ' ILE . 5.6 t 72.15 -67.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.41 72.46 0.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 110.918 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.13 139.5 28.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.827 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 4.3 t -140.0 142.38 36.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 7.3 m -96.83 136.49 37.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 20.4 t80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.894 179.969 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' B' ' 53' ' ' ALA . 5.6 mp -122.28 114.35 20.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.907 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.423 ' CG2' ' HB3' ' B' ' 31' ' ' ARG . 20.8 mm -96.2 105.03 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.027 0.441 . . . . 0.0 110.506 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.41 ' CD2' ' HG2' ' B' ' 52' ' ' GLN . 2.4 mm? -124.82 118.23 25.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.8 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.1 OUTLIER -55.68 139.83 43.5 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.43 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.737 ' HB3' HG21 ' A' ' 22' ' ' VAL . 3.8 mtp180 -151.37 148.4 28.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.029 0.442 . . . . 0.0 111.474 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.738 ' NE ' HG13 ' A' ' 25' ' ' VAL . 2.9 ttt180 175.91 -80.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.569 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t -32.75 -68.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.09 109.58 0.41 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.006 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.859 ' HB2' HG22 ' A' ' 22' ' ' VAL . 8.2 mm-40 -113.18 -173.63 2.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.553 0.216 . . . . 0.0 110.533 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 10' ' ' GLU . 0.7 OUTLIER 168.9 89.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.443 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.52 HD21 ' HB ' ' A' ' 20' ' ' VAL . 1.3 pt? -113.11 154.25 26.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.3 ttt -130.67 100.76 5.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.209 0.528 . . . . 0.0 111.348 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.5 HD13 ' HB ' ' B' ' 42' ' ' VAL . 2.6 tp -111.77 126.8 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.402 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 127.93 -104.56 0.68 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.965 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.9 p30 -162.34 8.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.9 mt-10 165.24 52.92 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.014 0.435 . . . . 0.0 110.316 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.646 HG12 ' HD2' ' A' ' 37' ' ' PRO . 13.7 m -115.27 -158.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.934 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.1 OUTLIER 167.05 106.86 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 34' ' ' VAL . 3.1 t -117.43 114.27 45.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.769 0.319 . . . . 0.0 111.172 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.741 HG23 ' O ' ' A' ' 10' ' ' GLU . 5.0 m -110.54 116.53 31.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.873 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.859 HG22 ' HB2' ' A' ' 10' ' ' GLU . 34.2 m -81.16 71.16 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -88.97 -145.76 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.562 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 31' ' ' ARG . . . 56.7 79.76 0.09 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.326 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.738 HG13 ' NE ' ' A' ' 7' ' ' ARG . 20.8 t -85.93 107.82 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.904 0.383 . . . . 0.0 111.602 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.99 155.67 43.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.03 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.78 154.93 52.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.583 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 67.68 -88.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.464 0.173 . . . . 0.0 110.685 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -104.63 125.68 50.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.804 0.335 . . . . 0.0 110.62 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.402 HG23 HD11 ' A' ' 32' ' ' ILE . 4.7 m -93.24 136.65 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.515 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 4.6 mtt180 -79.51 100.98 7.98 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.096 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.675 HG23 ' HA ' ' A' ' 22' ' ' VAL . 18.5 mm -87.35 133.79 29.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.66 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.96 119.02 6.32 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.266 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.649 ' HA ' HG13 ' A' ' 20' ' ' VAL . 24.3 t -109.55 129.61 64.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.929 0.395 . . . . 0.0 111.494 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.934 ' HB3' HG23 ' A' ' 19' ' ' THR . 2.1 t30 -123.47 107.25 11.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.183 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.18 146.62 46.87 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.635 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.646 ' HD2' HG12 ' A' ' 18' ' ' VAL . 82.8 Cg_endo -83.2 156.52 14.82 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.99 2.46 . . . . 0.0 112.278 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.92 15.59 4.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.352 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.29 -38.65 10.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.639 0.257 . . . . 0.0 110.973 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 15' ' ' GLY . 4.7 t -87.95 142.21 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.835 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 m -55.85 98.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.027 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 42' ' ' VAL . 13.4 p -122.2 120.82 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.222 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.19 136.09 50.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.442 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.413 ' NH2' ' NE ' ' B' ' 6' ' ' ARG . 24.4 ttt180 -156.69 -67.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 111.012 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.83 121.55 1.82 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.92 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.52 -42.43 82.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.61 -41.09 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.79 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -52.32 -46.71 66.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.701 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -86.71 -58.17 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 111.741 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.46 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 4.1 mtt180 -48.91 -20.29 0.49 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.9 mm -108.67 -52.67 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.632 0.253 . . . . 0.0 111.498 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.403 ' HG2' ' CD2' ' B' ' 4' ' ' LEU . 7.9 tp60 -66.81 -63.5 1.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.721 0.296 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.814 ' HB2' HD21 ' B' ' 2' ' ' LEU . . . -70.82 -32.13 69.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.982 0.42 . . . . 0.0 110.615 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -109.42 119.73 40.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.798 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -62.87 92.62 0.05 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.667 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m 69.04 -65.94 0.27 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.348 . . . . 0.0 110.794 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.34 132.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.997 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -141.88 130.94 23.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.814 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.55 174.13 11.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.033 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.57 145.16 39.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.822 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 32.8 p90 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.893 179.935 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.899 0.38 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.814 HD21 ' HB2' ' A' ' 53' ' ' ALA . 5.5 mp -122.26 114.41 20.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.425 ' CG2' ' HB3' ' A' ' 31' ' ' ARG . 20.6 mm -96.25 104.95 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 0.0 110.566 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.403 ' CD2' ' HG2' ' A' ' 52' ' ' GLN . 2.4 mm? -124.76 118.43 26.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.781 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -55.78 139.83 44.06 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.378 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.754 ' HB3' HG21 ' B' ' 22' ' ' VAL . 3.8 mtp180 -151.38 148.37 28.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.048 0.452 . . . . 0.0 111.496 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.741 ' NE ' HG13 ' B' ' 25' ' ' VAL . 2.9 ttt180 175.91 -80.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.591 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 25.1 t -32.76 -68.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.05 109.64 0.41 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.002 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.855 ' HB2' HG22 ' B' ' 22' ' ' VAL . 8.2 mm-40 -113.19 -173.59 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.548 0.213 . . . . 0.0 110.536 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' B' ' 10' ' ' GLU . 0.7 OUTLIER 168.87 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.426 179.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.522 HD21 ' HB ' ' B' ' 20' ' ' VAL . 1.3 pt? -113.19 154.26 26.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 12.3 ttt -130.71 100.82 5.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.233 0.54 . . . . 0.0 111.403 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.499 HD13 ' HB ' ' A' ' 42' ' ' VAL . 2.6 tp -111.89 126.81 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.342 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 127.96 -104.66 0.69 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.913 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 2.9 p30 -162.31 9.01 0.06 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.9 mt-10 165.25 52.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.025 0.44 . . . . 0.0 110.284 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.633 HG12 ' HD2' ' B' ' 37' ' ' PRO . 13.8 m -115.26 -158.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.216 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.944 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.1 OUTLIER 167.05 106.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.655 HG13 ' HA ' ' B' ' 34' ' ' VAL . 3.1 t -117.45 114.28 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.753 0.311 . . . . 0.0 111.18 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.752 HG23 ' O ' ' B' ' 10' ' ' GLU . 5.0 m -110.54 116.54 31.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.849 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.855 HG22 ' HB2' ' B' ' 10' ' ' GLU . 34.2 m -81.11 71.1 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.601 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.42 HD12 ' N ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -88.94 -145.72 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.576 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' B' ' 31' ' ' ARG . . . 56.68 79.76 0.09 OUTLIER Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.363 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.741 HG13 ' NE ' ' B' ' 7' ' ' ARG . 20.9 t -86.0 107.83 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 120.96 0.41 . . . . 0.0 111.638 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.03 155.65 43.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.003 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.73 154.95 52.68 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.555 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 67.64 -88.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.492 0.187 . . . . 0.0 110.654 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -104.64 125.66 50.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.0 110.64 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 m -93.21 136.67 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.555 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.6 mtt180 -79.51 100.88 7.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.1 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.668 HG23 ' HA ' ' B' ' 22' ' ' VAL . 18.6 mm -87.31 133.76 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.68 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.92 118.96 6.3 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.306 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.655 ' HA ' HG13 ' B' ' 20' ' ' VAL . 24.0 t -109.51 129.67 63.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.922 0.391 . . . . 0.0 111.556 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.944 ' HB3' HG23 ' B' ' 19' ' ' THR . 2.1 t30 -123.41 107.22 11.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.247 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.19 146.6 46.76 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.622 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.633 ' HD2' HG12 ' B' ' 18' ' ' VAL . 82.7 Cg_endo -83.17 156.52 14.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.013 2.475 . . . . 0.0 112.271 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.95 15.57 4.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.303 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -38.6 10.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.662 0.268 . . . . 0.0 111.016 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 15' ' ' GLY . 4.7 t -87.94 142.19 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.868 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 3.0 m -55.9 98.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.971 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.511 HG13 ' O ' ' B' ' 42' ' ' VAL . 13.4 p -122.19 120.81 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.265 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.21 136.04 50.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.432 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.414 ' NH2' ' NE ' ' A' ' 6' ' ' ARG . 24.6 ttt180 -156.62 -67.17 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.939 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.77 121.61 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.42 -42.48 82.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -41.03 87.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.799 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -52.35 -46.65 66.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.634 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -86.84 -58.09 2.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.758 0.313 . . . . 0.0 111.804 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.467 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 4.1 mtt180 -48.95 -20.16 0.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.821 HG23 ' HB2' ' B' ' 56' ' ' SER . 36.6 mm -108.78 -52.63 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.629 0.252 . . . . 0.0 111.524 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.41 ' HG2' ' CD2' ' A' ' 4' ' ' LEU . 8.1 tp60 -66.87 -63.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.763 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.822 ' HB2' HD21 ' A' ' 2' ' ' LEU . . . -70.89 -32.2 69.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 110.589 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 0.5 OUTLIER -108.65 119.59 39.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.615 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.35 103.0 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.589 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.821 ' HB2' HG23 ' B' ' 51' ' ' ILE . 35.7 t -67.66 171.29 6.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.038 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -148.9 110.81 4.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.624 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -90.63 -72.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.954 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 7.1 m -57.72 117.5 4.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 7.3 m -97.97 135.98 38.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.874 -179.961 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.731 ' C ' HD13 ' A' ' 2' ' ' LEU . 1.7 ttm . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.964 0.412 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.731 HD13 ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -122.24 111.69 17.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.823 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 3' ' ' ILE . 2.8 tt -106.06 116.66 50.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.1 0.476 . . . . 0.0 111.3 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.87 HD22 ' CD2' ' B' ' 48' ' ' TYR . 0.4 OUTLIER -123.9 123.4 40.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.336 179.354 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -63.61 80.07 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.888 0.375 . . . . 0.0 111.664 -179.17 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.546 ' HD3' HG21 ' A' ' 22' ' ' VAL . 23.5 mtt180 -78.79 143.22 36.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.126 0.489 . . . . 0.0 110.514 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.435 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 2.9 tmt_? -173.36 -13.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.864 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.61 -58.74 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.702 0.286 . . . . 0.0 111.175 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.57 105.55 0.21 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.803 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.2 -73.82 0.65 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.906 0.384 . . . . 0.0 110.723 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 m 69.53 102.39 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.49 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.644 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -109.94 154.59 22.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.626 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.3 ttt -127.2 100.07 5.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.98 0.419 . . . . 0.0 110.747 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.644 HD13 ' N ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -115.85 138.16 47.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.752 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.644 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 121.28 -106.01 1.08 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.104 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.4 t70 -159.57 7.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.7 mt-10 162.66 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.036 0.446 . . . . 0.0 110.151 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.774 HG12 ' CD ' ' A' ' 37' ' ' PRO . 13.3 m -116.38 -158.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.649 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.951 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 173.57 102.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.644 ' HB ' HD23 ' A' ' 12' ' ' LEU . 27.5 t -110.48 103.96 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.5 m -89.27 106.37 18.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.904 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.546 HG21 ' HD3' ' A' ' 6' ' ' ARG . 32.0 m -76.7 -168.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.899 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.724 ' O ' HG11 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -173.38 141.3 0.89 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.103 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.481 ' H ' HD13 ' A' ' 23' ' ' LEU . . . -125.37 -24.54 1.58 Allowed Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.477 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.94 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.536 0.208 . . . . 0.0 110.63 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.91 165.5 0.13 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.747 0.308 . . . . 0.0 110.56 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.81 -99.98 0.01 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.569 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -101.36 -30.92 11.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 110.377 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.448 ' HB3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -119.82 136.65 54.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.955 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 23' ' ' LEU . 12.0 t -93.21 128.39 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 111.681 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 2.4 ttp180 -80.8 99.54 8.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.445 HG13 ' HB2' ' B' ' 6' ' ' ARG . 9.5 mm -88.77 127.43 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.931 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.03 109.99 3.4 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.486 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.574 ' HA ' HG13 ' A' ' 20' ' ' VAL . 21.5 t -111.73 102.93 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.936 0.398 . . . . 0.0 111.468 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.951 ' HB3' HG23 ' A' ' 19' ' ' THR . 1.8 t-20 -91.59 107.44 19.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.641 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.95 138.62 33.04 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.454 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.774 ' CD ' HG12 ' A' ' 18' ' ' VAL . 83.7 Cg_endo -77.69 156.09 31.45 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.603 2.202 . . . . 0.0 112.102 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -82.01 2.25 31.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.564 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.84 -39.33 20.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.72 0.295 . . . . 0.0 111.267 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 t -86.78 146.85 5.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.885 0.374 . . . . 0.0 110.995 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.97 100.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.5 p -122.3 122.31 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -128.11 136.42 51.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.706 0.289 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.668 HH22 HD23 ' B' ' 2' ' ' LEU . 0.5 OUTLIER -142.92 -175.78 4.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.489 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 1.9 mp0 -57.3 145.78 30.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.843 0.354 . . . . 0.0 110.874 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.67 -65.29 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.507 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -52.08 -40.77 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.387 -179.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.861 ' CD2' HD22 ' B' ' 4' ' ' LEU . 7.9 t80 -46.9 -67.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.436 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' A' ' 53' ' ' ALA . 48.5 mt-30 -71.96 -22.01 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.551 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -70.5 -15.95 62.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.649 0.261 . . . . 0.0 111.571 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.528 HG23 ' OE1' ' A' ' 52' ' ' GLN . 6.9 tt -112.15 -25.18 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.634 0.254 . . . . 0.0 111.5 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.562 ' HB3' HD12 ' B' ' 2' ' ' LEU . 0.6 OUTLIER -106.79 -55.81 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.257 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB2' ' HG2' ' A' ' 49' ' ' GLN . . . -65.08 -71.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.1 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -108.0 116.61 32.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.772 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.49 109.08 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.558 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 t -53.54 -65.01 0.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.761 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -92.9 91.8 7.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -67.36 153.92 42.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.987 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.1 t -110.0 95.9 5.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 m -116.38 134.51 54.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.743 ' C ' HD13 ' B' ' 2' ' ' LEU . 1.7 ttm . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.88 0.371 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.743 HD13 ' C ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -122.28 111.71 17.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.45 HG23 ' O ' ' B' ' 3' ' ' ILE . 2.7 tt -106.11 116.69 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.167 0.508 . . . . 0.0 111.233 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.861 HD22 ' CD2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -123.88 123.52 40.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.315 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -63.64 80.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.872 0.368 . . . . 0.0 111.623 -179.189 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.558 ' HD3' HG21 ' B' ' 22' ' ' VAL . 23.5 mtt180 -78.88 143.32 36.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.151 0.501 . . . . 0.0 110.503 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.432 ' HA ' ' HA3' ' B' ' 24' ' ' GLY . 2.9 tmt_? -173.37 -13.25 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.859 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 t -116.64 -58.68 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.674 0.273 . . . . 0.0 111.131 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.53 105.55 0.21 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.804 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.14 -73.89 0.65 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 110.77 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 8.8 m 69.61 102.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.436 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.4 OUTLIER -109.87 154.58 22.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.664 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 8.3 ttt -127.15 100.02 5.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.988 0.423 . . . . 0.0 110.769 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.639 HD13 ' N ' ' B' ' 15' ' ' GLY . 0.0 OUTLIER -115.76 138.2 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.734 179.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.639 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 121.28 -105.96 1.07 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.109 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 1.4 t70 -159.58 7.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.7 mt-10 162.69 59.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.981 0.42 . . . . 0.0 110.102 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.776 HG12 ' CD ' ' B' ' 37' ' ' PRO . 13.4 m -116.4 -158.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.632 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.934 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.1 OUTLIER 173.61 102.73 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.642 ' HB ' HD23 ' B' ' 12' ' ' LEU . 27.6 t -110.44 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 33.2 m -89.28 106.37 18.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.946 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.558 HG21 ' HD3' ' B' ' 6' ' ' ARG . 32.2 m -76.79 -168.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.905 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.725 ' O ' HG11 ' B' ' 30' ' ' VAL . 0.2 OUTLIER -173.38 141.32 0.9 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.095 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.481 ' H ' HD13 ' B' ' 23' ' ' LEU . . . -125.41 -24.43 1.59 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.97 130.79 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.525 0.202 . . . . 0.0 110.622 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.88 165.53 0.13 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 110.578 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.87 -100.01 0.01 OUTLIER Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.506 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -101.37 -30.88 11.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 110.372 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.448 ' HB3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -119.82 136.56 54.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.965 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.725 HG11 ' O ' ' B' ' 23' ' ' LEU . 12.1 t -93.18 128.44 44.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.916 0.389 . . . . 0.0 111.636 -178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 2.4 ttp180 -80.8 99.52 8.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.46 HG13 ' HB2' ' A' ' 6' ' ' ARG . 9.6 mm -88.8 127.46 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.878 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.03 109.95 3.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.429 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.581 ' HA ' HG13 ' B' ' 20' ' ' VAL . 21.4 t -111.7 102.94 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 111.48 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.934 ' HB3' HG23 ' B' ' 19' ' ' THR . 1.8 t-20 -91.62 107.43 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.622 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.97 138.59 32.99 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.475 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.776 ' CD ' HG12 ' B' ' 18' ' ' VAL . 84.3 Cg_endo -77.67 156.08 31.55 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.654 2.236 . . . . 0.0 112.134 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -82.03 2.28 31.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.603 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.88 -39.36 19.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.66 0.266 . . . . 0.0 111.187 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 t -86.67 146.8 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.042 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.01 100.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.467 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.5 p -122.3 122.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.752 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -128.1 136.4 51.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.684 0.278 . . . . 0.0 110.862 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.672 HH22 HD23 ' A' ' 2' ' ' LEU . 0.5 OUTLIER -142.93 -175.79 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.491 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' B' ' 48' ' ' TYR . 1.9 mp0 -57.31 145.7 31.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.86 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.62 -65.29 0.58 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.546 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.665 HD13 ' O ' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -52.07 -40.8 30.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.37 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.87 ' CD2' HD22 ' A' ' 4' ' ' LEU . 8.0 t80 -46.86 -67.69 0.26 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.414 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.462 ' HG2' ' HB2' ' B' ' 53' ' ' ALA . 48.5 mt-30 -71.95 -21.95 61.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.632 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' B' ' 47' ' ' ILE . 61.0 mtt180 -70.57 -15.95 62.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.579 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.53 HG23 ' OE1' ' B' ' 52' ' ' GLN . 6.9 tt -112.17 -25.08 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.614 0.245 . . . . 0.0 111.501 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.536 ' HB3' HD12 ' A' ' 2' ' ' LEU . 0.6 OUTLIER -106.82 -55.81 2.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 111.242 -179.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.462 ' HB2' ' HG2' ' B' ' 49' ' ' GLN . . . -65.04 -71.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.168 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -108.33 116.97 32.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.35 103.68 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t -57.55 -71.29 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.014 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 61.74 176.8 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.818 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 67.11 -69.11 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.067 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 96.6 p -153.19 169.95 21.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.812 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.09 120.86 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.942 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmm? . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.821 0.343 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.402 ' HB2' ' NH1' ' B' ' 44' ' ' ARG . 4.1 mp -115.93 109.49 17.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 3' ' ' ILE . 18.3 tt -84.52 111.35 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 0.0 111.443 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -113.18 156.25 23.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.729 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.551 ' N ' HD23 ' A' ' 4' ' ' LEU . 0.2 OUTLIER -94.71 122.55 37.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 111.382 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.442 ' HB2' HG13 ' B' ' 32' ' ' ILE . 0.6 OUTLIER -95.6 148.97 21.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.645 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.621 ' HG3' HG13 ' A' ' 30' ' ' VAL . 0.1 OUTLIER 81.13 85.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.821 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.653 HG23 ' HA2' ' A' ' 24' ' ' GLY . 47.3 t 80.72 56.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.287 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.43 ' H ' HG21 ' A' ' 22' ' ' VAL . . . -140.51 -147.58 5.0 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.632 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.23 119.24 37.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 111.61 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 21' ' ' THR . 14.4 p -57.03 145.08 31.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.304 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.798 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -112.6 154.42 26.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.694 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.7 ttp -128.94 100.34 5.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.751 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.498 HD11 HG11 ' B' ' 18' ' ' VAL . 0.0 OUTLIER -114.64 138.72 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.015 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.411 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 123.9 -106.27 0.95 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.151 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.588 ' OD2' HG22 ' A' ' 40' ' ' VAL . 1.4 p30 -158.58 7.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.6 OUTLIER 161.74 58.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.902 0.382 . . . . 0.0 110.044 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.796 HG12 ' HD2' ' A' ' 37' ' ' PRO . 10.7 m -114.37 -156.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.357 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.974 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 173.15 104.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.974 179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.798 ' HB ' HD23 ' A' ' 12' ' ' LEU . 24.8 t -102.66 101.66 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.852 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.629 ' HA ' HG22 ' A' ' 11' ' ' THR . 9.8 t -95.35 157.42 15.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.631 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.43 HG21 ' H ' ' A' ' 9' ' ' GLY . 6.4 m -107.86 -172.39 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.309 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.2 tm? -124.05 -52.2 1.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 0.0 110.427 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.653 ' HA2' HG23 ' A' ' 8' ' ' VAL . . . 91.85 -43.47 2.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.996 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.56 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 4.0 t -85.65 149.91 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.525 0.202 . . . . 0.0 111.41 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 25' ' ' VAL . 28.1 tttp 99.07 122.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.068 0.547 . . . . 0.0 110.743 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.77 -179.51 37.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.762 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 63.63 -86.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -86.46 136.74 32.99 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.821 HG12 HD11 ' A' ' 32' ' ' ILE . 4.1 t -93.24 114.15 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.351 . . . . 0.0 110.874 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.56 ' HD2' HD11 ' B' ' 3' ' ' ILE . 8.9 mmt180 -89.28 99.87 12.77 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.888 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.821 HD11 HG12 ' A' ' 30' ' ' VAL . 24.0 mm -109.53 141.19 25.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.054 0.454 . . . . 0.0 111.667 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.82 107.48 2.58 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.919 -0.657 . . . . 0.0 111.987 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.587 HG13 HG22 ' A' ' 20' ' ' VAL . 21.4 t -97.8 103.41 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.904 0.383 . . . . 0.0 111.103 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.974 ' HB3' HG23 ' A' ' 19' ' ' THR . 1.2 t-20 -90.57 107.3 19.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.87 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.75 140.03 37.43 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.259 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.796 ' HD2' HG12 ' A' ' 18' ' ' VAL . 85.9 Cg_endo -77.74 156.18 31.32 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.642 2.228 . . . . 0.0 112.28 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -80.32 0.16 34.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.355 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -78.01 -39.77 41.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.714 0.292 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.588 HG22 ' OD2' ' A' ' 16' ' ' ASP . 5.5 t -87.8 140.88 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.91 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 t -62.48 102.26 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.379 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.2 p -122.24 120.69 61.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -128.31 136.45 51.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.793 0.33 . . . . 0.0 111.199 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.4 ' NH1' ' HB2' ' B' ' 2' ' ' LEU . 63.4 mtt180 -139.62 -50.68 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.45 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 1.3 tp10 -178.29 141.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.514 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.51 -45.74 84.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.217 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -73.02 -38.51 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.67 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 45' ' ' GLU . 4.1 m-85 -51.54 -50.16 60.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -85.9 -52.81 5.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -16.35 12.62 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 mm -115.76 -57.92 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.409 ' CB ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -66.39 -48.07 71.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.104 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.85 -28.25 26.17 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 111.307 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -120.33 134.29 55.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 57' ' ' GLN . 9.1 mttp -59.65 87.02 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.147 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.5 t 64.63 -72.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.176 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -147.88 164.36 33.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.832 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -94.81 87.23 4.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 p -170.75 -66.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 p -105.12 133.07 50.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.838 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmm? . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.804 0.335 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.4 ' HB2' ' NH1' ' A' ' 44' ' ' ARG . 4.2 mp -115.96 109.5 17.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.847 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.58 HG23 ' O ' ' B' ' 3' ' ' ILE . 18.3 tt -84.49 111.42 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.487 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.564 HD23 ' N ' ' B' ' 5' ' ' THR . 1.0 OUTLIER -113.21 156.21 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.739 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.564 ' N ' HD23 ' B' ' 4' ' ' LEU . 0.2 OUTLIER -94.69 122.55 37.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.363 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.6 OUTLIER -95.65 148.97 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.635 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.61 ' HG3' HG13 ' B' ' 30' ' ' VAL . 0.1 OUTLIER 81.22 85.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.767 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.653 HG23 ' HA2' ' B' ' 24' ' ' GLY . 47.3 t 80.64 56.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.287 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.426 ' H ' HG21 ' B' ' 22' ' ' VAL . . . -140.5 -147.57 4.99 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.589 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.24 119.16 36.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.889 0.376 . . . . 0.0 111.614 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.632 HG22 ' HA ' ' B' ' 21' ' ' THR . 14.5 p -57.04 145.04 31.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.263 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.807 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.2 OUTLIER -112.58 154.42 26.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.693 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 3.7 ttp -128.91 100.35 5.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.849 0.356 . . . . 0.0 110.723 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.504 HD11 HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -114.66 138.77 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.981 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.407 ' HA2' HG11 ' A' ' 40' ' ' VAL . . . 123.83 -106.18 0.95 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.16 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.583 ' OD2' HG22 ' B' ' 40' ' ' VAL . 1.4 p30 -158.6 7.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 0.6 OUTLIER 161.77 58.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.018 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.782 HG12 ' HD2' ' B' ' 37' ' ' PRO . 10.6 m -114.31 -157.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.968 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 173.21 104.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.981 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.807 ' HB ' HD23 ' B' ' 12' ' ' LEU . 24.7 t -102.65 101.71 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.898 0.38 . . . . 0.0 110.807 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.632 ' HA ' HG22 ' B' ' 11' ' ' THR . 9.9 t -95.36 157.41 15.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.609 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.426 HG21 ' H ' ' B' ' 9' ' ' GLY . 6.4 m -107.81 -172.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.304 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.428 ' HA ' HD22 ' B' ' 23' ' ' LEU . 1.2 tm? -124.09 -52.19 1.76 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.83 0.347 . . . . 0.0 110.411 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.653 ' HA2' HG23 ' B' ' 8' ' ' VAL . . . 91.92 -43.41 2.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.989 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' B' ' 26' ' ' LYS . 4.0 t -85.77 149.94 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.492 0.187 . . . . 0.0 111.36 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' B' ' 25' ' ' VAL . 28.1 tttp 99.0 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.067 0.547 . . . . 0.0 110.799 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.78 -179.53 37.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.763 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 63.64 -86.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -86.46 136.71 33.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.793 HG12 HD11 ' B' ' 32' ' ' ILE . 4.1 t -93.19 114.1 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.351 . . . . 0.0 110.896 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.563 ' HD2' HD11 ' A' ' 3' ' ' ILE . 8.9 mmt180 -89.29 99.86 12.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.865 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.793 HD11 HG12 ' B' ' 30' ' ' VAL . 24.0 mm -109.49 141.22 25.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.031 0.443 . . . . 0.0 111.719 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.85 107.53 2.58 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.979 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.584 HG13 HG22 ' B' ' 20' ' ' VAL . 21.4 t -97.85 103.43 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.926 0.393 . . . . 0.0 111.103 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.968 ' HB3' HG23 ' B' ' 19' ' ' THR . 1.2 t-20 -90.59 107.28 19.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.831 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.73 140.1 37.63 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.243 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.782 ' HD2' HG12 ' B' ' 18' ' ' VAL . 86.0 Cg_endo -77.78 156.16 31.13 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.673 2.249 . . . . 0.0 112.268 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -80.31 0.23 33.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.428 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -78.07 -39.7 40.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.703 0.287 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.583 HG22 ' OD2' ' B' ' 16' ' ' ASP . 5.5 t -87.89 140.9 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.89 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -62.37 102.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.394 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.489 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.3 p -122.2 120.67 61.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.726 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -128.29 136.47 51.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.795 0.331 . . . . 0.0 111.147 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.402 ' NH1' ' HB2' ' A' ' 2' ' ' LEU . 63.7 mtt180 -139.62 -50.65 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.409 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 1.3 tp10 -178.3 141.34 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.543 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.51 -45.78 84.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.188 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.99 -38.52 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.651 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.421 ' HB2' ' HB3' ' B' ' 45' ' ' GLU . 4.1 m-85 -51.54 -50.15 60.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.75 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -85.92 -52.86 5.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.409 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 0.2 OUTLIER -58.09 -16.21 12.24 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.011 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 17.1 mm -115.91 -57.88 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.413 ' CB ' ' O ' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -66.45 -48.06 71.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.09 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.84 -28.28 26.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 111.341 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' B' ' 55' ' ' LYS . 7.1 mt-10 -120.33 137.32 54.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.228 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' B' ' 54' ' ' GLU . 3.2 mtmp? 70.06 -97.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.931 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p 61.53 149.91 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.769 0.319 . . . . 0.0 110.756 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -153.69 -65.44 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.962 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.22 -148.56 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.688 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 1.8 m 78.22 108.42 0.07 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.904 0.383 . . . . 0.0 110.897 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.04 136.38 54.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.887 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.918 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.909 0.385 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.734 ' HG ' ' HB2' ' B' ' 53' ' ' ALA . 1.7 mp -116.46 105.46 12.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.7 tt -84.8 108.99 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.673 HD13 ' NE ' ' B' ' 44' ' ' ARG . 1.9 tp -112.98 156.64 22.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.257 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.563 HG21 ' OE1' ' B' ' 29' ' ' GLN . 0.3 OUTLIER -90.96 124.24 35.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.868 0.366 . . . . 0.0 111.021 179.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.498 ' HB2' ' CG1' ' B' ' 32' ' ' ILE . 0.0 OUTLIER -93.22 148.42 22.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.237 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.716 ' HD3' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER 83.34 90.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.401 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.518 HG23 ' C ' ' A' ' 7' ' ' ARG . 6.3 t 84.25 62.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.58 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.68 -146.9 4.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.383 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.409 ' HB2' ' CZ ' ' B' ' 48' ' ' TYR . 3.8 tp10 -113.26 118.17 33.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.845 0.355 . . . . 0.0 111.442 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 21' ' ' THR . 19.2 p -51.93 150.26 4.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.963 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.746 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -110.88 154.5 23.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.846 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.661 ' HG2' HG22 ' A' ' 18' ' ' VAL . 6.7 ttm -127.26 100.36 6.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.995 0.426 . . . . 0.0 110.906 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.488 ' H ' HG21 ' A' ' 18' ' ' VAL . 3.8 tp -111.93 129.35 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.441 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 127.76 -102.76 0.61 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.165 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 5.4 p30 -166.24 8.41 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 31.6 tp10 167.29 57.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.661 HG22 ' HG2' ' A' ' 13' ' ' MET . 5.8 m -114.98 -157.93 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.7 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER 172.49 99.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.746 ' HB ' HD23 ' A' ' 12' ' ' LEU . 20.9 t -102.96 103.08 14.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.812 0.339 . . . . 0.0 111.77 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.678 ' HA ' HG22 ' A' ' 11' ' ' THR . 44.4 m -87.22 146.84 25.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.242 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.825 ' HA ' HG23 ' A' ' 32' ' ' ILE . 30.5 m -109.75 76.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -99.88 -151.11 0.39 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.307 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 31' ' ' ARG . . . 56.52 73.6 0.42 Allowed Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.098 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.716 HG13 ' HD3' ' A' ' 7' ' ' ARG . 24.7 t -85.92 107.33 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.011 0.434 . . . . 0.0 111.627 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.58 ' H ' HG12 ' A' ' 30' ' ' VAL . 1.1 mttt -137.21 142.82 42.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.906 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.53 -44.11 28.81 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.434 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -104.53 -86.25 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.939 0.369 . . . . 0.0 111.452 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.558 ' OE1' HG21 ' B' ' 5' ' ' THR . 5.7 mt-30 -84.85 116.15 23.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.759 0.314 . . . . 0.0 111.172 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 26' ' ' LYS . 31.0 m -93.81 136.51 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.189 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.531 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 4.9 mtt-85 -87.92 99.25 12.0 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.025 0.44 . . . . 0.0 110.1 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.825 HG23 ' HA ' ' A' ' 22' ' ' VAL . 27.3 mm -92.87 141.81 14.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.235 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.08 108.75 3.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.689 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.486 ' HA ' HG13 ' A' ' 20' ' ' VAL . 27.1 t -99.35 103.49 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.803 0.335 . . . . 0.0 111.049 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.1 t-20 -90.78 107.22 19.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.186 0.517 . . . . 0.0 110.62 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.43 141.32 38.57 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.247 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.641 ' CD ' HG12 ' A' ' 18' ' ' VAL . 86.0 Cg_endo -77.99 156.19 30.38 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.615 2.21 . . . . 0.0 112.272 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -83.26 3.78 29.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.498 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -86.01 -36.87 19.5 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.695 0.283 . . . . 0.0 111.099 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.44 HG12 ' O ' ' B' ' 15' ' ' GLY . 11.1 t -90.8 141.35 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.042 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -59.03 105.68 0.35 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.218 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.9 p -122.24 122.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.007 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.14 136.23 50.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.654 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.677 ' NE ' HD13 ' B' ' 4' ' ' LEU . 0.0 OUTLIER -154.47 59.43 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 0.0 110.778 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.07 136.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -65.39 -41.85 93.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.834 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.7 mm -67.32 -54.43 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.129 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.586 ' CD1' HD11 ' B' ' 4' ' ' LEU . 8.0 m-85 -47.19 -43.37 21.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.478 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.603 ' HG2' HD21 ' B' ' 2' ' ' LEU . 0.3 OUTLIER -78.29 -55.01 5.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.353 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 84.8 mmt-85 -56.93 -12.84 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.692 HG23 ' HB3' ' A' ' 56' ' ' SER . 30.1 mm -107.85 -57.3 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.715 0.293 . . . . 0.0 111.237 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.447 ' OE1' HD12 ' B' ' 4' ' ' LEU . 32.6 mt-30 -72.75 -57.99 3.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.892 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.725 ' HB2' ' HG ' ' B' ' 2' ' ' LEU . . . -67.29 -34.69 77.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 0.0 110.844 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 1.6 mt-10 -120.47 129.19 53.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.648 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -49.62 108.37 0.2 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.723 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.692 ' HB3' HG23 ' A' ' 51' ' ' ILE . 96.2 p -57.45 159.57 4.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.797 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -148.16 143.28 26.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.994 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.14 -178.88 5.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -134.18 120.98 20.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.34 134.34 54.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.924 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.895 -179.968 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.871 0.367 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.725 ' HG ' ' HB2' ' A' ' 53' ' ' ALA . 1.7 mp -116.47 105.5 12.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.76 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.599 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.7 tt -84.76 108.99 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.266 0.555 . . . . 0.0 111.143 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.677 HD13 ' NE ' ' A' ' 44' ' ' ARG . 2.0 tp -113.03 156.65 22.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.178 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.558 HG21 ' OE1' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -90.92 124.25 35.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.849 0.357 . . . . 0.0 111.028 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.497 ' HB2' ' CG1' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -93.21 148.34 22.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.243 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.727 ' HD3' HG13 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 83.32 90.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.402 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.523 HG23 ' C ' ' B' ' 7' ' ' ARG . 6.4 t 84.32 62.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.554 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.74 -146.96 4.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.394 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 3.8 tp10 -113.22 118.14 33.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 111.44 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.667 HG22 ' HA ' ' B' ' 21' ' ' THR . 19.2 p -51.92 150.22 4.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.736 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.2 OUTLIER -110.81 154.43 23.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.889 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.68 ' HG2' HG22 ' B' ' 18' ' ' VAL . 6.8 ttm -127.27 100.37 6.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.971 0.415 . . . . 0.0 110.872 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.486 ' H ' HG21 ' B' ' 18' ' ' VAL . 3.8 tp -111.9 129.32 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.44 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 127.78 -102.76 0.61 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.17 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 5.5 p30 -166.26 8.59 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.579 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 31.6 tp10 167.18 57.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.68 HG22 ' HG2' ' B' ' 13' ' ' MET . 5.8 m -114.96 -157.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.729 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.648 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.2 OUTLIER 172.48 99.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.736 ' HB ' HD23 ' B' ' 12' ' ' LEU . 21.0 t -102.94 103.04 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.791 0.329 . . . . 0.0 111.838 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.667 ' HA ' HG22 ' B' ' 11' ' ' THR . 45.0 m -87.22 146.89 25.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.232 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.809 ' HA ' HG23 ' B' ' 32' ' ' ILE . 30.3 m -109.76 77.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.421 HD12 ' N ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -100.0 -151.09 0.39 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.28 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' B' ' 31' ' ' ARG . . . 56.56 73.56 0.43 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.112 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.727 HG13 ' HD3' ' B' ' 7' ' ' ARG . 24.5 t -85.9 107.39 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.01 0.433 . . . . 0.0 111.607 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.591 ' H ' HG12 ' B' ' 30' ' ' VAL . 1.1 mttt -137.25 142.86 42.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.838 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.56 -44.14 29.02 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.42 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -104.53 -86.22 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.956 0.378 . . . . 0.0 111.478 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.563 ' OE1' HG21 ' A' ' 5' ' ' THR . 5.6 mt-30 -84.92 116.1 23.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.789 0.328 . . . . 0.0 111.204 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.591 HG12 ' H ' ' B' ' 26' ' ' LYS . 30.9 m -93.69 136.61 24.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.533 ' O ' ' HA3' ' B' ' 24' ' ' GLY . 4.9 mtt-85 -88.04 99.25 12.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.809 HG23 ' HA ' ' B' ' 22' ' ' VAL . 27.4 mm -92.81 141.74 14.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.24 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.06 108.74 3.01 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.719 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.474 ' HA ' HG13 ' B' ' 20' ' ' VAL . 27.0 t -99.33 103.5 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.843 0.354 . . . . 0.0 111.086 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' B' ' 19' ' ' THR . 1.1 t-20 -90.78 107.24 19.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 110.597 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.5 141.29 38.57 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.288 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.638 ' CD ' HG12 ' B' ' 18' ' ' VAL . 84.7 Cg_endo -77.92 156.13 30.61 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.663 2.242 . . . . 0.0 112.221 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -83.19 3.75 29.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.524 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -85.98 -36.93 19.49 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.696 0.284 . . . . 0.0 111.091 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 15' ' ' GLY . 11.0 t -90.65 141.29 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 111.055 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -59.06 105.69 0.35 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.184 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.466 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.9 p -122.28 122.55 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.11 136.25 50.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.734 0.302 . . . . 0.0 110.627 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.673 ' NE ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -154.54 59.42 0.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.744 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.11 136.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -65.4 -41.86 93.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 36.4 mm -67.32 -54.48 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.581 ' CD1' HD11 ' A' ' 4' ' ' LEU . 8.2 m-85 -47.15 -43.31 20.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.537 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.596 ' HG2' HD21 ' A' ' 2' ' ' LEU . 0.3 OUTLIER -78.36 -54.98 5.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.331 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.42 ' HA ' ' HB2' ' B' ' 54' ' ' GLU . 84.8 mmt-85 -56.97 -12.94 2.29 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.73 -57.33 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.676 0.274 . . . . 0.0 111.25 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.439 ' OE1' HD12 ' A' ' 4' ' ' LEU . 32.5 mt-30 -72.72 -57.88 3.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.734 ' HB2' ' HG ' ' A' ' 2' ' ' LEU . . . -67.41 -34.51 77.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.978 0.418 . . . . 0.0 110.847 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 1.6 mt-10 -121.77 133.58 54.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.795 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.18 101.48 0.72 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.626 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.06 -66.32 0.26 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.98 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.68 166.92 19.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -177.04 110.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.799 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 35.4 t -58.77 106.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 10.8 m -96.56 120.95 37.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.955 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 t80 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.916 179.978 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.793 0.33 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.75 HD12 ' HB2' ' B' ' 53' ' ' ALA . 9.6 tt -118.86 110.72 17.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.3 tt -96.86 105.36 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.143 0.497 . . . . 0.0 110.829 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.8 124.31 41.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.15 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -60.13 141.82 55.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.618 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -145.36 145.38 31.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.209 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.618 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 8.7 tmm_? 165.33 -10.86 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.224 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 8' ' ' VAL . 17.6 t -149.38 1.31 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.93 -156.54 31.64 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.009 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.27 -163.91 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.764 0.316 . . . . 0.0 111.048 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.731 HG22 ' HA ' ' A' ' 21' ' ' THR . 17.6 p -107.53 163.14 13.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.746 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -112.24 154.68 25.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.264 179.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.63 100.16 5.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 111.251 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.517 HG23 HG23 ' B' ' 14' ' ' ILE . 6.9 tp -112.6 138.9 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.459 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.419 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 118.64 -104.54 1.11 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.3 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 4.2 t0 -153.51 1.0 0.25 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 3.2 mt-10 163.74 61.29 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.408 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.756 HG12 ' CD ' ' A' ' 37' ' ' PRO . 10.3 m -116.4 -157.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.308 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.953 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.2 OUTLIER 174.53 106.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.746 ' HB ' HD23 ' A' ' 12' ' ' LEU . 13.2 t -102.87 106.09 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.93 0.395 . . . . 0.0 111.676 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.731 ' HA ' HG22 ' A' ' 11' ' ' THR . 25.1 m -87.79 106.23 17.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.347 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.477 HG21 ' HG2' ' A' ' 6' ' ' ARG . 11.1 m -80.79 57.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.731 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.525 HD12 ' H ' ' A' ' 24' ' ' GLY . 32.0 tp -116.23 148.8 40.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.132 0.491 . . . . 0.0 110.692 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.525 ' H ' HD12 ' A' ' 23' ' ' LEU . . . 128.99 65.0 0.11 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.4 HG22 ' HG2' ' A' ' 7' ' ' ARG . 2.5 t -85.36 107.78 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 121.168 0.509 . . . . 0.0 112.241 -177.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.69 143.36 45.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.601 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.2 145.28 22.39 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.863 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.85 -82.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.636 0.255 . . . . 0.0 111.234 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -96.22 126.59 41.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.798 0.332 . . . . 0.0 111.091 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.765 HG21 HG21 ' B' ' 30' ' ' VAL . 26.3 t -93.58 134.35 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.07 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 6.4 mtm-85 -84.27 105.08 14.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' B' ' 6' ' ' ARG . 17.7 mm -91.89 133.91 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.331 . . . . 0.0 111.171 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.81 115.05 4.97 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.728 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.475 ' HA ' HG13 ' A' ' 20' ' ' VAL . 19.9 t -115.64 103.54 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.001 0.429 . . . . 0.0 111.814 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.953 ' HB3' HG23 ' A' ' 19' ' ' THR . 4.9 t-20 -97.44 107.44 19.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.219 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.71 150.07 72.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.783 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.756 ' CD ' HG12 ' A' ' 18' ' ' VAL . 87.5 Cg_endo -83.74 156.48 13.8 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.081 2.521 . . . . 0.0 112.188 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 19.91 4.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.298 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.76 -38.81 5.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.662 0.267 . . . . 0.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.421 HG12 ' O ' ' B' ' 15' ' ' GLY . 11.6 t -80.52 146.24 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.862 0.363 . . . . 0.0 110.947 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.65 106.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.115 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 42' ' ' VAL . 10.3 p -122.1 122.19 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.58 136.04 50.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.433 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -172.5 -69.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -164.49 121.29 1.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -65.38 -28.46 69.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.68 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.599 HG22 HD12 ' A' ' 51' ' ' ILE . 29.5 mm -70.95 -53.24 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.225 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -53.42 -42.55 67.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.405 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -78.12 -50.83 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.684 0.278 . . . . 0.0 111.51 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -61.03 -13.26 15.36 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.599 HD12 HG22 ' A' ' 47' ' ' ILE . 55.4 mt -112.39 -52.89 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.322 . . . . 0.0 111.151 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HG3' HD23 ' B' ' 4' ' ' LEU . 0.6 OUTLIER -69.13 -57.54 5.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.081 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.74 ' HB2' HD12 ' B' ' 2' ' ' LEU . . . -79.31 -32.3 43.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 111.253 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.13 125.57 52.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -55.62 92.35 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.612 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -68.6 0.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.783 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.79 -48.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.754 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -179.9 -67.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.753 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.41 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.82 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 m -100.3 143.11 30.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.4 t80 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.887 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.795 0.331 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.74 HD12 ' HB2' ' A' ' 53' ' ' ALA . 9.6 tt -118.93 110.73 17.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.616 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.3 tt -96.91 105.39 17.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.136 0.494 . . . . 0.0 110.798 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' B' ' 4' ' ' LEU . 0.2 OUTLIER -124.83 124.39 41.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.113 179.637 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -60.16 141.82 55.3 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.136 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.613 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -145.33 145.46 31.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.858 0.361 . . . . 0.0 111.156 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.613 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 8.7 tmm_? 165.31 -10.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.219 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.562 ' O ' HG12 ' B' ' 8' ' ' VAL . 17.7 t -149.3 1.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.97 -156.47 31.59 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.982 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.32 -164.0 1.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.332 . . . . 0.0 111.057 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.746 HG22 ' HA ' ' B' ' 21' ' ' THR . 17.6 p -107.47 163.18 13.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.2 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.771 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.1 OUTLIER -112.3 154.68 25.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.232 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -128.67 100.09 5.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 111.26 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.517 HG23 HG23 ' A' ' 14' ' ' ILE . 6.9 tp -112.55 138.89 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.536 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.421 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 118.65 -104.47 1.1 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.324 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 4.2 t0 -153.55 0.95 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.424 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 3.2 mt-10 163.73 61.27 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.966 0.413 . . . . 0.0 110.39 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.759 HG12 ' CD ' ' B' ' 37' ' ' PRO . 10.2 m -116.44 -157.08 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.327 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.935 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.2 OUTLIER 174.53 106.43 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.771 ' HB ' HD23 ' B' ' 12' ' ' LEU . 13.2 t -102.92 106.13 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.978 0.418 . . . . 0.0 111.632 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.746 ' HA ' HG22 ' B' ' 11' ' ' THR . 25.1 m -87.81 106.25 17.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.361 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.477 HG21 ' HG2' ' B' ' 6' ' ' ARG . 11.0 m -80.83 57.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.696 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.517 HD12 ' H ' ' B' ' 24' ' ' GLY . 32.2 tp -116.34 148.84 40.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.157 0.503 . . . . 0.0 110.659 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.517 ' H ' HD12 ' B' ' 23' ' ' LEU . . . 129.01 64.99 0.11 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.37 107.83 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.225 0.536 . . . . 0.0 112.215 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.78 143.29 45.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.595 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.11 145.21 22.16 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.986 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.92 -82.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.636 0.255 . . . . 0.0 111.196 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -96.3 126.62 41.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.842 0.353 . . . . 0.0 111.028 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.765 HG21 HG21 ' A' ' 30' ' ' VAL . 26.3 t -93.53 134.38 31.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 6.4 mtm-85 -84.27 105.08 14.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.761 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.466 HG13 ' HB2' ' A' ' 6' ' ' ARG . 17.8 mm -91.97 134.03 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.349 . . . . 0.0 111.119 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.9 115.0 4.94 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.707 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.467 ' HA ' HG13 ' B' ' 20' ' ' VAL . 19.8 t -115.61 103.55 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 111.851 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.935 ' HB3' HG23 ' B' ' 19' ' ' THR . 4.9 t-20 -97.39 107.42 19.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.244 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.75 150.06 72.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.79 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.759 ' CD ' HG12 ' B' ' 18' ' ' VAL . 87.0 Cg_endo -83.71 156.38 13.83 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.063 2.509 . . . . 0.0 112.229 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 19.93 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.346 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.77 -38.75 5.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.714 0.293 . . . . 0.0 111.125 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 15' ' ' GLY . 11.6 t -80.53 146.21 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.981 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.54 106.31 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.196 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.461 HG13 ' O ' ' B' ' 42' ' ' VAL . 10.2 p -122.15 122.24 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.811 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.6 136.12 50.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.368 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -172.64 -69.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 0.0 110.797 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 21.3 tp10 -164.49 121.24 1.59 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -65.32 -28.47 69.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.671 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.601 HG22 HD12 ' B' ' 51' ' ' ILE . 29.4 mm -70.92 -53.31 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' B' ' 45' ' ' GLU . 6.7 m-85 -53.32 -42.59 66.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.491 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -78.16 -50.82 11.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.527 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -61.02 -13.26 15.21 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.601 HD12 HG22 ' B' ' 47' ' ' ILE . 55.4 mt -112.38 -52.98 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.0 111.104 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.09 -57.58 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.105 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.75 ' HB2' HD12 ' A' ' 2' ' ' LEU . . . -79.26 -32.15 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.283 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -110.15 128.2 55.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -68.07 86.56 0.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.725 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.44 -71.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.016 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -107.81 -70.89 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.04 111.74 7.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 55.0 m -108.84 101.6 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.6 p -98.94 127.05 44.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.843 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.853 0.359 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.787 HD21 HD23 ' A' ' 4' ' ' LEU . 5.5 tt -116.3 114.09 23.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 mm -92.08 105.58 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.108 0.48 . . . . 0.0 110.625 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.933 HD11 ' CE1' ' B' ' 48' ' ' TYR . 0.2 OUTLIER -119.32 156.75 29.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.589 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.679 ' H ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -95.25 129.03 42.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.24 179.1 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.653 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 15.9 mtt180 -142.35 146.85 35.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.689 ' O ' HG22 ' A' ' 25' ' ' VAL . 1.1 ttm180 165.33 -6.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.75 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.89 -62.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.808 0.337 . . . . 0.0 110.982 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.75 61.92 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.724 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -72.95 -69.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 110.625 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 m 71.75 101.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.483 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.506 HD13 HH22 ' A' ' 6' ' ' ARG . 1.1 pt? -111.26 154.77 23.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.075 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -127.61 100.06 5.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.016 0.436 . . . . 0.0 111.179 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.779 HD11 HG11 ' B' ' 18' ' ' VAL . 0.0 OUTLIER -113.77 134.27 57.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.25 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.446 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 123.89 -104.91 0.86 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.061 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -150.19 1.6 0.48 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.3 mt-10 159.09 67.04 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.133 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.766 HG11 HD11 ' B' ' 14' ' ' ILE . 9.9 m -119.53 -155.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.723 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER 172.94 102.15 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.704 HG22 HG13 ' A' ' 34' ' ' VAL . 38.3 t -113.35 110.79 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -107.3 107.83 18.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.15 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.778 HG12 ' CG2' ' A' ' 32' ' ' ILE . 29.9 m -80.28 74.87 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.062 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.478 HD12 ' H ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -63.72 -156.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' H ' HD12 ' A' ' 23' ' ' LEU . . . 83.06 71.9 1.3 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.92 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 7' ' ' ARG . 10.7 t -86.19 107.68 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.083 0.468 . . . . 0.0 111.938 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.53 165.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -170.63 13.46 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.298 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.9 -28.57 14.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.882 0.372 . . . . 0.0 110.554 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -121.1 136.68 54.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.565 HG12 HD13 ' A' ' 32' ' ' ILE . 4.0 t -93.31 115.31 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.373 . . . . 0.0 111.553 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.51 98.84 7.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.874 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.778 ' CG2' HG12 ' A' ' 22' ' ' VAL . 4.6 mm -94.03 125.28 46.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.426 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.44 103.6 1.98 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.978 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.704 HG13 HG22 ' A' ' 20' ' ' VAL . 17.7 t -98.27 103.66 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.941 0.4 . . . . 0.0 111.893 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -92.63 107.46 19.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.077 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.8 147.71 55.38 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.017 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.655 ' HD2' HG12 ' A' ' 18' ' ' VAL . 88.4 Cg_endo -79.66 156.55 24.57 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.966 2.444 . . . . 0.0 111.99 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -90.63 29.74 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.38 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.44 -40.32 5.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.669 0.271 . . . . 0.0 111.147 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.71 149.08 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.93 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.77 97.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.094 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 42' ' ' VAL . 7.5 p -122.49 121.48 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.948 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.96 136.15 50.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.725 0.298 . . . . 0.0 110.404 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' B' ' 12' ' ' LEU . 0.0 OUTLIER -149.54 -62.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.719 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' OE2' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -171.47 133.49 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -65.36 -36.32 83.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.088 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 48' ' ' TYR . 1.7 tp -74.28 -47.9 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.583 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.931 ' CE1' HD11 ' B' ' 4' ' ' LEU . 2.0 m-85 -55.84 -38.14 69.65 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -64.62 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -55.33 -15.86 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.9 mm -103.61 -56.55 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.653 0.263 . . . . 0.0 111.564 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.495 ' OE1' HD22 ' B' ' 4' ' ' LEU . 2.5 mm-40 -77.0 -56.97 4.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.678 0.275 . . . . 0.0 111.228 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.771 ' HB2' ' CD1' ' B' ' 2' ' ' LEU . . . -70.48 -25.27 63.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.297 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 16.0 tt0 -131.6 146.75 52.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.916 0.388 . . . . 0.0 111.203 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 18.4 mtpt 67.49 -99.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.734 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.95 161.31 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.861 0.363 . . . . 0.0 110.886 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -60.94 -169.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.774 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -106.12 -50.47 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.805 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.1 -68.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.3 t -122.03 140.18 52.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.774 0.321 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.788 HD21 HD23 ' B' ' 4' ' ' LEU . 5.5 tt -116.43 114.12 23.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 mm -92.06 105.53 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.052 0.453 . . . . 0.0 110.623 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.931 HD11 ' CE1' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -119.25 156.8 29.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.645 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.677 ' H ' HD13 ' B' ' 4' ' ' LEU . 0.0 OUTLIER -95.33 129.1 42.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.231 179.128 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.645 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 16.0 mtt180 -142.39 146.85 35.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.691 ' O ' HG22 ' B' ' 25' ' ' VAL . 1.1 ttm180 165.29 -6.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.725 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.96 -62.9 2.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.782 0.325 . . . . 0.0 111.009 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.76 61.98 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.726 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -72.96 -69.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.612 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 5.7 m 71.75 101.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.551 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.513 HD13 HH22 ' B' ' 6' ' ' ARG . 1.1 pt? -111.11 154.74 23.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.154 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -127.64 100.11 5.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.062 0.458 . . . . 0.0 111.172 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.766 HD11 HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -113.75 134.27 57.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.228 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.443 ' N ' HD13 ' B' ' 14' ' ' ILE . . . 123.84 -104.88 0.86 Allowed Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.099 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 0.8 OUTLIER -150.2 1.59 0.47 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.3 mt-10 159.1 67.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.874 0.368 . . . . 0.0 110.175 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.779 HG11 HD11 ' A' ' 14' ' ' ILE . 10.0 m -119.53 -155.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 120.839 0.352 . . . . 0.0 111.703 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.653 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.1 OUTLIER 172.92 102.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.711 HG22 HG13 ' B' ' 34' ' ' VAL . 38.4 t -113.37 110.86 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -107.34 107.79 18.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.23 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.764 HG12 ' CG2' ' B' ' 32' ' ' ILE . 30.5 m -80.24 74.98 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.019 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.486 HD12 ' H ' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -63.8 -156.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.731 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.486 ' H ' HD12 ' B' ' 23' ' ' LEU . . . 83.13 71.87 1.3 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.921 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.691 HG22 ' O ' ' B' ' 7' ' ' ARG . 10.7 t -86.22 107.66 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.083 0.468 . . . . 0.0 111.948 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.6 165.22 0.29 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.804 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.64 -170.64 13.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.324 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.88 -28.49 14.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.91 0.386 . . . . 0.0 110.579 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -121.19 136.7 54.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.97 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.556 HG12 HD13 ' B' ' 32' ' ' ILE . 4.0 t -93.35 115.37 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.948 0.404 . . . . 0.0 111.535 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.57 98.81 7.79 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.861 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.764 ' CG2' HG12 ' B' ' 22' ' ' VAL . 4.6 mm -93.98 125.28 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.417 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.51 103.56 1.97 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.964 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.711 HG13 HG22 ' B' ' 20' ' ' VAL . 17.5 t -98.15 103.63 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.937 0.399 . . . . 0.0 111.945 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -92.7 107.54 19.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.034 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.82 147.65 55.11 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.016 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.668 ' HD2' HG12 ' B' ' 18' ' ' VAL . 88.8 Cg_endo -79.69 156.59 24.5 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.982 2.454 . . . . 0.0 112.0 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -90.71 29.81 1.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.328 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.43 -40.31 5.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.711 0.291 . . . . 0.0 111.159 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.0 t -81.7 149.1 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.78 97.8 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.076 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.457 HG13 ' O ' ' B' ' 42' ' ' VAL . 7.4 p -122.56 121.46 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.91 136.15 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.676 0.274 . . . . 0.0 110.433 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.462 ' HG2' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -149.6 -62.72 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.952 0.406 . . . . 0.0 110.724 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.417 ' OE2' HG22 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -171.46 133.47 0.81 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.463 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.7 OUTLIER -65.28 -36.34 83.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.52 HG23 ' N ' ' B' ' 48' ' ' TYR . 1.7 tp -74.31 -47.89 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.562 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.933 ' CE1' HD11 ' A' ' 4' ' ' LEU . 2.0 m-85 -55.66 -38.3 69.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -64.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' B' ' 46' ' ' GLU . 0.0 OUTLIER -55.28 -15.79 2.77 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.642 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 39.9 mm -103.65 -56.44 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.604 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.497 ' OE1' HD22 ' A' ' 4' ' ' LEU . 2.5 mm-40 -77.17 -56.86 4.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.758 0.313 . . . . 0.0 111.233 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.773 ' HB2' ' CD1' ' A' ' 2' ' ' LEU . . . -70.55 -25.17 62.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.203 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -132.32 146.05 51.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 0.0 111.179 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 mttm 52.04 19.23 0.97 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.337 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 2.1 t -68.25 155.43 39.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.776 0.322 . . . . 0.0 110.587 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.31 105.33 11.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.696 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -147.25 162.36 39.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.29 -25.46 10.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.068 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.15 127.82 38.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.876 0.369 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.888 0.375 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.783 HD13 ' HB2' ' B' ' 53' ' ' ALA . 7.8 tp -121.21 112.37 18.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.7 tt -99.79 105.74 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.222 0.535 . . . . 0.0 110.795 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.568 HD22 ' HG3' ' B' ' 52' ' ' GLN . 1.9 mm? -124.41 120.71 32.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.752 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -55.45 141.63 35.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.738 0.304 . . . . 0.0 110.806 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.739 ' HB2' HG21 ' A' ' 22' ' ' VAL . 5.3 mtt180 -150.95 143.94 24.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.058 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.716 ' HD2' HG13 ' A' ' 25' ' ' VAL . 5.7 ttp180 169.7 -4.17 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.756 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.44 -71.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.68 0.276 . . . . 0.0 111.199 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.88 90.48 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.697 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.637 ' O ' HG23 ' A' ' 11' ' ' THR . 57.9 mm-40 -110.15 -174.39 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.637 0.256 . . . . 0.0 110.56 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER 170.82 101.28 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 111.041 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.474 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 1.2 pt? -115.31 154.1 29.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.397 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.407 ' HG2' HG22 ' A' ' 18' ' ' VAL . 2.1 ttm -129.53 100.7 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.096 0.474 . . . . 0.0 111.092 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.86 HG23 HG23 ' B' ' 14' ' ' ILE . 2.4 tp -114.73 123.29 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.531 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.54 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 133.23 -107.18 0.67 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.116 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -148.47 5.09 0.71 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 1.7 tt0 154.61 72.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.893 0.477 . . . . 0.0 109.969 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.592 HG11 ' CG1' ' B' ' 14' ' ' ILE . 9.1 m -122.31 -152.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.35 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.898 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 169.41 103.69 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' A' ' 34' ' ' VAL . 31.3 t -116.43 113.79 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.96 0.41 . . . . 0.0 111.858 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 t -110.88 112.9 25.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.33 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.923 HG12 HG23 ' A' ' 32' ' ' ILE . 26.9 m -80.81 75.55 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.802 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.61 -138.02 0.1 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.531 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 31' ' ' ARG . . . 53.02 77.33 0.15 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.466 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.716 HG13 ' HD2' ' A' ' 7' ' ' ARG . 36.2 t -85.84 107.91 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 111.709 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.789 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -130.74 141.11 50.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.691 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.39 -50.39 5.58 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.57 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -101.57 -83.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.863 0.332 . . . . 0.0 111.262 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.438 ' HB3' HG22 ' B' ' 5' ' ' THR . 14.0 mp0 -87.18 118.99 26.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.0 111.126 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.789 HG12 ' H ' ' A' ' 26' ' ' LYS . 15.4 m -93.33 136.34 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.186 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.613 ' HB3' HD11 ' B' ' 3' ' ' ILE . 5.0 mtm180 -78.13 106.44 10.01 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.483 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.923 HG23 HG12 ' A' ' 22' ' ' VAL . 32.5 mm -87.35 135.46 25.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.597 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.35 120.71 6.41 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.355 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.751 ' HA ' HG13 ' A' ' 20' ' ' VAL . 17.4 t -116.08 103.61 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.41 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.898 ' HB3' HG23 ' A' ' 19' ' ' THR . 0.7 OUTLIER -98.08 107.67 20.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.571 179.641 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.35 142.36 26.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.503 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.486 ' HD2' HG12 ' A' ' 18' ' ' VAL . 95.0 Cg_endo -79.29 156.35 25.67 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.724 2.283 . . . . 0.0 112.164 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.52 3.39 21.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.55 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -78.59 -41.91 30.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.71 0.291 . . . . 0.0 111.17 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.534 HG12 ' O ' ' B' ' 15' ' ' GLY . 6.3 t -87.3 152.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.929 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 m -66.55 100.26 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.892 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.588 ' HB ' HD13 ' B' ' 14' ' ' ILE . 13.4 p -122.15 120.67 61.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.239 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.31 136.12 50.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.542 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' NH2' HG21 ' A' ' 42' ' ' VAL . 32.4 mtt85 -141.09 -64.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 0.0 110.805 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HB2' ' CG ' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -168.88 136.15 1.9 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.748 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -55.0 -53.57 54.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.493 ' HA ' HD13 ' A' ' 51' ' ' ILE . 12.8 tt -65.08 -41.99 93.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.459 ' CG ' ' HB2' ' A' ' 45' ' ' GLU . 3.5 m-85 -45.46 -48.31 13.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.578 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -89.0 -49.33 6.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.463 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.637 ' C ' HD12 ' A' ' 51' ' ' ILE . 7.8 mtp180 -53.59 -17.37 2.07 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.637 HD12 ' C ' ' A' ' 50' ' ' ARG . 1.3 mp -111.52 -51.12 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.699 0.285 . . . . 0.0 111.013 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.565 ' HG3' HD22 ' B' ' 4' ' ' LEU . 0.5 OUTLIER -73.18 -60.36 2.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.937 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.777 ' HB2' HD13 ' B' ' 2' ' ' LEU . . . -69.08 -36.61 77.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.895 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 2.4 mt-10 -114.31 123.8 50.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -46.38 107.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.289 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.411 ' HB3' HG23 ' A' ' 51' ' ' ILE . 24.6 p -63.59 163.41 11.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.987 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.52 91.71 4.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.67 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -129.1 161.62 29.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.024 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.3 p -149.0 82.96 1.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.722 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 m -91.94 127.17 37.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.834 0.35 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.777 HD13 ' HB2' ' A' ' 53' ' ' ALA . 7.7 tp -121.18 112.31 18.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.624 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.7 tt -99.77 105.73 17.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.146 0.498 . . . . 0.0 110.85 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.565 HD22 ' HG3' ' A' ' 52' ' ' GLN . 1.9 mm? -124.36 120.68 32.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.769 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -55.43 141.57 35.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.323 . . . . 0.0 110.735 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.744 ' HB2' HG21 ' B' ' 22' ' ' VAL . 5.3 mtt180 -150.95 143.95 24.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.707 ' HD2' HG13 ' B' ' 25' ' ' VAL . 5.7 ttp180 169.71 -4.13 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.758 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.45 -71.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.672 0.273 . . . . 0.0 111.171 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.88 90.4 0.13 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.703 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.625 ' O ' HG23 ' B' ' 11' ' ' THR . 58.0 mm-40 -110.09 -174.36 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.636 0.255 . . . . 0.0 110.591 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.625 HG23 ' O ' ' B' ' 10' ' ' GLU . 0.1 OUTLIER 170.79 101.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.082 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.469 ' CD2' ' HB ' ' B' ' 20' ' ' VAL . 1.2 pt? -115.33 154.08 29.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.427 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.413 ' HG2' HG22 ' B' ' 18' ' ' VAL . 2.1 ttm -129.46 100.73 5.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.057 0.456 . . . . 0.0 111.076 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.86 HG23 HG23 ' A' ' 14' ' ' ILE . 2.4 tp -114.83 123.31 70.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.493 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.534 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 133.2 -107.17 0.67 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.159 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.1 OUTLIER -148.4 5.09 0.71 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 1.7 tt0 154.65 72.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.895 0.478 . . . . 0.0 110.026 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.579 HG11 ' CG1' ' A' ' 14' ' ' ILE . 9.3 m -122.32 -152.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.305 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.925 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 169.45 103.74 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' B' ' 34' ' ' VAL . 31.9 t -116.47 113.82 44.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.931 0.396 . . . . 0.0 111.798 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 2.0 t -110.93 112.87 25.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.303 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.926 HG12 HG23 ' B' ' 32' ' ' ILE . 27.0 m -80.72 75.48 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.84 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.55 -138.03 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.565 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' B' ' 31' ' ' ARG . . . 52.96 77.35 0.14 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.481 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.707 HG13 ' HD2' ' B' ' 7' ' ' ARG . 37.2 t -85.9 107.9 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.037 0.446 . . . . 0.0 111.674 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.778 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.1 OUTLIER -130.64 141.09 50.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.657 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.43 -50.37 5.62 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.267 -0.492 . . . . 0.0 113.587 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -101.61 -83.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.813 0.306 . . . . 0.0 111.235 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.448 ' HB3' HG22 ' A' ' 5' ' ' THR . 14.0 mp0 -87.22 118.99 27.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.915 0.388 . . . . 0.0 111.121 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.778 HG12 ' H ' ' B' ' 26' ' ' LYS . 15.4 m -93.32 136.38 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.145 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.598 ' HB3' HD11 ' A' ' 3' ' ' ILE . 5.0 mtm180 -78.14 106.42 10.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.532 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.926 HG23 HG12 ' B' ' 22' ' ' VAL . 32.6 mm -87.33 135.4 25.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.002 0.429 . . . . 0.0 111.545 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.29 120.66 6.4 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.374 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.751 ' HA ' HG13 ' B' ' 20' ' ' VAL . 17.4 t -116.04 103.67 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 0.0 111.429 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.925 ' HB3' HG23 ' B' ' 19' ' ' THR . 0.7 OUTLIER -98.15 107.69 20.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.544 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.36 142.33 26.31 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.533 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.496 ' HD2' HG12 ' B' ' 18' ' ' VAL . 94.6 Cg_endo -79.28 156.33 25.69 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.73 2.287 . . . . 0.0 112.195 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.51 3.45 21.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.537 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -78.69 -41.88 29.92 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.683 0.278 . . . . 0.0 111.129 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 15' ' ' GLY . 6.3 t -87.26 152.07 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.987 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -66.62 100.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.585 ' HB ' HD13 ' A' ' 14' ' ' ILE . 13.3 p -122.16 120.66 61.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.233 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.35 136.06 50.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.74 0.305 . . . . 0.0 110.576 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.426 ' NH2' HG21 ' B' ' 42' ' ' VAL . 32.4 mtt85 -141.03 -64.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.899 0.38 . . . . 0.0 110.819 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.457 ' HB2' ' CG ' ' B' ' 48' ' ' TYR . 0.8 OUTLIER -168.85 136.21 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.738 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -55.02 -53.66 52.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.009 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.506 ' HA ' HD13 ' B' ' 51' ' ' ILE . 12.8 tt -64.98 -42.01 93.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.457 ' CG ' ' HB2' ' B' ' 45' ' ' GLU . 3.5 m-85 -45.4 -48.37 13.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.568 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -89.02 -49.34 6.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.464 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.635 ' C ' HD12 ' B' ' 51' ' ' ILE . 7.8 mtp180 -53.56 -17.37 2.05 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.635 HD12 ' C ' ' B' ' 50' ' ' ARG . 1.3 mp -111.56 -50.98 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.708 0.289 . . . . 0.0 111.065 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.568 ' HG3' HD22 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -73.3 -60.32 2.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.896 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.783 ' HB2' HD13 ' A' ' 2' ' ' LEU . . . -69.07 -36.63 77.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.886 0.374 . . . . 0.0 110.92 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' B' ' 50' ' ' ARG . 2.4 mt-10 -114.2 123.45 49.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.783 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -56.87 104.28 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.142 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 21.5 t -96.89 -155.74 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.4 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.6 107.55 11.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.778 0.323 . . . . 0.0 110.626 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -137.56 -67.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.934 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 35.7 p -157.35 133.59 9.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.9 121.05 38.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.935 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.839 0.352 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' B' ' 53' ' ' ALA . 7.4 tt -114.1 105.39 13.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 3' ' ' ILE . 3.9 tt -100.96 105.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.279 0.561 . . . . 0.0 111.08 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.587 HD13 ' CD2' ' B' ' 48' ' ' TYR . 0.9 OUTLIER -125.22 119.71 29.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.85 179.339 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.693 HG23 ' HG2' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -58.02 149.55 22.99 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.724 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.19 144.32 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.978 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.746 ' HD3' HG13 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -163.93 25.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.561 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.52 -52.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.981 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.17 89.18 0.1 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.676 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.8 55.48 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.0 0.429 . . . . 0.0 110.674 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -61.45 101.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.457 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.559 HD23 ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -111.12 154.23 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.991 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -133.19 99.7 4.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.279 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.779 HG23 HG23 ' B' ' 14' ' ' ILE . 8.8 tp -118.04 138.7 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.723 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.501 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 122.06 -108.23 1.27 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.441 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -143.47 -5.41 0.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 3.2 tt0 163.31 65.28 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.729 HG12 ' HD2' ' A' ' 37' ' ' PRO . 11.5 m -117.28 -160.78 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.511 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER 175.74 104.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.814 HG12 HG13 ' A' ' 34' ' ' VAL . 27.2 m -115.54 106.87 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.65 109.51 21.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.361 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.676 HG11 ' CD1' ' B' ' 32' ' ' ILE . 8.9 p -77.84 70.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.602 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.81 -147.24 0.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.544 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 31' ' ' ARG . . . 63.19 79.67 0.14 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.165 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.746 HG13 ' HD3' ' A' ' 7' ' ' ARG . 85.9 t -85.91 107.36 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.001 0.429 . . . . 0.0 111.619 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.662 ' H ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -133.95 139.2 45.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.875 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.77 -50.66 7.15 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 113.753 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -101.36 -87.46 0.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.018 0.409 . . . . 0.0 111.452 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.87 119.63 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 26' ' ' LYS . 18.5 m -93.3 136.83 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.631 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.696 ' HG2' HG23 ' B' ' 5' ' ' THR . 4.8 mmt180 -76.99 103.76 7.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.944 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.686 ' CD1' HG11 ' B' ' 22' ' ' VAL . 8.4 mt -87.33 131.3 35.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.401 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.86 110.59 3.77 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.173 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.814 HG13 HG12 ' A' ' 20' ' ' VAL . 28.0 t -110.76 103.04 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.973 0.416 . . . . 0.0 111.565 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.8 t-20 -96.04 107.3 19.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.287 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.68 145.99 53.5 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.761 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.729 ' HD2' HG12 ' A' ' 18' ' ' VAL . 92.2 Cg_endo -79.47 156.32 25.07 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.87 2.38 . . . . 0.0 112.145 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.35 35.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -119.17 -38.76 2.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.035 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.49 HG12 ' O ' ' B' ' 15' ' ' GLY . 7.6 t -80.24 155.08 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.935 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -59.13 112.6 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 42' ' ' VAL . 11.9 p -122.04 121.0 62.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -129.03 128.16 43.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.369 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.42 -69.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -157.03 116.66 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.78 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -60.92 -35.78 77.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 51' ' ' ILE . 1.2 tp -74.79 -43.34 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.601 ' CD2' HD13 ' B' ' 4' ' ' LEU . 6.4 m-85 -51.5 -43.26 62.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.334 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 8.7 pt20 -82.17 -41.74 19.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.255 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.417 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 7.3 mtm180 -72.62 0.17 11.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 47' ' ' ILE . 11.1 tt -114.99 -45.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.756 0.312 . . . . 0.0 111.28 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.493 ' N ' HG23 ' A' ' 51' ' ' ILE . 31.2 mm-40 -90.22 -50.07 6.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.732 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.489 ' HB2' HD12 ' B' ' 2' ' ' LEU . . . -75.23 -43.56 51.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -102.55 118.66 37.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.626 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.23 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.854 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.446 ' HB2' ' HA ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -88.22 41.85 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.207 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 63.46 131.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.921 0.391 . . . . 0.0 111.118 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -133.25 -43.32 0.86 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.837 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 95.6 p -144.21 92.76 2.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.782 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 p -103.31 126.43 50.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.018 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.95 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.84 0.352 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 53' ' ' ALA . 7.4 tt -114.16 105.44 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.827 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.636 HG23 ' O ' ' B' ' 3' ' ' ILE . 3.9 tt -100.98 105.16 17.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.22 0.533 . . . . 0.0 111.021 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.601 HD13 ' CD2' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -125.23 119.74 29.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.809 179.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.696 HG23 ' HG2' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -58.0 149.68 22.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.68 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.11 144.41 0.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.98 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.744 ' HD3' HG13 ' B' ' 25' ' ' VAL . 0.8 OUTLIER -164.03 25.93 0.07 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.638 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.51 -52.46 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.982 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.24 89.21 0.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.64 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.86 55.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.022 0.439 . . . . 0.0 110.648 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 25.7 m -61.53 101.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.522 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.565 HD23 ' CG2' ' B' ' 20' ' ' VAL . 0.1 OUTLIER -111.03 154.23 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.013 179.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -133.2 99.68 4.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.419 . . . . 0.0 111.289 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.779 HG23 HG23 ' A' ' 14' ' ' ILE . 8.7 tp -118.06 138.72 47.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.721 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.49 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 122.04 -108.11 1.26 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.528 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 0.8 OUTLIER -143.55 -5.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 3.3 tt0 163.23 65.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.755 HG12 ' HD2' ' B' ' 37' ' ' PRO . 11.6 m -117.22 -160.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.518 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.721 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.4 OUTLIER 175.71 104.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.798 HG12 HG13 ' B' ' 34' ' ' VAL . 27.7 m -115.51 106.78 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.57 109.46 21.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.376 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.686 HG11 ' CD1' ' A' ' 32' ' ' ILE . 8.9 p -77.81 70.4 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.582 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.95 -147.22 0.16 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.543 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.509 ' HA3' ' HB2' ' B' ' 31' ' ' ARG . . . 63.25 79.6 0.15 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.158 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.744 HG13 ' HD3' ' B' ' 7' ' ' ARG . 86.6 t -85.88 107.38 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.023 0.439 . . . . 0.0 111.614 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.657 ' H ' HG12 ' B' ' 30' ' ' VAL . 0.0 OUTLIER -133.94 139.22 45.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.814 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.76 -50.69 7.13 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.755 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -101.31 -87.51 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.984 0.392 . . . . 0.0 111.421 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.84 119.61 25.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.9 0.381 . . . . 0.0 110.865 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.657 HG12 ' H ' ' B' ' 26' ' ' LYS . 18.4 m -93.3 136.88 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.624 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.693 ' HG2' HG23 ' A' ' 5' ' ' THR . 4.8 mmt180 -77.03 103.7 7.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.049 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.676 ' CD1' HG11 ' A' ' 22' ' ' VAL . 8.5 mt -87.33 131.35 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.411 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.91 110.61 3.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.201 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.798 HG13 HG12 ' B' ' 20' ' ' VAL . 28.1 t -110.8 103.1 14.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.921 0.391 . . . . 0.0 111.524 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' B' ' 19' ' ' THR . 1.8 t-20 -96.08 107.29 19.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.279 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.67 145.92 53.25 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.815 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.755 ' HD2' HG12 ' B' ' 18' ' ' VAL . 93.0 Cg_endo -79.43 156.36 25.22 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.863 2.375 . . . . 0.0 112.129 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.38 35.01 1.02 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.146 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -119.09 -38.9 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.741 0.305 . . . . 0.0 111.076 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 15' ' ' GLY . 7.5 t -80.15 155.03 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -59.09 112.62 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.053 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.498 HG13 ' O ' ' B' ' 42' ' ' VAL . 11.9 p -122.07 121.03 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -129.05 128.18 43.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.343 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 -69.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.72 0.295 . . . . 0.0 111.057 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -157.03 116.71 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.928 0.394 . . . . 0.0 110.734 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -60.94 -35.79 77.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.876 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.637 ' O ' HG22 ' B' ' 51' ' ' ILE . 1.2 tp -74.74 -43.38 47.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.111 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.587 ' CD2' HD13 ' A' ' 4' ' ' LEU . 6.4 m-85 -51.35 -43.36 61.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.325 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 8.7 pt20 -82.15 -41.83 19.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.229 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -72.54 0.17 11.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.637 HG22 ' O ' ' B' ' 47' ' ' ILE . 11.1 tt -115.04 -45.66 4.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.755 0.312 . . . . 0.0 111.242 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.49 ' N ' HG23 ' B' ' 51' ' ' ILE . 31.3 mm-40 -90.15 -50.05 6.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.714 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' A' ' 2' ' ' LEU . . . -75.25 -43.51 51.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.824 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.51 121.21 42.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.733 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 87.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 21.2 p -62.76 -176.06 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.028 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -172.77 171.3 4.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.804 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -57.97 -29.08 64.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.985 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 2.0 p -175.63 145.93 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.803 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.5 p -121.47 133.15 55.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 48.6 p90 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.897 179.975 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.832 0.349 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.451 HD22 HH21 ' B' ' 44' ' ' ARG . 0.7 OUTLIER -116.96 109.69 17.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 mm -97.2 105.34 17.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.09 0.471 . . . . 0.0 110.789 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.467 ' HG ' ' CG ' ' B' ' 48' ' ' TYR . 0.1 OUTLIER -124.23 110.42 14.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.2 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.3 OUTLIER -62.9 77.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.961 0.41 . . . . 0.0 111.474 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.471 ' HB2' HG13 ' B' ' 32' ' ' ILE . 3.8 mtt-85 -80.12 143.68 33.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.321 0.581 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.637 ' HD3' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -170.59 -7.48 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.878 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -161.32 12.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.49 -139.25 9.36 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.864 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -107.08 -164.54 0.99 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.785 0.326 . . . . 0.0 111.178 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.612 HG22 HG23 ' A' ' 21' ' ' THR . 8.3 p -110.02 169.34 8.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 12' ' ' LEU . 1.6 pt? -109.35 154.31 22.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.597 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.564 ' HG2' HG22 ' A' ' 18' ' ' VAL . 1.6 ttp -129.73 100.29 5.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.07 0.462 . . . . 0.0 111.186 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.691 HG23 HG23 ' B' ' 14' ' ' ILE . 3.1 tp -114.32 124.69 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.486 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.52 ' O ' HG12 ' B' ' 40' ' ' VAL . . . 132.11 -105.35 0.6 Allowed Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.058 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 2.2 t70 -160.81 11.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER 159.17 61.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.851 0.46 . . . . 0.0 109.781 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.564 HG22 ' HG2' ' A' ' 13' ' ' MET . 8.8 m -118.3 -157.7 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.676 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.935 HG23 ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 167.32 102.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.77 HG13 ' HA ' ' A' ' 34' ' ' VAL . 25.7 t -118.65 113.85 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.982 0.42 . . . . 0.0 111.951 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.612 HG23 HG22 ' A' ' 11' ' ' THR . 4.0 m -96.03 113.08 24.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.549 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.786 HG11 HG21 ' B' ' 32' ' ' ILE . 30.5 m -76.78 -19.0 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.862 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER 62.89 -76.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.044 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 7' ' ' ARG . . . 92.41 -40.81 2.83 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.16 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.637 HG22 ' HD3' ' A' ' 7' ' ' ARG . 1.1 t -85.59 139.17 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.666 0.233 . . . . 0.0 110.938 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER 164.37 165.58 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.943 0.401 . . . . 0.0 110.715 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' GLN . . . -76.71 105.59 2.05 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.151 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m120 64.45 -72.53 0.06 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 111.23 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.505 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -84.46 136.93 33.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.682 179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.7 t -93.15 119.86 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.907 0.384 . . . . 0.0 111.794 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 0.1 OUTLIER -75.75 98.59 4.16 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.045 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.795 HG21 HG11 ' B' ' 22' ' ' VAL . 11.2 mm -92.18 123.42 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.39 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.77 119.24 6.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.26 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.77 ' HA ' HG13 ' A' ' 20' ' ' VAL . 22.0 t -109.74 103.73 15.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.922 0.391 . . . . 0.0 111.253 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.935 ' HB3' HG23 ' A' ' 19' ' ' THR . 3.6 t-20 -100.61 107.52 19.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.286 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.96 147.69 42.46 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.697 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.508 ' HD2' HG12 ' A' ' 18' ' ' VAL . 79.0 Cg_endo -77.51 156.52 32.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.866 2.377 . . . . 0.0 112.126 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 30.35 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.25 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -106.08 -37.96 6.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.77 0.319 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.509 HG12 ' O ' ' B' ' 15' ' ' GLY . 21.3 t -90.73 147.53 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -54.6 100.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.18 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.524 ' HB ' HD13 ' B' ' 14' ' ' ILE . 12.4 p -122.4 124.56 71.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.08 136.32 51.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.601 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.455 HH21 HD22 ' B' ' 2' ' ' LEU . 2.3 mpp_? -147.74 -176.85 5.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.57 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.455 ' HB3' ' CG ' ' A' ' 48' ' ' TYR . 2.7 tt0 -59.32 137.99 57.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -61.29 2.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.595 ' CG1' HD11 ' A' ' 51' ' ' ILE . 6.8 tt -54.73 -42.05 59.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.349 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.473 ' CG ' ' HG ' ' B' ' 4' ' ' LEU . 4.5 m-30 -46.24 -58.85 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.691 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 41.1 mt-30 -75.97 -20.99 57.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.625 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -73.19 -13.84 61.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.596 0.236 . . . . 0.0 111.458 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.595 HD11 ' CG1' ' A' ' 47' ' ' ILE . 28.6 mt -108.91 -33.11 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.723 0.297 . . . . 0.0 111.361 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.93 -50.84 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.342 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -62.23 -69.03 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.924 0.393 . . . . 0.0 110.771 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -113.94 118.62 34.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.507 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -57.25 101.73 0.07 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.643 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.82 -156.43 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -73.62 157.98 35.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.745 0.307 . . . . 0.0 110.701 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.03 -53.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.805 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.67 31.81 3.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.746 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.88 120.45 33.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.83 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.895 -179.945 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.815 0.34 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.455 HD22 HH21 ' A' ' 44' ' ' ARG . 0.7 OUTLIER -116.87 109.65 17.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 13.0 mm -97.13 105.29 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.075 0.464 . . . . 0.0 110.861 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.473 ' HG ' ' CG ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -124.22 110.45 14.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.178 179.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -62.95 77.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.011 0.434 . . . . 0.0 111.497 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.46 ' HB2' HG13 ' A' ' 32' ' ' ILE . 3.7 mtt-85 -80.06 143.67 33.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.329 0.585 . . . . 0.0 111.022 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.642 ' HD3' HG22 ' B' ' 25' ' ' VAL . 0.0 OUTLIER -170.56 -7.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.905 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.451 HG13 ' O ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -161.24 12.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.43 -139.26 9.35 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.896 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -107.12 -164.5 0.99 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.159 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.621 HG22 HG23 ' B' ' 21' ' ' THR . 8.5 p -110.07 169.37 8.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.481 HD23 ' H ' ' B' ' 12' ' ' LEU . 1.6 pt? -109.39 154.36 22.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.519 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.569 ' HG2' HG22 ' B' ' 18' ' ' VAL . 1.6 ttp -129.76 100.26 5.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.462 . . . . 0.0 111.159 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.691 HG23 HG23 ' A' ' 14' ' ' ILE . 3.1 tp -114.34 124.64 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.502 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.509 ' O ' HG12 ' A' ' 40' ' ' VAL . . . 132.13 -105.46 0.61 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.127 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' B' ' 17' ' ' GLU . 2.2 t70 -160.67 12.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' B' ' 16' ' ' ASP . 0.2 OUTLIER 159.03 61.86 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.854 0.462 . . . . 0.0 109.77 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.569 HG22 ' HG2' ' B' ' 13' ' ' MET . 8.8 m -118.41 -157.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.656 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.946 HG23 ' HB3' ' B' ' 35' ' ' ASN . 0.0 OUTLIER 167.4 102.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.748 HG13 ' HA ' ' B' ' 34' ' ' VAL . 25.8 t -118.72 113.74 42.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.4 . . . . 0.0 111.946 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.621 HG23 HG22 ' B' ' 11' ' ' THR . 4.0 m -95.96 113.16 24.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.795 HG11 HG21 ' A' ' 32' ' ' ILE . 31.0 m -76.75 -19.05 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.872 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.578 HD12 ' O ' ' B' ' 25' ' ' VAL . 0.2 OUTLIER 62.93 -76.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.02 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' B' ' 7' ' ' ARG . . . 92.42 -40.85 2.82 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.165 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.642 HG22 ' HD3' ' B' ' 7' ' ' ARG . 1.2 t -85.61 139.21 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.644 0.222 . . . . 0.0 110.943 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER 164.37 165.62 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.95 0.405 . . . . 0.0 110.736 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 29' ' ' GLN . . . -76.72 105.61 2.05 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.056 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m120 64.5 -72.63 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.903 0.382 . . . . 0.0 111.161 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' B' ' 26' ' ' LYS . 0.0 OUTLIER -84.47 136.98 33.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.631 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.14 119.82 41.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.847 0.356 . . . . 0.0 111.819 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -75.77 98.63 4.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.048 179.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.786 HG21 HG11 ' A' ' 22' ' ' VAL . 11.3 mm -92.18 123.33 44.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.334 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.71 119.23 6.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.332 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.748 ' HA ' HG13 ' B' ' 20' ' ' VAL . 22.0 t -109.73 103.7 15.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.878 0.371 . . . . 0.0 111.291 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.946 ' HB3' HG23 ' B' ' 19' ' ' THR . 3.6 t-20 -100.58 107.57 19.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.256 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.02 147.77 42.57 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.682 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.49 ' HD2' HG12 ' B' ' 18' ' ' VAL . 79.5 Cg_endo -77.6 156.49 31.95 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.836 2.357 . . . . 0.0 112.161 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 30.22 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.233 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -106.01 -38.02 6.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.808 0.337 . . . . 0.0 110.89 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 15' ' ' GLY . 21.2 t -90.63 147.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.947 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -54.58 100.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.204 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.513 ' HB ' HD13 ' A' ' 14' ' ' ILE . 12.4 p -122.34 124.54 71.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.09 136.29 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.631 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.451 HH21 HD22 ' A' ' 2' ' ' LEU . 2.3 mpp_? -147.74 -176.85 5.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.31 . . . . 0.0 110.631 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.453 ' HB3' ' CG ' ' B' ' 48' ' ' TYR . 2.7 tt0 -59.34 138.07 57.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 110.801 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -61.31 2.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.589 ' CG1' HD11 ' B' ' 51' ' ' ILE . 6.8 tt -54.72 -42.14 59.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.481 ' HD1' HG23 ' B' ' 47' ' ' ILE . 4.5 m-30 -46.2 -58.81 3.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.687 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 41.1 mt-30 -76.05 -20.93 57.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.609 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -73.28 -13.72 61.18 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 111.41 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.589 HD11 ' CG1' ' B' ' 47' ' ' ILE . 28.9 mt -109.09 -33.04 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.709 0.29 . . . . 0.0 111.357 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.98 -50.85 3.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.347 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' B' ' 49' ' ' GLN . . . -62.23 -69.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.969 0.414 . . . . 0.0 110.791 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -114.05 119.59 37.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.402 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -57.66 103.64 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.733 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 77.0 p -160.03 71.18 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.994 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -59.93 -40.63 89.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 56.17 32.39 20.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.024 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 59.5 p -88.05 89.19 7.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.969 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.42 145.03 24.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 54.2 p90 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.939 -179.985 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.789 0.328 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' B' ' 53' ' ' ALA . 2.0 mp -122.22 116.69 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.805 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 3' ' ' ILE . 4.2 tt -103.11 105.31 18.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.181 0.515 . . . . 0.0 110.786 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.611 HD22 ' CD1' ' B' ' 48' ' ' TYR . 4.1 tp -125.19 124.19 41.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.021 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' B' ' 31' ' ' ARG . 0.2 OUTLIER -55.6 140.66 40.31 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.376 179.458 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 6.1 mtp85 -151.65 142.97 23.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.939 0.4 . . . . 0.0 111.426 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 172.82 -0.52 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.784 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.3 t -148.73 116.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.796 0.331 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.78 63.45 5.23 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.71 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.479 ' C ' HG22 ' A' ' 11' ' ' THR . 28.4 mm-40 -106.64 173.27 6.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.538 0.209 . . . . 0.0 110.723 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.479 HG22 ' C ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER 164.47 101.26 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.326 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.869 HD23 ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -109.07 154.19 22.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.785 179.022 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -131.81 100.24 5.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.931 0.396 . . . . 0.0 111.307 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.91 HG23 HG23 ' B' ' 14' ' ' ILE . 7.2 tp -119.12 115.44 47.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.679 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.08 -106.76 0.51 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.912 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 11.8 t70 -150.74 8.64 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 2.1 mt-10 155.74 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.839 0.455 . . . . 0.0 109.879 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.802 HG12 ' HD2' ' A' ' 37' ' ' PRO . 16.6 m -135.58 131.41 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.861 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.1 m -116.09 117.05 29.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.869 ' HB ' HD23 ' A' ' 12' ' ' LEU . 4.9 t -108.89 110.84 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 111.784 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 t -102.24 104.61 15.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.239 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.003 HG23 HD12 ' A' ' 32' ' ' ILE . 5.6 p -80.88 71.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.241 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.11 -143.38 0.2 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.528 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.23 80.87 0.06 OUTLIER Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.797 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 30' ' ' VAL . 14.2 t -110.28 108.28 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 120.844 0.354 . . . . 0.0 111.324 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -167.03 135.2 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.623 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.51 -153.33 19.26 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.765 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.65 -52.73 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.494 ' HB3' HG22 ' B' ' 5' ' ' THR . 43.5 mt-30 -84.93 114.62 22.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 32' ' ' ILE . 3.7 m -93.07 137.14 23.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' B' ' 5' ' ' THR . 35.7 mtt180 -76.0 104.26 6.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.332 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.003 HD12 HG23 ' A' ' 22' ' ' VAL . 12.6 mm -87.22 137.38 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.901 0.381 . . . . 0.0 111.344 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.85 121.71 6.31 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.413 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.59 ' HA ' HG13 ' A' ' 20' ' ' VAL . 14.9 t -118.09 103.64 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.953 0.406 . . . . 0.0 111.431 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.25 107.59 19.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.299 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.07 144.82 22.6 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.822 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.802 ' HD2' HG12 ' A' ' 18' ' ' VAL . 93.0 Cg_endo -83.0 156.27 15.17 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.85 2.367 . . . . 0.0 111.971 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 42.73 1.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.214 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -113.36 -43.72 3.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.715 0.293 . . . . 0.0 110.94 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 41' ' ' SER . 5.1 t -83.43 160.9 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.844 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -59.79 99.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.715 -179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 42' ' ' VAL . 8.1 p -122.38 122.93 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.956 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.34 136.18 50.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.193 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.414 ' HD3' ' CD2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -161.76 -165.18 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.321 . . . . 0.0 110.766 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -64.26 136.71 57.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -55.08 -61.21 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 tt -55.95 -38.96 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.315 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.601 ' CD1' HD22 ' B' ' 4' ' ' LEU . 43.3 t80 -46.71 -61.91 1.62 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.657 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -76.35 -21.29 56.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.438 -179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 6.9 tpt180 -73.66 -10.94 60.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.424 HG13 ' N ' ' A' ' 52' ' ' GLN . 1.7 pt -114.29 -28.88 2.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.424 ' N ' HG13 ' A' ' 51' ' ' ILE . 13.1 mm-40 -104.83 -54.27 2.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.732 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -62.15 -66.01 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.699 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -110.26 117.52 33.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.648 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.29 107.93 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.484 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.82 160.24 12.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.891 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -63.13 -66.48 0.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -82.54 147.17 28.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.814 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 p -144.74 29.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.067 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.9 m -93.25 145.03 24.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.805 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.917 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.818 0.342 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 53' ' ' ALA . 2.0 mp -122.26 116.63 24.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.879 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.636 HG23 ' O ' ' B' ' 3' ' ' ILE . 4.2 tt -103.09 105.33 18.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.198 0.523 . . . . 0.0 110.774 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.601 HD22 ' CD1' ' A' ' 48' ' ' TYR . 4.1 tp -125.2 124.21 41.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.064 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -55.64 140.67 40.48 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.36 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' B' ' 7' ' ' ARG . 6.1 mtp85 -151.67 142.96 23.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.946 0.403 . . . . 0.0 111.427 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER 172.8 -0.54 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.821 179.438 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 17.3 t -148.66 116.75 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.781 0.324 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.7 63.47 5.21 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.705 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.472 ' C ' HG22 ' B' ' 11' ' ' THR . 28.3 mm-40 -106.6 173.33 6.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.503 0.192 . . . . 0.0 110.768 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.472 HG22 ' C ' ' B' ' 10' ' ' GLU . 0.6 OUTLIER 164.47 101.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.409 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' B' ' 20' ' ' VAL . 0.0 OUTLIER -109.0 154.19 22.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.789 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.504 ' HA ' ' O ' ' B' ' 18' ' ' VAL . 0.5 OUTLIER -131.8 100.22 5.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 111.322 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.91 HG23 HG23 ' A' ' 14' ' ' ILE . 7.2 tp -119.06 115.45 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.708 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.08 -106.71 0.51 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.94 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' B' ' 17' ' ' GLU . 11.8 t70 -150.8 8.7 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' B' ' 16' ' ' ASP . 2.1 mt-10 155.7 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.811 0.444 . . . . 0.0 109.878 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.801 HG12 ' HD2' ' B' ' 37' ' ' PRO . 16.5 m -135.64 131.42 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.827 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -116.05 117.04 29.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.858 ' HB ' HD23 ' B' ' 12' ' ' LEU . 4.8 t -108.86 110.82 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.868 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . . . . . . . . . 1.4 t -102.22 104.62 15.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.216 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.97 HG23 HD12 ' B' ' 32' ' ' ILE . 5.6 p -80.88 71.04 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.291 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -143.35 0.2 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.476 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.19 80.79 0.06 OUTLIER Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.887 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' B' ' 30' ' ' VAL . 14.0 t -110.21 108.28 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 111.309 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -167.07 135.09 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.658 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.59 -153.36 19.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.806 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.67 -52.61 10.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 110.853 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.5 ' HB3' HG22 ' A' ' 5' ' ' THR . 43.5 mt-30 -84.95 114.59 22.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.984 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.712 HG23 HD11 ' B' ' 32' ' ' ILE . 3.7 m -93.02 137.16 23.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.093 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 35.8 mtt180 -76.02 104.28 6.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.348 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.97 HD12 HG23 ' B' ' 22' ' ' VAL . 12.8 mm -87.29 137.37 21.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.933 0.396 . . . . 0.0 111.37 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.9 121.77 6.32 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.373 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.592 ' HA ' HG13 ' B' ' 20' ' ' VAL . 15.0 t -118.08 103.64 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 0.0 111.426 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.35 107.58 19.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.233 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.03 144.85 22.77 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.799 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.801 ' HD2' HG12 ' B' ' 18' ' ' VAL . 93.0 Cg_endo -82.97 156.23 15.23 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.92 2.413 . . . . 0.0 111.979 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.81 42.67 1.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.218 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -113.26 -43.77 3.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.784 0.326 . . . . 0.0 110.971 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.445 HG12 ' N ' ' B' ' 41' ' ' SER . 5.1 t -83.46 160.93 3.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.769 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.445 ' N ' HG12 ' B' ' 40' ' ' VAL . 0.8 OUTLIER -59.71 99.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.758 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.455 HG13 ' O ' ' B' ' 42' ' ' VAL . 8.1 p -122.4 122.89 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.954 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.34 136.16 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.414 ' HD3' ' CD2' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -161.76 -165.19 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.754 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.6 OUTLIER -64.32 136.67 57.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.966 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' B' ' 50' ' ' ARG . 0.7 OUTLIER -54.97 -61.27 2.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 tt -55.98 -38.91 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.299 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.611 ' CD1' HD22 ' A' ' 4' ' ' LEU . 43.1 t80 -46.74 -61.99 1.59 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.645 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 0.0 OUTLIER -76.26 -21.29 56.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.455 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' B' ' 46' ' ' GLU . 7.0 tpt180 -73.73 -10.9 60.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.572 0.225 . . . . 0.0 111.565 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.425 HG13 ' N ' ' B' ' 52' ' ' GLN . 1.7 pt -114.35 -28.62 2.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.797 0.332 . . . . 0.0 111.166 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.425 ' N ' HG13 ' B' ' 51' ' ' ILE . 13.0 mm-40 -104.95 -54.39 2.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' B' ' 49' ' ' GLN . . . -62.11 -65.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.726 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -110.5 117.82 34.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.546 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' B' ' 57' ' ' GLN . 1.5 tptm -64.73 95.23 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.453 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.56 -69.05 0.14 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.718 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' B' ' 55' ' ' LYS . 0.3 OUTLIER 68.12 61.44 0.4 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.091 179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 70.25 129.16 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.04 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 55.0 p -161.65 122.55 2.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.727 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 95.5 p -91.81 127.31 37.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.073 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.906 179.988 . . . . . . . . 0 0 . 1 stop_ save_